data_1s6o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1s6o _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.08 148.11 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.24 0.616 . . . . 0.0 110.113 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 141.8 37.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 171.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 130.65 56.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.53 151.74 39.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.244 1.818 . . . . 0.0 108.842 -176.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -95.37 136.92 35.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.41 67.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -70.26 170.15 12.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.811 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 O-C-N 121.248 -0.908 . . . . 0.0 113.504 170.328 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.3 t -52.21 -43.59 64.33 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.9 m -46.43 -60.24 2.47 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.655 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -48.79 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -57.24 -63.87 1.08 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.975 0.893 . . . . 0.0 110.085 -174.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.56 -54.96 8.39 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.826 1.679 . . . . 0.0 112.778 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -56.83 -56.61 19.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.179 0.989 . . . . 0.0 109.7 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.86 -28.29 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 110.51 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.51 -24.41 7.46 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.757 1.17 . . . . 0.0 114.306 170.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -87.55 -11.16 49.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 119.826 1.813 . . . . 0.0 111.381 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 139.09 55.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.796 0.808 . . . . 0.0 110.77 -171.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 115.73 4.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.386 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.54 -19.75 23.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.576 -1.124 . . . . 0.0 112.445 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.84 139.19 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 118.853 1.326 . . . . 0.0 109.79 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.8 -39.05 3.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.659 1.184 . . . . 0.0 110.74 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -149.73 156.78 42.44 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.795 -0.566 . . . . 0.0 109.852 172.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -137.2 145.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.565 1.546 . . . . 0.0 108.204 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -138.44 114.85 10.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.719 1.607 . . . . 0.0 107.008 166.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -102.61 129.9 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.129 0.877 . . . . 0.0 109.995 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.1 t -115.89 86.65 2.52 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.505 1.122 . . . . 0.0 108.119 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -39.07 69.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.386 -0.34 . . . . 0.0 110.374 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.93 -58.51 2.74 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.01 1.324 . . . . 0.0 110.694 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -79.09 -10.2 59.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.789 0.804 . . . . 0.0 110.456 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.83 24.41 13.74 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.101 1.761 . . . . 0.0 109.552 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -142.83 157.94 44.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.681 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.13 155.99 40.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -171.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.7 m -128.82 121.87 29.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.0 mt -118.73 155.17 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.38 126.48 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -156.77 179.86 8.88 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.673 1.589 . . . . 0.0 109.536 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.86 142.43 45.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.11 74.71 2.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.16 3.24 . . . . 0.0 110.125 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.36 -57.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.137 1.375 . . . . 0.0 107.452 176.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.54 -19.85 30.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.144 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 tp -128.32 152.3 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 111.074 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -89.62 27.56 1.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.917 0.887 . . . . 0.0 112.783 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 t 72.28 -60.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 128.147 2.579 . . . . 0.0 109.501 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.4 -35.98 30.07 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.797 1.239 . . . . 0.0 109.873 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -46.55 -46.62 19.49 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.659 0.599 . . . . 0.0 110.89 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.25 -52.57 1.48 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.583 1.153 . . . . 0.0 113.159 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -46.13 63.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 109.801 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 4.3 mptp? -57.71 -29.09 64.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.452 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -63.53 -41.95 98.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.625 -0.672 . . . . 0.0 109.29 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.83 -44.99 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.389 174.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' ' 59' ' ' LYS . 74.8 mt-10 -53.28 -46.4 69.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.57 43.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.064 1.346 . . . . 0.0 113.495 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -64.04 -28.05 69.53 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.238 0.926 . . . . 0.0 110.459 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.39 -34.88 2.36 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.73 118.82 74.12 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.311 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.13 107.92 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.192 1.928 . . . . 0.0 109.089 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.95 -168.15 1.62 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.881 1.273 . . . . 0.0 108.394 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -164.15 161.05 22.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.908 -0.495 . . . . 0.0 111.755 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 110.378 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.08 148.11 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.24 0.616 . . . . 0.0 110.113 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 141.8 37.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 171.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 130.65 56.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.53 151.74 39.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.244 1.818 . . . . 0.0 108.842 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -95.37 136.92 35.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.41 67.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -70.26 170.15 12.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.811 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 O-C-N 121.248 -0.908 . . . . 0.0 113.504 170.328 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.3 t -52.21 -43.59 64.33 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.9 m -46.43 -60.24 2.47 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.655 169.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -48.79 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -57.24 -63.87 1.08 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.975 0.893 . . . . 0.0 110.085 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.56 -54.96 8.39 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.826 1.679 . . . . 0.0 112.778 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -56.83 -56.61 19.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.179 0.989 . . . . 0.0 109.7 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.86 -28.29 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 110.51 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.51 -24.41 7.46 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.757 1.17 . . . . 0.0 114.306 170.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -87.55 -11.16 49.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 119.826 1.813 . . . . 0.0 111.381 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 139.09 55.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.796 0.808 . . . . 0.0 110.77 -171.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 115.73 4.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.386 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.54 -19.75 23.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.576 -1.124 . . . . 0.0 112.445 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.84 139.19 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 118.853 1.326 . . . . 0.0 109.79 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.8 -39.05 3.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.659 1.184 . . . . 0.0 110.74 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -149.73 156.78 42.44 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.795 -0.566 . . . . 0.0 109.852 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -137.2 145.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.565 1.546 . . . . 0.0 108.204 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -138.44 114.85 10.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.719 1.607 . . . . 0.0 107.008 166.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -102.61 129.9 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.129 0.877 . . . . 0.0 109.995 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.1 t -115.89 86.65 2.52 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.505 1.122 . . . . 0.0 108.119 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -39.07 69.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.386 -0.34 . . . . 0.0 110.374 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.93 -58.51 2.74 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.01 1.324 . . . . 0.0 110.694 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -79.09 -10.2 59.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.789 0.804 . . . . 0.0 110.456 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.83 24.41 13.74 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.101 1.761 . . . . 0.0 109.552 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -142.83 157.94 44.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.681 -166.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.13 155.99 40.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -171.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.7 m -128.82 121.87 29.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.0 mt -118.73 155.17 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.38 126.48 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -156.77 179.86 8.88 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.673 1.589 . . . . 0.0 109.536 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.86 142.43 45.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.11 74.71 2.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.16 3.24 . . . . 0.0 110.125 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.36 -57.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.137 1.375 . . . . 0.0 107.452 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.54 -19.85 30.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.144 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 tp -128.32 152.3 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 111.074 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -89.62 27.56 1.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.917 0.887 . . . . 0.0 112.783 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 t 72.28 -60.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 128.147 2.579 . . . . 0.0 109.501 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.4 -35.98 30.07 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.797 1.239 . . . . 0.0 109.873 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -46.55 -46.62 19.49 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.659 0.599 . . . . 0.0 110.89 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.25 -52.57 1.48 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.583 1.153 . . . . 0.0 113.159 173.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -46.13 63.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 109.801 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 4.3 mptp? -57.71 -29.09 64.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.452 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -63.53 -41.95 98.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.625 -0.672 . . . . 0.0 109.29 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.83 -44.99 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.389 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' ' 59' ' ' LYS . 74.8 mt-10 -53.28 -46.4 69.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.57 43.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.064 1.346 . . . . 0.0 113.495 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -64.04 -28.05 69.53 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.238 0.926 . . . . 0.0 110.459 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.39 -34.88 2.36 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.73 118.82 74.12 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.311 -175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.13 107.92 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.192 1.928 . . . . 0.0 109.089 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.95 -168.15 1.62 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.881 1.273 . . . . 0.0 108.394 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -164.15 161.05 22.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.908 -0.495 . . . . 0.0 111.755 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 110.378 179.445 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.448 -0.572 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.64 133.83 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 123.99 0.916 . . . . 0.0 108.593 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tt -113.21 148.15 36.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.366 1.466 . . . . 0.0 108.21 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.97 123.02 46.97 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 161.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -115.44 163.05 16.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.233 1.013 . . . . 0.0 109.585 169.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -108.72 131.3 55.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.988 2.115 . . . . 0.0 106.408 170.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.05 60.32 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 126.523 1.929 . . . . 0.0 106.869 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -58.77 133.38 55.91 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.764 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.107 178.709 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.223 -0.337 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 p -53.43 -43.42 67.99 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.7 m -42.01 -62.53 0.9 Allowed 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.921 0.888 . . . . 0.0 112.19 165.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.99 -48.93 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 123.908 0.883 . . . . 0.0 108.932 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -57.25 -61.07 2.73 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.47 1.128 . . . . 0.0 109.332 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.76 -53.95 19.61 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.754 1.645 . . . . 0.0 112.308 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.5 -52.55 65.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.017 0.909 . . . . 0.0 110.068 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.3 mm -57.54 -31.82 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.708 1.203 . . . . 0.0 111.116 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.13 -18.87 10.0 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.753 -1.026 . . . . 0.0 114.227 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -86.81 -11.79 49.9 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.637 1.719 . . . . 0.0 111.095 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 135.82 45.85 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 122.269 1.033 . . . . 0.0 111.748 -170.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -57.74 110.37 0.88 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.85 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.13 -24.11 9.51 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 119.251 -0.749 . . . . 0.0 112.661 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 t -80.01 136.08 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 118.213 1.007 . . . . 0.0 109.245 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -107.14 -38.83 5.89 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.703 1.201 . . . . 0.0 110.442 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.59 167.34 30.42 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.218 -0.926 . . . . 0.0 110.62 172.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.9 tt -150.91 144.43 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.276 1.03 . . . . 0.0 108.561 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -129.58 129.62 44.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.898 1.679 . . . . 0.0 106.518 167.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.82 123.42 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.581 1.082 . . . . 0.0 110.982 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.5 t -81.25 158.98 24.63 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.107 0.563 . . . . 0.0 110.045 174.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.87 -67.93 0.83 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 163.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.08 -54.65 8.16 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 126.193 1.797 . . . . 0.0 110.678 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -77.64 -18.74 56.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.252 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 55.06 18.82 2.47 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 127.146 2.178 . . . . 0.0 111.409 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -101.05 152.12 20.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.596 1.558 . . . . 0.0 107.933 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.04 152.52 37.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.846 -0.534 . . . . 0.0 109.866 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 m -130.35 115.73 17.32 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -171.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.88 157.99 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.32 116.57 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 167.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -159.07 178.69 9.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.425 1.49 . . . . 0.0 109.549 -173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -138.97 149.62 62.25 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.31 75.52 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.229 3.286 . . . . 0.0 109.936 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.58 -57.0 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.259 1.423 . . . . 0.0 107.414 170.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.8 mt -90.25 -23.03 21.34 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.452 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 tp -121.68 149.06 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 119.083 0.856 . . . . 0.0 110.31 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 m -82.86 24.17 0.77 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 71.13 -65.74 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 128.737 2.815 . . . . 0.0 109.055 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -68.88 -39.85 79.55 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.434 1.094 . . . . 0.0 109.215 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -42.32 -54.19 3.86 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.403 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -49.86 10.75 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.583 0.753 . . . . 0.0 110.952 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -42.9 71.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.648 0.779 . . . . 0.0 111.422 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -56.23 -35.09 66.97 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.046 -1.033 . . . . 0.0 112.652 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -62.13 -42.28 99.08 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.66 -47.43 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 118.017 -0.992 . . . . 0.0 111.523 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -50.76 -49.27 58.49 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.149 1.341 . . . . 0.0 109.238 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.85 -19.07 48.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.28 1.832 . . . . 0.0 114.051 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mmm -61.33 -28.72 69.42 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.656 1.116 . . . . 0.0 110.15 169.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.02 38.86 0.55 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.051 1.31 . . . . 0.0 111.554 169.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -148.88 122.18 4.58 Favored Pre-proline 0 C--O 1.224 -0.28 0 CA-C-O 117.314 -1.326 . . . . 0.0 108.055 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.81 111.26 1.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.018 1.812 . . . . 0.0 109.452 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.17 -176.35 3.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -160.48 149.77 17.29 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 120.399 -1.438 . . . . 0.0 111.196 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -175.37 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.875 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.86 119.49 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 125.931 1.692 . . . . 0.0 111.28 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.67 131.3 56.99 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.229 1.012 . . . . 0.0 108.881 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.4 119.17 38.35 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.896 1.279 . . . . 0.0 110.495 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -113.34 153.24 28.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.766 1.226 . . . . 0.0 109.931 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.92 133.88 43.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 169.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.82 68.0 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.5 150.23 48.32 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.674 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 O-C-N 121.666 -0.646 . . . . 0.0 113.597 170.794 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.9 p . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.8 m -55.64 -38.5 69.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.22 -52.75 60.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.589 0.233 . . . . 0.0 110.678 171.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.11 -53.48 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.45 -61.31 2.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.078 0.942 . . . . 0.0 110.195 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.52 -55.57 7.88 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.719 1.628 . . . . 0.0 112.471 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.66 -48.76 75.93 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.37 1.085 . . . . 0.0 110.322 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.4 mm -59.46 -33.42 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.498 0.719 . . . . 0.0 110.171 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.8 -13.62 8.51 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.489 1.042 . . . . 0.0 114.073 172.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.13 -14.27 31.47 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.388 1.594 . . . . 0.0 109.936 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.41 137.33 52.66 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 122.655 1.217 . . . . 0.0 112.886 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -54.69 108.0 0.35 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.438 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.27 -24.65 9.14 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-O 118.67 -1.072 . . . . 0.0 111.992 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.9 135.36 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 118.579 1.19 . . . . 0.0 108.873 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -108.05 -42.35 4.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.658 1.583 . . . . 0.0 109.919 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -152.1 159.73 43.59 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.8 tt -143.25 152.48 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 108.495 172.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.49 110.99 5.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.743 2.017 . . . . 0.0 105.676 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.55 130.93 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.022 0.929 . . . . 0.0 109.376 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 t -117.23 90.37 3.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.15 -46.07 65.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -41.96 -58.83 1.93 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.626 1.17 . . . . 0.0 111.54 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -78.07 -7.41 56.91 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.836 0.827 . . . . 0.0 111.328 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 65.07 15.77 10.18 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 127.175 2.19 . . . . 0.0 110.7 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -132.53 154.55 49.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.824 1.649 . . . . 0.0 109.685 -166.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.02 165.57 30.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -134.87 126.76 29.39 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp -108.94 152.95 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 167.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.74 117.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -156.73 -179.42 8.17 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.945 1.298 . . . . 0.0 109.147 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -131.4 147.89 67.93 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.373 1.069 . . . . 0.0 112.915 173.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.25 73.04 2.14 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.977 3.118 . . . . 0.0 109.662 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.84 -62.28 0.29 Allowed 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.195 0.998 . . . . 0.0 108.803 175.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.8 mt -83.65 -24.14 31.5 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.604 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 tp -114.11 156.84 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.109 0.963 . . . . 0.0 109.207 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.85 17.49 1.51 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.04 0.536 . . . . 0.0 112.281 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 68.64 -59.63 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.941 2.096 . . . . 0.0 109.402 -165.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -88.57 -28.36 20.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.909 -167.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -40.81 -53.12 2.92 Favored 'General case' 0 C--N 1.343 0.321 0 O-C-N 124.069 0.856 . . . . 0.0 110.543 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -43.18 -67.96 0.23 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.586 1.154 . . . . 0.0 110.544 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -46.65 84.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.949 -0.469 . . . . 0.0 110.756 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -51.94 -32.67 34.09 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -69.2 -43.46 74.07 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.566 1.075 . . . . 0.0 109.327 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.96 -39.78 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.795 -0.621 . . . . 0.0 109.671 173.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.23 -55.31 36.45 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.928 0.785 . . . . 0.0 108.945 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.31 -30.56 51.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.332 1.853 . . . . 0.0 113.425 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 26.4 mmt -50.7 -35.78 32.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.065 0.848 . . . . 0.0 111.426 172.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.96 41.63 0.44 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.378 0.99 . . . . 0.0 111.648 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -145.95 126.63 7.23 Favored Pre-proline 0 C--O 1.223 -0.323 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.54 111.06 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.483 1.456 . . . . 0.0 109.052 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.79 -169.24 1.46 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -164.58 149.6 9.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.621 -0.674 . . . . 0.0 110.837 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.441 -0.918 0 CA-C-O 121.188 0.518 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.5 t -78.61 134.54 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 124.916 1.286 . . . . 0.0 108.679 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.42 129.13 44.29 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.37 130.87 42.0 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.042 0.937 . . . . 0.0 110.099 170.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -131.18 146.55 52.38 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.306 1.442 . . . . 0.0 108.786 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HZ1' ' CD ' ' A' ' 10' ' ' GLU . 3.0 mmtp -82.8 150.7 26.45 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.64 66.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.037 0.935 . . . . 0.0 108.707 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' ' 8' ' ' LYS . 6.0 mm-40 -62.53 158.75 17.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.763 -176.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.457 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 175.19 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.6 t -55.68 -39.99 71.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -168.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -49.31 -58.47 5.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.454 0.301 . . . . 0.0 111.716 168.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.07 -52.38 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -58.79 -62.38 1.91 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.766 0.793 . . . . 0.0 110.29 -172.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.16 -55.36 6.61 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.132 1.825 . . . . 0.0 112.534 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -60.64 -54.04 50.14 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.564 1.182 . . . . 0.0 109.776 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 mm -55.24 -33.8 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.196 0.999 . . . . 0.0 110.81 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.56 -23.13 9.09 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.035 1.302 . . . . 0.0 114.184 173.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -89.75 -12.59 38.9 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.589 1.694 . . . . 0.0 111.455 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.56 135.35 51.4 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.108 0.956 . . . . 0.0 110.84 -172.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -56.54 106.06 0.26 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.489 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.42 -26.44 6.64 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-O 119.054 -0.859 . . . . 0.0 112.225 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.03 132.03 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 118.476 1.138 . . . . 0.0 108.575 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -109.11 -31.02 7.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.695 0.798 . . . . 0.0 110.884 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -159.91 170.3 21.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.255 0.934 . . . . 0.0 110.475 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.2 tt -152.6 147.16 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.703 0.801 . . . . 0.0 109.867 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -136.98 106.8 6.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.025 1.73 . . . . 0.0 107.292 168.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.8 t -93.3 113.33 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 119.43 1.014 . . . . 0.0 109.55 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.88 73.18 1.75 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 tt -46.37 -50.39 16.56 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.397 1.079 . . . . 0.0 110.424 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.83 -53.98 2.19 Favored 'General case' 0 CA--C 1.523 -0.084 0 C-N-CA 125.827 1.651 . . . . 0.0 111.628 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.1 -16.11 58.28 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.57 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 70.25 8.51 6.67 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.977 2.111 . . . . 0.0 111.605 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -124.76 143.95 50.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.862 2.065 . . . . 0.0 107.889 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.71 157.2 42.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.431 1.092 . . . . 0.0 108.72 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 m -130.49 104.69 7.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.506 1.922 . . . . 0.0 107.151 -171.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.81 153.45 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.17 117.2 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.054 0.942 . . . . 0.0 109.753 168.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -158.71 178.81 9.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.654 1.182 . . . . 0.0 110.811 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.69 142.62 37.35 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 124.121 0.968 . . . . 0.0 112.208 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.43 75.06 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.871 3.048 . . . . 0.0 110.314 172.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -140.52 -54.55 0.51 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.4 mt -89.63 -22.69 22.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.261 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.1 tp -119.54 150.24 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.877 0.871 . . . . 0.0 110.003 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.2 m -86.26 29.13 0.77 Allowed 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.261 0.5 OUTLIER 74.02 -56.69 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.631 2.372 . . . . 0.0 111.14 175.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -85.38 -36.18 20.89 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.571 1.548 . . . . 0.0 109.749 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -42.89 -50.87 5.71 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 123.842 0.714 . . . . 0.0 110.972 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.91 -53.4 3.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 123.907 0.883 . . . . 0.0 112.113 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -45.63 61.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.304 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -55.09 -29.54 57.79 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -61.72 -43.18 99.36 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.745 0.702 . . . . 0.0 109.714 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.98 -49.35 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.626 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -51.92 -48.4 64.22 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.25 -19.95 56.84 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.06 1.744 . . . . 0.0 113.973 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.0 mmm -60.91 -34.08 74.12 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.74 1.155 . . . . 0.0 109.466 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.29 -33.33 2.01 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -75.39 119.39 76.78 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.026 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.53 117.32 4.51 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.21 1.94 . . . . 0.0 108.596 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.3 -172.37 2.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.857 0.463 . . . . 0.0 109.905 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.58 137.77 9.2 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.277 0 C-N-CA 125.348 1.459 . . . . 0.0 107.819 171.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.1 t -97.16 126.62 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 125.972 1.709 . . . . 0.0 110.632 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.82 153.56 20.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.363 1.865 . . . . 0.0 108.108 170.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -125.19 126.28 44.98 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.447 1.099 . . . . 0.0 109.08 163.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.7 ptp -121.07 161.84 21.03 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.715 1.606 . . . . 0.0 110.823 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -98.99 134.01 42.43 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.507 1.923 . . . . 0.0 108.577 165.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.4 t -116.3 71.01 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 126.369 1.867 . . . . 0.0 106.617 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -77.43 174.15 11.16 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.623 0.769 . . . . 0.0 110.745 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.838 0 CA-C-O 119.24 -0.756 . . . . 0.0 112.919 171.211 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.2 t -50.28 -42.32 52.15 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -46.55 -58.2 4.03 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.106 0.563 . . . . 0.0 111.626 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -58.57 -48.56 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 123.644 0.777 . . . . 0.0 109.727 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.07 -64.67 0.76 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 122.52 1.152 . . . . 0.0 110.485 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.9 -54.13 8.3 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.531 2.015 . . . . 0.0 112.244 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -54.79 43.17 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.967 0.883 . . . . 0.0 110.103 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.4 mm -59.14 -31.45 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.074 0.95 . . . . 0.0 110.91 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.05 -15.73 22.74 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.741 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -90.84 -11.43 39.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.627 1.714 . . . . 0.0 111.172 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.32 132.6 48.73 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.427 1.108 . . . . 0.0 111.068 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -57.97 107.98 0.53 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.299 172.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.08 -15.94 13.29 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.823 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 t -87.97 128.69 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 119.033 1.416 . . . . 0.0 109.426 -175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -83.62 -51.34 7.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.948 0.899 . . . . 0.0 110.282 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -158.42 167.97 28.24 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.616 0.643 . . . . 0.0 110.734 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.7 tt -142.49 140.26 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 125.591 1.557 . . . . 0.0 109.073 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -129.55 112.45 13.75 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.638 1.575 . . . . 0.0 107.414 168.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.21 108.82 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 C-N-CA 124.053 0.941 . . . . 0.0 109.6 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 m -82.42 113.74 20.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.18 179.71 0.19 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 158.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 67.54 -65.05 0.25 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 127.968 2.507 . . . . 0.0 109.498 -170.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.99 -22.96 66.49 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.247 1.019 . . . . 0.0 111.176 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 64.61 15.48 9.71 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.913 2.085 . . . . 0.0 111.91 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -120.38 132.31 55.21 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.786 1.234 . . . . 0.0 109.228 -169.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.32 150.29 47.28 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.735 0.814 . . . . 0.0 108.975 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.36 130.41 52.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.7 mt -126.7 158.34 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.88 122.68 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -158.64 179.79 8.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.93 1.292 . . . . 0.0 110.888 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -136.24 154.1 77.0 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 164.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.92 74.71 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.752 3.635 . . . . 0.0 109.958 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.01 -57.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.684 1.194 . . . . 0.0 108.081 170.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 mt -87.78 -28.03 21.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.809 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.2 tp -119.64 144.38 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 118.703 0.683 . . . . 0.0 109.882 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 m -81.57 31.05 0.35 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 72.24 -61.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 129.172 2.989 . . . . 0.0 110.166 176.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -82.81 -36.52 25.48 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.41 1.884 . . . . 0.0 109.355 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -42.06 -52.71 4.17 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.455 0.702 . . . . 0.0 111.055 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -36.48 -52.86 0.86 Allowed 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.712 2.005 . . . . 0.0 111.804 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.59 -38.55 65.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.29 1.036 . . . . 0.0 112.551 175.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -57.73 -33.17 68.15 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.632 -1.292 . . . . 0.0 112.548 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -62.66 -40.33 96.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -58.78 -46.32 90.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 117.919 -1.039 . . . . 0.0 111.75 170.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.97 -49.59 59.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.873 1.215 . . . . 0.0 108.031 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.89 -18.86 61.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.303 1.841 . . . . 0.0 114.207 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.7 mmm -62.14 -21.43 65.03 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.689 1.132 . . . . 0.0 110.532 168.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.71 34.57 2.03 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 125.238 1.399 . . . . 0.0 110.859 172.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -148.34 125.63 5.63 Favored Pre-proline 0 N--CA 1.456 -0.138 0 CA-C-O 117.764 -1.112 . . . . 0.0 108.395 -173.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.69 116.57 3.62 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.119 1.879 . . . . 0.0 110.372 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.13 -179.64 3.89 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.602 0.761 . . . . 0.0 109.465 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -162.9 149.12 12.36 Favored 'General case' 0 C--O 1.224 -0.265 0 O-C-N 120.323 -1.485 . . . . 0.0 111.809 -169.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.228 -0.056 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.1 t . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.1 t -77.4 141.26 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.637 1.575 . . . . 0.0 109.159 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -144.02 127.92 17.38 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 42' ' ' GLU . 2.5 mmmp? -89.73 134.18 34.3 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.544 1.137 . . . . 0.0 109.859 171.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.87 141.64 47.46 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.08 0.952 . . . . 0.0 110.824 176.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.26 136.13 35.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.25 84.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 171.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -76.63 173.71 11.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 122.088 0.947 . . . . 0.0 110.982 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.914 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.626 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t -54.69 -39.87 68.57 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -170.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 m -49.34 -55.67 12.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.576 0.35 . . . . 0.0 111.783 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.79 -50.69 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.614 0.766 . . . . 0.0 109.179 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -52.16 -66.11 0.44 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.942 0.877 . . . . 0.0 110.124 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.82 -54.92 8.72 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.529 2.014 . . . . 0.0 112.23 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.63 -55.26 37.36 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.12 0.96 . . . . 0.0 109.802 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 mm -59.58 -31.08 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 123.598 0.759 . . . . 0.0 110.445 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.84 -16.81 19.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.921 1.248 . . . . 0.0 113.921 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -89.1 -13.76 37.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.605 1.703 . . . . 0.0 110.632 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.32 133.08 43.76 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.468 1.128 . . . . 0.0 112.284 -172.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -55.58 108.72 0.46 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.58 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.62 -25.76 7.53 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 119.186 -0.785 . . . . 0.0 111.976 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.53 131.5 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -97.75 -47.19 5.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.181 0.992 . . . . 0.0 109.374 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -154.94 166.89 32.14 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.805 -0.559 . . . . 0.0 110.316 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 tt -153.38 142.92 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.187 0.995 . . . . 0.0 109.922 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -139.55 117.3 11.58 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.179 1.792 . . . . 0.0 106.937 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -112.84 105.69 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 119.875 1.216 . . . . 0.0 109.242 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -97.24 88.15 4.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.58 -43.92 62.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.291 0.636 . . . . 0.0 110.882 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.33 -54.21 1.45 Allowed 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 125.946 1.698 . . . . 0.0 110.924 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.03 -13.41 57.39 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.681 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 66.12 9.32 6.17 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.106 2.163 . . . . 0.0 111.506 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 6' ' ' LYS . 2.3 tt0 -129.67 155.86 45.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.581 1.952 . . . . 0.0 108.599 -172.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.26 155.94 49.37 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.146 0.978 . . . . 0.0 108.854 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.1 m -122.64 112.27 17.76 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.92 2.088 . . . . 0.0 105.557 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 mt -102.56 168.52 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.51 120.31 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -160.14 179.61 8.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.612 1.165 . . . . 0.0 110.917 -171.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.51 146.94 59.7 Favored Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -69.66 74.28 1.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.605 2.87 . . . . 0.0 109.507 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.94 -62.75 0.48 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.731 1.212 . . . . 0.0 108.249 172.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.1 mt -85.54 -21.25 28.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.992 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 54' ' ' VAL . 11.0 tp -125.02 144.79 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 118.616 0.644 . . . . 0.0 110.069 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 m -76.13 28.9 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' A' ' 52' ' ' ILE 0.272 0.5 OUTLIER 70.74 -53.1 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 128.979 2.912 . . . . 0.0 111.801 178.589 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -44.83 15.22 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 127.313 2.245 . . . . 0.0 109.705 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -43.51 -51.94 6.44 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.171 0.588 . . . . 0.0 110.742 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -29.39 -63.16 0.12 Allowed 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 126.86 2.064 . . . . 0.0 110.716 172.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -45.76 36.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -59.4 -19.68 49.05 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.401 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -43.82 97.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.861 0.755 . . . . 0.0 110.022 170.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.94 -48.83 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -54.37 -47.56 72.49 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.14 -22.12 64.39 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.229 1.412 . . . . 0.0 113.953 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -63.41 -28.49 70.02 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.208 1.367 . . . . 0.0 110.071 170.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.99 -32.93 2.91 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.683 1.135 . . . . 0.0 110.743 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -73.69 126.03 90.0 Favored Pre-proline 0 N--CA 1.455 -0.191 0 CA-C-O 118.602 -0.714 . . . . 0.0 109.311 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.45 113.72 2.59 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.912 1.741 . . . . 0.0 109.687 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.25 174.61 6.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.972 0.909 . . . . 0.0 108.614 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.9 127.56 6.64 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -174.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.311 0 C-N-CA 124.997 1.319 . . . . 0.0 109.574 172.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.9 t -78.61 140.54 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.953 1.301 . . . . 0.0 108.68 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.19 142.02 48.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.774 2.029 . . . . 0.0 106.536 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.52 124.25 51.45 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.139 0.976 . . . . 0.0 109.122 173.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.7 ptm -117.91 155.01 30.93 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.98 1.312 . . . . 0.0 110.317 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.33 133.44 37.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 172.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.63 64.33 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.228 1.011 . . . . 0.0 109.004 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.92 166.19 16.17 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.986 0.898 . . . . 0.0 111.293 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 O-C-N 121.738 -0.601 . . . . 0.0 113.05 175.349 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p . . . . . 0 C--O 1.22 -0.459 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -44.87 -41.09 6.8 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -49.82 -58.95 4.35 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.259 0.552 . . . . 0.0 111.061 168.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.85 -46.37 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.091 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -53.07 -65.24 0.59 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.425 1.466 . . . . 0.0 110.177 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.25 -55.12 6.83 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.467 1.508 . . . . 0.0 112.027 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -56.6 -53.17 60.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.795 0.797 . . . . 0.0 110.535 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.8 mm -61.49 -28.38 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.526 1.131 . . . . 0.0 110.479 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.92 -20.78 6.64 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.923 -0.932 . . . . 0.0 114.271 169.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -87.92 -14.86 38.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.89 1.845 . . . . 0.0 111.259 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 136.21 53.04 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 122.269 1.033 . . . . 0.0 111.668 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -57.68 111.25 1.07 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.532 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.97 -22.12 12.8 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 123.9 0.762 . . . . 0.0 112.757 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.2 132.58 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 118.122 0.961 . . . . 0.0 108.944 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -97.36 -47.33 5.74 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.643 1.177 . . . . 0.0 109.751 171.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -153.91 163.79 39.47 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.361 -0.837 . . . . 0.0 110.616 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 tt -146.2 136.75 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.299 1.439 . . . . 0.0 109.098 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.78 104.69 6.43 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.834 1.653 . . . . 0.0 107.592 168.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.0 t -100.96 126.91 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 124.371 1.068 . . . . 0.0 109.993 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 m -114.5 93.76 4.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.12 0.968 . . . . 0.0 109.301 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.39 -49.74 6.97 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.466 1.106 . . . . 0.0 109.496 169.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.85 -58.87 2.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.677 1.591 . . . . 0.0 111.428 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.93 -14.69 59.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.55 -172.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 70.33 3.5 4.47 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.05 2.14 . . . . 0.0 111.81 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -119.16 157.86 27.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.563 1.945 . . . . 0.0 108.651 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.36 155.1 48.85 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.642 0.777 . . . . 0.0 109.564 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 m -124.99 116.81 22.74 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.4 mt -121.08 159.78 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.28 117.98 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.39 0.996 . . . . 0.0 110.019 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -161.21 -178.93 7.04 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.459 1.104 . . . . 0.0 111.457 -172.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.72 146.8 63.5 Favored Pre-proline 0 N--CA 1.467 0.376 0 C-N-CA 124.898 1.279 . . . . 0.0 113.946 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.26 69.44 2.52 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 124.121 3.214 . . . . 0.0 109.896 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.62 -63.96 0.36 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.11 0.964 . . . . 0.0 108.969 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.2 mt -79.72 -21.85 44.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.862 -0.59 . . . . 0.0 110.426 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 54' ' ' VAL . 8.6 tp -124.83 145.12 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 118.507 0.594 . . . . 0.0 109.955 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -80.64 29.62 0.31 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.814 0.845 . . . . 0.0 112.975 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 52' ' ' ILE . 0.5 OUTLIER 74.64 -56.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 128.46 2.704 . . . . 0.0 111.095 173.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.63 -40.67 20.46 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.213 1.805 . . . . 0.0 109.477 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -41.24 -53.15 3.26 Favored 'General case' 0 C--N 1.346 0.44 0 O-C-N 124.183 0.927 . . . . 0.0 110.837 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.71 -60.96 0.29 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.165 1.786 . . . . 0.0 111.053 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -41.95 68.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.092 0.957 . . . . 0.0 111.005 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -56.33 -28.28 58.43 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -64.79 -41.83 95.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.733 -0.604 . . . . 0.0 109.672 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -63.46 -49.18 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.449 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -53.39 -46.86 69.84 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.73 -20.53 49.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.555 1.542 . . . . 0.0 114.179 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.2 mmm -63.18 -30.18 71.38 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.777 1.171 . . . . 0.0 109.865 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.55 -32.25 2.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -79.85 116.57 62.04 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-O 117.819 -1.086 . . . . 0.0 108.468 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.25 123.81 12.78 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.765 1.643 . . . . 0.0 108.42 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.35 -165.74 1.02 Allowed 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 122.764 0.426 . . . . 0.0 110.271 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -162.42 138.34 7.42 Favored 'General case' 0 CA--C 1.522 -0.097 0 O-C-N 121.487 -0.758 . . . . 0.0 111.315 176.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 CA--C 1.531 0.223 0 C-N-CA 124.468 1.107 . . . . 0.0 108.677 173.206 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.63 134.34 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 123.775 0.83 . . . . 0.0 110.692 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.83 139.29 54.11 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 172.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -108.46 123.2 48.51 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.0 ptm -116.07 167.9 10.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.35 1.06 . . . . 0.0 109.957 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -114.31 134.24 55.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.485 2.314 . . . . 0.0 106.86 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 t -124.99 62.4 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.309 1.843 . . . . 0.0 107.686 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.88 145.45 46.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.28 0.562 . . . . 0.0 111.724 -170.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 178.043 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p . . . . . 0 C--O 1.217 -0.627 0 CA-C-O 118.043 -0.98 . . . . 0.0 113.518 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t -36.86 -42.96 0.42 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.112 1.365 . . . . 0.0 113.501 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.15 -57.06 11.74 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.46 0.704 . . . . 0.0 111.273 171.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.41 -48.86 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.214 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -56.21 -59.37 5.04 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 119.936 1.244 . . . . 0.0 110.79 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -41.38 -56.93 3.31 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.852 1.692 . . . . 0.0 112.158 170.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -57.2 -53.41 58.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.014 0.907 . . . . 0.0 110.506 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.1 mm -59.65 -28.04 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 125.158 1.383 . . . . 0.0 110.704 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.83 -19.2 9.81 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.735 -1.036 . . . . 0.0 114.299 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -88.18 -9.99 51.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.859 1.829 . . . . 0.0 111.333 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.8 136.22 46.99 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.172 0.987 . . . . 0.0 111.594 -171.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.78 113.86 2.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.078 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.26 -16.99 31.99 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-O 119.136 -0.813 . . . . 0.0 112.903 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 t -79.32 130.14 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 118.238 1.019 . . . . 0.0 108.581 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -97.05 -49.14 5.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.439 1.096 . . . . 0.0 109.47 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -152.81 170.54 20.05 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.625 -0.672 . . . . 0.0 110.673 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 tt -144.11 149.24 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.619 1.168 . . . . 0.0 109.407 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -143.55 98.44 3.25 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.141 2.176 . . . . 0.0 107.711 169.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.2 t -99.62 128.24 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.554 1.142 . . . . 0.0 109.013 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 t -103.51 110.03 21.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.329 0.652 . . . . 0.0 110.602 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.37 158.36 20.73 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 71.36 -55.82 0.65 Allowed 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 129.069 2.948 . . . . 0.0 109.926 -174.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.01 -29.28 70.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.841 -174.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 64.61 16.07 10.08 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.19 2.196 . . . . 0.0 112.471 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -107.18 139.3 41.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.64 156.3 45.67 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.794 -0.566 . . . . 0.0 110.105 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.9 m -130.46 125.8 35.33 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.2 mt -118.33 153.25 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.62 120.84 65.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -157.71 -179.67 8.37 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 125.395 1.478 . . . . 0.0 109.628 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -140.75 151.85 64.2 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 123.221 0.609 . . . . 0.0 112.515 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -82.02 64.37 8.41 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.949 3.1 . . . . 0.0 108.684 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.52 -61.1 1.03 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.023 1.329 . . . . 0.0 107.474 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.2 mt -88.33 -20.71 25.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.666 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 tp -120.7 145.08 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 119.205 0.911 . . . . 0.0 110.488 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -83.96 28.32 0.61 Allowed 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 71.39 -60.07 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 128.867 2.867 . . . . 0.0 110.545 176.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -74.54 -41.11 61.17 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.804 1.242 . . . . 0.0 108.491 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -42.81 -49.86 5.71 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 123.277 0.631 . . . . 0.0 111.551 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.74 -53.74 4.4 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.859 0.864 . . . . 0.0 111.126 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.49 -44.91 77.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 122.087 -0.383 . . . . 0.0 110.761 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -54.04 -33.91 58.63 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.937 -0.477 . . . . 0.0 112.094 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -64.14 -42.67 96.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.43 0.692 . . . . 0.0 109.564 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.01 -46.83 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.791 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -51.67 -49.96 61.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.897 1.226 . . . . 0.0 108.674 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.86 -19.82 31.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.283 1.833 . . . . 0.0 114.27 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.1 mmm -61.82 -31.28 71.5 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.63 1.105 . . . . 0.0 110.214 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.7 39.48 0.57 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.544 1.069 . . . . 0.0 111.461 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -145.45 125.78 7.21 Favored Pre-proline 0 C--O 1.225 -0.217 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.98 107.81 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.19 1.927 . . . . 0.0 109.611 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.56 -177.59 3.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -175.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -163.49 156.1 18.19 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.121 -0.987 . . . . 0.0 111.612 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.4 t . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -178.094 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.9 t . . . . . 0 C--O 1.234 0.249 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.15 132.12 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.379 1.472 . . . . 0.0 109.957 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.56 157.85 32.72 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.371 1.469 . . . . 0.0 109.621 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -119.05 123.56 44.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.436 1.094 . . . . 0.0 108.581 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -122.79 144.66 49.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.077 1.351 . . . . 0.0 110.474 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -87.96 133.14 34.0 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.328 2.251 . . . . 0.0 108.313 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.35 65.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 126.959 2.104 . . . . 0.0 107.966 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -71.77 153.83 41.71 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.822 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.846 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.821 173.446 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -57.93 -37.28 73.81 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -166.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.8 m -51.54 -54.15 30.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.724 0.297 . . . . 0.0 111.541 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -59.25 -49.5 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -53.28 -65.06 0.63 Allowed 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 122.322 1.058 . . . . 0.0 110.4 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.56 -42.71 44.57 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.197 1.856 . . . . 0.0 113.364 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -68.67 -61.23 1.91 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.934 1.367 . . . . 0.0 109.593 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.06 -41.49 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.621 1.169 . . . . 0.0 110.37 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.73 -21.55 29.74 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.406 1.479 . . . . 0.0 113.633 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -91.35 -15.44 29.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.076 1.438 . . . . 0.0 110.836 177.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.34 134.14 52.91 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.537 1.16 . . . . 0.0 111.508 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -50.35 107.77 0.18 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.255 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.42 -29.08 5.8 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.958 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.1 t -79.45 137.25 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 118.353 1.077 . . . . 0.0 109.167 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -102.34 -43.35 5.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.039 1.335 . . . . 0.0 110.642 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -158.61 162.5 37.31 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.41 -0.806 . . . . 0.0 110.151 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 tt -144.43 141.32 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.625 1.57 . . . . 0.0 109.192 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -129.34 121.7 28.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.513 1.925 . . . . 0.0 107.046 164.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.3 t -107.47 109.02 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 119.93 1.241 . . . . 0.0 110.052 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.7 t -90.79 91.63 8.45 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.693 0.759 . . . . 0.0 109.324 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.61 166.62 0.88 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.656 163.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 66.48 -56.42 0.39 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 128.338 2.655 . . . . 0.0 110.45 -165.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -64.81 -30.27 71.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.214 1.007 . . . . 0.0 109.88 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 68.73 25.27 6.42 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 127.812 2.445 . . . . 0.0 110.255 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -125.03 127.26 46.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.714 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.1 145.45 49.25 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.061 0.945 . . . . 0.0 109.515 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.71 120.3 31.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -176.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.2 mt -128.1 157.54 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -173.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.4 p -125.32 127.81 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -155.85 176.2 12.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 110.528 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.09 145.61 54.73 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.627 1.171 . . . . 0.0 113.192 172.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -72.32 75.86 2.33 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.409 3.406 . . . . 0.0 109.887 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.05 -55.42 0.11 Allowed 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.831 -0.543 . . . . 0.0 109.902 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.14 -24.61 27.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.607 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.4 tp -124.82 145.08 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.295 0.638 . . . . 0.0 110.206 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.57 23.74 0.12 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 75.4 -53.77 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.24 1.816 . . . . 0.0 110.194 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -95.64 -33.82 12.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.151 2.18 . . . . 0.0 110.169 -172.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -42.32 -53.31 4.22 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.035 0.934 . . . . 0.0 110.532 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -37.72 -57.74 0.96 Allowed 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 126.183 1.793 . . . . 0.0 111.96 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.38 -42.76 61.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.992 0.917 . . . . 0.0 111.656 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.43 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 5.2 mptp? -50.69 -29.47 11.3 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.148 -0.97 . . . . 0.0 113.208 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -62.68 -35.99 81.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -69.7 -46.24 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 123.682 0.793 . . . . 0.0 109.099 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.43 ' CD ' ' HZ1' ' A' ' 59' ' ' LYS . 92.0 mt-10 -51.09 -49.34 60.86 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.01 -20.16 62.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.426 1.491 . . . . 0.0 114.041 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 81.3 mmm -63.99 -28.45 69.82 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.886 1.221 . . . . 0.0 109.874 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.41 -33.13 2.71 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.434 1.016 . . . . 0.0 110.957 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -80.85 119.06 75.05 Favored Pre-proline 0 N--CA 1.455 -0.18 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.169 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.8 120.71 8.19 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.873 1.716 . . . . 0.0 109.52 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.68 177.85 5.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.562 1.545 . . . . 0.0 108.562 -176.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.93 158.65 35.39 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 122.924 0.49 . . . . 0.0 111.218 -173.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.9 t -87.21 124.9 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.115 2.166 . . . . 0.0 110.299 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.26 142.69 41.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.623 1.169 . . . . 0.0 109.401 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 123.49 48.66 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.416 1.486 . . . . 0.0 108.95 170.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.7 ptm -125.96 134.75 51.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.067 1.347 . . . . 0.0 111.468 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 129.38 39.08 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 t -112.02 73.83 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.03 164.77 10.02 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.784 0.802 . . . . 0.0 111.101 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.102 0 O-C-N 121.629 -0.669 . . . . 0.0 112.589 177.415 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.0 p . . . . . 0 C--O 1.223 -0.321 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.8 t -56.85 -38.8 73.19 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -168.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.8 m -47.51 -60.39 2.56 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.654 167.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.55 -48.95 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -56.83 -68.0 0.26 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.875 0.845 . . . . 0.0 111.663 -177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.63 -48.93 22.5 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.735 1.636 . . . . 0.0 111.834 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -63.72 -55.49 22.9 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 117.945 0.872 . . . . 0.0 110.312 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.8 mm -50.67 -41.35 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.93 0.892 . . . . 0.0 110.436 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.07 -22.75 13.95 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.953 1.739 . . . . 0.0 114.138 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -94.31 -20.78 19.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 118.892 1.346 . . . . 0.0 110.492 177.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 134.21 50.69 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 122.727 1.251 . . . . 0.0 111.68 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -53.62 113.68 1.27 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.088 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.62 -26.39 7.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 118.269 -1.295 . . . . 0.0 112.141 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.99 140.44 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 118.926 1.363 . . . . 0.0 109.457 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -103.61 -41.16 6.04 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.598 167.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -159.72 163.34 34.81 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.529 -0.732 . . . . 0.0 109.941 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.4 tt -147.38 148.71 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 124.952 1.301 . . . . 0.0 108.946 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 102.74 4.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.907 1.683 . . . . 0.0 107.861 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -91.23 133.42 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.61 1.164 . . . . 0.0 108.894 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 t -122.49 102.63 8.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.045 0.938 . . . . 0.0 110.52 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.63 -58.24 7.88 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.641 0.777 . . . . 0.0 110.758 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -42.24 -54.46 3.69 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.218 1.407 . . . . 0.0 110.942 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.26 -19.21 51.17 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.938 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 65.88 18.88 11.22 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.205 2.202 . . . . 0.0 110.996 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.29 163.57 20.46 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.249 2.22 . . . . 0.0 108.431 -171.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.15 133.65 17.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.064 0.545 . . . . 0.0 109.839 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.1 m -106.47 100.94 10.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.5 mt -90.75 165.66 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.1 t -139.67 120.41 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -157.14 176.17 13.09 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.706 0.802 . . . . 0.0 111.757 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -122.81 139.91 32.2 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -69.61 84.0 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.245 3.296 . . . . 0.0 109.574 174.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -168.43 -61.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.0 mt -82.16 -25.92 33.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.219 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.2 tp -117.79 161.2 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 123.501 0.721 . . . . 0.0 110.423 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 m -93.86 26.79 3.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.219 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 70.11 -59.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 129.406 3.082 . . . . 0.0 110.49 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.91 -32.49 40.19 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.444 1.498 . . . . 0.0 109.562 -175.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -49.44 -48.75 47.2 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 5.4 mtt -44.93 -53.5 7.56 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.213 0.605 . . . . 0.0 111.512 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.406 ' CE ' ' HD2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -72.47 -36.61 68.51 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.559 -0.713 . . . . 0.0 112.569 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.406 ' HD2' ' CE ' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -61.29 -31.68 71.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 120.535 -1.353 . . . . 0.0 110.835 176.087 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -35.14 80.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.9 -47.25 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.003 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -50.96 -48.73 60.92 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.37 0.986 . . . . 0.0 108.697 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.05 -21.72 46.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.457 1.103 . . . . 0.0 113.664 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.9 mmt -66.91 -28.03 67.98 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.553 1.069 . . . . 0.0 110.786 172.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.62 -33.38 3.0 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.759 1.171 . . . . 0.0 110.731 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -78.36 115.56 52.14 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.19 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -62.27 121.83 10.01 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.695 1.596 . . . . 0.0 109.146 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.95 163.77 26.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.662 0.785 . . . . 0.0 109.039 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.28 140.34 21.12 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 125.211 1.405 . . . . 0.0 109.588 -156.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.333 -0.15 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.57 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.27 124.29 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 125.579 1.552 . . . . 0.0 108.954 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.1 tp -107.57 143.21 36.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.358 1.863 . . . . 0.0 107.144 169.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -111.6 120.71 43.01 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 164.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.0 ptm -111.57 162.51 15.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.709 1.203 . . . . 0.0 109.909 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' NZ ' ' OE1' ' A' ' 10' ' ' GLU . 3.0 mmtp -97.2 125.88 42.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.506 1.523 . . . . 0.0 108.748 168.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 t -116.73 72.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 126.693 1.997 . . . . 0.0 106.83 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS 0.271 3.6 pt-20 -82.48 176.77 9.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.33 0.652 . . . . 0.0 111.657 177.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.127 0 O-C-N 121.541 -0.724 . . . . 0.0 112.006 -175.929 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.5 p . . . . . 0 C--O 1.222 -0.377 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 m -55.79 -38.78 70.4 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -167.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.84 -53.69 48.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 171.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.04 -53.03 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -56.71 -65.06 0.68 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.804 0.811 . . . . 0.0 110.069 -174.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.26 -52.66 17.64 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.323 1.916 . . . . 0.0 112.238 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.38 -52.78 63.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.106 0.953 . . . . 0.0 109.864 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.0 mm -58.77 -30.82 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 123.176 0.59 . . . . 0.0 111.203 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.11 -20.39 27.62 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.886 1.232 . . . . 0.0 113.6 174.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.8 -9.94 47.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.368 1.584 . . . . 0.0 110.96 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.44 133.11 48.93 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.354 1.073 . . . . 0.0 110.764 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -54.66 104.89 0.13 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.807 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.18 -26.94 5.71 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 118.991 -0.894 . . . . 0.0 113.102 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.6 t -79.69 131.84 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 118.483 1.141 . . . . 0.0 110.042 -172.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -98.36 -47.31 5.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.528 1.531 . . . . 0.0 110.022 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -151.33 167.36 28.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.253 0.478 . . . . 0.0 110.191 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.8 tt -149.61 143.97 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.069 1.348 . . . . 0.0 109.439 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -130.19 122.69 28.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.309 2.244 . . . . 0.0 105.865 167.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.1 t -117.81 103.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 120.279 1.4 . . . . 0.0 109.52 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 m -85.21 99.45 11.11 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 mt -53.84 170.26 0.13 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.902 158.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 67.59 -60.6 0.38 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 127.991 2.516 . . . . 0.0 110.417 -171.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -24.86 67.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.574 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 65.55 23.12 11.79 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.469 1.908 . . . . 0.0 111.182 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -119.76 135.24 54.93 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.809 0.844 . . . . 0.0 109.706 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.12 152.85 51.02 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 m -129.38 120.71 26.01 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.136 1.774 . . . . 0.0 106.482 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.57 154.34 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.52 119.05 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -158.0 -179.69 8.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.825 1.25 . . . . 0.0 109.163 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -133.12 146.06 59.5 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.15 75.05 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 124.414 3.409 . . . . 0.0 109.983 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.99 -60.03 0.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.804 1.242 . . . . 0.0 107.991 172.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -80.67 -27.47 37.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.064 -0.493 . . . . 0.0 110.464 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.4 tp -122.23 144.16 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.739 0.816 . . . . 0.0 109.99 -175.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.2 m -77.29 23.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 72.12 -63.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 128.602 2.761 . . . . 0.0 109.095 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -42.08 74.33 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.019 0.928 . . . . 0.0 108.819 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -38.9 -60.17 0.88 Allowed 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.075 0.95 . . . . 0.0 110.935 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -36.58 -57.05 0.79 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.811 1.644 . . . . 0.0 111.627 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -40.86 69.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.395 0.678 . . . . 0.0 111.705 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -60.42 -26.02 66.39 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 120.986 -1.071 . . . . 0.0 112.789 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -62.81 -37.75 88.0 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.6 mp -63.9 -45.05 98.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 117.55 -1.214 . . . . 0.0 111.528 173.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -49.87 -49.98 47.41 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.44 1.473 . . . . 0.0 108.304 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.07 -20.25 51.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.672 1.189 . . . . 0.0 113.848 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.5 mmt -65.19 -25.94 67.94 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.481 1.037 . . . . 0.0 110.58 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.68 -27.71 4.34 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.446 1.022 . . . . 0.0 111.197 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -86.37 123.0 71.97 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.51 130.74 30.99 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 N-CA-C 108.632 -1.334 . . . . 0.0 108.632 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.42 -176.53 3.61 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.364 0.666 . . . . 0.0 109.276 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.97 151.02 30.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.119 -0.988 . . . . 0.0 110.864 -175.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.164 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.3 t . . . . . 0 C--O 1.233 0.187 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.1 t -85.3 133.71 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 125.748 1.619 . . . . 0.0 109.624 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -124.05 146.19 48.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.696 1.599 . . . . 0.0 108.673 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.81 113.82 26.88 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.198 1.799 . . . . 0.0 109.133 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.4 mtt -109.2 131.53 54.98 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.738 0.815 . . . . 0.0 109.88 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -78.23 119.11 21.13 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 167.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.52 85.14 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.85 -175.35 3.03 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.543 0.737 . . . . 0.0 109.431 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.098 0 O-C-N 121.371 -0.831 . . . . 0.0 113.356 175.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.15 -38.93 68.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -168.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.6 m -48.84 -60.85 2.41 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.404 168.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.9 -50.57 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -58.65 -63.5 1.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.391 1.091 . . . . 0.0 109.153 -172.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.51 -56.59 6.29 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.99 1.757 . . . . 0.0 112.731 173.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -57.1 -52.59 64.67 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.114 0.957 . . . . 0.0 110.017 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.6 -27.43 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 123.718 0.807 . . . . 0.0 110.686 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.82 -19.95 11.81 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.069 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -85.79 -14.24 45.76 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.592 1.696 . . . . 0.0 110.146 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 132.63 48.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 122.438 1.114 . . . . 0.0 111.699 -172.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -57.78 107.03 0.41 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.25 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.38 -22.43 8.36 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.194 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.3 t -78.28 127.89 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 118.709 1.255 . . . . 0.0 108.841 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -89.67 -50.27 6.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.299 1.04 . . . . 0.0 108.77 172.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -154.25 160.89 42.03 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 118.988 0.813 . . . . 0.0 110.448 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 tt -141.77 142.27 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.623 1.569 . . . . 0.0 109.719 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -145.54 113.11 6.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.392 1.477 . . . . 0.0 107.753 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.9 t -113.0 92.47 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.47 1.508 . . . . 0.0 110.299 -172.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.1 m -82.13 78.59 8.79 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 124.171 0.988 . . . . 0.0 110.613 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.2 -42.04 28.9 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.312 0.645 . . . . 0.0 111.856 174.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -42.48 -51.86 4.88 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 125.94 1.696 . . . . 0.0 110.471 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -81.19 -13.66 58.36 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.15 -173.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 64.18 35.01 10.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 126.995 2.118 . . . . 0.0 109.572 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -156.15 144.45 19.92 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 125.434 1.709 . . . . 0.0 109.966 -166.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.5 157.91 41.38 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.402 1.081 . . . . 0.0 110.224 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 m -139.49 121.01 15.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.7 mt -124.9 162.89 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.079 1.351 . . . . 0.0 108.44 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 p -132.79 127.31 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 174.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -155.84 177.95 10.82 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.601 1.16 . . . . 0.0 108.818 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -126.25 142.41 42.66 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.314 1.046 . . . . 0.0 113.122 171.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.96 72.12 3.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.878 3.719 . . . . 0.0 110.402 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.68 -56.65 0.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.175 0.99 . . . . 0.0 108.605 172.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.38 -31.09 37.87 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tp -118.64 144.1 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 123.464 0.705 . . . . 0.0 109.668 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 m -81.95 27.81 0.45 Allowed 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -173.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 69.84 -64.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 129.582 3.153 . . . . 0.0 109.284 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -72.97 -39.6 65.99 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.48 1.112 . . . . 0.0 108.647 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -40.7 -55.94 2.27 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.43 1.092 . . . . 0.0 111.574 -173.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.13 -60.73 0.85 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.554 1.142 . . . . 0.0 110.082 177.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -32.98 70.89 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.093 -176.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -64.54 -29.55 70.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 119.194 -2.191 . . . . 0.0 111.537 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -63.32 -44.15 95.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.13 -43.5 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.908 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -55.25 -54.15 47.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.771 1.169 . . . . 0.0 107.978 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.15 -27.73 64.05 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.816 1.646 . . . . 0.0 114.174 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.9 mmt -52.63 -28.77 22.82 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.362 0.983 . . . . 0.0 111.187 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.87 39.98 0.62 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 124.641 1.115 . . . . 0.0 110.908 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -149.07 119.22 4.05 Favored Pre-proline 0 N--CA 1.457 -0.093 0 CA-C-O 117.995 -1.002 . . . . 0.0 108.438 -175.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.48 109.87 1.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.905 1.737 . . . . 0.0 109.597 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.9 -168.36 1.31 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.949 1.3 . . . . 0.0 108.449 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -163.44 152.56 14.49 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.117 0.967 . . . . 0.0 110.504 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 64.2 t . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 170.39 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.32 121.3 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.657 1.983 . . . . 0.0 108.688 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.7 tp -112.22 119.31 37.93 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.134 0.574 . . . . 0.0 110.553 171.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.07 126.97 36.31 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.957 1.303 . . . . 0.0 109.552 170.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -132.37 157.79 43.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.975 1.31 . . . . 0.0 109.702 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 133.91 36.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 t -128.98 79.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.957 1.303 . . . . 0.0 108.448 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.66 147.18 29.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.865 0 CA-C-O 119.307 -0.718 . . . . 0.0 113.569 170.98 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.224 -0.278 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -53.01 -39.15 62.92 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -170.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.3 m -51.29 -57.9 7.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 O-C-N 123.291 0.369 . . . . 0.0 111.587 170.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.4 -51.36 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.5 -61.78 2.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.091 0.948 . . . . 0.0 110.229 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.15 -54.17 13.12 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.948 1.737 . . . . 0.0 112.391 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -59.37 -52.36 65.96 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.111 0.955 . . . . 0.0 110.541 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.2 mm -57.22 -36.8 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 123.834 0.854 . . . . 0.0 110.143 177.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.12 -20.13 33.9 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.844 1.212 . . . . 0.0 114.137 172.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -84.88 -27.44 26.67 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.477 1.638 . . . . 0.0 109.99 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.22 139.34 52.25 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.443 1.116 . . . . 0.0 112.722 -168.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -53.8 115.11 1.82 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.051 1.34 . . . . 0.0 111.52 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.72 -28.57 6.4 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 124.064 0.84 . . . . 0.0 112.053 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.68 141.38 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 117.468 0.634 . . . . 0.0 110.051 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -121.1 -21.61 6.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.4 1.08 . . . . 0.0 111.811 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -160.41 164.63 32.17 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.398 0.999 . . . . 0.0 109.706 172.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 tt -155.5 143.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 123.91 0.884 . . . . 0.0 108.655 174.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.28 113.71 10.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.284 1.833 . . . . 0.0 106.527 171.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -100.34 103.13 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.229 0.922 . . . . 0.0 109.606 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -74.0 73.29 1.67 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.303 1.041 . . . . 0.0 110.267 175.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.66 161.07 0.37 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.426 1.49 . . . . 0.0 109.772 167.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 65.46 -53.5 0.35 Allowed 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 128.042 2.537 . . . . 0.0 110.952 -162.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -67.59 -23.36 65.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -172.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 68.95 26.62 5.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.987 2.115 . . . . 0.0 111.864 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -117.82 150.04 39.82 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.59 1.556 . . . . 0.0 106.876 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.03 159.9 43.42 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.295 -0.878 . . . . 0.0 109.564 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 m -132.6 106.32 7.74 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.713 1.605 . . . . 0.0 107.399 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 mt -90.08 163.16 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.45 117.86 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.153 1.381 . . . . 0.0 108.325 168.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -157.48 -178.2 7.16 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.31 1.444 . . . . 0.0 110.846 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -132.02 144.75 54.47 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.398 1.479 . . . . 0.0 113.86 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.22 68.88 4.1 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.752 3.635 . . . . 0.0 110.025 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.19 -57.06 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.541 1.136 . . . . 0.0 108.771 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.1 -20.52 37.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.65 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.1 tp -127.88 150.61 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 123.128 0.571 . . . . 0.0 110.475 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.6 m -79.46 25.02 0.33 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -176.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 71.3 -61.48 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.952 2.501 . . . . 0.0 108.889 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.08 -38.31 61.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.887 -174.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -45.95 -51.24 13.69 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.819 0.736 . . . . 0.0 111.981 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.78 -54.61 6.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.225 1.01 . . . . 0.0 111.71 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -64.64 -49.38 71.25 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.652 -0.655 . . . . 0.0 110.653 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -65.62 -24.94 67.17 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.228 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -62.4 -47.49 83.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.41 -45.85 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -58.08 -49.67 76.1 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.64 -26.81 65.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.391 1.476 . . . . 0.0 113.442 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.0 mmm -54.88 -32.95 61.42 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.626 1.103 . . . . 0.0 110.387 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.6 -42.71 0.79 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -75.6 111.21 13.2 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.353 -171.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.81 110.3 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.169 1.913 . . . . 0.0 109.161 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.37 -167.16 1.27 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.192 1.397 . . . . 0.0 108.813 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.98 134.78 5.14 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.296 0.953 . . . . 0.0 113.025 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 C--N 1.338 0.093 0 C-N-CA 123.399 0.68 . . . . 0.0 110.058 174.842 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.19 133.71 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 124.535 1.134 . . . . 0.0 109.669 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.7 tp -119.97 131.72 55.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.45 1.5 . . . . 0.0 108.748 172.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -93.17 117.04 29.61 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.349 1.06 . . . . 0.0 108.516 167.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.8 ptm -114.61 156.99 23.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.392 0.677 . . . . 0.0 109.211 172.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -100.29 129.34 46.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.54 1.536 . . . . 0.0 107.052 170.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.06 69.41 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.82 163.66 25.36 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.29 0.567 . . . . 0.0 109.594 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 O-C-N 121.004 -1.06 . . . . 0.0 113.101 172.693 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.4 t -52.18 -45.18 65.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -165.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.5 m -48.5 -56.75 7.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.22 0.208 . . . . 0.0 111.117 169.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -59.93 -49.34 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 123.414 0.686 . . . . 0.0 109.415 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -59.61 -61.55 2.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.918 0.887 . . . . 0.0 109.555 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.86 -56.95 6.37 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.708 1.623 . . . . 0.0 112.401 172.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -57.68 -54.05 51.24 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.018 0.909 . . . . 0.0 110.269 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 mm -60.97 -31.94 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 124.016 0.926 . . . . 0.0 110.921 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.41 -17.9 27.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.886 1.232 . . . . 0.0 113.657 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -84.79 -13.62 50.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.941 1.371 . . . . 0.0 110.392 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.63 140.49 44.33 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.93 0.871 . . . . 0.0 111.983 -169.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -59.7 114.57 2.82 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.059 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.59 -24.5 10.31 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.212 0.911 . . . . 0.0 112.317 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.61 137.63 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 118.035 0.918 . . . . 0.0 110.126 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -106.91 -48.36 3.51 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.937 1.295 . . . . 0.0 109.554 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.04 161.84 41.97 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -178.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 tt -149.49 140.11 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 123.676 0.791 . . . . 0.0 109.246 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -135.88 101.08 4.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.795 2.038 . . . . 0.0 107.279 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -98.85 118.69 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.809 0.844 . . . . 0.0 109.128 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.9 m -98.3 90.88 4.97 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.632 0.773 . . . . 0.0 108.995 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.6 170.55 0.25 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.392 161.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 71.15 -57.36 0.6 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.092 2.557 . . . . 0.0 108.601 -168.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.69 -27.07 64.7 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.569 -174.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 70.07 20.63 6.39 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 111.862 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.16 144.94 42.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.921 1.688 . . . . 0.0 108.244 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.79 155.75 47.91 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 121.328 -0.857 . . . . 0.0 110.035 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 m -126.07 115.22 19.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.918 1.687 . . . . 0.0 106.635 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.7 mt -108.41 154.91 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.31 122.28 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 118.734 0.697 . . . . 0.0 109.789 168.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -156.25 177.82 11.0 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.952 1.701 . . . . 0.0 108.872 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -124.2 136.89 28.17 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 119.427 1.012 . . . . 0.0 111.736 169.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.8 73.07 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.136 3.224 . . . . 0.0 110.332 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -135.3 -50.57 0.75 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.4 mt -94.02 -17.63 22.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.782 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.2 tp -119.78 150.4 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.519 1.054 . . . . 0.0 110.21 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.3 m -83.54 19.82 1.51 Allowed 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 70.67 -62.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 128.038 2.535 . . . . 0.0 109.573 -177.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -70.2 -38.05 75.24 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -49.75 -47.64 50.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 123.534 0.521 . . . . 0.0 111.442 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -40.93 -52.09 3.14 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 177.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.09 -44.92 68.07 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.276 -0.265 . . . . 0.0 110.89 177.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -54.85 -32.17 60.37 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.593 -0.692 . . . . 0.0 112.7 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -37.85 88.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.38 -50.99 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.909 170.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -52.34 -46.82 66.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.336 0.971 . . . . 0.0 109.393 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.44 -21.36 50.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.94 1.696 . . . . 0.0 113.554 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.9 mmt -65.51 -31.95 73.29 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.372 0.987 . . . . 0.0 110.15 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.89 -37.01 1.47 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.906 0.765 . . . . 0.0 111.301 173.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -75.91 116.36 54.77 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 117.784 -1.103 . . . . 0.0 108.876 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.24 120.24 7.61 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.124 1.883 . . . . 0.0 108.685 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.08 -170.3 1.73 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.808 0.813 . . . . 0.0 109.413 -175.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.35 152.99 19.16 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.841 -1.162 . . . . 0.0 110.674 -176.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -173.848 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.8 t -79.25 115.61 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 126.074 1.75 . . . . 0.0 109.231 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.6 tt -89.21 155.86 19.14 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.663 0.785 . . . . 0.0 109.493 169.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -135.44 116.63 14.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.0 ptm -128.99 153.2 47.8 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.948 1.299 . . . . 0.0 110.792 -170.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.99 129.16 49.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.076 0.951 . . . . 0.0 108.598 170.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.05 76.45 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 125.379 1.472 . . . . 0.0 107.77 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.3 114.79 3.37 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.126 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 C-N-CA 124.978 1.275 . . . . 0.0 111.407 -179.848 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -54.64 -36.35 64.46 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 m -52.32 -58.66 5.97 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 123.105 0.253 . . . . 0.0 111.18 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.33 -52.21 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -58.21 -67.37 0.35 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.881 0.848 . . . . 0.0 110.996 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.33 -51.68 11.57 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.581 1.563 . . . . 0.0 112.358 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -63.99 -48.84 74.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.09 0.945 . . . . 0.0 110.362 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.2 mm -59.44 -30.15 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 O-C-N 122.059 -0.401 . . . . 0.0 110.954 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.81 -23.24 6.72 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.391 0.996 . . . . 0.0 114.253 170.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -81.86 -18.22 44.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.799 1.799 . . . . 0.0 111.524 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.28 136.34 56.47 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.865 0.84 . . . . 0.0 111.038 -165.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -56.27 100.66 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.794 1.238 . . . . 0.0 110.324 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.96 -27.2 5.18 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.059 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.31 134.84 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 118.598 1.199 . . . . 0.0 109.76 -172.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -105.64 -36.97 6.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.771 1.228 . . . . 0.0 110.309 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -159.05 169.77 23.52 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.296 0.953 . . . . 0.0 111.459 173.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -150.14 152.67 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.548 1.539 . . . . 0.0 108.932 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -150.38 116.2 5.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.706 1.603 . . . . 0.0 108.345 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.3 t -110.96 117.76 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.639 1.576 . . . . 0.0 109.96 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.4 m -103.23 108.21 19.34 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.445 1.498 . . . . 0.0 110.107 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mt -60.55 -179.05 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.485 1.114 . . . . 0.0 110.308 164.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 63.43 -70.06 0.07 Allowed 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 128.103 2.561 . . . . 0.0 111.029 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -61.57 -28.36 69.29 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.043 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.59 60.43 1.34 Allowed 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 126.711 2.005 . . . . 0.0 111.359 173.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -151.57 156.44 40.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.18 166.52 24.48 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.873 -0.517 . . . . 0.0 109.953 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.36 144.0 34.3 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.2 mt -123.25 162.95 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.27 1.5 p -134.55 113.27 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 119.243 0.929 . . . . 0.0 108.715 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -158.96 179.54 8.98 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.077 1.351 . . . . 0.0 109.578 -170.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.74 147.92 53.55 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.47 79.33 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.666 2.911 . . . . 0.0 109.901 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.22 -52.62 0.5 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.765 1.626 . . . . 0.0 107.147 166.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.05 -22.69 18.98 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.236 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 tp -129.13 147.67 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 123.724 0.81 . . . . 0.0 111.204 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -80.74 27.24 0.38 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -170.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 71.67 -60.65 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 127.879 2.472 . . . . 0.0 109.862 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.54 -42.32 52.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.009 1.324 . . . . 0.0 109.304 -177.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -50.47 -52.97 33.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 123.566 0.541 . . . . 0.0 110.648 -171.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -36.93 -63.38 0.42 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.774 1.229 . . . . 0.0 111.538 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -39.24 72.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.771 -0.581 . . . . 0.0 110.359 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -58.29 -27.33 63.98 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.04 -1.038 . . . . 0.0 113.162 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -41.99 96.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.766 1.167 . . . . 0.0 108.787 176.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.77 -39.09 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.314 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -60.43 -49.84 75.97 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.87 -28.89 64.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.438 1.095 . . . . 0.0 113.195 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.0 mmt -53.05 -34.34 56.06 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.215 0.916 . . . . 0.0 111.463 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.56 -38.91 1.33 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -73.3 113.06 18.63 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.585 -173.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.74 108.63 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.08 1.853 . . . . 0.0 108.384 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.09 -177.43 4.13 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.305 1.042 . . . . 0.0 108.336 -171.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -156.91 140.18 15.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.099 0.863 . . . . 0.0 112.69 -165.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.226 -0.171 0 C-N-CA 126.667 1.987 . . . . 0.0 109.887 -176.915 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.84 125.36 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.38 137.16 48.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -177.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -93.13 129.32 39.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.263 0.625 . . . . 0.0 111.079 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.0 mtt -108.44 155.24 20.81 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.171 0.988 . . . . 0.0 109.977 169.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 118.35 36.59 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 167.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.0 t -100.86 76.91 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.13 168.73 19.42 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.686 0.755 . . . . 0.0 111.675 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.109 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.206 -178.854 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.2 t -50.7 -43.14 57.65 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 m -49.53 -56.2 10.7 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.248 -0.283 . . . . 0.0 111.064 170.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.31 -49.11 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.294 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -51.81 -67.65 0.23 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.52 1.054 . . . . 0.0 110.806 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.33 -50.17 29.89 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.621 1.582 . . . . 0.0 111.882 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.23 -55.31 36.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.696 0.748 . . . . 0.0 109.846 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.9 mm -61.79 -28.75 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 124.2 1.0 . . . . 0.0 110.726 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.45 -20.36 16.45 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.632 1.11 . . . . 0.0 113.581 173.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -90.13 -6.22 55.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.304 1.552 . . . . 0.0 111.408 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.21 135.65 47.63 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 122.044 0.926 . . . . 0.0 111.291 -173.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -57.95 101.63 0.08 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.292 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.46 -24.85 6.41 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.821 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 t -81.95 137.76 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 118.917 1.358 . . . . 0.0 108.253 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -117.35 -34.59 4.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.087 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.11 161.28 38.4 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.818 1.19 . . . . 0.0 110.332 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tt -152.75 143.43 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.628 1.171 . . . . 0.0 110.054 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -141.08 108.68 5.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.365 1.866 . . . . 0.0 108.164 168.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.62 118.48 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 124.731 1.212 . . . . 0.0 109.352 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 t -104.89 82.45 1.87 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.441 1.097 . . . . 0.0 109.164 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -49.37 62.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.988 0.915 . . . . 0.0 111.3 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -44.43 -51.91 8.27 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 125.162 1.385 . . . . 0.0 110.866 172.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -75.58 -9.55 58.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.946 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 62.7 24.03 14.3 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.034 2.134 . . . . 0.0 110.896 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -141.78 160.42 40.23 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.89 1.276 . . . . 0.0 109.678 -170.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.99 158.87 43.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.8 0.84 . . . . 0.0 109.364 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.3 m -132.65 108.05 8.8 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 127.526 2.33 . . . . 0.0 106.202 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mt -116.82 156.23 18.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 124.044 0.938 . . . . 0.0 108.81 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.257 0.5 OUTLIER -132.3 114.07 22.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 118.078 0.399 . . . . 0.0 109.94 -175.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -157.41 179.05 9.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.402 1.081 . . . . 0.0 110.248 -169.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -141.17 132.18 13.47 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 123.902 0.881 . . . . 0.0 110.482 -170.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.22 73.5 2.07 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.751 2.968 . . . . 0.0 110.108 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -144.79 -51.7 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -87.87 -27.84 21.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.707 -0.664 . . . . 0.0 111.236 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.3 tp -120.93 143.6 32.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 CA-C-N 118.897 0.771 . . . . 0.0 110.169 -175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -83.44 31.37 0.46 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -171.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.284 0.5 OUTLIER 74.78 -58.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 128.411 2.684 . . . . 0.0 111.447 170.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -80.77 -38.95 27.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.463 1.905 . . . . 0.0 108.247 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.8 -53.53 7.33 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 123.774 0.83 . . . . 0.0 111.696 -174.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -34.9 -56.98 0.56 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.613 1.565 . . . . 0.0 110.065 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -42.09 71.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.765 0.426 . . . . 0.0 111.14 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -56.76 -28.5 61.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -63.22 -44.18 95.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.37 -46.26 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 117.987 -1.006 . . . . 0.0 111.038 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -52.12 -51.83 55.36 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.754 1.161 . . . . 0.0 108.421 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.59 -20.9 63.83 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.55 2.34 . . . . 0.0 114.056 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.4 mmt -54.82 -32.61 60.6 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.625 1.102 . . . . 0.0 110.123 168.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.47 43.08 0.48 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -147.05 132.61 9.24 Favored Pre-proline 0 C--O 1.223 -0.296 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.7 123.34 11.54 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 121.083 1.423 . . . . 0.0 108.953 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.71 175.02 9.37 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.572 1.177 . . . . 0.0 110.102 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.98 150.91 24.75 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.992 -1.068 . . . . 0.0 111.017 -163.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -174.23 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.3 t -92.08 132.42 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 125.501 1.52 . . . . 0.0 108.47 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.33 129.91 55.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 170.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HZ3' ' CD ' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -105.59 121.9 44.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.29 1.436 . . . . 0.0 107.127 169.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -129.91 140.21 50.99 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.302 0.641 . . . . 0.0 110.479 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.84 145.22 34.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 164.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 t -136.16 72.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.663 1.585 . . . . 0.0 107.269 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -71.45 176.17 4.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.684 0.754 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 CA-C-O 119.553 -0.581 . . . . 0.0 113.149 166.935 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.95 -36.31 65.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -168.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.3 m -49.98 -61.66 2.01 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.871 167.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.83 -51.1 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.31 -63.82 1.13 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.516 0.674 . . . . 0.0 110.549 -173.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.7 -54.38 6.69 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.998 1.761 . . . . 0.0 112.165 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -59.3 -54.38 47.46 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.151 0.975 . . . . 0.0 110.447 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.1 mm -56.52 -33.33 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.448 0.699 . . . . 0.0 111.302 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.65 -20.44 17.91 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.645 1.117 . . . . 0.0 113.904 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -84.59 -20.25 31.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.646 1.723 . . . . 0.0 111.138 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 136.24 53.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 122.339 1.066 . . . . 0.0 111.75 -167.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.59 115.15 1.81 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.905 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.88 -22.38 12.7 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-O 119.076 -0.847 . . . . 0.0 112.507 176.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.25 128.31 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 118.318 1.059 . . . . 0.0 109.388 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -88.6 -48.47 7.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.935 1.294 . . . . 0.0 109.116 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.72 171.27 19.84 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.309 0.958 . . . . 0.0 111.124 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 tt -141.55 142.78 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 124.703 1.201 . . . . 0.0 109.677 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.78 106.79 6.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.259 1.424 . . . . 0.0 107.774 170.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.64 125.76 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.2 1.0 . . . . 0.0 109.352 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -115.01 82.62 1.77 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.725 1.21 . . . . 0.0 108.283 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -52.23 -44.29 64.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.836 0.854 . . . . 0.0 110.298 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -40.89 -55.19 2.55 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.95 1.3 . . . . 0.0 111.085 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -79.68 -7.61 58.69 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.234 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 61.49 23.66 13.9 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.551 2.34 . . . . 0.0 111.283 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.464 ' CD ' ' HZ3' ' A' ' 6' ' ' LYS . 12.8 tt0 -139.69 159.81 41.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.034 -168.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.63 159.03 44.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.299 0.64 . . . . 0.0 109.482 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.4 m -132.77 119.89 20.9 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.8 mt -106.64 155.17 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.45 121.19 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 168.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -157.75 -177.3 6.47 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 127.478 2.311 . . . . 0.0 107.95 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -137.76 149.05 63.31 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 119.98 1.264 . . . . 0.0 112.278 170.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.56 72.49 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.259 3.306 . . . . 0.0 110.266 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.15 -61.43 0.42 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.242 1.417 . . . . 0.0 108.372 173.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.1 mt -84.75 -19.82 32.05 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.798 -0.62 . . . . 0.0 110.815 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 tp -123.97 152.33 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 123.288 0.635 . . . . 0.0 110.143 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 m -81.39 20.27 0.89 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.141 0.977 . . . . 0.0 113.433 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 66.91 -61.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 129.23 3.012 . . . . 0.0 109.84 -172.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.94 -39.0 72.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.643 0.777 . . . . 0.0 110.066 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -47.47 -50.7 22.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.364 0.415 . . . . 0.0 111.663 -174.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.21 -48.22 6.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 122.934 0.494 . . . . 0.0 111.626 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -51.66 24.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 122.227 -0.296 . . . . 0.0 110.71 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -57.99 -27.6 63.63 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -60.51 -51.38 69.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.894 0.877 . . . . 0.0 108.681 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.95 -50.14 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.659 173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -53.93 -47.44 71.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.34 -20.64 60.12 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.441 1.496 . . . . 0.0 114.227 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.7 mmt -60.94 -29.97 69.94 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.956 1.253 . . . . 0.0 110.348 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.42 -34.74 1.7 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 173.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -77.09 110.53 12.39 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.192 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.72 116.95 4.23 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.737 1.625 . . . . 0.0 109.217 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.84 -169.5 2.13 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.236 1.014 . . . . 0.0 109.438 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.46 136.87 8.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.753 1.16 . . . . 0.0 113.355 -169.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.529 0.168 0 C-N-CA 124.76 1.224 . . . . 0.0 108.913 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.592 0.711 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.7 t -80.69 136.45 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 125.262 1.425 . . . . 0.0 109.784 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.65 138.37 52.81 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.274 1.83 . . . . 0.0 108.077 177.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -110.68 114.79 28.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.806 1.242 . . . . 0.0 109.77 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.5 ptp -109.52 151.5 26.67 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.372 1.069 . . . . 0.0 109.827 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -89.67 133.34 34.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 163.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 t -118.71 78.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -72.91 167.93 20.0 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.928 0.87 . . . . 0.0 111.475 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.352 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.4 m -49.08 -40.91 33.69 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -175.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.3 m -48.99 -58.49 4.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.144 0.497 . . . . 0.0 111.698 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.58 -45.24 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 123.937 0.895 . . . . 0.0 108.988 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -54.35 -62.5 1.62 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.645 1.111 . . . . 0.0 110.568 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.4 -54.01 14.34 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.352 1.453 . . . . 0.0 111.754 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -60.73 -58.14 9.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.624 0.712 . . . . 0.0 110.45 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.31 -39.05 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.063 0.945 . . . . 0.0 110.3 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.06 -13.98 9.97 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.042 1.306 . . . . 0.0 113.829 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -95.5 -15.35 22.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.849 1.324 . . . . 0.0 110.667 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 141.2 55.66 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 119.528 1.058 . . . . 0.0 111.96 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -59.32 114.32 2.6 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.677 173.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.05 -22.74 9.62 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.436 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.16 139.01 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 117.966 0.883 . . . . 0.0 109.265 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -105.48 -45.87 4.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.468 1.507 . . . . 0.0 110.207 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.59 161.7 42.06 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 tt -146.78 140.49 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.712 1.205 . . . . 0.0 109.375 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.63 105.18 6.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.319 1.847 . . . . 0.0 106.903 173.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.56 116.44 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.816 1.189 . . . . 0.0 108.862 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -80.47 179.69 7.6 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.338 0.589 . . . . 0.0 110.176 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.2 -59.74 1.3 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.284 1.434 . . . . 0.0 108.225 173.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -43.84 -54.64 5.09 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.983 1.313 . . . . 0.0 110.083 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -80.55 -12.66 59.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.012 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 61.95 15.76 7.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.963 1.705 . . . . 0.0 112.736 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -124.76 156.72 37.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.556 1.543 . . . . 0.0 109.689 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.56 152.63 47.04 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.538 0.735 . . . . 0.0 110.104 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.3 m -128.24 113.85 16.19 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.548 1.939 . . . . 0.0 105.991 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.73 160.59 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -128.51 119.11 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -158.28 178.13 10.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.261 1.424 . . . . 0.0 110.239 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -133.53 149.82 73.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.295 1.038 . . . . 0.0 113.547 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.68 80.67 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.665 2.91 . . . . 0.0 109.114 169.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.2 -61.2 0.25 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.46 1.104 . . . . 0.0 108.073 173.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.9 mt -87.59 -21.12 25.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.003 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 tp -123.96 148.79 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.07 0.948 . . . . 0.0 109.851 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.0 m -79.39 23.98 0.37 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.256 0.8 OUTLIER 70.09 -57.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 128.047 2.539 . . . . 0.0 110.054 -176.18 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.09 -40.7 37.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.398 1.079 . . . . 0.0 110.144 -176.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -48.19 -48.44 34.69 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 122.739 0.415 . . . . 0.0 111.668 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -37.89 -56.43 1.11 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.695 1.198 . . . . 0.0 112.212 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.17 -45.19 42.28 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.254 1.021 . . . . 0.0 112.478 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.44 -29.36 15.82 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.191 -0.943 . . . . 0.0 112.663 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -62.27 -34.31 76.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -70.1 -44.32 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 118.419 -0.801 . . . . 0.0 109.811 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -50.86 -49.34 59.25 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.51 44.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.273 1.029 . . . . 0.0 113.756 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.3 mmm -66.8 -30.85 71.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.444 1.02 . . . . 0.0 110.247 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.23 -36.91 1.99 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.315 0.96 . . . . 0.0 111.142 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -79.56 123.73 84.09 Favored Pre-proline 0 N--CA 1.455 -0.179 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.305 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.15 118.33 5.35 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.508 1.472 . . . . 0.0 108.596 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.76 -174.56 2.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -162.87 143.79 9.73 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.888 -1.132 . . . . 0.0 110.935 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.751 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.7 t . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 t -77.1 121.41 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.96 132.75 56.36 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.551 1.54 . . . . 0.0 106.897 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.97 137.84 36.94 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.2 1.0 . . . . 0.0 110.196 171.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -138.71 147.44 42.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.177 0.991 . . . . 0.0 109.882 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -92.25 128.56 38.14 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 t -120.65 73.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 125.24 1.416 . . . . 0.0 108.755 -171.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -73.27 174.7 7.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.784 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 O-C-N 121.807 -0.558 . . . . 0.0 113.015 167.517 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 m -56.4 -38.19 71.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -169.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -50.18 -59.34 4.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.75 0.42 . . . . 0.0 110.404 168.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.72 -49.34 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 118.563 -0.732 . . . . 0.0 109.372 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.38 -65.65 0.54 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.063 0.847 . . . . 0.0 111.071 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.9 -52.22 26.68 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.117 1.342 . . . . 0.0 112.206 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -52.15 -58.05 7.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.533 0.733 . . . . 0.0 109.461 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.44 -34.98 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.6 1.16 . . . . 0.0 111.108 -176.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.87 -23.03 10.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.01 1.29 . . . . 0.0 113.664 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -89.36 -17.22 29.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.577 1.188 . . . . 0.0 110.239 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.43 136.63 49.71 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.327 1.06 . . . . 0.0 111.688 -173.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -52.08 109.27 0.36 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.037 1.335 . . . . 0.0 111.111 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.24 -23.48 8.56 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 118.928 -0.929 . . . . 0.0 112.788 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.3 t -79.79 142.9 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 118.49 1.145 . . . . 0.0 110.056 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -117.12 -40.24 3.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.546 1.138 . . . . 0.0 111.812 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.89 165.68 34.7 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.748 0.704 . . . . 0.0 109.168 173.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -143.95 145.05 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.518 1.527 . . . . 0.0 108.417 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -139.99 97.98 3.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.424 2.29 . . . . 0.0 107.101 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -96.09 116.43 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.131 0.972 . . . . 0.0 109.09 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.8 t -108.72 80.01 1.29 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.02 -41.01 67.53 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.855 0.462 . . . . 0.0 111.747 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.81 -55.05 3.83 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.93 1.292 . . . . 0.0 110.584 168.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -78.57 -19.83 51.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.75 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 72.65 4.72 5.07 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.796 2.438 . . . . 0.0 111.627 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -109.99 151.95 26.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.541 1.536 . . . . 0.0 109.02 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.6 157.81 44.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.991 0.916 . . . . 0.0 108.63 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -129.33 121.56 27.72 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.8 mt -111.52 153.35 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.254 7.0 p -117.87 114.7 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.991 0.917 . . . . 0.0 108.906 173.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -158.95 178.93 9.55 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.721 1.208 . . . . 0.0 110.681 -171.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -138.19 144.73 44.48 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.6 71.93 1.4 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.547 3.498 . . . . 0.0 110.826 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.32 -58.15 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.399 1.08 . . . . 0.0 108.507 172.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.3 mt -87.5 -21.81 25.26 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.877 -0.582 . . . . 0.0 110.869 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.0 tp -118.76 151.12 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 123.622 0.769 . . . . 0.0 109.823 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 m -85.88 29.83 0.7 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.637 0.775 . . . . 0.0 112.72 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.265 0.5 OUTLIER 73.76 -59.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.085 2.554 . . . . 0.0 110.4 176.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -81.01 -38.01 28.2 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.303 1.441 . . . . 0.0 109.786 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -43.76 -48.69 8.1 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 123.747 0.655 . . . . 0.0 111.346 -174.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.24 -53.74 3.11 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.661 0.784 . . . . 0.0 112.029 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -47.22 54.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.199 0.2 . . . . 0.0 110.619 177.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -54.54 -28.38 45.16 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -62.53 -52.24 64.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.5 mp -58.2 -43.14 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.183 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -55.48 -53.71 52.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.5 -27.35 62.47 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.172 1.789 . . . . 0.0 114.097 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.2 mmm -51.37 -31.45 22.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.687 1.13 . . . . 0.0 110.974 172.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.63 42.72 0.28 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -146.82 120.52 5.07 Favored Pre-proline 0 C--O 1.227 -0.087 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.13 102.04 0.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.953 1.769 . . . . 0.0 109.345 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.22 -175.47 3.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.819 0.848 . . . . 0.0 108.898 -175.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.33 143.83 15.34 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 125.546 1.538 . . . . 0.0 108.42 172.067 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.2 t . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.72 120.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.88 156.02 37.01 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.555 1.142 . . . . 0.0 109.237 -177.103 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.35 123.05 45.45 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.401 0.681 . . . . 0.0 110.039 177.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.1 mmt -105.95 157.72 17.3 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.703 1.201 . . . . 0.0 109.052 174.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.93 127.14 54.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 168.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.5 73.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.329 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.9 169.84 17.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.801 -174.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.231 0 CA-C-O 118.934 -0.926 . . . . 0.0 113.708 172.524 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.5 t -53.08 -39.31 63.23 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -172.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.5 m -45.77 -61.36 1.75 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 123.194 0.598 . . . . 0.0 112.561 165.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.78 -49.12 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.317 1.047 . . . . 0.0 108.975 178.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -56.41 -65.91 0.53 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.989 0.916 . . . . 0.0 109.428 -176.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.05 -52.83 11.51 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.195 1.379 . . . . 0.0 112.492 176.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.19 -55.42 35.16 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.851 0.825 . . . . 0.0 110.233 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.7 mm -60.59 -30.07 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 123.797 0.839 . . . . 0.0 110.851 -178.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.85 -19.52 6.98 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.07 171.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -90.51 -13.53 34.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 119.784 1.792 . . . . 0.0 111.217 177.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.65 134.0 50.36 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.496 1.141 . . . . 0.0 111.033 -173.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -55.55 110.9 0.78 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.116 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.38 -25.42 8.2 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.329 176.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 t -81.28 136.06 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 118.194 0.997 . . . . 0.0 109.045 -177.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -101.72 -42.92 6.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.797 1.239 . . . . 0.0 110.201 173.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 ttt-85 -153.98 161.35 42.03 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.849 0.75 . . . . 0.0 109.987 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 tt -149.08 139.33 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.583 1.153 . . . . 0.0 109.545 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -139.6 114.81 9.71 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.094 1.758 . . . . 0.0 106.593 174.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -113.99 126.23 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.986 1.314 . . . . 0.0 109.07 -178.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.3 t -84.58 172.41 11.63 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.536 0.684 . . . . 0.0 110.345 172.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.1 -63.25 1.48 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 170.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -52.64 -49.96 64.13 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.29 1.036 . . . . 0.0 109.313 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.9 -18.09 59.53 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.292 -172.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 62.62 4.74 1.46 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.324 1.85 . . . . 0.0 113.239 -175.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -107.86 152.93 23.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.263 1.825 . . . . 0.0 108.014 -169.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.13 161.27 37.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.47 0.708 . . . . 0.0 109.833 178.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.7 m -137.68 118.29 13.96 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 mt -120.27 160.85 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.244 1.018 . . . . 0.0 108.282 178.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.263 14.1 p -130.25 114.89 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.355 0.662 . . . . 0.0 109.888 178.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -158.97 178.66 9.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.229 1.011 . . . . 0.0 111.392 -175.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -134.65 148.82 68.89 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.419 1.088 . . . . 0.0 113.177 173.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.69 74.83 0.85 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.403 3.402 . . . . 0.0 110.006 171.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.26 -61.31 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.752 1.221 . . . . 0.0 107.812 170.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.4 mt -85.66 -20.86 28.79 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.092 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 54' ' ' VAL . 10.9 tp -123.4 147.3 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 m -79.81 27.0 0.31 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.36 0.982 . . . . 0.0 112.68 -176.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 52' ' ' ILE 0.27 0.5 OUTLIER 73.25 -54.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 128.01 2.524 . . . . 0.0 110.817 179.334 . . . . . . . . 4 4 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -88.3 -32.81 18.27 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.597 0.759 . . . . 0.0 111.218 -178.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -40.76 -51.57 3.07 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 123.254 0.622 . . . . 0.0 110.775 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -37.0 -63.94 0.39 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.443 1.497 . . . . 0.0 109.922 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.3 -43.99 97.54 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.905 -0.497 . . . . 0.0 111.091 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -58.08 -31.64 67.28 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -60.18 -48.38 81.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -58.6 -48.37 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.863 175.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -52.15 -50.79 61.06 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.324 0.966 . . . . 0.0 108.477 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.27 -21.46 61.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.067 1.747 . . . . 0.0 114.036 -177.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.0 mmt -63.26 -23.95 67.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.955 1.252 . . . . 0.0 110.478 172.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.99 40.77 0.74 Allowed Glycine 0 C--N 1.338 0.66 0 C-N-CA 124.279 0.942 . . . . 0.0 111.358 170.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -148.53 123.3 4.94 Favored Pre-proline 0 C--O 1.226 -0.152 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.8 118.28 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.361 1.374 . . . . 0.0 109.078 -178.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.66 -171.13 1.83 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.96 152.45 13.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.036 -1.04 . . . . 0.0 111.206 -173.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.448 -0.565 0 C-N-CA 126.362 1.865 . . . . 0.0 106.383 -178.097 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.2 t . . . . . 0 CA--C 1.521 -0.142 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.82 141.78 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.64 131.91 23.41 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.773 0.829 . . . . 0.0 109.266 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.472 ' HZ3' ' CD ' ' A' ' 42' ' ' GLU . 1.4 mtmt -103.62 129.78 50.96 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.04 1.336 . . . . 0.0 111.387 178.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.3 ptp -127.01 159.68 33.4 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.294 1.038 . . . . 0.0 110.67 176.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -98.73 124.81 43.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.014 1.726 . . . . 0.0 107.681 164.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -111.97 77.44 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.065 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 169.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.283 10.6 pt-20 -84.2 165.63 18.23 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.665 178.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.113 0 CA-C-O 119.459 -0.634 . . . . 0.0 113.759 176.644 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.222 -0.38 0 CA-C-O 118.381 -0.819 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -49.32 -37.17 23.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -175.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.25 -51.37 69.85 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 175.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.59 -53.38 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.176 172.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -55.86 -61.1 2.59 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.325 0.966 . . . . 0.0 109.92 -171.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.48 -52.9 22.53 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.319 1.438 . . . . 0.0 111.729 177.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -60.7 -50.86 71.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.047 0.923 . . . . 0.0 110.323 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.5 mm -66.33 -24.33 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.89 0.876 . . . . 0.0 110.788 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.11 -14.55 32.72 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.604 170.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -84.54 -12.93 53.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.64 1.72 . . . . 0.0 110.607 173.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.63 135.31 46.88 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 122.307 1.051 . . . . 0.0 111.447 -171.156 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -60.93 113.77 2.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.221 177.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.83 -21.87 15.47 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-O 119.366 -0.686 . . . . 0.0 112.945 175.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 t -81.59 131.34 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.26 -51.34 5.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.151 1.38 . . . . 0.0 109.163 174.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -152.1 160.86 43.33 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tt -143.51 141.55 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.151 1.38 . . . . 0.0 108.488 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.54 125.93 20.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.734 1.614 . . . . 0.0 107.097 171.023 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -115.95 154.31 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.026 1.33 . . . . 0.0 107.696 -178.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.2 t -130.28 155.53 46.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.111 0.964 . . . . 0.0 109.216 176.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -104.36 -59.71 1.7 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.299 1.84 . . . . 0.0 108.732 -177.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.79 -58.27 7.85 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.065 1.346 . . . . 0.0 109.619 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.7 -22.36 62.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.32 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 55.75 59.29 3.9 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 126.581 1.952 . . . . 0.0 109.775 176.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.472 ' CD ' ' HZ3' ' A' ' 6' ' ' LYS . 14.9 tt0 -156.34 160.72 39.95 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.465 1.506 . . . . 0.0 107.137 -172.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.63 159.04 43.01 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 118.931 0.787 . . . . 0.0 110.536 174.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.9 m -126.23 130.28 50.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 174.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.36 163.66 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.4 117.71 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.108 0.963 . . . . 0.0 108.846 176.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -159.61 -177.14 6.18 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.535 1.134 . . . . 0.0 111.255 -171.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -136.73 152.61 74.7 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 165.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.79 76.55 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.32 3.347 . . . . 0.0 109.541 171.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.71 -62.43 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.227 1.011 . . . . 0.0 108.679 175.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.9 mt -84.14 -27.21 28.3 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 119.361 -0.352 . . . . 0.0 110.142 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.4 tp -117.74 146.74 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.321 1.048 . . . . 0.0 109.281 177.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -84.1 27.78 0.65 Allowed 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.262 0.9 OUTLIER 70.42 -57.54 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 128.787 2.835 . . . . 0.0 111.42 179.883 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.72 -33.56 40.78 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.08 1.352 . . . . 0.0 110.04 -177.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -52.87 -49.61 65.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 123.203 0.314 . . . . 0.0 110.777 -177.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -31.57 -58.67 0.26 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.491 1.516 . . . . 0.0 111.283 172.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -46.71 67.13 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.177 -0.327 . . . . 0.0 111.306 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.8 -32.02 59.73 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.819 -0.551 . . . . 0.0 112.321 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -42.16 99.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.19 -47.94 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.694 172.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -49.79 -51.07 42.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.17 0.986 . . . . 0.0 108.835 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.84 -19.59 51.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.781 2.032 . . . . 0.0 114.056 -178.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.8 mmm -61.34 -30.47 70.53 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.626 1.103 . . . . 0.0 109.626 170.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.25 40.68 0.39 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.839 1.209 . . . . 0.0 111.553 170.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -148.62 122.12 4.66 Favored Pre-proline 0 C--O 1.223 -0.291 0 CA-C-O 117.12 -1.419 . . . . 0.0 107.604 -177.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -62.69 118.66 5.56 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.623 1.549 . . . . 0.0 109.001 -176.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.78 175.16 6.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.216 1.008 . . . . 0.0 109.991 -178.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.81 138.67 18.02 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.95 -1.094 . . . . 0.0 111.178 -170.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -177.186 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.443 -0.777 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.49 135.44 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.67 144.41 50.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.272 1.429 . . . . 0.0 107.375 178.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.06 129.04 55.74 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.431 1.492 . . . . 0.0 109.136 174.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 ptp -124.04 152.07 43.04 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.614 1.166 . . . . 0.0 109.877 179.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -89.94 151.43 21.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 162.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -132.27 68.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -62.9 115.47 4.41 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.672 -170.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.912 0 CA-C-O 119.389 -0.673 . . . . 0.0 113.37 173.611 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 m -55.33 -36.25 66.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -171.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.6 m -50.76 -60.63 2.86 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.416 0.447 . . . . 0.0 111.051 167.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.9 -51.22 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -57.49 -66.75 0.41 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.552 0.691 . . . . 0.0 110.63 -174.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.19 -51.26 26.36 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.881 1.705 . . . . 0.0 111.911 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -54.89 -56.68 16.92 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.813 0.806 . . . . 0.0 109.367 177.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.9 mm -64.24 -28.56 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 C-N-CA 123.157 0.583 . . . . 0.0 111.052 -174.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.78 -19.98 23.43 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.376 0.989 . . . . 0.0 113.44 171.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -85.84 -18.61 32.37 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 119.627 1.714 . . . . 0.0 109.419 177.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.46 133.7 49.02 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.453 1.121 . . . . 0.0 111.336 -172.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -58.23 111.43 1.2 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.027 175.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.67 -27.34 6.28 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-O 119.165 -0.797 . . . . 0.0 112.639 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.07 136.19 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 118.167 0.984 . . . . 0.0 109.382 -176.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -107.87 -46.0 3.87 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.581 1.152 . . . . 0.0 110.668 176.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.61 159.7 42.37 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.5 tt -142.7 148.15 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.072 1.349 . . . . 0.0 109.854 179.1 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -145.27 113.11 6.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.791 2.036 . . . . 0.0 108.193 171.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.0 t -102.92 120.66 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.23 1.012 . . . . 0.0 110.168 176.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 m -102.72 89.32 3.46 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.516 1.126 . . . . 0.0 109.061 175.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 mt -58.81 173.66 0.41 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.201 160.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 66.41 -65.63 0.19 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 127.968 2.507 . . . . 0.0 109.574 -170.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -27.85 69.0 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.095 178.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.93 50.82 0.8 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.674 2.39 . . . . 0.0 111.718 172.628 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -140.22 148.16 41.11 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.217 2.207 . . . . 0.0 106.206 -174.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.43 155.84 45.13 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 120.924 -1.11 . . . . 0.0 109.679 172.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.76 136.66 34.35 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.41 163.17 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.36 119.1 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -159.0 -179.33 7.95 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.684 1.194 . . . . 0.0 109.908 -172.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -138.23 144.1 41.79 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.1 80.27 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.305 3.337 . . . . 0.0 109.921 174.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -158.35 -54.32 0.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.7 mt -86.75 -29.48 22.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.417 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 tp -115.68 145.13 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m -78.24 23.49 0.28 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 -175.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 76.03 -58.51 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 127.27 2.228 . . . . 0.0 109.786 176.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.99 -39.26 42.93 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.476 1.511 . . . . 0.0 109.669 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -40.39 -57.11 1.86 Allowed 'General case' 0 C--N 1.345 0.388 0 C-N-CA 123.942 0.897 . . . . 0.0 111.043 -178.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.5 -58.29 0.33 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.999 1.72 . . . . 0.0 110.477 175.505 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -48.08 51.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.151 -0.343 . . . . 0.0 111.838 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 5.6 mptp? -55.93 -30.43 61.64 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -174.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.6 -46.41 89.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -63.93 -47.11 92.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.008 175.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.41 ' CD ' ' HZ1' ' A' ' 59' ' ' LYS . 94.5 mt-10 -50.38 -51.94 41.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.79 -18.83 57.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.503 1.921 . . . . 0.0 114.209 -178.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.6 mmm -59.12 -29.76 67.62 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.874 1.216 . . . . 0.0 109.796 170.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.94 44.36 0.28 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 124.347 0.975 . . . . 0.0 110.851 171.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -146.76 120.98 5.16 Favored Pre-proline 0 C--O 1.225 -0.196 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -175.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.22 99.01 0.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.942 1.761 . . . . 0.0 110.086 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.22 -176.63 2.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -174.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.6 141.13 11.57 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.6 0.36 . . . . 0.0 111.572 -176.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.09 143.73 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 124.619 1.168 . . . . 0.0 111.389 -175.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.43 132.86 53.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.278 1.431 . . . . 0.0 108.191 175.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.43 109.71 21.49 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.301 1.44 . . . . 0.0 107.648 175.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.7 ptm -113.39 164.78 13.16 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.691 0.796 . . . . 0.0 111.084 174.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -109.99 131.02 55.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 129.711 3.204 . . . . 0.0 106.581 177.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 t -121.25 77.69 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.03 177.13 4.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.954 0.883 . . . . 0.0 111.7 -176.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.809 0 O-C-N 121.626 -0.671 . . . . 0.0 111.546 176.58 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 t -55.04 -38.31 67.81 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -164.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -49.36 -58.4 5.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.876 0.47 . . . . 0.0 111.789 167.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.65 -51.43 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.752 0.821 . . . . 0.0 108.914 176.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.32 -63.59 1.14 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.28 0.632 . . . . 0.0 110.436 -174.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.98 -53.57 14.1 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.712 1.625 . . . . 0.0 112.411 174.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -62.14 -51.67 66.93 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.199 0.999 . . . . 0.0 110.925 -176.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 mm -55.63 -35.88 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.738 0.815 . . . . 0.0 110.537 173.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.01 -12.45 22.61 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.626 1.108 . . . . 0.0 114.006 173.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -87.94 -20.35 26.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.447 1.623 . . . . 0.0 109.914 172.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 131.78 45.82 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.714 1.245 . . . . 0.0 112.156 -172.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -50.06 107.29 0.15 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.551 170.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.7 -27.3 6.29 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-O 118.9 -0.945 . . . . 0.0 112.464 175.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 t -81.9 133.15 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.37 -41.97 5.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.342 0.519 . . . . 0.0 111.931 167.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 161.73 35.16 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.161 0.891 . . . . 0.0 110.006 -175.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 tt -152.68 146.99 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.95 0.9 . . . . 0.0 110.96 -176.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -144.84 102.27 3.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.579 1.952 . . . . 0.0 108.658 169.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.5 t -99.26 100.1 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.286 1.034 . . . . 0.0 110.089 177.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.0 m -89.12 77.53 7.55 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.92 0.888 . . . . 0.0 109.609 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.0 tp -53.61 -35.12 60.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.596 0.758 . . . . 0.0 110.334 177.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -38.71 -52.3 1.68 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.361 1.464 . . . . 0.0 111.325 167.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.28 -7.14 58.73 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.096 -173.152 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 63.56 17.1 10.14 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.969 2.108 . . . . 0.0 111.312 -172.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -139.61 145.29 38.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.79 1.236 . . . . 0.0 110.225 -170.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.03 147.79 46.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.401 0.68 . . . . 0.0 110.809 -167.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -130.15 110.81 11.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.99 1.716 . . . . 0.0 107.073 -167.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.21 171.46 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.65 123.76 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.096 0.862 . . . . 0.0 109.619 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -155.93 176.73 12.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.776 0.83 . . . . 0.0 110.711 -174.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -123.65 141.14 35.79 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.236 1.014 . . . . 0.0 112.367 175.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.39 81.04 1.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.151 3.234 . . . . 0.0 109.753 176.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 -51.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.5 0.72 . . . . 0.0 109.512 177.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.4 mt -86.72 -36.59 18.57 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -179.208 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.5 tp -109.4 149.5 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 m -86.64 32.91 0.64 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 122.912 0.485 . . . . 0.0 111.645 -174.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 68.55 -56.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 129.911 3.284 . . . . 0.0 111.641 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -96.21 -26.81 15.29 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 126.846 2.059 . . . . 0.0 110.689 -170.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -43.18 -48.46 6.46 Favored 'General case' 0 C--N 1.347 0.484 0 O-C-N 123.524 0.515 . . . . 0.0 110.723 177.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -47.24 -61.52 1.86 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 123.272 0.629 . . . . 0.0 111.267 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.24 -45.44 93.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.232 1.013 . . . . 0.0 110.395 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -57.19 -27.88 62.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.876 176.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -47.89 75.45 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 175.288 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.64 -45.01 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.563 -0.732 . . . . 0.0 109.604 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -54.74 -52.94 60.95 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 122.128 0.966 . . . . 0.0 108.796 176.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.69 -24.52 66.81 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.683 1.593 . . . . 0.0 113.416 -174.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.6 mmm -53.38 -35.11 59.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.26 0.937 . . . . 0.0 110.179 168.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.94 -30.48 2.56 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.59 1.091 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.93 127.98 60.07 Favored Pre-proline 0 N--CA 1.456 -0.154 0 CA-C-O 118.389 -0.815 . . . . 0.0 108.945 -173.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.92 129.14 26.36 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.061 1.841 . . . . 0.0 109.383 -178.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.46 165.71 24.55 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.622 0.725 . . . . 0.0 109.723 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -156.0 153.58 29.72 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.192 -0.942 . . . . 0.0 110.786 -161.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.456 -0.166 0 C-N-CA 124.01 0.924 . . . . 0.0 109.183 -171.594 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 t . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.02 130.36 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.29 1.036 . . . . 0.0 110.901 -177.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.97 152.32 42.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.732 1.613 . . . . 0.0 108.072 175.106 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.58 136.79 54.7 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.501 1.12 . . . . 0.0 109.063 174.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 ptp -126.4 143.1 51.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.8 1.64 . . . . 0.0 109.209 -177.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.26 131.39 34.74 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 167.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.12 84.55 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.84 161.6 30.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.428 0.632 . . . . 0.0 112.516 -174.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.334 0 C-N-CA 123.69 0.662 . . . . 0.0 113.739 176.058 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 C--O 1.221 -0.44 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.8 t -53.16 -41.92 65.63 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -172.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.6 m -48.27 -56.68 7.4 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.651 168.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.45 -49.16 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -53.28 -66.67 0.35 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.341 0.973 . . . . 0.0 110.593 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.25 -53.93 8.95 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.728 1.633 . . . . 0.0 112.396 176.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -57.55 -51.0 71.27 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 117.825 0.813 . . . . 0.0 110.317 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.1 mm -62.98 -28.61 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.216 0.607 . . . . 0.0 110.603 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.61 -17.07 8.08 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 118.705 -1.053 . . . . 0.0 114.207 169.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -87.43 -18.02 30.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 120.123 1.961 . . . . 0.0 111.093 174.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.3 136.0 56.74 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.068 0.937 . . . . 0.0 110.566 -171.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -68.46 119.69 13.34 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.642 -175.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.59 -20.14 23.09 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-O 118.824 -0.987 . . . . 0.0 112.937 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.77 136.66 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 118.669 1.234 . . . . 0.0 109.547 -177.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -100.98 -47.79 4.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.054 1.342 . . . . 0.0 110.181 174.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.97 161.04 43.02 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.42 0.554 . . . . 0.0 109.53 -178.127 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 tt -138.5 145.03 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.5 1.52 . . . . 0.0 109.234 177.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -138.7 106.89 5.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.223 2.209 . . . . 0.0 107.582 171.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.5 t -102.05 98.96 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.308 0.958 . . . . 0.0 110.335 176.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 m -88.31 82.16 7.11 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.288 1.035 . . . . 0.0 109.61 177.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.94 -43.69 50.12 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.58 0.752 . . . . 0.0 111.367 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.63 -52.45 2.22 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 125.953 1.701 . . . . 0.0 111.204 170.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -82.71 -9.62 59.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.88 -172.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 64.04 20.43 12.19 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.323 1.849 . . . . 0.0 111.279 -178.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -144.23 141.71 30.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.208 1.403 . . . . 0.0 109.354 -169.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.65 151.77 44.49 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.902 0.881 . . . . 0.0 109.476 -178.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.1 m -124.52 119.57 29.5 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 127.105 2.162 . . . . 0.0 105.667 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.3 mt -125.07 161.19 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.04 123.97 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -156.22 173.14 17.28 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.506 1.122 . . . . 0.0 109.238 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.51 146.85 51.12 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 170.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -71.66 75.99 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.757 3.638 . . . . 0.0 110.332 177.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -151.85 -54.67 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.5 mt -89.28 -22.47 22.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.669 -177.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tp -121.47 149.46 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.785 0.834 . . . . 0.0 109.537 177.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.9 m -84.95 30.46 0.58 Allowed 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 123.491 0.717 . . . . 0.0 112.098 -175.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 72.1 -62.77 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 128.931 2.893 . . . . 0.0 108.568 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -84.92 -31.07 23.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.98 -171.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -43.96 -51.81 7.41 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 123.83 0.706 . . . . 0.0 110.965 -179.287 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.79 -61.11 0.88 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.061 1.344 . . . . 0.0 109.193 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -44.86 88.08 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.027 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -54.4 -33.57 59.57 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.942 0.792 . . . . 0.0 112.913 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -59.75 -47.39 85.87 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.28 -48.93 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.912 174.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -53.59 -48.21 69.44 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.101 0.953 . . . . 0.0 109.042 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.13 -20.05 62.23 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.324 1.449 . . . . 0.0 113.546 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 79.9 mmm -62.43 -29.84 70.8 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.687 1.13 . . . . 0.0 109.933 170.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.93 -34.93 2.1 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.064 0.84 . . . . 0.0 111.046 177.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -82.07 112.76 38.23 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-O 117.482 -1.247 . . . . 0.0 108.201 -178.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -60.64 137.15 71.54 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.506 1.471 . . . . 0.0 108.888 -179.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.53 -162.98 0.98 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.839 0.456 . . . . 0.0 110.098 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -170.07 148.48 3.4 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.658 0.783 . . . . 0.0 111.226 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.563 0 C-N-CA 124.581 1.152 . . . . 0.0 108.283 177.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.6 t -79.27 140.48 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.491 1.116 . . . . 0.0 109.063 -177.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.58 129.29 50.96 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 126.17 1.788 . . . . 0.0 106.989 173.679 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -108.82 130.44 55.4 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.806 0.691 . . . . 0.0 109.615 172.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -138.21 157.65 45.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.162 0.985 . . . . 0.0 110.989 -172.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.7 144.52 26.6 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 170.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 t -128.61 66.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.58 1.552 . . . . 0.0 107.485 175.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.77 173.44 12.48 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.293 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.193 0 CA-C-O 119.273 -0.737 . . . . 0.0 113.809 175.172 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.224 -0.283 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 m -55.81 -37.13 68.23 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -163.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.9 m -52.38 -56.56 14.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 168.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.29 -49.63 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -53.21 -64.03 0.95 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.122 0.963 . . . . 0.0 110.9 -177.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.84 -51.28 13.42 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.632 1.587 . . . . 0.0 112.902 174.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -60.54 -63.72 1.2 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.618 0.709 . . . . 0.0 109.866 -178.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -53.24 -40.06 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.071 1.348 . . . . 0.0 110.613 -179.62 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.81 -23.66 16.01 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.012 1.291 . . . . 0.0 113.568 177.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -88.67 -17.01 30.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 119.151 1.475 . . . . 0.0 111.147 178.142 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 134.6 53.38 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.472 1.13 . . . . 0.0 111.861 -172.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -52.73 107.18 0.2 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.137 176.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.29 -32.76 4.03 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-O 119.144 -0.809 . . . . 0.0 111.773 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.29 136.99 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 118.093 0.947 . . . . 0.0 109.283 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -103.2 -45.63 4.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.273 1.429 . . . . 0.0 110.478 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -153.66 160.22 42.3 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.82 -0.55 . . . . 0.0 110.004 -178.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.8 tt -141.01 140.02 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.331 1.452 . . . . 0.0 109.776 178.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -133.05 117.16 17.23 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.8 1.64 . . . . 0.0 107.782 165.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.2 t -108.61 107.61 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 124.491 1.117 . . . . 0.0 109.868 177.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -89.5 89.47 7.86 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.48 -45.93 69.8 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.381 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -41.84 -61.18 1.17 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 126.114 1.766 . . . . 0.0 110.709 171.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -75.38 -9.92 58.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.05 -174.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 67.28 6.79 5.06 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 127.313 2.245 . . . . 0.0 111.741 -174.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -119.88 144.11 47.57 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.331 1.853 . . . . 0.0 108.132 -171.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.01 155.14 48.53 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.37 0.668 . . . . 0.0 109.23 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 m -135.68 112.74 10.38 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 126.195 1.798 . . . . 0.0 106.521 -171.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.94 169.08 6.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -137.78 123.71 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -159.23 -178.33 7.11 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.105 1.362 . . . . 0.0 109.982 -173.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -130.6 150.35 76.09 Favored Pre-proline 0 C--N 1.347 0.499 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 164.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.45 74.81 0.55 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.698 3.599 . . . . 0.0 109.506 169.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -147.62 -61.86 0.27 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.859 1.264 . . . . 0.0 107.617 -177.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.5 mt -91.98 -21.63 20.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.126 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 54' ' ' VAL . 11.3 tp -121.52 146.86 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.095 0.958 . . . . 0.0 108.637 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.4 m -82.39 31.93 0.4 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 119.378 0.99 . . . . 0.0 113.03 -174.032 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 52' ' ' ILE 0.252 0.5 OUTLIER 72.64 -62.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 127.876 2.47 . . . . 0.0 108.01 -177.082 . . . . . . . . 4 4 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -86.43 -28.09 23.74 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.89 -170.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -46.54 -44.89 18.23 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.36 0.527 . . . . 0.0 110.779 177.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.9 -69.22 0.14 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.22 1.408 . . . . 0.0 109.954 173.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -41.97 97.58 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.64 -0.663 . . . . 0.0 110.756 -177.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -59.61 -24.79 64.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.959 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.91 -39.92 96.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.646 1.112 . . . . 0.0 109.074 173.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.88 -49.42 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -54.18 -46.12 72.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.04 -19.44 64.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.813 1.645 . . . . 0.0 114.371 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.2 mmm -59.82 -28.69 67.68 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 120.243 1.383 . . . . 0.0 109.602 168.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.08 -25.89 4.83 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.445 1.021 . . . . 0.0 110.791 175.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -75.38 123.65 88.73 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.73 111.37 1.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.064 1.843 . . . . 0.0 109.273 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.9 -174.46 2.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.435 1.094 . . . . 0.0 108.27 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -169.65 146.21 3.25 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.722 0.692 . . . . 0.0 112.383 -167.073 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.453 -0.28 0 C-N-CA 125.15 1.38 . . . . 0.0 109.352 178.147 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.7 t -77.05 153.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.47 135.83 35.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.374 -1.714 . . . . 0.0 106.374 173.271 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -111.7 135.13 52.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.131 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -143.14 143.14 31.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.599 0.76 . . . . 0.0 110.883 -176.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -75.75 147.42 39.31 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 166.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.28 48.6 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 126.014 1.726 . . . . 0.0 108.725 178.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -58.4 142.96 46.86 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.802 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.0 171.89 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.3 t -55.07 -41.62 71.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 119.084 0.856 . . . . 0.0 112.361 -166.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.1 m -45.13 -60.1 2.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.431 0.693 . . . . 0.0 112.245 165.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mp -57.72 -48.56 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 124.028 0.931 . . . . 0.0 109.152 178.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -56.97 -62.5 1.7 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.492 1.139 . . . . 0.0 109.445 -174.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.12 -56.02 8.18 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.302 1.429 . . . . 0.0 112.304 173.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -61.56 -50.36 72.94 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.871 0.836 . . . . 0.0 110.911 -176.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.41 -34.0 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 124.079 0.952 . . . . 0.0 110.539 177.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.67 -17.56 6.77 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.926 -0.93 . . . . 0.0 114.812 170.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -86.89 -18.08 31.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.793 1.797 . . . . 0.0 110.816 176.147 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.7 141.78 48.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.949 0.881 . . . . 0.0 112.243 -168.657 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -59.13 117.55 4.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.929 0.892 . . . . 0.0 111.04 175.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.79 -24.99 12.27 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.269 173.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.96 142.5 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -108.84 -45.85 3.73 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.134 1.374 . . . . 0.0 109.455 172.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -154.01 162.83 40.91 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.466 -0.771 . . . . 0.0 110.305 177.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.7 tt -145.99 138.03 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 124.505 1.122 . . . . 0.0 109.137 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -130.53 117.88 20.26 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.628 1.971 . . . . 0.0 106.781 172.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.1 t -117.24 114.93 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.067 1.303 . . . . 0.0 109.474 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.1 t -90.22 106.54 18.55 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.921 -0.487 . . . . 0.0 109.829 -179.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -48.52 40.84 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 164.686 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -56.3 -59.55 4.78 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.035 0.534 . . . . 0.0 111.029 -178.316 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -74.6 -21.4 59.49 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.231 1.015 . . . . 0.0 110.723 -170.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 62.63 19.73 11.53 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.181 1.792 . . . . 0.0 110.36 -172.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -120.54 156.04 32.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.303 1.841 . . . . 0.0 108.286 175.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.47 154.38 46.6 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.463 1.105 . . . . 0.0 109.011 -178.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.8 m -125.64 111.55 15.1 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -177.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 78.5 mt -98.99 161.0 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 171.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 p -124.42 121.17 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 162.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -157.06 176.41 12.79 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.84 1.656 . . . . 0.0 108.72 -178.017 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.08 150.5 74.44 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 120.735 1.607 . . . . 0.0 113.734 169.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.67 72.3 1.41 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 124.745 3.63 . . . . 0.0 110.145 176.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -143.59 -60.12 0.41 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.302 1.041 . . . . 0.0 108.579 177.097 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.6 mt -88.18 -21.32 24.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.656 179.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 tp -120.86 148.67 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.124 0.57 . . . . 0.0 110.053 178.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.1 m -83.33 26.57 0.64 Allowed 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.272 0.5 OUTLIER 71.38 -61.14 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 128.913 2.885 . . . . 0.0 110.063 177.514 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -43.16 71.56 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.492 1.117 . . . . 0.0 108.863 179.374 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -44.67 -51.61 9.01 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 123.542 0.526 . . . . 0.0 111.28 -173.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.06 -52.64 5.25 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.225 0.61 . . . . 0.0 111.986 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -46.37 73.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 122.095 -0.378 . . . . 0.0 110.452 178.356 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -59.6 -28.82 67.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.136 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -61.31 -46.1 91.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 173.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.9 -48.42 88.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.32 173.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -51.32 -50.89 58.52 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.65 -19.43 49.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.5 1.92 . . . . 0.0 114.678 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.9 mmt -57.7 -32.15 67.09 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 120.106 1.321 . . . . 0.0 109.595 170.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.18 43.27 0.33 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.448 1.023 . . . . 0.0 110.844 173.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -145.11 121.53 6.07 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.78 94.37 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.605 2.203 . . . . 0.0 109.738 -175.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.97 -172.46 2.08 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.362 1.065 . . . . 0.0 108.637 -172.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.24 132.35 2.47 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 118.503 0.592 . . . . 0.0 112.381 -175.356 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 123.172 0.589 . . . . 0.0 110.168 174.977 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.31 138.95 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 124.442 1.097 . . . . 0.0 108.775 173.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.34 130.66 52.89 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.465 1.506 . . . . 0.0 107.074 175.002 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -101.21 116.78 33.61 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.615 1.566 . . . . 0.0 108.196 170.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.8 ptp -119.54 135.96 54.55 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.842 0.857 . . . . 0.0 110.339 178.459 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -74.95 153.93 38.35 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 167.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.25 72.85 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 176.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -62.55 166.89 4.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.717 0.77 . . . . 0.0 111.386 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 174.59 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.7 t -53.58 -41.64 66.78 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -175.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.6 m -49.36 -57.6 6.61 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.608 170.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.26 -49.48 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.84 -64.22 0.98 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.088 0.947 . . . . 0.0 110.02 -175.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.34 -53.69 9.29 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.931 1.729 . . . . 0.0 112.584 174.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -58.3 8.38 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.874 0.837 . . . . 0.0 109.658 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.3 -33.23 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.779 1.231 . . . . 0.0 111.044 -176.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.49 -21.43 13.67 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.329 0.966 . . . . 0.0 114.013 173.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -85.1 -19.71 31.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.747 1.773 . . . . 0.0 111.372 176.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.65 137.17 49.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 122.231 1.015 . . . . 0.0 111.932 -166.635 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -52.91 113.4 1.08 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.86 177.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.34 -26.52 8.59 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-O 119.072 -0.849 . . . . 0.0 112.323 175.173 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.2 t -79.57 131.17 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 118.214 1.007 . . . . 0.0 109.18 -176.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -91.54 -55.7 3.4 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.896 0.879 . . . . 0.0 109.185 168.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.35 159.09 43.58 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.535 1.061 . . . . 0.0 109.788 -175.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -140.1 140.78 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.403 1.481 . . . . 0.0 110.107 176.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.05 124.51 31.02 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.576 1.55 . . . . 0.0 107.931 168.136 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.9 t -110.13 89.46 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.846 1.203 . . . . 0.0 110.89 177.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -76.88 78.08 3.46 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.686 1.194 . . . . 0.0 110.427 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.78 -41.6 11.05 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.483 0.713 . . . . 0.0 111.962 178.744 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.57 -54.38 1.16 Allowed 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 126.453 1.901 . . . . 0.0 111.379 170.334 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -84.95 -10.54 56.95 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.466 -171.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 61.92 21.0 11.96 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.325 1.45 . . . . 0.0 110.326 -174.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -136.86 144.21 43.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.624 1.57 . . . . 0.0 108.885 -172.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.49 149.56 48.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.932 1.293 . . . . 0.0 108.727 179.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.5 m -120.69 115.28 23.04 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -176.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 86.8 mt -107.32 159.97 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 171.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.72 125.79 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 167.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -155.42 -177.24 6.41 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 126.447 1.899 . . . . 0.0 107.749 -175.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -138.02 144.5 43.99 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 120.112 1.324 . . . . 0.0 110.559 167.271 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.48 77.28 0.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.071 3.18 . . . . 0.0 110.025 176.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -149.17 -53.44 0.17 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.884 0.873 . . . . 0.0 109.13 174.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -88.19 -25.14 23.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.12 0.568 . . . . 0.0 110.843 176.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.8 tp -118.95 147.43 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.012 0.925 . . . . 0.0 109.648 178.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.4 m -83.47 24.27 0.85 Allowed 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.256 0.5 OUTLIER 72.61 -59.85 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 127.871 2.468 . . . . 0.0 109.86 179.884 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.31 -35.85 40.5 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.211 1.804 . . . . 0.0 109.78 -175.353 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -42.22 -53.76 3.95 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 123.538 0.735 . . . . 0.0 111.458 177.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.89 -49.04 5.91 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.388 1.075 . . . . 0.0 112.087 -176.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -49.33 38.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.1 -0.375 . . . . 0.0 110.999 174.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -53.98 -30.04 45.44 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -57.29 -52.03 67.0 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.388 0.613 . . . . 0.0 109.525 172.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -58.19 -49.91 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.453 173.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -52.98 -48.35 67.52 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.56 -21.62 60.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.379 1.472 . . . . 0.0 114.036 179.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 29.4 mmt -64.17 -30.02 71.1 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.869 1.213 . . . . 0.0 110.526 172.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.37 -33.11 2.19 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 176.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -73.51 107.51 3.49 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-O 117.776 -1.107 . . . . 0.0 108.732 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.75 118.91 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 108.071 -1.55 . . . . 0.0 108.071 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.08 -167.39 1.54 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.254 0.479 . . . . 0.0 110.404 -174.349 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -160.1 151.09 19.12 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -175.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.5 t . . . . . 0 C--N 1.339 0.135 0 C-N-CA 126.65 1.98 . . . . 0.0 108.834 179.035 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.85 145.92 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 123.163 0.585 . . . . 0.0 109.984 177.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -141.94 138.38 31.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.1 116.39 24.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.309 1.444 . . . . 0.0 107.684 -173.769 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -121.79 149.9 42.64 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.841 1.256 . . . . 0.0 110.893 -172.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -98.95 132.62 44.13 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.835 1.654 . . . . 0.0 108.129 177.139 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.14 64.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.372 1.069 . . . . 0.0 110.218 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.93 153.18 41.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.823 179.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.037 174.895 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.4 p . . . . . 0 C--O 1.222 -0.343 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.6 m -54.12 -36.73 63.58 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -170.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -52.18 -57.86 8.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.103 0.252 . . . . 0.0 111.125 169.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.1 -54.28 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.203 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -57.65 -65.02 0.7 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.631 0.729 . . . . 0.0 110.746 -172.314 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.48 -53.55 12.25 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.726 1.631 . . . . 0.0 111.98 176.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -64.21 -50.62 67.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.112 0.956 . . . . 0.0 110.563 -176.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.6 mm -54.99 -39.2 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 123.406 0.682 . . . . 0.0 110.629 175.603 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.11 -20.18 13.97 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.016 1.293 . . . . 0.0 113.978 173.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -92.38 -19.42 22.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 118.987 1.393 . . . . 0.0 109.593 178.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.34 134.3 50.07 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.815 1.293 . . . . 0.0 111.816 -176.101 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.57 110.84 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.522 176.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.3 -25.83 7.25 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 119.085 -0.842 . . . . 0.0 112.219 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.24 136.02 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 118.382 1.091 . . . . 0.0 109.002 -178.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -107.89 -43.75 4.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.244 1.018 . . . . 0.0 110.736 175.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -155.79 161.14 40.71 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.772 0.715 . . . . 0.0 110.324 177.489 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 tt -141.01 144.68 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.896 1.278 . . . . 0.0 110.421 -176.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.02 98.82 3.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.329 1.852 . . . . 0.0 108.727 172.26 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -92.19 112.24 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.381 1.072 . . . . 0.0 110.042 176.382 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 m -94.98 90.96 6.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.705 1.202 . . . . 0.0 108.877 173.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mt -57.91 177.44 0.11 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.223 162.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.23 -61.3 0.39 Allowed 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 127.88 2.472 . . . . 0.0 109.45 -167.352 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -68.23 -17.75 64.39 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.989 0.423 . . . . 0.0 111.22 -177.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 67.21 41.83 2.45 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 127.332 2.253 . . . . 0.0 110.613 -178.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -144.27 141.93 30.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.827 -166.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.18 150.8 44.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.466 -0.771 . . . . 0.0 109.843 -177.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -130.51 121.52 25.93 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -176.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 mp -126.44 159.87 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 124.744 1.218 . . . . 0.0 108.271 -175.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.3 p -129.39 118.57 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.512 0.725 . . . . 0.0 109.597 178.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -159.19 -178.98 7.59 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.677 1.591 . . . . 0.0 109.864 -172.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -148.06 144.56 19.07 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.94 77.85 0.58 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.295 3.33 . . . . 0.0 110.684 175.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.57 -54.45 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.941 1.296 . . . . 0.0 107.586 168.218 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.7 mt -94.78 -21.37 18.76 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.843 -0.599 . . . . 0.0 111.91 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.404 ' C ' ' H ' ' A' ' 54' ' ' VAL . 11.2 tp -120.87 145.97 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.047 0.939 . . . . 0.0 109.554 -177.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 m -74.0 24.56 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.404 ' H ' ' C ' ' A' ' 52' ' ' ILE . 0.8 OUTLIER 73.28 -58.07 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 127.249 2.22 . . . . 0.0 109.626 -177.885 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -80.93 -42.35 21.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.445 1.498 . . . . 0.0 109.647 -174.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -41.16 -51.04 3.51 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.882 0.873 . . . . 0.0 111.87 -174.516 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -40.31 -59.91 1.19 Allowed 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.217 1.407 . . . . 0.0 111.464 -178.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 tptp -73.93 -43.61 57.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -57.49 -26.91 62.0 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.149 -0.969 . . . . 0.0 112.313 -174.151 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.96 -41.81 88.36 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.031 0.832 . . . . 0.0 109.128 174.102 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -62.83 -33.97 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.179 176.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -61.39 -52.66 63.67 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.48 -31.84 64.43 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.206 1.002 . . . . 0.0 112.716 -174.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.9 mmm -51.27 -36.34 41.69 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.479 0.582 . . . . 0.0 111.43 171.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.29 -36.79 1.45 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.285 0.945 . . . . 0.0 111.281 176.666 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -68.01 115.29 26.93 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.263 -173.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.76 101.49 0.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.428 2.085 . . . . 0.0 108.815 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.09 168.42 19.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -168.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.68 148.5 39.2 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.324 -0.86 . . . . 0.0 112.549 -166.077 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.437 -1.12 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.5 t -79.6 145.67 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 124.83 1.252 . . . . 0.0 109.801 -178.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.54 149.42 46.72 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 126.138 1.775 . . . . 0.0 107.845 176.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.76 144.85 31.18 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.276 0.943 . . . . 0.0 111.71 155.86 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.89 153.72 45.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.116 1.766 . . . . 0.0 108.94 175.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -114.81 138.94 50.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.325 1.05 . . . . 0.0 108.529 177.224 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.04 68.86 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.857 0.863 . . . . 0.0 110.988 -172.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -68.29 165.96 17.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.103 0.478 . . . . 0.0 110.261 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 O-C-N 121.604 -0.685 . . . . 0.0 114.063 168.958 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 m -54.02 -37.13 63.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -168.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.8 m -50.06 -61.31 2.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.568 0.542 . . . . 0.0 111.246 168.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.6 -50.81 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -56.45 -67.59 0.29 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.129 0.966 . . . . 0.0 110.891 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.68 -49.87 26.76 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.097 1.808 . . . . 0.0 112.124 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -62.62 -52.17 64.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.872 0.836 . . . . 0.0 109.62 -178.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.0 mm -55.57 -36.28 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.183 0.593 . . . . 0.0 111.202 175.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.51 -19.13 11.96 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.738 -1.034 . . . . 0.0 113.807 175.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -90.25 -18.98 24.69 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 119.653 1.726 . . . . 0.0 111.16 176.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.12 133.85 47.56 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.659 1.219 . . . . 0.0 112.39 -170.267 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -52.62 106.34 0.15 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.449 176.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.69 -30.74 4.57 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-O 119.475 -0.625 . . . . 0.0 111.917 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 t -82.8 140.61 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 117.691 0.745 . . . . 0.0 109.552 -173.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -111.25 -41.87 4.06 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.947 0.899 . . . . 0.0 111.689 174.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.45 159.23 43.4 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.822 -0.549 . . . . 0.0 109.704 -179.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.2 tt -146.59 145.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.59 1.556 . . . . 0.0 107.704 173.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -136.56 109.17 7.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.104 2.161 . . . . 0.0 106.465 173.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -102.44 120.28 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.916 1.235 . . . . 0.0 109.191 175.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 t -105.91 90.48 3.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.169 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -46.13 67.02 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.356 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -56.95 2.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.968 1.707 . . . . 0.0 110.755 170.192 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -17.75 60.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.032 -175.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 73.12 2.53 4.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.837 2.455 . . . . 0.0 112.052 -175.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -111.24 151.57 28.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.406 1.882 . . . . 0.0 109.699 -179.274 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.04 160.2 31.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 163.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.8 m -119.96 128.03 53.2 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 175.74 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.0 mt -122.74 162.84 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -135.77 117.88 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.27 0.628 . . . . 0.0 110.277 177.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.28 -179.32 8.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.141 1.376 . . . . 0.0 110.043 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -135.71 149.77 69.97 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.209 1.004 . . . . 0.0 113.05 177.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.09 67.88 7.99 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.374 3.382 . . . . 0.0 109.928 -176.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 -55.99 0.26 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.865 0.866 . . . . 0.0 109.223 177.071 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.92 -29.03 35.62 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.048 -0.501 . . . . 0.0 109.811 -177.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 54' ' ' VAL . 10.7 tp -118.93 145.4 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 123.433 0.693 . . . . 0.0 109.403 -178.16 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.9 m -81.67 33.83 0.38 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -174.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER 74.36 -61.68 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 128.065 2.546 . . . . 0.0 108.262 175.966 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.43 -40.17 23.79 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 124.483 1.113 . . . . 0.0 109.758 -174.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -40.48 -48.54 2.8 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 123.888 0.743 . . . . 0.0 111.413 -174.465 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -34.78 -65.5 0.21 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.862 1.665 . . . . 0.0 110.872 174.385 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HZ3' ' CB ' ' A' ' 68' ' ' ALA . 1.1 tmtt? -75.98 -41.88 50.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.671 -0.643 . . . . 0.0 112.185 178.48 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -58.31 -22.29 52.43 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.845 -174.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -62.65 -42.08 99.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.766 0.712 . . . . 0.0 109.351 173.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.75 -49.68 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.102 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -54.45 -44.72 72.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.78 -22.66 62.46 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.82 1.248 . . . . 0.0 114.144 176.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.0 mmt -66.34 -28.62 68.8 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.145 1.338 . . . . 0.0 110.586 170.532 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.21 -42.71 1.28 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -62.31 110.95 3.82 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.901 0.88 . . . . 0.0 110.824 -173.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.99 96.69 0.7 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.54 2.16 . . . . 0.0 109.575 -175.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.429 ' CB ' ' HZ3' ' A' ' 58' ' ' LYS . . . -108.74 -161.17 0.75 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.948 0.899 . . . . 0.0 109.51 -174.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -162.56 146.51 11.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.367 0.531 . . . . 0.0 112.179 -177.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 C-N-CA 125.57 1.548 . . . . 0.0 108.531 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.44 175.77 10.26 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 124.874 0.985 . . . . 0.0 111.097 -171.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.54 136.9 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.624 1.169 . . . . 0.0 108.373 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.08 148.11 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.24 0.616 . . . . 0.0 110.113 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 141.8 37.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 171.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 130.65 56.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.53 151.74 39.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.244 1.818 . . . . 0.0 108.842 -176.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -95.37 136.92 35.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.41 67.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -70.26 170.15 12.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.811 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.7 -42.94 2.76 Favored Glycine 0 CA--C 1.529 0.926 0 O-C-N 121.248 -0.908 . . . . 0.0 113.504 170.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.1 mtt -58.46 -52.52 65.3 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.574 1.187 . . . . 0.0 111.306 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.5 t 46.92 24.13 0.33 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.475 1.91 . . . . 0.0 115.246 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -149.87 132.95 16.26 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -74.91 56.83 0.76 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.037 1.335 . . . . 0.0 111.018 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -149.67 21.2 0.91 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.101 0.96 . . . . 0.0 110.211 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.15 63.36 1.1 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p -121.3 -78.01 0.59 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.3 t -52.21 -43.59 64.33 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.9 m -46.43 -60.24 2.47 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.655 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -48.79 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -57.24 -63.87 1.08 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.975 0.893 . . . . 0.0 110.085 -174.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.56 -54.96 8.39 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.826 1.679 . . . . 0.0 112.778 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -56.83 -56.61 19.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.179 0.989 . . . . 0.0 109.7 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.86 -28.29 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 110.51 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.51 -24.41 7.46 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.757 1.17 . . . . 0.0 114.306 170.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -87.55 -11.16 49.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 119.826 1.813 . . . . 0.0 111.381 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 139.09 55.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.796 0.808 . . . . 0.0 110.77 -171.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 115.73 4.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.386 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.54 -19.75 23.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.576 -1.124 . . . . 0.0 112.445 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.84 139.19 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 118.853 1.326 . . . . 0.0 109.79 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.8 -39.05 3.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.659 1.184 . . . . 0.0 110.74 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -149.73 156.78 42.44 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.795 -0.566 . . . . 0.0 109.852 172.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -137.2 145.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.565 1.546 . . . . 0.0 108.204 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -138.44 114.85 10.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.719 1.607 . . . . 0.0 107.008 166.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -102.61 129.9 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.129 0.877 . . . . 0.0 109.995 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.1 t -115.89 86.65 2.52 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.505 1.122 . . . . 0.0 108.119 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -39.07 69.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.386 -0.34 . . . . 0.0 110.374 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.93 -58.51 2.74 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.01 1.324 . . . . 0.0 110.694 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -79.09 -10.2 59.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.789 0.804 . . . . 0.0 110.456 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.83 24.41 13.74 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.101 1.761 . . . . 0.0 109.552 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -142.83 157.94 44.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.681 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.13 155.99 40.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -171.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.7 m -128.82 121.87 29.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.0 mt -118.73 155.17 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.38 126.48 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -156.77 179.86 8.88 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.673 1.589 . . . . 0.0 109.536 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.86 142.43 45.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.11 74.71 2.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.16 3.24 . . . . 0.0 110.125 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.36 -57.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.137 1.375 . . . . 0.0 107.452 176.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.54 -19.85 30.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.144 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 tp -128.32 152.3 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 111.074 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -89.62 27.56 1.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.917 0.887 . . . . 0.0 112.783 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 t 72.28 -60.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 128.147 2.579 . . . . 0.0 109.501 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.4 -35.98 30.07 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.797 1.239 . . . . 0.0 109.873 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -46.55 -46.62 19.49 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.659 0.599 . . . . 0.0 110.89 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.25 -52.57 1.48 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.583 1.153 . . . . 0.0 113.159 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -46.13 63.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 109.801 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 4.3 mptp? -57.71 -29.09 64.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.452 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -63.53 -41.95 98.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.625 -0.672 . . . . 0.0 109.29 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.83 -44.99 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.389 174.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' ' 59' ' ' LYS . 74.8 mt-10 -53.28 -46.4 69.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.57 43.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.064 1.346 . . . . 0.0 113.495 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -64.04 -28.05 69.53 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.238 0.926 . . . . 0.0 110.459 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.39 -34.88 2.36 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.73 118.82 74.12 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.311 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.13 107.92 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.192 1.928 . . . . 0.0 109.089 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.95 -168.15 1.62 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.881 1.273 . . . . 0.0 108.394 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -164.15 161.05 22.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.908 -0.495 . . . . 0.0 111.755 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -98.62 119.43 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 110.378 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -98.57 -61.01 1.43 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.989 -0.444 . . . . 0.0 111.077 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -101.93 179.31 4.37 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.639 0.775 . . . . 0.0 109.4 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.52 177.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 124.807 1.243 . . . . 0.0 107.796 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.4 151.09 41.3 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.22 172.79 39.06 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 172.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 . . . . . 0 C--O 1.254 1.319 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 171.746 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.44 175.77 10.26 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 124.874 0.985 . . . . 0.0 111.097 -171.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.54 136.9 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.624 1.169 . . . . 0.0 108.373 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.08 148.11 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.24 0.616 . . . . 0.0 110.113 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 141.8 37.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 171.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 130.65 56.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.53 151.74 39.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.244 1.818 . . . . 0.0 108.842 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -95.37 136.92 35.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.41 67.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -70.26 170.15 12.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.811 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.7 -42.94 2.76 Favored Glycine 0 CA--C 1.529 0.926 0 O-C-N 121.248 -0.908 . . . . 0.0 113.504 170.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.1 mtt -58.46 -52.52 65.3 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.574 1.187 . . . . 0.0 111.306 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.5 t 46.92 24.13 0.33 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.475 1.91 . . . . 0.0 115.246 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -149.87 132.95 16.26 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -74.91 56.83 0.76 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.037 1.335 . . . . 0.0 111.018 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -149.67 21.2 0.91 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.101 0.96 . . . . 0.0 110.211 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.15 63.36 1.1 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p -121.3 -78.01 0.59 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.3 t -52.21 -43.59 64.33 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.9 m -46.43 -60.24 2.47 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.655 169.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -48.79 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -57.24 -63.87 1.08 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.975 0.893 . . . . 0.0 110.085 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.56 -54.96 8.39 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.826 1.679 . . . . 0.0 112.778 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -56.83 -56.61 19.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.179 0.989 . . . . 0.0 109.7 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.86 -28.29 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 110.51 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.51 -24.41 7.46 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.757 1.17 . . . . 0.0 114.306 170.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -87.55 -11.16 49.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 119.826 1.813 . . . . 0.0 111.381 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 139.09 55.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.796 0.808 . . . . 0.0 110.77 -171.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 115.73 4.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.386 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.54 -19.75 23.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.576 -1.124 . . . . 0.0 112.445 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.84 139.19 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 118.853 1.326 . . . . 0.0 109.79 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.8 -39.05 3.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.659 1.184 . . . . 0.0 110.74 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -149.73 156.78 42.44 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.795 -0.566 . . . . 0.0 109.852 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -137.2 145.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.565 1.546 . . . . 0.0 108.204 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -138.44 114.85 10.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.719 1.607 . . . . 0.0 107.008 166.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -102.61 129.9 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.129 0.877 . . . . 0.0 109.995 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.1 t -115.89 86.65 2.52 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.505 1.122 . . . . 0.0 108.119 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -39.07 69.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.386 -0.34 . . . . 0.0 110.374 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.93 -58.51 2.74 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.01 1.324 . . . . 0.0 110.694 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -79.09 -10.2 59.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.789 0.804 . . . . 0.0 110.456 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.83 24.41 13.74 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.101 1.761 . . . . 0.0 109.552 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -142.83 157.94 44.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.681 -166.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.13 155.99 40.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -171.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.7 m -128.82 121.87 29.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.0 mt -118.73 155.17 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.38 126.48 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -156.77 179.86 8.88 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.673 1.589 . . . . 0.0 109.536 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.86 142.43 45.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.11 74.71 2.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.16 3.24 . . . . 0.0 110.125 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.36 -57.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.137 1.375 . . . . 0.0 107.452 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.54 -19.85 30.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.144 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 tp -128.32 152.3 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 111.074 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -89.62 27.56 1.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.917 0.887 . . . . 0.0 112.783 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 t 72.28 -60.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 128.147 2.579 . . . . 0.0 109.501 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.4 -35.98 30.07 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.797 1.239 . . . . 0.0 109.873 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -46.55 -46.62 19.49 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.659 0.599 . . . . 0.0 110.89 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.25 -52.57 1.48 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.583 1.153 . . . . 0.0 113.159 173.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -46.13 63.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 109.801 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 4.3 mptp? -57.71 -29.09 64.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.452 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -63.53 -41.95 98.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.625 -0.672 . . . . 0.0 109.29 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.83 -44.99 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.389 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' ' 59' ' ' LYS . 74.8 mt-10 -53.28 -46.4 69.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.57 43.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.064 1.346 . . . . 0.0 113.495 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -64.04 -28.05 69.53 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.238 0.926 . . . . 0.0 110.459 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.39 -34.88 2.36 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.73 118.82 74.12 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.311 -175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.13 107.92 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.192 1.928 . . . . 0.0 109.089 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.95 -168.15 1.62 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.881 1.273 . . . . 0.0 108.394 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -164.15 161.05 22.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.908 -0.495 . . . . 0.0 111.755 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -98.62 119.43 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 110.378 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -98.57 -61.01 1.43 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.989 -0.444 . . . . 0.0 111.077 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -101.93 179.31 4.37 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.639 0.775 . . . . 0.0 109.4 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.52 177.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 124.807 1.243 . . . . 0.0 107.796 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.4 151.09 41.3 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.22 172.79 39.06 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 . . . . . 0 C--O 1.254 1.319 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 171.746 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.092 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -70.31 -178.36 1.68 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.797 2.039 . . . . 0.0 109.334 163.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.0 t -116.6 136.96 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 126.263 1.825 . . . . 0.0 108.381 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.64 133.83 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 123.99 0.916 . . . . 0.0 108.593 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tt -113.21 148.15 36.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.366 1.466 . . . . 0.0 108.21 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.97 123.02 46.97 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 161.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -115.44 163.05 16.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.233 1.013 . . . . 0.0 109.585 169.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -108.72 131.3 55.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.988 2.115 . . . . 0.0 106.408 170.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.05 60.32 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 126.523 1.929 . . . . 0.0 106.869 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -58.77 133.38 55.91 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.14 -45.36 1.33 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.107 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.5 mmt -77.48 69.1 3.69 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.026 1.413 . . . . 0.0 109.266 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 t -121.5 0.62 9.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.953 1.301 . . . . 0.0 111.802 -173.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.5 m -77.39 -81.48 0.09 Allowed 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.594 -0.691 . . . . 0.0 111.01 -173.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -170.62 130.9 0.87 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.2 t 55.79 51.1 12.88 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.639 1.575 . . . . 0.0 112.949 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 m -125.64 53.84 1.53 Allowed 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.266 1.427 . . . . 0.0 107.924 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.7 p -135.59 -69.61 0.49 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.709 1.204 . . . . 0.0 108.253 -172.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 p -53.43 -43.42 67.99 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.7 m -42.01 -62.53 0.9 Allowed 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.921 0.888 . . . . 0.0 112.19 165.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.99 -48.93 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 123.908 0.883 . . . . 0.0 108.932 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -57.25 -61.07 2.73 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.47 1.128 . . . . 0.0 109.332 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.76 -53.95 19.61 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.754 1.645 . . . . 0.0 112.308 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.5 -52.55 65.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.017 0.909 . . . . 0.0 110.068 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.3 mm -57.54 -31.82 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.708 1.203 . . . . 0.0 111.116 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.13 -18.87 10.0 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.753 -1.026 . . . . 0.0 114.227 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -86.81 -11.79 49.9 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.637 1.719 . . . . 0.0 111.095 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 135.82 45.85 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 122.269 1.033 . . . . 0.0 111.748 -170.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -57.74 110.37 0.88 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.85 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.13 -24.11 9.51 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 119.251 -0.749 . . . . 0.0 112.661 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 t -80.01 136.08 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 118.213 1.007 . . . . 0.0 109.245 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -107.14 -38.83 5.89 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.703 1.201 . . . . 0.0 110.442 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.59 167.34 30.42 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.218 -0.926 . . . . 0.0 110.62 172.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.9 tt -150.91 144.43 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.276 1.03 . . . . 0.0 108.561 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -129.58 129.62 44.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.898 1.679 . . . . 0.0 106.518 167.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.82 123.42 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.581 1.082 . . . . 0.0 110.982 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.5 t -81.25 158.98 24.63 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.107 0.563 . . . . 0.0 110.045 174.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.87 -67.93 0.83 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 163.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.08 -54.65 8.16 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 126.193 1.797 . . . . 0.0 110.678 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -77.64 -18.74 56.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.252 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 55.06 18.82 2.47 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 127.146 2.178 . . . . 0.0 111.409 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -101.05 152.12 20.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.596 1.558 . . . . 0.0 107.933 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.04 152.52 37.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.846 -0.534 . . . . 0.0 109.866 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 m -130.35 115.73 17.32 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -171.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.88 157.99 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.32 116.57 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 167.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -159.07 178.69 9.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.425 1.49 . . . . 0.0 109.549 -173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -138.97 149.62 62.25 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.31 75.52 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.229 3.286 . . . . 0.0 109.936 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.58 -57.0 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.259 1.423 . . . . 0.0 107.414 170.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.8 mt -90.25 -23.03 21.34 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.452 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 tp -121.68 149.06 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 119.083 0.856 . . . . 0.0 110.31 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 m -82.86 24.17 0.77 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 71.13 -65.74 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 128.737 2.815 . . . . 0.0 109.055 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -68.88 -39.85 79.55 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.434 1.094 . . . . 0.0 109.215 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -42.32 -54.19 3.86 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.403 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -49.86 10.75 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.583 0.753 . . . . 0.0 110.952 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -42.9 71.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.648 0.779 . . . . 0.0 111.422 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -56.23 -35.09 66.97 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.046 -1.033 . . . . 0.0 112.652 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -62.13 -42.28 99.08 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.66 -47.43 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 118.017 -0.992 . . . . 0.0 111.523 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -50.76 -49.27 58.49 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.149 1.341 . . . . 0.0 109.238 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.85 -19.07 48.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.28 1.832 . . . . 0.0 114.051 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mmm -61.33 -28.72 69.42 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.656 1.116 . . . . 0.0 110.15 169.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.02 38.86 0.55 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.051 1.31 . . . . 0.0 111.554 169.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -148.88 122.18 4.58 Favored Pre-proline 0 C--O 1.224 -0.28 0 CA-C-O 117.314 -1.326 . . . . 0.0 108.055 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.81 111.26 1.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.018 1.812 . . . . 0.0 109.452 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.17 -176.35 3.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -160.48 149.77 17.29 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 120.399 -1.438 . . . . 0.0 111.196 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.07 127.74 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.8 mtpm? -78.52 -73.21 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 121.156 -0.218 . . . . 0.0 111.582 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -158.74 153.75 25.16 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.087 0.955 . . . . 0.0 108.49 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -159.2 120.48 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.741 1.216 . . . . 0.0 110.209 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -157.06 158.07 35.78 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.945 1.298 . . . . 0.0 107.862 167.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.43 -122.12 2.18 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.268 0.937 . . . . 0.0 111.916 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.042 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.493 ' N ' ' OXT' ' A' ' 76' ' ' ARG . . . . . . . . 0 N--CA 1.471 0.975 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -168.86 140.16 2.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.41 146.49 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 123.688 0.795 . . . . 0.0 109.284 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.86 119.49 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 125.931 1.692 . . . . 0.0 111.28 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.67 131.3 56.99 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.229 1.012 . . . . 0.0 108.881 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.4 119.17 38.35 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.896 1.279 . . . . 0.0 110.495 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -113.34 153.24 28.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.766 1.226 . . . . 0.0 109.931 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.92 133.88 43.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 169.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.82 68.0 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.5 150.23 48.32 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.674 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.75 -40.99 2.24 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.666 -0.646 . . . . 0.0 113.597 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.1 mtt -62.46 117.22 5.88 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.578 1.189 . . . . 0.0 108.772 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.6 t -120.17 142.4 49.0 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.339 1.055 . . . . 0.0 110.041 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 t 68.0 122.51 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.646 1.979 . . . . 0.0 111.895 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -47.85 103.48 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.302 1.041 . . . . 0.0 111.865 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 m -170.03 -64.49 0.02 OUTLIER 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.672 1.589 . . . . 0.0 108.886 -172.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.2 m -77.79 71.7 4.28 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.9 p -136.09 -75.71 0.43 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.401 1.48 . . . . 0.0 107.116 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.8 m -55.64 -38.5 69.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.22 -52.75 60.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.589 0.233 . . . . 0.0 110.678 171.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.11 -53.48 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.45 -61.31 2.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.078 0.942 . . . . 0.0 110.195 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.52 -55.57 7.88 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.719 1.628 . . . . 0.0 112.471 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.66 -48.76 75.93 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.37 1.085 . . . . 0.0 110.322 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.4 mm -59.46 -33.42 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.498 0.719 . . . . 0.0 110.171 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.8 -13.62 8.51 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.489 1.042 . . . . 0.0 114.073 172.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.13 -14.27 31.47 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.388 1.594 . . . . 0.0 109.936 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.41 137.33 52.66 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 122.655 1.217 . . . . 0.0 112.886 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -54.69 108.0 0.35 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.438 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.27 -24.65 9.14 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-O 118.67 -1.072 . . . . 0.0 111.992 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.9 135.36 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 118.579 1.19 . . . . 0.0 108.873 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -108.05 -42.35 4.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.658 1.583 . . . . 0.0 109.919 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -152.1 159.73 43.59 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.8 tt -143.25 152.48 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 108.495 172.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.49 110.99 5.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.743 2.017 . . . . 0.0 105.676 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.55 130.93 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.022 0.929 . . . . 0.0 109.376 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 t -117.23 90.37 3.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.15 -46.07 65.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -41.96 -58.83 1.93 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.626 1.17 . . . . 0.0 111.54 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -78.07 -7.41 56.91 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.836 0.827 . . . . 0.0 111.328 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 65.07 15.77 10.18 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 127.175 2.19 . . . . 0.0 110.7 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -132.53 154.55 49.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.824 1.649 . . . . 0.0 109.685 -166.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.02 165.57 30.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -134.87 126.76 29.39 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp -108.94 152.95 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 167.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.74 117.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -156.73 -179.42 8.17 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.945 1.298 . . . . 0.0 109.147 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -131.4 147.89 67.93 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.373 1.069 . . . . 0.0 112.915 173.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.25 73.04 2.14 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.977 3.118 . . . . 0.0 109.662 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.84 -62.28 0.29 Allowed 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.195 0.998 . . . . 0.0 108.803 175.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.8 mt -83.65 -24.14 31.5 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.604 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 tp -114.11 156.84 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.109 0.963 . . . . 0.0 109.207 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.85 17.49 1.51 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.04 0.536 . . . . 0.0 112.281 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 68.64 -59.63 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.941 2.096 . . . . 0.0 109.402 -165.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -88.57 -28.36 20.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.909 -167.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -40.81 -53.12 2.92 Favored 'General case' 0 C--N 1.343 0.321 0 O-C-N 124.069 0.856 . . . . 0.0 110.543 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -43.18 -67.96 0.23 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.586 1.154 . . . . 0.0 110.544 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -46.65 84.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.949 -0.469 . . . . 0.0 110.756 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -51.94 -32.67 34.09 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -69.2 -43.46 74.07 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.566 1.075 . . . . 0.0 109.327 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.96 -39.78 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.795 -0.621 . . . . 0.0 109.671 173.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.23 -55.31 36.45 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.928 0.785 . . . . 0.0 108.945 174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.31 -30.56 51.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.332 1.853 . . . . 0.0 113.425 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 26.4 mmt -50.7 -35.78 32.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.065 0.848 . . . . 0.0 111.426 172.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.96 41.63 0.44 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.378 0.99 . . . . 0.0 111.648 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -145.95 126.63 7.23 Favored Pre-proline 0 C--O 1.223 -0.323 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.54 111.06 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.483 1.456 . . . . 0.0 109.052 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.79 -169.24 1.46 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -164.58 149.6 9.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.621 -0.674 . . . . 0.0 110.837 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.39 131.1 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -73.22 -94.46 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.774 0.671 . . . . 0.0 111.135 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.92 150.27 25.73 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 tp -157.2 146.35 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 126.433 1.893 . . . . 0.0 106.556 -172.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -156.39 161.37 40.12 Favored 'General case' 0 N--CA 1.458 -0.035 0 C-N-CA 126.904 2.082 . . . . 0.0 105.986 166.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.91 173.85 33.89 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.493 ' OXT' ' N ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.855 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 165.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.939 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 7.23 84.1 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 129.624 3.17 . . . . 0.0 113.711 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -108.54 146.89 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 123.683 0.793 . . . . 0.0 109.794 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.5 t -78.61 134.54 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 124.916 1.286 . . . . 0.0 108.679 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.42 129.13 44.29 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.37 130.87 42.0 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.042 0.937 . . . . 0.0 110.099 170.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -131.18 146.55 52.38 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.306 1.442 . . . . 0.0 108.786 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HZ1' ' CD ' ' A' ' 10' ' ' GLU . 3.0 mmtp -82.8 150.7 26.45 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.64 66.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.037 0.935 . . . . 0.0 108.707 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' ' 8' ' ' LYS . 6.0 mm-40 -62.53 158.75 17.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.763 -176.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.12 -60.69 0.36 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.5 mmm -70.34 131.15 43.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.327 0.564 . . . . 0.0 110.198 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -132.84 -33.03 1.21 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.483 1.113 . . . . 0.0 111.763 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.8 p -91.85 141.01 29.12 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.405 0.682 . . . . 0.0 109.465 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.29 111.26 1.15 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.39 -85.29 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.962 1.305 . . . . 0.0 108.081 -178.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.29 81.67 1.02 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.87 0.843 . . . . 0.0 109.727 -170.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.6 p -132.55 -80.26 0.5 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.629 1.972 . . . . 0.0 106.518 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.6 t -55.68 -39.99 71.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -168.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -49.31 -58.47 5.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.454 0.301 . . . . 0.0 111.716 168.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.07 -52.38 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -58.79 -62.38 1.91 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.766 0.793 . . . . 0.0 110.29 -172.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.16 -55.36 6.61 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.132 1.825 . . . . 0.0 112.534 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -60.64 -54.04 50.14 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.564 1.182 . . . . 0.0 109.776 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 mm -55.24 -33.8 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.196 0.999 . . . . 0.0 110.81 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.56 -23.13 9.09 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.035 1.302 . . . . 0.0 114.184 173.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -89.75 -12.59 38.9 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.589 1.694 . . . . 0.0 111.455 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.56 135.35 51.4 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.108 0.956 . . . . 0.0 110.84 -172.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -56.54 106.06 0.26 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.489 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.42 -26.44 6.64 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-O 119.054 -0.859 . . . . 0.0 112.225 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.03 132.03 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 118.476 1.138 . . . . 0.0 108.575 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -109.11 -31.02 7.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.695 0.798 . . . . 0.0 110.884 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -159.91 170.3 21.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.255 0.934 . . . . 0.0 110.475 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.2 tt -152.6 147.16 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.703 0.801 . . . . 0.0 109.867 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -136.98 106.8 6.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.025 1.73 . . . . 0.0 107.292 168.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.8 t -93.3 113.33 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 119.43 1.014 . . . . 0.0 109.55 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.88 73.18 1.75 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 tt -46.37 -50.39 16.56 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.397 1.079 . . . . 0.0 110.424 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.83 -53.98 2.19 Favored 'General case' 0 CA--C 1.523 -0.084 0 C-N-CA 125.827 1.651 . . . . 0.0 111.628 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.1 -16.11 58.28 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.57 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 70.25 8.51 6.67 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.977 2.111 . . . . 0.0 111.605 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -124.76 143.95 50.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.862 2.065 . . . . 0.0 107.889 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.71 157.2 42.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.431 1.092 . . . . 0.0 108.72 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.8 m -130.49 104.69 7.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.506 1.922 . . . . 0.0 107.151 -171.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.81 153.45 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.17 117.2 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.054 0.942 . . . . 0.0 109.753 168.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -158.71 178.81 9.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.654 1.182 . . . . 0.0 110.811 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.69 142.62 37.35 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 124.121 0.968 . . . . 0.0 112.208 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.43 75.06 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.871 3.048 . . . . 0.0 110.314 172.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -140.52 -54.55 0.51 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.4 mt -89.63 -22.69 22.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.261 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.1 tp -119.54 150.24 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.877 0.871 . . . . 0.0 110.003 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.2 m -86.26 29.13 0.77 Allowed 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.261 0.5 OUTLIER 74.02 -56.69 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.631 2.372 . . . . 0.0 111.14 175.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -85.38 -36.18 20.89 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.571 1.548 . . . . 0.0 109.749 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -42.89 -50.87 5.71 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 123.842 0.714 . . . . 0.0 110.972 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.91 -53.4 3.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 123.907 0.883 . . . . 0.0 112.113 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -45.63 61.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.304 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -55.09 -29.54 57.79 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -61.72 -43.18 99.36 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.745 0.702 . . . . 0.0 109.714 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.98 -49.35 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.626 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -51.92 -48.4 64.22 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.25 -19.95 56.84 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.06 1.744 . . . . 0.0 113.973 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.0 mmm -60.91 -34.08 74.12 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.74 1.155 . . . . 0.0 109.466 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.29 -33.33 2.01 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -75.39 119.39 76.78 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.026 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.53 117.32 4.51 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.21 1.94 . . . . 0.0 108.596 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.3 -172.37 2.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.857 0.463 . . . . 0.0 109.905 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.58 137.77 9.2 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.11 136.62 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.348 1.459 . . . . 0.0 107.819 171.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -88.03 -77.77 0.34 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -155.4 143.81 20.3 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 119.269 0.94 . . . . 0.0 110.283 -175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -154.92 114.17 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.831 1.253 . . . . 0.0 108.074 -164.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -160.59 140.71 11.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.7 81.02 0.06 OUTLIER Glycine 0 CA--C 1.531 1.039 0 CA-C-N 120.142 1.337 . . . . 0.0 115.436 -169.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.245 0 C-N-CA 129.019 2.928 . . . . 0.0 108.673 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.952 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -116.18 173.86 6.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.63 1.172 . . . . 0.0 109.833 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -97.23 151.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -168.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.1 t -97.16 126.62 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 125.972 1.709 . . . . 0.0 110.632 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.82 153.56 20.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.363 1.865 . . . . 0.0 108.108 170.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -125.19 126.28 44.98 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.447 1.099 . . . . 0.0 109.08 163.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.7 ptp -121.07 161.84 21.03 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.715 1.606 . . . . 0.0 110.823 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -98.99 134.01 42.43 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.507 1.923 . . . . 0.0 108.577 165.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.4 t -116.3 71.01 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 126.369 1.867 . . . . 0.0 106.617 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -77.43 174.15 11.16 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.623 0.769 . . . . 0.0 110.745 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.56 -50.45 3.54 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.24 -0.756 . . . . 0.0 112.919 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -40.0 -55.66 2.0 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.772 1.629 . . . . 0.0 111.456 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.251 5.9 t 50.78 -170.59 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.148 1.779 . . . . 0.0 113.441 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 t 65.4 156.2 0.09 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.211 1.804 . . . . 0.0 112.163 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.73 39.52 0.42 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.517 -1.364 . . . . 0.0 112.226 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 t -171.0 108.14 0.29 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.121 1.368 . . . . 0.0 109.19 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.4 p 178.82 53.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.656 1.582 . . . . 0.0 108.006 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -130.54 -73.52 0.55 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.2 t -50.28 -42.32 52.15 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -46.55 -58.2 4.03 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.106 0.563 . . . . 0.0 111.626 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -58.57 -48.56 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 123.644 0.777 . . . . 0.0 109.727 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.07 -64.67 0.76 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 122.52 1.152 . . . . 0.0 110.485 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.9 -54.13 8.3 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.531 2.015 . . . . 0.0 112.244 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -54.79 43.17 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.967 0.883 . . . . 0.0 110.103 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.4 mm -59.14 -31.45 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.074 0.95 . . . . 0.0 110.91 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.05 -15.73 22.74 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.741 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -90.84 -11.43 39.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.627 1.714 . . . . 0.0 111.172 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.32 132.6 48.73 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.427 1.108 . . . . 0.0 111.068 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -57.97 107.98 0.53 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.299 172.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.08 -15.94 13.29 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.823 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 t -87.97 128.69 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 119.033 1.416 . . . . 0.0 109.426 -175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -83.62 -51.34 7.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.948 0.899 . . . . 0.0 110.282 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -158.42 167.97 28.24 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.616 0.643 . . . . 0.0 110.734 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.7 tt -142.49 140.26 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 125.591 1.557 . . . . 0.0 109.073 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -129.55 112.45 13.75 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.638 1.575 . . . . 0.0 107.414 168.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.21 108.82 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 C-N-CA 124.053 0.941 . . . . 0.0 109.6 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 m -82.42 113.74 20.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.18 179.71 0.19 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 158.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 67.54 -65.05 0.25 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 127.968 2.507 . . . . 0.0 109.498 -170.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.99 -22.96 66.49 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.247 1.019 . . . . 0.0 111.176 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 64.61 15.48 9.71 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.913 2.085 . . . . 0.0 111.91 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -120.38 132.31 55.21 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.786 1.234 . . . . 0.0 109.228 -169.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.32 150.29 47.28 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.735 0.814 . . . . 0.0 108.975 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.36 130.41 52.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.7 mt -126.7 158.34 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.88 122.68 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -158.64 179.79 8.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.93 1.292 . . . . 0.0 110.888 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -136.24 154.1 77.0 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 164.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.92 74.71 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.752 3.635 . . . . 0.0 109.958 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.01 -57.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.684 1.194 . . . . 0.0 108.081 170.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 mt -87.78 -28.03 21.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.809 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.2 tp -119.64 144.38 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 118.703 0.683 . . . . 0.0 109.882 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 m -81.57 31.05 0.35 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 72.24 -61.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 129.172 2.989 . . . . 0.0 110.166 176.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -82.81 -36.52 25.48 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.41 1.884 . . . . 0.0 109.355 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -42.06 -52.71 4.17 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.455 0.702 . . . . 0.0 111.055 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -36.48 -52.86 0.86 Allowed 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.712 2.005 . . . . 0.0 111.804 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.59 -38.55 65.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.29 1.036 . . . . 0.0 112.551 175.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -57.73 -33.17 68.15 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.632 -1.292 . . . . 0.0 112.548 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -62.66 -40.33 96.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -58.78 -46.32 90.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 117.919 -1.039 . . . . 0.0 111.75 170.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.97 -49.59 59.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.873 1.215 . . . . 0.0 108.031 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.89 -18.86 61.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.303 1.841 . . . . 0.0 114.207 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.7 mmm -62.14 -21.43 65.03 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.689 1.132 . . . . 0.0 110.532 168.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.71 34.57 2.03 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 125.238 1.399 . . . . 0.0 110.859 172.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -148.34 125.63 5.63 Favored Pre-proline 0 N--CA 1.456 -0.138 0 CA-C-O 117.764 -1.112 . . . . 0.0 108.395 -173.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.69 116.57 3.62 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.119 1.879 . . . . 0.0 110.372 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.13 -179.64 3.89 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.602 0.761 . . . . 0.0 109.465 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -162.9 149.12 12.36 Favored 'General case' 0 C--O 1.224 -0.265 0 O-C-N 120.323 -1.485 . . . . 0.0 111.809 -169.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 t -98.89 129.44 49.26 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.056 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -100.73 -63.7 1.11 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.78 0.432 . . . . 0.0 110.671 170.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.59 153.33 19.84 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.8 tt -142.66 167.4 14.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 124.837 1.255 . . . . 0.0 108.904 -173.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.57 70.13 1.77 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.679 1.992 . . . . 0.0 111.174 -167.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.85 -161.51 35.29 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.92 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 154.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -154.22 159.69 41.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.073 0.949 . . . . 0.0 109.27 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.1 t -122.86 136.67 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 125.31 1.444 . . . . 0.0 108.288 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.1 t -77.4 141.26 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.637 1.575 . . . . 0.0 109.159 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -144.02 127.92 17.38 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 42' ' ' GLU . 2.5 mmmp? -89.73 134.18 34.3 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.544 1.137 . . . . 0.0 109.859 171.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.87 141.64 47.46 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.08 0.952 . . . . 0.0 110.824 176.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.26 136.13 35.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.25 84.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 171.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -76.63 173.71 11.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 122.088 0.947 . . . . 0.0 110.982 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.5 -58.01 4.13 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.8 mmt -68.21 73.9 0.22 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.638 1.209 . . . . 0.0 109.746 173.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 p -85.59 -44.66 12.44 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 128.552 2.741 . . . . 0.0 108.843 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.18 151.87 39.92 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.044 0.538 . . . . 0.0 110.386 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -69.38 177.72 2.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.522 0.677 . . . . 0.0 111.974 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t 72.97 47.82 0.19 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.397 1.079 . . . . 0.0 111.577 168.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.01 66.48 0.47 Allowed 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 171.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -133.83 -70.57 0.52 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.585 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t -54.69 -39.87 68.57 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -170.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 m -49.34 -55.67 12.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.576 0.35 . . . . 0.0 111.783 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.79 -50.69 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.614 0.766 . . . . 0.0 109.179 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -52.16 -66.11 0.44 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.942 0.877 . . . . 0.0 110.124 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.82 -54.92 8.72 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.529 2.014 . . . . 0.0 112.23 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.63 -55.26 37.36 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.12 0.96 . . . . 0.0 109.802 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 mm -59.58 -31.08 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 123.598 0.759 . . . . 0.0 110.445 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.84 -16.81 19.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.921 1.248 . . . . 0.0 113.921 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -89.1 -13.76 37.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.605 1.703 . . . . 0.0 110.632 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.32 133.08 43.76 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.468 1.128 . . . . 0.0 112.284 -172.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -55.58 108.72 0.46 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.58 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.62 -25.76 7.53 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 119.186 -0.785 . . . . 0.0 111.976 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.53 131.5 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -97.75 -47.19 5.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.181 0.992 . . . . 0.0 109.374 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -154.94 166.89 32.14 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.805 -0.559 . . . . 0.0 110.316 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 tt -153.38 142.92 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.187 0.995 . . . . 0.0 109.922 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -139.55 117.3 11.58 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.179 1.792 . . . . 0.0 106.937 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -112.84 105.69 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 119.875 1.216 . . . . 0.0 109.242 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -97.24 88.15 4.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.58 -43.92 62.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.291 0.636 . . . . 0.0 110.882 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.33 -54.21 1.45 Allowed 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 125.946 1.698 . . . . 0.0 110.924 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.03 -13.41 57.39 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.681 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 66.12 9.32 6.17 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.106 2.163 . . . . 0.0 111.506 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 6' ' ' LYS . 2.3 tt0 -129.67 155.86 45.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.581 1.952 . . . . 0.0 108.599 -172.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.26 155.94 49.37 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.146 0.978 . . . . 0.0 108.854 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.1 m -122.64 112.27 17.76 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.92 2.088 . . . . 0.0 105.557 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 mt -102.56 168.52 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.51 120.31 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -160.14 179.61 8.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.612 1.165 . . . . 0.0 110.917 -171.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.51 146.94 59.7 Favored Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -69.66 74.28 1.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.605 2.87 . . . . 0.0 109.507 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.94 -62.75 0.48 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.731 1.212 . . . . 0.0 108.249 172.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.1 mt -85.54 -21.25 28.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.992 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 54' ' ' VAL . 11.0 tp -125.02 144.79 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 118.616 0.644 . . . . 0.0 110.069 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 m -76.13 28.9 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' A' ' 52' ' ' ILE 0.272 0.5 OUTLIER 70.74 -53.1 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 128.979 2.912 . . . . 0.0 111.801 178.589 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -44.83 15.22 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 127.313 2.245 . . . . 0.0 109.705 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -43.51 -51.94 6.44 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.171 0.588 . . . . 0.0 110.742 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -29.39 -63.16 0.12 Allowed 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 126.86 2.064 . . . . 0.0 110.716 172.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -45.76 36.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -59.4 -19.68 49.05 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.401 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -43.82 97.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.861 0.755 . . . . 0.0 110.022 170.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.94 -48.83 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -54.37 -47.56 72.49 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.14 -22.12 64.39 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.229 1.412 . . . . 0.0 113.953 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -63.41 -28.49 70.02 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.208 1.367 . . . . 0.0 110.071 170.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.99 -32.93 2.91 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.683 1.135 . . . . 0.0 110.743 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -73.69 126.03 90.0 Favored Pre-proline 0 N--CA 1.455 -0.191 0 CA-C-O 118.602 -0.714 . . . . 0.0 109.311 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.45 113.72 2.59 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.912 1.741 . . . . 0.0 109.687 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.25 174.61 6.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.972 0.909 . . . . 0.0 108.614 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.9 127.56 6.64 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -174.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.77 137.39 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.997 1.319 . . . . 0.0 109.574 172.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -84.1 -101.26 0.05 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.264 0.626 . . . . 0.0 111.253 171.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -151.85 140.27 20.54 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.312 1.045 . . . . 0.0 108.615 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.66 131.17 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 127.534 2.334 . . . . 0.0 106.443 -174.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -158.24 158.48 34.56 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.339 0.972 . . . . 0.0 110.642 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.63 -174.18 39.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 116.887 -1.53 . . . . 0.0 109.747 167.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -44.59 133.96 5.59 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.823 1.249 . . . . 0.0 111.564 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.73 146.62 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.275 0.63 . . . . 0.0 110.042 -176.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.9 t -78.61 140.54 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.953 1.301 . . . . 0.0 108.68 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.19 142.02 48.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.774 2.029 . . . . 0.0 106.536 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.52 124.25 51.45 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.139 0.976 . . . . 0.0 109.122 173.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.7 ptm -117.91 155.01 30.93 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.98 1.312 . . . . 0.0 110.317 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.33 133.44 37.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 172.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.63 64.33 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.228 1.011 . . . . 0.0 109.004 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.92 166.19 16.17 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.986 0.898 . . . . 0.0 111.293 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.98 -46.38 2.66 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 121.738 -0.601 . . . . 0.0 113.05 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.6 mtt -59.16 110.51 1.08 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.287 1.043 . . . . 0.0 109.779 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 t -115.1 147.63 39.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.391 1.076 . . . . 0.0 108.9 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.9 m 62.57 162.34 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.334 1.854 . . . . 0.0 113.095 -177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -75.11 69.2 1.97 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.829 0.823 . . . . 0.0 109.422 173.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 m -117.57 -54.37 2.37 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.385 1.874 . . . . 0.0 109.092 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.7 m -88.48 -103.58 0.08 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p 22.99 -89.26 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 127.877 2.471 . . . . 0.0 113.824 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -44.87 -41.09 6.8 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -49.82 -58.95 4.35 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.259 0.552 . . . . 0.0 111.061 168.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.85 -46.37 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.091 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -53.07 -65.24 0.59 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.425 1.466 . . . . 0.0 110.177 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.25 -55.12 6.83 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.467 1.508 . . . . 0.0 112.027 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -56.6 -53.17 60.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.795 0.797 . . . . 0.0 110.535 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.8 mm -61.49 -28.38 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.526 1.131 . . . . 0.0 110.479 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.92 -20.78 6.64 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.923 -0.932 . . . . 0.0 114.271 169.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -87.92 -14.86 38.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.89 1.845 . . . . 0.0 111.259 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 136.21 53.04 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 122.269 1.033 . . . . 0.0 111.668 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -57.68 111.25 1.07 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.532 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.97 -22.12 12.8 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 123.9 0.762 . . . . 0.0 112.757 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.2 132.58 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 118.122 0.961 . . . . 0.0 108.944 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -97.36 -47.33 5.74 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.643 1.177 . . . . 0.0 109.751 171.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -153.91 163.79 39.47 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.361 -0.837 . . . . 0.0 110.616 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 tt -146.2 136.75 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.299 1.439 . . . . 0.0 109.098 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.78 104.69 6.43 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.834 1.653 . . . . 0.0 107.592 168.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.0 t -100.96 126.91 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 124.371 1.068 . . . . 0.0 109.993 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 m -114.5 93.76 4.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.12 0.968 . . . . 0.0 109.301 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.39 -49.74 6.97 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.466 1.106 . . . . 0.0 109.496 169.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.85 -58.87 2.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.677 1.591 . . . . 0.0 111.428 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.93 -14.69 59.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.55 -172.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 70.33 3.5 4.47 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.05 2.14 . . . . 0.0 111.81 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -119.16 157.86 27.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.563 1.945 . . . . 0.0 108.651 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.36 155.1 48.85 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.642 0.777 . . . . 0.0 109.564 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 m -124.99 116.81 22.74 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.4 mt -121.08 159.78 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.28 117.98 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.39 0.996 . . . . 0.0 110.019 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -161.21 -178.93 7.04 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.459 1.104 . . . . 0.0 111.457 -172.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.72 146.8 63.5 Favored Pre-proline 0 N--CA 1.467 0.376 0 C-N-CA 124.898 1.279 . . . . 0.0 113.946 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.26 69.44 2.52 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 124.121 3.214 . . . . 0.0 109.896 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.62 -63.96 0.36 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.11 0.964 . . . . 0.0 108.969 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.2 mt -79.72 -21.85 44.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.862 -0.59 . . . . 0.0 110.426 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 54' ' ' VAL . 8.6 tp -124.83 145.12 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 118.507 0.594 . . . . 0.0 109.955 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -80.64 29.62 0.31 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.814 0.845 . . . . 0.0 112.975 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 52' ' ' ILE . 0.5 OUTLIER 74.64 -56.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 128.46 2.704 . . . . 0.0 111.095 173.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.63 -40.67 20.46 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.213 1.805 . . . . 0.0 109.477 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -41.24 -53.15 3.26 Favored 'General case' 0 C--N 1.346 0.44 0 O-C-N 124.183 0.927 . . . . 0.0 110.837 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.71 -60.96 0.29 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.165 1.786 . . . . 0.0 111.053 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -41.95 68.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.092 0.957 . . . . 0.0 111.005 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -56.33 -28.28 58.43 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -64.79 -41.83 95.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.733 -0.604 . . . . 0.0 109.672 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -63.46 -49.18 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.449 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -53.39 -46.86 69.84 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.73 -20.53 49.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.555 1.542 . . . . 0.0 114.179 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.2 mmm -63.18 -30.18 71.38 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.777 1.171 . . . . 0.0 109.865 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.55 -32.25 2.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -79.85 116.57 62.04 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-O 117.819 -1.086 . . . . 0.0 108.468 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.25 123.81 12.78 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.765 1.643 . . . . 0.0 108.42 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.35 -165.74 1.02 Allowed 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 122.764 0.426 . . . . 0.0 110.271 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -162.42 138.34 7.42 Favored 'General case' 0 CA--C 1.522 -0.097 0 O-C-N 121.487 -0.758 . . . . 0.0 111.315 176.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.01 132.06 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 124.468 1.107 . . . . 0.0 108.677 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 mtpt -82.55 -83.03 0.13 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 117.858 0.299 . . . . 0.0 110.987 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -155.81 141.43 17.87 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.39 123.41 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 125.787 1.635 . . . . 0.0 107.563 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -147.98 143.38 27.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 168.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.3 -133.83 4.23 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 . . . . . 0 C--O 1.245 0.839 0 N-CA-C 104.006 -2.59 . . . . 0.0 104.006 176.823 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.164 0 CA-C-O 116.893 -2.059 . . . . 0.0 108.277 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 31.67 71.02 0.08 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.522 1.929 . . . . 0.0 113.722 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.2 t -110.37 142.35 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.555 1.542 . . . . 0.0 108.759 -173.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.63 134.34 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 123.775 0.83 . . . . 0.0 110.692 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.83 139.29 54.11 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 172.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -108.46 123.2 48.51 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.0 ptm -116.07 167.9 10.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.35 1.06 . . . . 0.0 109.957 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -114.31 134.24 55.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.485 2.314 . . . . 0.0 106.86 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 t -124.99 62.4 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.309 1.843 . . . . 0.0 107.686 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.88 145.45 46.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.28 0.562 . . . . 0.0 111.724 -170.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.33 -46.3 1.16 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.7 mmm -80.94 104.85 11.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.172 0.486 . . . . 0.0 110.951 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.2 p -114.97 -59.35 2.03 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.66 1.184 . . . . 0.0 109.948 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.5 p -55.6 133.67 50.58 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.248 0.619 . . . . 0.0 110.964 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -61.04 164.87 4.63 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -170.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.8 t 81.65 84.23 0.04 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.11 2.164 . . . . 0.0 111.947 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.4 t -163.95 -111.05 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.687 -1.149 . . . . 0.0 109.382 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p 27.42 -88.05 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 128.109 2.564 . . . . 0.0 113.518 169.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t -36.86 -42.96 0.42 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.112 1.365 . . . . 0.0 113.501 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.15 -57.06 11.74 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.46 0.704 . . . . 0.0 111.273 171.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.41 -48.86 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.214 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -56.21 -59.37 5.04 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 119.936 1.244 . . . . 0.0 110.79 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -41.38 -56.93 3.31 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.852 1.692 . . . . 0.0 112.158 170.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -57.2 -53.41 58.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.014 0.907 . . . . 0.0 110.506 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.1 mm -59.65 -28.04 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 125.158 1.383 . . . . 0.0 110.704 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.83 -19.2 9.81 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.735 -1.036 . . . . 0.0 114.299 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -88.18 -9.99 51.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.859 1.829 . . . . 0.0 111.333 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.8 136.22 46.99 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.172 0.987 . . . . 0.0 111.594 -171.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.78 113.86 2.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.078 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.26 -16.99 31.99 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-O 119.136 -0.813 . . . . 0.0 112.903 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 t -79.32 130.14 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 118.238 1.019 . . . . 0.0 108.581 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -97.05 -49.14 5.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.439 1.096 . . . . 0.0 109.47 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -152.81 170.54 20.05 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.625 -0.672 . . . . 0.0 110.673 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 tt -144.11 149.24 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.619 1.168 . . . . 0.0 109.407 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -143.55 98.44 3.25 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.141 2.176 . . . . 0.0 107.711 169.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.2 t -99.62 128.24 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.554 1.142 . . . . 0.0 109.013 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 t -103.51 110.03 21.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.329 0.652 . . . . 0.0 110.602 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.37 158.36 20.73 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 71.36 -55.82 0.65 Allowed 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 129.069 2.948 . . . . 0.0 109.926 -174.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.01 -29.28 70.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.841 -174.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 64.61 16.07 10.08 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.19 2.196 . . . . 0.0 112.471 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -107.18 139.3 41.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.64 156.3 45.67 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.794 -0.566 . . . . 0.0 110.105 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.9 m -130.46 125.8 35.33 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.2 mt -118.33 153.25 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.62 120.84 65.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -157.71 -179.67 8.37 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 125.395 1.478 . . . . 0.0 109.628 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -140.75 151.85 64.2 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 123.221 0.609 . . . . 0.0 112.515 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -82.02 64.37 8.41 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.949 3.1 . . . . 0.0 108.684 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.52 -61.1 1.03 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.023 1.329 . . . . 0.0 107.474 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.2 mt -88.33 -20.71 25.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.666 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 tp -120.7 145.08 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 119.205 0.911 . . . . 0.0 110.488 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -83.96 28.32 0.61 Allowed 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 71.39 -60.07 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 128.867 2.867 . . . . 0.0 110.545 176.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -74.54 -41.11 61.17 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.804 1.242 . . . . 0.0 108.491 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -42.81 -49.86 5.71 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 123.277 0.631 . . . . 0.0 111.551 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.74 -53.74 4.4 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.859 0.864 . . . . 0.0 111.126 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.49 -44.91 77.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 122.087 -0.383 . . . . 0.0 110.761 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -54.04 -33.91 58.63 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.937 -0.477 . . . . 0.0 112.094 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -64.14 -42.67 96.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.43 0.692 . . . . 0.0 109.564 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.01 -46.83 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.791 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -51.67 -49.96 61.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.897 1.226 . . . . 0.0 108.674 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.86 -19.82 31.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.283 1.833 . . . . 0.0 114.27 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.1 mmm -61.82 -31.28 71.5 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.63 1.105 . . . . 0.0 110.214 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.7 39.48 0.57 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.544 1.069 . . . . 0.0 111.461 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -145.45 125.78 7.21 Favored Pre-proline 0 C--O 1.225 -0.217 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.98 107.81 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.19 1.927 . . . . 0.0 109.611 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.56 -177.59 3.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -175.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -163.49 156.1 18.19 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.121 -0.987 . . . . 0.0 111.612 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.4 t -106.42 118.68 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -94.42 -67.81 0.83 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.458 0.303 . . . . 0.0 110.632 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -86.95 176.37 7.69 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.4 tt -159.99 169.6 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -73.37 145.07 46.18 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.756 1.162 . . . . 0.0 111.728 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.06 63.02 0.29 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.467 1.032 . . . . 0.0 111.353 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.255 1.375 0 C-N-CA 124.813 1.245 . . . . 0.0 111.691 171.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.964 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 178.05 148.99 0.18 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 -161.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.9 t -147.51 147.28 17.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.15 132.12 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.379 1.472 . . . . 0.0 109.957 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.56 157.85 32.72 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.371 1.469 . . . . 0.0 109.621 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -119.05 123.56 44.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.436 1.094 . . . . 0.0 108.581 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -122.79 144.66 49.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.077 1.351 . . . . 0.0 110.474 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -87.96 133.14 34.0 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.328 2.251 . . . . 0.0 108.313 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.35 65.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 126.959 2.104 . . . . 0.0 107.966 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -71.77 153.83 41.71 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.822 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.61 -43.46 2.07 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.821 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.6 mtt -63.49 127.92 33.51 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.505 1.152 . . . . 0.0 108.779 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -133.03 149.09 52.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.157 0.983 . . . . 0.0 108.651 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.5 m 68.58 140.82 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.811 2.045 . . . . 0.0 112.166 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -63.55 84.03 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.184 0.994 . . . . 0.0 109.959 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -149.24 -59.36 0.21 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.822 1.649 . . . . 0.0 108.511 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.9 m -77.72 69.94 4.03 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.3 p -133.33 -73.8 0.49 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.447 1.499 . . . . 0.0 107.224 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -57.93 -37.28 73.81 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -166.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.8 m -51.54 -54.15 30.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.724 0.297 . . . . 0.0 111.541 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -59.25 -49.5 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -53.28 -65.06 0.63 Allowed 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 122.322 1.058 . . . . 0.0 110.4 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.56 -42.71 44.57 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.197 1.856 . . . . 0.0 113.364 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -68.67 -61.23 1.91 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.934 1.367 . . . . 0.0 109.593 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.06 -41.49 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.621 1.169 . . . . 0.0 110.37 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.73 -21.55 29.74 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.406 1.479 . . . . 0.0 113.633 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -91.35 -15.44 29.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.076 1.438 . . . . 0.0 110.836 177.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.34 134.14 52.91 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.537 1.16 . . . . 0.0 111.508 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -50.35 107.77 0.18 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.255 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.42 -29.08 5.8 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.958 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.1 t -79.45 137.25 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 118.353 1.077 . . . . 0.0 109.167 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -102.34 -43.35 5.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.039 1.335 . . . . 0.0 110.642 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -158.61 162.5 37.31 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.41 -0.806 . . . . 0.0 110.151 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 tt -144.43 141.32 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.625 1.57 . . . . 0.0 109.192 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -129.34 121.7 28.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.513 1.925 . . . . 0.0 107.046 164.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.3 t -107.47 109.02 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 119.93 1.241 . . . . 0.0 110.052 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.7 t -90.79 91.63 8.45 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.693 0.759 . . . . 0.0 109.324 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.61 166.62 0.88 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.656 163.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 66.48 -56.42 0.39 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 128.338 2.655 . . . . 0.0 110.45 -165.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -64.81 -30.27 71.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.214 1.007 . . . . 0.0 109.88 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 68.73 25.27 6.42 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 127.812 2.445 . . . . 0.0 110.255 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -125.03 127.26 46.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.714 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.1 145.45 49.25 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.061 0.945 . . . . 0.0 109.515 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.71 120.3 31.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -176.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.2 mt -128.1 157.54 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -173.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.4 p -125.32 127.81 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -155.85 176.2 12.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 110.528 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.09 145.61 54.73 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.627 1.171 . . . . 0.0 113.192 172.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -72.32 75.86 2.33 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.409 3.406 . . . . 0.0 109.887 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.05 -55.42 0.11 Allowed 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.831 -0.543 . . . . 0.0 109.902 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.14 -24.61 27.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.607 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.4 tp -124.82 145.08 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.295 0.638 . . . . 0.0 110.206 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.57 23.74 0.12 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 75.4 -53.77 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.24 1.816 . . . . 0.0 110.194 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -95.64 -33.82 12.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.151 2.18 . . . . 0.0 110.169 -172.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -42.32 -53.31 4.22 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.035 0.934 . . . . 0.0 110.532 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -37.72 -57.74 0.96 Allowed 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 126.183 1.793 . . . . 0.0 111.96 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.38 -42.76 61.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.992 0.917 . . . . 0.0 111.656 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.43 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 5.2 mptp? -50.69 -29.47 11.3 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.148 -0.97 . . . . 0.0 113.208 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -62.68 -35.99 81.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -69.7 -46.24 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 123.682 0.793 . . . . 0.0 109.099 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' CD ' ' HZ1' ' A' ' 59' ' ' LYS . 92.0 mt-10 -51.09 -49.34 60.86 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.01 -20.16 62.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.426 1.491 . . . . 0.0 114.041 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 81.3 mmm -63.99 -28.45 69.82 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.886 1.221 . . . . 0.0 109.874 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.41 -33.13 2.71 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.434 1.016 . . . . 0.0 110.957 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -80.85 119.06 75.05 Favored Pre-proline 0 N--CA 1.455 -0.18 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.169 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.8 120.71 8.19 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.873 1.716 . . . . 0.0 109.52 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.68 177.85 5.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.562 1.545 . . . . 0.0 108.562 -176.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.93 158.65 35.39 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 122.924 0.49 . . . . 0.0 111.218 -173.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.0 126.21 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -99.84 -61.59 1.35 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.688 0.395 . . . . 0.0 110.852 172.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -95.8 169.1 10.24 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.2 tt -150.7 175.73 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -75.36 178.96 5.47 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.251 1.021 . . . . 0.0 110.375 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.34 171.82 12.88 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.301 1.429 . . . . 0.0 111.036 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.311 0 CA-C-O 115.78 -2.057 . . . . 0.0 106.442 172.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.163 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.46 121.02 13.4 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.07 0.948 . . . . 0.0 109.773 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -136.56 156.94 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.504 1.521 . . . . 0.0 108.908 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.9 t -87.21 124.9 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.115 2.166 . . . . 0.0 110.299 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.26 142.69 41.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.623 1.169 . . . . 0.0 109.401 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 123.49 48.66 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.416 1.486 . . . . 0.0 108.95 170.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.7 ptm -125.96 134.75 51.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.067 1.347 . . . . 0.0 111.468 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 129.38 39.08 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 t -112.02 73.83 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.03 164.77 10.02 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.784 0.802 . . . . 0.0 111.101 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.79 -41.71 2.39 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 121.629 -0.669 . . . . 0.0 112.589 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 ttm -46.05 123.8 4.92 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.435 1.094 . . . . 0.0 109.761 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.8 t -152.03 139.49 19.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.26 162.25 0.05 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.978 1.711 . . . . 0.0 112.186 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -58.88 87.41 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.106 0.963 . . . . 0.0 111.535 -171.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.9 t -172.95 170.85 4.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.937 1.295 . . . . 0.0 107.695 -164.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 m 37.13 52.44 1.13 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.884 1.674 . . . . 0.0 112.598 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.0 p -127.08 -76.1 0.58 Allowed 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.8 t -56.85 -38.8 73.19 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -168.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.8 m -47.51 -60.39 2.56 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.654 167.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.55 -48.95 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -56.83 -68.0 0.26 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.875 0.845 . . . . 0.0 111.663 -177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.63 -48.93 22.5 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.735 1.636 . . . . 0.0 111.834 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -63.72 -55.49 22.9 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 117.945 0.872 . . . . 0.0 110.312 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.8 mm -50.67 -41.35 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.93 0.892 . . . . 0.0 110.436 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.07 -22.75 13.95 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.953 1.739 . . . . 0.0 114.138 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -94.31 -20.78 19.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 118.892 1.346 . . . . 0.0 110.492 177.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 134.21 50.69 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 122.727 1.251 . . . . 0.0 111.68 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -53.62 113.68 1.27 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.088 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.62 -26.39 7.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 118.269 -1.295 . . . . 0.0 112.141 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.99 140.44 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 118.926 1.363 . . . . 0.0 109.457 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -103.61 -41.16 6.04 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.598 167.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -159.72 163.34 34.81 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.529 -0.732 . . . . 0.0 109.941 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.4 tt -147.38 148.71 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 124.952 1.301 . . . . 0.0 108.946 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 102.74 4.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.907 1.683 . . . . 0.0 107.861 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -91.23 133.42 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.61 1.164 . . . . 0.0 108.894 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 t -122.49 102.63 8.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.045 0.938 . . . . 0.0 110.52 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.63 -58.24 7.88 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.641 0.777 . . . . 0.0 110.758 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -42.24 -54.46 3.69 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.218 1.407 . . . . 0.0 110.942 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.26 -19.21 51.17 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.938 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 65.88 18.88 11.22 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.205 2.202 . . . . 0.0 110.996 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.29 163.57 20.46 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.249 2.22 . . . . 0.0 108.431 -171.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.15 133.65 17.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.064 0.545 . . . . 0.0 109.839 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.1 m -106.47 100.94 10.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.5 mt -90.75 165.66 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.1 t -139.67 120.41 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -157.14 176.17 13.09 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.706 0.802 . . . . 0.0 111.757 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -122.81 139.91 32.2 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -69.61 84.0 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.245 3.296 . . . . 0.0 109.574 174.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -168.43 -61.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.0 mt -82.16 -25.92 33.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.219 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.2 tp -117.79 161.2 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 123.501 0.721 . . . . 0.0 110.423 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 m -93.86 26.79 3.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.219 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 70.11 -59.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 129.406 3.082 . . . . 0.0 110.49 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.91 -32.49 40.19 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.444 1.498 . . . . 0.0 109.562 -175.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -49.44 -48.75 47.2 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 5.4 mtt -44.93 -53.5 7.56 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.213 0.605 . . . . 0.0 111.512 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.406 ' CE ' ' HD2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -72.47 -36.61 68.51 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.559 -0.713 . . . . 0.0 112.569 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.406 ' HD2' ' CE ' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -61.29 -31.68 71.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 120.535 -1.353 . . . . 0.0 110.835 176.087 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -35.14 80.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.9 -47.25 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.003 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -50.96 -48.73 60.92 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.37 0.986 . . . . 0.0 108.697 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.05 -21.72 46.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.457 1.103 . . . . 0.0 113.664 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.9 mmt -66.91 -28.03 67.98 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.553 1.069 . . . . 0.0 110.786 172.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.62 -33.38 3.0 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.759 1.171 . . . . 0.0 110.731 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -78.36 115.56 52.14 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.19 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -62.27 121.83 10.01 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.695 1.596 . . . . 0.0 109.146 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.95 163.77 26.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.662 0.785 . . . . 0.0 109.039 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.28 140.34 21.12 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 125.211 1.405 . . . . 0.0 109.588 -156.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.2 t -91.53 127.25 43.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -100.26 -64.43 1.04 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.895 0.478 . . . . 0.0 110.689 171.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -92.2 170.4 9.84 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.66 177.06 3.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.89 1.276 . . . . 0.0 109.128 -174.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -75.4 176.32 7.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.923 1.289 . . . . 0.0 109.339 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.2 -176.15 17.55 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.322 0.963 . . . . 0.0 111.328 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 . . . . . 0 C--O 1.249 1.045 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 173.267 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.689 0 N-CA-C 107.289 -2.325 . . . . 0.0 107.289 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 22.85 65.63 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.934 2.094 . . . . 0.0 114.363 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.18 145.18 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 124.532 1.133 . . . . 0.0 109.404 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.27 124.29 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 125.579 1.552 . . . . 0.0 108.954 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.1 tp -107.57 143.21 36.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.358 1.863 . . . . 0.0 107.144 169.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -111.6 120.71 43.01 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 164.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.0 ptm -111.57 162.51 15.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.709 1.203 . . . . 0.0 109.909 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' NZ ' ' OE1' ' A' ' 10' ' ' GLU . 3.0 mmtp -97.2 125.88 42.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.506 1.523 . . . . 0.0 108.748 168.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 t -116.73 72.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 126.693 1.997 . . . . 0.0 106.83 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS 0.271 3.6 pt-20 -82.48 176.77 9.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.33 0.652 . . . . 0.0 111.657 177.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.94 -57.53 3.93 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.541 -0.724 . . . . 0.0 112.006 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -58.56 130.22 45.78 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.328 1.064 . . . . 0.0 110.294 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.0 t -165.97 74.68 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.121 0.969 . . . . 0.0 109.176 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.7 p -158.78 28.2 0.22 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.251 -0.906 . . . . 0.0 113.118 -171.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 35.05 51.56 0.55 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.473 1.909 . . . . 0.0 113.643 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 t -161.02 -50.62 0.05 OUTLIER 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.661 0.784 . . . . 0.0 109.725 -169.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.4 m -72.5 69.34 0.85 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.685 0.794 . . . . 0.0 111.065 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.5 p -131.14 -72.91 0.54 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 m -55.79 -38.78 70.4 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -167.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.84 -53.69 48.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 171.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.04 -53.03 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -56.71 -65.06 0.68 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.804 0.811 . . . . 0.0 110.069 -174.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.26 -52.66 17.64 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.323 1.916 . . . . 0.0 112.238 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.38 -52.78 63.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.106 0.953 . . . . 0.0 109.864 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.0 mm -58.77 -30.82 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 123.176 0.59 . . . . 0.0 111.203 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.11 -20.39 27.62 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.886 1.232 . . . . 0.0 113.6 174.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.8 -9.94 47.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.368 1.584 . . . . 0.0 110.96 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.44 133.11 48.93 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.354 1.073 . . . . 0.0 110.764 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -54.66 104.89 0.13 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.807 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.18 -26.94 5.71 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 118.991 -0.894 . . . . 0.0 113.102 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.6 t -79.69 131.84 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 118.483 1.141 . . . . 0.0 110.042 -172.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -98.36 -47.31 5.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.528 1.531 . . . . 0.0 110.022 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -151.33 167.36 28.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.253 0.478 . . . . 0.0 110.191 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.8 tt -149.61 143.97 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.069 1.348 . . . . 0.0 109.439 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -130.19 122.69 28.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.309 2.244 . . . . 0.0 105.865 167.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.1 t -117.81 103.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 120.279 1.4 . . . . 0.0 109.52 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 m -85.21 99.45 11.11 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 mt -53.84 170.26 0.13 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.902 158.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 67.59 -60.6 0.38 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 127.991 2.516 . . . . 0.0 110.417 -171.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -24.86 67.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.574 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 65.55 23.12 11.79 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.469 1.908 . . . . 0.0 111.182 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -119.76 135.24 54.93 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.809 0.844 . . . . 0.0 109.706 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.12 152.85 51.02 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 m -129.38 120.71 26.01 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.136 1.774 . . . . 0.0 106.482 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.57 154.34 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.52 119.05 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -158.0 -179.69 8.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.825 1.25 . . . . 0.0 109.163 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -133.12 146.06 59.5 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.15 75.05 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 124.414 3.409 . . . . 0.0 109.983 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.99 -60.03 0.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.804 1.242 . . . . 0.0 107.991 172.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -80.67 -27.47 37.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.064 -0.493 . . . . 0.0 110.464 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.4 tp -122.23 144.16 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.739 0.816 . . . . 0.0 109.99 -175.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.2 m -77.29 23.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 72.12 -63.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 128.602 2.761 . . . . 0.0 109.095 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -42.08 74.33 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.019 0.928 . . . . 0.0 108.819 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -38.9 -60.17 0.88 Allowed 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.075 0.95 . . . . 0.0 110.935 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -36.58 -57.05 0.79 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.811 1.644 . . . . 0.0 111.627 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -40.86 69.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.395 0.678 . . . . 0.0 111.705 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -60.42 -26.02 66.39 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 120.986 -1.071 . . . . 0.0 112.789 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -62.81 -37.75 88.0 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.6 mp -63.9 -45.05 98.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 117.55 -1.214 . . . . 0.0 111.528 173.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -49.87 -49.98 47.41 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.44 1.473 . . . . 0.0 108.304 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.07 -20.25 51.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.672 1.189 . . . . 0.0 113.848 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.5 mmt -65.19 -25.94 67.94 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.481 1.037 . . . . 0.0 110.58 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.68 -27.71 4.34 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.446 1.022 . . . . 0.0 111.197 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -86.37 123.0 71.97 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.51 130.74 30.99 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 N-CA-C 108.632 -1.334 . . . . 0.0 108.632 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.42 -176.53 3.61 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.364 0.666 . . . . 0.0 109.276 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.97 151.02 30.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.119 -0.988 . . . . 0.0 110.864 -175.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -119.31 133.01 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -78.16 -83.09 0.09 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.208 0.603 . . . . 0.0 110.562 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.47 149.19 23.77 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 tp -158.5 125.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 123.982 0.913 . . . . 0.0 109.357 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -150.32 163.06 39.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.35 168.59 38.8 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.981 -1.485 . . . . 0.0 110.837 -176.95 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.065 0 N-CA-C 108.489 -1.845 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -63.62 122.35 16.12 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.795 1.297 . . . . 0.0 107.652 167.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.3 t -145.61 148.85 17.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.1 t -85.3 133.71 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 125.748 1.619 . . . . 0.0 109.624 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -124.05 146.19 48.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.696 1.599 . . . . 0.0 108.673 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.81 113.82 26.88 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.198 1.799 . . . . 0.0 109.133 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.4 mtt -109.2 131.53 54.98 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.738 0.815 . . . . 0.0 109.88 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -78.23 119.11 21.13 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 167.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.52 85.14 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.85 -175.35 3.03 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.543 0.737 . . . . 0.0 109.431 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.77 -40.79 2.29 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 121.371 -0.831 . . . . 0.0 113.356 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -49.32 130.85 20.06 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.378 1.089 . . . . 0.0 110.111 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t -44.58 -58.65 2.89 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.786 1.234 . . . . 0.0 112.152 -174.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 165.13 126.13 0.01 OUTLIER 'General case' 0 C--N 1.338 0.107 0 C-N-CA 127.228 2.211 . . . . 0.0 107.436 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 36.22 43.65 0.23 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.398 1.879 . . . . 0.0 114.538 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 t -146.93 39.55 1.03 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -176.78 70.28 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.912 1.285 . . . . 0.0 108.256 174.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p -120.02 -76.85 0.58 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.15 -38.93 68.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -168.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.6 m -48.84 -60.85 2.41 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.404 168.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.9 -50.57 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -58.65 -63.5 1.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.391 1.091 . . . . 0.0 109.153 -172.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.51 -56.59 6.29 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.99 1.757 . . . . 0.0 112.731 173.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -57.1 -52.59 64.67 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.114 0.957 . . . . 0.0 110.017 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.6 -27.43 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 123.718 0.807 . . . . 0.0 110.686 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.82 -19.95 11.81 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.069 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -85.79 -14.24 45.76 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.592 1.696 . . . . 0.0 110.146 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 132.63 48.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 122.438 1.114 . . . . 0.0 111.699 -172.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -57.78 107.03 0.41 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.25 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.38 -22.43 8.36 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.194 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.3 t -78.28 127.89 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 118.709 1.255 . . . . 0.0 108.841 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -89.67 -50.27 6.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.299 1.04 . . . . 0.0 108.77 172.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -154.25 160.89 42.03 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 118.988 0.813 . . . . 0.0 110.448 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 tt -141.77 142.27 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.623 1.569 . . . . 0.0 109.719 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -145.54 113.11 6.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.392 1.477 . . . . 0.0 107.753 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.9 t -113.0 92.47 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.47 1.508 . . . . 0.0 110.299 -172.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.1 m -82.13 78.59 8.79 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 124.171 0.988 . . . . 0.0 110.613 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.2 -42.04 28.9 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.312 0.645 . . . . 0.0 111.856 174.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -42.48 -51.86 4.88 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 125.94 1.696 . . . . 0.0 110.471 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -81.19 -13.66 58.36 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.15 -173.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 64.18 35.01 10.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 126.995 2.118 . . . . 0.0 109.572 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -156.15 144.45 19.92 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 125.434 1.709 . . . . 0.0 109.966 -166.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.5 157.91 41.38 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.402 1.081 . . . . 0.0 110.224 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 m -139.49 121.01 15.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.7 mt -124.9 162.89 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.079 1.351 . . . . 0.0 108.44 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 p -132.79 127.31 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 174.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -155.84 177.95 10.82 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.601 1.16 . . . . 0.0 108.818 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -126.25 142.41 42.66 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.314 1.046 . . . . 0.0 113.122 171.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.96 72.12 3.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.878 3.719 . . . . 0.0 110.402 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.68 -56.65 0.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.175 0.99 . . . . 0.0 108.605 172.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.38 -31.09 37.87 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tp -118.64 144.1 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 123.464 0.705 . . . . 0.0 109.668 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 m -81.95 27.81 0.45 Allowed 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -173.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 69.84 -64.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 129.582 3.153 . . . . 0.0 109.284 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -72.97 -39.6 65.99 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.48 1.112 . . . . 0.0 108.647 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -40.7 -55.94 2.27 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.43 1.092 . . . . 0.0 111.574 -173.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.13 -60.73 0.85 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.554 1.142 . . . . 0.0 110.082 177.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -32.98 70.89 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.093 -176.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -64.54 -29.55 70.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 119.194 -2.191 . . . . 0.0 111.537 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -63.32 -44.15 95.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.13 -43.5 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.908 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -55.25 -54.15 47.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.771 1.169 . . . . 0.0 107.978 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.15 -27.73 64.05 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.816 1.646 . . . . 0.0 114.174 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.9 mmt -52.63 -28.77 22.82 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.362 0.983 . . . . 0.0 111.187 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.87 39.98 0.62 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 124.641 1.115 . . . . 0.0 110.908 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -149.07 119.22 4.05 Favored Pre-proline 0 N--CA 1.457 -0.093 0 CA-C-O 117.995 -1.002 . . . . 0.0 108.438 -175.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.48 109.87 1.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.905 1.737 . . . . 0.0 109.597 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.9 -168.36 1.31 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.949 1.3 . . . . 0.0 108.449 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -163.44 152.56 14.49 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.117 0.967 . . . . 0.0 110.504 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 64.2 t -94.35 128.32 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 170.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -98.7 -68.48 0.8 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.215 0.461 . . . . 0.0 111.165 169.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -88.52 175.48 7.56 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 tt -156.89 177.37 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 119.394 0.997 . . . . 0.0 109.368 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.61 143.22 48.29 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.538 1.063 . . . . 0.0 108.283 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.84 -174.04 46.75 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 . . . . . 0 C--O 1.248 0.988 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 169.922 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 76' ' ' ARG . . . . . . . . 0 N--CA 1.468 0.784 0 N-CA-C 106.449 -2.661 . . . . 0.0 106.449 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -30.03 101.21 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.551 1.94 . . . . 0.0 113.588 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.1 149.29 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.934 0.894 . . . . 0.0 109.185 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.32 121.3 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.657 1.983 . . . . 0.0 108.688 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.7 tp -112.22 119.31 37.93 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.134 0.574 . . . . 0.0 110.553 171.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.07 126.97 36.31 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.957 1.303 . . . . 0.0 109.552 170.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -132.37 157.79 43.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.975 1.31 . . . . 0.0 109.702 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 133.91 36.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 t -128.98 79.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.957 1.303 . . . . 0.0 108.448 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.66 147.18 29.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.2 -38.54 2.55 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.307 -0.718 . . . . 0.0 113.569 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -56.35 120.46 7.66 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.427 1.114 . . . . 0.0 109.762 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 t -76.97 50.64 0.74 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.443 1.097 . . . . 0.0 111.675 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p 46.35 -162.44 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.661 1.584 . . . . 0.0 112.517 -167.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.6 m170 46.08 92.85 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.098 1.759 . . . . 0.0 114.806 174.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.4 t 66.62 -153.93 0.23 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.767 0.827 . . . . 0.0 109.595 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m 60.97 34.57 19.36 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.954 0.902 . . . . 0.0 109.608 -169.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.91 -72.33 0.69 Allowed 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 170.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -53.01 -39.15 62.92 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -170.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.3 m -51.29 -57.9 7.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 O-C-N 123.291 0.369 . . . . 0.0 111.587 170.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.4 -51.36 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.5 -61.78 2.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.091 0.948 . . . . 0.0 110.229 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.15 -54.17 13.12 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.948 1.737 . . . . 0.0 112.391 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -59.37 -52.36 65.96 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.111 0.955 . . . . 0.0 110.541 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.2 mm -57.22 -36.8 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 123.834 0.854 . . . . 0.0 110.143 177.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.12 -20.13 33.9 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.844 1.212 . . . . 0.0 114.137 172.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -84.88 -27.44 26.67 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.477 1.638 . . . . 0.0 109.99 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.22 139.34 52.25 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.443 1.116 . . . . 0.0 112.722 -168.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -53.8 115.11 1.82 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.051 1.34 . . . . 0.0 111.52 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.72 -28.57 6.4 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 124.064 0.84 . . . . 0.0 112.053 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.68 141.38 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 117.468 0.634 . . . . 0.0 110.051 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -121.1 -21.61 6.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.4 1.08 . . . . 0.0 111.811 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -160.41 164.63 32.17 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.398 0.999 . . . . 0.0 109.706 172.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 tt -155.5 143.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 123.91 0.884 . . . . 0.0 108.655 174.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.28 113.71 10.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.284 1.833 . . . . 0.0 106.527 171.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -100.34 103.13 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.229 0.922 . . . . 0.0 109.606 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -74.0 73.29 1.67 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.303 1.041 . . . . 0.0 110.267 175.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.66 161.07 0.37 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.426 1.49 . . . . 0.0 109.772 167.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 65.46 -53.5 0.35 Allowed 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 128.042 2.537 . . . . 0.0 110.952 -162.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -67.59 -23.36 65.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -172.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 68.95 26.62 5.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.987 2.115 . . . . 0.0 111.864 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -117.82 150.04 39.82 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.59 1.556 . . . . 0.0 106.876 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.03 159.9 43.42 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.295 -0.878 . . . . 0.0 109.564 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 m -132.6 106.32 7.74 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.713 1.605 . . . . 0.0 107.399 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 mt -90.08 163.16 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.45 117.86 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.153 1.381 . . . . 0.0 108.325 168.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -157.48 -178.2 7.16 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.31 1.444 . . . . 0.0 110.846 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -132.02 144.75 54.47 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.398 1.479 . . . . 0.0 113.86 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.22 68.88 4.1 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.752 3.635 . . . . 0.0 110.025 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.19 -57.06 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.541 1.136 . . . . 0.0 108.771 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.1 -20.52 37.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.65 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.1 tp -127.88 150.61 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 123.128 0.571 . . . . 0.0 110.475 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.6 m -79.46 25.02 0.33 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -176.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 71.3 -61.48 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.952 2.501 . . . . 0.0 108.889 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.08 -38.31 61.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.887 -174.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -45.95 -51.24 13.69 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.819 0.736 . . . . 0.0 111.981 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.78 -54.61 6.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.225 1.01 . . . . 0.0 111.71 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -64.64 -49.38 71.25 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.652 -0.655 . . . . 0.0 110.653 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -65.62 -24.94 67.17 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.228 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -62.4 -47.49 83.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.41 -45.85 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -58.08 -49.67 76.1 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.64 -26.81 65.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.391 1.476 . . . . 0.0 113.442 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.0 mmm -54.88 -32.95 61.42 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.626 1.103 . . . . 0.0 110.387 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.6 -42.71 0.79 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -75.6 111.21 13.2 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.353 -171.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.81 110.3 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.169 1.913 . . . . 0.0 109.161 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.37 -167.16 1.27 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.192 1.397 . . . . 0.0 108.813 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.98 134.78 5.14 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.296 0.953 . . . . 0.0 113.025 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.6 p -87.5 138.38 19.19 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 C-N-CA 123.399 0.68 . . . . 0.0 110.058 174.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -83.29 -86.84 0.11 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.768 0.427 . . . . 0.0 110.308 173.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -157.14 157.62 34.8 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.54 150.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.871 2.069 . . . . 0.0 106.625 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.34 147.89 21.17 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 165.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.12 133.21 8.12 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.576 1.084 . . . . 0.0 111.945 -165.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 1' ' ' GLY . 58.1 ttt180 . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.132 -1.414 . . . . 0.0 112.728 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.082 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -164.88 155.28 14.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -169.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.28 147.53 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.399 1.479 . . . . 0.0 109.378 -174.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.19 133.71 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 124.535 1.134 . . . . 0.0 109.669 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.7 tp -119.97 131.72 55.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.45 1.5 . . . . 0.0 108.748 172.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -93.17 117.04 29.61 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.349 1.06 . . . . 0.0 108.516 167.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.8 ptm -114.61 156.99 23.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.392 0.677 . . . . 0.0 109.211 172.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -100.29 129.34 46.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.54 1.536 . . . . 0.0 107.052 170.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.06 69.41 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.82 163.66 25.36 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.29 0.567 . . . . 0.0 109.594 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.44 -40.11 2.84 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 121.004 -1.06 . . . . 0.0 113.101 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.3 mtt -67.86 84.76 0.21 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.676 1.238 . . . . 0.0 109.506 172.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.7 p -99.5 26.11 6.41 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.756 1.223 . . . . 0.0 111.587 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.1 t -117.79 118.3 31.66 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.197 0.999 . . . . 0.0 108.36 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -49.58 -40.16 37.7 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.072 0.549 . . . . 0.0 111.882 -174.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 t -80.26 56.39 2.47 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.814 -0.554 . . . . 0.0 110.698 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 m -139.33 49.45 1.82 Allowed 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.3 p -120.48 -76.15 0.58 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 173.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.4 t -52.18 -45.18 65.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -165.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.5 m -48.5 -56.75 7.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.22 0.208 . . . . 0.0 111.117 169.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -59.93 -49.34 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 123.414 0.686 . . . . 0.0 109.415 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -59.61 -61.55 2.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.918 0.887 . . . . 0.0 109.555 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.86 -56.95 6.37 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.708 1.623 . . . . 0.0 112.401 172.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -57.68 -54.05 51.24 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.018 0.909 . . . . 0.0 110.269 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 mm -60.97 -31.94 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 124.016 0.926 . . . . 0.0 110.921 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.41 -17.9 27.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.886 1.232 . . . . 0.0 113.657 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -84.79 -13.62 50.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.941 1.371 . . . . 0.0 110.392 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.63 140.49 44.33 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.93 0.871 . . . . 0.0 111.983 -169.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -59.7 114.57 2.82 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.059 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.59 -24.5 10.31 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.212 0.911 . . . . 0.0 112.317 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.61 137.63 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 118.035 0.918 . . . . 0.0 110.126 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -106.91 -48.36 3.51 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.937 1.295 . . . . 0.0 109.554 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.04 161.84 41.97 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -178.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 tt -149.49 140.11 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 123.676 0.791 . . . . 0.0 109.246 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -135.88 101.08 4.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.795 2.038 . . . . 0.0 107.279 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -98.85 118.69 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.809 0.844 . . . . 0.0 109.128 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.9 m -98.3 90.88 4.97 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.632 0.773 . . . . 0.0 108.995 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.6 170.55 0.25 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.392 161.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 71.15 -57.36 0.6 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.092 2.557 . . . . 0.0 108.601 -168.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.69 -27.07 64.7 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.569 -174.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 70.07 20.63 6.39 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 111.862 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.16 144.94 42.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.921 1.688 . . . . 0.0 108.244 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.79 155.75 47.91 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 121.328 -0.857 . . . . 0.0 110.035 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 m -126.07 115.22 19.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.918 1.687 . . . . 0.0 106.635 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.7 mt -108.41 154.91 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.31 122.28 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 118.734 0.697 . . . . 0.0 109.789 168.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -156.25 177.82 11.0 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.952 1.701 . . . . 0.0 108.872 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -124.2 136.89 28.17 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 119.427 1.012 . . . . 0.0 111.736 169.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.8 73.07 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.136 3.224 . . . . 0.0 110.332 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -135.3 -50.57 0.75 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.4 mt -94.02 -17.63 22.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.782 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.2 tp -119.78 150.4 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.519 1.054 . . . . 0.0 110.21 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.3 m -83.54 19.82 1.51 Allowed 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 70.67 -62.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 128.038 2.535 . . . . 0.0 109.573 -177.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -70.2 -38.05 75.24 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -49.75 -47.64 50.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 123.534 0.521 . . . . 0.0 111.442 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -40.93 -52.09 3.14 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 177.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.09 -44.92 68.07 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.276 -0.265 . . . . 0.0 110.89 177.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -54.85 -32.17 60.37 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.593 -0.692 . . . . 0.0 112.7 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -37.85 88.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.38 -50.99 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.909 170.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -52.34 -46.82 66.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.336 0.971 . . . . 0.0 109.393 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.44 -21.36 50.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.94 1.696 . . . . 0.0 113.554 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.9 mmt -65.51 -31.95 73.29 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.372 0.987 . . . . 0.0 110.15 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.89 -37.01 1.47 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.906 0.765 . . . . 0.0 111.301 173.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -75.91 116.36 54.77 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 117.784 -1.103 . . . . 0.0 108.876 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.24 120.24 7.61 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.124 1.883 . . . . 0.0 108.685 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.08 -170.3 1.73 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.808 0.813 . . . . 0.0 109.413 -175.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.35 152.99 19.16 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.841 -1.162 . . . . 0.0 110.674 -176.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.84 132.08 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -173.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -83.5 -127.66 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.622 0.576 . . . . 0.0 109.526 172.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.2 146.98 33.28 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 118.695 0.68 . . . . 0.0 110.129 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 tp -157.43 125.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -156.87 154.74 30.29 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.01 75.57 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 106.98 -2.448 . . . . 0.0 106.98 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 116.714 -1.612 . . . . 0.0 108.564 176.897 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.034 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -108.18 -164.03 0.93 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.365 1.066 . . . . 0.0 109.641 -159.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.3 t -82.88 123.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.8 t -79.25 115.61 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 126.074 1.75 . . . . 0.0 109.231 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.6 tt -89.21 155.86 19.14 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.663 0.785 . . . . 0.0 109.493 169.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -135.44 116.63 14.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.0 ptm -128.99 153.2 47.8 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.948 1.299 . . . . 0.0 110.792 -170.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.99 129.16 49.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.076 0.951 . . . . 0.0 108.598 170.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.05 76.45 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 125.379 1.472 . . . . 0.0 107.77 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.3 114.79 3.37 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.126 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.98 -67.35 0.54 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.978 1.275 . . . . 0.0 111.407 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.9 mmt -80.75 93.53 6.22 Favored 'General case' 0 C--N 1.335 -0.034 0 O-C-N 121.936 -0.743 . . . . 0.0 111.129 -166.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 t -124.99 12.04 8.34 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.474 1.11 . . . . 0.0 112.855 -172.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -152.91 109.87 3.48 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.927 -1.108 . . . . 0.0 109.816 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -1.82 78.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 128.967 2.907 . . . . 0.0 115.362 -172.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 t -166.46 153.96 9.76 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -175.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 34.61 73.78 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.121 1.768 . . . . 0.0 113.229 176.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 p -127.13 -71.98 0.66 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -54.64 -36.35 64.46 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 m -52.32 -58.66 5.97 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 123.105 0.253 . . . . 0.0 111.18 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.33 -52.21 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -58.21 -67.37 0.35 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.881 0.848 . . . . 0.0 110.996 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.33 -51.68 11.57 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.581 1.563 . . . . 0.0 112.358 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -63.99 -48.84 74.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.09 0.945 . . . . 0.0 110.362 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.2 mm -59.44 -30.15 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 O-C-N 122.059 -0.401 . . . . 0.0 110.954 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.81 -23.24 6.72 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.391 0.996 . . . . 0.0 114.253 170.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -81.86 -18.22 44.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.799 1.799 . . . . 0.0 111.524 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.28 136.34 56.47 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.865 0.84 . . . . 0.0 111.038 -165.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -56.27 100.66 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.794 1.238 . . . . 0.0 110.324 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.96 -27.2 5.18 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.059 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.31 134.84 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 118.598 1.199 . . . . 0.0 109.76 -172.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -105.64 -36.97 6.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.771 1.228 . . . . 0.0 110.309 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -159.05 169.77 23.52 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.296 0.953 . . . . 0.0 111.459 173.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -150.14 152.67 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.548 1.539 . . . . 0.0 108.932 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -150.38 116.2 5.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.706 1.603 . . . . 0.0 108.345 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.3 t -110.96 117.76 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.639 1.576 . . . . 0.0 109.96 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.4 m -103.23 108.21 19.34 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.445 1.498 . . . . 0.0 110.107 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mt -60.55 -179.05 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.485 1.114 . . . . 0.0 110.308 164.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 63.43 -70.06 0.07 Allowed 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 128.103 2.561 . . . . 0.0 111.029 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -61.57 -28.36 69.29 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.043 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.59 60.43 1.34 Allowed 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 126.711 2.005 . . . . 0.0 111.359 173.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -151.57 156.44 40.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.18 166.52 24.48 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.873 -0.517 . . . . 0.0 109.953 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.36 144.0 34.3 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.2 mt -123.25 162.95 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.27 1.5 p -134.55 113.27 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 119.243 0.929 . . . . 0.0 108.715 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -158.96 179.54 8.98 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.077 1.351 . . . . 0.0 109.578 -170.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.74 147.92 53.55 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.47 79.33 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.666 2.911 . . . . 0.0 109.901 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.22 -52.62 0.5 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.765 1.626 . . . . 0.0 107.147 166.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.05 -22.69 18.98 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.236 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 tp -129.13 147.67 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 123.724 0.81 . . . . 0.0 111.204 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -80.74 27.24 0.38 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -170.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 71.67 -60.65 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 127.879 2.472 . . . . 0.0 109.862 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.54 -42.32 52.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.009 1.324 . . . . 0.0 109.304 -177.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -50.47 -52.97 33.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 123.566 0.541 . . . . 0.0 110.648 -171.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -36.93 -63.38 0.42 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.774 1.229 . . . . 0.0 111.538 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -39.24 72.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.771 -0.581 . . . . 0.0 110.359 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -58.29 -27.33 63.98 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.04 -1.038 . . . . 0.0 113.162 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -41.99 96.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.766 1.167 . . . . 0.0 108.787 176.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.77 -39.09 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.314 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -60.43 -49.84 75.97 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.87 -28.89 64.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.438 1.095 . . . . 0.0 113.195 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.0 mmt -53.05 -34.34 56.06 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.215 0.916 . . . . 0.0 111.463 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.56 -38.91 1.33 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -73.3 113.06 18.63 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.585 -173.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.74 108.63 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.08 1.853 . . . . 0.0 108.384 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.09 -177.43 4.13 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.305 1.042 . . . . 0.0 108.336 -171.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -156.91 140.18 15.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.099 0.863 . . . . 0.0 112.69 -165.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -102.23 133.13 46.73 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 126.667 1.987 . . . . 0.0 109.887 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -82.71 -77.39 0.24 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.885 0.474 . . . . 0.0 110.792 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.17 157.85 35.17 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.49 115.62 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.58 1.152 . . . . 0.0 110.145 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -155.59 160.01 40.12 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.89 161.82 4.72 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 123.797 0.686 . . . . 0.0 112.356 175.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.005 -1.474 . . . . 0.0 110.533 179.767 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.009 0 CA-C-O 118.392 -1.227 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 38.44 56.28 1.8 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.483 1.135 . . . . 0.0 111.161 -172.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t -81.17 126.2 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 124.825 1.25 . . . . 0.0 107.993 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.84 125.36 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.38 137.16 48.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -177.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -93.13 129.32 39.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.263 0.625 . . . . 0.0 111.079 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.0 mtt -108.44 155.24 20.81 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.171 0.988 . . . . 0.0 109.977 169.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 118.35 36.59 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 167.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.0 t -100.86 76.91 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.13 168.73 19.42 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.686 0.755 . . . . 0.0 111.675 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.8 -46.51 2.36 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.206 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -51.92 102.51 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.916 0.858 . . . . 0.0 110.295 171.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -123.52 33.22 5.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.729 1.211 . . . . 0.0 110.353 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.1 t -156.58 138.43 14.33 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.427 0.691 . . . . 0.0 109.692 174.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -73.72 43.3 0.15 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.441 1.496 . . . . 0.0 113.705 -171.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -137.93 12.87 2.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.136 0.974 . . . . 0.0 111.027 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.7 m -127.58 60.01 1.43 Allowed 'General case' 0 C--N 1.339 0.135 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.73 -75.31 0.5 Allowed 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.2 t -50.7 -43.14 57.65 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 m -49.53 -56.2 10.7 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.248 -0.283 . . . . 0.0 111.064 170.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.31 -49.11 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.294 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -51.81 -67.65 0.23 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.52 1.054 . . . . 0.0 110.806 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.33 -50.17 29.89 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.621 1.582 . . . . 0.0 111.882 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.23 -55.31 36.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.696 0.748 . . . . 0.0 109.846 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.9 mm -61.79 -28.75 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 124.2 1.0 . . . . 0.0 110.726 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.45 -20.36 16.45 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.632 1.11 . . . . 0.0 113.581 173.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -90.13 -6.22 55.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.304 1.552 . . . . 0.0 111.408 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.21 135.65 47.63 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 122.044 0.926 . . . . 0.0 111.291 -173.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -57.95 101.63 0.08 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.292 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.46 -24.85 6.41 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.821 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 t -81.95 137.76 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 118.917 1.358 . . . . 0.0 108.253 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -117.35 -34.59 4.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.087 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.11 161.28 38.4 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.818 1.19 . . . . 0.0 110.332 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tt -152.75 143.43 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.628 1.171 . . . . 0.0 110.054 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -141.08 108.68 5.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.365 1.866 . . . . 0.0 108.164 168.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.62 118.48 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 124.731 1.212 . . . . 0.0 109.352 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 t -104.89 82.45 1.87 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.441 1.097 . . . . 0.0 109.164 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -49.37 62.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.988 0.915 . . . . 0.0 111.3 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -44.43 -51.91 8.27 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 125.162 1.385 . . . . 0.0 110.866 172.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -75.58 -9.55 58.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.946 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 62.7 24.03 14.3 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.034 2.134 . . . . 0.0 110.896 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -141.78 160.42 40.23 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.89 1.276 . . . . 0.0 109.678 -170.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.99 158.87 43.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.8 0.84 . . . . 0.0 109.364 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.3 m -132.65 108.05 8.8 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 127.526 2.33 . . . . 0.0 106.202 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mt -116.82 156.23 18.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 124.044 0.938 . . . . 0.0 108.81 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.257 0.5 OUTLIER -132.3 114.07 22.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 118.078 0.399 . . . . 0.0 109.94 -175.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -157.41 179.05 9.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.402 1.081 . . . . 0.0 110.248 -169.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -141.17 132.18 13.47 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 123.902 0.881 . . . . 0.0 110.482 -170.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.22 73.5 2.07 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.751 2.968 . . . . 0.0 110.108 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -144.79 -51.7 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -87.87 -27.84 21.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.707 -0.664 . . . . 0.0 111.236 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.3 tp -120.93 143.6 32.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 CA-C-N 118.897 0.771 . . . . 0.0 110.169 -175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -83.44 31.37 0.46 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -171.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.284 0.5 OUTLIER 74.78 -58.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 128.411 2.684 . . . . 0.0 111.447 170.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -80.77 -38.95 27.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.463 1.905 . . . . 0.0 108.247 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.8 -53.53 7.33 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 123.774 0.83 . . . . 0.0 111.696 -174.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -34.9 -56.98 0.56 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.613 1.565 . . . . 0.0 110.065 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -42.09 71.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.765 0.426 . . . . 0.0 111.14 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -56.76 -28.5 61.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -63.22 -44.18 95.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.37 -46.26 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 117.987 -1.006 . . . . 0.0 111.038 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -52.12 -51.83 55.36 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.754 1.161 . . . . 0.0 108.421 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.59 -20.9 63.83 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.55 2.34 . . . . 0.0 114.056 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.4 mmt -54.82 -32.61 60.6 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.625 1.102 . . . . 0.0 110.123 168.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.47 43.08 0.48 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -147.05 132.61 9.24 Favored Pre-proline 0 C--O 1.223 -0.296 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.7 123.34 11.54 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 121.083 1.423 . . . . 0.0 108.953 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.71 175.02 9.37 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.572 1.177 . . . . 0.0 110.102 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.98 150.91 24.75 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.992 -1.068 . . . . 0.0 111.017 -163.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -126.58 125.21 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -174.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.3 mtmt -77.57 -71.06 0.44 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.262 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -157.19 138.8 14.02 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 tp -147.97 102.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.371 1.468 . . . . 0.0 107.281 -174.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -156.46 154.66 30.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.456 0.571 . . . . 0.0 110.052 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.21 -173.0 31.43 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 107.587 -2.205 . . . . 0.0 107.587 -175.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 . . . . . 0 C--O 1.25 1.129 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 179.293 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.032 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -131.26 89.11 2.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.669 0.788 . . . . 0.0 109.442 -168.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.52 138.35 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 127.123 2.169 . . . . 0.0 107.1 174.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.3 t -92.08 132.42 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 125.501 1.52 . . . . 0.0 108.47 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.33 129.91 55.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 170.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HZ3' ' CD ' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -105.59 121.9 44.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.29 1.436 . . . . 0.0 107.127 169.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -129.91 140.21 50.99 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.302 0.641 . . . . 0.0 110.479 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.84 145.22 34.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 164.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 t -136.16 72.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.663 1.585 . . . . 0.0 107.269 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -71.45 176.17 4.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.684 0.754 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.74 -48.17 3.94 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.553 -0.581 . . . . 0.0 113.149 166.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -56.54 144.58 31.05 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.345 1.073 . . . . 0.0 109.577 172.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.4 t -143.21 138.26 29.56 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.554 0.742 . . . . 0.0 109.82 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m 60.01 152.8 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.775 2.03 . . . . 0.0 111.368 -168.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -71.74 70.68 0.71 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.465 -0.772 . . . . 0.0 111.352 -172.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.3 t -123.64 -79.79 0.62 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.571 1.948 . . . . 0.0 107.719 -166.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 60.9 m -68.36 72.53 0.21 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.041 1.337 . . . . 0.0 109.742 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.2 p -139.05 -86.73 0.23 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.408 1.883 . . . . 0.0 106.629 -174.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.95 -36.31 65.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -168.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.3 m -49.98 -61.66 2.01 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.871 167.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.83 -51.1 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.31 -63.82 1.13 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.516 0.674 . . . . 0.0 110.549 -173.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.7 -54.38 6.69 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.998 1.761 . . . . 0.0 112.165 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -59.3 -54.38 47.46 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.151 0.975 . . . . 0.0 110.447 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.1 mm -56.52 -33.33 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.448 0.699 . . . . 0.0 111.302 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.65 -20.44 17.91 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.645 1.117 . . . . 0.0 113.904 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -84.59 -20.25 31.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.646 1.723 . . . . 0.0 111.138 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 136.24 53.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 122.339 1.066 . . . . 0.0 111.75 -167.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.59 115.15 1.81 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.905 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.88 -22.38 12.7 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-O 119.076 -0.847 . . . . 0.0 112.507 176.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.25 128.31 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 118.318 1.059 . . . . 0.0 109.388 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -88.6 -48.47 7.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.935 1.294 . . . . 0.0 109.116 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.72 171.27 19.84 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.309 0.958 . . . . 0.0 111.124 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 tt -141.55 142.78 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 124.703 1.201 . . . . 0.0 109.677 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.78 106.79 6.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.259 1.424 . . . . 0.0 107.774 170.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.64 125.76 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.2 1.0 . . . . 0.0 109.352 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -115.01 82.62 1.77 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.725 1.21 . . . . 0.0 108.283 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -52.23 -44.29 64.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.836 0.854 . . . . 0.0 110.298 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -40.89 -55.19 2.55 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.95 1.3 . . . . 0.0 111.085 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -79.68 -7.61 58.69 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.234 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 61.49 23.66 13.9 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.551 2.34 . . . . 0.0 111.283 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.464 ' CD ' ' HZ3' ' A' ' 6' ' ' LYS . 12.8 tt0 -139.69 159.81 41.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.034 -168.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.63 159.03 44.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.299 0.64 . . . . 0.0 109.482 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.4 m -132.77 119.89 20.9 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.8 mt -106.64 155.17 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.45 121.19 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 168.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -157.75 -177.3 6.47 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 127.478 2.311 . . . . 0.0 107.95 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -137.76 149.05 63.31 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 119.98 1.264 . . . . 0.0 112.278 170.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.56 72.49 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.259 3.306 . . . . 0.0 110.266 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.15 -61.43 0.42 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.242 1.417 . . . . 0.0 108.372 173.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.1 mt -84.75 -19.82 32.05 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.798 -0.62 . . . . 0.0 110.815 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 tp -123.97 152.33 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 123.288 0.635 . . . . 0.0 110.143 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 m -81.39 20.27 0.89 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.141 0.977 . . . . 0.0 113.433 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 66.91 -61.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 129.23 3.012 . . . . 0.0 109.84 -172.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.94 -39.0 72.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.643 0.777 . . . . 0.0 110.066 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -47.47 -50.7 22.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.364 0.415 . . . . 0.0 111.663 -174.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.21 -48.22 6.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 122.934 0.494 . . . . 0.0 111.626 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -51.66 24.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 122.227 -0.296 . . . . 0.0 110.71 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -57.99 -27.6 63.63 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -60.51 -51.38 69.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.894 0.877 . . . . 0.0 108.681 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.95 -50.14 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.659 173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -53.93 -47.44 71.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.34 -20.64 60.12 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.441 1.496 . . . . 0.0 114.227 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.7 mmt -60.94 -29.97 69.94 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.956 1.253 . . . . 0.0 110.348 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.42 -34.74 1.7 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 173.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -77.09 110.53 12.39 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.192 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.72 116.95 4.23 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.737 1.625 . . . . 0.0 109.217 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.84 -169.5 2.13 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.236 1.014 . . . . 0.0 109.438 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.46 136.87 8.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.753 1.16 . . . . 0.0 113.355 -169.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.04 136.11 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.76 1.224 . . . . 0.0 108.913 174.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -96.46 -70.63 0.71 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 74' ' ' GLU . 22.3 tttt -147.12 158.89 44.09 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -176.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -145.63 83.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 125.461 1.504 . . . . 0.0 110.735 -159.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 72' ' ' LYS . 19.6 pt-20 -161.4 177.41 10.14 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.416 0.553 . . . . 0.0 111.941 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.52 -157.33 6.44 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.433 0.54 . . . . 0.0 111.938 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 116.908 -1.52 . . . . 0.0 108.937 173.459 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.26 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -117.25 171.12 8.16 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.253 1.021 . . . . 0.0 109.151 -169.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.07 142.33 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.592 0.711 . . . . 0.0 109.896 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.7 t -80.69 136.45 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 125.262 1.425 . . . . 0.0 109.784 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.65 138.37 52.81 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.274 1.83 . . . . 0.0 108.077 177.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -110.68 114.79 28.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.806 1.242 . . . . 0.0 109.77 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.5 ptp -109.52 151.5 26.67 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.372 1.069 . . . . 0.0 109.827 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -89.67 133.34 34.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 163.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 t -118.71 78.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -72.91 167.93 20.0 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.928 0.87 . . . . 0.0 111.475 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.18 -76.95 1.04 Allowed Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.8 ttp 46.75 -127.78 1.53 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.372 1.469 . . . . 0.0 112.349 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.6 t -162.77 -171.89 2.88 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.194 1.361 . . . . 0.0 109.385 171.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.0 m -51.57 -70.91 0.07 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 126.182 1.793 . . . . 0.0 113.246 -170.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -140.88 43.38 1.82 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.669 0.747 . . . . 0.0 109.612 177.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.5 t -158.7 -152.41 0.33 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m 51.44 46.59 26.27 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -165.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 p -128.62 -77.09 0.56 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.4 m -49.08 -40.91 33.69 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -175.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.3 m -48.99 -58.49 4.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.144 0.497 . . . . 0.0 111.698 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.58 -45.24 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 123.937 0.895 . . . . 0.0 108.988 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -54.35 -62.5 1.62 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.645 1.111 . . . . 0.0 110.568 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.4 -54.01 14.34 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.352 1.453 . . . . 0.0 111.754 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -60.73 -58.14 9.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.624 0.712 . . . . 0.0 110.45 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.31 -39.05 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.063 0.945 . . . . 0.0 110.3 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.06 -13.98 9.97 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.042 1.306 . . . . 0.0 113.829 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -95.5 -15.35 22.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.849 1.324 . . . . 0.0 110.667 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 141.2 55.66 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 119.528 1.058 . . . . 0.0 111.96 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -59.32 114.32 2.6 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.677 173.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.05 -22.74 9.62 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.436 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.16 139.01 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 117.966 0.883 . . . . 0.0 109.265 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -105.48 -45.87 4.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.468 1.507 . . . . 0.0 110.207 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.59 161.7 42.06 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 tt -146.78 140.49 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.712 1.205 . . . . 0.0 109.375 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.63 105.18 6.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.319 1.847 . . . . 0.0 106.903 173.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.56 116.44 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.816 1.189 . . . . 0.0 108.862 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -80.47 179.69 7.6 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.338 0.589 . . . . 0.0 110.176 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.2 -59.74 1.3 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.284 1.434 . . . . 0.0 108.225 173.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -43.84 -54.64 5.09 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.983 1.313 . . . . 0.0 110.083 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -80.55 -12.66 59.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.012 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 61.95 15.76 7.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.963 1.705 . . . . 0.0 112.736 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -124.76 156.72 37.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.556 1.543 . . . . 0.0 109.689 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.56 152.63 47.04 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.538 0.735 . . . . 0.0 110.104 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.3 m -128.24 113.85 16.19 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.548 1.939 . . . . 0.0 105.991 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.73 160.59 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -128.51 119.11 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -158.28 178.13 10.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.261 1.424 . . . . 0.0 110.239 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -133.53 149.82 73.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.295 1.038 . . . . 0.0 113.547 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.68 80.67 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.665 2.91 . . . . 0.0 109.114 169.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.2 -61.2 0.25 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.46 1.104 . . . . 0.0 108.073 173.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.9 mt -87.59 -21.12 25.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.003 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 tp -123.96 148.79 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.07 0.948 . . . . 0.0 109.851 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.0 m -79.39 23.98 0.37 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.256 0.8 OUTLIER 70.09 -57.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 128.047 2.539 . . . . 0.0 110.054 -176.18 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.09 -40.7 37.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.398 1.079 . . . . 0.0 110.144 -176.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -48.19 -48.44 34.69 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 122.739 0.415 . . . . 0.0 111.668 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -37.89 -56.43 1.11 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.695 1.198 . . . . 0.0 112.212 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.17 -45.19 42.28 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.254 1.021 . . . . 0.0 112.478 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.44 -29.36 15.82 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.191 -0.943 . . . . 0.0 112.663 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -62.27 -34.31 76.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -70.1 -44.32 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 118.419 -0.801 . . . . 0.0 109.811 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -50.86 -49.34 59.25 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.51 44.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.273 1.029 . . . . 0.0 113.756 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.3 mmm -66.8 -30.85 71.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.444 1.02 . . . . 0.0 110.247 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.23 -36.91 1.99 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.315 0.96 . . . . 0.0 111.142 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -79.56 123.73 84.09 Favored Pre-proline 0 N--CA 1.455 -0.179 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.305 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.15 118.33 5.35 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.508 1.472 . . . . 0.0 108.596 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.76 -174.56 2.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -162.87 143.79 9.73 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.888 -1.132 . . . . 0.0 110.935 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.2 t -111.8 132.61 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -77.41 -74.44 0.25 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.811 0.444 . . . . 0.0 111.046 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -156.7 151.24 25.57 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.3 tp -155.39 138.5 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 125.034 1.334 . . . . 0.0 108.979 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -159.19 147.02 17.58 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.741 1.217 . . . . 0.0 108.974 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.46 109.6 0.3 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -171.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? . . . . . 0 C--O 1.249 1.053 0 CA-C-O 116.636 -1.65 . . . . 0.0 110.224 -159.37 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.444 0 CA-C-O 119.801 -0.444 . . . . 0.0 113.66 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -87.63 179.83 6.45 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.95 1.3 . . . . 0.0 109.137 -164.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.7 t -83.62 125.78 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -173.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 t -77.1 121.41 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.96 132.75 56.36 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.551 1.54 . . . . 0.0 106.897 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.97 137.84 36.94 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.2 1.0 . . . . 0.0 110.196 171.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -138.71 147.44 42.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.177 0.991 . . . . 0.0 109.882 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -92.25 128.56 38.14 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 t -120.65 73.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 125.24 1.416 . . . . 0.0 108.755 -171.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -73.27 174.7 7.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.784 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.18 -45.66 3.25 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 121.807 -0.558 . . . . 0.0 113.015 167.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -56.2 153.93 8.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.04 0.92 . . . . 0.0 109.508 167.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -142.87 129.24 19.99 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.805 0.842 . . . . 0.0 109.378 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 m 60.93 175.54 0.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.114 1.365 . . . . 0.0 112.208 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -74.96 56.24 0.74 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.196 0.999 . . . . 0.0 111.173 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.9 p -104.09 -80.87 0.53 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.753 1.221 . . . . 0.0 107.956 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.73 68.95 1.75 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.321 1.448 . . . . 0.0 108.375 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.5 p -129.71 -78.1 0.55 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 m -56.4 -38.19 71.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -169.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -50.18 -59.34 4.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.75 0.42 . . . . 0.0 110.404 168.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.72 -49.34 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 118.563 -0.732 . . . . 0.0 109.372 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.38 -65.65 0.54 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.063 0.847 . . . . 0.0 111.071 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.9 -52.22 26.68 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.117 1.342 . . . . 0.0 112.206 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -52.15 -58.05 7.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.533 0.733 . . . . 0.0 109.461 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.44 -34.98 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.6 1.16 . . . . 0.0 111.108 -176.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.87 -23.03 10.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.01 1.29 . . . . 0.0 113.664 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -89.36 -17.22 29.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.577 1.188 . . . . 0.0 110.239 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.43 136.63 49.71 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.327 1.06 . . . . 0.0 111.688 -173.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -52.08 109.27 0.36 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.037 1.335 . . . . 0.0 111.111 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.24 -23.48 8.56 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 118.928 -0.929 . . . . 0.0 112.788 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.3 t -79.79 142.9 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 118.49 1.145 . . . . 0.0 110.056 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -117.12 -40.24 3.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.546 1.138 . . . . 0.0 111.812 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.89 165.68 34.7 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.748 0.704 . . . . 0.0 109.168 173.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -143.95 145.05 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.518 1.527 . . . . 0.0 108.417 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -139.99 97.98 3.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.424 2.29 . . . . 0.0 107.101 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -96.09 116.43 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.131 0.972 . . . . 0.0 109.09 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.8 t -108.72 80.01 1.29 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.02 -41.01 67.53 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.855 0.462 . . . . 0.0 111.747 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.81 -55.05 3.83 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.93 1.292 . . . . 0.0 110.584 168.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -78.57 -19.83 51.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.75 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 72.65 4.72 5.07 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.796 2.438 . . . . 0.0 111.627 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -109.99 151.95 26.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.541 1.536 . . . . 0.0 109.02 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.6 157.81 44.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.991 0.916 . . . . 0.0 108.63 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -129.33 121.56 27.72 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.8 mt -111.52 153.35 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.254 7.0 p -117.87 114.7 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.991 0.917 . . . . 0.0 108.906 173.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -158.95 178.93 9.55 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.721 1.208 . . . . 0.0 110.681 -171.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -138.19 144.73 44.48 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.6 71.93 1.4 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.547 3.498 . . . . 0.0 110.826 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.32 -58.15 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.399 1.08 . . . . 0.0 108.507 172.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.3 mt -87.5 -21.81 25.26 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.877 -0.582 . . . . 0.0 110.869 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.0 tp -118.76 151.12 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 123.622 0.769 . . . . 0.0 109.823 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 m -85.88 29.83 0.7 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.637 0.775 . . . . 0.0 112.72 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.265 0.5 OUTLIER 73.76 -59.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.085 2.554 . . . . 0.0 110.4 176.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -81.01 -38.01 28.2 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.303 1.441 . . . . 0.0 109.786 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -43.76 -48.69 8.1 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 123.747 0.655 . . . . 0.0 111.346 -174.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.24 -53.74 3.11 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.661 0.784 . . . . 0.0 112.029 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -47.22 54.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.199 0.2 . . . . 0.0 110.619 177.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -54.54 -28.38 45.16 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -62.53 -52.24 64.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.5 mp -58.2 -43.14 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.183 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -55.48 -53.71 52.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.5 -27.35 62.47 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.172 1.789 . . . . 0.0 114.097 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.2 mmm -51.37 -31.45 22.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.687 1.13 . . . . 0.0 110.974 172.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.63 42.72 0.28 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -146.82 120.52 5.07 Favored Pre-proline 0 C--O 1.227 -0.087 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.13 102.04 0.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.953 1.769 . . . . 0.0 109.345 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.22 -175.47 3.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.819 0.848 . . . . 0.0 108.898 -175.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.33 143.83 15.34 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.97 136.71 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.546 1.538 . . . . 0.0 108.42 172.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -79.16 -81.81 0.11 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.543 0.156 . . . . 0.0 111.031 171.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -156.28 144.12 19.51 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.538 -0.726 . . . . 0.0 109.169 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -145.86 122.88 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 126.581 1.953 . . . . 0.0 105.838 -173.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.64 153.35 26.63 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.797 0.839 . . . . 0.0 109.023 171.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.98 113.68 0.91 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.413 1.006 . . . . 0.0 111.256 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? . . . . . 0 C--O 1.254 1.302 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.503 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.95 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.13 137.18 22.54 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.106 0.962 . . . . 0.0 111.832 -174.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.18 126.46 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 124.915 1.286 . . . . 0.0 108.561 -174.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.72 120.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.88 156.02 37.01 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.555 1.142 . . . . 0.0 109.237 -177.103 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.35 123.05 45.45 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.401 0.681 . . . . 0.0 110.039 177.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.1 mmt -105.95 157.72 17.3 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.703 1.201 . . . . 0.0 109.052 174.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.93 127.14 54.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 168.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.5 73.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.329 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.9 169.84 17.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.801 -174.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.73 -40.72 1.85 Allowed Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.934 -0.926 . . . . 0.0 113.708 172.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -59.88 80.31 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.581 1.153 . . . . 0.0 110.693 174.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.19 -38.8 12.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.844 1.658 . . . . 0.0 110.7 -174.294 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 p -59.86 134.18 56.79 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.21 42.67 0.42 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -165.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.9 t -172.13 85.51 0.07 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.797 1.239 . . . . 0.0 108.104 173.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 t -160.06 57.17 0.36 Allowed 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 p -135.68 -69.82 0.49 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.241 -172.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.5 t -53.08 -39.31 63.23 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -172.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.5 m -45.77 -61.36 1.75 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 123.194 0.598 . . . . 0.0 112.561 165.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.78 -49.12 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.317 1.047 . . . . 0.0 108.975 178.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -56.41 -65.91 0.53 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.989 0.916 . . . . 0.0 109.428 -176.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.05 -52.83 11.51 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.195 1.379 . . . . 0.0 112.492 176.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.19 -55.42 35.16 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.851 0.825 . . . . 0.0 110.233 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.7 mm -60.59 -30.07 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 123.797 0.839 . . . . 0.0 110.851 -178.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.85 -19.52 6.98 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.07 171.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -90.51 -13.53 34.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 119.784 1.792 . . . . 0.0 111.217 177.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.65 134.0 50.36 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.496 1.141 . . . . 0.0 111.033 -173.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -55.55 110.9 0.78 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.116 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.38 -25.42 8.2 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.329 176.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 t -81.28 136.06 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 118.194 0.997 . . . . 0.0 109.045 -177.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -101.72 -42.92 6.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.797 1.239 . . . . 0.0 110.201 173.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 ttt-85 -153.98 161.35 42.03 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.849 0.75 . . . . 0.0 109.987 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 tt -149.08 139.33 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.583 1.153 . . . . 0.0 109.545 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -139.6 114.81 9.71 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.094 1.758 . . . . 0.0 106.593 174.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -113.99 126.23 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.986 1.314 . . . . 0.0 109.07 -178.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.3 t -84.58 172.41 11.63 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.536 0.684 . . . . 0.0 110.345 172.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.1 -63.25 1.48 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 170.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -52.64 -49.96 64.13 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.29 1.036 . . . . 0.0 109.313 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.9 -18.09 59.53 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.292 -172.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 62.62 4.74 1.46 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.324 1.85 . . . . 0.0 113.239 -175.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -107.86 152.93 23.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.263 1.825 . . . . 0.0 108.014 -169.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.13 161.27 37.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.47 0.708 . . . . 0.0 109.833 178.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.7 m -137.68 118.29 13.96 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 mt -120.27 160.85 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.244 1.018 . . . . 0.0 108.282 178.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.263 14.1 p -130.25 114.89 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.355 0.662 . . . . 0.0 109.888 178.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -158.97 178.66 9.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.229 1.011 . . . . 0.0 111.392 -175.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -134.65 148.82 68.89 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.419 1.088 . . . . 0.0 113.177 173.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.69 74.83 0.85 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.403 3.402 . . . . 0.0 110.006 171.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.26 -61.31 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.752 1.221 . . . . 0.0 107.812 170.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.4 mt -85.66 -20.86 28.79 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.092 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 54' ' ' VAL . 10.9 tp -123.4 147.3 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 m -79.81 27.0 0.31 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.36 0.982 . . . . 0.0 112.68 -176.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 52' ' ' ILE 0.27 0.5 OUTLIER 73.25 -54.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 128.01 2.524 . . . . 0.0 110.817 179.334 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -88.3 -32.81 18.27 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.597 0.759 . . . . 0.0 111.218 -178.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -40.76 -51.57 3.07 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 123.254 0.622 . . . . 0.0 110.775 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -37.0 -63.94 0.39 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.443 1.497 . . . . 0.0 109.922 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.3 -43.99 97.54 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.905 -0.497 . . . . 0.0 111.091 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -58.08 -31.64 67.28 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -60.18 -48.38 81.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -58.6 -48.37 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.863 175.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -52.15 -50.79 61.06 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.324 0.966 . . . . 0.0 108.477 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.27 -21.46 61.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.067 1.747 . . . . 0.0 114.036 -177.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.0 mmt -63.26 -23.95 67.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.955 1.252 . . . . 0.0 110.478 172.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.99 40.77 0.74 Allowed Glycine 0 C--N 1.338 0.66 0 C-N-CA 124.279 0.942 . . . . 0.0 111.358 170.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -148.53 123.3 4.94 Favored Pre-proline 0 C--O 1.226 -0.152 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.8 118.28 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.361 1.374 . . . . 0.0 109.078 -178.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.66 -171.13 1.83 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.96 152.45 13.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.036 -1.04 . . . . 0.0 111.206 -173.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 p -118.62 124.23 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 126.362 1.865 . . . . 0.0 106.383 -178.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -74.91 -80.26 0.08 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.883 175.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -156.75 155.84 32.31 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 170.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -155.68 111.71 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.861 2.064 . . . . 0.0 107.41 -170.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -155.3 155.67 34.16 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.847 1.259 . . . . 0.0 107.795 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.69 169.33 37.9 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 172.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 . . . . . 0 C--O 1.25 1.116 0 C-N-CA 126.97 2.108 . . . . 0.0 109.235 -168.577 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.11 0 CA-C-O 118.649 -1.084 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -163.63 60.13 0.17 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 117.619 0.709 . . . . 0.0 110.967 -171.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.2 t -100.97 127.63 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 173.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.82 141.78 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.64 131.91 23.41 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.773 0.829 . . . . 0.0 109.266 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.472 ' HZ3' ' CD ' ' A' ' 42' ' ' GLU . 1.4 mtmt -103.62 129.78 50.96 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.04 1.336 . . . . 0.0 111.387 178.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.3 ptp -127.01 159.68 33.4 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.294 1.038 . . . . 0.0 110.67 176.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -98.73 124.81 43.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.014 1.726 . . . . 0.0 107.681 164.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -111.97 77.44 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.065 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 169.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.283 10.6 pt-20 -84.2 165.63 18.23 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.665 178.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.88 -35.99 4.39 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.459 -0.634 . . . . 0.0 113.759 176.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -65.57 159.83 23.78 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.78 1.29 . . . . 0.0 111.954 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.2 p -90.14 166.1 13.59 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.438 1.095 . . . . 0.0 110.608 -178.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.8 p -57.73 138.03 55.91 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.74 0.416 . . . . 0.0 110.546 175.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.8 t60 40.24 65.61 0.73 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.784 1.634 . . . . 0.0 113.077 176.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -160.07 27.88 0.17 Allowed 'General case' 0 CA--C 1.535 0.368 0 O-C-N 122.005 -0.434 . . . . 0.0 111.998 -170.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.6 p -167.33 -111.59 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.493 -167.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.7 p 33.82 -98.03 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 127.483 2.313 . . . . 0.0 111.931 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -49.32 -37.17 23.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -175.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.25 -51.37 69.85 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 175.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.59 -53.38 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.176 172.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -55.86 -61.1 2.59 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.325 0.966 . . . . 0.0 109.92 -171.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.48 -52.9 22.53 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.319 1.438 . . . . 0.0 111.729 177.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -60.7 -50.86 71.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.047 0.923 . . . . 0.0 110.323 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.5 mm -66.33 -24.33 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.89 0.876 . . . . 0.0 110.788 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.11 -14.55 32.72 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.604 170.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -84.54 -12.93 53.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.64 1.72 . . . . 0.0 110.607 173.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.63 135.31 46.88 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 122.307 1.051 . . . . 0.0 111.447 -171.156 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -60.93 113.77 2.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.221 177.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.83 -21.87 15.47 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-O 119.366 -0.686 . . . . 0.0 112.945 175.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 t -81.59 131.34 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.26 -51.34 5.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.151 1.38 . . . . 0.0 109.163 174.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -152.1 160.86 43.33 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tt -143.51 141.55 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.151 1.38 . . . . 0.0 108.488 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.54 125.93 20.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.734 1.614 . . . . 0.0 107.097 171.023 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -115.95 154.31 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.026 1.33 . . . . 0.0 107.696 -178.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.2 t -130.28 155.53 46.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.111 0.964 . . . . 0.0 109.216 176.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -104.36 -59.71 1.7 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.299 1.84 . . . . 0.0 108.732 -177.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.79 -58.27 7.85 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.065 1.346 . . . . 0.0 109.619 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.7 -22.36 62.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.32 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 55.75 59.29 3.9 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 126.581 1.952 . . . . 0.0 109.775 176.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.472 ' CD ' ' HZ3' ' A' ' 6' ' ' LYS . 14.9 tt0 -156.34 160.72 39.95 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.465 1.506 . . . . 0.0 107.137 -172.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.63 159.04 43.01 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 118.931 0.787 . . . . 0.0 110.536 174.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.9 m -126.23 130.28 50.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 174.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.36 163.66 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.4 117.71 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.108 0.963 . . . . 0.0 108.846 176.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -159.61 -177.14 6.18 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.535 1.134 . . . . 0.0 111.255 -171.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -136.73 152.61 74.7 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 165.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.79 76.55 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.32 3.347 . . . . 0.0 109.541 171.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.71 -62.43 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.227 1.011 . . . . 0.0 108.679 175.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.9 mt -84.14 -27.21 28.3 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 119.361 -0.352 . . . . 0.0 110.142 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.4 tp -117.74 146.74 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.321 1.048 . . . . 0.0 109.281 177.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -84.1 27.78 0.65 Allowed 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.262 0.9 OUTLIER 70.42 -57.54 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 128.787 2.835 . . . . 0.0 111.42 179.883 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.72 -33.56 40.78 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.08 1.352 . . . . 0.0 110.04 -177.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -52.87 -49.61 65.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 123.203 0.314 . . . . 0.0 110.777 -177.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -31.57 -58.67 0.26 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.491 1.516 . . . . 0.0 111.283 172.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -46.71 67.13 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.177 -0.327 . . . . 0.0 111.306 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.8 -32.02 59.73 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.819 -0.551 . . . . 0.0 112.321 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -42.16 99.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.19 -47.94 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.694 172.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -49.79 -51.07 42.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.17 0.986 . . . . 0.0 108.835 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.84 -19.59 51.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.781 2.032 . . . . 0.0 114.056 -178.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.8 mmm -61.34 -30.47 70.53 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.626 1.103 . . . . 0.0 109.626 170.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.25 40.68 0.39 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.839 1.209 . . . . 0.0 111.553 170.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -148.62 122.12 4.66 Favored Pre-proline 0 C--O 1.223 -0.291 0 CA-C-O 117.12 -1.419 . . . . 0.0 107.604 -177.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -62.69 118.66 5.56 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.623 1.549 . . . . 0.0 109.001 -176.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.78 175.16 6.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.216 1.008 . . . . 0.0 109.991 -178.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.81 138.67 18.02 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.95 -1.094 . . . . 0.0 111.178 -170.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.6 p -114.11 131.19 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -177.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -80.19 -83.04 0.11 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.93 146.97 17.96 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.108 0.563 . . . . 0.0 110.297 176.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.91 133.27 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 127.543 2.337 . . . . 0.0 106.624 -177.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.97 161.42 39.6 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 165.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -47.36 119.94 5.19 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 174.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 . . . . . 0 C--O 1.251 1.173 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.585 -174.97 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.844 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 19.93 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.113 2.165 . . . . 0.0 115.364 173.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.14 130.92 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.49 135.44 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.67 144.41 50.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.272 1.429 . . . . 0.0 107.375 178.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.06 129.04 55.74 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.431 1.492 . . . . 0.0 109.136 174.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 ptp -124.04 152.07 43.04 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.614 1.166 . . . . 0.0 109.877 179.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -89.94 151.43 21.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 162.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -132.27 68.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -62.9 115.47 4.41 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.672 -170.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 119.26 -34.41 4.3 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.389 -0.673 . . . . 0.0 113.37 173.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -72.05 110.53 6.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.091 1.446 . . . . 0.0 108.078 173.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 t -160.07 61.81 0.35 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.852 0.751 . . . . 0.0 111.27 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 t -158.85 71.96 0.56 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.222 -0.299 . . . . 0.0 110.234 174.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 10.38 70.35 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.709 2.803 . . . . 0.0 114.588 -179.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.1 t -159.84 -70.99 0.08 Allowed 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -174.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.5 m -65.5 78.37 0.07 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.587 1.155 . . . . 0.0 110.73 -176.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.6 p -140.53 -84.44 0.22 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.978 2.111 . . . . 0.0 106.403 -179.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 m -55.33 -36.25 66.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -171.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.6 m -50.76 -60.63 2.86 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.416 0.447 . . . . 0.0 111.051 167.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.9 -51.22 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -57.49 -66.75 0.41 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.552 0.691 . . . . 0.0 110.63 -174.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.19 -51.26 26.36 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.881 1.705 . . . . 0.0 111.911 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -54.89 -56.68 16.92 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.813 0.806 . . . . 0.0 109.367 177.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.9 mm -64.24 -28.56 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 C-N-CA 123.157 0.583 . . . . 0.0 111.052 -174.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.78 -19.98 23.43 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.376 0.989 . . . . 0.0 113.44 171.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -85.84 -18.61 32.37 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 119.627 1.714 . . . . 0.0 109.419 177.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.46 133.7 49.02 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.453 1.121 . . . . 0.0 111.336 -172.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -58.23 111.43 1.2 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.027 175.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.67 -27.34 6.28 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-O 119.165 -0.797 . . . . 0.0 112.639 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.07 136.19 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 118.167 0.984 . . . . 0.0 109.382 -176.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -107.87 -46.0 3.87 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.581 1.152 . . . . 0.0 110.668 176.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.61 159.7 42.37 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.5 tt -142.7 148.15 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.072 1.349 . . . . 0.0 109.854 179.1 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -145.27 113.11 6.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.791 2.036 . . . . 0.0 108.193 171.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.0 t -102.92 120.66 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.23 1.012 . . . . 0.0 110.168 176.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 m -102.72 89.32 3.46 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.516 1.126 . . . . 0.0 109.061 175.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 mt -58.81 173.66 0.41 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.201 160.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 66.41 -65.63 0.19 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 127.968 2.507 . . . . 0.0 109.574 -170.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -27.85 69.0 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.095 178.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.93 50.82 0.8 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.674 2.39 . . . . 0.0 111.718 172.628 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -140.22 148.16 41.11 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.217 2.207 . . . . 0.0 106.206 -174.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.43 155.84 45.13 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 120.924 -1.11 . . . . 0.0 109.679 172.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.76 136.66 34.35 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.41 163.17 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.36 119.1 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -159.0 -179.33 7.95 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.684 1.194 . . . . 0.0 109.908 -172.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -138.23 144.1 41.79 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.1 80.27 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.305 3.337 . . . . 0.0 109.921 174.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -158.35 -54.32 0.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.7 mt -86.75 -29.48 22.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.417 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 tp -115.68 145.13 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m -78.24 23.49 0.28 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 -175.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 76.03 -58.51 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 127.27 2.228 . . . . 0.0 109.786 176.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.99 -39.26 42.93 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.476 1.511 . . . . 0.0 109.669 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -40.39 -57.11 1.86 Allowed 'General case' 0 C--N 1.345 0.388 0 C-N-CA 123.942 0.897 . . . . 0.0 111.043 -178.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.5 -58.29 0.33 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.999 1.72 . . . . 0.0 110.477 175.505 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -48.08 51.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.151 -0.343 . . . . 0.0 111.838 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 5.6 mptp? -55.93 -30.43 61.64 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -174.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.6 -46.41 89.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -63.93 -47.11 92.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.008 175.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.41 ' CD ' ' HZ1' ' A' ' 59' ' ' LYS . 94.5 mt-10 -50.38 -51.94 41.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.79 -18.83 57.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.503 1.921 . . . . 0.0 114.209 -178.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.6 mmm -59.12 -29.76 67.62 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.874 1.216 . . . . 0.0 109.796 170.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.94 44.36 0.28 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 124.347 0.975 . . . . 0.0 110.851 171.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -146.76 120.98 5.16 Favored Pre-proline 0 C--O 1.225 -0.196 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -175.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.22 99.01 0.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.942 1.761 . . . . 0.0 110.086 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.22 -176.63 2.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -174.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.6 141.13 11.57 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.6 0.36 . . . . 0.0 111.572 -176.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -95.12 143.61 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.22 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -83.29 -89.72 0.09 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.418 1.087 . . . . 0.0 110.171 175.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 142.14 22.63 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.8 127.74 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 129.133 2.973 . . . . 0.0 103.925 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -162.98 151.79 14.59 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 119.204 0.911 . . . . 0.0 110.178 167.141 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.25 -156.61 23.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 174.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.1 ttm105 . . . . . 0 C--O 1.255 1.373 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 170.451 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.402 ' N ' ' OE1' ' A' ' 2' ' ' GLU . . . . . . . . 0 N--CA 1.473 1.114 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.824 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 1' ' ' GLY . 1.6 mp0 -99.04 158.49 15.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.684 0.794 . . . . 0.0 109.902 -174.36 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.3 t -124.07 151.55 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.511 1.524 . . . . 0.0 108.411 -176.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.09 143.73 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 124.619 1.168 . . . . 0.0 111.389 -175.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.43 132.86 53.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.278 1.431 . . . . 0.0 108.191 175.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.43 109.71 21.49 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.301 1.44 . . . . 0.0 107.648 175.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.7 ptm -113.39 164.78 13.16 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.691 0.796 . . . . 0.0 111.084 174.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -109.99 131.02 55.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 129.711 3.204 . . . . 0.0 106.581 177.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 t -121.25 77.69 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.03 177.13 4.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.954 0.883 . . . . 0.0 111.7 -176.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.47 -53.61 4.5 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.626 -0.671 . . . . 0.0 111.546 176.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.7 mmt -69.23 131.83 45.54 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.205 -0.585 . . . . 0.0 110.008 175.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 t -164.36 46.84 0.11 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.539 0.735 . . . . 0.0 110.199 179.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.2 t -154.5 45.22 0.54 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.508 -0.745 . . . . 0.0 111.09 -179.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 24.66 57.69 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.288 2.235 . . . . 0.0 114.158 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.3 t -159.43 40.65 0.21 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -173.056 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.99 69.03 0.08 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.9 p -129.85 -79.09 0.55 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 t -55.04 -38.31 67.81 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -164.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -49.36 -58.4 5.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.876 0.47 . . . . 0.0 111.789 167.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.65 -51.43 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.752 0.821 . . . . 0.0 108.914 176.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.32 -63.59 1.14 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.28 0.632 . . . . 0.0 110.436 -174.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.98 -53.57 14.1 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.712 1.625 . . . . 0.0 112.411 174.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -62.14 -51.67 66.93 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.199 0.999 . . . . 0.0 110.925 -176.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 mm -55.63 -35.88 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.738 0.815 . . . . 0.0 110.537 173.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.01 -12.45 22.61 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.626 1.108 . . . . 0.0 114.006 173.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -87.94 -20.35 26.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.447 1.623 . . . . 0.0 109.914 172.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 131.78 45.82 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.714 1.245 . . . . 0.0 112.156 -172.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -50.06 107.29 0.15 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.551 170.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.7 -27.3 6.29 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-O 118.9 -0.945 . . . . 0.0 112.464 175.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 t -81.9 133.15 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.37 -41.97 5.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.342 0.519 . . . . 0.0 111.931 167.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 161.73 35.16 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.161 0.891 . . . . 0.0 110.006 -175.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 tt -152.68 146.99 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.95 0.9 . . . . 0.0 110.96 -176.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -144.84 102.27 3.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.579 1.952 . . . . 0.0 108.658 169.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.5 t -99.26 100.1 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.286 1.034 . . . . 0.0 110.089 177.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.0 m -89.12 77.53 7.55 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.92 0.888 . . . . 0.0 109.609 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.0 tp -53.61 -35.12 60.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.596 0.758 . . . . 0.0 110.334 177.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -38.71 -52.3 1.68 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.361 1.464 . . . . 0.0 111.325 167.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.28 -7.14 58.73 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.096 -173.152 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 63.56 17.1 10.14 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.969 2.108 . . . . 0.0 111.312 -172.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -139.61 145.29 38.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.79 1.236 . . . . 0.0 110.225 -170.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.03 147.79 46.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.401 0.68 . . . . 0.0 110.809 -167.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -130.15 110.81 11.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.99 1.716 . . . . 0.0 107.073 -167.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.21 171.46 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.65 123.76 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.096 0.862 . . . . 0.0 109.619 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -155.93 176.73 12.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.776 0.83 . . . . 0.0 110.711 -174.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -123.65 141.14 35.79 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.236 1.014 . . . . 0.0 112.367 175.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.39 81.04 1.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.151 3.234 . . . . 0.0 109.753 176.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 -51.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.5 0.72 . . . . 0.0 109.512 177.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.4 mt -86.72 -36.59 18.57 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -179.208 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.5 tp -109.4 149.5 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 m -86.64 32.91 0.64 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 122.912 0.485 . . . . 0.0 111.645 -174.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 68.55 -56.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 129.911 3.284 . . . . 0.0 111.641 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -96.21 -26.81 15.29 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 126.846 2.059 . . . . 0.0 110.689 -170.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -43.18 -48.46 6.46 Favored 'General case' 0 C--N 1.347 0.484 0 O-C-N 123.524 0.515 . . . . 0.0 110.723 177.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -47.24 -61.52 1.86 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 123.272 0.629 . . . . 0.0 111.267 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.24 -45.44 93.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.232 1.013 . . . . 0.0 110.395 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -57.19 -27.88 62.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.876 176.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -47.89 75.45 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 175.288 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.64 -45.01 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.563 -0.732 . . . . 0.0 109.604 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -54.74 -52.94 60.95 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 122.128 0.966 . . . . 0.0 108.796 176.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.69 -24.52 66.81 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.683 1.593 . . . . 0.0 113.416 -174.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.6 mmm -53.38 -35.11 59.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.26 0.937 . . . . 0.0 110.179 168.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.94 -30.48 2.56 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.59 1.091 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.93 127.98 60.07 Favored Pre-proline 0 N--CA 1.456 -0.154 0 CA-C-O 118.389 -0.815 . . . . 0.0 108.945 -173.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.92 129.14 26.36 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.061 1.841 . . . . 0.0 109.383 -178.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.46 165.71 24.55 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.622 0.725 . . . . 0.0 109.723 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -156.0 153.58 29.72 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.192 -0.942 . . . . 0.0 110.786 -161.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.88 122.06 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.01 0.924 . . . . 0.0 109.183 -171.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.3 mttt -94.25 -54.99 3.34 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.203 0.601 . . . . 0.0 110.87 177.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -123.46 136.99 54.88 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.787 0.435 . . . . 0.0 110.142 -175.059 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.7 177.56 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.119 2.168 . . . . 0.0 110.183 -168.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.07 176.89 9.24 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.368 1.467 . . . . 0.0 111.059 -176.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 55.4 -154.15 12.13 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.598 0.618 . . . . 0.0 112.07 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.375 1.07 . . . . 0.0 111.915 166.021 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.298 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -51.02 149.92 3.36 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 131.439 3.896 . . . . 0.0 111.909 169.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 t -138.77 151.09 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 126.083 1.753 . . . . 0.0 107.656 -178.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.02 130.36 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.29 1.036 . . . . 0.0 110.901 -177.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.97 152.32 42.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.732 1.613 . . . . 0.0 108.072 175.106 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.58 136.79 54.7 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.501 1.12 . . . . 0.0 109.063 174.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 ptp -126.4 143.1 51.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.8 1.64 . . . . 0.0 109.209 -177.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.26 131.39 34.74 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 167.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.12 84.55 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.84 161.6 30.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.428 0.632 . . . . 0.0 112.516 -174.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.35 -47.69 1.73 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.69 0.662 . . . . 0.0 113.739 176.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.4 ttp -56.94 109.79 0.7 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.488 1.515 . . . . 0.0 109.93 -175.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -119.08 153.15 35.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.488 1.115 . . . . 0.0 110.622 -171.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.3 m 67.96 151.41 0.08 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.066 2.146 . . . . 0.0 112.261 179.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -76.42 58.02 1.27 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.322 1.049 . . . . 0.0 111.288 -174.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.7 t -133.54 -69.27 0.55 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.186 1.394 . . . . 0.0 107.449 -167.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.1 m -70.44 77.1 0.56 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 168.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.4 p -148.17 -80.49 0.14 Allowed 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.757 1.623 . . . . 0.0 107.15 178.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.8 t -53.16 -41.92 65.63 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -172.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.6 m -48.27 -56.68 7.4 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.651 168.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.45 -49.16 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -53.28 -66.67 0.35 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.341 0.973 . . . . 0.0 110.593 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.25 -53.93 8.95 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.728 1.633 . . . . 0.0 112.396 176.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -57.55 -51.0 71.27 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 117.825 0.813 . . . . 0.0 110.317 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.1 mm -62.98 -28.61 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.216 0.607 . . . . 0.0 110.603 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.61 -17.07 8.08 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 118.705 -1.053 . . . . 0.0 114.207 169.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -87.43 -18.02 30.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 120.123 1.961 . . . . 0.0 111.093 174.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.3 136.0 56.74 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.068 0.937 . . . . 0.0 110.566 -171.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -68.46 119.69 13.34 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.642 -175.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.59 -20.14 23.09 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-O 118.824 -0.987 . . . . 0.0 112.937 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.77 136.66 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 118.669 1.234 . . . . 0.0 109.547 -177.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -100.98 -47.79 4.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.054 1.342 . . . . 0.0 110.181 174.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.97 161.04 43.02 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.42 0.554 . . . . 0.0 109.53 -178.127 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 tt -138.5 145.03 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.5 1.52 . . . . 0.0 109.234 177.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -138.7 106.89 5.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.223 2.209 . . . . 0.0 107.582 171.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.5 t -102.05 98.96 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.308 0.958 . . . . 0.0 110.335 176.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 m -88.31 82.16 7.11 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.288 1.035 . . . . 0.0 109.61 177.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.94 -43.69 50.12 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.58 0.752 . . . . 0.0 111.367 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.63 -52.45 2.22 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 125.953 1.701 . . . . 0.0 111.204 170.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -82.71 -9.62 59.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.88 -172.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 64.04 20.43 12.19 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.323 1.849 . . . . 0.0 111.279 -178.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -144.23 141.71 30.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.208 1.403 . . . . 0.0 109.354 -169.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.65 151.77 44.49 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.902 0.881 . . . . 0.0 109.476 -178.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.1 m -124.52 119.57 29.5 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 127.105 2.162 . . . . 0.0 105.667 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.3 mt -125.07 161.19 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.04 123.97 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -156.22 173.14 17.28 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.506 1.122 . . . . 0.0 109.238 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.51 146.85 51.12 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 170.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -71.66 75.99 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.757 3.638 . . . . 0.0 110.332 177.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -151.85 -54.67 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.5 mt -89.28 -22.47 22.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.669 -177.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tp -121.47 149.46 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.785 0.834 . . . . 0.0 109.537 177.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.9 m -84.95 30.46 0.58 Allowed 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 123.491 0.717 . . . . 0.0 112.098 -175.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 72.1 -62.77 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 128.931 2.893 . . . . 0.0 108.568 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -84.92 -31.07 23.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.98 -171.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -43.96 -51.81 7.41 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 123.83 0.706 . . . . 0.0 110.965 -179.287 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.79 -61.11 0.88 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.061 1.344 . . . . 0.0 109.193 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -44.86 88.08 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.027 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -54.4 -33.57 59.57 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.942 0.792 . . . . 0.0 112.913 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -59.75 -47.39 85.87 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.28 -48.93 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.912 174.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -53.59 -48.21 69.44 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.101 0.953 . . . . 0.0 109.042 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.13 -20.05 62.23 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.324 1.449 . . . . 0.0 113.546 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 79.9 mmm -62.43 -29.84 70.8 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.687 1.13 . . . . 0.0 109.933 170.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.93 -34.93 2.1 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.064 0.84 . . . . 0.0 111.046 177.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -82.07 112.76 38.23 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-O 117.482 -1.247 . . . . 0.0 108.201 -178.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -60.64 137.15 71.54 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.506 1.471 . . . . 0.0 108.888 -179.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.53 -162.98 0.98 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.839 0.456 . . . . 0.0 110.098 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -170.07 148.48 3.4 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.658 0.783 . . . . 0.0 111.226 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.84 128.66 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.581 1.152 . . . . 0.0 108.283 177.026 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -105.34 -68.98 0.84 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 117.895 0.316 . . . . 0.0 111.101 168.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -89.01 174.29 7.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.0 tt -156.84 177.88 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.271 1.828 . . . . 0.0 106.672 -172.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.4 176.33 7.59 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.289 1.404 . . . . 0.0 110.02 -178.245 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.05 -161.29 28.44 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.284 0 C-N-CA 127.721 2.408 . . . . 0.0 104.895 -178.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.269 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.04 122.12 10.24 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.219 1.51 . . . . 0.0 109.51 179.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.4 143.91 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.624 1.17 . . . . 0.0 108.802 -178.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.6 t -79.27 140.48 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.491 1.116 . . . . 0.0 109.063 -177.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.58 129.29 50.96 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 126.17 1.788 . . . . 0.0 106.989 173.679 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -108.82 130.44 55.4 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.806 0.691 . . . . 0.0 109.615 172.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -138.21 157.65 45.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.162 0.985 . . . . 0.0 110.989 -172.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.7 144.52 26.6 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 170.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 t -128.61 66.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.58 1.552 . . . . 0.0 107.485 175.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.77 173.44 12.48 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.293 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.42 -40.12 1.51 Allowed Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.273 -0.737 . . . . 0.0 113.809 175.172 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.67 143.07 2.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.219 1.01 . . . . 0.0 111.978 177.039 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 t -54.98 148.63 13.15 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.112 167.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.8 m -60.65 162.1 6.96 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 166.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 t60 8.89 79.46 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.249 3.02 . . . . 0.0 114.598 -177.658 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 m -172.14 -62.57 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.862 1.265 . . . . 0.0 109.299 177.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.4 m -80.1 65.17 5.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.967 0.413 . . . . 0.0 110.792 -172.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.6 p -120.18 -80.65 0.62 Allowed 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 167.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 m -55.81 -37.13 68.23 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -163.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.9 m -52.38 -56.56 14.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 168.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.29 -49.63 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -53.21 -64.03 0.95 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.122 0.963 . . . . 0.0 110.9 -177.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.84 -51.28 13.42 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.632 1.587 . . . . 0.0 112.902 174.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -60.54 -63.72 1.2 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.618 0.709 . . . . 0.0 109.866 -178.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -53.24 -40.06 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.071 1.348 . . . . 0.0 110.613 -179.62 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.81 -23.66 16.01 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.012 1.291 . . . . 0.0 113.568 177.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -88.67 -17.01 30.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 119.151 1.475 . . . . 0.0 111.147 178.142 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 134.6 53.38 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.472 1.13 . . . . 0.0 111.861 -172.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -52.73 107.18 0.2 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.137 176.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.29 -32.76 4.03 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-O 119.144 -0.809 . . . . 0.0 111.773 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.29 136.99 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 118.093 0.947 . . . . 0.0 109.283 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -103.2 -45.63 4.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.273 1.429 . . . . 0.0 110.478 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -153.66 160.22 42.3 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.82 -0.55 . . . . 0.0 110.004 -178.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.8 tt -141.01 140.02 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.331 1.452 . . . . 0.0 109.776 178.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -133.05 117.16 17.23 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.8 1.64 . . . . 0.0 107.782 165.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.2 t -108.61 107.61 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 124.491 1.117 . . . . 0.0 109.868 177.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -89.5 89.47 7.86 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.48 -45.93 69.8 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.381 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -41.84 -61.18 1.17 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 126.114 1.766 . . . . 0.0 110.709 171.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -75.38 -9.92 58.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.05 -174.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 67.28 6.79 5.06 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 127.313 2.245 . . . . 0.0 111.741 -174.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -119.88 144.11 47.57 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.331 1.853 . . . . 0.0 108.132 -171.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.01 155.14 48.53 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.37 0.668 . . . . 0.0 109.23 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 m -135.68 112.74 10.38 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 126.195 1.798 . . . . 0.0 106.521 -171.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.94 169.08 6.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -137.78 123.71 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -159.23 -178.33 7.11 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.105 1.362 . . . . 0.0 109.982 -173.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -130.6 150.35 76.09 Favored Pre-proline 0 C--N 1.347 0.499 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 164.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.45 74.81 0.55 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.698 3.599 . . . . 0.0 109.506 169.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -147.62 -61.86 0.27 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.859 1.264 . . . . 0.0 107.617 -177.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.5 mt -91.98 -21.63 20.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.126 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 54' ' ' VAL . 11.3 tp -121.52 146.86 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.095 0.958 . . . . 0.0 108.637 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.4 m -82.39 31.93 0.4 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 119.378 0.99 . . . . 0.0 113.03 -174.032 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 52' ' ' ILE 0.252 0.5 OUTLIER 72.64 -62.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 127.876 2.47 . . . . 0.0 108.01 -177.082 . . . . . . . . 4 4 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -86.43 -28.09 23.74 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.89 -170.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -46.54 -44.89 18.23 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.36 0.527 . . . . 0.0 110.779 177.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.9 -69.22 0.14 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.22 1.408 . . . . 0.0 109.954 173.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -41.97 97.58 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.64 -0.663 . . . . 0.0 110.756 -177.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -59.61 -24.79 64.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.959 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.91 -39.92 96.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.646 1.112 . . . . 0.0 109.074 173.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.88 -49.42 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -54.18 -46.12 72.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.04 -19.44 64.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.813 1.645 . . . . 0.0 114.371 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.2 mmm -59.82 -28.69 67.68 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 120.243 1.383 . . . . 0.0 109.602 168.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.08 -25.89 4.83 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.445 1.021 . . . . 0.0 110.791 175.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -75.38 123.65 88.73 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.73 111.37 1.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.064 1.843 . . . . 0.0 109.273 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.9 -174.46 2.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.435 1.094 . . . . 0.0 108.27 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -169.65 146.21 3.25 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.722 0.692 . . . . 0.0 112.383 -167.073 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.3 t -80.96 130.37 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.15 1.38 . . . . 0.0 109.352 178.147 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -95.86 -55.91 2.84 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 160.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -147.58 78.27 1.46 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.437 0.295 . . . . 0.0 110.262 -172.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 tt -85.75 52.5 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 111.186 -178.144 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -161.99 168.58 22.57 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.338 1.455 . . . . 0.0 107.148 173.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.27 -131.01 2.79 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.427 1.013 . . . . 0.0 112.64 -179.173 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 . . . . . 0 C--O 1.249 1.041 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -177.784 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.902 0 N-CA-C 106.615 -2.594 . . . . 0.0 106.615 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -57.49 126.1 25.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.593 1.196 . . . . 0.0 110.464 -177.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 m -120.01 153.75 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 126.343 1.857 . . . . 0.0 108.915 -177.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.7 t -77.05 153.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.47 135.83 35.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.374 -1.714 . . . . 0.0 106.374 173.271 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -111.7 135.13 52.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.131 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -143.14 143.14 31.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.599 0.76 . . . . 0.0 110.883 -176.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -75.75 147.42 39.31 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 166.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.28 48.6 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 126.014 1.726 . . . . 0.0 108.725 178.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -58.4 142.96 46.86 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.26 -33.53 4.96 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.0 171.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.7 mtm -57.99 145.25 36.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.29 1.045 . . . . 0.0 109.737 176.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -78.57 -164.11 0.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.222 1.009 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.6 p -60.72 -179.69 0.13 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.744 -0.598 . . . . 0.0 111.625 173.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -48.57 72.29 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.25 2.62 . . . . 0.0 115.074 -174.607 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.7 t -162.55 30.15 0.11 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.811 1.244 . . . . 0.0 109.226 -168.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -163.82 -145.93 0.1 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -177.662 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 61.16 -71.49 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 125.776 1.631 . . . . 0.0 111.285 -176.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.3 t -55.07 -41.62 71.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 119.084 0.856 . . . . 0.0 112.361 -166.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.1 m -45.13 -60.1 2.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.431 0.693 . . . . 0.0 112.245 165.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mp -57.72 -48.56 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 124.028 0.931 . . . . 0.0 109.152 178.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -56.97 -62.5 1.7 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.492 1.139 . . . . 0.0 109.445 -174.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.12 -56.02 8.18 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.302 1.429 . . . . 0.0 112.304 173.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -61.56 -50.36 72.94 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.871 0.836 . . . . 0.0 110.911 -176.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.41 -34.0 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 124.079 0.952 . . . . 0.0 110.539 177.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.67 -17.56 6.77 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.926 -0.93 . . . . 0.0 114.812 170.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -86.89 -18.08 31.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.793 1.797 . . . . 0.0 110.816 176.147 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.7 141.78 48.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.949 0.881 . . . . 0.0 112.243 -168.657 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -59.13 117.55 4.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.929 0.892 . . . . 0.0 111.04 175.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.79 -24.99 12.27 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.269 173.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.96 142.5 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -108.84 -45.85 3.73 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.134 1.374 . . . . 0.0 109.455 172.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -154.01 162.83 40.91 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.466 -0.771 . . . . 0.0 110.305 177.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.7 tt -145.99 138.03 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 124.505 1.122 . . . . 0.0 109.137 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -130.53 117.88 20.26 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.628 1.971 . . . . 0.0 106.781 172.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.1 t -117.24 114.93 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.067 1.303 . . . . 0.0 109.474 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.1 t -90.22 106.54 18.55 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.921 -0.487 . . . . 0.0 109.829 -179.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -48.52 40.84 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 164.686 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -56.3 -59.55 4.78 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.035 0.534 . . . . 0.0 111.029 -178.316 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -74.6 -21.4 59.49 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.231 1.015 . . . . 0.0 110.723 -170.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 62.63 19.73 11.53 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.181 1.792 . . . . 0.0 110.36 -172.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -120.54 156.04 32.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.303 1.841 . . . . 0.0 108.286 175.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.47 154.38 46.6 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.463 1.105 . . . . 0.0 109.011 -178.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.8 m -125.64 111.55 15.1 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -177.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 78.5 mt -98.99 161.0 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 171.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 p -124.42 121.17 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 162.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -157.06 176.41 12.79 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.84 1.656 . . . . 0.0 108.72 -178.017 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.08 150.5 74.44 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 120.735 1.607 . . . . 0.0 113.734 169.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.67 72.3 1.41 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 124.745 3.63 . . . . 0.0 110.145 176.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -143.59 -60.12 0.41 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.302 1.041 . . . . 0.0 108.579 177.097 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.6 mt -88.18 -21.32 24.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.656 179.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 tp -120.86 148.67 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.124 0.57 . . . . 0.0 110.053 178.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.1 m -83.33 26.57 0.64 Allowed 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.272 0.5 OUTLIER 71.38 -61.14 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 128.913 2.885 . . . . 0.0 110.063 177.514 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -43.16 71.56 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.492 1.117 . . . . 0.0 108.863 179.374 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -44.67 -51.61 9.01 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 123.542 0.526 . . . . 0.0 111.28 -173.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.06 -52.64 5.25 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.225 0.61 . . . . 0.0 111.986 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -46.37 73.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 122.095 -0.378 . . . . 0.0 110.452 178.356 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -59.6 -28.82 67.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.136 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -61.31 -46.1 91.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 173.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.9 -48.42 88.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.32 173.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -51.32 -50.89 58.52 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.65 -19.43 49.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.5 1.92 . . . . 0.0 114.678 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.9 mmt -57.7 -32.15 67.09 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 120.106 1.321 . . . . 0.0 109.595 170.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.18 43.27 0.33 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.448 1.023 . . . . 0.0 110.844 173.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -145.11 121.53 6.07 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.78 94.37 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.605 2.203 . . . . 0.0 109.738 -175.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.97 -172.46 2.08 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.362 1.065 . . . . 0.0 108.637 -172.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.24 132.35 2.47 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 118.503 0.592 . . . . 0.0 112.381 -175.356 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -83.1 140.6 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 123.172 0.589 . . . . 0.0 110.168 174.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.8 mtpm? -93.73 -122.14 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.284 0.633 . . . . 0.0 110.33 167.417 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -79.37 162.83 25.3 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.244 0.929 . . . . 0.0 111.468 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.6 54.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 125.542 1.537 . . . . 0.0 110.874 -173.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -157.58 167.41 30.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.072 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.55 -84.93 0.27 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.234 0.921 . . . . 0.0 112.087 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 . . . . . 0 C--O 1.249 1.072 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 178.597 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.823 ' CA ' ' H2 ' ' A' ' 1' ' ' GLY . . . . . . . . 0 C--O 1.224 -0.493 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 60.21 58.0 2.77 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 123.0 1.381 . . . . 0.0 110.901 177.05 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.11 124.52 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 127.055 2.142 . . . . 0.0 107.414 168.338 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.31 138.95 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 124.442 1.097 . . . . 0.0 108.775 173.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.34 130.66 52.89 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.465 1.506 . . . . 0.0 107.074 175.002 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -101.21 116.78 33.61 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.615 1.566 . . . . 0.0 108.196 170.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.8 ptp -119.54 135.96 54.55 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.842 0.857 . . . . 0.0 110.339 178.459 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -74.95 153.93 38.35 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 167.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.25 72.85 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 176.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -62.55 166.89 4.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.717 0.77 . . . . 0.0 111.386 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.68 -56.67 4.21 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 174.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.4 mmm -59.27 135.75 57.74 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.475 0.637 . . . . 0.0 109.524 174.037 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -147.47 -28.22 0.36 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -170.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.6 t -117.42 115.8 25.91 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -177.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -40.69 108.95 0.1 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.704 1.601 . . . . 0.0 111.789 -170.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.1 t -165.7 -86.89 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -168.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.4 77.11 0.17 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-O 121.988 0.899 . . . . 0.0 109.322 173.593 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.1 p -135.53 -83.36 0.4 Allowed 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.484 2.314 . . . . 0.0 105.237 -178.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.7 t -53.58 -41.64 66.78 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -175.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.6 m -49.36 -57.6 6.61 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.608 170.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.26 -49.48 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.84 -64.22 0.98 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.088 0.947 . . . . 0.0 110.02 -175.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.34 -53.69 9.29 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.931 1.729 . . . . 0.0 112.584 174.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -58.3 8.38 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.874 0.837 . . . . 0.0 109.658 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.3 -33.23 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.779 1.231 . . . . 0.0 111.044 -176.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.49 -21.43 13.67 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.329 0.966 . . . . 0.0 114.013 173.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -85.1 -19.71 31.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.747 1.773 . . . . 0.0 111.372 176.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.65 137.17 49.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 122.231 1.015 . . . . 0.0 111.932 -166.635 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -52.91 113.4 1.08 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.86 177.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.34 -26.52 8.59 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-O 119.072 -0.849 . . . . 0.0 112.323 175.173 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.2 t -79.57 131.17 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 118.214 1.007 . . . . 0.0 109.18 -176.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -91.54 -55.7 3.4 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.896 0.879 . . . . 0.0 109.185 168.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.35 159.09 43.58 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.535 1.061 . . . . 0.0 109.788 -175.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -140.1 140.78 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.403 1.481 . . . . 0.0 110.107 176.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.05 124.51 31.02 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.576 1.55 . . . . 0.0 107.931 168.136 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.9 t -110.13 89.46 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.846 1.203 . . . . 0.0 110.89 177.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -76.88 78.08 3.46 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.686 1.194 . . . . 0.0 110.427 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.78 -41.6 11.05 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.483 0.713 . . . . 0.0 111.962 178.744 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.57 -54.38 1.16 Allowed 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 126.453 1.901 . . . . 0.0 111.379 170.334 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -84.95 -10.54 56.95 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.466 -171.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 61.92 21.0 11.96 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.325 1.45 . . . . 0.0 110.326 -174.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.472 ' CD ' ' HZ3' ' A' ' 71' ' ' LYS . 9.1 tt0 -136.86 144.21 43.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.624 1.57 . . . . 0.0 108.885 -172.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.49 149.56 48.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.932 1.293 . . . . 0.0 108.727 179.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.5 m -120.69 115.28 23.04 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -176.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 86.8 mt -107.32 159.97 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 171.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.72 125.79 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 167.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -155.42 -177.24 6.41 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 126.447 1.899 . . . . 0.0 107.749 -175.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.657 ' HB2' ' N ' ' A' ' 1' ' ' GLY . 1.6 tt0 -138.02 144.5 43.99 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 120.112 1.324 . . . . 0.0 110.559 167.271 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.48 77.28 0.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.071 3.18 . . . . 0.0 110.025 176.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -149.17 -53.44 0.17 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.884 0.873 . . . . 0.0 109.13 174.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -88.19 -25.14 23.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.12 0.568 . . . . 0.0 110.843 176.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.8 tp -118.95 147.43 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.012 0.925 . . . . 0.0 109.648 178.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.4 m -83.47 24.27 0.85 Allowed 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.256 0.5 OUTLIER 72.61 -59.85 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 127.871 2.468 . . . . 0.0 109.86 179.884 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.31 -35.85 40.5 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.211 1.804 . . . . 0.0 109.78 -175.353 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -42.22 -53.76 3.95 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 123.538 0.735 . . . . 0.0 111.458 177.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.89 -49.04 5.91 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.388 1.075 . . . . 0.0 112.087 -176.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -49.33 38.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.1 -0.375 . . . . 0.0 110.999 174.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -53.98 -30.04 45.44 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -57.29 -52.03 67.0 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.388 0.613 . . . . 0.0 109.525 172.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -58.19 -49.91 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.453 173.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -52.98 -48.35 67.52 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.56 -21.62 60.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.379 1.472 . . . . 0.0 114.036 179.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 29.4 mmt -64.17 -30.02 71.1 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.869 1.213 . . . . 0.0 110.526 172.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.37 -33.11 2.19 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 176.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -73.51 107.51 3.49 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-O 117.776 -1.107 . . . . 0.0 108.732 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.75 118.91 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 108.071 -1.55 . . . . 0.0 108.071 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.08 -167.39 1.54 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.254 0.479 . . . . 0.0 110.404 -174.349 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -160.1 151.09 19.12 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -175.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.45 127.83 58.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 C-N-CA 126.65 1.98 . . . . 0.0 108.834 179.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.472 ' HZ3' ' CD ' ' A' ' 42' ' ' GLU . 5.6 mtpm? -93.43 -77.01 0.46 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.502 178.17 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -115.33 154.74 28.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.59 1.086 . . . . 0.0 110.18 176.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pp -134.29 56.96 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 123.821 0.849 . . . . 0.0 112.906 -179.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -161.01 160.31 30.47 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 164.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.59 -85.21 1.17 Allowed Glycine 0 CA--C 1.521 0.464 0 CA-C-O 119.591 -0.561 . . . . 0.0 114.077 -170.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 . . . . . 0 C--O 1.249 1.04 0 C-N-CA 126.999 2.12 . . . . 0.0 105.421 -157.12 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.757 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 8.71 81.36 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 129.476 3.11 . . . . 0.0 114.547 165.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.5 t -92.35 129.64 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.327 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.85 145.92 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 123.163 0.585 . . . . 0.0 109.984 177.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -141.94 138.38 31.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.1 116.39 24.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.309 1.444 . . . . 0.0 107.684 -173.769 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -121.79 149.9 42.64 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.841 1.256 . . . . 0.0 110.893 -172.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -98.95 132.62 44.13 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.835 1.654 . . . . 0.0 108.129 177.139 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.14 64.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.372 1.069 . . . . 0.0 110.218 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.93 153.18 41.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.823 179.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.26 -22.03 14.42 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.037 174.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.3 ttp -67.48 128.38 36.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.985 0.893 . . . . 0.0 109.869 -178.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -77.82 167.07 22.11 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.082 0.953 . . . . 0.0 111.902 -171.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 t -58.72 155.37 12.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.07 0.948 . . . . 0.0 111.714 -177.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -8.84 87.55 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.205 3.002 . . . . 0.0 115.006 -171.466 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 t -165.99 -77.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -171.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.7 m -75.62 75.02 2.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.4 p -133.04 -77.52 0.49 Allowed 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 168.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.6 m -54.12 -36.73 63.58 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -170.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -52.18 -57.86 8.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.103 0.252 . . . . 0.0 111.125 169.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.1 -54.28 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.203 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -57.65 -65.02 0.7 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.631 0.729 . . . . 0.0 110.746 -172.314 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.48 -53.55 12.25 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.726 1.631 . . . . 0.0 111.98 176.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -64.21 -50.62 67.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.112 0.956 . . . . 0.0 110.563 -176.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.6 mm -54.99 -39.2 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 123.406 0.682 . . . . 0.0 110.629 175.603 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.11 -20.18 13.97 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.016 1.293 . . . . 0.0 113.978 173.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -92.38 -19.42 22.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 118.987 1.393 . . . . 0.0 109.593 178.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.34 134.3 50.07 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.815 1.293 . . . . 0.0 111.816 -176.101 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.57 110.84 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.522 176.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.3 -25.83 7.25 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 119.085 -0.842 . . . . 0.0 112.219 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.24 136.02 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 118.382 1.091 . . . . 0.0 109.002 -178.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -107.89 -43.75 4.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.244 1.018 . . . . 0.0 110.736 175.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -155.79 161.14 40.71 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.772 0.715 . . . . 0.0 110.324 177.489 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 tt -141.01 144.68 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.896 1.278 . . . . 0.0 110.421 -176.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.02 98.82 3.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.329 1.852 . . . . 0.0 108.727 172.26 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -92.19 112.24 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.381 1.072 . . . . 0.0 110.042 176.382 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 m -94.98 90.96 6.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.705 1.202 . . . . 0.0 108.877 173.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mt -57.91 177.44 0.11 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.223 162.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.23 -61.3 0.39 Allowed 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 127.88 2.472 . . . . 0.0 109.45 -167.352 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -68.23 -17.75 64.39 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.989 0.423 . . . . 0.0 111.22 -177.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 67.21 41.83 2.45 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 127.332 2.253 . . . . 0.0 110.613 -178.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -144.27 141.93 30.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.827 -166.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.18 150.8 44.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.466 -0.771 . . . . 0.0 109.843 -177.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -130.51 121.52 25.93 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -176.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 mp -126.44 159.87 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 124.744 1.218 . . . . 0.0 108.271 -175.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.3 p -129.39 118.57 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.512 0.725 . . . . 0.0 109.597 178.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -159.19 -178.98 7.59 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.677 1.591 . . . . 0.0 109.864 -172.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -148.06 144.56 19.07 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.94 77.85 0.58 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.295 3.33 . . . . 0.0 110.684 175.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.57 -54.45 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.941 1.296 . . . . 0.0 107.586 168.218 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.7 mt -94.78 -21.37 18.76 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.843 -0.599 . . . . 0.0 111.91 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.404 ' C ' ' H ' ' A' ' 54' ' ' VAL . 11.2 tp -120.87 145.97 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.047 0.939 . . . . 0.0 109.554 -177.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 m -74.0 24.56 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.404 ' H ' ' C ' ' A' ' 52' ' ' ILE . 0.8 OUTLIER 73.28 -58.07 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 127.249 2.22 . . . . 0.0 109.626 -177.885 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -80.93 -42.35 21.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.445 1.498 . . . . 0.0 109.647 -174.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -41.16 -51.04 3.51 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.882 0.873 . . . . 0.0 111.87 -174.516 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -40.31 -59.91 1.19 Allowed 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.217 1.407 . . . . 0.0 111.464 -178.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 tptp -73.93 -43.61 57.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -57.49 -26.91 62.0 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.149 -0.969 . . . . 0.0 112.313 -174.151 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.96 -41.81 88.36 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.031 0.832 . . . . 0.0 109.128 174.102 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -62.83 -33.97 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.179 176.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -61.39 -52.66 63.67 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.48 -31.84 64.43 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.206 1.002 . . . . 0.0 112.716 -174.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.9 mmm -51.27 -36.34 41.69 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.479 0.582 . . . . 0.0 111.43 171.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.29 -36.79 1.45 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.285 0.945 . . . . 0.0 111.281 176.666 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -68.01 115.29 26.93 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.263 -173.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.76 101.49 0.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.428 2.085 . . . . 0.0 108.815 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.09 168.42 19.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -168.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.68 148.5 39.2 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.324 -0.86 . . . . 0.0 112.549 -166.077 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.82 144.73 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.662 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -83.11 -85.11 0.12 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.568 0.747 . . . . 0.0 109.719 173.327 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -157.03 147.38 21.2 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.86 123.29 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 125.67 1.588 . . . . 0.0 107.488 173.105 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.89 151.42 25.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.226 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.51 105.43 3.15 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -179.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.398 -1.287 . . . . 0.0 109.541 170.58 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -162.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.796 1.238 . . . . 0.0 112.192 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.57 125.42 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 124.76 1.224 . . . . 0.0 108.759 -174.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.5 t -79.6 145.67 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 124.83 1.252 . . . . 0.0 109.801 -178.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.54 149.42 46.72 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 126.138 1.775 . . . . 0.0 107.845 176.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.76 144.85 31.18 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.276 0.943 . . . . 0.0 111.71 155.86 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.89 153.72 45.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.116 1.766 . . . . 0.0 108.94 175.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -114.81 138.94 50.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.325 1.05 . . . . 0.0 108.529 177.224 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.04 68.86 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.857 0.863 . . . . 0.0 110.988 -172.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -68.29 165.96 17.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.103 0.478 . . . . 0.0 110.261 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.41 -34.82 1.55 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 121.604 -0.685 . . . . 0.0 114.063 168.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.9 151.01 7.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.034 0.917 . . . . 0.0 111.477 174.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -69.81 178.07 2.79 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.625 173.218 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 t -105.4 145.98 30.07 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.242 1.017 . . . . 0.0 111.147 -175.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 43.72 53.31 6.07 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.416 2.286 . . . . 0.0 112.712 -177.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.56 18.69 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -171.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.7 p -164.85 56.15 0.13 Allowed 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.142 -0.974 . . . . 0.0 110.41 -167.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.8 p -122.69 -80.36 0.63 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 173.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 m -54.02 -37.13 63.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -168.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.8 m -50.06 -61.31 2.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.568 0.542 . . . . 0.0 111.246 168.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.6 -50.81 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -56.45 -67.59 0.29 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.129 0.966 . . . . 0.0 110.891 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.68 -49.87 26.76 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.097 1.808 . . . . 0.0 112.124 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -62.62 -52.17 64.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.872 0.836 . . . . 0.0 109.62 -178.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.0 mm -55.57 -36.28 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.183 0.593 . . . . 0.0 111.202 175.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.51 -19.13 11.96 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.738 -1.034 . . . . 0.0 113.807 175.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -90.25 -18.98 24.69 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 119.653 1.726 . . . . 0.0 111.16 176.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.12 133.85 47.56 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.659 1.219 . . . . 0.0 112.39 -170.267 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -52.62 106.34 0.15 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.449 176.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.69 -30.74 4.57 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-O 119.475 -0.625 . . . . 0.0 111.917 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 t -82.8 140.61 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 117.691 0.745 . . . . 0.0 109.552 -173.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -111.25 -41.87 4.06 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.947 0.899 . . . . 0.0 111.689 174.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.45 159.23 43.4 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.822 -0.549 . . . . 0.0 109.704 -179.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.2 tt -146.59 145.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.59 1.556 . . . . 0.0 107.704 173.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -136.56 109.17 7.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.104 2.161 . . . . 0.0 106.465 173.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -102.44 120.28 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.916 1.235 . . . . 0.0 109.191 175.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 t -105.91 90.48 3.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.169 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -46.13 67.02 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.356 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -56.95 2.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.968 1.707 . . . . 0.0 110.755 170.192 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -17.75 60.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.032 -175.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 73.12 2.53 4.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.837 2.455 . . . . 0.0 112.052 -175.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -111.24 151.57 28.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.406 1.882 . . . . 0.0 109.699 -179.274 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.04 160.2 31.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 163.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.8 m -119.96 128.03 53.2 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 175.74 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.0 mt -122.74 162.84 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -135.77 117.88 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.27 0.628 . . . . 0.0 110.277 177.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.28 -179.32 8.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.141 1.376 . . . . 0.0 110.043 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -135.71 149.77 69.97 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.209 1.004 . . . . 0.0 113.05 177.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.09 67.88 7.99 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.374 3.382 . . . . 0.0 109.928 -176.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 -55.99 0.26 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.865 0.866 . . . . 0.0 109.223 177.071 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.92 -29.03 35.62 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.048 -0.501 . . . . 0.0 109.811 -177.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 54' ' ' VAL . 10.7 tp -118.93 145.4 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 123.433 0.693 . . . . 0.0 109.403 -178.16 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.9 m -81.67 33.83 0.38 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -174.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER 74.36 -61.68 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 128.065 2.546 . . . . 0.0 108.262 175.966 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.43 -40.17 23.79 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 124.483 1.113 . . . . 0.0 109.758 -174.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -40.48 -48.54 2.8 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 123.888 0.743 . . . . 0.0 111.413 -174.465 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -34.78 -65.5 0.21 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.862 1.665 . . . . 0.0 110.872 174.385 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HZ3' ' CB ' ' A' ' 68' ' ' ALA . 1.1 tmtt? -75.98 -41.88 50.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.671 -0.643 . . . . 0.0 112.185 178.48 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -58.31 -22.29 52.43 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.845 -174.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -62.65 -42.08 99.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.766 0.712 . . . . 0.0 109.351 173.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.75 -49.68 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.102 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -54.45 -44.72 72.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.78 -22.66 62.46 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.82 1.248 . . . . 0.0 114.144 176.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.0 mmt -66.34 -28.62 68.8 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.145 1.338 . . . . 0.0 110.586 170.532 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.21 -42.71 1.28 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -62.31 110.95 3.82 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.901 0.88 . . . . 0.0 110.824 -173.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.99 96.69 0.7 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.54 2.16 . . . . 0.0 109.575 -175.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.429 ' CB ' ' HZ3' ' A' ' 58' ' ' LYS . . . -108.74 -161.17 0.75 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.948 0.899 . . . . 0.0 109.51 -174.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -162.56 146.51 11.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.367 0.531 . . . . 0.0 112.179 -177.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.12 137.21 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.57 1.548 . . . . 0.0 108.531 174.374 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -78.9 -101.12 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.115 0.566 . . . . 0.0 110.456 172.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -156.69 149.8 24.06 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -177.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.47 110.27 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.266 1.826 . . . . 0.0 106.831 -175.284 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.35 142.12 16.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 71.02 0.03 OUTLIER Glycine 0 C--N 1.341 0.807 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -176.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.311 0 CA-C-O 117.027 -1.463 . . . . 0.0 109.589 -170.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.08 148.11 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.24 0.616 . . . . 0.0 110.113 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.627 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -139.48 141.8 37.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 171.379 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 130.65 56.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -121.53 151.74 39.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.244 1.818 . . . . 0.0 108.842 -176.111 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -95.37 136.92 35.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.41 67.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -70.26 170.15 12.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.811 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 O-C-N 121.248 -0.908 . . . . 0.0 113.504 170.328 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.3 t -52.21 -43.59 64.33 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.9 m -46.43 -60.24 2.47 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.655 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -48.79 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -57.24 -63.87 1.08 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.975 0.893 . . . . 0.0 110.085 -174.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.56 -54.96 8.39 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.826 1.679 . . . . 0.0 112.778 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -56.83 -56.61 19.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.179 0.989 . . . . 0.0 109.7 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.86 -28.29 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 110.51 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.51 -24.41 7.46 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.757 1.17 . . . . 0.0 114.306 170.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -87.55 -11.16 49.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 119.826 1.813 . . . . 0.0 111.381 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 139.09 55.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.796 0.808 . . . . 0.0 110.77 -171.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 115.73 4.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.386 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.54 -19.75 23.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.576 -1.124 . . . . 0.0 112.445 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.84 139.19 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 118.853 1.326 . . . . 0.0 109.79 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.8 -39.05 3.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.659 1.184 . . . . 0.0 110.74 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -149.73 156.78 42.44 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.795 -0.566 . . . . 0.0 109.852 172.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -137.2 145.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.565 1.546 . . . . 0.0 108.204 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -138.44 114.85 10.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.719 1.607 . . . . 0.0 107.008 166.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -102.61 129.9 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.129 0.877 . . . . 0.0 109.995 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.1 t -115.89 86.65 2.52 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.505 1.122 . . . . 0.0 108.119 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -39.07 69.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.386 -0.34 . . . . 0.0 110.374 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.93 -58.51 2.74 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.01 1.324 . . . . 0.0 110.694 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -79.09 -10.2 59.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.789 0.804 . . . . 0.0 110.456 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.83 24.41 13.74 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.101 1.761 . . . . 0.0 109.552 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -142.83 157.94 44.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.681 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HB3' ' SD ' ' A' ' 7' ' ' MET . . . -150.13 155.99 40.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -171.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.7 m -128.82 121.87 29.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.459 ' HB ' HD12 ' A' ' 5' ' ' LEU . 49.0 mt -118.73 155.17 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.38 126.48 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -156.77 179.86 8.88 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.673 1.589 . . . . 0.0 109.536 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.86 142.43 45.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.11 74.71 2.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.16 3.24 . . . . 0.0 110.125 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.36 -57.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.137 1.375 . . . . 0.0 107.452 176.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.54 -19.85 30.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.144 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.8 tp -128.32 152.3 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 111.074 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -89.62 27.56 1.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.917 0.887 . . . . 0.0 112.783 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 t 72.28 -60.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 128.147 2.579 . . . . 0.0 109.501 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.4 -35.98 30.07 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.797 1.239 . . . . 0.0 109.873 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -46.55 -46.62 19.49 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.659 0.599 . . . . 0.0 110.89 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.25 -52.57 1.48 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.583 1.153 . . . . 0.0 113.159 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -46.13 63.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 109.801 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -57.71 -29.09 64.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.452 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -63.53 -41.95 98.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.625 -0.672 . . . . 0.0 109.29 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.83 -44.99 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.389 174.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -53.28 -46.4 69.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.57 43.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.064 1.346 . . . . 0.0 113.495 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -64.04 -28.05 69.53 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.238 0.926 . . . . 0.0 110.459 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.39 -34.88 2.36 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.73 118.82 74.12 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.311 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.13 107.92 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.192 1.928 . . . . 0.0 109.089 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.95 -168.15 1.62 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.881 1.273 . . . . 0.0 108.394 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -164.15 161.05 22.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.908 -0.495 . . . . 0.0 111.755 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 110.378 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.08 148.11 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.24 0.616 . . . . 0.0 110.113 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.627 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -139.48 141.8 37.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 171.379 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 130.65 56.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -121.53 151.74 39.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.244 1.818 . . . . 0.0 108.842 -176.111 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -95.37 136.92 35.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.41 67.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -70.26 170.15 12.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.811 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 O-C-N 121.248 -0.908 . . . . 0.0 113.504 170.328 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.3 t -52.21 -43.59 64.33 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.9 m -46.43 -60.24 2.47 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.655 169.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -48.79 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -57.24 -63.87 1.08 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.975 0.893 . . . . 0.0 110.085 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.56 -54.96 8.39 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.826 1.679 . . . . 0.0 112.778 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -56.83 -56.61 19.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.179 0.989 . . . . 0.0 109.7 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.86 -28.29 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 110.51 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.51 -24.41 7.46 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.757 1.17 . . . . 0.0 114.306 170.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -87.55 -11.16 49.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 119.826 1.813 . . . . 0.0 111.381 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 139.09 55.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.796 0.808 . . . . 0.0 110.77 -171.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 115.73 4.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.386 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.54 -19.75 23.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.576 -1.124 . . . . 0.0 112.445 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.84 139.19 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 118.853 1.326 . . . . 0.0 109.79 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.8 -39.05 3.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.659 1.184 . . . . 0.0 110.74 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -149.73 156.78 42.44 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.795 -0.566 . . . . 0.0 109.852 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -137.2 145.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.565 1.546 . . . . 0.0 108.204 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -138.44 114.85 10.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.719 1.607 . . . . 0.0 107.008 166.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -102.61 129.9 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.129 0.877 . . . . 0.0 109.995 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.1 t -115.89 86.65 2.52 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.505 1.122 . . . . 0.0 108.119 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -39.07 69.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.386 -0.34 . . . . 0.0 110.374 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.93 -58.51 2.74 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.01 1.324 . . . . 0.0 110.694 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -79.09 -10.2 59.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.789 0.804 . . . . 0.0 110.456 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.83 24.41 13.74 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.101 1.761 . . . . 0.0 109.552 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -142.83 157.94 44.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.681 -166.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HB3' ' SD ' ' A' ' 7' ' ' MET . . . -150.13 155.99 40.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -171.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.7 m -128.82 121.87 29.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.459 ' HB ' HD12 ' A' ' 5' ' ' LEU . 49.0 mt -118.73 155.17 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.38 126.48 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -156.77 179.86 8.88 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.673 1.589 . . . . 0.0 109.536 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.86 142.43 45.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.11 74.71 2.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.16 3.24 . . . . 0.0 110.125 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.36 -57.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.137 1.375 . . . . 0.0 107.452 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.54 -19.85 30.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.144 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.8 tp -128.32 152.3 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 111.074 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -89.62 27.56 1.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.917 0.887 . . . . 0.0 112.783 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 t 72.28 -60.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 128.147 2.579 . . . . 0.0 109.501 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.4 -35.98 30.07 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.797 1.239 . . . . 0.0 109.873 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -46.55 -46.62 19.49 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.659 0.599 . . . . 0.0 110.89 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.25 -52.57 1.48 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.583 1.153 . . . . 0.0 113.159 173.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -46.13 63.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 109.801 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -57.71 -29.09 64.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.452 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -63.53 -41.95 98.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.625 -0.672 . . . . 0.0 109.29 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.83 -44.99 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.389 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -53.28 -46.4 69.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.57 43.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.064 1.346 . . . . 0.0 113.495 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -64.04 -28.05 69.53 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.238 0.926 . . . . 0.0 110.459 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.39 -34.88 2.36 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.73 118.82 74.12 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.311 -175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.13 107.92 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.192 1.928 . . . . 0.0 109.089 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.95 -168.15 1.62 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.881 1.273 . . . . 0.0 108.394 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -164.15 161.05 22.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.908 -0.495 . . . . 0.0 111.755 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 110.378 179.445 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.448 -0.572 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.64 133.83 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 123.99 0.916 . . . . 0.0 108.593 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.503 HD11 ' CG2' ' A' ' 70' ' ' VAL . 2.5 tt -113.21 148.15 36.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.366 1.466 . . . . 0.0 108.21 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.97 123.02 46.97 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 161.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.429 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 12.3 ptt? -115.44 163.05 16.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.233 1.013 . . . . 0.0 109.585 169.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -108.72 131.3 55.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.988 2.115 . . . . 0.0 106.408 170.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.05 60.32 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 126.523 1.929 . . . . 0.0 106.869 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -58.77 133.38 55.91 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.764 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.107 178.709 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.223 -0.337 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 p -53.43 -43.42 67.99 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.7 m -42.01 -62.53 0.9 Allowed 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.921 0.888 . . . . 0.0 112.19 165.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.99 -48.93 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 123.908 0.883 . . . . 0.0 108.932 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -57.25 -61.07 2.73 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.47 1.128 . . . . 0.0 109.332 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.76 -53.95 19.61 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.754 1.645 . . . . 0.0 112.308 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.5 -52.55 65.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.017 0.909 . . . . 0.0 110.068 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 34' ' ' ILE . 23.3 mm -57.54 -31.82 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.708 1.203 . . . . 0.0 111.116 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.13 -18.87 10.0 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.753 -1.026 . . . . 0.0 114.227 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -86.81 -11.79 49.9 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.637 1.719 . . . . 0.0 111.095 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 135.82 45.85 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 122.269 1.033 . . . . 0.0 111.748 -170.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -57.74 110.37 0.88 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.85 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.13 -24.11 9.51 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 119.251 -0.749 . . . . 0.0 112.661 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 t -80.01 136.08 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 118.213 1.007 . . . . 0.0 109.245 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -107.14 -38.83 5.89 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.703 1.201 . . . . 0.0 110.442 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.59 167.34 30.42 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.218 -0.926 . . . . 0.0 110.62 172.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 25' ' ' ILE . 13.9 tt -150.91 144.43 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.276 1.03 . . . . 0.0 108.561 177.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -129.58 129.62 44.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.898 1.679 . . . . 0.0 106.518 167.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.82 123.42 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.581 1.082 . . . . 0.0 110.982 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.5 t -81.25 158.98 24.63 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.107 0.563 . . . . 0.0 110.045 174.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.87 -67.93 0.83 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 163.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.08 -54.65 8.16 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 126.193 1.797 . . . . 0.0 110.678 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -77.64 -18.74 56.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.252 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 55.06 18.82 2.47 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 127.146 2.178 . . . . 0.0 111.409 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -101.05 152.12 20.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.596 1.558 . . . . 0.0 107.933 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -148.04 152.52 37.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.846 -0.534 . . . . 0.0 109.866 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 m -130.35 115.73 17.32 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -171.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.88 157.99 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.32 116.57 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 167.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.446 ' OH ' HD13 ' A' ' 5' ' ' LEU . 40.8 p90 -159.07 178.69 9.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.425 1.49 . . . . 0.0 109.549 -173.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -138.97 149.62 62.25 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.31 75.52 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.229 3.286 . . . . 0.0 109.936 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.58 -57.0 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.259 1.423 . . . . 0.0 107.414 170.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.8 mt -90.25 -23.03 21.34 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.452 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 56' ' ' GLU . 9.6 tp -121.68 149.06 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 119.083 0.856 . . . . 0.0 110.31 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 m -82.86 24.17 0.77 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 71.13 -65.74 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 128.737 2.815 . . . . 0.0 109.055 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -68.88 -39.85 79.55 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.434 1.094 . . . . 0.0 109.215 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' HB3' HD11 ' A' ' 52' ' ' ILE . 2.7 mt-10 -42.32 -54.19 3.86 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.403 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -49.86 10.75 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.583 0.753 . . . . 0.0 110.952 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -42.9 71.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.648 0.779 . . . . 0.0 111.422 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -56.23 -35.09 66.97 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.046 -1.033 . . . . 0.0 112.652 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -62.13 -42.28 99.08 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.66 -47.43 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 118.017 -0.992 . . . . 0.0 111.523 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.48 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 6.1 mt-10 -50.76 -49.27 58.49 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.149 1.341 . . . . 0.0 109.238 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.85 -19.07 48.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.28 1.832 . . . . 0.0 114.051 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mmm -61.33 -28.72 69.42 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.656 1.116 . . . . 0.0 110.15 169.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.02 38.86 0.55 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.051 1.31 . . . . 0.0 111.554 169.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -148.88 122.18 4.58 Favored Pre-proline 0 C--O 1.224 -0.28 0 CA-C-O 117.314 -1.326 . . . . 0.0 108.055 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.81 111.26 1.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.018 1.812 . . . . 0.0 109.452 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.48 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -109.17 -176.35 3.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -160.48 149.77 17.29 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 120.399 -1.438 . . . . 0.0 111.196 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.503 ' CG2' HD11 ' A' ' 5' ' ' LEU . 8.4 p . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.875 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.86 119.49 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 125.931 1.692 . . . . 0.0 111.28 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.664 HD21 HG22 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -116.67 131.3 56.99 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.229 1.012 . . . . 0.0 108.881 178.421 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.487 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -101.4 119.17 38.35 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.896 1.279 . . . . 0.0 110.495 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.526 ' SD ' HD11 ' A' ' 45' ' ' ILE . 9.6 ptt? -113.34 153.24 28.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.766 1.226 . . . . 0.0 109.931 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.92 133.88 43.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 169.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.82 68.0 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.5 150.23 48.32 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.674 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 O-C-N 121.666 -0.646 . . . . 0.0 113.597 170.794 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.9 p . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.8 m -55.64 -38.5 69.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.22 -52.75 60.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.589 0.233 . . . . 0.0 110.678 171.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.11 -53.48 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.45 -61.31 2.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.078 0.942 . . . . 0.0 110.195 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.52 -55.57 7.88 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.719 1.628 . . . . 0.0 112.471 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.66 -48.76 75.93 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.37 1.085 . . . . 0.0 110.322 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.426 HG21 HD12 ' A' ' 34' ' ' ILE . 26.4 mm -59.46 -33.42 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.498 0.719 . . . . 0.0 110.171 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.8 -13.62 8.51 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.489 1.042 . . . . 0.0 114.073 172.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.13 -14.27 31.47 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.388 1.594 . . . . 0.0 109.936 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.41 137.33 52.66 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 122.655 1.217 . . . . 0.0 112.886 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -54.69 108.0 0.35 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.438 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.27 -24.65 9.14 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-O 118.67 -1.072 . . . . 0.0 111.992 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.9 135.36 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 118.579 1.19 . . . . 0.0 108.873 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -108.05 -42.35 4.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.658 1.583 . . . . 0.0 109.919 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -152.1 159.73 43.59 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 25' ' ' ILE . 15.8 tt -143.25 152.48 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 108.495 172.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.49 110.99 5.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.743 2.017 . . . . 0.0 105.676 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.55 130.93 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.022 0.929 . . . . 0.0 109.376 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 t -117.23 90.37 3.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.15 -46.07 65.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -41.96 -58.83 1.93 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.626 1.17 . . . . 0.0 111.54 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -78.07 -7.41 56.91 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.836 0.827 . . . . 0.0 111.328 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 65.07 15.77 10.18 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 127.175 2.19 . . . . 0.0 110.7 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -132.53 154.55 49.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.824 1.649 . . . . 0.0 109.685 -166.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.02 165.57 30.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -134.87 126.76 29.39 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.526 HD11 ' SD ' ' A' ' 7' ' ' MET . 1.3 mp -108.94 152.95 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 167.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.74 117.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -156.73 -179.42 8.17 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.945 1.298 . . . . 0.0 109.147 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -131.4 147.89 67.93 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.373 1.069 . . . . 0.0 112.915 173.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.25 73.04 2.14 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.977 3.118 . . . . 0.0 109.662 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.84 -62.28 0.29 Allowed 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.195 0.998 . . . . 0.0 108.803 175.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.8 mt -83.65 -24.14 31.5 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.604 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.0 tp -114.11 156.84 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.109 0.963 . . . . 0.0 109.207 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.85 17.49 1.51 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.04 0.536 . . . . 0.0 112.281 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 68.64 -59.63 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.941 2.096 . . . . 0.0 109.402 -165.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -88.57 -28.36 20.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.909 -167.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' HB3' HD11 ' A' ' 52' ' ' ILE . 2.1 mt-10 -40.81 -53.12 2.92 Favored 'General case' 0 C--N 1.343 0.321 0 O-C-N 124.069 0.856 . . . . 0.0 110.543 177.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -43.18 -67.96 0.23 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.586 1.154 . . . . 0.0 110.544 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -46.65 84.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.949 -0.469 . . . . 0.0 110.756 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -51.94 -32.67 34.09 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -69.2 -43.46 74.07 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.566 1.075 . . . . 0.0 109.327 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.96 -39.78 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.795 -0.621 . . . . 0.0 109.671 173.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 11.5 mt-10 -57.23 -55.31 36.45 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.928 0.785 . . . . 0.0 108.945 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.31 -30.56 51.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.332 1.853 . . . . 0.0 113.425 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 26.4 mmt -50.7 -35.78 32.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.065 0.848 . . . . 0.0 111.426 172.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.96 41.63 0.44 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.378 0.99 . . . . 0.0 111.648 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -145.95 126.63 7.23 Favored Pre-proline 0 C--O 1.223 -0.323 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.54 111.06 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.483 1.456 . . . . 0.0 109.052 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.495 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -108.79 -169.24 1.46 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -164.58 149.6 9.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.621 -0.674 . . . . 0.0 110.837 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.664 HG22 HD21 ' A' ' 5' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.441 -0.918 0 CA-C-O 121.188 0.518 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.403 HG13 HG23 ' A' ' 44' ' ' THR . 4.5 t -78.61 134.54 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 124.916 1.286 . . . . 0.0 108.679 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.573 HD21 HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -129.42 129.13 44.29 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.37 130.87 42.0 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.042 0.937 . . . . 0.0 110.099 170.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -131.18 146.55 52.38 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.306 1.442 . . . . 0.0 108.786 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -82.8 150.7 26.45 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.64 66.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.037 0.935 . . . . 0.0 108.707 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.53 158.75 17.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.763 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.457 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 175.19 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.6 t -55.68 -39.99 71.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -168.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -49.31 -58.47 5.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.454 0.301 . . . . 0.0 111.716 168.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.07 -52.38 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -58.79 -62.38 1.91 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.766 0.793 . . . . 0.0 110.29 -172.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.16 -55.36 6.61 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.132 1.825 . . . . 0.0 112.534 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -60.64 -54.04 50.14 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.564 1.182 . . . . 0.0 109.776 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 mm -55.24 -33.8 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.196 0.999 . . . . 0.0 110.81 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.56 -23.13 9.09 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.035 1.302 . . . . 0.0 114.184 173.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -89.75 -12.59 38.9 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.589 1.694 . . . . 0.0 111.455 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.56 135.35 51.4 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.108 0.956 . . . . 0.0 110.84 -172.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -56.54 106.06 0.26 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.489 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.42 -26.44 6.64 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-O 119.054 -0.859 . . . . 0.0 112.225 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.03 132.03 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 118.476 1.138 . . . . 0.0 108.575 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -109.11 -31.02 7.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.695 0.798 . . . . 0.0 110.884 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -159.91 170.3 21.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.255 0.934 . . . . 0.0 110.475 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.2 tt -152.6 147.16 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.703 0.801 . . . . 0.0 109.867 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -136.98 106.8 6.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.025 1.73 . . . . 0.0 107.292 168.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.8 t -93.3 113.33 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 119.43 1.014 . . . . 0.0 109.55 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.88 73.18 1.75 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 tt -46.37 -50.39 16.56 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.397 1.079 . . . . 0.0 110.424 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.83 -53.98 2.19 Favored 'General case' 0 CA--C 1.523 -0.084 0 C-N-CA 125.827 1.651 . . . . 0.0 111.628 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.1 -16.11 58.28 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.57 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 70.25 8.51 6.67 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.977 2.111 . . . . 0.0 111.605 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -124.76 143.95 50.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.862 2.065 . . . . 0.0 107.889 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.71 157.2 42.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.431 1.092 . . . . 0.0 108.72 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.403 HG23 HG13 ' A' ' 4' ' ' VAL . 7.8 m -130.49 104.69 7.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.506 1.922 . . . . 0.0 107.151 -171.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.81 153.45 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.17 117.2 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.054 0.942 . . . . 0.0 109.753 168.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -158.71 178.81 9.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.654 1.182 . . . . 0.0 110.811 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.69 142.62 37.35 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 124.121 0.968 . . . . 0.0 112.208 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.425 ' HB3' HG23 ' A' ' 54' ' ' VAL . 72.8 Cg_endo -69.43 75.06 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.871 3.048 . . . . 0.0 110.314 172.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -140.52 -54.55 0.51 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.4 mt -89.63 -22.69 22.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.261 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.551 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.1 tp -119.54 150.24 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.877 0.871 . . . . 0.0 110.003 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.2 m -86.26 29.13 0.77 Allowed 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 49' ' ' PRO 0.261 0.5 OUTLIER 74.02 -56.69 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.631 2.372 . . . . 0.0 111.14 175.771 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -85.38 -36.18 20.89 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.571 1.548 . . . . 0.0 109.749 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HB3' HD11 ' A' ' 52' ' ' ILE . 5.8 mm-40 -42.89 -50.87 5.71 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 123.842 0.714 . . . . 0.0 110.972 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.91 -53.4 3.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 123.907 0.883 . . . . 0.0 112.113 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -45.63 61.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.304 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -55.09 -29.54 57.79 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -61.72 -43.18 99.36 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.745 0.702 . . . . 0.0 109.714 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.98 -49.35 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.626 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -51.92 -48.4 64.22 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.25 -19.95 56.84 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.06 1.744 . . . . 0.0 113.973 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.0 mmm -60.91 -34.08 74.12 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.74 1.155 . . . . 0.0 109.466 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.29 -33.33 2.01 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -75.39 119.39 76.78 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.026 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.53 117.32 4.51 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.21 1.94 . . . . 0.0 108.596 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.3 -172.37 2.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.857 0.463 . . . . 0.0 109.905 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.58 137.77 9.2 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.573 HG22 HD21 ' A' ' 5' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.277 0 C-N-CA 125.348 1.459 . . . . 0.0 107.819 171.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.1 t -97.16 126.62 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 125.972 1.709 . . . . 0.0 110.632 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.82 153.56 20.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.363 1.865 . . . . 0.0 108.108 170.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -125.19 126.28 44.98 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.447 1.099 . . . . 0.0 109.08 163.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.7 ptp -121.07 161.84 21.03 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.715 1.606 . . . . 0.0 110.823 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -98.99 134.01 42.43 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.507 1.923 . . . . 0.0 108.577 165.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.4 t -116.3 71.01 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 126.369 1.867 . . . . 0.0 106.617 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -77.43 174.15 11.16 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.623 0.769 . . . . 0.0 110.745 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.838 0 CA-C-O 119.24 -0.756 . . . . 0.0 112.919 171.211 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.2 t -50.28 -42.32 52.15 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -46.55 -58.2 4.03 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.106 0.563 . . . . 0.0 111.626 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -58.57 -48.56 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 123.644 0.777 . . . . 0.0 109.727 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.465 ' HA ' HG21 ' A' ' 34' ' ' ILE . 38.1 mt-10 -55.07 -64.67 0.76 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 122.52 1.152 . . . . 0.0 110.485 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.9 -54.13 8.3 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.531 2.015 . . . . 0.0 112.244 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -54.79 43.17 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.967 0.883 . . . . 0.0 110.103 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.4 mm -59.14 -31.45 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.074 0.95 . . . . 0.0 110.91 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.05 -15.73 22.74 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.741 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -90.84 -11.43 39.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.627 1.714 . . . . 0.0 111.172 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.32 132.6 48.73 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.427 1.108 . . . . 0.0 111.068 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -57.97 107.98 0.53 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.299 172.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.08 -15.94 13.29 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.823 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 t -87.97 128.69 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 119.033 1.416 . . . . 0.0 109.426 -175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -83.62 -51.34 7.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.948 0.899 . . . . 0.0 110.282 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -158.42 167.97 28.24 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.616 0.643 . . . . 0.0 110.734 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.465 HG21 ' HA ' ' A' ' 22' ' ' GLU . 5.7 tt -142.49 140.26 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 125.591 1.557 . . . . 0.0 109.073 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -129.55 112.45 13.75 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.638 1.575 . . . . 0.0 107.414 168.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.21 108.82 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 C-N-CA 124.053 0.941 . . . . 0.0 109.6 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 m -82.42 113.74 20.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.18 179.71 0.19 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 158.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 67.54 -65.05 0.25 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 127.968 2.507 . . . . 0.0 109.498 -170.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.99 -22.96 66.49 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.247 1.019 . . . . 0.0 111.176 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 64.61 15.48 9.71 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.913 2.085 . . . . 0.0 111.91 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -120.38 132.31 55.21 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.786 1.234 . . . . 0.0 109.228 -169.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.32 150.29 47.28 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.735 0.814 . . . . 0.0 108.975 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.36 130.41 52.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.7 mt -126.7 158.34 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.88 122.68 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -158.64 179.79 8.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.93 1.292 . . . . 0.0 110.888 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -136.24 154.1 77.0 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 164.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.92 74.71 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.752 3.635 . . . . 0.0 109.958 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.01 -57.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.684 1.194 . . . . 0.0 108.081 170.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 mt -87.78 -28.03 21.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.809 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.462 ' HA ' HD12 ' A' ' 52' ' ' ILE . 9.2 tp -119.64 144.38 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 118.703 0.683 . . . . 0.0 109.882 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 m -81.57 31.05 0.35 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 72.24 -61.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 129.172 2.989 . . . . 0.0 110.166 176.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -82.81 -36.52 25.48 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.41 1.884 . . . . 0.0 109.355 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' HB3' HD11 ' A' ' 52' ' ' ILE . 1.4 mt-10 -42.06 -52.71 4.17 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.455 0.702 . . . . 0.0 111.055 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -36.48 -52.86 0.86 Allowed 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.712 2.005 . . . . 0.0 111.804 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.59 -38.55 65.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.29 1.036 . . . . 0.0 112.551 175.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -57.73 -33.17 68.15 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.632 -1.292 . . . . 0.0 112.548 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -62.66 -40.33 96.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -58.78 -46.32 90.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 117.919 -1.039 . . . . 0.0 111.75 170.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.97 -49.59 59.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.873 1.215 . . . . 0.0 108.031 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.89 -18.86 61.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.303 1.841 . . . . 0.0 114.207 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.7 mmm -62.14 -21.43 65.03 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.689 1.132 . . . . 0.0 110.532 168.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.71 34.57 2.03 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 125.238 1.399 . . . . 0.0 110.859 172.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -148.34 125.63 5.63 Favored Pre-proline 0 N--CA 1.456 -0.138 0 CA-C-O 117.764 -1.112 . . . . 0.0 108.395 -173.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.69 116.57 3.62 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.119 1.879 . . . . 0.0 110.372 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.13 -179.64 3.89 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.602 0.761 . . . . 0.0 109.465 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -162.9 149.12 12.36 Favored 'General case' 0 C--O 1.224 -0.265 0 O-C-N 120.323 -1.485 . . . . 0.0 111.809 -169.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.228 -0.056 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.995 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.1 t . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.1 t -77.4 141.26 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.637 1.575 . . . . 0.0 109.159 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -144.02 127.92 17.38 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -89.73 134.18 34.3 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.544 1.137 . . . . 0.0 109.859 171.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.87 141.64 47.46 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.08 0.952 . . . . 0.0 110.824 176.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.26 136.13 35.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.25 84.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 171.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -76.63 173.71 11.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 122.088 0.947 . . . . 0.0 110.982 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.914 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.626 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t -54.69 -39.87 68.57 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -170.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 m -49.34 -55.67 12.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.576 0.35 . . . . 0.0 111.783 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.79 -50.69 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.614 0.766 . . . . 0.0 109.179 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -52.16 -66.11 0.44 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.942 0.877 . . . . 0.0 110.124 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.82 -54.92 8.72 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.529 2.014 . . . . 0.0 112.23 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.63 -55.26 37.36 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.12 0.96 . . . . 0.0 109.802 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 mm -59.58 -31.08 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 123.598 0.759 . . . . 0.0 110.445 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.84 -16.81 19.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.921 1.248 . . . . 0.0 113.921 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -89.1 -13.76 37.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.605 1.703 . . . . 0.0 110.632 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.32 133.08 43.76 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.468 1.128 . . . . 0.0 112.284 -172.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -55.58 108.72 0.46 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.58 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.62 -25.76 7.53 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 119.186 -0.785 . . . . 0.0 111.976 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.53 131.5 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -97.75 -47.19 5.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.181 0.992 . . . . 0.0 109.374 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -154.94 166.89 32.14 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.805 -0.559 . . . . 0.0 110.316 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 tt -153.38 142.92 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.187 0.995 . . . . 0.0 109.922 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -139.55 117.3 11.58 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.179 1.792 . . . . 0.0 106.937 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -112.84 105.69 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 119.875 1.216 . . . . 0.0 109.242 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -97.24 88.15 4.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.58 -43.92 62.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.291 0.636 . . . . 0.0 110.882 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.33 -54.21 1.45 Allowed 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 125.946 1.698 . . . . 0.0 110.924 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.03 -13.41 57.39 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.681 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 66.12 9.32 6.17 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.106 2.163 . . . . 0.0 111.506 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -129.67 155.86 45.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.581 1.952 . . . . 0.0 108.599 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.26 155.94 49.37 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.146 0.978 . . . . 0.0 108.854 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.1 m -122.64 112.27 17.76 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.92 2.088 . . . . 0.0 105.557 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 mt -102.56 168.52 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.51 120.31 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -160.14 179.61 8.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.612 1.165 . . . . 0.0 110.917 -171.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.51 146.94 59.7 Favored Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -69.66 74.28 1.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.605 2.87 . . . . 0.0 109.507 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.94 -62.75 0.48 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.731 1.212 . . . . 0.0 108.249 172.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.1 mt -85.54 -21.25 28.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.992 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.0 tp -125.02 144.79 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 118.616 0.644 . . . . 0.0 110.069 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 m -76.13 28.9 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.272 0.5 OUTLIER 70.74 -53.1 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 128.979 2.912 . . . . 0.0 111.801 178.589 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -44.83 15.22 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 127.313 2.245 . . . . 0.0 109.705 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HB3' HD11 ' A' ' 52' ' ' ILE . 8.3 mt-10 -43.51 -51.94 6.44 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.171 0.588 . . . . 0.0 110.742 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -29.39 -63.16 0.12 Allowed 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 126.86 2.064 . . . . 0.0 110.716 172.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -45.76 36.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -59.4 -19.68 49.05 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.401 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -43.82 97.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.861 0.755 . . . . 0.0 110.022 170.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.94 -48.83 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -54.37 -47.56 72.49 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.14 -22.12 64.39 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.229 1.412 . . . . 0.0 113.953 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -63.41 -28.49 70.02 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.208 1.367 . . . . 0.0 110.071 170.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.99 -32.93 2.91 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.683 1.135 . . . . 0.0 110.743 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -73.69 126.03 90.0 Favored Pre-proline 0 N--CA 1.455 -0.191 0 CA-C-O 118.602 -0.714 . . . . 0.0 109.311 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.45 113.72 2.59 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.912 1.741 . . . . 0.0 109.687 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.25 174.61 6.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.972 0.909 . . . . 0.0 108.614 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.9 127.56 6.64 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -174.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.311 0 C-N-CA 124.997 1.319 . . . . 0.0 109.574 172.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.9 t -78.61 140.54 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.953 1.301 . . . . 0.0 108.68 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.401 HD13 ' C ' ' A' ' 5' ' ' LEU . 0.6 OUTLIER -133.19 142.02 48.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.774 2.029 . . . . 0.0 106.536 179.316 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -110.52 124.25 51.45 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.139 0.976 . . . . 0.0 109.122 173.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.7 ptm -117.91 155.01 30.93 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.98 1.312 . . . . 0.0 110.317 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.33 133.44 37.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 172.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.63 64.33 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.228 1.011 . . . . 0.0 109.004 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.92 166.19 16.17 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.986 0.898 . . . . 0.0 111.293 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 O-C-N 121.738 -0.601 . . . . 0.0 113.05 175.349 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.519 HG21 ' HB2' ' A' ' 38' ' ' LEU . 81.0 p . . . . . 0 C--O 1.22 -0.459 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -44.87 -41.09 6.8 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -49.82 -58.95 4.35 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.259 0.552 . . . . 0.0 111.061 168.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.85 -46.37 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.091 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -53.07 -65.24 0.59 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.425 1.466 . . . . 0.0 110.177 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.25 -55.12 6.83 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.467 1.508 . . . . 0.0 112.027 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -56.6 -53.17 60.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.795 0.797 . . . . 0.0 110.535 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.8 mm -61.49 -28.38 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.526 1.131 . . . . 0.0 110.479 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.92 -20.78 6.64 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.923 -0.932 . . . . 0.0 114.271 169.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -87.92 -14.86 38.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.89 1.845 . . . . 0.0 111.259 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 136.21 53.04 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 122.269 1.033 . . . . 0.0 111.668 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -57.68 111.25 1.07 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.532 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.97 -22.12 12.8 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 123.9 0.762 . . . . 0.0 112.757 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.2 132.58 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 118.122 0.961 . . . . 0.0 108.944 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -97.36 -47.33 5.74 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.643 1.177 . . . . 0.0 109.751 171.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -153.91 163.79 39.47 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.361 -0.837 . . . . 0.0 110.616 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 tt -146.2 136.75 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.299 1.439 . . . . 0.0 109.098 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.78 104.69 6.43 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.834 1.653 . . . . 0.0 107.592 168.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 43' ' ' ALA . 89.0 t -100.96 126.91 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 124.371 1.068 . . . . 0.0 109.993 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 m -114.5 93.76 4.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.12 0.968 . . . . 0.0 109.301 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.519 ' HB2' HG21 ' A' ' 18' ' ' THR . 0.3 OUTLIER -43.39 -49.74 6.97 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.466 1.106 . . . . 0.0 109.496 169.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.414 ' N ' HD13 ' A' ' 38' ' ' LEU . 1.3 m-20 -44.85 -58.87 2.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.677 1.591 . . . . 0.0 111.428 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.93 -14.69 59.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.55 -172.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 70.33 3.5 4.47 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.05 2.14 . . . . 0.0 111.81 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -119.16 157.86 27.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.563 1.945 . . . . 0.0 108.651 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.413 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -138.36 155.1 48.85 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.642 0.777 . . . . 0.0 109.564 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 m -124.99 116.81 22.74 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.4 mt -121.08 159.78 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.28 117.98 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.39 0.996 . . . . 0.0 110.019 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -161.21 -178.93 7.04 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.459 1.104 . . . . 0.0 111.457 -172.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.72 146.8 63.5 Favored Pre-proline 0 N--CA 1.467 0.376 0 C-N-CA 124.898 1.279 . . . . 0.0 113.946 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.26 69.44 2.52 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 124.121 3.214 . . . . 0.0 109.896 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.62 -63.96 0.36 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.11 0.964 . . . . 0.0 108.969 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.2 mt -79.72 -21.85 44.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.862 -0.59 . . . . 0.0 110.426 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 56' ' ' GLU . 8.6 tp -124.83 145.12 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 118.507 0.594 . . . . 0.0 109.955 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -80.64 29.62 0.31 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.814 0.845 . . . . 0.0 112.975 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 74.64 -56.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 128.46 2.704 . . . . 0.0 111.095 173.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.63 -40.67 20.46 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.213 1.805 . . . . 0.0 109.477 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.469 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mm-40 -41.24 -53.15 3.26 Favored 'General case' 0 C--N 1.346 0.44 0 O-C-N 124.183 0.927 . . . . 0.0 110.837 -173.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.71 -60.96 0.29 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.165 1.786 . . . . 0.0 111.053 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -41.95 68.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.092 0.957 . . . . 0.0 111.005 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -56.33 -28.28 58.43 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -64.79 -41.83 95.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.733 -0.604 . . . . 0.0 109.672 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -63.46 -49.18 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.449 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 4.2 mt-10 -53.39 -46.86 69.84 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.73 -20.53 49.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.555 1.542 . . . . 0.0 114.179 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.2 mmm -63.18 -30.18 71.38 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.777 1.171 . . . . 0.0 109.865 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.55 -32.25 2.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -79.85 116.57 62.04 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-O 117.819 -1.086 . . . . 0.0 108.468 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.25 123.81 12.78 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.765 1.643 . . . . 0.0 108.42 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.466 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -113.35 -165.74 1.02 Allowed 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 122.764 0.426 . . . . 0.0 110.271 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -162.42 138.34 7.42 Favored 'General case' 0 CA--C 1.522 -0.097 0 O-C-N 121.487 -0.758 . . . . 0.0 111.315 176.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 CA--C 1.531 0.223 0 C-N-CA 124.468 1.107 . . . . 0.0 108.677 173.206 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.63 134.34 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 123.775 0.83 . . . . 0.0 110.692 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.541 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -123.83 139.29 54.11 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 172.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -108.46 123.2 48.51 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 45' ' ' ILE . 15.0 ptm -116.07 167.9 10.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.35 1.06 . . . . 0.0 109.957 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -114.31 134.24 55.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.485 2.314 . . . . 0.0 106.86 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 t -124.99 62.4 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.309 1.843 . . . . 0.0 107.686 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.88 145.45 46.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.28 0.562 . . . . 0.0 111.724 -170.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 178.043 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.752 HG22 HG12 ' A' ' 36' ' ' VAL . 70.7 p . . . . . 0 C--O 1.217 -0.627 0 CA-C-O 118.043 -0.98 . . . . 0.0 113.518 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t -36.86 -42.96 0.42 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.112 1.365 . . . . 0.0 113.501 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.15 -57.06 11.74 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.46 0.704 . . . . 0.0 111.273 171.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.41 -48.86 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.214 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -56.21 -59.37 5.04 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 119.936 1.244 . . . . 0.0 110.79 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -41.38 -56.93 3.31 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.852 1.692 . . . . 0.0 112.158 170.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -57.2 -53.41 58.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.014 0.907 . . . . 0.0 110.506 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.427 HG23 ' HE3' ' A' ' 57' ' ' MET . 29.1 mm -59.65 -28.04 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 125.158 1.383 . . . . 0.0 110.704 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.83 -19.2 9.81 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.735 -1.036 . . . . 0.0 114.299 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -88.18 -9.99 51.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.859 1.829 . . . . 0.0 111.333 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.8 136.22 46.99 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.172 0.987 . . . . 0.0 111.594 -171.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.78 113.86 2.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.078 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.26 -16.99 31.99 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-O 119.136 -0.813 . . . . 0.0 112.903 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 t -79.32 130.14 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 118.238 1.019 . . . . 0.0 108.581 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -97.05 -49.14 5.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.439 1.096 . . . . 0.0 109.47 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -152.81 170.54 20.05 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.625 -0.672 . . . . 0.0 110.673 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 tt -144.11 149.24 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.619 1.168 . . . . 0.0 109.407 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -143.55 98.44 3.25 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.141 2.176 . . . . 0.0 107.711 169.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.752 HG12 HG22 ' A' ' 18' ' ' THR . 91.2 t -99.62 128.24 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.554 1.142 . . . . 0.0 109.013 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 t -103.51 110.03 21.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.329 0.652 . . . . 0.0 110.602 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.585 HD23 ' H ' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -63.37 158.36 20.73 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.585 ' H ' HD23 ' A' ' 38' ' ' LEU . 3.7 m-20 71.36 -55.82 0.65 Allowed 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 129.069 2.948 . . . . 0.0 109.926 -174.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.01 -29.28 70.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.841 -174.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 64.61 16.07 10.08 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.19 2.196 . . . . 0.0 112.471 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -107.18 139.3 41.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB1' HG22 ' A' ' 36' ' ' VAL . . . -141.64 156.3 45.67 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.794 -0.566 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.9 m -130.46 125.8 35.33 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.491 HD11 ' SD ' ' A' ' 7' ' ' MET . 12.2 mt -118.33 153.25 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.62 120.84 65.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -157.71 -179.67 8.37 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 125.395 1.478 . . . . 0.0 109.628 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -140.75 151.85 64.2 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 123.221 0.609 . . . . 0.0 112.515 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -82.02 64.37 8.41 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.949 3.1 . . . . 0.0 108.684 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.52 -61.1 1.03 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.023 1.329 . . . . 0.0 107.474 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.2 mt -88.33 -20.71 25.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.666 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.7 tp -120.7 145.08 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 119.205 0.911 . . . . 0.0 110.488 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -83.96 28.32 0.61 Allowed 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 71.39 -60.07 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 128.867 2.867 . . . . 0.0 110.545 176.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -74.54 -41.11 61.17 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.804 1.242 . . . . 0.0 108.491 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mt-10 -42.81 -49.86 5.71 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 123.277 0.631 . . . . 0.0 111.551 -174.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.437 ' SD ' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -42.74 -53.74 4.4 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.859 0.864 . . . . 0.0 111.126 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.49 -44.91 77.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 122.087 -0.383 . . . . 0.0 110.761 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -54.04 -33.91 58.63 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.937 -0.477 . . . . 0.0 112.094 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -64.14 -42.67 96.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.43 0.692 . . . . 0.0 109.564 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.01 -46.83 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.791 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 11.0 mt-10 -51.67 -49.96 61.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.897 1.226 . . . . 0.0 108.674 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.86 -19.82 31.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.283 1.833 . . . . 0.0 114.27 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.1 mmm -61.82 -31.28 71.5 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.63 1.105 . . . . 0.0 110.214 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.7 39.48 0.57 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.544 1.069 . . . . 0.0 111.461 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -145.45 125.78 7.21 Favored Pre-proline 0 C--O 1.225 -0.217 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.98 107.81 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.19 1.927 . . . . 0.0 109.611 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.612 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -107.56 -177.59 3.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -163.49 156.1 18.19 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.121 -0.987 . . . . 0.0 111.612 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.4 t . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -178.094 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.9 t . . . . . 0 C--O 1.234 0.249 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.15 132.12 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.379 1.472 . . . . 0.0 109.957 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.568 HD22 ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -123.56 157.85 32.72 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.371 1.469 . . . . 0.0 109.621 171.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.541 ' N ' HD22 ' A' ' 5' ' ' LEU . 11.3 ttpt -119.05 123.56 44.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.436 1.094 . . . . 0.0 108.581 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -122.79 144.66 49.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.077 1.351 . . . . 0.0 110.474 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -87.96 133.14 34.0 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.328 2.251 . . . . 0.0 108.313 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.35 65.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 126.959 2.104 . . . . 0.0 107.966 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -71.77 153.83 41.71 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.822 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.846 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.821 173.446 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -57.93 -37.28 73.81 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -166.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.8 m -51.54 -54.15 30.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.724 0.297 . . . . 0.0 111.541 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -59.25 -49.5 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -53.28 -65.06 0.63 Allowed 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 122.322 1.058 . . . . 0.0 110.4 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.56 -42.71 44.57 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.197 1.856 . . . . 0.0 113.364 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -68.67 -61.23 1.91 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.934 1.367 . . . . 0.0 109.593 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.06 -41.49 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.621 1.169 . . . . 0.0 110.37 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.73 -21.55 29.74 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.406 1.479 . . . . 0.0 113.633 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -91.35 -15.44 29.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.076 1.438 . . . . 0.0 110.836 177.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.34 134.14 52.91 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.537 1.16 . . . . 0.0 111.508 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -50.35 107.77 0.18 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.255 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.42 -29.08 5.8 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.958 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.1 t -79.45 137.25 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 118.353 1.077 . . . . 0.0 109.167 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -102.34 -43.35 5.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.039 1.335 . . . . 0.0 110.642 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -158.61 162.5 37.31 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.41 -0.806 . . . . 0.0 110.151 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 tt -144.43 141.32 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.625 1.57 . . . . 0.0 109.192 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -129.34 121.7 28.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.513 1.925 . . . . 0.0 107.046 164.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.3 t -107.47 109.02 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 119.93 1.241 . . . . 0.0 110.052 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.7 t -90.79 91.63 8.45 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.693 0.759 . . . . 0.0 109.324 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.61 166.62 0.88 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.656 163.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 66.48 -56.42 0.39 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 128.338 2.655 . . . . 0.0 110.45 -165.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -64.81 -30.27 71.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.214 1.007 . . . . 0.0 109.88 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 68.73 25.27 6.42 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 127.812 2.445 . . . . 0.0 110.255 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -125.03 127.26 46.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.714 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.1 145.45 49.25 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.061 0.945 . . . . 0.0 109.515 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.71 120.3 31.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -176.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.2 mt -128.1 157.54 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -173.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.4 p -125.32 127.81 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -155.85 176.2 12.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 110.528 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.09 145.61 54.73 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.627 1.171 . . . . 0.0 113.192 172.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -72.32 75.86 2.33 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.409 3.406 . . . . 0.0 109.887 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.05 -55.42 0.11 Allowed 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.831 -0.543 . . . . 0.0 109.902 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.14 -24.61 27.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.607 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.4 tp -124.82 145.08 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.295 0.638 . . . . 0.0 110.206 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.57 23.74 0.12 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 75.4 -53.77 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.24 1.816 . . . . 0.0 110.194 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -95.64 -33.82 12.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.151 2.18 . . . . 0.0 110.169 -172.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -42.32 -53.31 4.22 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.035 0.934 . . . . 0.0 110.532 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -37.72 -57.74 0.96 Allowed 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 126.183 1.793 . . . . 0.0 111.96 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.405 ' HE2' HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -73.38 -42.76 61.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.992 0.917 . . . . 0.0 111.656 178.085 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -50.69 -29.47 11.3 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.148 -0.97 . . . . 0.0 113.208 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -62.68 -35.99 81.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -69.7 -46.24 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 123.682 0.793 . . . . 0.0 109.099 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -51.09 -49.34 60.86 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.01 -20.16 62.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.426 1.491 . . . . 0.0 114.041 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 81.3 mmm -63.99 -28.45 69.82 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.886 1.221 . . . . 0.0 109.874 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.41 -33.13 2.71 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.434 1.016 . . . . 0.0 110.957 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -80.85 119.06 75.05 Favored Pre-proline 0 N--CA 1.455 -0.18 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.169 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.8 120.71 8.19 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.873 1.716 . . . . 0.0 109.52 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.68 177.85 5.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.562 1.545 . . . . 0.0 108.562 -176.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.93 158.65 35.39 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 122.924 0.49 . . . . 0.0 111.218 -173.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.405 HG23 ' HE2' ' A' ' 58' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.9 t -87.21 124.9 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.115 2.166 . . . . 0.0 110.299 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.26 142.69 41.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.623 1.169 . . . . 0.0 109.401 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 123.49 48.66 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.416 1.486 . . . . 0.0 108.95 170.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.7 ptm -125.96 134.75 51.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.067 1.347 . . . . 0.0 111.468 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 129.38 39.08 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 t -112.02 73.83 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.03 164.77 10.02 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.784 0.802 . . . . 0.0 111.101 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.102 0 O-C-N 121.629 -0.669 . . . . 0.0 112.589 177.415 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.0 p . . . . . 0 C--O 1.223 -0.321 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.8 t -56.85 -38.8 73.19 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -168.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.8 m -47.51 -60.39 2.56 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.654 167.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.55 -48.95 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.52 ' HA ' HG21 ' A' ' 34' ' ' ILE . 53.5 mt-10 -56.83 -68.0 0.26 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.875 0.845 . . . . 0.0 111.663 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.63 -48.93 22.5 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.735 1.636 . . . . 0.0 111.834 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -63.72 -55.49 22.9 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 117.945 0.872 . . . . 0.0 110.312 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.546 ' CG2' HG21 ' A' ' 31' ' ' VAL . 10.8 mm -50.67 -41.35 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.93 0.892 . . . . 0.0 110.436 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.07 -22.75 13.95 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.953 1.739 . . . . 0.0 114.138 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -94.31 -20.78 19.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 118.892 1.346 . . . . 0.0 110.492 177.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 134.21 50.69 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 122.727 1.251 . . . . 0.0 111.68 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -53.62 113.68 1.27 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.088 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.62 -26.39 7.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 118.269 -1.295 . . . . 0.0 112.141 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.811 HG23 ' HE2' ' A' ' 57' ' ' MET . 2.2 t -75.99 140.44 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 118.926 1.363 . . . . 0.0 109.457 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.503 ' HB2' HG12 ' A' ' 46' ' ' VAL . 7.8 mm-40 -103.61 -41.16 6.04 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.598 167.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -159.72 163.34 34.81 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.529 -0.732 . . . . 0.0 109.941 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 22' ' ' GLU . 14.4 tt -147.38 148.71 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 124.952 1.301 . . . . 0.0 108.946 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 102.74 4.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.907 1.683 . . . . 0.0 107.861 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -91.23 133.42 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.61 1.164 . . . . 0.0 108.894 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 t -122.49 102.63 8.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.045 0.938 . . . . 0.0 110.52 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.63 -58.24 7.88 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.641 0.777 . . . . 0.0 110.758 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -42.24 -54.46 3.69 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.218 1.407 . . . . 0.0 110.942 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.26 -19.21 51.17 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.938 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 65.88 18.88 11.22 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.205 2.202 . . . . 0.0 110.996 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.29 163.57 20.46 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.249 2.22 . . . . 0.0 108.431 -171.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.15 133.65 17.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.064 0.545 . . . . 0.0 109.839 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.1 m -106.47 100.94 10.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -173.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.4 HG12 HD12 ' A' ' 34' ' ' ILE . 80.5 mt -90.75 165.66 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 32' ' ' GLN . 1.1 t -139.67 120.41 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -157.14 176.17 13.09 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.706 0.802 . . . . 0.0 111.757 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -122.81 139.91 32.2 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -69.61 84.0 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.245 3.296 . . . . 0.0 109.574 174.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -168.43 -61.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.0 mt -82.16 -25.92 33.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.219 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 52' ' ' ILE . 11.2 tp -117.79 161.2 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 123.501 0.721 . . . . 0.0 110.423 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 m -93.86 26.79 3.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.219 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 70.11 -59.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 129.406 3.082 . . . . 0.0 110.49 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.91 -32.49 40.19 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.444 1.498 . . . . 0.0 109.562 -175.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -49.44 -48.75 47.2 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.811 ' HE2' HG23 ' A' ' 31' ' ' VAL . 5.4 mtt -44.93 -53.5 7.56 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.213 0.605 . . . . 0.0 111.512 174.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.539 ' HD3' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -72.47 -36.61 68.51 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.559 -0.713 . . . . 0.0 112.569 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.449 ' HD2' ' CE ' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -61.29 -31.68 71.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 120.535 -1.353 . . . . 0.0 110.835 176.087 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -35.14 80.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.9 -47.25 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.003 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -50.96 -48.73 60.92 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.37 0.986 . . . . 0.0 108.697 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.05 -21.72 46.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.457 1.103 . . . . 0.0 113.664 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.9 mmt -66.91 -28.03 67.98 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.553 1.069 . . . . 0.0 110.786 172.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.62 -33.38 3.0 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.759 1.171 . . . . 0.0 110.731 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -78.36 115.56 52.14 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.19 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -62.27 121.83 10.01 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.695 1.596 . . . . 0.0 109.146 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.95 163.77 26.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.662 0.785 . . . . 0.0 109.039 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CA ' ' HD2' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -151.28 140.34 21.12 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 125.211 1.405 . . . . 0.0 109.588 -156.034 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.539 HG23 ' HD3' ' A' ' 58' ' ' LYS . 1.2 t . . . . . 0 C--N 1.333 -0.15 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.27 124.29 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 125.579 1.552 . . . . 0.0 108.954 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.1 tp -107.57 143.21 36.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.358 1.863 . . . . 0.0 107.144 169.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -111.6 120.71 43.01 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 164.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.0 ptm -111.57 162.51 15.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.709 1.203 . . . . 0.0 109.909 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -97.2 125.88 42.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.506 1.523 . . . . 0.0 108.748 168.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 t -116.73 72.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 126.693 1.997 . . . . 0.0 106.83 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.271 3.6 pt-20 -82.48 176.77 9.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.33 0.652 . . . . 0.0 111.657 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.127 0 O-C-N 121.541 -0.724 . . . . 0.0 112.006 -175.929 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.5 p . . . . . 0 C--O 1.222 -0.377 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 m -55.79 -38.78 70.4 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -167.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.84 -53.69 48.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 171.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.04 -53.03 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -56.71 -65.06 0.68 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.804 0.811 . . . . 0.0 110.069 -174.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.26 -52.66 17.64 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.323 1.916 . . . . 0.0 112.238 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.38 -52.78 63.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.106 0.953 . . . . 0.0 109.864 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.0 mm -58.77 -30.82 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 123.176 0.59 . . . . 0.0 111.203 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.11 -20.39 27.62 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.886 1.232 . . . . 0.0 113.6 174.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.8 -9.94 47.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.368 1.584 . . . . 0.0 110.96 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.44 133.11 48.93 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.354 1.073 . . . . 0.0 110.764 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -54.66 104.89 0.13 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.807 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.18 -26.94 5.71 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 118.991 -0.894 . . . . 0.0 113.102 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.6 t -79.69 131.84 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 118.483 1.141 . . . . 0.0 110.042 -172.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -98.36 -47.31 5.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.528 1.531 . . . . 0.0 110.022 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -151.33 167.36 28.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.253 0.478 . . . . 0.0 110.191 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.8 tt -149.61 143.97 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.069 1.348 . . . . 0.0 109.439 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -130.19 122.69 28.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.309 2.244 . . . . 0.0 105.865 167.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG22 ' HB1' ' A' ' 43' ' ' ALA . 69.1 t -117.81 103.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 120.279 1.4 . . . . 0.0 109.52 176.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 m -85.21 99.45 11.11 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 mt -53.84 170.26 0.13 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.902 158.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 67.59 -60.6 0.38 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 127.991 2.516 . . . . 0.0 110.417 -171.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -24.86 67.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.574 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 65.55 23.12 11.79 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.469 1.908 . . . . 0.0 111.182 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -119.76 135.24 54.93 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.809 0.844 . . . . 0.0 109.706 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB1' HG22 ' A' ' 36' ' ' VAL . . . -132.12 152.85 51.02 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 m -129.38 120.71 26.01 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.136 1.774 . . . . 0.0 106.482 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.57 154.34 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.52 119.05 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -158.0 -179.69 8.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.825 1.25 . . . . 0.0 109.163 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -133.12 146.06 59.5 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.15 75.05 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 124.414 3.409 . . . . 0.0 109.983 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.99 -60.03 0.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.804 1.242 . . . . 0.0 107.991 172.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -80.67 -27.47 37.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.064 -0.493 . . . . 0.0 110.464 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.4 tp -122.23 144.16 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.739 0.816 . . . . 0.0 109.99 -175.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.2 m -77.29 23.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 72.12 -63.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 128.602 2.761 . . . . 0.0 109.095 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -42.08 74.33 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.019 0.928 . . . . 0.0 108.819 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -38.9 -60.17 0.88 Allowed 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.075 0.95 . . . . 0.0 110.935 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -36.58 -57.05 0.79 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.811 1.644 . . . . 0.0 111.627 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -40.86 69.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.395 0.678 . . . . 0.0 111.705 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -60.42 -26.02 66.39 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 120.986 -1.071 . . . . 0.0 112.789 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -62.81 -37.75 88.0 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.6 mp -63.9 -45.05 98.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 117.55 -1.214 . . . . 0.0 111.528 173.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -49.87 -49.98 47.41 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.44 1.473 . . . . 0.0 108.304 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.07 -20.25 51.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.672 1.189 . . . . 0.0 113.848 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.5 mmt -65.19 -25.94 67.94 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.481 1.037 . . . . 0.0 110.58 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.68 -27.71 4.34 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.446 1.022 . . . . 0.0 111.197 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -86.37 123.0 71.97 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.51 130.74 30.99 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 N-CA-C 108.632 -1.334 . . . . 0.0 108.632 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.42 -176.53 3.61 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.364 0.666 . . . . 0.0 109.276 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.97 151.02 30.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.119 -0.988 . . . . 0.0 110.864 -175.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.164 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.3 t . . . . . 0 C--O 1.233 0.187 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.1 t -85.3 133.71 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 125.748 1.619 . . . . 0.0 109.624 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.708 HD23 ' N ' ' A' ' 6' ' ' LYS . 6.0 tt -124.05 146.19 48.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.696 1.599 . . . . 0.0 108.673 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.708 ' N ' HD23 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -109.81 113.82 26.88 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.198 1.799 . . . . 0.0 109.133 178.453 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.4 mtt -109.2 131.53 54.98 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.738 0.815 . . . . 0.0 109.88 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -78.23 119.11 21.13 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 167.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.52 85.14 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.85 -175.35 3.03 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.543 0.737 . . . . 0.0 109.431 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.098 0 O-C-N 121.371 -0.831 . . . . 0.0 113.356 175.997 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.15 -38.93 68.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -168.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.6 m -48.84 -60.85 2.41 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.404 168.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.9 -50.57 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -58.65 -63.5 1.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.391 1.091 . . . . 0.0 109.153 -172.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.51 -56.59 6.29 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.99 1.757 . . . . 0.0 112.731 173.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -57.1 -52.59 64.67 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.114 0.957 . . . . 0.0 110.017 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.6 -27.43 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 123.718 0.807 . . . . 0.0 110.686 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.82 -19.95 11.81 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.069 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -85.79 -14.24 45.76 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.592 1.696 . . . . 0.0 110.146 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 132.63 48.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 122.438 1.114 . . . . 0.0 111.699 -172.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -57.78 107.03 0.41 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.25 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.38 -22.43 8.36 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.194 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.3 t -78.28 127.89 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 118.709 1.255 . . . . 0.0 108.841 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -89.67 -50.27 6.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.299 1.04 . . . . 0.0 108.77 172.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -154.25 160.89 42.03 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 118.988 0.813 . . . . 0.0 110.448 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 tt -141.77 142.27 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.623 1.569 . . . . 0.0 109.719 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -145.54 113.11 6.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.392 1.477 . . . . 0.0 107.753 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.9 t -113.0 92.47 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.47 1.508 . . . . 0.0 110.299 -172.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.1 m -82.13 78.59 8.79 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 124.171 0.988 . . . . 0.0 110.613 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.2 -42.04 28.9 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.312 0.645 . . . . 0.0 111.856 174.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -42.48 -51.86 4.88 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 125.94 1.696 . . . . 0.0 110.471 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -81.19 -13.66 58.36 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.15 -173.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 64.18 35.01 10.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 126.995 2.118 . . . . 0.0 109.572 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -156.15 144.45 19.92 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 125.434 1.709 . . . . 0.0 109.966 -166.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.5 157.91 41.38 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.402 1.081 . . . . 0.0 110.224 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 m -139.49 121.01 15.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.7 mt -124.9 162.89 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.079 1.351 . . . . 0.0 108.44 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 p -132.79 127.31 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 174.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -155.84 177.95 10.82 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.601 1.16 . . . . 0.0 108.818 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -126.25 142.41 42.66 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.314 1.046 . . . . 0.0 113.122 171.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.96 72.12 3.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.878 3.719 . . . . 0.0 110.402 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.68 -56.65 0.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.175 0.99 . . . . 0.0 108.605 172.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.38 -31.09 37.87 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.459 ' HA ' HD12 ' A' ' 52' ' ' ILE . 9.0 tp -118.64 144.1 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 123.464 0.705 . . . . 0.0 109.668 -177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 m -81.95 27.81 0.45 Allowed 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -173.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 69.84 -64.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 129.582 3.153 . . . . 0.0 109.284 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -72.97 -39.6 65.99 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.48 1.112 . . . . 0.0 108.647 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.403 ' HB3' HD11 ' A' ' 52' ' ' ILE . 4.1 mm-40 -40.7 -55.94 2.27 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.43 1.092 . . . . 0.0 111.574 -173.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.13 -60.73 0.85 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.554 1.142 . . . . 0.0 110.082 177.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HZ2' ' HB3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -70.37 -32.98 70.89 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.093 -176.608 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -64.54 -29.55 70.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 119.194 -2.191 . . . . 0.0 111.537 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -63.32 -44.15 95.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.13 -43.5 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.908 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -55.25 -54.15 47.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.771 1.169 . . . . 0.0 107.978 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.15 -27.73 64.05 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.816 1.646 . . . . 0.0 114.174 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.9 mmt -52.63 -28.77 22.82 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.362 0.983 . . . . 0.0 111.187 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.87 39.98 0.62 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 124.641 1.115 . . . . 0.0 110.908 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -149.07 119.22 4.05 Favored Pre-proline 0 N--CA 1.457 -0.093 0 CA-C-O 117.995 -1.002 . . . . 0.0 108.438 -175.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.48 109.87 1.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.905 1.737 . . . . 0.0 109.597 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.9 -168.36 1.31 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.949 1.3 . . . . 0.0 108.449 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -163.44 152.56 14.49 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.117 0.967 . . . . 0.0 110.504 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 64.2 t . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 170.39 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.32 121.3 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.657 1.983 . . . . 0.0 108.688 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.7 tp -112.22 119.31 37.93 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.134 0.574 . . . . 0.0 110.553 171.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.07 126.97 36.31 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.957 1.303 . . . . 0.0 109.552 170.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -132.37 157.79 43.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.975 1.31 . . . . 0.0 109.702 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 133.91 36.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 t -128.98 79.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.957 1.303 . . . . 0.0 108.448 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.66 147.18 29.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.865 0 CA-C-O 119.307 -0.718 . . . . 0.0 113.569 170.98 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.224 -0.278 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -53.01 -39.15 62.92 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -170.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.3 m -51.29 -57.9 7.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 O-C-N 123.291 0.369 . . . . 0.0 111.587 170.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.4 -51.36 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.5 -61.78 2.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.091 0.948 . . . . 0.0 110.229 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.15 -54.17 13.12 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.948 1.737 . . . . 0.0 112.391 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -59.37 -52.36 65.96 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.111 0.955 . . . . 0.0 110.541 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.415 HG21 HD12 ' A' ' 34' ' ' ILE . 19.2 mm -57.22 -36.8 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 123.834 0.854 . . . . 0.0 110.143 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.12 -20.13 33.9 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.844 1.212 . . . . 0.0 114.137 172.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -84.88 -27.44 26.67 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.477 1.638 . . . . 0.0 109.99 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.22 139.34 52.25 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.443 1.116 . . . . 0.0 112.722 -168.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -53.8 115.11 1.82 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.051 1.34 . . . . 0.0 111.52 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.72 -28.57 6.4 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 124.064 0.84 . . . . 0.0 112.053 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.68 141.38 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 117.468 0.634 . . . . 0.0 110.051 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -121.1 -21.61 6.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.4 1.08 . . . . 0.0 111.811 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -160.41 164.63 32.17 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.398 0.999 . . . . 0.0 109.706 172.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.415 HD12 HG21 ' A' ' 25' ' ' ILE . 15.4 tt -155.5 143.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 123.91 0.884 . . . . 0.0 108.655 174.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.28 113.71 10.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.284 1.833 . . . . 0.0 106.527 171.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -100.34 103.13 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.229 0.922 . . . . 0.0 109.606 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -74.0 73.29 1.67 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.303 1.041 . . . . 0.0 110.267 175.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -50.66 161.07 0.37 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.426 1.49 . . . . 0.0 109.772 167.152 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.575 ' H ' HD13 ' A' ' 38' ' ' LEU . 20.3 m-20 65.46 -53.5 0.35 Allowed 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 128.042 2.537 . . . . 0.0 110.952 -162.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -67.59 -23.36 65.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -172.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 68.95 26.62 5.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.987 2.115 . . . . 0.0 111.864 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -117.82 150.04 39.82 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.59 1.556 . . . . 0.0 106.876 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.03 159.9 43.42 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.295 -0.878 . . . . 0.0 109.564 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 m -132.6 106.32 7.74 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.713 1.605 . . . . 0.0 107.399 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 mt -90.08 163.16 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.45 117.86 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.153 1.381 . . . . 0.0 108.325 168.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -157.48 -178.2 7.16 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.31 1.444 . . . . 0.0 110.846 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -132.02 144.75 54.47 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.398 1.479 . . . . 0.0 113.86 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.22 68.88 4.1 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.752 3.635 . . . . 0.0 110.025 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.19 -57.06 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.541 1.136 . . . . 0.0 108.771 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.1 -20.52 37.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.65 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.1 tp -127.88 150.61 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 123.128 0.571 . . . . 0.0 110.475 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.6 m -79.46 25.02 0.33 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -176.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 71.3 -61.48 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.952 2.501 . . . . 0.0 108.889 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.08 -38.31 61.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.887 -174.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HB3' HD11 ' A' ' 52' ' ' ILE . 22.8 mt-10 -45.95 -51.24 13.69 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.819 0.736 . . . . 0.0 111.981 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.78 -54.61 6.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.225 1.01 . . . . 0.0 111.71 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -64.64 -49.38 71.25 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.652 -0.655 . . . . 0.0 110.653 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -65.62 -24.94 67.17 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.228 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -62.4 -47.49 83.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.41 -45.85 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -58.08 -49.67 76.1 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.64 -26.81 65.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.391 1.476 . . . . 0.0 113.442 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.0 mmm -54.88 -32.95 61.42 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.626 1.103 . . . . 0.0 110.387 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.6 -42.71 0.79 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -75.6 111.21 13.2 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.353 -171.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.81 110.3 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.169 1.913 . . . . 0.0 109.161 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.37 -167.16 1.27 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.192 1.397 . . . . 0.0 108.813 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.98 134.78 5.14 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.296 0.953 . . . . 0.0 113.025 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 C--N 1.338 0.093 0 C-N-CA 123.399 0.68 . . . . 0.0 110.058 174.842 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.19 133.71 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 124.535 1.134 . . . . 0.0 109.669 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.7 tp -119.97 131.72 55.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.45 1.5 . . . . 0.0 108.748 172.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -93.17 117.04 29.61 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.349 1.06 . . . . 0.0 108.516 167.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.48 ' SD ' HD11 ' A' ' 45' ' ' ILE . 14.8 ptm -114.61 156.99 23.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.392 0.677 . . . . 0.0 109.211 172.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -100.29 129.34 46.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.54 1.536 . . . . 0.0 107.052 170.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.06 69.41 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.82 163.66 25.36 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.29 0.567 . . . . 0.0 109.594 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 O-C-N 121.004 -1.06 . . . . 0.0 113.101 172.693 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.4 t -52.18 -45.18 65.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -165.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.5 m -48.5 -56.75 7.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.22 0.208 . . . . 0.0 111.117 169.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -59.93 -49.34 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 123.414 0.686 . . . . 0.0 109.415 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -59.61 -61.55 2.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.918 0.887 . . . . 0.0 109.555 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.86 -56.95 6.37 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.708 1.623 . . . . 0.0 112.401 172.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -57.68 -54.05 51.24 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.018 0.909 . . . . 0.0 110.269 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 mm -60.97 -31.94 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 124.016 0.926 . . . . 0.0 110.921 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.41 -17.9 27.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.886 1.232 . . . . 0.0 113.657 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -84.79 -13.62 50.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.941 1.371 . . . . 0.0 110.392 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.63 140.49 44.33 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.93 0.871 . . . . 0.0 111.983 -169.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -59.7 114.57 2.82 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.059 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.59 -24.5 10.31 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.212 0.911 . . . . 0.0 112.317 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.61 137.63 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 118.035 0.918 . . . . 0.0 110.126 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -106.91 -48.36 3.51 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.937 1.295 . . . . 0.0 109.554 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.04 161.84 41.97 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -178.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 tt -149.49 140.11 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 123.676 0.791 . . . . 0.0 109.246 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -135.88 101.08 4.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.795 2.038 . . . . 0.0 107.279 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -98.85 118.69 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.809 0.844 . . . . 0.0 109.128 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.9 m -98.3 90.88 4.97 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.632 0.773 . . . . 0.0 108.995 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.6 170.55 0.25 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.392 161.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 71.15 -57.36 0.6 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.092 2.557 . . . . 0.0 108.601 -168.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.69 -27.07 64.7 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.569 -174.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 70.07 20.63 6.39 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 111.862 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.16 144.94 42.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.921 1.688 . . . . 0.0 108.244 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.79 155.75 47.91 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 121.328 -0.857 . . . . 0.0 110.035 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 m -126.07 115.22 19.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.918 1.687 . . . . 0.0 106.635 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.48 HD11 ' SD ' ' A' ' 7' ' ' MET . 35.7 mt -108.41 154.91 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.31 122.28 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 118.734 0.697 . . . . 0.0 109.789 168.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -156.25 177.82 11.0 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.952 1.701 . . . . 0.0 108.872 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -124.2 136.89 28.17 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 119.427 1.012 . . . . 0.0 111.736 169.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.8 73.07 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.136 3.224 . . . . 0.0 110.332 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -135.3 -50.57 0.75 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.4 mt -94.02 -17.63 22.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.782 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 52' ' ' ILE . 11.2 tp -119.78 150.4 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.519 1.054 . . . . 0.0 110.21 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.3 m -83.54 19.82 1.51 Allowed 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 70.67 -62.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 128.038 2.535 . . . . 0.0 109.573 -177.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -70.2 -38.05 75.24 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -49.75 -47.64 50.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 123.534 0.521 . . . . 0.0 111.442 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -40.93 -52.09 3.14 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 177.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.09 -44.92 68.07 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.276 -0.265 . . . . 0.0 110.89 177.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -54.85 -32.17 60.37 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.593 -0.692 . . . . 0.0 112.7 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -37.85 88.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.38 -50.99 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.909 170.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 8.2 mt-10 -52.34 -46.82 66.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.336 0.971 . . . . 0.0 109.393 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.44 -21.36 50.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.94 1.696 . . . . 0.0 113.554 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.9 mmt -65.51 -31.95 73.29 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.372 0.987 . . . . 0.0 110.15 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.89 -37.01 1.47 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.906 0.765 . . . . 0.0 111.301 173.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -75.91 116.36 54.77 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 117.784 -1.103 . . . . 0.0 108.876 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.24 120.24 7.61 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.124 1.883 . . . . 0.0 108.685 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.403 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -115.08 -170.3 1.73 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.808 0.813 . . . . 0.0 109.413 -175.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.35 152.99 19.16 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.841 -1.162 . . . . 0.0 110.674 -176.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -173.848 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.8 t -79.25 115.61 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 126.074 1.75 . . . . 0.0 109.231 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 6' ' ' LYS . 6.6 tt -89.21 155.86 19.14 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.663 0.785 . . . . 0.0 109.493 169.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' N ' HD23 ' A' ' 5' ' ' LEU . 3.6 tmtt? -135.44 116.63 14.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.511 ' SD ' HD11 ' A' ' 45' ' ' ILE . 5.0 ptm -128.99 153.2 47.8 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.948 1.299 . . . . 0.0 110.792 -170.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.99 129.16 49.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.076 0.951 . . . . 0.0 108.598 170.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.05 76.45 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 125.379 1.472 . . . . 0.0 107.77 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.3 114.79 3.37 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.126 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 C-N-CA 124.978 1.275 . . . . 0.0 111.407 -179.848 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -54.64 -36.35 64.46 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 m -52.32 -58.66 5.97 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 123.105 0.253 . . . . 0.0 111.18 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.33 -52.21 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -58.21 -67.37 0.35 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.881 0.848 . . . . 0.0 110.996 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.33 -51.68 11.57 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.581 1.563 . . . . 0.0 112.358 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -63.99 -48.84 74.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.09 0.945 . . . . 0.0 110.362 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.2 mm -59.44 -30.15 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 O-C-N 122.059 -0.401 . . . . 0.0 110.954 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.81 -23.24 6.72 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.391 0.996 . . . . 0.0 114.253 170.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -81.86 -18.22 44.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.799 1.799 . . . . 0.0 111.524 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.28 136.34 56.47 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.865 0.84 . . . . 0.0 111.038 -165.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -56.27 100.66 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.794 1.238 . . . . 0.0 110.324 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.96 -27.2 5.18 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.059 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.31 134.84 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 118.598 1.199 . . . . 0.0 109.76 -172.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -105.64 -36.97 6.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.771 1.228 . . . . 0.0 110.309 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -159.05 169.77 23.52 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.296 0.953 . . . . 0.0 111.459 173.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -150.14 152.67 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.548 1.539 . . . . 0.0 108.932 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -150.38 116.2 5.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.706 1.603 . . . . 0.0 108.345 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.3 t -110.96 117.76 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.639 1.576 . . . . 0.0 109.96 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.4 m -103.23 108.21 19.34 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.445 1.498 . . . . 0.0 110.107 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mt -60.55 -179.05 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.485 1.114 . . . . 0.0 110.308 164.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 63.43 -70.06 0.07 Allowed 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 128.103 2.561 . . . . 0.0 111.029 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -61.57 -28.36 69.29 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.043 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.59 60.43 1.34 Allowed 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 126.711 2.005 . . . . 0.0 111.359 173.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -151.57 156.44 40.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.18 166.52 24.48 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.873 -0.517 . . . . 0.0 109.953 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.36 144.0 34.3 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.511 HD11 ' SD ' ' A' ' 7' ' ' MET . 13.2 mt -123.25 162.95 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.27 1.5 p -134.55 113.27 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 119.243 0.929 . . . . 0.0 108.715 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -158.96 179.54 8.98 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.077 1.351 . . . . 0.0 109.578 -170.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.74 147.92 53.55 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.47 79.33 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.666 2.911 . . . . 0.0 109.901 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.22 -52.62 0.5 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.765 1.626 . . . . 0.0 107.147 166.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.05 -22.69 18.98 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.236 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 tp -129.13 147.67 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 123.724 0.81 . . . . 0.0 111.204 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -80.74 27.24 0.38 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -170.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 71.67 -60.65 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 127.879 2.472 . . . . 0.0 109.862 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.54 -42.32 52.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.009 1.324 . . . . 0.0 109.304 -177.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -50.47 -52.97 33.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 123.566 0.541 . . . . 0.0 110.648 -171.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -36.93 -63.38 0.42 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.774 1.229 . . . . 0.0 111.538 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -39.24 72.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.771 -0.581 . . . . 0.0 110.359 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -58.29 -27.33 63.98 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.04 -1.038 . . . . 0.0 113.162 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -41.99 96.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.766 1.167 . . . . 0.0 108.787 176.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.77 -39.09 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.314 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -60.43 -49.84 75.97 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.87 -28.89 64.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.438 1.095 . . . . 0.0 113.195 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.0 mmt -53.05 -34.34 56.06 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.215 0.916 . . . . 0.0 111.463 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.56 -38.91 1.33 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -73.3 113.06 18.63 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.585 -173.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.74 108.63 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.08 1.853 . . . . 0.0 108.384 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.09 -177.43 4.13 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.305 1.042 . . . . 0.0 108.336 -171.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -156.91 140.18 15.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.099 0.863 . . . . 0.0 112.69 -165.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.226 -0.171 0 C-N-CA 126.667 1.987 . . . . 0.0 109.887 -176.915 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.84 125.36 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.595 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -131.38 137.16 48.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -93.13 129.32 39.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.263 0.625 . . . . 0.0 111.079 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.465 ' CG ' HD11 ' A' ' 5' ' ' LEU . 27.0 mtt -108.44 155.24 20.81 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.171 0.988 . . . . 0.0 109.977 169.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 118.35 36.59 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 167.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.0 t -100.86 76.91 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.13 168.73 19.42 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.686 0.755 . . . . 0.0 111.675 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.109 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.206 -178.854 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.2 t -50.7 -43.14 57.65 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 m -49.53 -56.2 10.7 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.248 -0.283 . . . . 0.0 111.064 170.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.31 -49.11 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.294 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -51.81 -67.65 0.23 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.52 1.054 . . . . 0.0 110.806 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.33 -50.17 29.89 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.621 1.582 . . . . 0.0 111.882 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.23 -55.31 36.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.696 0.748 . . . . 0.0 109.846 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.9 mm -61.79 -28.75 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 124.2 1.0 . . . . 0.0 110.726 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.45 -20.36 16.45 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.632 1.11 . . . . 0.0 113.581 173.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -90.13 -6.22 55.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.304 1.552 . . . . 0.0 111.408 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.21 135.65 47.63 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 122.044 0.926 . . . . 0.0 111.291 -173.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -57.95 101.63 0.08 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.292 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.46 -24.85 6.41 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.821 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 t -81.95 137.76 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 118.917 1.358 . . . . 0.0 108.253 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -117.35 -34.59 4.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.087 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.11 161.28 38.4 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.818 1.19 . . . . 0.0 110.332 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tt -152.75 143.43 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.628 1.171 . . . . 0.0 110.054 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -141.08 108.68 5.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.365 1.866 . . . . 0.0 108.164 168.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.62 118.48 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 124.731 1.212 . . . . 0.0 109.352 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 t -104.89 82.45 1.87 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.441 1.097 . . . . 0.0 109.164 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -49.37 62.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.988 0.915 . . . . 0.0 111.3 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -44.43 -51.91 8.27 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 125.162 1.385 . . . . 0.0 110.866 172.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -75.58 -9.55 58.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.946 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 62.7 24.03 14.3 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.034 2.134 . . . . 0.0 110.896 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -141.78 160.42 40.23 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.89 1.276 . . . . 0.0 109.678 -170.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.99 158.87 43.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.8 0.84 . . . . 0.0 109.364 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.3 m -132.65 108.05 8.8 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 127.526 2.33 . . . . 0.0 106.202 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mt -116.82 156.23 18.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 124.044 0.938 . . . . 0.0 108.81 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.257 0.5 OUTLIER -132.3 114.07 22.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 118.078 0.399 . . . . 0.0 109.94 -175.476 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.444 ' HE1' HD12 ' A' ' 5' ' ' LEU . 52.8 p90 -157.41 179.05 9.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.402 1.081 . . . . 0.0 110.248 -169.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -141.17 132.18 13.47 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 123.902 0.881 . . . . 0.0 110.482 -170.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.22 73.5 2.07 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.751 2.968 . . . . 0.0 110.108 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -144.79 -51.7 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -87.87 -27.84 21.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.707 -0.664 . . . . 0.0 111.236 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.3 tp -120.93 143.6 32.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 CA-C-N 118.897 0.771 . . . . 0.0 110.169 -175.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -83.44 31.37 0.46 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -171.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.284 0.5 OUTLIER 74.78 -58.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 128.411 2.684 . . . . 0.0 111.447 170.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -80.77 -38.95 27.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.463 1.905 . . . . 0.0 108.247 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HB3' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -44.8 -53.53 7.33 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 123.774 0.83 . . . . 0.0 111.696 -174.513 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -34.9 -56.98 0.56 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.613 1.565 . . . . 0.0 110.065 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -42.09 71.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.765 0.426 . . . . 0.0 111.14 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -56.76 -28.5 61.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -63.22 -44.18 95.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.37 -46.26 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 117.987 -1.006 . . . . 0.0 111.038 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -52.12 -51.83 55.36 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.754 1.161 . . . . 0.0 108.421 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.59 -20.9 63.83 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.55 2.34 . . . . 0.0 114.056 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.4 mmt -54.82 -32.61 60.6 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.625 1.102 . . . . 0.0 110.123 168.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.47 43.08 0.48 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -147.05 132.61 9.24 Favored Pre-proline 0 C--O 1.223 -0.296 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.7 123.34 11.54 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 121.083 1.423 . . . . 0.0 108.953 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.71 175.02 9.37 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.572 1.177 . . . . 0.0 110.102 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.98 150.91 24.75 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.992 -1.068 . . . . 0.0 111.017 -163.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.457 ' CG2' HD21 ' A' ' 5' ' ' LEU . 10.0 p . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -174.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.3 t -92.08 132.42 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 125.501 1.52 . . . . 0.0 108.47 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.483 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -110.33 129.91 55.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 170.071 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.59 121.9 44.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.29 1.436 . . . . 0.0 107.127 169.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.451 ' HB3' HD11 ' A' ' 5' ' ' LEU . 26.4 ptt? -129.91 140.21 50.99 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.302 0.641 . . . . 0.0 110.479 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.84 145.22 34.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 164.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 t -136.16 72.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.663 1.585 . . . . 0.0 107.269 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -71.45 176.17 4.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.684 0.754 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 CA-C-O 119.553 -0.581 . . . . 0.0 113.149 166.935 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.95 -36.31 65.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -168.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.3 m -49.98 -61.66 2.01 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.871 167.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.83 -51.1 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.31 -63.82 1.13 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.516 0.674 . . . . 0.0 110.549 -173.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.7 -54.38 6.69 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.998 1.761 . . . . 0.0 112.165 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -59.3 -54.38 47.46 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.151 0.975 . . . . 0.0 110.447 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.1 mm -56.52 -33.33 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.448 0.699 . . . . 0.0 111.302 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.65 -20.44 17.91 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.645 1.117 . . . . 0.0 113.904 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -84.59 -20.25 31.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.646 1.723 . . . . 0.0 111.138 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 136.24 53.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 122.339 1.066 . . . . 0.0 111.75 -167.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.59 115.15 1.81 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.905 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.88 -22.38 12.7 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-O 119.076 -0.847 . . . . 0.0 112.507 176.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.25 128.31 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 118.318 1.059 . . . . 0.0 109.388 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -88.6 -48.47 7.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.935 1.294 . . . . 0.0 109.116 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.72 171.27 19.84 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.309 0.958 . . . . 0.0 111.124 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 tt -141.55 142.78 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 124.703 1.201 . . . . 0.0 109.677 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.78 106.79 6.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.259 1.424 . . . . 0.0 107.774 170.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.64 125.76 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.2 1.0 . . . . 0.0 109.352 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -115.01 82.62 1.77 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.725 1.21 . . . . 0.0 108.283 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -52.23 -44.29 64.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.836 0.854 . . . . 0.0 110.298 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -40.89 -55.19 2.55 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.95 1.3 . . . . 0.0 111.085 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -79.68 -7.61 58.69 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.234 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 61.49 23.66 13.9 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.551 2.34 . . . . 0.0 111.283 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -139.69 159.81 41.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.034 -168.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.63 159.03 44.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.299 0.64 . . . . 0.0 109.482 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.4 m -132.77 119.89 20.9 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.8 mt -106.64 155.17 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.45 121.19 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 168.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -157.75 -177.3 6.47 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 127.478 2.311 . . . . 0.0 107.95 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -137.76 149.05 63.31 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 119.98 1.264 . . . . 0.0 112.278 170.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.56 72.49 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.259 3.306 . . . . 0.0 110.266 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.15 -61.43 0.42 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.242 1.417 . . . . 0.0 108.372 173.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.1 mt -84.75 -19.82 32.05 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.798 -0.62 . . . . 0.0 110.815 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.3 tp -123.97 152.33 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 123.288 0.635 . . . . 0.0 110.143 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 m -81.39 20.27 0.89 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.141 0.977 . . . . 0.0 113.433 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 66.91 -61.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 129.23 3.012 . . . . 0.0 109.84 -172.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.94 -39.0 72.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.643 0.777 . . . . 0.0 110.066 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.4 mt-10 -47.47 -50.7 22.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.364 0.415 . . . . 0.0 111.663 -174.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.21 -48.22 6.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 122.934 0.494 . . . . 0.0 111.626 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -51.66 24.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 122.227 -0.296 . . . . 0.0 110.71 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -57.99 -27.6 63.63 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -60.51 -51.38 69.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.894 0.877 . . . . 0.0 108.681 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.95 -50.14 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.659 173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -53.93 -47.44 71.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.34 -20.64 60.12 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.441 1.496 . . . . 0.0 114.227 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.7 mmt -60.94 -29.97 69.94 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.956 1.253 . . . . 0.0 110.348 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.42 -34.74 1.7 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 173.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -77.09 110.53 12.39 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.192 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.72 116.95 4.23 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.737 1.625 . . . . 0.0 109.217 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.84 -169.5 2.13 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.236 1.014 . . . . 0.0 109.438 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.46 136.87 8.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.753 1.16 . . . . 0.0 113.355 -169.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.529 0.168 0 C-N-CA 124.76 1.224 . . . . 0.0 108.913 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.592 0.711 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.7 t -80.69 136.45 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 125.262 1.425 . . . . 0.0 109.784 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.662 HD21 HG22 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -127.65 138.37 52.81 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.274 1.83 . . . . 0.0 108.077 177.031 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.556 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.2 ttpt -110.68 114.79 28.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.806 1.242 . . . . 0.0 109.77 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.5 ptp -109.52 151.5 26.67 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.372 1.069 . . . . 0.0 109.827 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -89.67 133.34 34.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 163.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 t -118.71 78.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -72.91 167.93 20.0 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.928 0.87 . . . . 0.0 111.475 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.352 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.468 HG22 HG12 ' A' ' 36' ' ' VAL . 9.9 p . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.4 m -49.08 -40.91 33.69 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -175.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.3 m -48.99 -58.49 4.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.144 0.497 . . . . 0.0 111.698 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.58 -45.24 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 123.937 0.895 . . . . 0.0 108.988 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HA ' HG21 ' A' ' 34' ' ' ILE . 47.1 mt-10 -54.35 -62.5 1.62 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.645 1.111 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.4 -54.01 14.34 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.352 1.453 . . . . 0.0 111.754 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -60.73 -58.14 9.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.624 0.712 . . . . 0.0 110.45 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.435 HG21 HD12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -57.31 -39.05 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.063 0.945 . . . . 0.0 110.3 -177.786 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.06 -13.98 9.97 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.042 1.306 . . . . 0.0 113.829 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -95.5 -15.35 22.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.849 1.324 . . . . 0.0 110.667 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 141.2 55.66 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 119.528 1.058 . . . . 0.0 111.96 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -59.32 114.32 2.6 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.677 173.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.05 -22.74 9.62 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.436 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.16 139.01 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 117.966 0.883 . . . . 0.0 109.265 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -105.48 -45.87 4.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.468 1.507 . . . . 0.0 110.207 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.59 161.7 42.06 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 22' ' ' GLU . 7.9 tt -146.78 140.49 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.712 1.205 . . . . 0.0 109.375 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.63 105.18 6.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.319 1.847 . . . . 0.0 106.903 173.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.468 HG12 HG22 ' A' ' 18' ' ' THR . 46.3 t -105.56 116.44 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.816 1.189 . . . . 0.0 108.862 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -80.47 179.69 7.6 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.338 0.589 . . . . 0.0 110.176 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.2 -59.74 1.3 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.284 1.434 . . . . 0.0 108.225 173.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -43.84 -54.64 5.09 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.983 1.313 . . . . 0.0 110.083 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -80.55 -12.66 59.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.012 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 61.95 15.76 7.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.963 1.705 . . . . 0.0 112.736 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -124.76 156.72 37.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.556 1.543 . . . . 0.0 109.689 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HB2' HG13 ' A' ' 36' ' ' VAL . . . -139.56 152.63 47.04 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.538 0.735 . . . . 0.0 110.104 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.3 m -128.24 113.85 16.19 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.548 1.939 . . . . 0.0 105.991 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.73 160.59 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -128.51 119.11 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -158.28 178.13 10.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.261 1.424 . . . . 0.0 110.239 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -133.53 149.82 73.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.295 1.038 . . . . 0.0 113.547 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.68 80.67 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.665 2.91 . . . . 0.0 109.114 169.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.2 -61.2 0.25 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.46 1.104 . . . . 0.0 108.073 173.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.9 mt -87.59 -21.12 25.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.003 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.2 tp -123.96 148.79 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.07 0.948 . . . . 0.0 109.851 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.0 m -79.39 23.98 0.37 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.256 0.8 OUTLIER 70.09 -57.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 128.047 2.539 . . . . 0.0 110.054 -176.18 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.09 -40.7 37.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.398 1.079 . . . . 0.0 110.144 -176.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -48.19 -48.44 34.69 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 122.739 0.415 . . . . 0.0 111.668 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -37.89 -56.43 1.11 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.695 1.198 . . . . 0.0 112.212 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.17 -45.19 42.28 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.254 1.021 . . . . 0.0 112.478 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.44 -29.36 15.82 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.191 -0.943 . . . . 0.0 112.663 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -62.27 -34.31 76.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -70.1 -44.32 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 118.419 -0.801 . . . . 0.0 109.811 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -50.86 -49.34 59.25 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.51 44.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.273 1.029 . . . . 0.0 113.756 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.3 mmm -66.8 -30.85 71.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.444 1.02 . . . . 0.0 110.247 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.23 -36.91 1.99 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.315 0.96 . . . . 0.0 111.142 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -79.56 123.73 84.09 Favored Pre-proline 0 N--CA 1.455 -0.179 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.305 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.15 118.33 5.35 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.508 1.472 . . . . 0.0 108.596 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.76 -174.56 2.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -162.87 143.79 9.73 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.888 -1.132 . . . . 0.0 110.935 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.662 HG22 HD21 ' A' ' 5' ' ' LEU . 1.2 t . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.7 t . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 t -77.1 121.41 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.602 HD21 HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -117.96 132.75 56.36 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.551 1.54 . . . . 0.0 106.897 175.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.97 137.84 36.94 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.2 1.0 . . . . 0.0 110.196 171.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -138.71 147.44 42.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.177 0.991 . . . . 0.0 109.882 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -92.25 128.56 38.14 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 t -120.65 73.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 125.24 1.416 . . . . 0.0 108.755 -171.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -73.27 174.7 7.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.784 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 O-C-N 121.807 -0.558 . . . . 0.0 113.015 167.517 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 m -56.4 -38.19 71.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -169.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -50.18 -59.34 4.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.75 0.42 . . . . 0.0 110.404 168.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.72 -49.34 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 118.563 -0.732 . . . . 0.0 109.372 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.38 -65.65 0.54 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.063 0.847 . . . . 0.0 111.071 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.9 -52.22 26.68 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.117 1.342 . . . . 0.0 112.206 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -52.15 -58.05 7.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.533 0.733 . . . . 0.0 109.461 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.44 -34.98 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.6 1.16 . . . . 0.0 111.108 -176.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.87 -23.03 10.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.01 1.29 . . . . 0.0 113.664 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -89.36 -17.22 29.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.577 1.188 . . . . 0.0 110.239 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.43 136.63 49.71 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.327 1.06 . . . . 0.0 111.688 -173.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -52.08 109.27 0.36 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.037 1.335 . . . . 0.0 111.111 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.24 -23.48 8.56 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 118.928 -0.929 . . . . 0.0 112.788 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.3 t -79.79 142.9 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 118.49 1.145 . . . . 0.0 110.056 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -117.12 -40.24 3.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.546 1.138 . . . . 0.0 111.812 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.89 165.68 34.7 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.748 0.704 . . . . 0.0 109.168 173.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -143.95 145.05 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.518 1.527 . . . . 0.0 108.417 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -139.99 97.98 3.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.424 2.29 . . . . 0.0 107.101 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -96.09 116.43 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.131 0.972 . . . . 0.0 109.09 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.8 t -108.72 80.01 1.29 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -54.02 -41.01 67.53 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.855 0.462 . . . . 0.0 111.747 -176.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.81 -55.05 3.83 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.93 1.292 . . . . 0.0 110.584 168.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -78.57 -19.83 51.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.75 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 72.65 4.72 5.07 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.796 2.438 . . . . 0.0 111.627 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -109.99 151.95 26.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.541 1.536 . . . . 0.0 109.02 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.6 157.81 44.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.991 0.916 . . . . 0.0 108.63 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -129.33 121.56 27.72 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.8 mt -111.52 153.35 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.254 7.0 p -117.87 114.7 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.991 0.917 . . . . 0.0 108.906 173.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -158.95 178.93 9.55 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.721 1.208 . . . . 0.0 110.681 -171.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -138.19 144.73 44.48 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HB3' HG23 ' A' ' 54' ' ' VAL . 73.9 Cg_endo -69.6 71.93 1.4 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.547 3.498 . . . . 0.0 110.826 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.32 -58.15 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.399 1.08 . . . . 0.0 108.507 172.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.3 mt -87.5 -21.81 25.26 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.877 -0.582 . . . . 0.0 110.869 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.0 tp -118.76 151.12 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 123.622 0.769 . . . . 0.0 109.823 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 m -85.88 29.83 0.7 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.637 0.775 . . . . 0.0 112.72 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 49' ' ' PRO 0.265 0.5 OUTLIER 73.76 -59.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.085 2.554 . . . . 0.0 110.4 176.115 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -81.01 -38.01 28.2 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.303 1.441 . . . . 0.0 109.786 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.555 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.8 mm-40 -43.76 -48.69 8.1 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 123.747 0.655 . . . . 0.0 111.346 -174.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.24 -53.74 3.11 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.661 0.784 . . . . 0.0 112.029 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -47.22 54.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.199 0.2 . . . . 0.0 110.619 177.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -54.54 -28.38 45.16 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -62.53 -52.24 64.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.5 mp -58.2 -43.14 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.183 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -55.48 -53.71 52.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.5 -27.35 62.47 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.172 1.789 . . . . 0.0 114.097 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.2 mmm -51.37 -31.45 22.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.687 1.13 . . . . 0.0 110.974 172.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.63 42.72 0.28 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -146.82 120.52 5.07 Favored Pre-proline 0 C--O 1.227 -0.087 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.13 102.04 0.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.953 1.769 . . . . 0.0 109.345 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.22 -175.47 3.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.819 0.848 . . . . 0.0 108.898 -175.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.33 143.83 15.34 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.602 HG22 HD21 ' A' ' 5' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 125.546 1.538 . . . . 0.0 108.42 172.067 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.2 t . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.72 120.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -123.88 156.02 37.01 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.555 1.142 . . . . 0.0 109.237 -177.103 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.592 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -102.35 123.05 45.45 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.401 0.681 . . . . 0.0 110.039 177.708 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.1 mmt -105.95 157.72 17.3 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.703 1.201 . . . . 0.0 109.052 174.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.93 127.14 54.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 168.488 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.5 73.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.329 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.9 169.84 17.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.801 -174.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.231 0 CA-C-O 118.934 -0.926 . . . . 0.0 113.708 172.524 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.5 t -53.08 -39.31 63.23 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -172.394 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.5 m -45.77 -61.36 1.75 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 123.194 0.598 . . . . 0.0 112.561 165.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.78 -49.12 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.317 1.047 . . . . 0.0 108.975 178.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -56.41 -65.91 0.53 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.989 0.916 . . . . 0.0 109.428 -176.203 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.05 -52.83 11.51 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.195 1.379 . . . . 0.0 112.492 176.206 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.19 -55.42 35.16 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.851 0.825 . . . . 0.0 110.233 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.7 mm -60.59 -30.07 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 123.797 0.839 . . . . 0.0 110.851 -178.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.85 -19.52 6.98 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.07 171.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -90.51 -13.53 34.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 119.784 1.792 . . . . 0.0 111.217 177.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.65 134.0 50.36 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.496 1.141 . . . . 0.0 111.033 -173.588 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -55.55 110.9 0.78 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.116 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.38 -25.42 8.2 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.329 176.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 t -81.28 136.06 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 118.194 0.997 . . . . 0.0 109.045 -177.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -101.72 -42.92 6.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.797 1.239 . . . . 0.0 110.201 173.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 ttt-85 -153.98 161.35 42.03 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.849 0.75 . . . . 0.0 109.987 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 tt -149.08 139.33 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.583 1.153 . . . . 0.0 109.545 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -139.6 114.81 9.71 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.094 1.758 . . . . 0.0 106.593 174.526 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -113.99 126.23 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.986 1.314 . . . . 0.0 109.07 -178.57 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.3 t -84.58 172.41 11.63 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.536 0.684 . . . . 0.0 110.345 172.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.1 -63.25 1.48 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 170.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -52.64 -49.96 64.13 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.29 1.036 . . . . 0.0 109.313 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.9 -18.09 59.53 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.292 -172.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 62.62 4.74 1.46 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.324 1.85 . . . . 0.0 113.239 -175.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -107.86 152.93 23.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.263 1.825 . . . . 0.0 108.014 -169.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.13 161.27 37.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.47 0.708 . . . . 0.0 109.833 178.117 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.7 m -137.68 118.29 13.96 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 mt -120.27 160.85 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.244 1.018 . . . . 0.0 108.282 178.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.263 14.1 p -130.25 114.89 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.355 0.662 . . . . 0.0 109.888 178.61 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -158.97 178.66 9.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.229 1.011 . . . . 0.0 111.392 -175.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.65 148.82 68.89 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.419 1.088 . . . . 0.0 113.177 173.562 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.69 74.83 0.85 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.403 3.402 . . . . 0.0 110.006 171.007 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.26 -61.31 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.752 1.221 . . . . 0.0 107.812 170.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.4 mt -85.66 -20.86 28.79 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.092 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.436 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.9 tp -123.4 147.3 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 m -79.81 27.0 0.31 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.36 0.982 . . . . 0.0 112.68 -176.549 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.27 0.5 OUTLIER 73.25 -54.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 128.01 2.524 . . . . 0.0 110.817 179.334 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -88.3 -32.81 18.27 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.597 0.759 . . . . 0.0 111.218 -178.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.436 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.5 mt-10 -40.76 -51.57 3.07 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 123.254 0.622 . . . . 0.0 110.775 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -37.0 -63.94 0.39 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.443 1.497 . . . . 0.0 109.922 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.3 -43.99 97.54 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.905 -0.497 . . . . 0.0 111.091 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -58.08 -31.64 67.28 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -60.18 -48.38 81.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -58.6 -48.37 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.863 175.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -52.15 -50.79 61.06 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.324 0.966 . . . . 0.0 108.477 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.27 -21.46 61.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.067 1.747 . . . . 0.0 114.036 -177.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.0 mmt -63.26 -23.95 67.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.955 1.252 . . . . 0.0 110.478 172.014 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.99 40.77 0.74 Allowed Glycine 0 C--N 1.338 0.66 0 C-N-CA 124.279 0.942 . . . . 0.0 111.358 170.54 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -148.53 123.3 4.94 Favored Pre-proline 0 C--O 1.226 -0.152 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.8 118.28 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.361 1.374 . . . . 0.0 109.078 -178.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.66 -171.13 1.83 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.96 152.45 13.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.036 -1.04 . . . . 0.0 111.206 -173.173 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.448 -0.565 0 C-N-CA 126.362 1.865 . . . . 0.0 106.383 -178.097 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.2 t . . . . . 0 CA--C 1.521 -0.142 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.82 141.78 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.707 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.583 HD21 HG22 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -142.64 131.91 23.41 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.773 0.829 . . . . 0.0 109.266 -179.579 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' N ' HD22 ' A' ' 5' ' ' LEU . 1.4 mtmt -103.62 129.78 50.96 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.04 1.336 . . . . 0.0 111.387 178.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.3 ptp -127.01 159.68 33.4 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.294 1.038 . . . . 0.0 110.67 176.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -98.73 124.81 43.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.014 1.726 . . . . 0.0 107.681 164.458 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -111.97 77.44 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.065 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 169.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.283 10.6 pt-20 -84.2 165.63 18.23 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.665 178.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.113 0 CA-C-O 119.459 -0.634 . . . . 0.0 113.759 176.644 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.222 -0.38 0 CA-C-O 118.381 -0.819 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -49.32 -37.17 23.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -175.552 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.25 -51.37 69.85 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 175.486 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.59 -53.38 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.176 172.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -55.86 -61.1 2.59 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.325 0.966 . . . . 0.0 109.92 -171.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.48 -52.9 22.53 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.319 1.438 . . . . 0.0 111.729 177.135 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -60.7 -50.86 71.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.047 0.923 . . . . 0.0 110.323 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.5 mm -66.33 -24.33 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.89 0.876 . . . . 0.0 110.788 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.11 -14.55 32.72 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.604 170.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -84.54 -12.93 53.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.64 1.72 . . . . 0.0 110.607 173.301 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.63 135.31 46.88 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 122.307 1.051 . . . . 0.0 111.447 -171.156 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -60.93 113.77 2.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.221 177.057 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.83 -21.87 15.47 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-O 119.366 -0.686 . . . . 0.0 112.945 175.054 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 t -81.59 131.34 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.829 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.26 -51.34 5.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.151 1.38 . . . . 0.0 109.163 174.422 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -152.1 160.86 43.33 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tt -143.51 141.55 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.151 1.38 . . . . 0.0 108.488 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.54 125.93 20.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.734 1.614 . . . . 0.0 107.097 171.023 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -115.95 154.31 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.026 1.33 . . . . 0.0 107.696 -178.365 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.2 t -130.28 155.53 46.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.111 0.964 . . . . 0.0 109.216 176.372 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -104.36 -59.71 1.7 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.299 1.84 . . . . 0.0 108.732 -177.155 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.79 -58.27 7.85 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.065 1.346 . . . . 0.0 109.619 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.7 -22.36 62.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.32 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 55.75 59.29 3.9 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 126.581 1.952 . . . . 0.0 109.775 176.565 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -156.34 160.72 39.95 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.465 1.506 . . . . 0.0 107.137 -172.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.63 159.04 43.01 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 118.931 0.787 . . . . 0.0 110.536 174.176 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.9 m -126.23 130.28 50.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 174.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.411 HG21 ' SD ' ' A' ' 57' ' ' MET . 2.6 mp -118.36 163.66 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.423 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.4 117.71 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.108 0.963 . . . . 0.0 108.846 176.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -159.61 -177.14 6.18 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.535 1.134 . . . . 0.0 111.255 -171.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -136.73 152.61 74.7 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 165.175 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.79 76.55 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.32 3.347 . . . . 0.0 109.541 171.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.71 -62.43 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.227 1.011 . . . . 0.0 108.679 175.271 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.9 mt -84.14 -27.21 28.3 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 119.361 -0.352 . . . . 0.0 110.142 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 52' ' ' ILE . 9.4 tp -117.74 146.74 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.321 1.048 . . . . 0.0 109.281 177.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -84.1 27.78 0.65 Allowed 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.59 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.262 0.9 OUTLIER 70.42 -57.54 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 128.787 2.835 . . . . 0.0 111.42 179.883 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.72 -33.56 40.78 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.08 1.352 . . . . 0.0 110.04 -177.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -52.87 -49.61 65.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 123.203 0.314 . . . . 0.0 110.777 -177.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -31.57 -58.67 0.26 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.491 1.516 . . . . 0.0 111.283 172.316 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -46.71 67.13 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.177 -0.327 . . . . 0.0 111.306 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.8 -32.02 59.73 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.819 -0.551 . . . . 0.0 112.321 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -42.16 99.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.208 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.19 -47.94 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.694 172.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 7.5 mt-10 -49.79 -51.07 42.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.17 0.986 . . . . 0.0 108.835 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.84 -19.59 51.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.781 2.032 . . . . 0.0 114.056 -178.21 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.8 mmm -61.34 -30.47 70.53 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.626 1.103 . . . . 0.0 109.626 170.359 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.25 40.68 0.39 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.839 1.209 . . . . 0.0 111.553 170.371 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -148.62 122.12 4.66 Favored Pre-proline 0 C--O 1.223 -0.291 0 CA-C-O 117.12 -1.419 . . . . 0.0 107.604 -177.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -62.69 118.66 5.56 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.623 1.549 . . . . 0.0 109.001 -176.253 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -120.78 175.16 6.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.216 1.008 . . . . 0.0 109.991 -178.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.81 138.67 18.02 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.95 -1.094 . . . . 0.0 111.178 -170.344 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.583 HG22 HD21 ' A' ' 5' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -177.186 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.443 -0.777 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.49 135.44 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.515 HD21 HG22 ' A' ' 70' ' ' VAL . 1.5 tm? -125.67 144.41 50.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.272 1.429 . . . . 0.0 107.375 178.368 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.409 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -117.06 129.04 55.74 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.431 1.492 . . . . 0.0 109.136 174.679 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 ptp -124.04 152.07 43.04 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.614 1.166 . . . . 0.0 109.877 179.124 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -89.94 151.43 21.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 162.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -132.27 68.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.01 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -62.9 115.47 4.41 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.672 -170.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.912 0 CA-C-O 119.389 -0.673 . . . . 0.0 113.37 173.611 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 m -55.33 -36.25 66.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -171.099 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.6 m -50.76 -60.63 2.86 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.416 0.447 . . . . 0.0 111.051 167.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.9 -51.22 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -57.49 -66.75 0.41 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.552 0.691 . . . . 0.0 110.63 -174.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.19 -51.26 26.36 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.881 1.705 . . . . 0.0 111.911 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -54.89 -56.68 16.92 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.813 0.806 . . . . 0.0 109.367 177.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.9 mm -64.24 -28.56 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 C-N-CA 123.157 0.583 . . . . 0.0 111.052 -174.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.78 -19.98 23.43 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.376 0.989 . . . . 0.0 113.44 171.225 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -85.84 -18.61 32.37 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 119.627 1.714 . . . . 0.0 109.419 177.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.46 133.7 49.02 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.453 1.121 . . . . 0.0 111.336 -172.129 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -58.23 111.43 1.2 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.027 175.417 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.67 -27.34 6.28 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-O 119.165 -0.797 . . . . 0.0 112.639 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.07 136.19 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 118.167 0.984 . . . . 0.0 109.382 -176.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -107.87 -46.0 3.87 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.581 1.152 . . . . 0.0 110.668 176.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.61 159.7 42.37 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.5 tt -142.7 148.15 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.072 1.349 . . . . 0.0 109.854 179.1 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -145.27 113.11 6.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.791 2.036 . . . . 0.0 108.193 171.075 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.0 t -102.92 120.66 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.23 1.012 . . . . 0.0 110.168 176.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 m -102.72 89.32 3.46 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.516 1.126 . . . . 0.0 109.061 175.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 38' ' ' LEU . 8.3 mt -58.81 173.66 0.41 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.201 160.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 66.41 -65.63 0.19 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 127.968 2.507 . . . . 0.0 109.574 -170.118 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -27.85 69.0 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.095 178.412 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.93 50.82 0.8 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.674 2.39 . . . . 0.0 111.718 172.628 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -140.22 148.16 41.11 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.217 2.207 . . . . 0.0 106.206 -174.739 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.43 155.84 45.13 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 120.924 -1.11 . . . . 0.0 109.679 172.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.76 136.66 34.35 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.474 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.41 163.17 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.36 119.1 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -159.0 -179.33 7.95 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.684 1.194 . . . . 0.0 109.908 -172.417 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -138.23 144.1 41.79 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.003 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.1 80.27 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.305 3.337 . . . . 0.0 109.921 174.399 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -158.35 -54.32 0.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.7 mt -86.75 -29.48 22.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.417 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.6 tp -115.68 145.13 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m -78.24 23.49 0.28 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 -175.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 76.03 -58.51 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 127.27 2.228 . . . . 0.0 109.786 176.199 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.99 -39.26 42.93 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.476 1.511 . . . . 0.0 109.669 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.407 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.4 mt-10 -40.39 -57.11 1.86 Allowed 'General case' 0 C--N 1.345 0.388 0 C-N-CA 123.942 0.897 . . . . 0.0 111.043 -178.381 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.5 -58.29 0.33 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.999 1.72 . . . . 0.0 110.477 175.505 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -48.08 51.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.151 -0.343 . . . . 0.0 111.838 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -55.93 -30.43 61.64 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -174.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.6 -46.41 89.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -63.93 -47.11 92.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.008 175.18 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -50.38 -51.94 41.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.79 -18.83 57.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.503 1.921 . . . . 0.0 114.209 -178.611 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.6 mmm -59.12 -29.76 67.62 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.874 1.216 . . . . 0.0 109.796 170.224 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.94 44.36 0.28 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 124.347 0.975 . . . . 0.0 110.851 171.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -146.76 120.98 5.16 Favored Pre-proline 0 C--O 1.225 -0.196 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -175.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.22 99.01 0.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.942 1.761 . . . . 0.0 110.086 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.22 -176.63 2.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -174.197 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.6 141.13 11.57 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.6 0.36 . . . . 0.0 111.572 -176.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.515 HG22 HD21 ' A' ' 5' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.22 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.09 143.73 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 124.619 1.168 . . . . 0.0 111.389 -175.474 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.43 132.86 53.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.278 1.431 . . . . 0.0 108.191 175.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.43 109.71 21.49 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.301 1.44 . . . . 0.0 107.648 175.329 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.7 ptm -113.39 164.78 13.16 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.691 0.796 . . . . 0.0 111.084 174.606 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -109.99 131.02 55.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 129.711 3.204 . . . . 0.0 106.581 177.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 t -121.25 77.69 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.236 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.03 177.13 4.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.954 0.883 . . . . 0.0 111.7 -176.223 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.809 0 O-C-N 121.626 -0.671 . . . . 0.0 111.546 176.58 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 t -55.04 -38.31 67.81 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -164.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -49.36 -58.4 5.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.876 0.47 . . . . 0.0 111.789 167.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.65 -51.43 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.752 0.821 . . . . 0.0 108.914 176.584 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.32 -63.59 1.14 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.28 0.632 . . . . 0.0 110.436 -174.196 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.98 -53.57 14.1 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.712 1.625 . . . . 0.0 112.411 174.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -62.14 -51.67 66.93 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.199 0.999 . . . . 0.0 110.925 -176.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 mm -55.63 -35.88 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.738 0.815 . . . . 0.0 110.537 173.598 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.01 -12.45 22.61 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.626 1.108 . . . . 0.0 114.006 173.656 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -87.94 -20.35 26.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.447 1.623 . . . . 0.0 109.914 172.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 131.78 45.82 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.714 1.245 . . . . 0.0 112.156 -172.644 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -50.06 107.29 0.15 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.551 170.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.7 -27.3 6.29 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-O 118.9 -0.945 . . . . 0.0 112.464 175.299 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 t -81.9 133.15 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.37 -41.97 5.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.342 0.519 . . . . 0.0 111.931 167.392 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.411 ' H ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -136.78 161.73 35.16 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.161 0.891 . . . . 0.0 110.006 -175.23 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 tt -152.68 146.99 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.95 0.9 . . . . 0.0 110.96 -176.489 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -144.84 102.27 3.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.579 1.952 . . . . 0.0 108.658 169.041 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.5 t -99.26 100.1 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.286 1.034 . . . . 0.0 110.089 177.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.0 m -89.12 77.53 7.55 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.92 0.888 . . . . 0.0 109.609 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.0 tp -53.61 -35.12 60.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.596 0.758 . . . . 0.0 110.334 177.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -38.71 -52.3 1.68 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.361 1.464 . . . . 0.0 111.325 167.138 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.28 -7.14 58.73 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.096 -173.152 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 63.56 17.1 10.14 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.969 2.108 . . . . 0.0 111.312 -172.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -139.61 145.29 38.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.79 1.236 . . . . 0.0 110.225 -170.229 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.03 147.79 46.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.401 0.68 . . . . 0.0 110.809 -167.336 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -130.15 110.81 11.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.99 1.716 . . . . 0.0 107.073 -167.44 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.21 171.46 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 33' ' ' ARG . 0.6 OUTLIER -141.65 123.76 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.096 0.862 . . . . 0.0 109.619 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -155.93 176.73 12.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.776 0.83 . . . . 0.0 110.711 -174.525 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -123.65 141.14 35.79 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.236 1.014 . . . . 0.0 112.367 175.289 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.39 81.04 1.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.151 3.234 . . . . 0.0 109.753 176.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 -51.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.5 0.72 . . . . 0.0 109.512 177.718 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.4 mt -86.72 -36.59 18.57 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -179.208 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.5 tp -109.4 149.5 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 m -86.64 32.91 0.64 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 122.912 0.485 . . . . 0.0 111.645 -174.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 68.55 -56.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 129.911 3.284 . . . . 0.0 111.641 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -96.21 -26.81 15.29 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 126.846 2.059 . . . . 0.0 110.689 -170.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -43.18 -48.46 6.46 Favored 'General case' 0 C--N 1.347 0.484 0 O-C-N 123.524 0.515 . . . . 0.0 110.723 177.596 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -47.24 -61.52 1.86 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 123.272 0.629 . . . . 0.0 111.267 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.24 -45.44 93.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.232 1.013 . . . . 0.0 110.395 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -57.19 -27.88 62.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.876 176.375 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -47.89 75.45 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 175.288 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.64 -45.01 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.563 -0.732 . . . . 0.0 109.604 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -54.74 -52.94 60.95 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 122.128 0.966 . . . . 0.0 108.796 176.011 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.69 -24.52 66.81 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.683 1.593 . . . . 0.0 113.416 -174.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.6 mmm -53.38 -35.11 59.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.26 0.937 . . . . 0.0 110.179 168.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.94 -30.48 2.56 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.59 1.091 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.93 127.98 60.07 Favored Pre-proline 0 N--CA 1.456 -0.154 0 CA-C-O 118.389 -0.815 . . . . 0.0 108.945 -173.554 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.92 129.14 26.36 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.061 1.841 . . . . 0.0 109.383 -178.571 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.46 165.71 24.55 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.622 0.725 . . . . 0.0 109.723 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -156.0 153.58 29.72 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.192 -0.942 . . . . 0.0 110.786 -161.218 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.456 -0.166 0 C-N-CA 124.01 0.924 . . . . 0.0 109.183 -171.594 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 t . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.02 130.36 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.29 1.036 . . . . 0.0 110.901 -177.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -123.97 152.32 42.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.732 1.613 . . . . 0.0 108.072 175.106 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.589 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.58 136.79 54.7 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.501 1.12 . . . . 0.0 109.063 174.874 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 ptp -126.4 143.1 51.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.8 1.64 . . . . 0.0 109.209 -177.186 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.26 131.39 34.74 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 167.345 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.12 84.55 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.293 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.84 161.6 30.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.428 0.632 . . . . 0.0 112.516 -174.169 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.334 0 C-N-CA 123.69 0.662 . . . . 0.0 113.739 176.058 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 C--O 1.221 -0.44 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.8 t -53.16 -41.92 65.63 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -172.721 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.6 m -48.27 -56.68 7.4 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.651 168.46 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.45 -49.16 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -53.28 -66.67 0.35 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.341 0.973 . . . . 0.0 110.593 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.25 -53.93 8.95 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.728 1.633 . . . . 0.0 112.396 176.36 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -57.55 -51.0 71.27 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 117.825 0.813 . . . . 0.0 110.317 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.1 mm -62.98 -28.61 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.216 0.607 . . . . 0.0 110.603 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.61 -17.07 8.08 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 118.705 -1.053 . . . . 0.0 114.207 169.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -87.43 -18.02 30.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 120.123 1.961 . . . . 0.0 111.093 174.721 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.3 136.0 56.74 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.068 0.937 . . . . 0.0 110.566 -171.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -68.46 119.69 13.34 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.642 -175.432 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.59 -20.14 23.09 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-O 118.824 -0.987 . . . . 0.0 112.937 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.77 136.66 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 118.669 1.234 . . . . 0.0 109.547 -177.169 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -100.98 -47.79 4.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.054 1.342 . . . . 0.0 110.181 174.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.97 161.04 43.02 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.42 0.554 . . . . 0.0 109.53 -178.127 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 tt -138.5 145.03 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.5 1.52 . . . . 0.0 109.234 177.043 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -138.7 106.89 5.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.223 2.209 . . . . 0.0 107.582 171.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.5 t -102.05 98.96 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.308 0.958 . . . . 0.0 110.335 176.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 m -88.31 82.16 7.11 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.288 1.035 . . . . 0.0 109.61 177.046 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -49.94 -43.69 50.12 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.58 0.752 . . . . 0.0 111.367 -179.581 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.63 -52.45 2.22 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 125.953 1.701 . . . . 0.0 111.204 170.342 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -82.71 -9.62 59.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.88 -172.032 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 64.04 20.43 12.19 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.323 1.849 . . . . 0.0 111.279 -178.085 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -144.23 141.71 30.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.208 1.403 . . . . 0.0 109.354 -169.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.65 151.77 44.49 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.902 0.881 . . . . 0.0 109.476 -178.345 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.1 m -124.52 119.57 29.5 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 127.105 2.162 . . . . 0.0 105.667 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.415 HG21 ' SD ' ' A' ' 57' ' ' MET . 58.3 mt -125.07 161.19 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.04 123.97 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.092 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -156.22 173.14 17.28 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.506 1.122 . . . . 0.0 109.238 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.51 146.85 51.12 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 170.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -71.66 75.99 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.757 3.638 . . . . 0.0 110.332 177.291 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -151.85 -54.67 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.821 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.5 mt -89.28 -22.47 22.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.669 -177.309 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' A' ' 56' ' ' GLU . 9.0 tp -121.47 149.46 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.785 0.834 . . . . 0.0 109.537 177.471 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.9 m -84.95 30.46 0.58 Allowed 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 123.491 0.717 . . . . 0.0 112.098 -175.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 72.1 -62.77 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 128.931 2.893 . . . . 0.0 108.568 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -84.92 -31.07 23.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.98 -171.517 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HB3' HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -43.96 -51.81 7.41 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 123.83 0.706 . . . . 0.0 110.965 -179.287 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.415 ' SD ' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -39.79 -61.11 0.88 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.061 1.344 . . . . 0.0 109.193 -179.977 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -44.86 88.08 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.027 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -54.4 -33.57 59.57 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.942 0.792 . . . . 0.0 112.913 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -59.75 -47.39 85.87 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.28 -48.93 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.912 174.127 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -53.59 -48.21 69.44 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.101 0.953 . . . . 0.0 109.042 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.13 -20.05 62.23 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.324 1.449 . . . . 0.0 113.546 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 79.9 mmm -62.43 -29.84 70.8 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.687 1.13 . . . . 0.0 109.933 170.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.93 -34.93 2.1 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.064 0.84 . . . . 0.0 111.046 177.209 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -82.07 112.76 38.23 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-O 117.482 -1.247 . . . . 0.0 108.201 -178.296 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -60.64 137.15 71.54 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.506 1.471 . . . . 0.0 108.888 -179.432 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.53 -162.98 0.98 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.839 0.456 . . . . 0.0 110.098 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -170.07 148.48 3.4 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.658 0.783 . . . . 0.0 111.226 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.563 0 C-N-CA 124.581 1.152 . . . . 0.0 108.283 177.026 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.6 t -79.27 140.48 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.491 1.116 . . . . 0.0 109.063 -177.606 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.55 HD22 ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -123.58 129.29 50.96 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 126.17 1.788 . . . . 0.0 106.989 173.679 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.55 ' N ' HD22 ' A' ' 5' ' ' LEU . 7.7 ttpt -108.82 130.44 55.4 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.806 0.691 . . . . 0.0 109.615 172.748 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -138.21 157.65 45.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.162 0.985 . . . . 0.0 110.989 -172.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.7 144.52 26.6 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 170.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 t -128.61 66.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.58 1.552 . . . . 0.0 107.485 175.539 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.77 173.44 12.48 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.293 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.193 0 CA-C-O 119.273 -0.737 . . . . 0.0 113.809 175.172 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.224 -0.283 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 m -55.81 -37.13 68.23 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -163.586 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.9 m -52.38 -56.56 14.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 168.704 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.29 -49.63 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.904 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -53.21 -64.03 0.95 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.122 0.963 . . . . 0.0 110.9 -177.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.84 -51.28 13.42 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.632 1.587 . . . . 0.0 112.902 174.643 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -60.54 -63.72 1.2 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.618 0.709 . . . . 0.0 109.866 -178.481 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -53.24 -40.06 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.071 1.348 . . . . 0.0 110.613 -179.62 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.81 -23.66 16.01 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.012 1.291 . . . . 0.0 113.568 177.168 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -88.67 -17.01 30.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 119.151 1.475 . . . . 0.0 111.147 178.142 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 134.6 53.38 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.472 1.13 . . . . 0.0 111.861 -172.755 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -52.73 107.18 0.2 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.137 176.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.29 -32.76 4.03 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-O 119.144 -0.809 . . . . 0.0 111.773 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.29 136.99 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 118.093 0.947 . . . . 0.0 109.283 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -103.2 -45.63 4.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.273 1.429 . . . . 0.0 110.478 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -153.66 160.22 42.3 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.82 -0.55 . . . . 0.0 110.004 -178.313 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.8 tt -141.01 140.02 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.331 1.452 . . . . 0.0 109.776 178.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -133.05 117.16 17.23 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.8 1.64 . . . . 0.0 107.782 165.784 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.2 t -108.61 107.61 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 124.491 1.117 . . . . 0.0 109.868 177.634 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -89.5 89.47 7.86 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.795 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.48 -45.93 69.8 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.381 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -41.84 -61.18 1.17 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 126.114 1.766 . . . . 0.0 110.709 171.184 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -75.38 -9.92 58.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.05 -174.563 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 67.28 6.79 5.06 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 127.313 2.245 . . . . 0.0 111.741 -174.339 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -119.88 144.11 47.57 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.331 1.853 . . . . 0.0 108.132 -171.593 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.01 155.14 48.53 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.37 0.668 . . . . 0.0 109.23 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 m -135.68 112.74 10.38 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 126.195 1.798 . . . . 0.0 106.521 -171.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.94 169.08 6.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -137.78 123.71 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.9 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -159.23 -178.33 7.11 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.105 1.362 . . . . 0.0 109.982 -173.862 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -130.6 150.35 76.09 Favored Pre-proline 0 C--N 1.347 0.499 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 164.301 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.45 74.81 0.55 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.698 3.599 . . . . 0.0 109.506 169.591 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -147.62 -61.86 0.27 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.859 1.264 . . . . 0.0 107.617 -177.227 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.5 mt -91.98 -21.63 20.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.126 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 52' ' ' ILE . 11.3 tp -121.52 146.86 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.095 0.958 . . . . 0.0 108.637 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.4 m -82.39 31.93 0.4 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 119.378 0.99 . . . . 0.0 113.03 -174.032 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.252 0.5 OUTLIER 72.64 -62.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 127.876 2.47 . . . . 0.0 108.01 -177.082 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -86.43 -28.09 23.74 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.89 -170.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -46.54 -44.89 18.23 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.36 0.527 . . . . 0.0 110.779 177.71 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.9 -69.22 0.14 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.22 1.408 . . . . 0.0 109.954 173.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -41.97 97.58 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.64 -0.663 . . . . 0.0 110.756 -177.671 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -59.61 -24.79 64.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.959 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.91 -39.92 96.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.646 1.112 . . . . 0.0 109.074 173.346 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.88 -49.42 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -54.18 -46.12 72.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.716 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.04 -19.44 64.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.813 1.645 . . . . 0.0 114.371 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.2 mmm -59.82 -28.69 67.68 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 120.243 1.383 . . . . 0.0 109.602 168.923 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.08 -25.89 4.83 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.445 1.021 . . . . 0.0 110.791 175.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -75.38 123.65 88.73 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.074 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.73 111.37 1.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.064 1.843 . . . . 0.0 109.273 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.9 -174.46 2.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.435 1.094 . . . . 0.0 108.27 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -169.65 146.21 3.25 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.722 0.692 . . . . 0.0 112.383 -167.073 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.453 -0.28 0 C-N-CA 125.15 1.38 . . . . 0.0 109.352 178.147 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.7 t -77.05 153.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.045 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.55 HD11 ' CG2' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -138.47 135.83 35.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.374 -1.714 . . . . 0.0 106.374 173.271 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -111.7 135.13 52.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.131 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -143.14 143.14 31.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.599 0.76 . . . . 0.0 110.883 -176.829 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -75.75 147.42 39.31 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 166.12 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.28 48.6 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 126.014 1.726 . . . . 0.0 108.725 178.139 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -58.4 142.96 46.86 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.782 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.802 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.0 171.89 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.3 t -55.07 -41.62 71.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 119.084 0.856 . . . . 0.0 112.361 -166.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.1 m -45.13 -60.1 2.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.431 0.693 . . . . 0.0 112.245 165.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mp -57.72 -48.56 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 124.028 0.931 . . . . 0.0 109.152 178.328 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -56.97 -62.5 1.7 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.492 1.139 . . . . 0.0 109.445 -174.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.12 -56.02 8.18 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.302 1.429 . . . . 0.0 112.304 173.716 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -61.56 -50.36 72.94 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.871 0.836 . . . . 0.0 110.911 -176.239 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.41 -34.0 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 124.079 0.952 . . . . 0.0 110.539 177.849 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.67 -17.56 6.77 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.926 -0.93 . . . . 0.0 114.812 170.766 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -86.89 -18.08 31.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.793 1.797 . . . . 0.0 110.816 176.147 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.7 141.78 48.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.949 0.881 . . . . 0.0 112.243 -168.657 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -59.13 117.55 4.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.929 0.892 . . . . 0.0 111.04 175.676 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.79 -24.99 12.27 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.269 173.472 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.96 142.5 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -108.84 -45.85 3.73 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.134 1.374 . . . . 0.0 109.455 172.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -154.01 162.83 40.91 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.466 -0.771 . . . . 0.0 110.305 177.041 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.7 tt -145.99 138.03 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 124.505 1.122 . . . . 0.0 109.137 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -130.53 117.88 20.26 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.628 1.971 . . . . 0.0 106.781 172.496 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.415 HG22 ' CB ' ' A' ' 43' ' ' ALA . 75.1 t -117.24 114.93 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.067 1.303 . . . . 0.0 109.474 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.1 t -90.22 106.54 18.55 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.921 -0.487 . . . . 0.0 109.829 -179.081 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.544 HD13 ' N ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -48.76 -48.52 40.84 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 164.686 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.544 ' N ' HD13 ' A' ' 38' ' ' LEU . 3.4 m-20 -56.3 -59.55 4.78 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.035 0.534 . . . . 0.0 111.029 -178.316 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -74.6 -21.4 59.49 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.231 1.015 . . . . 0.0 110.723 -170.568 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 62.63 19.73 11.53 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.181 1.792 . . . . 0.0 110.36 -172.326 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -120.54 156.04 32.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.303 1.841 . . . . 0.0 108.286 175.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -140.47 154.38 46.6 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.463 1.105 . . . . 0.0 109.011 -178.153 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.8 m -125.64 111.55 15.1 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -177.64 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 78.5 mt -98.99 161.0 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 171.283 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 p -124.42 121.17 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 162.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.457 ' CE2' HD13 ' A' ' 5' ' ' LEU . 14.1 p90 -157.06 176.41 12.79 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.84 1.656 . . . . 0.0 108.72 -178.017 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.08 150.5 74.44 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 120.735 1.607 . . . . 0.0 113.734 169.641 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.67 72.3 1.41 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 124.745 3.63 . . . . 0.0 110.145 176.894 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -143.59 -60.12 0.41 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.302 1.041 . . . . 0.0 108.579 177.097 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.6 mt -88.18 -21.32 24.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.656 179.687 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.59 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.6 tp -120.86 148.67 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.124 0.57 . . . . 0.0 110.053 178.875 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.1 m -83.33 26.57 0.64 Allowed 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.272 0.5 OUTLIER 71.38 -61.14 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 128.913 2.885 . . . . 0.0 110.063 177.514 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -43.16 71.56 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.492 1.117 . . . . 0.0 108.863 179.374 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.6 mt-10 -44.67 -51.61 9.01 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 123.542 0.526 . . . . 0.0 111.28 -173.084 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.06 -52.64 5.25 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.225 0.61 . . . . 0.0 111.986 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -46.37 73.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 122.095 -0.378 . . . . 0.0 110.452 178.356 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -59.6 -28.82 67.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.136 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -61.31 -46.1 91.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 173.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.9 -48.42 88.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.32 173.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -51.32 -50.89 58.52 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.332 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.65 -19.43 49.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.5 1.92 . . . . 0.0 114.678 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.9 mmt -57.7 -32.15 67.09 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 120.106 1.321 . . . . 0.0 109.595 170.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.18 43.27 0.33 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.448 1.023 . . . . 0.0 110.844 173.472 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -145.11 121.53 6.07 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.547 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.78 94.37 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.605 2.203 . . . . 0.0 109.738 -175.468 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.97 -172.46 2.08 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.362 1.065 . . . . 0.0 108.637 -172.383 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.24 132.35 2.47 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 118.503 0.592 . . . . 0.0 112.381 -175.356 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.55 ' CG2' HD11 ' A' ' 5' ' ' LEU . 9.7 p . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 123.172 0.589 . . . . 0.0 110.168 174.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.31 138.95 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 124.442 1.097 . . . . 0.0 108.775 173.306 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.411 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -124.34 130.66 52.89 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.465 1.506 . . . . 0.0 107.074 175.002 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -101.21 116.78 33.61 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.615 1.566 . . . . 0.0 108.196 170.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.8 ptp -119.54 135.96 54.55 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.842 0.857 . . . . 0.0 110.339 178.459 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -74.95 153.93 38.35 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 167.655 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.25 72.85 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 176.843 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -62.55 166.89 4.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.717 0.77 . . . . 0.0 111.386 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 174.59 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.409 HG22 HD23 ' A' ' 38' ' ' LEU . 19.1 p . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.7 t -53.58 -41.64 66.78 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -175.554 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.6 m -49.36 -57.6 6.61 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.608 170.123 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.26 -49.48 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.251 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.84 -64.22 0.98 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.088 0.947 . . . . 0.0 110.02 -175.013 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.34 -53.69 9.29 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.931 1.729 . . . . 0.0 112.584 174.419 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -58.3 8.38 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.874 0.837 . . . . 0.0 109.658 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.3 -33.23 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.779 1.231 . . . . 0.0 111.044 -176.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.49 -21.43 13.67 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.329 0.966 . . . . 0.0 114.013 173.147 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -85.1 -19.71 31.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.747 1.773 . . . . 0.0 111.372 176.624 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.65 137.17 49.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 122.231 1.015 . . . . 0.0 111.932 -166.635 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -52.91 113.4 1.08 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.86 177.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.34 -26.52 8.59 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-O 119.072 -0.849 . . . . 0.0 112.323 175.173 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.2 t -79.57 131.17 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 118.214 1.007 . . . . 0.0 109.18 -176.817 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -91.54 -55.7 3.4 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.896 0.879 . . . . 0.0 109.185 168.495 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.35 159.09 43.58 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.535 1.061 . . . . 0.0 109.788 -175.588 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -140.1 140.78 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.403 1.481 . . . . 0.0 110.107 176.333 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.05 124.51 31.02 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.576 1.55 . . . . 0.0 107.931 168.136 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.9 t -110.13 89.46 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.846 1.203 . . . . 0.0 110.89 177.095 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -76.88 78.08 3.46 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.686 1.194 . . . . 0.0 110.427 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -45.78 -41.6 11.05 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.483 0.713 . . . . 0.0 111.962 178.744 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.57 -54.38 1.16 Allowed 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 126.453 1.901 . . . . 0.0 111.379 170.334 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -84.95 -10.54 56.95 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.466 -171.883 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 61.92 21.0 11.96 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.325 1.45 . . . . 0.0 110.326 -174.113 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -136.86 144.21 43.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.624 1.57 . . . . 0.0 108.885 -172.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.49 149.56 48.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.932 1.293 . . . . 0.0 108.727 179.477 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.5 m -120.69 115.28 23.04 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -176.586 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 86.8 mt -107.32 159.97 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 171.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.72 125.79 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 167.371 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -155.42 -177.24 6.41 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 126.447 1.899 . . . . 0.0 107.749 -175.409 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -138.02 144.5 43.99 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 120.112 1.324 . . . . 0.0 110.559 167.271 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.48 77.28 0.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.071 3.18 . . . . 0.0 110.025 176.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -149.17 -53.44 0.17 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.884 0.873 . . . . 0.0 109.13 174.611 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -88.19 -25.14 23.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.12 0.568 . . . . 0.0 110.843 176.352 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.406 HD11 ' HB3' ' A' ' 56' ' ' GLU . 9.8 tp -118.95 147.43 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.012 0.925 . . . . 0.0 109.648 178.76 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.4 m -83.47 24.27 0.85 Allowed 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.673 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.256 0.5 OUTLIER 72.61 -59.85 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 127.871 2.468 . . . . 0.0 109.86 179.884 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.31 -35.85 40.5 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.211 1.804 . . . . 0.0 109.78 -175.353 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.406 ' HB3' HD11 ' A' ' 52' ' ' ILE . 5.5 mt-10 -42.22 -53.76 3.95 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 123.538 0.735 . . . . 0.0 111.458 177.447 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.89 -49.04 5.91 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.388 1.075 . . . . 0.0 112.087 -176.729 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -49.33 38.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.1 -0.375 . . . . 0.0 110.999 174.619 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -53.98 -30.04 45.44 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.044 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -57.29 -52.03 67.0 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.388 0.613 . . . . 0.0 109.525 172.069 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -58.19 -49.91 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.453 173.293 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -52.98 -48.35 67.52 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.452 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.56 -21.62 60.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.379 1.472 . . . . 0.0 114.036 179.518 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 29.4 mmt -64.17 -30.02 71.1 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.869 1.213 . . . . 0.0 110.526 172.177 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.37 -33.11 2.19 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 176.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -73.51 107.51 3.49 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-O 117.776 -1.107 . . . . 0.0 108.732 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.75 118.91 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 108.071 -1.55 . . . . 0.0 108.071 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.08 -167.39 1.54 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.254 0.479 . . . . 0.0 110.404 -174.349 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -160.1 151.09 19.12 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -175.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.5 t . . . . . 0 C--N 1.339 0.135 0 C-N-CA 126.65 1.98 . . . . 0.0 108.834 179.035 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.85 145.92 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 123.163 0.585 . . . . 0.0 109.984 177.467 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.66 HD21 HG22 ' A' ' 70' ' ' VAL . 1.4 tm? -141.94 138.38 31.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.698 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.548 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -122.1 116.39 24.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.309 1.444 . . . . 0.0 107.684 -173.769 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -121.79 149.9 42.64 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.841 1.256 . . . . 0.0 110.893 -172.379 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -98.95 132.62 44.13 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.835 1.654 . . . . 0.0 108.129 177.139 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.14 64.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.372 1.069 . . . . 0.0 110.218 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.93 153.18 41.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.823 179.09 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.037 174.895 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.4 p . . . . . 0 C--O 1.222 -0.343 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.6 m -54.12 -36.73 63.58 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -170.751 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -52.18 -57.86 8.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.103 0.252 . . . . 0.0 111.125 169.172 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.1 -54.28 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.203 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -57.65 -65.02 0.7 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.631 0.729 . . . . 0.0 110.746 -172.314 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.48 -53.55 12.25 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.726 1.631 . . . . 0.0 111.98 176.845 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -64.21 -50.62 67.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.112 0.956 . . . . 0.0 110.563 -176.293 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.6 mm -54.99 -39.2 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 123.406 0.682 . . . . 0.0 110.629 175.603 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.11 -20.18 13.97 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.016 1.293 . . . . 0.0 113.978 173.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -92.38 -19.42 22.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 118.987 1.393 . . . . 0.0 109.593 178.737 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.34 134.3 50.07 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.815 1.293 . . . . 0.0 111.816 -176.101 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.57 110.84 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.522 176.273 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.3 -25.83 7.25 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 119.085 -0.842 . . . . 0.0 112.219 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.24 136.02 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 118.382 1.091 . . . . 0.0 109.002 -178.824 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -107.89 -43.75 4.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.244 1.018 . . . . 0.0 110.736 175.17 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -155.79 161.14 40.71 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.772 0.715 . . . . 0.0 110.324 177.489 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 tt -141.01 144.68 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.896 1.278 . . . . 0.0 110.421 -176.548 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.02 98.82 3.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.329 1.852 . . . . 0.0 108.727 172.26 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -92.19 112.24 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.381 1.072 . . . . 0.0 110.042 176.382 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 m -94.98 90.96 6.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.705 1.202 . . . . 0.0 108.877 173.913 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 38' ' ' LEU . 5.7 mt -57.91 177.44 0.11 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.223 162.654 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.23 -61.3 0.39 Allowed 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 127.88 2.472 . . . . 0.0 109.45 -167.352 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -68.23 -17.75 64.39 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.989 0.423 . . . . 0.0 111.22 -177.32 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 67.21 41.83 2.45 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 127.332 2.253 . . . . 0.0 110.613 -178.706 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -144.27 141.93 30.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.827 -166.21 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.18 150.8 44.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.466 -0.771 . . . . 0.0 109.843 -177.083 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -130.51 121.52 25.93 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -176.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 mp -126.44 159.87 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 124.744 1.218 . . . . 0.0 108.271 -175.544 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.3 p -129.39 118.57 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.512 0.725 . . . . 0.0 109.597 178.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -159.19 -178.98 7.59 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.677 1.591 . . . . 0.0 109.864 -172.738 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -148.06 144.56 19.07 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HB3' HG23 ' A' ' 54' ' ' VAL . 49.7 Cg_endo -67.94 77.85 0.58 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.295 3.33 . . . . 0.0 110.684 175.424 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.57 -54.45 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.941 1.296 . . . . 0.0 107.586 168.218 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.7 mt -94.78 -21.37 18.76 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.843 -0.599 . . . . 0.0 111.91 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.2 tp -120.87 145.97 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.047 0.939 . . . . 0.0 109.554 -177.873 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 m -74.0 24.56 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.125 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 49' ' ' PRO . 0.8 OUTLIER 73.28 -58.07 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 127.249 2.22 . . . . 0.0 109.626 -177.885 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -80.93 -42.35 21.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.445 1.498 . . . . 0.0 109.647 -174.74 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.445 ' HB3' HD11 ' A' ' 52' ' ' ILE . 7.3 mt-10 -41.16 -51.04 3.51 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.882 0.873 . . . . 0.0 111.87 -174.516 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -40.31 -59.91 1.19 Allowed 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.217 1.407 . . . . 0.0 111.464 -178.303 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 tptp -73.93 -43.61 57.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -57.49 -26.91 62.0 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.149 -0.969 . . . . 0.0 112.313 -174.151 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.96 -41.81 88.36 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.031 0.832 . . . . 0.0 109.128 174.102 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -62.83 -33.97 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.179 176.496 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -61.39 -52.66 63.67 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.48 -31.84 64.43 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.206 1.002 . . . . 0.0 112.716 -174.811 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.9 mmm -51.27 -36.34 41.69 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.479 0.582 . . . . 0.0 111.43 171.383 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.29 -36.79 1.45 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.285 0.945 . . . . 0.0 111.281 176.666 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -68.01 115.29 26.93 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.263 -173.482 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.76 101.49 0.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.428 2.085 . . . . 0.0 108.815 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.09 168.42 19.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -168.32 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.68 148.5 39.2 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.324 -0.86 . . . . 0.0 112.549 -166.077 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.66 HG22 HD21 ' A' ' 5' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.662 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.437 -1.12 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.5 t -79.6 145.67 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 124.83 1.252 . . . . 0.0 109.801 -178.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.53 HD11 HG22 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -137.54 149.42 46.72 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 126.138 1.775 . . . . 0.0 107.845 176.778 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.76 144.85 31.18 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.276 0.943 . . . . 0.0 111.71 155.86 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -126.89 153.72 45.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.116 1.766 . . . . 0.0 108.94 175.979 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -114.81 138.94 50.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.325 1.05 . . . . 0.0 108.529 177.224 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.04 68.86 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.857 0.863 . . . . 0.0 110.988 -172.275 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -68.29 165.96 17.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.103 0.478 . . . . 0.0 110.261 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 O-C-N 121.604 -0.685 . . . . 0.0 114.063 168.958 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 m -54.02 -37.13 63.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -168.456 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.8 m -50.06 -61.31 2.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.568 0.542 . . . . 0.0 111.246 168.273 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.6 -50.81 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.437 ' HA ' HG21 ' A' ' 34' ' ' ILE . 47.7 mt-10 -56.45 -67.59 0.29 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.129 0.966 . . . . 0.0 110.891 -174.949 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.68 -49.87 26.76 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.097 1.808 . . . . 0.0 112.124 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -62.62 -52.17 64.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.872 0.836 . . . . 0.0 109.62 -178.525 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.417 HD12 ' CE ' ' A' ' 57' ' ' MET . 18.0 mm -55.57 -36.28 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.183 0.593 . . . . 0.0 111.202 175.362 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.51 -19.13 11.96 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.738 -1.034 . . . . 0.0 113.807 175.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -90.25 -18.98 24.69 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 119.653 1.726 . . . . 0.0 111.16 176.761 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.12 133.85 47.56 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.659 1.219 . . . . 0.0 112.39 -170.267 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -52.62 106.34 0.15 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.449 176.731 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.69 -30.74 4.57 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-O 119.475 -0.625 . . . . 0.0 111.917 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 t -82.8 140.61 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 117.691 0.745 . . . . 0.0 109.552 -173.222 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -111.25 -41.87 4.06 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.947 0.899 . . . . 0.0 111.689 174.656 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.45 159.23 43.4 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.822 -0.549 . . . . 0.0 109.704 -179.433 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 22' ' ' GLU . 9.2 tt -146.59 145.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.59 1.556 . . . . 0.0 107.704 173.999 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -136.56 109.17 7.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.104 2.161 . . . . 0.0 106.465 173.63 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -102.44 120.28 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.916 1.235 . . . . 0.0 109.191 175.553 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 t -105.91 90.48 3.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.169 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -46.13 67.02 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.356 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -56.95 2.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.968 1.707 . . . . 0.0 110.755 170.192 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -17.75 60.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.032 -175.298 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 73.12 2.53 4.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.837 2.455 . . . . 0.0 112.052 -175.822 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -111.24 151.57 28.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.406 1.882 . . . . 0.0 109.699 -179.274 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.485 ' HB3' ' SD ' ' A' ' 7' ' ' MET . . . -127.04 160.2 31.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 163.268 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.8 m -119.96 128.03 53.2 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 175.74 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.401 HG21 ' SD ' ' A' ' 57' ' ' MET . 16.0 mt -122.74 162.84 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -135.77 117.88 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.27 0.628 . . . . 0.0 110.277 177.107 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.28 -179.32 8.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.141 1.376 . . . . 0.0 110.043 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -135.71 149.77 69.97 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.209 1.004 . . . . 0.0 113.05 177.833 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.09 67.88 7.99 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.374 3.382 . . . . 0.0 109.928 -176.026 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 -55.99 0.26 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.865 0.866 . . . . 0.0 109.223 177.071 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.92 -29.03 35.62 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.048 -0.501 . . . . 0.0 109.811 -177.807 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.7 tp -118.93 145.4 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 123.433 0.693 . . . . 0.0 109.403 -178.16 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.9 m -81.67 33.83 0.38 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -174.314 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 74.36 -61.68 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 128.065 2.546 . . . . 0.0 108.262 175.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.43 -40.17 23.79 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 124.483 1.113 . . . . 0.0 109.758 -174.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.417 ' HB3' HD11 ' A' ' 52' ' ' ILE . 14.9 mt-10 -40.48 -48.54 2.8 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 123.888 0.743 . . . . 0.0 111.413 -174.465 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.417 ' CE ' HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -34.78 -65.5 0.21 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.862 1.665 . . . . 0.0 110.872 174.385 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -75.98 -41.88 50.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.671 -0.643 . . . . 0.0 112.185 178.48 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -58.31 -22.29 52.43 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.845 -174.502 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -62.65 -42.08 99.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.766 0.712 . . . . 0.0 109.351 173.056 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.75 -49.68 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.102 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -54.45 -44.72 72.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.78 -22.66 62.46 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.82 1.248 . . . . 0.0 114.144 176.613 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.0 mmt -66.34 -28.62 68.8 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.145 1.338 . . . . 0.0 110.586 170.532 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.21 -42.71 1.28 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -62.31 110.95 3.82 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.901 0.88 . . . . 0.0 110.824 -173.581 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.99 96.69 0.7 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.54 2.16 . . . . 0.0 109.575 -175.33 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.74 -161.17 0.75 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.948 0.899 . . . . 0.0 109.51 -174.611 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -162.56 146.51 11.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.367 0.531 . . . . 0.0 112.179 -177.547 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.53 HG22 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 C-N-CA 125.57 1.548 . . . . 0.0 108.531 174.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.44 175.77 10.26 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 124.874 0.985 . . . . 0.0 111.097 -171.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.54 136.9 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.624 1.169 . . . . 0.0 108.373 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.08 148.11 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.24 0.616 . . . . 0.0 110.113 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.627 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -139.48 141.8 37.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 171.379 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 130.65 56.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -121.53 151.74 39.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.244 1.818 . . . . 0.0 108.842 -176.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -95.37 136.92 35.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.41 67.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -70.26 170.15 12.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.811 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.7 -42.94 2.76 Favored Glycine 0 CA--C 1.529 0.926 0 O-C-N 121.248 -0.908 . . . . 0.0 113.504 170.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.1 mtt -58.46 -52.52 65.3 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.574 1.187 . . . . 0.0 111.306 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.5 t 46.92 24.13 0.33 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.475 1.91 . . . . 0.0 115.246 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -149.87 132.95 16.26 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -74.91 56.83 0.76 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.037 1.335 . . . . 0.0 111.018 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -149.67 21.2 0.91 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.101 0.96 . . . . 0.0 110.211 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.15 63.36 1.1 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p -121.3 -78.01 0.59 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.3 t -52.21 -43.59 64.33 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.9 m -46.43 -60.24 2.47 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.655 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -48.79 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -57.24 -63.87 1.08 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.975 0.893 . . . . 0.0 110.085 -174.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.56 -54.96 8.39 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.826 1.679 . . . . 0.0 112.778 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -56.83 -56.61 19.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.179 0.989 . . . . 0.0 109.7 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.86 -28.29 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 110.51 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.51 -24.41 7.46 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.757 1.17 . . . . 0.0 114.306 170.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -87.55 -11.16 49.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 119.826 1.813 . . . . 0.0 111.381 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 139.09 55.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.796 0.808 . . . . 0.0 110.77 -171.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 115.73 4.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.386 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.54 -19.75 23.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.576 -1.124 . . . . 0.0 112.445 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.84 139.19 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 118.853 1.326 . . . . 0.0 109.79 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.8 -39.05 3.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.659 1.184 . . . . 0.0 110.74 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -149.73 156.78 42.44 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.795 -0.566 . . . . 0.0 109.852 172.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -137.2 145.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.565 1.546 . . . . 0.0 108.204 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -138.44 114.85 10.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.719 1.607 . . . . 0.0 107.008 166.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -102.61 129.9 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.129 0.877 . . . . 0.0 109.995 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.1 t -115.89 86.65 2.52 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.505 1.122 . . . . 0.0 108.119 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -39.07 69.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.386 -0.34 . . . . 0.0 110.374 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.93 -58.51 2.74 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.01 1.324 . . . . 0.0 110.694 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -79.09 -10.2 59.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.789 0.804 . . . . 0.0 110.456 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.83 24.41 13.74 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.101 1.761 . . . . 0.0 109.552 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -142.83 157.94 44.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.681 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HB3' ' SD ' ' A' ' 7' ' ' MET . . . -150.13 155.99 40.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -171.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.7 m -128.82 121.87 29.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.459 ' HB ' HD12 ' A' ' 5' ' ' LEU . 49.0 mt -118.73 155.17 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.38 126.48 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -156.77 179.86 8.88 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.673 1.589 . . . . 0.0 109.536 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.86 142.43 45.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.11 74.71 2.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.16 3.24 . . . . 0.0 110.125 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.36 -57.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.137 1.375 . . . . 0.0 107.452 176.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.54 -19.85 30.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.144 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.8 tp -128.32 152.3 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 111.074 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -89.62 27.56 1.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.917 0.887 . . . . 0.0 112.783 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 t 72.28 -60.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 128.147 2.579 . . . . 0.0 109.501 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.4 -35.98 30.07 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.797 1.239 . . . . 0.0 109.873 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -46.55 -46.62 19.49 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.659 0.599 . . . . 0.0 110.89 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.25 -52.57 1.48 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.583 1.153 . . . . 0.0 113.159 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -46.13 63.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 109.801 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -57.71 -29.09 64.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.452 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -63.53 -41.95 98.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.625 -0.672 . . . . 0.0 109.29 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.83 -44.99 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.389 174.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -53.28 -46.4 69.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.57 43.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.064 1.346 . . . . 0.0 113.495 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -64.04 -28.05 69.53 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.238 0.926 . . . . 0.0 110.459 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.39 -34.88 2.36 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.73 118.82 74.12 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.311 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.13 107.92 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.192 1.928 . . . . 0.0 109.089 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.95 -168.15 1.62 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.881 1.273 . . . . 0.0 108.394 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -164.15 161.05 22.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.908 -0.495 . . . . 0.0 111.755 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -98.62 119.43 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 110.378 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -98.57 -61.01 1.43 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.989 -0.444 . . . . 0.0 111.077 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -101.93 179.31 4.37 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.639 0.775 . . . . 0.0 109.4 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.52 177.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 124.807 1.243 . . . . 0.0 107.796 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.4 151.09 41.3 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.22 172.79 39.06 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 172.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 . . . . . 0 C--O 1.254 1.319 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 171.746 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.44 175.77 10.26 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 124.874 0.985 . . . . 0.0 111.097 -171.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.54 136.9 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.624 1.169 . . . . 0.0 108.373 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.08 148.11 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.24 0.616 . . . . 0.0 110.113 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.627 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -139.48 141.8 37.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 171.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 130.65 56.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -121.53 151.74 39.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.244 1.818 . . . . 0.0 108.842 -176.111 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -95.37 136.92 35.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.41 67.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -70.26 170.15 12.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.811 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.7 -42.94 2.76 Favored Glycine 0 CA--C 1.529 0.926 0 O-C-N 121.248 -0.908 . . . . 0.0 113.504 170.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.1 mtt -58.46 -52.52 65.3 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.574 1.187 . . . . 0.0 111.306 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.5 t 46.92 24.13 0.33 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.475 1.91 . . . . 0.0 115.246 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -149.87 132.95 16.26 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -74.91 56.83 0.76 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.037 1.335 . . . . 0.0 111.018 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -149.67 21.2 0.91 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.101 0.96 . . . . 0.0 110.211 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.15 63.36 1.1 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p -121.3 -78.01 0.59 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.3 t -52.21 -43.59 64.33 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.9 m -46.43 -60.24 2.47 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.655 169.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -48.79 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -57.24 -63.87 1.08 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.975 0.893 . . . . 0.0 110.085 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.56 -54.96 8.39 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.826 1.679 . . . . 0.0 112.778 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -56.83 -56.61 19.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.179 0.989 . . . . 0.0 109.7 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.86 -28.29 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 110.51 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.51 -24.41 7.46 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.757 1.17 . . . . 0.0 114.306 170.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -87.55 -11.16 49.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 119.826 1.813 . . . . 0.0 111.381 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 139.09 55.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.796 0.808 . . . . 0.0 110.77 -171.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 115.73 4.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.386 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.54 -19.75 23.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.576 -1.124 . . . . 0.0 112.445 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.84 139.19 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 118.853 1.326 . . . . 0.0 109.79 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.8 -39.05 3.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.659 1.184 . . . . 0.0 110.74 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -149.73 156.78 42.44 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.795 -0.566 . . . . 0.0 109.852 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -137.2 145.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.565 1.546 . . . . 0.0 108.204 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -138.44 114.85 10.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.719 1.607 . . . . 0.0 107.008 166.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -102.61 129.9 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.129 0.877 . . . . 0.0 109.995 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.1 t -115.89 86.65 2.52 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.505 1.122 . . . . 0.0 108.119 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -39.07 69.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.386 -0.34 . . . . 0.0 110.374 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.93 -58.51 2.74 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.01 1.324 . . . . 0.0 110.694 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -79.09 -10.2 59.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.789 0.804 . . . . 0.0 110.456 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.83 24.41 13.74 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.101 1.761 . . . . 0.0 109.552 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -142.83 157.94 44.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.681 -166.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HB3' ' SD ' ' A' ' 7' ' ' MET . . . -150.13 155.99 40.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -171.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.7 m -128.82 121.87 29.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.459 ' HB ' HD12 ' A' ' 5' ' ' LEU . 49.0 mt -118.73 155.17 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.38 126.48 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -156.77 179.86 8.88 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.673 1.589 . . . . 0.0 109.536 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.86 142.43 45.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.11 74.71 2.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.16 3.24 . . . . 0.0 110.125 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.36 -57.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.137 1.375 . . . . 0.0 107.452 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.54 -19.85 30.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.144 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.8 tp -128.32 152.3 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 111.074 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -89.62 27.56 1.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.917 0.887 . . . . 0.0 112.783 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 t 72.28 -60.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 128.147 2.579 . . . . 0.0 109.501 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.4 -35.98 30.07 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.797 1.239 . . . . 0.0 109.873 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -46.55 -46.62 19.49 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.659 0.599 . . . . 0.0 110.89 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.25 -52.57 1.48 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.583 1.153 . . . . 0.0 113.159 173.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -46.13 63.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 109.801 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -57.71 -29.09 64.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.452 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -63.53 -41.95 98.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.625 -0.672 . . . . 0.0 109.29 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.83 -44.99 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.389 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -53.28 -46.4 69.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.57 43.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.064 1.346 . . . . 0.0 113.495 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -64.04 -28.05 69.53 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.238 0.926 . . . . 0.0 110.459 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.39 -34.88 2.36 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.73 118.82 74.12 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.311 -175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.13 107.92 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.192 1.928 . . . . 0.0 109.089 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.95 -168.15 1.62 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.881 1.273 . . . . 0.0 108.394 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -164.15 161.05 22.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.908 -0.495 . . . . 0.0 111.755 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -98.62 119.43 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 110.378 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -98.57 -61.01 1.43 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.989 -0.444 . . . . 0.0 111.077 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -101.93 179.31 4.37 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.639 0.775 . . . . 0.0 109.4 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.52 177.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 124.807 1.243 . . . . 0.0 107.796 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.4 151.09 41.3 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.22 172.79 39.06 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 . . . . . 0 C--O 1.254 1.319 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 171.746 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.092 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 32.4 mp0 -70.31 -178.36 1.68 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.797 2.039 . . . . 0.0 109.334 163.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.0 t -116.6 136.96 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 126.263 1.825 . . . . 0.0 108.381 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.64 133.83 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 123.99 0.916 . . . . 0.0 108.593 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.562 HD12 ' HB ' ' A' ' 73' ' ' ILE . 2.5 tt -113.21 148.15 36.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.366 1.466 . . . . 0.0 108.21 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.97 123.02 46.97 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 161.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.429 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 12.3 ptt? -115.44 163.05 16.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.233 1.013 . . . . 0.0 109.585 169.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -108.72 131.3 55.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.988 2.115 . . . . 0.0 106.408 170.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.05 60.32 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 126.523 1.929 . . . . 0.0 106.869 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -58.77 133.38 55.91 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.14 -45.36 1.33 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.107 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.5 mmt -77.48 69.1 3.69 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.026 1.413 . . . . 0.0 109.266 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 t -121.5 0.62 9.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.953 1.301 . . . . 0.0 111.802 -173.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.5 m -77.39 -81.48 0.09 Allowed 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.594 -0.691 . . . . 0.0 111.01 -173.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -170.62 130.9 0.87 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.432 ' H ' HD11 ' A' ' 38' ' ' LEU . 35.2 t 55.79 51.1 12.88 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.639 1.575 . . . . 0.0 112.949 174.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 m -125.64 53.84 1.53 Allowed 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.266 1.427 . . . . 0.0 107.924 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.7 p -135.59 -69.61 0.49 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.709 1.204 . . . . 0.0 108.253 -172.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 p -53.43 -43.42 67.99 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.7 m -42.01 -62.53 0.9 Allowed 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.921 0.888 . . . . 0.0 112.19 165.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.99 -48.93 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 123.908 0.883 . . . . 0.0 108.932 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -57.25 -61.07 2.73 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.47 1.128 . . . . 0.0 109.332 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.76 -53.95 19.61 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.754 1.645 . . . . 0.0 112.308 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.5 -52.55 65.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.017 0.909 . . . . 0.0 110.068 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 34' ' ' ILE . 23.3 mm -57.54 -31.82 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.708 1.203 . . . . 0.0 111.116 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.13 -18.87 10.0 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.753 -1.026 . . . . 0.0 114.227 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -86.81 -11.79 49.9 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.637 1.719 . . . . 0.0 111.095 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 135.82 45.85 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 122.269 1.033 . . . . 0.0 111.748 -170.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -57.74 110.37 0.88 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.85 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.13 -24.11 9.51 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 119.251 -0.749 . . . . 0.0 112.661 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 t -80.01 136.08 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 118.213 1.007 . . . . 0.0 109.245 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -107.14 -38.83 5.89 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.703 1.201 . . . . 0.0 110.442 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.59 167.34 30.42 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.218 -0.926 . . . . 0.0 110.62 172.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 25' ' ' ILE . 13.9 tt -150.91 144.43 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.276 1.03 . . . . 0.0 108.561 177.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -129.58 129.62 44.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.898 1.679 . . . . 0.0 106.518 167.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.82 123.42 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.581 1.082 . . . . 0.0 110.982 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.5 t -81.25 158.98 24.63 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.107 0.563 . . . . 0.0 110.045 174.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.432 HD11 ' H ' ' A' ' 16' ' ' SER . 1.5 mt -95.87 -67.93 0.83 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 163.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.08 -54.65 8.16 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 126.193 1.797 . . . . 0.0 110.678 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -77.64 -18.74 56.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.252 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 55.06 18.82 2.47 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 127.146 2.178 . . . . 0.0 111.409 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -101.05 152.12 20.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.596 1.558 . . . . 0.0 107.933 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -148.04 152.52 37.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.846 -0.534 . . . . 0.0 109.866 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 m -130.35 115.73 17.32 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -171.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.88 157.99 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.32 116.57 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 167.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.446 ' OH ' HD13 ' A' ' 5' ' ' LEU . 40.8 p90 -159.07 178.69 9.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.425 1.49 . . . . 0.0 109.549 -173.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -138.97 149.62 62.25 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.31 75.52 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.229 3.286 . . . . 0.0 109.936 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.58 -57.0 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.259 1.423 . . . . 0.0 107.414 170.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.8 mt -90.25 -23.03 21.34 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.452 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 56' ' ' GLU . 9.6 tp -121.68 149.06 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 119.083 0.856 . . . . 0.0 110.31 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 m -82.86 24.17 0.77 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 71.13 -65.74 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 128.737 2.815 . . . . 0.0 109.055 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -68.88 -39.85 79.55 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.434 1.094 . . . . 0.0 109.215 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' HB3' HD11 ' A' ' 52' ' ' ILE . 2.7 mt-10 -42.32 -54.19 3.86 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.403 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -49.86 10.75 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.583 0.753 . . . . 0.0 110.952 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -42.9 71.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.648 0.779 . . . . 0.0 111.422 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -56.23 -35.09 66.97 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.046 -1.033 . . . . 0.0 112.652 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -62.13 -42.28 99.08 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.66 -47.43 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 118.017 -0.992 . . . . 0.0 111.523 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 6.1 mt-10 -50.76 -49.27 58.49 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.149 1.341 . . . . 0.0 109.238 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.85 -19.07 48.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.28 1.832 . . . . 0.0 114.051 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mmm -61.33 -28.72 69.42 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.656 1.116 . . . . 0.0 110.15 169.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.02 38.86 0.55 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.051 1.31 . . . . 0.0 111.554 169.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -148.88 122.18 4.58 Favored Pre-proline 0 C--O 1.224 -0.28 0 CA-C-O 117.314 -1.326 . . . . 0.0 108.055 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.81 111.26 1.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.018 1.812 . . . . 0.0 109.452 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.48 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -109.17 -176.35 3.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -160.48 149.77 17.29 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 120.399 -1.438 . . . . 0.0 111.196 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.503 ' CG2' HD11 ' A' ' 5' ' ' LEU . 8.4 p -119.07 127.74 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -175.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.8 mtpm? -78.52 -73.21 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 121.156 -0.218 . . . . 0.0 111.582 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -158.74 153.75 25.16 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.087 0.955 . . . . 0.0 108.49 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.562 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -159.2 120.48 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.741 1.216 . . . . 0.0 110.209 173.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -157.06 158.07 35.78 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.945 1.298 . . . . 0.0 107.862 167.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.43 -122.12 2.18 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.268 0.937 . . . . 0.0 111.916 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.042 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.468 ' N ' ' OXT' ' A' ' 76' ' ' ARG . . . . . . . . 0 N--CA 1.471 0.975 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -168.86 140.16 2.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.41 146.49 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 123.688 0.795 . . . . 0.0 109.284 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.86 119.49 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 125.931 1.692 . . . . 0.0 111.28 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.664 HD21 HG22 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -116.67 131.3 56.99 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.229 1.012 . . . . 0.0 108.881 178.421 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.487 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -101.4 119.17 38.35 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.896 1.279 . . . . 0.0 110.495 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.526 ' SD ' HD11 ' A' ' 45' ' ' ILE . 9.6 ptt? -113.34 153.24 28.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.766 1.226 . . . . 0.0 109.931 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.92 133.88 43.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 169.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.82 68.0 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.5 150.23 48.32 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.674 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.75 -40.99 2.24 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.666 -0.646 . . . . 0.0 113.597 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.1 mtt -62.46 117.22 5.88 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.578 1.189 . . . . 0.0 108.772 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.6 t -120.17 142.4 49.0 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.339 1.055 . . . . 0.0 110.041 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 t 68.0 122.51 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.646 1.979 . . . . 0.0 111.895 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -47.85 103.48 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.302 1.041 . . . . 0.0 111.865 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 m -170.03 -64.49 0.02 OUTLIER 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.672 1.589 . . . . 0.0 108.886 -172.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.2 m -77.79 71.7 4.28 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.9 p -136.09 -75.71 0.43 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.401 1.48 . . . . 0.0 107.116 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.8 m -55.64 -38.5 69.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.22 -52.75 60.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.589 0.233 . . . . 0.0 110.678 171.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.11 -53.48 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.45 -61.31 2.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.078 0.942 . . . . 0.0 110.195 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.52 -55.57 7.88 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.719 1.628 . . . . 0.0 112.471 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.66 -48.76 75.93 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.37 1.085 . . . . 0.0 110.322 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.426 HG21 HD12 ' A' ' 34' ' ' ILE . 26.4 mm -59.46 -33.42 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.498 0.719 . . . . 0.0 110.171 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.8 -13.62 8.51 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.489 1.042 . . . . 0.0 114.073 172.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.13 -14.27 31.47 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.388 1.594 . . . . 0.0 109.936 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.41 137.33 52.66 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 122.655 1.217 . . . . 0.0 112.886 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -54.69 108.0 0.35 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.438 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.27 -24.65 9.14 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-O 118.67 -1.072 . . . . 0.0 111.992 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.9 135.36 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 118.579 1.19 . . . . 0.0 108.873 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -108.05 -42.35 4.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.658 1.583 . . . . 0.0 109.919 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -152.1 159.73 43.59 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 25' ' ' ILE . 15.8 tt -143.25 152.48 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 108.495 172.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.49 110.99 5.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.743 2.017 . . . . 0.0 105.676 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.55 130.93 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.022 0.929 . . . . 0.0 109.376 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 t -117.23 90.37 3.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.15 -46.07 65.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -41.96 -58.83 1.93 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.626 1.17 . . . . 0.0 111.54 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -78.07 -7.41 56.91 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.836 0.827 . . . . 0.0 111.328 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 65.07 15.77 10.18 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 127.175 2.19 . . . . 0.0 110.7 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -132.53 154.55 49.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.824 1.649 . . . . 0.0 109.685 -166.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.02 165.57 30.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -134.87 126.76 29.39 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.526 HD11 ' SD ' ' A' ' 7' ' ' MET . 1.3 mp -108.94 152.95 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 167.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.74 117.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -156.73 -179.42 8.17 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.945 1.298 . . . . 0.0 109.147 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -131.4 147.89 67.93 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.373 1.069 . . . . 0.0 112.915 173.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.25 73.04 2.14 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.977 3.118 . . . . 0.0 109.662 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.84 -62.28 0.29 Allowed 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.195 0.998 . . . . 0.0 108.803 175.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.8 mt -83.65 -24.14 31.5 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.604 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.0 tp -114.11 156.84 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.109 0.963 . . . . 0.0 109.207 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.85 17.49 1.51 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.04 0.536 . . . . 0.0 112.281 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 68.64 -59.63 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.941 2.096 . . . . 0.0 109.402 -165.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -88.57 -28.36 20.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.909 -167.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' HB3' HD11 ' A' ' 52' ' ' ILE . 2.1 mt-10 -40.81 -53.12 2.92 Favored 'General case' 0 C--N 1.343 0.321 0 O-C-N 124.069 0.856 . . . . 0.0 110.543 177.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -43.18 -67.96 0.23 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.586 1.154 . . . . 0.0 110.544 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -46.65 84.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.949 -0.469 . . . . 0.0 110.756 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -51.94 -32.67 34.09 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -69.2 -43.46 74.07 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.566 1.075 . . . . 0.0 109.327 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.96 -39.78 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.795 -0.621 . . . . 0.0 109.671 173.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 11.5 mt-10 -57.23 -55.31 36.45 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.928 0.785 . . . . 0.0 108.945 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.31 -30.56 51.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.332 1.853 . . . . 0.0 113.425 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 26.4 mmt -50.7 -35.78 32.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.065 0.848 . . . . 0.0 111.426 172.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.96 41.63 0.44 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.378 0.99 . . . . 0.0 111.648 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -145.95 126.63 7.23 Favored Pre-proline 0 C--O 1.223 -0.323 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.54 111.06 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.483 1.456 . . . . 0.0 109.052 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.495 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -108.79 -169.24 1.46 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -164.58 149.6 9.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.621 -0.674 . . . . 0.0 110.837 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.664 HG22 HD21 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -123.39 131.1 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -73.22 -94.46 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.774 0.671 . . . . 0.0 111.135 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.92 150.27 25.73 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.607 ' HB ' HD23 ' A' ' 5' ' ' LEU . 3.9 tp -157.2 146.35 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 126.433 1.893 . . . . 0.0 106.556 -172.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -156.39 161.37 40.12 Favored 'General case' 0 N--CA 1.458 -0.035 0 C-N-CA 126.904 2.082 . . . . 0.0 105.986 166.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.91 173.85 33.89 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.468 ' OXT' ' N ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.855 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 165.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.939 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 7.23 84.1 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 129.624 3.17 . . . . 0.0 113.711 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -108.54 146.89 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 123.683 0.793 . . . . 0.0 109.794 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.403 HG13 HG23 ' A' ' 44' ' ' THR . 4.5 t -78.61 134.54 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 124.916 1.286 . . . . 0.0 108.679 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.573 HD21 HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -129.42 129.13 44.29 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.37 130.87 42.0 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.042 0.937 . . . . 0.0 110.099 170.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -131.18 146.55 52.38 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.306 1.442 . . . . 0.0 108.786 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -82.8 150.7 26.45 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.64 66.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.037 0.935 . . . . 0.0 108.707 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.53 158.75 17.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.763 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.12 -60.69 0.36 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.5 mmm -70.34 131.15 43.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.327 0.564 . . . . 0.0 110.198 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -132.84 -33.03 1.21 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.483 1.113 . . . . 0.0 111.763 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.8 p -91.85 141.01 29.12 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.405 0.682 . . . . 0.0 109.465 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.29 111.26 1.15 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.39 -85.29 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.962 1.305 . . . . 0.0 108.081 -178.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.29 81.67 1.02 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.87 0.843 . . . . 0.0 109.727 -170.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.6 p -132.55 -80.26 0.5 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.629 1.972 . . . . 0.0 106.518 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.6 t -55.68 -39.99 71.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -168.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -49.31 -58.47 5.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.454 0.301 . . . . 0.0 111.716 168.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.07 -52.38 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -58.79 -62.38 1.91 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.766 0.793 . . . . 0.0 110.29 -172.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.16 -55.36 6.61 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.132 1.825 . . . . 0.0 112.534 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -60.64 -54.04 50.14 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.564 1.182 . . . . 0.0 109.776 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 mm -55.24 -33.8 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.196 0.999 . . . . 0.0 110.81 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.56 -23.13 9.09 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.035 1.302 . . . . 0.0 114.184 173.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -89.75 -12.59 38.9 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.589 1.694 . . . . 0.0 111.455 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.56 135.35 51.4 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.108 0.956 . . . . 0.0 110.84 -172.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -56.54 106.06 0.26 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.489 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.42 -26.44 6.64 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-O 119.054 -0.859 . . . . 0.0 112.225 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.03 132.03 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 118.476 1.138 . . . . 0.0 108.575 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -109.11 -31.02 7.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.695 0.798 . . . . 0.0 110.884 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -159.91 170.3 21.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.255 0.934 . . . . 0.0 110.475 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.2 tt -152.6 147.16 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.703 0.801 . . . . 0.0 109.867 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -136.98 106.8 6.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.025 1.73 . . . . 0.0 107.292 168.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.8 t -93.3 113.33 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 119.43 1.014 . . . . 0.0 109.55 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.88 73.18 1.75 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 tt -46.37 -50.39 16.56 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.397 1.079 . . . . 0.0 110.424 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.83 -53.98 2.19 Favored 'General case' 0 CA--C 1.523 -0.084 0 C-N-CA 125.827 1.651 . . . . 0.0 111.628 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.1 -16.11 58.28 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.57 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 70.25 8.51 6.67 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.977 2.111 . . . . 0.0 111.605 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -124.76 143.95 50.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.862 2.065 . . . . 0.0 107.889 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.71 157.2 42.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.431 1.092 . . . . 0.0 108.72 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.403 HG23 HG13 ' A' ' 4' ' ' VAL . 7.8 m -130.49 104.69 7.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.506 1.922 . . . . 0.0 107.151 -171.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.81 153.45 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.17 117.2 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.054 0.942 . . . . 0.0 109.753 168.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -158.71 178.81 9.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.654 1.182 . . . . 0.0 110.811 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.69 142.62 37.35 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 124.121 0.968 . . . . 0.0 112.208 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.425 ' HB3' HG23 ' A' ' 54' ' ' VAL . 72.8 Cg_endo -69.43 75.06 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.871 3.048 . . . . 0.0 110.314 172.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -140.52 -54.55 0.51 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.4 mt -89.63 -22.69 22.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.261 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.551 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.1 tp -119.54 150.24 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.877 0.871 . . . . 0.0 110.003 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.2 m -86.26 29.13 0.77 Allowed 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 49' ' ' PRO 0.261 0.5 OUTLIER 74.02 -56.69 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.631 2.372 . . . . 0.0 111.14 175.771 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -85.38 -36.18 20.89 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.571 1.548 . . . . 0.0 109.749 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HB3' HD11 ' A' ' 52' ' ' ILE . 5.8 mm-40 -42.89 -50.87 5.71 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 123.842 0.714 . . . . 0.0 110.972 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.91 -53.4 3.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 123.907 0.883 . . . . 0.0 112.113 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -45.63 61.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.304 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -55.09 -29.54 57.79 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -61.72 -43.18 99.36 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.745 0.702 . . . . 0.0 109.714 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.98 -49.35 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.626 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -51.92 -48.4 64.22 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.25 -19.95 56.84 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.06 1.744 . . . . 0.0 113.973 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.0 mmm -60.91 -34.08 74.12 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.74 1.155 . . . . 0.0 109.466 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.29 -33.33 2.01 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -75.39 119.39 76.78 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.026 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.53 117.32 4.51 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.21 1.94 . . . . 0.0 108.596 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.3 -172.37 2.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.857 0.463 . . . . 0.0 109.905 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.58 137.77 9.2 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.573 HG22 HD21 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -93.11 136.62 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.348 1.459 . . . . 0.0 107.819 171.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -88.03 -77.77 0.34 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.41 ' O ' HD23 ' A' ' 5' ' ' LEU . 13.7 tttp -155.4 143.81 20.3 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 119.269 0.94 . . . . 0.0 110.283 -175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -154.92 114.17 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.831 1.253 . . . . 0.0 108.074 -164.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -160.59 140.71 11.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.7 81.02 0.06 OUTLIER Glycine 0 CA--C 1.531 1.039 0 CA-C-N 120.142 1.337 . . . . 0.0 115.436 -169.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.245 0 C-N-CA 129.019 2.928 . . . . 0.0 108.673 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.952 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -116.18 173.86 6.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.63 1.172 . . . . 0.0 109.833 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -97.23 151.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -168.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.1 t -97.16 126.62 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 125.972 1.709 . . . . 0.0 110.632 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.82 153.56 20.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.363 1.865 . . . . 0.0 108.108 170.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -125.19 126.28 44.98 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.447 1.099 . . . . 0.0 109.08 163.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.7 ptp -121.07 161.84 21.03 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.715 1.606 . . . . 0.0 110.823 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -98.99 134.01 42.43 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.507 1.923 . . . . 0.0 108.577 165.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.4 t -116.3 71.01 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 126.369 1.867 . . . . 0.0 106.617 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -77.43 174.15 11.16 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.623 0.769 . . . . 0.0 110.745 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.56 -50.45 3.54 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.24 -0.756 . . . . 0.0 112.919 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -40.0 -55.66 2.0 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.772 1.629 . . . . 0.0 111.456 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.251 5.9 t 50.78 -170.59 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.148 1.779 . . . . 0.0 113.441 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 t 65.4 156.2 0.09 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.211 1.804 . . . . 0.0 112.163 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.73 39.52 0.42 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.517 -1.364 . . . . 0.0 112.226 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 t -171.0 108.14 0.29 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.121 1.368 . . . . 0.0 109.19 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.4 p 178.82 53.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.656 1.582 . . . . 0.0 108.006 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -130.54 -73.52 0.55 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.2 t -50.28 -42.32 52.15 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -46.55 -58.2 4.03 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.106 0.563 . . . . 0.0 111.626 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -58.57 -48.56 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 123.644 0.777 . . . . 0.0 109.727 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.465 ' HA ' HG21 ' A' ' 34' ' ' ILE . 38.1 mt-10 -55.07 -64.67 0.76 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 122.52 1.152 . . . . 0.0 110.485 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.9 -54.13 8.3 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.531 2.015 . . . . 0.0 112.244 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -54.79 43.17 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.967 0.883 . . . . 0.0 110.103 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.4 mm -59.14 -31.45 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.074 0.95 . . . . 0.0 110.91 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.05 -15.73 22.74 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.741 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -90.84 -11.43 39.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.627 1.714 . . . . 0.0 111.172 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.32 132.6 48.73 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.427 1.108 . . . . 0.0 111.068 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -57.97 107.98 0.53 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.299 172.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.08 -15.94 13.29 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.823 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 t -87.97 128.69 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 119.033 1.416 . . . . 0.0 109.426 -175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -83.62 -51.34 7.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.948 0.899 . . . . 0.0 110.282 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -158.42 167.97 28.24 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.616 0.643 . . . . 0.0 110.734 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.465 HG21 ' HA ' ' A' ' 22' ' ' GLU . 5.7 tt -142.49 140.26 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 125.591 1.557 . . . . 0.0 109.073 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -129.55 112.45 13.75 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.638 1.575 . . . . 0.0 107.414 168.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.21 108.82 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 C-N-CA 124.053 0.941 . . . . 0.0 109.6 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 m -82.42 113.74 20.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.18 179.71 0.19 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 158.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 67.54 -65.05 0.25 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 127.968 2.507 . . . . 0.0 109.498 -170.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.99 -22.96 66.49 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.247 1.019 . . . . 0.0 111.176 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 64.61 15.48 9.71 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.913 2.085 . . . . 0.0 111.91 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -120.38 132.31 55.21 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.786 1.234 . . . . 0.0 109.228 -169.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.32 150.29 47.28 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.735 0.814 . . . . 0.0 108.975 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.36 130.41 52.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.7 mt -126.7 158.34 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.88 122.68 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -158.64 179.79 8.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.93 1.292 . . . . 0.0 110.888 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -136.24 154.1 77.0 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 164.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.92 74.71 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.752 3.635 . . . . 0.0 109.958 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.01 -57.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.684 1.194 . . . . 0.0 108.081 170.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 mt -87.78 -28.03 21.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.809 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.462 ' HA ' HD12 ' A' ' 52' ' ' ILE . 9.2 tp -119.64 144.38 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 118.703 0.683 . . . . 0.0 109.882 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 m -81.57 31.05 0.35 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 72.24 -61.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 129.172 2.989 . . . . 0.0 110.166 176.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -82.81 -36.52 25.48 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.41 1.884 . . . . 0.0 109.355 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' HB3' HD11 ' A' ' 52' ' ' ILE . 1.4 mt-10 -42.06 -52.71 4.17 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.455 0.702 . . . . 0.0 111.055 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -36.48 -52.86 0.86 Allowed 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.712 2.005 . . . . 0.0 111.804 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.59 -38.55 65.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.29 1.036 . . . . 0.0 112.551 175.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -57.73 -33.17 68.15 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.632 -1.292 . . . . 0.0 112.548 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -62.66 -40.33 96.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -58.78 -46.32 90.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 117.919 -1.039 . . . . 0.0 111.75 170.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.97 -49.59 59.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.873 1.215 . . . . 0.0 108.031 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.89 -18.86 61.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.303 1.841 . . . . 0.0 114.207 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.7 mmm -62.14 -21.43 65.03 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.689 1.132 . . . . 0.0 110.532 168.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.71 34.57 2.03 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 125.238 1.399 . . . . 0.0 110.859 172.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -148.34 125.63 5.63 Favored Pre-proline 0 N--CA 1.456 -0.138 0 CA-C-O 117.764 -1.112 . . . . 0.0 108.395 -173.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.69 116.57 3.62 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.119 1.879 . . . . 0.0 110.372 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.13 -179.64 3.89 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.602 0.761 . . . . 0.0 109.465 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -162.9 149.12 12.36 Favored 'General case' 0 C--O 1.224 -0.265 0 O-C-N 120.323 -1.485 . . . . 0.0 111.809 -169.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 t -98.89 129.44 49.26 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.056 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -100.73 -63.7 1.11 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.78 0.432 . . . . 0.0 110.671 170.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.59 153.33 19.84 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.8 tt -142.66 167.4 14.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 124.837 1.255 . . . . 0.0 108.904 -173.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.57 70.13 1.77 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.679 1.992 . . . . 0.0 111.174 -167.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.85 -161.51 35.29 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.92 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 154.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -154.22 159.69 41.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.073 0.949 . . . . 0.0 109.27 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.1 t -122.86 136.67 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 125.31 1.444 . . . . 0.0 108.288 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.1 t -77.4 141.26 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.637 1.575 . . . . 0.0 109.159 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -144.02 127.92 17.38 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -89.73 134.18 34.3 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.544 1.137 . . . . 0.0 109.859 171.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.87 141.64 47.46 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.08 0.952 . . . . 0.0 110.824 176.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.26 136.13 35.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.25 84.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 171.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -76.63 173.71 11.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 122.088 0.947 . . . . 0.0 110.982 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.5 -58.01 4.13 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.8 mmt -68.21 73.9 0.22 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.638 1.209 . . . . 0.0 109.746 173.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 p -85.59 -44.66 12.44 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 128.552 2.741 . . . . 0.0 108.843 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.18 151.87 39.92 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.044 0.538 . . . . 0.0 110.386 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -69.38 177.72 2.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.522 0.677 . . . . 0.0 111.974 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t 72.97 47.82 0.19 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.397 1.079 . . . . 0.0 111.577 168.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.01 66.48 0.47 Allowed 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 171.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -133.83 -70.57 0.52 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.585 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t -54.69 -39.87 68.57 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -170.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 m -49.34 -55.67 12.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.576 0.35 . . . . 0.0 111.783 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.79 -50.69 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.614 0.766 . . . . 0.0 109.179 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -52.16 -66.11 0.44 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.942 0.877 . . . . 0.0 110.124 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.82 -54.92 8.72 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.529 2.014 . . . . 0.0 112.23 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.63 -55.26 37.36 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.12 0.96 . . . . 0.0 109.802 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 mm -59.58 -31.08 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 123.598 0.759 . . . . 0.0 110.445 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.84 -16.81 19.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.921 1.248 . . . . 0.0 113.921 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -89.1 -13.76 37.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.605 1.703 . . . . 0.0 110.632 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.32 133.08 43.76 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.468 1.128 . . . . 0.0 112.284 -172.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -55.58 108.72 0.46 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.58 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.62 -25.76 7.53 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 119.186 -0.785 . . . . 0.0 111.976 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.53 131.5 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -97.75 -47.19 5.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.181 0.992 . . . . 0.0 109.374 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -154.94 166.89 32.14 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.805 -0.559 . . . . 0.0 110.316 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 tt -153.38 142.92 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.187 0.995 . . . . 0.0 109.922 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -139.55 117.3 11.58 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.179 1.792 . . . . 0.0 106.937 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -112.84 105.69 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 119.875 1.216 . . . . 0.0 109.242 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -97.24 88.15 4.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.58 -43.92 62.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.291 0.636 . . . . 0.0 110.882 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.33 -54.21 1.45 Allowed 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 125.946 1.698 . . . . 0.0 110.924 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.03 -13.41 57.39 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.681 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 66.12 9.32 6.17 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.106 2.163 . . . . 0.0 111.506 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -129.67 155.86 45.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.581 1.952 . . . . 0.0 108.599 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.26 155.94 49.37 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.146 0.978 . . . . 0.0 108.854 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.1 m -122.64 112.27 17.76 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.92 2.088 . . . . 0.0 105.557 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 mt -102.56 168.52 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.51 120.31 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -160.14 179.61 8.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.612 1.165 . . . . 0.0 110.917 -171.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.51 146.94 59.7 Favored Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -69.66 74.28 1.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.605 2.87 . . . . 0.0 109.507 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.94 -62.75 0.48 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.731 1.212 . . . . 0.0 108.249 172.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.1 mt -85.54 -21.25 28.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.992 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.0 tp -125.02 144.79 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 118.616 0.644 . . . . 0.0 110.069 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 m -76.13 28.9 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.272 0.5 OUTLIER 70.74 -53.1 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 128.979 2.912 . . . . 0.0 111.801 178.589 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -44.83 15.22 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 127.313 2.245 . . . . 0.0 109.705 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HB3' HD11 ' A' ' 52' ' ' ILE . 8.3 mt-10 -43.51 -51.94 6.44 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.171 0.588 . . . . 0.0 110.742 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -29.39 -63.16 0.12 Allowed 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 126.86 2.064 . . . . 0.0 110.716 172.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -45.76 36.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -59.4 -19.68 49.05 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.401 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -43.82 97.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.861 0.755 . . . . 0.0 110.022 170.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.94 -48.83 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -54.37 -47.56 72.49 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.14 -22.12 64.39 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.229 1.412 . . . . 0.0 113.953 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -63.41 -28.49 70.02 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.208 1.367 . . . . 0.0 110.071 170.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.99 -32.93 2.91 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.683 1.135 . . . . 0.0 110.743 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -73.69 126.03 90.0 Favored Pre-proline 0 N--CA 1.455 -0.191 0 CA-C-O 118.602 -0.714 . . . . 0.0 109.311 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.45 113.72 2.59 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.912 1.741 . . . . 0.0 109.687 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.25 174.61 6.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.972 0.909 . . . . 0.0 108.614 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.9 127.56 6.64 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -174.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.77 137.39 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.997 1.319 . . . . 0.0 109.574 172.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -84.1 -101.26 0.05 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.264 0.626 . . . . 0.0 111.253 171.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -151.85 140.27 20.54 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.312 1.045 . . . . 0.0 108.615 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.66 131.17 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 127.534 2.334 . . . . 0.0 106.443 -174.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -158.24 158.48 34.56 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.339 0.972 . . . . 0.0 110.642 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.63 -174.18 39.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.4 ' H ' ' CD ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 116.887 -1.53 . . . . 0.0 109.747 167.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -44.59 133.96 5.59 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.823 1.249 . . . . 0.0 111.564 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.73 146.62 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.275 0.63 . . . . 0.0 110.042 -176.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.9 t -78.61 140.54 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.953 1.301 . . . . 0.0 108.68 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.497 HD23 ' HB ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -133.19 142.02 48.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.774 2.029 . . . . 0.0 106.536 179.316 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -110.52 124.25 51.45 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.139 0.976 . . . . 0.0 109.122 173.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.7 ptm -117.91 155.01 30.93 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.98 1.312 . . . . 0.0 110.317 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.33 133.44 37.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 172.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.63 64.33 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.228 1.011 . . . . 0.0 109.004 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.92 166.19 16.17 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.986 0.898 . . . . 0.0 111.293 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.98 -46.38 2.66 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 121.738 -0.601 . . . . 0.0 113.05 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.6 mtt -59.16 110.51 1.08 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.287 1.043 . . . . 0.0 109.779 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 t -115.1 147.63 39.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.391 1.076 . . . . 0.0 108.9 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.9 m 62.57 162.34 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.334 1.854 . . . . 0.0 113.095 -177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -75.11 69.2 1.97 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.829 0.823 . . . . 0.0 109.422 173.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 m -117.57 -54.37 2.37 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.385 1.874 . . . . 0.0 109.092 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.7 m -88.48 -103.58 0.08 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.519 HG21 ' HB2' ' A' ' 38' ' ' LEU . 81.0 p 22.99 -89.26 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 127.877 2.471 . . . . 0.0 113.824 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -44.87 -41.09 6.8 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -49.82 -58.95 4.35 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.259 0.552 . . . . 0.0 111.061 168.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.85 -46.37 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.091 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -53.07 -65.24 0.59 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.425 1.466 . . . . 0.0 110.177 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.25 -55.12 6.83 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.467 1.508 . . . . 0.0 112.027 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -56.6 -53.17 60.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.795 0.797 . . . . 0.0 110.535 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.8 mm -61.49 -28.38 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.526 1.131 . . . . 0.0 110.479 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.92 -20.78 6.64 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.923 -0.932 . . . . 0.0 114.271 169.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -87.92 -14.86 38.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.89 1.845 . . . . 0.0 111.259 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 136.21 53.04 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 122.269 1.033 . . . . 0.0 111.668 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -57.68 111.25 1.07 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.532 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.97 -22.12 12.8 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 123.9 0.762 . . . . 0.0 112.757 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.2 132.58 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 118.122 0.961 . . . . 0.0 108.944 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -97.36 -47.33 5.74 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.643 1.177 . . . . 0.0 109.751 171.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -153.91 163.79 39.47 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.361 -0.837 . . . . 0.0 110.616 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 tt -146.2 136.75 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.299 1.439 . . . . 0.0 109.098 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.78 104.69 6.43 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.834 1.653 . . . . 0.0 107.592 168.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 43' ' ' ALA . 89.0 t -100.96 126.91 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 124.371 1.068 . . . . 0.0 109.993 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 m -114.5 93.76 4.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.12 0.968 . . . . 0.0 109.301 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.519 ' HB2' HG21 ' A' ' 18' ' ' THR . 0.3 OUTLIER -43.39 -49.74 6.97 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.466 1.106 . . . . 0.0 109.496 169.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.414 ' N ' HD13 ' A' ' 38' ' ' LEU . 1.3 m-20 -44.85 -58.87 2.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.677 1.591 . . . . 0.0 111.428 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.93 -14.69 59.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.55 -172.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 70.33 3.5 4.47 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.05 2.14 . . . . 0.0 111.81 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -119.16 157.86 27.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.563 1.945 . . . . 0.0 108.651 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.413 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -138.36 155.1 48.85 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.642 0.777 . . . . 0.0 109.564 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 m -124.99 116.81 22.74 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.4 mt -121.08 159.78 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.28 117.98 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.39 0.996 . . . . 0.0 110.019 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -161.21 -178.93 7.04 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.459 1.104 . . . . 0.0 111.457 -172.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.72 146.8 63.5 Favored Pre-proline 0 N--CA 1.467 0.376 0 C-N-CA 124.898 1.279 . . . . 0.0 113.946 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.26 69.44 2.52 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 124.121 3.214 . . . . 0.0 109.896 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.62 -63.96 0.36 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.11 0.964 . . . . 0.0 108.969 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.2 mt -79.72 -21.85 44.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.862 -0.59 . . . . 0.0 110.426 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 56' ' ' GLU . 8.6 tp -124.83 145.12 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 118.507 0.594 . . . . 0.0 109.955 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -80.64 29.62 0.31 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.814 0.845 . . . . 0.0 112.975 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 74.64 -56.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 128.46 2.704 . . . . 0.0 111.095 173.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.63 -40.67 20.46 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.213 1.805 . . . . 0.0 109.477 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.469 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mm-40 -41.24 -53.15 3.26 Favored 'General case' 0 C--N 1.346 0.44 0 O-C-N 124.183 0.927 . . . . 0.0 110.837 -173.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.71 -60.96 0.29 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.165 1.786 . . . . 0.0 111.053 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -41.95 68.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.092 0.957 . . . . 0.0 111.005 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -56.33 -28.28 58.43 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -64.79 -41.83 95.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.733 -0.604 . . . . 0.0 109.672 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -63.46 -49.18 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.449 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 4.2 mt-10 -53.39 -46.86 69.84 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.73 -20.53 49.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.555 1.542 . . . . 0.0 114.179 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.2 mmm -63.18 -30.18 71.38 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.777 1.171 . . . . 0.0 109.865 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.55 -32.25 2.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -79.85 116.57 62.04 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-O 117.819 -1.086 . . . . 0.0 108.468 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.25 123.81 12.78 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.765 1.643 . . . . 0.0 108.42 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.466 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -113.35 -165.74 1.02 Allowed 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 122.764 0.426 . . . . 0.0 110.271 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -162.42 138.34 7.42 Favored 'General case' 0 CA--C 1.522 -0.097 0 O-C-N 121.487 -0.758 . . . . 0.0 111.315 176.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.01 132.06 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 124.468 1.107 . . . . 0.0 108.677 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 mtpt -82.55 -83.03 0.13 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 117.858 0.299 . . . . 0.0 110.987 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -155.81 141.43 17.87 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.497 ' HB ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -148.39 123.41 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 125.787 1.635 . . . . 0.0 107.563 177.097 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -147.98 143.38 27.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 168.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.3 -133.83 4.23 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 . . . . . 0 C--O 1.245 0.839 0 N-CA-C 104.006 -2.59 . . . . 0.0 104.006 176.823 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.164 0 CA-C-O 116.893 -2.059 . . . . 0.0 108.277 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 31.67 71.02 0.08 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.522 1.929 . . . . 0.0 113.722 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 74' ' ' GLU . 43.2 t -110.37 142.35 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.555 1.542 . . . . 0.0 108.759 -173.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.63 134.34 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 123.775 0.83 . . . . 0.0 110.692 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.541 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -123.83 139.29 54.11 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 172.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -108.46 123.2 48.51 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 45' ' ' ILE . 15.0 ptm -116.07 167.9 10.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.35 1.06 . . . . 0.0 109.957 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -114.31 134.24 55.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.485 2.314 . . . . 0.0 106.86 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 t -124.99 62.4 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.309 1.843 . . . . 0.0 107.686 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.88 145.45 46.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.28 0.562 . . . . 0.0 111.724 -170.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.33 -46.3 1.16 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.7 mmm -80.94 104.85 11.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.172 0.486 . . . . 0.0 110.951 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.2 p -114.97 -59.35 2.03 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.66 1.184 . . . . 0.0 109.948 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.5 p -55.6 133.67 50.58 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.248 0.619 . . . . 0.0 110.964 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -61.04 164.87 4.63 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -170.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.8 t 81.65 84.23 0.04 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.11 2.164 . . . . 0.0 111.947 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.4 t -163.95 -111.05 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.687 -1.149 . . . . 0.0 109.382 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.752 HG22 HG12 ' A' ' 36' ' ' VAL . 70.7 p 27.42 -88.05 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 128.109 2.564 . . . . 0.0 113.518 169.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t -36.86 -42.96 0.42 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.112 1.365 . . . . 0.0 113.501 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.15 -57.06 11.74 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.46 0.704 . . . . 0.0 111.273 171.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.41 -48.86 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.214 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -56.21 -59.37 5.04 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 119.936 1.244 . . . . 0.0 110.79 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -41.38 -56.93 3.31 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.852 1.692 . . . . 0.0 112.158 170.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -57.2 -53.41 58.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.014 0.907 . . . . 0.0 110.506 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.427 HG23 ' HE3' ' A' ' 57' ' ' MET . 29.1 mm -59.65 -28.04 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 125.158 1.383 . . . . 0.0 110.704 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.83 -19.2 9.81 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.735 -1.036 . . . . 0.0 114.299 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -88.18 -9.99 51.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.859 1.829 . . . . 0.0 111.333 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.8 136.22 46.99 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.172 0.987 . . . . 0.0 111.594 -171.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.78 113.86 2.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.078 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.26 -16.99 31.99 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-O 119.136 -0.813 . . . . 0.0 112.903 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 t -79.32 130.14 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 118.238 1.019 . . . . 0.0 108.581 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -97.05 -49.14 5.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.439 1.096 . . . . 0.0 109.47 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -152.81 170.54 20.05 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.625 -0.672 . . . . 0.0 110.673 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 tt -144.11 149.24 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.619 1.168 . . . . 0.0 109.407 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -143.55 98.44 3.25 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.141 2.176 . . . . 0.0 107.711 169.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.752 HG12 HG22 ' A' ' 18' ' ' THR . 91.2 t -99.62 128.24 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.554 1.142 . . . . 0.0 109.013 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 t -103.51 110.03 21.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.329 0.652 . . . . 0.0 110.602 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.585 HD23 ' H ' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -63.37 158.36 20.73 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.585 ' H ' HD23 ' A' ' 38' ' ' LEU . 3.7 m-20 71.36 -55.82 0.65 Allowed 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 129.069 2.948 . . . . 0.0 109.926 -174.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.01 -29.28 70.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.841 -174.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 64.61 16.07 10.08 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.19 2.196 . . . . 0.0 112.471 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -107.18 139.3 41.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB1' HG22 ' A' ' 36' ' ' VAL . . . -141.64 156.3 45.67 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.794 -0.566 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.9 m -130.46 125.8 35.33 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.491 HD11 ' SD ' ' A' ' 7' ' ' MET . 12.2 mt -118.33 153.25 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.62 120.84 65.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -157.71 -179.67 8.37 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 125.395 1.478 . . . . 0.0 109.628 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -140.75 151.85 64.2 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 123.221 0.609 . . . . 0.0 112.515 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -82.02 64.37 8.41 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.949 3.1 . . . . 0.0 108.684 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.52 -61.1 1.03 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.023 1.329 . . . . 0.0 107.474 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.2 mt -88.33 -20.71 25.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.666 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.7 tp -120.7 145.08 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 119.205 0.911 . . . . 0.0 110.488 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -83.96 28.32 0.61 Allowed 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 71.39 -60.07 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 128.867 2.867 . . . . 0.0 110.545 176.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -74.54 -41.11 61.17 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.804 1.242 . . . . 0.0 108.491 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mt-10 -42.81 -49.86 5.71 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 123.277 0.631 . . . . 0.0 111.551 -174.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.437 ' SD ' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -42.74 -53.74 4.4 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.859 0.864 . . . . 0.0 111.126 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.49 -44.91 77.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 122.087 -0.383 . . . . 0.0 110.761 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -54.04 -33.91 58.63 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.937 -0.477 . . . . 0.0 112.094 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -64.14 -42.67 96.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.43 0.692 . . . . 0.0 109.564 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.01 -46.83 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.791 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 11.0 mt-10 -51.67 -49.96 61.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.897 1.226 . . . . 0.0 108.674 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.86 -19.82 31.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.283 1.833 . . . . 0.0 114.27 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.1 mmm -61.82 -31.28 71.5 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.63 1.105 . . . . 0.0 110.214 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.7 39.48 0.57 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.544 1.069 . . . . 0.0 111.461 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -145.45 125.78 7.21 Favored Pre-proline 0 C--O 1.225 -0.217 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.98 107.81 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.19 1.927 . . . . 0.0 109.611 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.612 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -107.56 -177.59 3.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -163.49 156.1 18.19 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.121 -0.987 . . . . 0.0 111.612 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.4 t -106.42 118.68 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -94.42 -67.81 0.83 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.458 0.303 . . . . 0.0 110.632 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -86.95 176.37 7.69 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.4 tt -159.99 169.6 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.406 ' HA ' HG11 ' A' ' 3' ' ' VAL . 2.7 mp0 -73.37 145.07 46.18 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.756 1.162 . . . . 0.0 111.728 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.06 63.02 0.29 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.467 1.032 . . . . 0.0 111.353 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.255 1.375 0 C-N-CA 124.813 1.245 . . . . 0.0 111.691 171.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.964 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 178.05 148.99 0.18 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 -161.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.9 t -147.51 147.28 17.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.15 132.12 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.379 1.472 . . . . 0.0 109.957 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.568 HD22 ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -123.56 157.85 32.72 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.371 1.469 . . . . 0.0 109.621 171.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.541 ' N ' HD22 ' A' ' 5' ' ' LEU . 11.3 ttpt -119.05 123.56 44.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.436 1.094 . . . . 0.0 108.581 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -122.79 144.66 49.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.077 1.351 . . . . 0.0 110.474 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -87.96 133.14 34.0 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.328 2.251 . . . . 0.0 108.313 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.35 65.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 126.959 2.104 . . . . 0.0 107.966 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -71.77 153.83 41.71 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.822 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.61 -43.46 2.07 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.821 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.6 mtt -63.49 127.92 33.51 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.505 1.152 . . . . 0.0 108.779 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -133.03 149.09 52.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.157 0.983 . . . . 0.0 108.651 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.5 m 68.58 140.82 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.811 2.045 . . . . 0.0 112.166 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -63.55 84.03 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.184 0.994 . . . . 0.0 109.959 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -149.24 -59.36 0.21 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.822 1.649 . . . . 0.0 108.511 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.9 m -77.72 69.94 4.03 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.3 p -133.33 -73.8 0.49 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.447 1.499 . . . . 0.0 107.224 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -57.93 -37.28 73.81 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -166.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.8 m -51.54 -54.15 30.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.724 0.297 . . . . 0.0 111.541 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -59.25 -49.5 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -53.28 -65.06 0.63 Allowed 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 122.322 1.058 . . . . 0.0 110.4 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.56 -42.71 44.57 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.197 1.856 . . . . 0.0 113.364 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -68.67 -61.23 1.91 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.934 1.367 . . . . 0.0 109.593 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.06 -41.49 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.621 1.169 . . . . 0.0 110.37 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.73 -21.55 29.74 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.406 1.479 . . . . 0.0 113.633 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -91.35 -15.44 29.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.076 1.438 . . . . 0.0 110.836 177.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.34 134.14 52.91 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.537 1.16 . . . . 0.0 111.508 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -50.35 107.77 0.18 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.255 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.42 -29.08 5.8 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.958 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.1 t -79.45 137.25 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 118.353 1.077 . . . . 0.0 109.167 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -102.34 -43.35 5.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.039 1.335 . . . . 0.0 110.642 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -158.61 162.5 37.31 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.41 -0.806 . . . . 0.0 110.151 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 tt -144.43 141.32 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.625 1.57 . . . . 0.0 109.192 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -129.34 121.7 28.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.513 1.925 . . . . 0.0 107.046 164.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.3 t -107.47 109.02 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 119.93 1.241 . . . . 0.0 110.052 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.7 t -90.79 91.63 8.45 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.693 0.759 . . . . 0.0 109.324 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.61 166.62 0.88 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.656 163.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 66.48 -56.42 0.39 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 128.338 2.655 . . . . 0.0 110.45 -165.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -64.81 -30.27 71.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.214 1.007 . . . . 0.0 109.88 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 68.73 25.27 6.42 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 127.812 2.445 . . . . 0.0 110.255 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -125.03 127.26 46.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.714 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.1 145.45 49.25 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.061 0.945 . . . . 0.0 109.515 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.71 120.3 31.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -176.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.2 mt -128.1 157.54 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -173.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.4 p -125.32 127.81 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -155.85 176.2 12.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 110.528 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.09 145.61 54.73 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.627 1.171 . . . . 0.0 113.192 172.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -72.32 75.86 2.33 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.409 3.406 . . . . 0.0 109.887 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.05 -55.42 0.11 Allowed 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.831 -0.543 . . . . 0.0 109.902 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.14 -24.61 27.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.607 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.4 tp -124.82 145.08 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.295 0.638 . . . . 0.0 110.206 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.57 23.74 0.12 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 75.4 -53.77 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.24 1.816 . . . . 0.0 110.194 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -95.64 -33.82 12.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.151 2.18 . . . . 0.0 110.169 -172.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -42.32 -53.31 4.22 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.035 0.934 . . . . 0.0 110.532 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -37.72 -57.74 0.96 Allowed 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 126.183 1.793 . . . . 0.0 111.96 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.405 ' HE2' HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -73.38 -42.76 61.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.992 0.917 . . . . 0.0 111.656 178.085 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -50.69 -29.47 11.3 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.148 -0.97 . . . . 0.0 113.208 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -62.68 -35.99 81.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -69.7 -46.24 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 123.682 0.793 . . . . 0.0 109.099 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -51.09 -49.34 60.86 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.01 -20.16 62.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.426 1.491 . . . . 0.0 114.041 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 81.3 mmm -63.99 -28.45 69.82 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.886 1.221 . . . . 0.0 109.874 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.41 -33.13 2.71 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.434 1.016 . . . . 0.0 110.957 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -80.85 119.06 75.05 Favored Pre-proline 0 N--CA 1.455 -0.18 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.169 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.8 120.71 8.19 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.873 1.716 . . . . 0.0 109.52 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.68 177.85 5.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.562 1.545 . . . . 0.0 108.562 -176.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.93 158.65 35.39 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 122.924 0.49 . . . . 0.0 111.218 -173.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.405 HG23 ' HE2' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -105.0 126.21 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -99.84 -61.59 1.35 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.688 0.395 . . . . 0.0 110.852 172.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -95.8 169.1 10.24 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.2 tt -150.7 175.73 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -75.36 178.96 5.47 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.251 1.021 . . . . 0.0 110.375 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.34 171.82 12.88 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.301 1.429 . . . . 0.0 111.036 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.311 0 CA-C-O 115.78 -2.057 . . . . 0.0 106.442 172.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.163 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.46 121.02 13.4 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.07 0.948 . . . . 0.0 109.773 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -136.56 156.94 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.504 1.521 . . . . 0.0 108.908 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.9 t -87.21 124.9 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.115 2.166 . . . . 0.0 110.299 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.26 142.69 41.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.623 1.169 . . . . 0.0 109.401 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 123.49 48.66 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.416 1.486 . . . . 0.0 108.95 170.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.7 ptm -125.96 134.75 51.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.067 1.347 . . . . 0.0 111.468 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 129.38 39.08 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 t -112.02 73.83 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.03 164.77 10.02 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.784 0.802 . . . . 0.0 111.101 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.79 -41.71 2.39 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 121.629 -0.669 . . . . 0.0 112.589 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 ttm -46.05 123.8 4.92 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.435 1.094 . . . . 0.0 109.761 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.8 t -152.03 139.49 19.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.26 162.25 0.05 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.978 1.711 . . . . 0.0 112.186 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -58.88 87.41 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.106 0.963 . . . . 0.0 111.535 -171.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.9 t -172.95 170.85 4.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.937 1.295 . . . . 0.0 107.695 -164.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 m 37.13 52.44 1.13 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.884 1.674 . . . . 0.0 112.598 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.0 p -127.08 -76.1 0.58 Allowed 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.8 t -56.85 -38.8 73.19 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -168.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.8 m -47.51 -60.39 2.56 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.654 167.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.55 -48.95 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.52 ' HA ' HG21 ' A' ' 34' ' ' ILE . 53.5 mt-10 -56.83 -68.0 0.26 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.875 0.845 . . . . 0.0 111.663 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.63 -48.93 22.5 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.735 1.636 . . . . 0.0 111.834 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -63.72 -55.49 22.9 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 117.945 0.872 . . . . 0.0 110.312 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.546 ' CG2' HG21 ' A' ' 31' ' ' VAL . 10.8 mm -50.67 -41.35 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.93 0.892 . . . . 0.0 110.436 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.07 -22.75 13.95 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.953 1.739 . . . . 0.0 114.138 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -94.31 -20.78 19.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 118.892 1.346 . . . . 0.0 110.492 177.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 134.21 50.69 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 122.727 1.251 . . . . 0.0 111.68 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -53.62 113.68 1.27 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.088 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.62 -26.39 7.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 118.269 -1.295 . . . . 0.0 112.141 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.811 HG23 ' HE2' ' A' ' 57' ' ' MET . 2.2 t -75.99 140.44 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 118.926 1.363 . . . . 0.0 109.457 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.503 ' HB2' HG12 ' A' ' 46' ' ' VAL . 7.8 mm-40 -103.61 -41.16 6.04 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.598 167.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -159.72 163.34 34.81 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.529 -0.732 . . . . 0.0 109.941 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 22' ' ' GLU . 14.4 tt -147.38 148.71 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 124.952 1.301 . . . . 0.0 108.946 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 102.74 4.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.907 1.683 . . . . 0.0 107.861 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -91.23 133.42 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.61 1.164 . . . . 0.0 108.894 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 t -122.49 102.63 8.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.045 0.938 . . . . 0.0 110.52 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.63 -58.24 7.88 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.641 0.777 . . . . 0.0 110.758 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -42.24 -54.46 3.69 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.218 1.407 . . . . 0.0 110.942 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.26 -19.21 51.17 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.938 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 65.88 18.88 11.22 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.205 2.202 . . . . 0.0 110.996 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.29 163.57 20.46 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.249 2.22 . . . . 0.0 108.431 -171.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.15 133.65 17.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.064 0.545 . . . . 0.0 109.839 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.1 m -106.47 100.94 10.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -173.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.4 HG12 HD12 ' A' ' 34' ' ' ILE . 80.5 mt -90.75 165.66 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 32' ' ' GLN . 1.1 t -139.67 120.41 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -157.14 176.17 13.09 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.706 0.802 . . . . 0.0 111.757 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -122.81 139.91 32.2 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -69.61 84.0 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.245 3.296 . . . . 0.0 109.574 174.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -168.43 -61.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.0 mt -82.16 -25.92 33.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.219 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 52' ' ' ILE . 11.2 tp -117.79 161.2 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 123.501 0.721 . . . . 0.0 110.423 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 m -93.86 26.79 3.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.219 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 70.11 -59.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 129.406 3.082 . . . . 0.0 110.49 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.91 -32.49 40.19 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.444 1.498 . . . . 0.0 109.562 -175.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -49.44 -48.75 47.2 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.811 ' HE2' HG23 ' A' ' 31' ' ' VAL . 5.4 mtt -44.93 -53.5 7.56 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.213 0.605 . . . . 0.0 111.512 174.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.539 ' HD3' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -72.47 -36.61 68.51 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.559 -0.713 . . . . 0.0 112.569 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.449 ' HD2' ' CE ' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -61.29 -31.68 71.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 120.535 -1.353 . . . . 0.0 110.835 176.087 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -35.14 80.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.9 -47.25 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.003 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -50.96 -48.73 60.92 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.37 0.986 . . . . 0.0 108.697 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.05 -21.72 46.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.457 1.103 . . . . 0.0 113.664 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.9 mmt -66.91 -28.03 67.98 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.553 1.069 . . . . 0.0 110.786 172.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.62 -33.38 3.0 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.759 1.171 . . . . 0.0 110.731 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -78.36 115.56 52.14 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.19 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -62.27 121.83 10.01 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.695 1.596 . . . . 0.0 109.146 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.95 163.77 26.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.662 0.785 . . . . 0.0 109.039 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CA ' ' HD2' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -151.28 140.34 21.12 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 125.211 1.405 . . . . 0.0 109.588 -156.034 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.539 HG23 ' HD3' ' A' ' 58' ' ' LYS . 1.2 t -91.53 127.25 43.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -100.26 -64.43 1.04 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.895 0.478 . . . . 0.0 110.689 171.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -92.2 170.4 9.84 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.66 177.06 3.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.89 1.276 . . . . 0.0 109.128 -174.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -75.4 176.32 7.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.923 1.289 . . . . 0.0 109.339 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.2 -176.15 17.55 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.322 0.963 . . . . 0.0 111.328 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 . . . . . 0 C--O 1.249 1.045 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 173.267 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.689 0 N-CA-C 107.289 -2.325 . . . . 0.0 107.289 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 22.85 65.63 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.934 2.094 . . . . 0.0 114.363 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.18 145.18 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 124.532 1.133 . . . . 0.0 109.404 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.27 124.29 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 125.579 1.552 . . . . 0.0 108.954 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.455 HD13 ' HB ' ' A' ' 73' ' ' ILE . 16.1 tp -107.57 143.21 36.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.358 1.863 . . . . 0.0 107.144 169.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -111.6 120.71 43.01 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 164.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.0 ptm -111.57 162.51 15.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.709 1.203 . . . . 0.0 109.909 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -97.2 125.88 42.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.506 1.523 . . . . 0.0 108.748 168.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 t -116.73 72.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 126.693 1.997 . . . . 0.0 106.83 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.271 3.6 pt-20 -82.48 176.77 9.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.33 0.652 . . . . 0.0 111.657 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.94 -57.53 3.93 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.541 -0.724 . . . . 0.0 112.006 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -58.56 130.22 45.78 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.328 1.064 . . . . 0.0 110.294 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.0 t -165.97 74.68 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.121 0.969 . . . . 0.0 109.176 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.7 p -158.78 28.2 0.22 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.251 -0.906 . . . . 0.0 113.118 -171.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 35.05 51.56 0.55 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.473 1.909 . . . . 0.0 113.643 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 t -161.02 -50.62 0.05 OUTLIER 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.661 0.784 . . . . 0.0 109.725 -169.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.4 m -72.5 69.34 0.85 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.685 0.794 . . . . 0.0 111.065 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.5 p -131.14 -72.91 0.54 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 m -55.79 -38.78 70.4 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -167.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.84 -53.69 48.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 171.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.04 -53.03 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -56.71 -65.06 0.68 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.804 0.811 . . . . 0.0 110.069 -174.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.26 -52.66 17.64 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.323 1.916 . . . . 0.0 112.238 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.38 -52.78 63.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.106 0.953 . . . . 0.0 109.864 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.0 mm -58.77 -30.82 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 123.176 0.59 . . . . 0.0 111.203 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.11 -20.39 27.62 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.886 1.232 . . . . 0.0 113.6 174.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.8 -9.94 47.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.368 1.584 . . . . 0.0 110.96 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.44 133.11 48.93 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.354 1.073 . . . . 0.0 110.764 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -54.66 104.89 0.13 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.807 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.18 -26.94 5.71 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 118.991 -0.894 . . . . 0.0 113.102 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.6 t -79.69 131.84 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 118.483 1.141 . . . . 0.0 110.042 -172.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -98.36 -47.31 5.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.528 1.531 . . . . 0.0 110.022 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -151.33 167.36 28.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.253 0.478 . . . . 0.0 110.191 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.8 tt -149.61 143.97 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.069 1.348 . . . . 0.0 109.439 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -130.19 122.69 28.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.309 2.244 . . . . 0.0 105.865 167.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG22 ' HB1' ' A' ' 43' ' ' ALA . 69.1 t -117.81 103.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 120.279 1.4 . . . . 0.0 109.52 176.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 m -85.21 99.45 11.11 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 mt -53.84 170.26 0.13 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.902 158.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 67.59 -60.6 0.38 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 127.991 2.516 . . . . 0.0 110.417 -171.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -24.86 67.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.574 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 65.55 23.12 11.79 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.469 1.908 . . . . 0.0 111.182 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -119.76 135.24 54.93 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.809 0.844 . . . . 0.0 109.706 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB1' HG22 ' A' ' 36' ' ' VAL . . . -132.12 152.85 51.02 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 m -129.38 120.71 26.01 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.136 1.774 . . . . 0.0 106.482 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.57 154.34 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.52 119.05 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -158.0 -179.69 8.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.825 1.25 . . . . 0.0 109.163 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -133.12 146.06 59.5 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.15 75.05 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 124.414 3.409 . . . . 0.0 109.983 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.99 -60.03 0.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.804 1.242 . . . . 0.0 107.991 172.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -80.67 -27.47 37.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.064 -0.493 . . . . 0.0 110.464 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.4 tp -122.23 144.16 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.739 0.816 . . . . 0.0 109.99 -175.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.2 m -77.29 23.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 72.12 -63.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 128.602 2.761 . . . . 0.0 109.095 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -42.08 74.33 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.019 0.928 . . . . 0.0 108.819 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -38.9 -60.17 0.88 Allowed 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.075 0.95 . . . . 0.0 110.935 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -36.58 -57.05 0.79 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.811 1.644 . . . . 0.0 111.627 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -40.86 69.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.395 0.678 . . . . 0.0 111.705 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -60.42 -26.02 66.39 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 120.986 -1.071 . . . . 0.0 112.789 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -62.81 -37.75 88.0 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.6 mp -63.9 -45.05 98.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 117.55 -1.214 . . . . 0.0 111.528 173.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -49.87 -49.98 47.41 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.44 1.473 . . . . 0.0 108.304 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.07 -20.25 51.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.672 1.189 . . . . 0.0 113.848 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.5 mmt -65.19 -25.94 67.94 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.481 1.037 . . . . 0.0 110.58 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.68 -27.71 4.34 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.446 1.022 . . . . 0.0 111.197 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -86.37 123.0 71.97 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.51 130.74 30.99 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 N-CA-C 108.632 -1.334 . . . . 0.0 108.632 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.42 -176.53 3.61 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.364 0.666 . . . . 0.0 109.276 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.97 151.02 30.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.119 -0.988 . . . . 0.0 110.864 -175.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -119.31 133.01 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -78.16 -83.09 0.09 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.208 0.603 . . . . 0.0 110.562 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.47 149.19 23.77 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.455 ' HB ' HD13 ' A' ' 5' ' ' LEU . 3.3 tp -158.5 125.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 123.982 0.913 . . . . 0.0 109.357 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -150.32 163.06 39.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.35 168.59 38.8 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.981 -1.485 . . . . 0.0 110.837 -176.95 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.065 0 N-CA-C 108.489 -1.845 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -63.62 122.35 16.12 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.795 1.297 . . . . 0.0 107.652 167.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.3 t -145.61 148.85 17.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.1 t -85.3 133.71 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 125.748 1.619 . . . . 0.0 109.624 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.708 HD23 ' N ' ' A' ' 6' ' ' LYS . 6.0 tt -124.05 146.19 48.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.696 1.599 . . . . 0.0 108.673 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.708 ' N ' HD23 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -109.81 113.82 26.88 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.198 1.799 . . . . 0.0 109.133 178.453 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.4 mtt -109.2 131.53 54.98 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.738 0.815 . . . . 0.0 109.88 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -78.23 119.11 21.13 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 167.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.52 85.14 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.85 -175.35 3.03 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.543 0.737 . . . . 0.0 109.431 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.77 -40.79 2.29 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 121.371 -0.831 . . . . 0.0 113.356 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -49.32 130.85 20.06 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.378 1.089 . . . . 0.0 110.111 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t -44.58 -58.65 2.89 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.786 1.234 . . . . 0.0 112.152 -174.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 165.13 126.13 0.01 OUTLIER 'General case' 0 C--N 1.338 0.107 0 C-N-CA 127.228 2.211 . . . . 0.0 107.436 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 36.22 43.65 0.23 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.398 1.879 . . . . 0.0 114.538 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 t -146.93 39.55 1.03 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -176.78 70.28 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.912 1.285 . . . . 0.0 108.256 174.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p -120.02 -76.85 0.58 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.15 -38.93 68.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -168.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.6 m -48.84 -60.85 2.41 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.404 168.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.9 -50.57 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -58.65 -63.5 1.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.391 1.091 . . . . 0.0 109.153 -172.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.51 -56.59 6.29 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.99 1.757 . . . . 0.0 112.731 173.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -57.1 -52.59 64.67 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.114 0.957 . . . . 0.0 110.017 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.6 -27.43 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 123.718 0.807 . . . . 0.0 110.686 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.82 -19.95 11.81 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.069 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -85.79 -14.24 45.76 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.592 1.696 . . . . 0.0 110.146 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 132.63 48.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 122.438 1.114 . . . . 0.0 111.699 -172.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -57.78 107.03 0.41 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.25 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.38 -22.43 8.36 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.194 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.3 t -78.28 127.89 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 118.709 1.255 . . . . 0.0 108.841 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -89.67 -50.27 6.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.299 1.04 . . . . 0.0 108.77 172.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -154.25 160.89 42.03 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 118.988 0.813 . . . . 0.0 110.448 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 tt -141.77 142.27 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.623 1.569 . . . . 0.0 109.719 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -145.54 113.11 6.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.392 1.477 . . . . 0.0 107.753 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.9 t -113.0 92.47 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.47 1.508 . . . . 0.0 110.299 -172.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.1 m -82.13 78.59 8.79 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 124.171 0.988 . . . . 0.0 110.613 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.2 -42.04 28.9 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.312 0.645 . . . . 0.0 111.856 174.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -42.48 -51.86 4.88 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 125.94 1.696 . . . . 0.0 110.471 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -81.19 -13.66 58.36 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.15 -173.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 64.18 35.01 10.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 126.995 2.118 . . . . 0.0 109.572 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -156.15 144.45 19.92 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 125.434 1.709 . . . . 0.0 109.966 -166.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.5 157.91 41.38 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.402 1.081 . . . . 0.0 110.224 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 m -139.49 121.01 15.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.7 mt -124.9 162.89 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.079 1.351 . . . . 0.0 108.44 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 p -132.79 127.31 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 174.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -155.84 177.95 10.82 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.601 1.16 . . . . 0.0 108.818 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -126.25 142.41 42.66 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.314 1.046 . . . . 0.0 113.122 171.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.96 72.12 3.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.878 3.719 . . . . 0.0 110.402 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.68 -56.65 0.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.175 0.99 . . . . 0.0 108.605 172.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.38 -31.09 37.87 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.459 ' HA ' HD12 ' A' ' 52' ' ' ILE . 9.0 tp -118.64 144.1 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 123.464 0.705 . . . . 0.0 109.668 -177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 m -81.95 27.81 0.45 Allowed 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -173.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 69.84 -64.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 129.582 3.153 . . . . 0.0 109.284 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -72.97 -39.6 65.99 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.48 1.112 . . . . 0.0 108.647 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' HB3' HD11 ' A' ' 52' ' ' ILE . 4.1 mm-40 -40.7 -55.94 2.27 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.43 1.092 . . . . 0.0 111.574 -173.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.13 -60.73 0.85 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.554 1.142 . . . . 0.0 110.082 177.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HZ2' ' HB3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -70.37 -32.98 70.89 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.093 -176.608 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -64.54 -29.55 70.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 119.194 -2.191 . . . . 0.0 111.537 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -63.32 -44.15 95.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.13 -43.5 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.908 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -55.25 -54.15 47.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.771 1.169 . . . . 0.0 107.978 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.15 -27.73 64.05 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.816 1.646 . . . . 0.0 114.174 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.9 mmt -52.63 -28.77 22.82 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.362 0.983 . . . . 0.0 111.187 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.87 39.98 0.62 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 124.641 1.115 . . . . 0.0 110.908 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -149.07 119.22 4.05 Favored Pre-proline 0 N--CA 1.457 -0.093 0 CA-C-O 117.995 -1.002 . . . . 0.0 108.438 -175.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.48 109.87 1.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.905 1.737 . . . . 0.0 109.597 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.9 -168.36 1.31 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.949 1.3 . . . . 0.0 108.449 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -163.44 152.56 14.49 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.117 0.967 . . . . 0.0 110.504 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 64.2 t -94.35 128.32 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 170.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -98.7 -68.48 0.8 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.215 0.461 . . . . 0.0 111.165 169.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -88.52 175.48 7.56 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 tt -156.89 177.37 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 119.394 0.997 . . . . 0.0 109.368 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.61 143.22 48.29 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.538 1.063 . . . . 0.0 108.283 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.84 -174.04 46.75 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 . . . . . 0 C--O 1.248 0.988 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 169.922 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 76' ' ' ARG . . . . . . . . 0 N--CA 1.468 0.784 0 N-CA-C 106.449 -2.661 . . . . 0.0 106.449 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -30.03 101.21 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.551 1.94 . . . . 0.0 113.588 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.591 HG21 ' O ' ' A' ' 74' ' ' GLU . 3.9 p -117.1 149.29 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.934 0.894 . . . . 0.0 109.185 176.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.32 121.3 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.657 1.983 . . . . 0.0 108.688 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.433 HD13 ' HB ' ' A' ' 73' ' ' ILE . 16.7 tp -112.22 119.31 37.93 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.134 0.574 . . . . 0.0 110.553 171.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.07 126.97 36.31 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.957 1.303 . . . . 0.0 109.552 170.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -132.37 157.79 43.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.975 1.31 . . . . 0.0 109.702 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 133.91 36.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 t -128.98 79.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.957 1.303 . . . . 0.0 108.448 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.66 147.18 29.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.2 -38.54 2.55 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.307 -0.718 . . . . 0.0 113.569 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -56.35 120.46 7.66 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.427 1.114 . . . . 0.0 109.762 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 t -76.97 50.64 0.74 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.443 1.097 . . . . 0.0 111.675 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p 46.35 -162.44 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.661 1.584 . . . . 0.0 112.517 -167.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.6 m170 46.08 92.85 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.098 1.759 . . . . 0.0 114.806 174.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.4 t 66.62 -153.93 0.23 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.767 0.827 . . . . 0.0 109.595 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m 60.97 34.57 19.36 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.954 0.902 . . . . 0.0 109.608 -169.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.91 -72.33 0.69 Allowed 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 170.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -53.01 -39.15 62.92 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -170.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.3 m -51.29 -57.9 7.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 O-C-N 123.291 0.369 . . . . 0.0 111.587 170.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.4 -51.36 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.5 -61.78 2.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.091 0.948 . . . . 0.0 110.229 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.15 -54.17 13.12 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.948 1.737 . . . . 0.0 112.391 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -59.37 -52.36 65.96 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.111 0.955 . . . . 0.0 110.541 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.415 HG21 HD12 ' A' ' 34' ' ' ILE . 19.2 mm -57.22 -36.8 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 123.834 0.854 . . . . 0.0 110.143 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.12 -20.13 33.9 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.844 1.212 . . . . 0.0 114.137 172.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -84.88 -27.44 26.67 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.477 1.638 . . . . 0.0 109.99 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.22 139.34 52.25 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.443 1.116 . . . . 0.0 112.722 -168.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -53.8 115.11 1.82 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.051 1.34 . . . . 0.0 111.52 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.72 -28.57 6.4 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 124.064 0.84 . . . . 0.0 112.053 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.68 141.38 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 117.468 0.634 . . . . 0.0 110.051 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -121.1 -21.61 6.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.4 1.08 . . . . 0.0 111.811 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -160.41 164.63 32.17 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.398 0.999 . . . . 0.0 109.706 172.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.415 HD12 HG21 ' A' ' 25' ' ' ILE . 15.4 tt -155.5 143.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 123.91 0.884 . . . . 0.0 108.655 174.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.28 113.71 10.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.284 1.833 . . . . 0.0 106.527 171.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -100.34 103.13 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.229 0.922 . . . . 0.0 109.606 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -74.0 73.29 1.67 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.303 1.041 . . . . 0.0 110.267 175.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -50.66 161.07 0.37 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.426 1.49 . . . . 0.0 109.772 167.152 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.575 ' H ' HD13 ' A' ' 38' ' ' LEU . 20.3 m-20 65.46 -53.5 0.35 Allowed 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 128.042 2.537 . . . . 0.0 110.952 -162.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -67.59 -23.36 65.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -172.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 68.95 26.62 5.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.987 2.115 . . . . 0.0 111.864 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -117.82 150.04 39.82 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.59 1.556 . . . . 0.0 106.876 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.03 159.9 43.42 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.295 -0.878 . . . . 0.0 109.564 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 m -132.6 106.32 7.74 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.713 1.605 . . . . 0.0 107.399 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 mt -90.08 163.16 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.45 117.86 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.153 1.381 . . . . 0.0 108.325 168.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -157.48 -178.2 7.16 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.31 1.444 . . . . 0.0 110.846 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -132.02 144.75 54.47 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.398 1.479 . . . . 0.0 113.86 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.22 68.88 4.1 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.752 3.635 . . . . 0.0 110.025 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.19 -57.06 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.541 1.136 . . . . 0.0 108.771 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.1 -20.52 37.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.65 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.1 tp -127.88 150.61 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 123.128 0.571 . . . . 0.0 110.475 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.6 m -79.46 25.02 0.33 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -176.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 71.3 -61.48 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.952 2.501 . . . . 0.0 108.889 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.08 -38.31 61.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.887 -174.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HB3' HD11 ' A' ' 52' ' ' ILE . 22.8 mt-10 -45.95 -51.24 13.69 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.819 0.736 . . . . 0.0 111.981 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.78 -54.61 6.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.225 1.01 . . . . 0.0 111.71 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -64.64 -49.38 71.25 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.652 -0.655 . . . . 0.0 110.653 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -65.62 -24.94 67.17 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.228 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -62.4 -47.49 83.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.41 -45.85 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -58.08 -49.67 76.1 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.64 -26.81 65.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.391 1.476 . . . . 0.0 113.442 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.0 mmm -54.88 -32.95 61.42 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.626 1.103 . . . . 0.0 110.387 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.6 -42.71 0.79 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -75.6 111.21 13.2 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.353 -171.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.81 110.3 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.169 1.913 . . . . 0.0 109.161 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.37 -167.16 1.27 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.192 1.397 . . . . 0.0 108.813 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.98 134.78 5.14 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.296 0.953 . . . . 0.0 113.025 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.6 p -87.5 138.38 19.19 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 C-N-CA 123.399 0.68 . . . . 0.0 110.058 174.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -83.29 -86.84 0.11 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.768 0.427 . . . . 0.0 110.308 173.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -157.14 157.62 34.8 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.433 ' HB ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -153.54 150.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.871 2.069 . . . . 0.0 106.625 -178.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.591 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -157.34 147.89 21.17 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 165.195 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.12 133.21 8.12 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.576 1.084 . . . . 0.0 111.945 -165.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 1' ' ' GLY . 58.1 ttt180 . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.132 -1.414 . . . . 0.0 112.728 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.082 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -164.88 155.28 14.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -169.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.467 HG23 HD11 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -134.28 147.53 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.399 1.479 . . . . 0.0 109.378 -174.355 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.19 133.71 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 124.535 1.134 . . . . 0.0 109.669 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.423 HD13 ' HB ' ' A' ' 73' ' ' ILE . 16.7 tp -119.97 131.72 55.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.45 1.5 . . . . 0.0 108.748 172.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -93.17 117.04 29.61 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.349 1.06 . . . . 0.0 108.516 167.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.48 ' SD ' HD11 ' A' ' 45' ' ' ILE . 14.8 ptm -114.61 156.99 23.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.392 0.677 . . . . 0.0 109.211 172.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -100.29 129.34 46.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.54 1.536 . . . . 0.0 107.052 170.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.06 69.41 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.82 163.66 25.36 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.29 0.567 . . . . 0.0 109.594 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.44 -40.11 2.84 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 121.004 -1.06 . . . . 0.0 113.101 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.3 mtt -67.86 84.76 0.21 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.676 1.238 . . . . 0.0 109.506 172.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.7 p -99.5 26.11 6.41 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.756 1.223 . . . . 0.0 111.587 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.1 t -117.79 118.3 31.66 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.197 0.999 . . . . 0.0 108.36 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -49.58 -40.16 37.7 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.072 0.549 . . . . 0.0 111.882 -174.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 t -80.26 56.39 2.47 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.814 -0.554 . . . . 0.0 110.698 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 m -139.33 49.45 1.82 Allowed 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.3 p -120.48 -76.15 0.58 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 173.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.4 t -52.18 -45.18 65.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -165.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.5 m -48.5 -56.75 7.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.22 0.208 . . . . 0.0 111.117 169.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -59.93 -49.34 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 123.414 0.686 . . . . 0.0 109.415 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -59.61 -61.55 2.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.918 0.887 . . . . 0.0 109.555 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.86 -56.95 6.37 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.708 1.623 . . . . 0.0 112.401 172.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -57.68 -54.05 51.24 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.018 0.909 . . . . 0.0 110.269 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 mm -60.97 -31.94 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 124.016 0.926 . . . . 0.0 110.921 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.41 -17.9 27.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.886 1.232 . . . . 0.0 113.657 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -84.79 -13.62 50.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.941 1.371 . . . . 0.0 110.392 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.63 140.49 44.33 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.93 0.871 . . . . 0.0 111.983 -169.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -59.7 114.57 2.82 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.059 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.59 -24.5 10.31 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.212 0.911 . . . . 0.0 112.317 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.61 137.63 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 118.035 0.918 . . . . 0.0 110.126 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -106.91 -48.36 3.51 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.937 1.295 . . . . 0.0 109.554 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.04 161.84 41.97 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -178.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 tt -149.49 140.11 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 123.676 0.791 . . . . 0.0 109.246 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -135.88 101.08 4.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.795 2.038 . . . . 0.0 107.279 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -98.85 118.69 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.809 0.844 . . . . 0.0 109.128 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.9 m -98.3 90.88 4.97 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.632 0.773 . . . . 0.0 108.995 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.6 170.55 0.25 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.392 161.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 71.15 -57.36 0.6 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.092 2.557 . . . . 0.0 108.601 -168.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.69 -27.07 64.7 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.569 -174.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 70.07 20.63 6.39 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 111.862 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.16 144.94 42.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.921 1.688 . . . . 0.0 108.244 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.79 155.75 47.91 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 121.328 -0.857 . . . . 0.0 110.035 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 m -126.07 115.22 19.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.918 1.687 . . . . 0.0 106.635 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.48 HD11 ' SD ' ' A' ' 7' ' ' MET . 35.7 mt -108.41 154.91 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.31 122.28 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 118.734 0.697 . . . . 0.0 109.789 168.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -156.25 177.82 11.0 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.952 1.701 . . . . 0.0 108.872 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -124.2 136.89 28.17 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 119.427 1.012 . . . . 0.0 111.736 169.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.8 73.07 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.136 3.224 . . . . 0.0 110.332 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -135.3 -50.57 0.75 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.4 mt -94.02 -17.63 22.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.782 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 52' ' ' ILE . 11.2 tp -119.78 150.4 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.519 1.054 . . . . 0.0 110.21 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.3 m -83.54 19.82 1.51 Allowed 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 70.67 -62.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 128.038 2.535 . . . . 0.0 109.573 -177.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -70.2 -38.05 75.24 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -49.75 -47.64 50.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 123.534 0.521 . . . . 0.0 111.442 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -40.93 -52.09 3.14 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 177.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.09 -44.92 68.07 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.276 -0.265 . . . . 0.0 110.89 177.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -54.85 -32.17 60.37 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.593 -0.692 . . . . 0.0 112.7 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -37.85 88.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.38 -50.99 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.909 170.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 8.2 mt-10 -52.34 -46.82 66.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.336 0.971 . . . . 0.0 109.393 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.44 -21.36 50.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.94 1.696 . . . . 0.0 113.554 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.9 mmt -65.51 -31.95 73.29 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.372 0.987 . . . . 0.0 110.15 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.89 -37.01 1.47 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.906 0.765 . . . . 0.0 111.301 173.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -75.91 116.36 54.77 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 117.784 -1.103 . . . . 0.0 108.876 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.24 120.24 7.61 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.124 1.883 . . . . 0.0 108.685 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.403 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -115.08 -170.3 1.73 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.808 0.813 . . . . 0.0 109.413 -175.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.35 152.99 19.16 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.841 -1.162 . . . . 0.0 110.674 -176.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.84 132.08 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -83.5 -127.66 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.622 0.576 . . . . 0.0 109.526 172.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.2 146.98 33.28 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 118.695 0.68 . . . . 0.0 110.129 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.467 HD11 HG23 ' A' ' 3' ' ' VAL . 1.9 tp -157.43 125.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -156.87 154.74 30.29 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.01 75.57 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 106.98 -2.448 . . . . 0.0 106.98 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 116.714 -1.612 . . . . 0.0 108.564 176.897 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.034 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -108.18 -164.03 0.93 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.365 1.066 . . . . 0.0 109.641 -159.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.3 t -82.88 123.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.8 t -79.25 115.61 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 126.074 1.75 . . . . 0.0 109.231 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 6' ' ' LYS . 6.6 tt -89.21 155.86 19.14 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.663 0.785 . . . . 0.0 109.493 169.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' N ' HD23 ' A' ' 5' ' ' LEU . 3.6 tmtt? -135.44 116.63 14.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.511 ' SD ' HD11 ' A' ' 45' ' ' ILE . 5.0 ptm -128.99 153.2 47.8 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.948 1.299 . . . . 0.0 110.792 -170.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.99 129.16 49.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.076 0.951 . . . . 0.0 108.598 170.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.05 76.45 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 125.379 1.472 . . . . 0.0 107.77 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.3 114.79 3.37 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.126 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.98 -67.35 0.54 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.978 1.275 . . . . 0.0 111.407 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.9 mmt -80.75 93.53 6.22 Favored 'General case' 0 C--N 1.335 -0.034 0 O-C-N 121.936 -0.743 . . . . 0.0 111.129 -166.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 t -124.99 12.04 8.34 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.474 1.11 . . . . 0.0 112.855 -172.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -152.91 109.87 3.48 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.927 -1.108 . . . . 0.0 109.816 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.432 ' HA ' HD13 ' A' ' 38' ' ' LEU . 12.6 t-80 -1.82 78.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 128.967 2.907 . . . . 0.0 115.362 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 t -166.46 153.96 9.76 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -175.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 34.61 73.78 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.121 1.768 . . . . 0.0 113.229 176.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 p -127.13 -71.98 0.66 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -54.64 -36.35 64.46 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 m -52.32 -58.66 5.97 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 123.105 0.253 . . . . 0.0 111.18 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.33 -52.21 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -58.21 -67.37 0.35 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.881 0.848 . . . . 0.0 110.996 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.33 -51.68 11.57 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.581 1.563 . . . . 0.0 112.358 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -63.99 -48.84 74.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.09 0.945 . . . . 0.0 110.362 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.2 mm -59.44 -30.15 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 O-C-N 122.059 -0.401 . . . . 0.0 110.954 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.81 -23.24 6.72 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.391 0.996 . . . . 0.0 114.253 170.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -81.86 -18.22 44.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.799 1.799 . . . . 0.0 111.524 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.28 136.34 56.47 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.865 0.84 . . . . 0.0 111.038 -165.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -56.27 100.66 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.794 1.238 . . . . 0.0 110.324 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.96 -27.2 5.18 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.059 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.31 134.84 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 118.598 1.199 . . . . 0.0 109.76 -172.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -105.64 -36.97 6.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.771 1.228 . . . . 0.0 110.309 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -159.05 169.77 23.52 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.296 0.953 . . . . 0.0 111.459 173.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -150.14 152.67 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.548 1.539 . . . . 0.0 108.932 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -150.38 116.2 5.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.706 1.603 . . . . 0.0 108.345 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.3 t -110.96 117.76 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.639 1.576 . . . . 0.0 109.96 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.4 m -103.23 108.21 19.34 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.445 1.498 . . . . 0.0 110.107 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 15' ' ' HIS . 3.5 mt -60.55 -179.05 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.485 1.114 . . . . 0.0 110.308 164.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 63.43 -70.06 0.07 Allowed 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 128.103 2.561 . . . . 0.0 111.029 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -61.57 -28.36 69.29 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.043 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.59 60.43 1.34 Allowed 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 126.711 2.005 . . . . 0.0 111.359 173.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -151.57 156.44 40.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.18 166.52 24.48 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.873 -0.517 . . . . 0.0 109.953 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.36 144.0 34.3 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.511 HD11 ' SD ' ' A' ' 7' ' ' MET . 13.2 mt -123.25 162.95 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.27 1.5 p -134.55 113.27 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 119.243 0.929 . . . . 0.0 108.715 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -158.96 179.54 8.98 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.077 1.351 . . . . 0.0 109.578 -170.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.74 147.92 53.55 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.47 79.33 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.666 2.911 . . . . 0.0 109.901 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.22 -52.62 0.5 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.765 1.626 . . . . 0.0 107.147 166.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.05 -22.69 18.98 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.236 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 tp -129.13 147.67 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 123.724 0.81 . . . . 0.0 111.204 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -80.74 27.24 0.38 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -170.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 71.67 -60.65 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 127.879 2.472 . . . . 0.0 109.862 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.54 -42.32 52.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.009 1.324 . . . . 0.0 109.304 -177.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -50.47 -52.97 33.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 123.566 0.541 . . . . 0.0 110.648 -171.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -36.93 -63.38 0.42 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.774 1.229 . . . . 0.0 111.538 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -39.24 72.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.771 -0.581 . . . . 0.0 110.359 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -58.29 -27.33 63.98 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.04 -1.038 . . . . 0.0 113.162 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -41.99 96.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.766 1.167 . . . . 0.0 108.787 176.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.77 -39.09 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.314 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -60.43 -49.84 75.97 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.87 -28.89 64.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.438 1.095 . . . . 0.0 113.195 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.0 mmt -53.05 -34.34 56.06 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.215 0.916 . . . . 0.0 111.463 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.56 -38.91 1.33 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -73.3 113.06 18.63 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.585 -173.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.74 108.63 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.08 1.853 . . . . 0.0 108.384 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.09 -177.43 4.13 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.305 1.042 . . . . 0.0 108.336 -171.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -156.91 140.18 15.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.099 0.863 . . . . 0.0 112.69 -165.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -102.23 133.13 46.73 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 126.667 1.987 . . . . 0.0 109.887 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -82.71 -77.39 0.24 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.885 0.474 . . . . 0.0 110.792 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.17 157.85 35.17 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.49 115.62 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.58 1.152 . . . . 0.0 110.145 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -155.59 160.01 40.12 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.89 161.82 4.72 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 123.797 0.686 . . . . 0.0 112.356 175.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.005 -1.474 . . . . 0.0 110.533 179.767 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.009 0 CA-C-O 118.392 -1.227 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 38.44 56.28 1.8 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.483 1.135 . . . . 0.0 111.161 -172.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t -81.17 126.2 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 124.825 1.25 . . . . 0.0 107.993 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.84 125.36 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.595 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -131.38 137.16 48.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -93.13 129.32 39.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.263 0.625 . . . . 0.0 111.079 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.465 ' CG ' HD11 ' A' ' 5' ' ' LEU . 27.0 mtt -108.44 155.24 20.81 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.171 0.988 . . . . 0.0 109.977 169.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 118.35 36.59 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 167.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.0 t -100.86 76.91 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.13 168.73 19.42 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.686 0.755 . . . . 0.0 111.675 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.8 -46.51 2.36 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.206 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.416 ' HB3' HD21 ' A' ' 38' ' ' LEU . 1.4 mpt? -51.92 102.51 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.916 0.858 . . . . 0.0 110.295 171.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -123.52 33.22 5.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.729 1.211 . . . . 0.0 110.353 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.1 t -156.58 138.43 14.33 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.427 0.691 . . . . 0.0 109.692 174.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -73.72 43.3 0.15 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.441 1.496 . . . . 0.0 113.705 -171.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -137.93 12.87 2.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.136 0.974 . . . . 0.0 111.027 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.7 m -127.58 60.01 1.43 Allowed 'General case' 0 C--N 1.339 0.135 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.73 -75.31 0.5 Allowed 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.2 t -50.7 -43.14 57.65 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 m -49.53 -56.2 10.7 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.248 -0.283 . . . . 0.0 111.064 170.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.31 -49.11 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.294 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -51.81 -67.65 0.23 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.52 1.054 . . . . 0.0 110.806 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.33 -50.17 29.89 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.621 1.582 . . . . 0.0 111.882 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.23 -55.31 36.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.696 0.748 . . . . 0.0 109.846 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.9 mm -61.79 -28.75 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 124.2 1.0 . . . . 0.0 110.726 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.45 -20.36 16.45 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.632 1.11 . . . . 0.0 113.581 173.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -90.13 -6.22 55.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.304 1.552 . . . . 0.0 111.408 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.21 135.65 47.63 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 122.044 0.926 . . . . 0.0 111.291 -173.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -57.95 101.63 0.08 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.292 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.46 -24.85 6.41 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.821 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 t -81.95 137.76 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 118.917 1.358 . . . . 0.0 108.253 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -117.35 -34.59 4.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.087 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.11 161.28 38.4 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.818 1.19 . . . . 0.0 110.332 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tt -152.75 143.43 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.628 1.171 . . . . 0.0 110.054 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -141.08 108.68 5.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.365 1.866 . . . . 0.0 108.164 168.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.62 118.48 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 124.731 1.212 . . . . 0.0 109.352 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 t -104.89 82.45 1.87 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.441 1.097 . . . . 0.0 109.164 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 12' ' ' MET . 0.2 OUTLIER -51.53 -49.37 62.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.988 0.915 . . . . 0.0 111.3 -176.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -44.43 -51.91 8.27 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 125.162 1.385 . . . . 0.0 110.866 172.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -75.58 -9.55 58.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.946 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 62.7 24.03 14.3 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.034 2.134 . . . . 0.0 110.896 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -141.78 160.42 40.23 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.89 1.276 . . . . 0.0 109.678 -170.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.99 158.87 43.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.8 0.84 . . . . 0.0 109.364 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.3 m -132.65 108.05 8.8 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 127.526 2.33 . . . . 0.0 106.202 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mt -116.82 156.23 18.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 124.044 0.938 . . . . 0.0 108.81 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.257 0.5 OUTLIER -132.3 114.07 22.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 118.078 0.399 . . . . 0.0 109.94 -175.476 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.444 ' HE1' HD12 ' A' ' 5' ' ' LEU . 52.8 p90 -157.41 179.05 9.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.402 1.081 . . . . 0.0 110.248 -169.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -141.17 132.18 13.47 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 123.902 0.881 . . . . 0.0 110.482 -170.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.22 73.5 2.07 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.751 2.968 . . . . 0.0 110.108 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -144.79 -51.7 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -87.87 -27.84 21.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.707 -0.664 . . . . 0.0 111.236 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.3 tp -120.93 143.6 32.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 CA-C-N 118.897 0.771 . . . . 0.0 110.169 -175.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -83.44 31.37 0.46 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -171.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.284 0.5 OUTLIER 74.78 -58.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 128.411 2.684 . . . . 0.0 111.447 170.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -80.77 -38.95 27.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.463 1.905 . . . . 0.0 108.247 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HB3' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -44.8 -53.53 7.33 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 123.774 0.83 . . . . 0.0 111.696 -174.513 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -34.9 -56.98 0.56 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.613 1.565 . . . . 0.0 110.065 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -42.09 71.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.765 0.426 . . . . 0.0 111.14 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -56.76 -28.5 61.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -63.22 -44.18 95.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.37 -46.26 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 117.987 -1.006 . . . . 0.0 111.038 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -52.12 -51.83 55.36 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.754 1.161 . . . . 0.0 108.421 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.59 -20.9 63.83 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.55 2.34 . . . . 0.0 114.056 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.4 mmt -54.82 -32.61 60.6 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.625 1.102 . . . . 0.0 110.123 168.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.47 43.08 0.48 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -147.05 132.61 9.24 Favored Pre-proline 0 C--O 1.223 -0.296 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.7 123.34 11.54 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 121.083 1.423 . . . . 0.0 108.953 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.71 175.02 9.37 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.572 1.177 . . . . 0.0 110.102 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.98 150.91 24.75 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.992 -1.068 . . . . 0.0 111.017 -163.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.457 ' CG2' HD21 ' A' ' 5' ' ' LEU . 10.0 p -126.58 125.21 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -174.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.3 mtmt -77.57 -71.06 0.44 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.262 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.42 ' O ' HD23 ' A' ' 5' ' ' LEU . 14.7 mttt -157.19 138.8 14.02 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 tp -147.97 102.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.371 1.468 . . . . 0.0 107.281 -174.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -156.46 154.66 30.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.456 0.571 . . . . 0.0 110.052 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.21 -173.0 31.43 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 107.587 -2.205 . . . . 0.0 107.587 -175.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 . . . . . 0 C--O 1.25 1.129 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 179.293 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.032 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -131.26 89.11 2.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.669 0.788 . . . . 0.0 109.442 -168.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.52 138.35 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 127.123 2.169 . . . . 0.0 107.1 174.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.3 t -92.08 132.42 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 125.501 1.52 . . . . 0.0 108.47 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.516 HD23 HG23 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -110.33 129.91 55.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 170.071 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.59 121.9 44.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.29 1.436 . . . . 0.0 107.127 169.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.451 ' HB3' HD11 ' A' ' 5' ' ' LEU . 26.4 ptt? -129.91 140.21 50.99 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.302 0.641 . . . . 0.0 110.479 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.84 145.22 34.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 164.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 t -136.16 72.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.663 1.585 . . . . 0.0 107.269 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -71.45 176.17 4.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.684 0.754 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.74 -48.17 3.94 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.553 -0.581 . . . . 0.0 113.149 166.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.43 ' HB3' HD11 ' A' ' 38' ' ' LEU . 2.3 mpt? -56.54 144.58 31.05 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.345 1.073 . . . . 0.0 109.577 172.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.4 t -143.21 138.26 29.56 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.554 0.742 . . . . 0.0 109.82 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m 60.01 152.8 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.775 2.03 . . . . 0.0 111.368 -168.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -71.74 70.68 0.71 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.465 -0.772 . . . . 0.0 111.352 -172.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.3 t -123.64 -79.79 0.62 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.571 1.948 . . . . 0.0 107.719 -166.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 60.9 m -68.36 72.53 0.21 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.041 1.337 . . . . 0.0 109.742 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.2 p -139.05 -86.73 0.23 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.408 1.883 . . . . 0.0 106.629 -174.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.95 -36.31 65.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -168.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.3 m -49.98 -61.66 2.01 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.871 167.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.83 -51.1 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.31 -63.82 1.13 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.516 0.674 . . . . 0.0 110.549 -173.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.7 -54.38 6.69 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.998 1.761 . . . . 0.0 112.165 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -59.3 -54.38 47.46 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.151 0.975 . . . . 0.0 110.447 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.1 mm -56.52 -33.33 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.448 0.699 . . . . 0.0 111.302 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.65 -20.44 17.91 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.645 1.117 . . . . 0.0 113.904 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -84.59 -20.25 31.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.646 1.723 . . . . 0.0 111.138 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 136.24 53.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 122.339 1.066 . . . . 0.0 111.75 -167.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.59 115.15 1.81 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.905 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.88 -22.38 12.7 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-O 119.076 -0.847 . . . . 0.0 112.507 176.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.25 128.31 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 118.318 1.059 . . . . 0.0 109.388 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -88.6 -48.47 7.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.935 1.294 . . . . 0.0 109.116 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.72 171.27 19.84 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.309 0.958 . . . . 0.0 111.124 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 tt -141.55 142.78 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 124.703 1.201 . . . . 0.0 109.677 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.78 106.79 6.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.259 1.424 . . . . 0.0 107.774 170.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.64 125.76 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.2 1.0 . . . . 0.0 109.352 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -115.01 82.62 1.77 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.725 1.21 . . . . 0.0 108.283 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.43 HD11 ' HB3' ' A' ' 12' ' ' MET . 3.9 tt -52.23 -44.29 64.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.836 0.854 . . . . 0.0 110.298 176.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -40.89 -55.19 2.55 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.95 1.3 . . . . 0.0 111.085 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -79.68 -7.61 58.69 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.234 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 61.49 23.66 13.9 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.551 2.34 . . . . 0.0 111.283 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -139.69 159.81 41.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.034 -168.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.63 159.03 44.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.299 0.64 . . . . 0.0 109.482 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.4 m -132.77 119.89 20.9 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.8 mt -106.64 155.17 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.45 121.19 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 168.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -157.75 -177.3 6.47 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 127.478 2.311 . . . . 0.0 107.95 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -137.76 149.05 63.31 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 119.98 1.264 . . . . 0.0 112.278 170.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.56 72.49 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.259 3.306 . . . . 0.0 110.266 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.15 -61.43 0.42 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.242 1.417 . . . . 0.0 108.372 173.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.1 mt -84.75 -19.82 32.05 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.798 -0.62 . . . . 0.0 110.815 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.3 tp -123.97 152.33 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 123.288 0.635 . . . . 0.0 110.143 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 m -81.39 20.27 0.89 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.141 0.977 . . . . 0.0 113.433 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 66.91 -61.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 129.23 3.012 . . . . 0.0 109.84 -172.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.94 -39.0 72.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.643 0.777 . . . . 0.0 110.066 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.4 mt-10 -47.47 -50.7 22.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.364 0.415 . . . . 0.0 111.663 -174.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.21 -48.22 6.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 122.934 0.494 . . . . 0.0 111.626 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -51.66 24.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 122.227 -0.296 . . . . 0.0 110.71 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -57.99 -27.6 63.63 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -60.51 -51.38 69.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.894 0.877 . . . . 0.0 108.681 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.95 -50.14 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.659 173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -53.93 -47.44 71.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.34 -20.64 60.12 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.441 1.496 . . . . 0.0 114.227 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.7 mmt -60.94 -29.97 69.94 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.956 1.253 . . . . 0.0 110.348 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.42 -34.74 1.7 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 173.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -77.09 110.53 12.39 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.192 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.72 116.95 4.23 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.737 1.625 . . . . 0.0 109.217 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.84 -169.5 2.13 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.236 1.014 . . . . 0.0 109.438 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.46 136.87 8.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.753 1.16 . . . . 0.0 113.355 -169.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.04 136.11 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.76 1.224 . . . . 0.0 108.913 174.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -96.46 -70.63 0.71 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -147.12 158.89 44.09 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.516 HG23 HD23 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -145.63 83.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 125.461 1.504 . . . . 0.0 110.735 -159.596 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -161.4 177.41 10.14 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.416 0.553 . . . . 0.0 111.941 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.52 -157.33 6.44 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.433 0.54 . . . . 0.0 111.938 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 116.908 -1.52 . . . . 0.0 108.937 173.459 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.26 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -117.25 171.12 8.16 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.253 1.021 . . . . 0.0 109.151 -169.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.793 HG13 HD11 ' A' ' 73' ' ' ILE . 7.4 p -95.07 142.33 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.592 0.711 . . . . 0.0 109.896 -174.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.7 t -80.69 136.45 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 125.262 1.425 . . . . 0.0 109.784 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.662 HD21 HG22 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -127.65 138.37 52.81 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.274 1.83 . . . . 0.0 108.077 177.031 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.556 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.2 ttpt -110.68 114.79 28.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.806 1.242 . . . . 0.0 109.77 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.5 ptp -109.52 151.5 26.67 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.372 1.069 . . . . 0.0 109.827 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -89.67 133.34 34.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 163.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 t -118.71 78.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -72.91 167.93 20.0 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.928 0.87 . . . . 0.0 111.475 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.18 -76.95 1.04 Allowed Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.8 ttp 46.75 -127.78 1.53 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.372 1.469 . . . . 0.0 112.349 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.6 t -162.77 -171.89 2.88 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.194 1.361 . . . . 0.0 109.385 171.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.0 m -51.57 -70.91 0.07 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 126.182 1.793 . . . . 0.0 113.246 -170.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -140.88 43.38 1.82 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.669 0.747 . . . . 0.0 109.612 177.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.5 t -158.7 -152.41 0.33 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m 51.44 46.59 26.27 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -165.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.468 HG22 HG12 ' A' ' 36' ' ' VAL . 9.9 p -128.62 -77.09 0.56 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 174.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.4 m -49.08 -40.91 33.69 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -175.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.3 m -48.99 -58.49 4.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.144 0.497 . . . . 0.0 111.698 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.58 -45.24 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 123.937 0.895 . . . . 0.0 108.988 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HA ' HG21 ' A' ' 34' ' ' ILE . 47.1 mt-10 -54.35 -62.5 1.62 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.645 1.111 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.4 -54.01 14.34 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.352 1.453 . . . . 0.0 111.754 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -60.73 -58.14 9.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.624 0.712 . . . . 0.0 110.45 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.435 HG21 HD12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -57.31 -39.05 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.063 0.945 . . . . 0.0 110.3 -177.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.06 -13.98 9.97 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.042 1.306 . . . . 0.0 113.829 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -95.5 -15.35 22.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.849 1.324 . . . . 0.0 110.667 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 141.2 55.66 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 119.528 1.058 . . . . 0.0 111.96 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -59.32 114.32 2.6 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.677 173.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.05 -22.74 9.62 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.436 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.16 139.01 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 117.966 0.883 . . . . 0.0 109.265 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -105.48 -45.87 4.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.468 1.507 . . . . 0.0 110.207 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.59 161.7 42.06 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 22' ' ' GLU . 7.9 tt -146.78 140.49 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.712 1.205 . . . . 0.0 109.375 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.63 105.18 6.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.319 1.847 . . . . 0.0 106.903 173.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.468 HG12 HG22 ' A' ' 18' ' ' THR . 46.3 t -105.56 116.44 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.816 1.189 . . . . 0.0 108.862 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -80.47 179.69 7.6 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.338 0.589 . . . . 0.0 110.176 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.2 -59.74 1.3 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.284 1.434 . . . . 0.0 108.225 173.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -43.84 -54.64 5.09 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.983 1.313 . . . . 0.0 110.083 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -80.55 -12.66 59.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.012 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 61.95 15.76 7.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.963 1.705 . . . . 0.0 112.736 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -124.76 156.72 37.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.556 1.543 . . . . 0.0 109.689 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HB2' HG13 ' A' ' 36' ' ' VAL . . . -139.56 152.63 47.04 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.538 0.735 . . . . 0.0 110.104 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.3 m -128.24 113.85 16.19 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.548 1.939 . . . . 0.0 105.991 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.73 160.59 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -128.51 119.11 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -158.28 178.13 10.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.261 1.424 . . . . 0.0 110.239 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -133.53 149.82 73.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.295 1.038 . . . . 0.0 113.547 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.68 80.67 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.665 2.91 . . . . 0.0 109.114 169.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.2 -61.2 0.25 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.46 1.104 . . . . 0.0 108.073 173.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.9 mt -87.59 -21.12 25.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.003 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.2 tp -123.96 148.79 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.07 0.948 . . . . 0.0 109.851 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.0 m -79.39 23.98 0.37 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.256 0.8 OUTLIER 70.09 -57.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 128.047 2.539 . . . . 0.0 110.054 -176.18 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.09 -40.7 37.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.398 1.079 . . . . 0.0 110.144 -176.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -48.19 -48.44 34.69 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 122.739 0.415 . . . . 0.0 111.668 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -37.89 -56.43 1.11 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.695 1.198 . . . . 0.0 112.212 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.17 -45.19 42.28 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.254 1.021 . . . . 0.0 112.478 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.44 -29.36 15.82 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.191 -0.943 . . . . 0.0 112.663 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -62.27 -34.31 76.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -70.1 -44.32 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 118.419 -0.801 . . . . 0.0 109.811 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -50.86 -49.34 59.25 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.51 44.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.273 1.029 . . . . 0.0 113.756 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.3 mmm -66.8 -30.85 71.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.444 1.02 . . . . 0.0 110.247 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.23 -36.91 1.99 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.315 0.96 . . . . 0.0 111.142 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -79.56 123.73 84.09 Favored Pre-proline 0 N--CA 1.455 -0.179 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.305 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.15 118.33 5.35 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.508 1.472 . . . . 0.0 108.596 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.76 -174.56 2.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -162.87 143.79 9.73 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.888 -1.132 . . . . 0.0 110.935 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.662 HG22 HD21 ' A' ' 5' ' ' LEU . 1.2 t -111.8 132.61 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -77.41 -74.44 0.25 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.811 0.444 . . . . 0.0 111.046 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -156.7 151.24 25.57 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.793 HD11 HG13 ' A' ' 3' ' ' VAL . 4.3 tp -155.39 138.5 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 125.034 1.334 . . . . 0.0 108.979 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.439 ' O ' HG21 ' A' ' 3' ' ' VAL . 8.4 pt-20 -159.19 147.02 17.58 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.741 1.217 . . . . 0.0 108.974 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.46 109.6 0.3 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -171.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? . . . . . 0 C--O 1.249 1.053 0 CA-C-O 116.636 -1.65 . . . . 0.0 110.224 -159.37 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.444 0 CA-C-O 119.801 -0.444 . . . . 0.0 113.66 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.46 ' HB2' HG22 ' A' ' 46' ' ' VAL . 23.3 mp0 -87.63 179.83 6.45 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.95 1.3 . . . . 0.0 109.137 -164.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.7 t -83.62 125.78 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -173.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 t -77.1 121.41 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.602 HD21 HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -117.96 132.75 56.36 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.551 1.54 . . . . 0.0 106.897 175.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.97 137.84 36.94 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.2 1.0 . . . . 0.0 110.196 171.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -138.71 147.44 42.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.177 0.991 . . . . 0.0 109.882 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -92.25 128.56 38.14 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 t -120.65 73.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 125.24 1.416 . . . . 0.0 108.755 -171.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -73.27 174.7 7.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.784 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.18 -45.66 3.25 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 121.807 -0.558 . . . . 0.0 113.015 167.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -56.2 153.93 8.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.04 0.92 . . . . 0.0 109.508 167.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -142.87 129.24 19.99 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.805 0.842 . . . . 0.0 109.378 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 m 60.93 175.54 0.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.114 1.365 . . . . 0.0 112.208 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -74.96 56.24 0.74 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.196 0.999 . . . . 0.0 111.173 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.9 p -104.09 -80.87 0.53 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.753 1.221 . . . . 0.0 107.956 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.73 68.95 1.75 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.321 1.448 . . . . 0.0 108.375 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.5 p -129.71 -78.1 0.55 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 m -56.4 -38.19 71.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -169.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -50.18 -59.34 4.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.75 0.42 . . . . 0.0 110.404 168.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.72 -49.34 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 118.563 -0.732 . . . . 0.0 109.372 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.38 -65.65 0.54 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.063 0.847 . . . . 0.0 111.071 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.9 -52.22 26.68 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.117 1.342 . . . . 0.0 112.206 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -52.15 -58.05 7.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.533 0.733 . . . . 0.0 109.461 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.44 -34.98 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.6 1.16 . . . . 0.0 111.108 -176.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.87 -23.03 10.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.01 1.29 . . . . 0.0 113.664 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -89.36 -17.22 29.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.577 1.188 . . . . 0.0 110.239 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.43 136.63 49.71 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.327 1.06 . . . . 0.0 111.688 -173.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -52.08 109.27 0.36 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.037 1.335 . . . . 0.0 111.111 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.24 -23.48 8.56 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 118.928 -0.929 . . . . 0.0 112.788 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.3 t -79.79 142.9 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 118.49 1.145 . . . . 0.0 110.056 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -117.12 -40.24 3.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.546 1.138 . . . . 0.0 111.812 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.89 165.68 34.7 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.748 0.704 . . . . 0.0 109.168 173.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -143.95 145.05 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.518 1.527 . . . . 0.0 108.417 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -139.99 97.98 3.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.424 2.29 . . . . 0.0 107.101 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -96.09 116.43 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.131 0.972 . . . . 0.0 109.09 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.8 t -108.72 80.01 1.29 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -54.02 -41.01 67.53 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.855 0.462 . . . . 0.0 111.747 -176.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.81 -55.05 3.83 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.93 1.292 . . . . 0.0 110.584 168.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -78.57 -19.83 51.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.75 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 72.65 4.72 5.07 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.796 2.438 . . . . 0.0 111.627 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -109.99 151.95 26.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.541 1.536 . . . . 0.0 109.02 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.6 157.81 44.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.991 0.916 . . . . 0.0 108.63 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -129.33 121.56 27.72 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.8 mt -111.52 153.35 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 2' ' ' GLU 0.254 7.0 p -117.87 114.7 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.991 0.917 . . . . 0.0 108.906 173.095 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -158.95 178.93 9.55 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.721 1.208 . . . . 0.0 110.681 -171.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -138.19 144.73 44.48 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HB3' HG23 ' A' ' 54' ' ' VAL . 73.9 Cg_endo -69.6 71.93 1.4 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.547 3.498 . . . . 0.0 110.826 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.32 -58.15 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.399 1.08 . . . . 0.0 108.507 172.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.3 mt -87.5 -21.81 25.26 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.877 -0.582 . . . . 0.0 110.869 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.0 tp -118.76 151.12 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 123.622 0.769 . . . . 0.0 109.823 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 m -85.88 29.83 0.7 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.637 0.775 . . . . 0.0 112.72 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 49' ' ' PRO 0.265 0.5 OUTLIER 73.76 -59.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.085 2.554 . . . . 0.0 110.4 176.115 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -81.01 -38.01 28.2 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.303 1.441 . . . . 0.0 109.786 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.555 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.8 mm-40 -43.76 -48.69 8.1 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 123.747 0.655 . . . . 0.0 111.346 -174.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.24 -53.74 3.11 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.661 0.784 . . . . 0.0 112.029 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -47.22 54.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.199 0.2 . . . . 0.0 110.619 177.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -54.54 -28.38 45.16 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -62.53 -52.24 64.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.5 mp -58.2 -43.14 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.183 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -55.48 -53.71 52.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.5 -27.35 62.47 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.172 1.789 . . . . 0.0 114.097 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.2 mmm -51.37 -31.45 22.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.687 1.13 . . . . 0.0 110.974 172.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.63 42.72 0.28 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -146.82 120.52 5.07 Favored Pre-proline 0 C--O 1.227 -0.087 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.13 102.04 0.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.953 1.769 . . . . 0.0 109.345 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.22 -175.47 3.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.819 0.848 . . . . 0.0 108.898 -175.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.33 143.83 15.34 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.602 HG22 HD21 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -93.97 136.71 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.546 1.538 . . . . 0.0 108.42 172.067 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -79.16 -81.81 0.11 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.543 0.156 . . . . 0.0 111.031 171.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -156.28 144.12 19.51 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.538 -0.726 . . . . 0.0 109.169 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -145.86 122.88 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 126.581 1.953 . . . . 0.0 105.838 -173.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.64 153.35 26.63 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.797 0.839 . . . . 0.0 109.023 171.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.98 113.68 0.91 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.413 1.006 . . . . 0.0 111.256 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? . . . . . 0 C--O 1.254 1.302 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.503 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.95 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.13 137.18 22.54 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.106 0.962 . . . . 0.0 111.832 -174.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.18 126.46 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 124.915 1.286 . . . . 0.0 108.561 -174.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.72 120.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -123.88 156.02 37.01 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.555 1.142 . . . . 0.0 109.237 -177.103 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.592 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -102.35 123.05 45.45 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.401 0.681 . . . . 0.0 110.039 177.708 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.1 mmt -105.95 157.72 17.3 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.703 1.201 . . . . 0.0 109.052 174.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.93 127.14 54.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 168.488 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.5 73.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.329 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.9 169.84 17.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.801 -174.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.73 -40.72 1.85 Allowed Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.934 -0.926 . . . . 0.0 113.708 172.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -59.88 80.31 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.581 1.153 . . . . 0.0 110.693 174.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.19 -38.8 12.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.844 1.658 . . . . 0.0 110.7 -174.294 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 p -59.86 134.18 56.79 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.21 42.67 0.42 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -165.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.9 t -172.13 85.51 0.07 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.797 1.239 . . . . 0.0 108.104 173.291 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 t -160.06 57.17 0.36 Allowed 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.09 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 p -135.68 -69.82 0.49 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.241 -172.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.5 t -53.08 -39.31 63.23 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -172.394 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.5 m -45.77 -61.36 1.75 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 123.194 0.598 . . . . 0.0 112.561 165.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.78 -49.12 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.317 1.047 . . . . 0.0 108.975 178.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -56.41 -65.91 0.53 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.989 0.916 . . . . 0.0 109.428 -176.203 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.05 -52.83 11.51 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.195 1.379 . . . . 0.0 112.492 176.206 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.19 -55.42 35.16 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.851 0.825 . . . . 0.0 110.233 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.7 mm -60.59 -30.07 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 123.797 0.839 . . . . 0.0 110.851 -178.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.85 -19.52 6.98 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.07 171.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -90.51 -13.53 34.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 119.784 1.792 . . . . 0.0 111.217 177.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.65 134.0 50.36 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.496 1.141 . . . . 0.0 111.033 -173.588 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -55.55 110.9 0.78 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.116 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.38 -25.42 8.2 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.329 176.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 t -81.28 136.06 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 118.194 0.997 . . . . 0.0 109.045 -177.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -101.72 -42.92 6.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.797 1.239 . . . . 0.0 110.201 173.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 ttt-85 -153.98 161.35 42.03 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.849 0.75 . . . . 0.0 109.987 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 tt -149.08 139.33 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.583 1.153 . . . . 0.0 109.545 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -139.6 114.81 9.71 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.094 1.758 . . . . 0.0 106.593 174.526 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -113.99 126.23 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.986 1.314 . . . . 0.0 109.07 -178.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.3 t -84.58 172.41 11.63 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.536 0.684 . . . . 0.0 110.345 172.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.1 -63.25 1.48 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 170.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -52.64 -49.96 64.13 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.29 1.036 . . . . 0.0 109.313 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.9 -18.09 59.53 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.292 -172.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 62.62 4.74 1.46 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.324 1.85 . . . . 0.0 113.239 -175.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -107.86 152.93 23.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.263 1.825 . . . . 0.0 108.014 -169.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.13 161.27 37.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.47 0.708 . . . . 0.0 109.833 178.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.7 m -137.68 118.29 13.96 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 mt -120.27 160.85 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.244 1.018 . . . . 0.0 108.282 178.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.263 14.1 p -130.25 114.89 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.355 0.662 . . . . 0.0 109.888 178.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -158.97 178.66 9.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.229 1.011 . . . . 0.0 111.392 -175.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -134.65 148.82 68.89 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.419 1.088 . . . . 0.0 113.177 173.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.69 74.83 0.85 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.403 3.402 . . . . 0.0 110.006 171.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.26 -61.31 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.752 1.221 . . . . 0.0 107.812 170.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.4 mt -85.66 -20.86 28.79 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.092 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.436 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.9 tp -123.4 147.3 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 m -79.81 27.0 0.31 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.36 0.982 . . . . 0.0 112.68 -176.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.27 0.5 OUTLIER 73.25 -54.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 128.01 2.524 . . . . 0.0 110.817 179.334 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -88.3 -32.81 18.27 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.597 0.759 . . . . 0.0 111.218 -178.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.436 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.5 mt-10 -40.76 -51.57 3.07 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 123.254 0.622 . . . . 0.0 110.775 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -37.0 -63.94 0.39 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.443 1.497 . . . . 0.0 109.922 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.3 -43.99 97.54 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.905 -0.497 . . . . 0.0 111.091 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -58.08 -31.64 67.28 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -60.18 -48.38 81.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -58.6 -48.37 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.863 175.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -52.15 -50.79 61.06 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.324 0.966 . . . . 0.0 108.477 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.27 -21.46 61.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.067 1.747 . . . . 0.0 114.036 -177.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.0 mmt -63.26 -23.95 67.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.955 1.252 . . . . 0.0 110.478 172.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.99 40.77 0.74 Allowed Glycine 0 C--N 1.338 0.66 0 C-N-CA 124.279 0.942 . . . . 0.0 111.358 170.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -148.53 123.3 4.94 Favored Pre-proline 0 C--O 1.226 -0.152 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.8 118.28 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.361 1.374 . . . . 0.0 109.078 -178.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.66 -171.13 1.83 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.96 152.45 13.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.036 -1.04 . . . . 0.0 111.206 -173.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 p -118.62 124.23 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 126.362 1.865 . . . . 0.0 106.383 -178.097 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -74.91 -80.26 0.08 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.883 175.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -156.75 155.84 32.31 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 170.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -155.68 111.71 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.861 2.064 . . . . 0.0 107.41 -170.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -155.3 155.67 34.16 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.847 1.259 . . . . 0.0 107.795 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.69 169.33 37.9 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 172.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 . . . . . 0 C--O 1.25 1.116 0 C-N-CA 126.97 2.108 . . . . 0.0 109.235 -168.577 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.11 0 CA-C-O 118.649 -1.084 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -163.63 60.13 0.17 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 117.619 0.709 . . . . 0.0 110.967 -171.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.2 t -100.97 127.63 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 173.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.82 141.78 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.707 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.652 HD23 ' HB ' ' A' ' 73' ' ' ILE . 0.7 OUTLIER -142.64 131.91 23.41 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.773 0.829 . . . . 0.0 109.266 -179.579 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' N ' HD22 ' A' ' 5' ' ' LEU . 1.4 mtmt -103.62 129.78 50.96 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.04 1.336 . . . . 0.0 111.387 178.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.3 ptp -127.01 159.68 33.4 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.294 1.038 . . . . 0.0 110.67 176.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -98.73 124.81 43.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.014 1.726 . . . . 0.0 107.681 164.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -111.97 77.44 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.065 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 169.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.283 10.6 pt-20 -84.2 165.63 18.23 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.665 178.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.88 -35.99 4.39 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.459 -0.634 . . . . 0.0 113.759 176.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -65.57 159.83 23.78 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.78 1.29 . . . . 0.0 111.954 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.2 p -90.14 166.1 13.59 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.438 1.095 . . . . 0.0 110.608 -178.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.8 p -57.73 138.03 55.91 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.74 0.416 . . . . 0.0 110.546 175.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.8 t60 40.24 65.61 0.73 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.784 1.634 . . . . 0.0 113.077 176.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -160.07 27.88 0.17 Allowed 'General case' 0 CA--C 1.535 0.368 0 O-C-N 122.005 -0.434 . . . . 0.0 111.998 -170.079 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.554 ' SG ' HD21 ' A' ' 38' ' ' LEU . 15.6 p -167.33 -111.59 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.493 -167.559 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.7 p 33.82 -98.03 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 127.483 2.313 . . . . 0.0 111.931 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -49.32 -37.17 23.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -175.552 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.25 -51.37 69.85 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 175.486 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.59 -53.38 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.176 172.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -55.86 -61.1 2.59 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.325 0.966 . . . . 0.0 109.92 -171.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.48 -52.9 22.53 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.319 1.438 . . . . 0.0 111.729 177.135 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -60.7 -50.86 71.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.047 0.923 . . . . 0.0 110.323 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.5 mm -66.33 -24.33 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.89 0.876 . . . . 0.0 110.788 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.11 -14.55 32.72 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.604 170.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -84.54 -12.93 53.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.64 1.72 . . . . 0.0 110.607 173.301 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.63 135.31 46.88 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 122.307 1.051 . . . . 0.0 111.447 -171.156 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -60.93 113.77 2.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.221 177.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.83 -21.87 15.47 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-O 119.366 -0.686 . . . . 0.0 112.945 175.054 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 t -81.59 131.34 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.26 -51.34 5.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.151 1.38 . . . . 0.0 109.163 174.422 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -152.1 160.86 43.33 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tt -143.51 141.55 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.151 1.38 . . . . 0.0 108.488 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.54 125.93 20.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.734 1.614 . . . . 0.0 107.097 171.023 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -115.95 154.31 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.026 1.33 . . . . 0.0 107.696 -178.365 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.2 t -130.28 155.53 46.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.111 0.964 . . . . 0.0 109.216 176.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.554 HD21 ' SG ' ' A' ' 17' ' ' CYS . 3.6 mt -104.36 -59.71 1.7 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.299 1.84 . . . . 0.0 108.732 -177.155 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.79 -58.27 7.85 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.065 1.346 . . . . 0.0 109.619 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.7 -22.36 62.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.32 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 55.75 59.29 3.9 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 126.581 1.952 . . . . 0.0 109.775 176.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -156.34 160.72 39.95 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.465 1.506 . . . . 0.0 107.137 -172.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.63 159.04 43.01 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 118.931 0.787 . . . . 0.0 110.536 174.176 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.9 m -126.23 130.28 50.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 174.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.411 HG21 ' SD ' ' A' ' 57' ' ' MET . 2.6 mp -118.36 163.66 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.423 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.4 117.71 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.108 0.963 . . . . 0.0 108.846 176.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -159.61 -177.14 6.18 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.535 1.134 . . . . 0.0 111.255 -171.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -136.73 152.61 74.7 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 165.175 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.79 76.55 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.32 3.347 . . . . 0.0 109.541 171.018 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.71 -62.43 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.227 1.011 . . . . 0.0 108.679 175.271 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.9 mt -84.14 -27.21 28.3 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 119.361 -0.352 . . . . 0.0 110.142 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 52' ' ' ILE . 9.4 tp -117.74 146.74 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.321 1.048 . . . . 0.0 109.281 177.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -84.1 27.78 0.65 Allowed 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.59 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.434 ' CG2' HD12 ' A' ' 73' ' ' ILE 0.262 0.9 OUTLIER 70.42 -57.54 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 128.787 2.835 . . . . 0.0 111.42 179.883 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.72 -33.56 40.78 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.08 1.352 . . . . 0.0 110.04 -177.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -52.87 -49.61 65.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 123.203 0.314 . . . . 0.0 110.777 -177.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -31.57 -58.67 0.26 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.491 1.516 . . . . 0.0 111.283 172.316 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -46.71 67.13 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.177 -0.327 . . . . 0.0 111.306 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.8 -32.02 59.73 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.819 -0.551 . . . . 0.0 112.321 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -42.16 99.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.208 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.19 -47.94 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.694 172.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 7.5 mt-10 -49.79 -51.07 42.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.17 0.986 . . . . 0.0 108.835 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.84 -19.59 51.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.781 2.032 . . . . 0.0 114.056 -178.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.8 mmm -61.34 -30.47 70.53 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.626 1.103 . . . . 0.0 109.626 170.359 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.25 40.68 0.39 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.839 1.209 . . . . 0.0 111.553 170.371 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -148.62 122.12 4.66 Favored Pre-proline 0 C--O 1.223 -0.291 0 CA-C-O 117.12 -1.419 . . . . 0.0 107.604 -177.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -62.69 118.66 5.56 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.623 1.549 . . . . 0.0 109.001 -176.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -120.78 175.16 6.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.216 1.008 . . . . 0.0 109.991 -178.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.81 138.67 18.02 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.95 -1.094 . . . . 0.0 111.178 -170.344 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.583 HG22 HD21 ' A' ' 5' ' ' LEU . 1.6 p -114.11 131.19 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -177.186 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -80.19 -83.04 0.11 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.93 146.97 17.96 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.108 0.563 . . . . 0.0 110.297 176.353 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.652 ' HB ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -148.91 133.27 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 127.543 2.337 . . . . 0.0 106.624 -177.586 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.97 161.42 39.6 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 165.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -47.36 119.94 5.19 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 174.092 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 . . . . . 0 C--O 1.251 1.173 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.585 -174.97 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.844 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 19.93 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.113 2.165 . . . . 0.0 115.364 173.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.14 130.92 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.49 135.44 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.515 HD23 ' HB ' ' A' ' 73' ' ' ILE . 1.5 tm? -125.67 144.41 50.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.272 1.429 . . . . 0.0 107.375 178.368 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.409 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -117.06 129.04 55.74 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.431 1.492 . . . . 0.0 109.136 174.679 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 ptp -124.04 152.07 43.04 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.614 1.166 . . . . 0.0 109.877 179.124 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -89.94 151.43 21.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 162.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG12 ' SD ' ' A' ' 12' ' ' MET . 1.6 t -132.27 68.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -62.9 115.47 4.41 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.672 -170.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 119.26 -34.41 4.3 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.389 -0.673 . . . . 0.0 113.37 173.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.44 ' HB3' HD21 ' A' ' 38' ' ' LEU . 1.7 mpt? -72.05 110.53 6.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.091 1.446 . . . . 0.0 108.078 173.411 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 t -160.07 61.81 0.35 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.852 0.751 . . . . 0.0 111.27 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 t -158.85 71.96 0.56 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.222 -0.299 . . . . 0.0 110.234 174.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 10.38 70.35 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.709 2.803 . . . . 0.0 114.588 -179.211 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.1 t -159.84 -70.99 0.08 Allowed 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -174.057 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.5 m -65.5 78.37 0.07 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.587 1.155 . . . . 0.0 110.73 -176.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.6 p -140.53 -84.44 0.22 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.978 2.111 . . . . 0.0 106.403 -179.008 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 m -55.33 -36.25 66.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -171.099 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.6 m -50.76 -60.63 2.86 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.416 0.447 . . . . 0.0 111.051 167.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.9 -51.22 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -57.49 -66.75 0.41 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.552 0.691 . . . . 0.0 110.63 -174.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.19 -51.26 26.36 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.881 1.705 . . . . 0.0 111.911 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -54.89 -56.68 16.92 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.813 0.806 . . . . 0.0 109.367 177.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.9 mm -64.24 -28.56 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 C-N-CA 123.157 0.583 . . . . 0.0 111.052 -174.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.78 -19.98 23.43 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.376 0.989 . . . . 0.0 113.44 171.225 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -85.84 -18.61 32.37 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 119.627 1.714 . . . . 0.0 109.419 177.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.46 133.7 49.02 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.453 1.121 . . . . 0.0 111.336 -172.129 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -58.23 111.43 1.2 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.027 175.417 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.67 -27.34 6.28 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-O 119.165 -0.797 . . . . 0.0 112.639 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.07 136.19 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 118.167 0.984 . . . . 0.0 109.382 -176.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -107.87 -46.0 3.87 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.581 1.152 . . . . 0.0 110.668 176.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.61 159.7 42.37 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.5 tt -142.7 148.15 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.072 1.349 . . . . 0.0 109.854 179.1 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -145.27 113.11 6.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.791 2.036 . . . . 0.0 108.193 171.075 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.0 t -102.92 120.66 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.23 1.012 . . . . 0.0 110.168 176.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 m -102.72 89.32 3.46 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.516 1.126 . . . . 0.0 109.061 175.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 12' ' ' MET . 8.3 mt -58.81 173.66 0.41 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.201 160.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 66.41 -65.63 0.19 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 127.968 2.507 . . . . 0.0 109.574 -170.118 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -27.85 69.0 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.095 178.412 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.93 50.82 0.8 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.674 2.39 . . . . 0.0 111.718 172.628 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -140.22 148.16 41.11 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.217 2.207 . . . . 0.0 106.206 -174.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.43 155.84 45.13 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 120.924 -1.11 . . . . 0.0 109.679 172.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.76 136.66 34.35 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.41 163.17 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.36 119.1 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -159.0 -179.33 7.95 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.684 1.194 . . . . 0.0 109.908 -172.417 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -138.23 144.1 41.79 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.003 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.1 80.27 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.305 3.337 . . . . 0.0 109.921 174.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -158.35 -54.32 0.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.7 mt -86.75 -29.48 22.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.417 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.6 tp -115.68 145.13 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m -78.24 23.49 0.28 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 -175.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 76.03 -58.51 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 127.27 2.228 . . . . 0.0 109.786 176.199 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.99 -39.26 42.93 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.476 1.511 . . . . 0.0 109.669 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.407 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.4 mt-10 -40.39 -57.11 1.86 Allowed 'General case' 0 C--N 1.345 0.388 0 C-N-CA 123.942 0.897 . . . . 0.0 111.043 -178.381 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.5 -58.29 0.33 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.999 1.72 . . . . 0.0 110.477 175.505 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -48.08 51.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.151 -0.343 . . . . 0.0 111.838 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -55.93 -30.43 61.64 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -174.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.6 -46.41 89.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -63.93 -47.11 92.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.008 175.18 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -50.38 -51.94 41.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.79 -18.83 57.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.503 1.921 . . . . 0.0 114.209 -178.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.6 mmm -59.12 -29.76 67.62 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.874 1.216 . . . . 0.0 109.796 170.224 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.94 44.36 0.28 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 124.347 0.975 . . . . 0.0 110.851 171.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -146.76 120.98 5.16 Favored Pre-proline 0 C--O 1.225 -0.196 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -175.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.22 99.01 0.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.942 1.761 . . . . 0.0 110.086 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.22 -176.63 2.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -174.197 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.6 141.13 11.57 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.6 0.36 . . . . 0.0 111.572 -176.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.515 HG22 HD21 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -95.12 143.61 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.22 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -83.29 -89.72 0.09 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.418 1.087 . . . . 0.0 110.171 175.633 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 142.14 22.63 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.515 ' HB ' HD23 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -134.8 127.74 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 129.133 2.973 . . . . 0.0 103.925 179.563 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -162.98 151.79 14.59 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 119.204 0.911 . . . . 0.0 110.178 167.141 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.25 -156.61 23.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 174.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.1 ttm105 . . . . . 0 C--O 1.255 1.373 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 170.451 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.114 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -99.04 158.49 15.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.684 0.794 . . . . 0.0 109.902 -174.36 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.3 t -124.07 151.55 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.511 1.524 . . . . 0.0 108.411 -176.587 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.09 143.73 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 124.619 1.168 . . . . 0.0 111.389 -175.474 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.43 132.86 53.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.278 1.431 . . . . 0.0 108.191 175.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.43 109.71 21.49 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.301 1.44 . . . . 0.0 107.648 175.329 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.7 ptm -113.39 164.78 13.16 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.691 0.796 . . . . 0.0 111.084 174.606 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -109.99 131.02 55.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 129.711 3.204 . . . . 0.0 106.581 177.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 t -121.25 77.69 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.236 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.03 177.13 4.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.954 0.883 . . . . 0.0 111.7 -176.223 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.47 -53.61 4.5 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.626 -0.671 . . . . 0.0 111.546 176.58 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.7 mmt -69.23 131.83 45.54 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.205 -0.585 . . . . 0.0 110.008 175.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 t -164.36 46.84 0.11 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.539 0.735 . . . . 0.0 110.199 179.627 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.2 t -154.5 45.22 0.54 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.508 -0.745 . . . . 0.0 111.09 -179.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 24.66 57.69 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.288 2.235 . . . . 0.0 114.158 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.3 t -159.43 40.65 0.21 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -173.056 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.99 69.03 0.08 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.014 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.9 p -129.85 -79.09 0.55 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 t -55.04 -38.31 67.81 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -164.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -49.36 -58.4 5.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.876 0.47 . . . . 0.0 111.789 167.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.65 -51.43 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.752 0.821 . . . . 0.0 108.914 176.584 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.32 -63.59 1.14 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.28 0.632 . . . . 0.0 110.436 -174.196 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.98 -53.57 14.1 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.712 1.625 . . . . 0.0 112.411 174.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -62.14 -51.67 66.93 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.199 0.999 . . . . 0.0 110.925 -176.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 mm -55.63 -35.88 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.738 0.815 . . . . 0.0 110.537 173.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.01 -12.45 22.61 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.626 1.108 . . . . 0.0 114.006 173.656 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -87.94 -20.35 26.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.447 1.623 . . . . 0.0 109.914 172.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 131.78 45.82 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.714 1.245 . . . . 0.0 112.156 -172.644 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -50.06 107.29 0.15 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.551 170.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.7 -27.3 6.29 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-O 118.9 -0.945 . . . . 0.0 112.464 175.299 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 t -81.9 133.15 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.37 -41.97 5.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.342 0.519 . . . . 0.0 111.931 167.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.411 ' H ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -136.78 161.73 35.16 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.161 0.891 . . . . 0.0 110.006 -175.23 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 tt -152.68 146.99 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.95 0.9 . . . . 0.0 110.96 -176.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -144.84 102.27 3.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.579 1.952 . . . . 0.0 108.658 169.041 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.5 t -99.26 100.1 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.286 1.034 . . . . 0.0 110.089 177.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.0 m -89.12 77.53 7.55 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.92 0.888 . . . . 0.0 109.609 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.0 tp -53.61 -35.12 60.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.596 0.758 . . . . 0.0 110.334 177.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -38.71 -52.3 1.68 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.361 1.464 . . . . 0.0 111.325 167.138 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.28 -7.14 58.73 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.096 -173.152 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 63.56 17.1 10.14 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.969 2.108 . . . . 0.0 111.312 -172.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -139.61 145.29 38.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.79 1.236 . . . . 0.0 110.225 -170.229 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.03 147.79 46.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.401 0.68 . . . . 0.0 110.809 -167.336 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -130.15 110.81 11.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.99 1.716 . . . . 0.0 107.073 -167.44 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.21 171.46 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 33' ' ' ARG . 0.6 OUTLIER -141.65 123.76 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.096 0.862 . . . . 0.0 109.619 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -155.93 176.73 12.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.776 0.83 . . . . 0.0 110.711 -174.525 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -123.65 141.14 35.79 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.236 1.014 . . . . 0.0 112.367 175.289 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.39 81.04 1.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.151 3.234 . . . . 0.0 109.753 176.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 -51.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.5 0.72 . . . . 0.0 109.512 177.718 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.4 mt -86.72 -36.59 18.57 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -179.208 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.5 tp -109.4 149.5 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 m -86.64 32.91 0.64 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 122.912 0.485 . . . . 0.0 111.645 -174.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 68.55 -56.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 129.911 3.284 . . . . 0.0 111.641 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -96.21 -26.81 15.29 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 126.846 2.059 . . . . 0.0 110.689 -170.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -43.18 -48.46 6.46 Favored 'General case' 0 C--N 1.347 0.484 0 O-C-N 123.524 0.515 . . . . 0.0 110.723 177.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -47.24 -61.52 1.86 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 123.272 0.629 . . . . 0.0 111.267 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.24 -45.44 93.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.232 1.013 . . . . 0.0 110.395 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -57.19 -27.88 62.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.876 176.375 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -47.89 75.45 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 175.288 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.64 -45.01 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.563 -0.732 . . . . 0.0 109.604 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -54.74 -52.94 60.95 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 122.128 0.966 . . . . 0.0 108.796 176.011 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.69 -24.52 66.81 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.683 1.593 . . . . 0.0 113.416 -174.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.6 mmm -53.38 -35.11 59.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.26 0.937 . . . . 0.0 110.179 168.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.94 -30.48 2.56 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.59 1.091 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.93 127.98 60.07 Favored Pre-proline 0 N--CA 1.456 -0.154 0 CA-C-O 118.389 -0.815 . . . . 0.0 108.945 -173.554 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.92 129.14 26.36 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.061 1.841 . . . . 0.0 109.383 -178.571 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.46 165.71 24.55 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.622 0.725 . . . . 0.0 109.723 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -156.0 153.58 29.72 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.192 -0.942 . . . . 0.0 110.786 -161.218 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.88 122.06 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.01 0.924 . . . . 0.0 109.183 -171.594 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.3 mttt -94.25 -54.99 3.34 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.203 0.601 . . . . 0.0 110.87 177.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -123.46 136.99 54.88 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.787 0.435 . . . . 0.0 110.142 -175.059 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.7 177.56 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.119 2.168 . . . . 0.0 110.183 -168.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.07 176.89 9.24 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.368 1.467 . . . . 0.0 111.059 -176.112 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 55.4 -154.15 12.13 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.598 0.618 . . . . 0.0 112.07 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.375 1.07 . . . . 0.0 111.915 166.021 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.298 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -51.02 149.92 3.36 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 131.439 3.896 . . . . 0.0 111.909 169.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 t -138.77 151.09 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 126.083 1.753 . . . . 0.0 107.656 -178.055 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.02 130.36 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.29 1.036 . . . . 0.0 110.901 -177.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -123.97 152.32 42.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.732 1.613 . . . . 0.0 108.072 175.106 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.589 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.58 136.79 54.7 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.501 1.12 . . . . 0.0 109.063 174.874 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 ptp -126.4 143.1 51.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.8 1.64 . . . . 0.0 109.209 -177.186 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.26 131.39 34.74 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 167.345 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.12 84.55 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.293 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.84 161.6 30.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.428 0.632 . . . . 0.0 112.516 -174.169 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.35 -47.69 1.73 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.69 0.662 . . . . 0.0 113.739 176.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.4 ttp -56.94 109.79 0.7 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.488 1.515 . . . . 0.0 109.93 -175.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -119.08 153.15 35.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.488 1.115 . . . . 0.0 110.622 -171.18 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.3 m 67.96 151.41 0.08 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.066 2.146 . . . . 0.0 112.261 179.231 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -76.42 58.02 1.27 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.322 1.049 . . . . 0.0 111.288 -174.497 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.7 t -133.54 -69.27 0.55 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.186 1.394 . . . . 0.0 107.449 -167.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.1 m -70.44 77.1 0.56 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 168.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.4 p -148.17 -80.49 0.14 Allowed 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.757 1.623 . . . . 0.0 107.15 178.54 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.8 t -53.16 -41.92 65.63 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -172.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.6 m -48.27 -56.68 7.4 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.651 168.46 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.45 -49.16 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -53.28 -66.67 0.35 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.341 0.973 . . . . 0.0 110.593 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.25 -53.93 8.95 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.728 1.633 . . . . 0.0 112.396 176.36 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -57.55 -51.0 71.27 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 117.825 0.813 . . . . 0.0 110.317 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.1 mm -62.98 -28.61 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.216 0.607 . . . . 0.0 110.603 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.61 -17.07 8.08 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 118.705 -1.053 . . . . 0.0 114.207 169.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -87.43 -18.02 30.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 120.123 1.961 . . . . 0.0 111.093 174.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.3 136.0 56.74 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.068 0.937 . . . . 0.0 110.566 -171.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -68.46 119.69 13.34 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.642 -175.432 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.59 -20.14 23.09 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-O 118.824 -0.987 . . . . 0.0 112.937 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.77 136.66 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 118.669 1.234 . . . . 0.0 109.547 -177.169 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -100.98 -47.79 4.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.054 1.342 . . . . 0.0 110.181 174.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.97 161.04 43.02 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.42 0.554 . . . . 0.0 109.53 -178.127 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 tt -138.5 145.03 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.5 1.52 . . . . 0.0 109.234 177.043 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -138.7 106.89 5.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.223 2.209 . . . . 0.0 107.582 171.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.5 t -102.05 98.96 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.308 0.958 . . . . 0.0 110.335 176.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 m -88.31 82.16 7.11 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.288 1.035 . . . . 0.0 109.61 177.046 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -49.94 -43.69 50.12 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.58 0.752 . . . . 0.0 111.367 -179.581 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.63 -52.45 2.22 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 125.953 1.701 . . . . 0.0 111.204 170.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -82.71 -9.62 59.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.88 -172.032 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 64.04 20.43 12.19 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.323 1.849 . . . . 0.0 111.279 -178.085 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -144.23 141.71 30.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.208 1.403 . . . . 0.0 109.354 -169.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.65 151.77 44.49 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.902 0.881 . . . . 0.0 109.476 -178.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.1 m -124.52 119.57 29.5 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 127.105 2.162 . . . . 0.0 105.667 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.415 HG21 ' SD ' ' A' ' 57' ' ' MET . 58.3 mt -125.07 161.19 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.04 123.97 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.092 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -156.22 173.14 17.28 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.506 1.122 . . . . 0.0 109.238 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.51 146.85 51.12 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 170.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -71.66 75.99 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.757 3.638 . . . . 0.0 110.332 177.291 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -151.85 -54.67 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.821 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.5 mt -89.28 -22.47 22.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.669 -177.309 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' A' ' 56' ' ' GLU . 9.0 tp -121.47 149.46 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.785 0.834 . . . . 0.0 109.537 177.471 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.9 m -84.95 30.46 0.58 Allowed 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 123.491 0.717 . . . . 0.0 112.098 -175.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 72.1 -62.77 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 128.931 2.893 . . . . 0.0 108.568 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -84.92 -31.07 23.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.98 -171.517 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HB3' HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -43.96 -51.81 7.41 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 123.83 0.706 . . . . 0.0 110.965 -179.287 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.415 ' SD ' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -39.79 -61.11 0.88 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.061 1.344 . . . . 0.0 109.193 -179.977 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -44.86 88.08 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.027 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -54.4 -33.57 59.57 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.942 0.792 . . . . 0.0 112.913 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -59.75 -47.39 85.87 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.28 -48.93 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.912 174.127 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -53.59 -48.21 69.44 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.101 0.953 . . . . 0.0 109.042 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.13 -20.05 62.23 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.324 1.449 . . . . 0.0 113.546 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 79.9 mmm -62.43 -29.84 70.8 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.687 1.13 . . . . 0.0 109.933 170.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.93 -34.93 2.1 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.064 0.84 . . . . 0.0 111.046 177.209 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -82.07 112.76 38.23 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-O 117.482 -1.247 . . . . 0.0 108.201 -178.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -60.64 137.15 71.54 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.506 1.471 . . . . 0.0 108.888 -179.432 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.53 -162.98 0.98 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.839 0.456 . . . . 0.0 110.098 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -170.07 148.48 3.4 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.658 0.783 . . . . 0.0 111.226 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.84 128.66 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.581 1.152 . . . . 0.0 108.283 177.026 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -105.34 -68.98 0.84 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 117.895 0.316 . . . . 0.0 111.101 168.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HB2' ' H ' ' A' ' 6' ' ' LYS . 31.4 mtpt -89.01 174.29 7.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.413 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.0 tt -156.84 177.88 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.271 1.828 . . . . 0.0 106.672 -172.03 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.4 176.33 7.59 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.289 1.404 . . . . 0.0 110.02 -178.245 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.05 -161.29 28.44 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.284 0 C-N-CA 127.721 2.408 . . . . 0.0 104.895 -178.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.269 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.04 122.12 10.24 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.219 1.51 . . . . 0.0 109.51 179.007 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.4 143.91 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.624 1.17 . . . . 0.0 108.802 -178.8 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.6 t -79.27 140.48 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.491 1.116 . . . . 0.0 109.063 -177.606 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.55 HD22 ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -123.58 129.29 50.96 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 126.17 1.788 . . . . 0.0 106.989 173.679 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.55 ' N ' HD22 ' A' ' 5' ' ' LEU . 7.7 ttpt -108.82 130.44 55.4 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.806 0.691 . . . . 0.0 109.615 172.748 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -138.21 157.65 45.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.162 0.985 . . . . 0.0 110.989 -172.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.7 144.52 26.6 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 170.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 t -128.61 66.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.58 1.552 . . . . 0.0 107.485 175.539 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.77 173.44 12.48 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.293 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.42 -40.12 1.51 Allowed Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.273 -0.737 . . . . 0.0 113.809 175.172 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.67 143.07 2.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.219 1.01 . . . . 0.0 111.978 177.039 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 t -54.98 148.63 13.15 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.112 167.415 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.8 m -60.65 162.1 6.96 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 166.217 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 t60 8.89 79.46 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.249 3.02 . . . . 0.0 114.598 -177.658 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 m -172.14 -62.57 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.862 1.265 . . . . 0.0 109.299 177.345 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.4 m -80.1 65.17 5.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.967 0.413 . . . . 0.0 110.792 -172.773 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.6 p -120.18 -80.65 0.62 Allowed 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 167.547 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 m -55.81 -37.13 68.23 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -163.586 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.9 m -52.38 -56.56 14.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 168.704 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.29 -49.63 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.904 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -53.21 -64.03 0.95 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.122 0.963 . . . . 0.0 110.9 -177.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.84 -51.28 13.42 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.632 1.587 . . . . 0.0 112.902 174.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -60.54 -63.72 1.2 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.618 0.709 . . . . 0.0 109.866 -178.481 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -53.24 -40.06 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.071 1.348 . . . . 0.0 110.613 -179.62 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.81 -23.66 16.01 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.012 1.291 . . . . 0.0 113.568 177.168 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -88.67 -17.01 30.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 119.151 1.475 . . . . 0.0 111.147 178.142 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 134.6 53.38 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.472 1.13 . . . . 0.0 111.861 -172.755 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -52.73 107.18 0.2 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.137 176.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.29 -32.76 4.03 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-O 119.144 -0.809 . . . . 0.0 111.773 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.29 136.99 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 118.093 0.947 . . . . 0.0 109.283 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -103.2 -45.63 4.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.273 1.429 . . . . 0.0 110.478 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -153.66 160.22 42.3 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.82 -0.55 . . . . 0.0 110.004 -178.313 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.8 tt -141.01 140.02 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.331 1.452 . . . . 0.0 109.776 178.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -133.05 117.16 17.23 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.8 1.64 . . . . 0.0 107.782 165.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.2 t -108.61 107.61 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 124.491 1.117 . . . . 0.0 109.868 177.634 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -89.5 89.47 7.86 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.795 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.48 -45.93 69.8 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.381 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -41.84 -61.18 1.17 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 126.114 1.766 . . . . 0.0 110.709 171.184 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -75.38 -9.92 58.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.05 -174.563 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 67.28 6.79 5.06 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 127.313 2.245 . . . . 0.0 111.741 -174.339 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -119.88 144.11 47.57 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.331 1.853 . . . . 0.0 108.132 -171.593 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.01 155.14 48.53 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.37 0.668 . . . . 0.0 109.23 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 m -135.68 112.74 10.38 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 126.195 1.798 . . . . 0.0 106.521 -171.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.94 169.08 6.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -137.78 123.71 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -159.23 -178.33 7.11 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.105 1.362 . . . . 0.0 109.982 -173.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -130.6 150.35 76.09 Favored Pre-proline 0 C--N 1.347 0.499 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 164.301 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.45 74.81 0.55 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.698 3.599 . . . . 0.0 109.506 169.591 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -147.62 -61.86 0.27 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.859 1.264 . . . . 0.0 107.617 -177.227 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.5 mt -91.98 -21.63 20.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.126 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 52' ' ' ILE . 11.3 tp -121.52 146.86 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.095 0.958 . . . . 0.0 108.637 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.4 m -82.39 31.93 0.4 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 119.378 0.99 . . . . 0.0 113.03 -174.032 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.252 0.5 OUTLIER 72.64 -62.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 127.876 2.47 . . . . 0.0 108.01 -177.082 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -86.43 -28.09 23.74 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.89 -170.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -46.54 -44.89 18.23 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.36 0.527 . . . . 0.0 110.779 177.71 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.9 -69.22 0.14 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.22 1.408 . . . . 0.0 109.954 173.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -41.97 97.58 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.64 -0.663 . . . . 0.0 110.756 -177.671 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -59.61 -24.79 64.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.959 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.91 -39.92 96.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.646 1.112 . . . . 0.0 109.074 173.346 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.88 -49.42 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -54.18 -46.12 72.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.04 -19.44 64.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.813 1.645 . . . . 0.0 114.371 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.2 mmm -59.82 -28.69 67.68 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 120.243 1.383 . . . . 0.0 109.602 168.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.08 -25.89 4.83 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.445 1.021 . . . . 0.0 110.791 175.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -75.38 123.65 88.73 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.074 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.73 111.37 1.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.064 1.843 . . . . 0.0 109.273 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.9 -174.46 2.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.435 1.094 . . . . 0.0 108.27 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -169.65 146.21 3.25 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.722 0.692 . . . . 0.0 112.383 -167.073 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.3 t -80.96 130.37 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.15 1.38 . . . . 0.0 109.352 178.147 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -95.86 -55.91 2.84 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 160.238 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -147.58 78.27 1.46 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.437 0.295 . . . . 0.0 110.262 -172.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 tt -85.75 52.5 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 111.186 -178.144 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -161.99 168.58 22.57 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.338 1.455 . . . . 0.0 107.148 173.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.27 -131.01 2.79 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.427 1.013 . . . . 0.0 112.64 -179.173 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 . . . . . 0 C--O 1.249 1.041 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -177.784 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.902 0 N-CA-C 106.615 -2.594 . . . . 0.0 106.615 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -57.49 126.1 25.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.593 1.196 . . . . 0.0 110.464 -177.16 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 m -120.01 153.75 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 126.343 1.857 . . . . 0.0 108.915 -177.56 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.7 t -77.05 153.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.045 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.55 HD11 ' CG2' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -138.47 135.83 35.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.374 -1.714 . . . . 0.0 106.374 173.271 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -111.7 135.13 52.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.131 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -143.14 143.14 31.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.599 0.76 . . . . 0.0 110.883 -176.829 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -75.75 147.42 39.31 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 166.12 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.28 48.6 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 126.014 1.726 . . . . 0.0 108.725 178.139 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -58.4 142.96 46.86 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.782 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.26 -33.53 4.96 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.0 171.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.7 mtm -57.99 145.25 36.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.29 1.045 . . . . 0.0 109.737 176.46 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -78.57 -164.11 0.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.222 1.009 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.6 p -60.72 -179.69 0.13 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.744 -0.598 . . . . 0.0 111.625 173.678 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -48.57 72.29 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.25 2.62 . . . . 0.0 115.074 -174.607 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.7 t -162.55 30.15 0.11 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.811 1.244 . . . . 0.0 109.226 -168.568 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -163.82 -145.93 0.1 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -177.662 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 61.16 -71.49 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 125.776 1.631 . . . . 0.0 111.285 -176.132 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.3 t -55.07 -41.62 71.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 119.084 0.856 . . . . 0.0 112.361 -166.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.1 m -45.13 -60.1 2.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.431 0.693 . . . . 0.0 112.245 165.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mp -57.72 -48.56 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 124.028 0.931 . . . . 0.0 109.152 178.328 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -56.97 -62.5 1.7 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.492 1.139 . . . . 0.0 109.445 -174.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.12 -56.02 8.18 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.302 1.429 . . . . 0.0 112.304 173.716 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -61.56 -50.36 72.94 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.871 0.836 . . . . 0.0 110.911 -176.239 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.41 -34.0 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 124.079 0.952 . . . . 0.0 110.539 177.849 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.67 -17.56 6.77 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.926 -0.93 . . . . 0.0 114.812 170.766 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -86.89 -18.08 31.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.793 1.797 . . . . 0.0 110.816 176.147 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.7 141.78 48.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.949 0.881 . . . . 0.0 112.243 -168.657 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -59.13 117.55 4.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.929 0.892 . . . . 0.0 111.04 175.676 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.79 -24.99 12.27 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.269 173.472 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.96 142.5 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -108.84 -45.85 3.73 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.134 1.374 . . . . 0.0 109.455 172.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -154.01 162.83 40.91 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.466 -0.771 . . . . 0.0 110.305 177.041 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.7 tt -145.99 138.03 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 124.505 1.122 . . . . 0.0 109.137 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -130.53 117.88 20.26 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.628 1.971 . . . . 0.0 106.781 172.496 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.415 HG22 ' CB ' ' A' ' 43' ' ' ALA . 75.1 t -117.24 114.93 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.067 1.303 . . . . 0.0 109.474 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.1 t -90.22 106.54 18.55 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.921 -0.487 . . . . 0.0 109.829 -179.081 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.544 HD13 ' N ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -48.76 -48.52 40.84 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 164.686 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.544 ' N ' HD13 ' A' ' 38' ' ' LEU . 3.4 m-20 -56.3 -59.55 4.78 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.035 0.534 . . . . 0.0 111.029 -178.316 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -74.6 -21.4 59.49 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.231 1.015 . . . . 0.0 110.723 -170.568 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 62.63 19.73 11.53 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.181 1.792 . . . . 0.0 110.36 -172.326 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -120.54 156.04 32.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.303 1.841 . . . . 0.0 108.286 175.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -140.47 154.38 46.6 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.463 1.105 . . . . 0.0 109.011 -178.153 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.8 m -125.64 111.55 15.1 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -177.64 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 78.5 mt -98.99 161.0 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 171.283 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 p -124.42 121.17 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 162.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.457 ' CE2' HD13 ' A' ' 5' ' ' LEU . 14.1 p90 -157.06 176.41 12.79 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.84 1.656 . . . . 0.0 108.72 -178.017 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.08 150.5 74.44 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 120.735 1.607 . . . . 0.0 113.734 169.641 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.67 72.3 1.41 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 124.745 3.63 . . . . 0.0 110.145 176.894 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -143.59 -60.12 0.41 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.302 1.041 . . . . 0.0 108.579 177.097 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.6 mt -88.18 -21.32 24.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.656 179.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.59 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.6 tp -120.86 148.67 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.124 0.57 . . . . 0.0 110.053 178.875 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.1 m -83.33 26.57 0.64 Allowed 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.272 0.5 OUTLIER 71.38 -61.14 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 128.913 2.885 . . . . 0.0 110.063 177.514 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -43.16 71.56 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.492 1.117 . . . . 0.0 108.863 179.374 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.6 mt-10 -44.67 -51.61 9.01 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 123.542 0.526 . . . . 0.0 111.28 -173.084 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.06 -52.64 5.25 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.225 0.61 . . . . 0.0 111.986 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -46.37 73.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 122.095 -0.378 . . . . 0.0 110.452 178.356 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -59.6 -28.82 67.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.136 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -61.31 -46.1 91.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 173.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.9 -48.42 88.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.32 173.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -51.32 -50.89 58.52 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.332 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.65 -19.43 49.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.5 1.92 . . . . 0.0 114.678 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.9 mmt -57.7 -32.15 67.09 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 120.106 1.321 . . . . 0.0 109.595 170.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.18 43.27 0.33 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.448 1.023 . . . . 0.0 110.844 173.472 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -145.11 121.53 6.07 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.547 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.78 94.37 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.605 2.203 . . . . 0.0 109.738 -175.468 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.97 -172.46 2.08 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.362 1.065 . . . . 0.0 108.637 -172.383 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.24 132.35 2.47 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 118.503 0.592 . . . . 0.0 112.381 -175.356 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.55 ' CG2' HD11 ' A' ' 5' ' ' LEU . 9.7 p -83.1 140.6 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 123.172 0.589 . . . . 0.0 110.168 174.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.8 mtpm? -93.73 -122.14 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.284 0.633 . . . . 0.0 110.33 167.417 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -79.37 162.83 25.3 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.244 0.929 . . . . 0.0 111.468 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.6 54.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 125.542 1.537 . . . . 0.0 110.874 -173.728 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -157.58 167.41 30.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.072 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.55 -84.93 0.27 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.234 0.921 . . . . 0.0 112.087 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 . . . . . 0 C--O 1.249 1.072 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 178.597 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.722 ' N ' ' HB2' ' A' ' 48' ' ' GLN . . . . . . . . 0 C--O 1.224 -0.493 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 60.21 58.0 2.77 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 123.0 1.381 . . . . 0.0 110.901 177.05 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.11 124.52 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 127.055 2.142 . . . . 0.0 107.414 168.338 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.31 138.95 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 124.442 1.097 . . . . 0.0 108.775 173.306 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.411 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -124.34 130.66 52.89 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.465 1.506 . . . . 0.0 107.074 175.002 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -101.21 116.78 33.61 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.615 1.566 . . . . 0.0 108.196 170.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.8 ptp -119.54 135.96 54.55 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.842 0.857 . . . . 0.0 110.339 178.459 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -74.95 153.93 38.35 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 167.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.25 72.85 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 176.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -62.55 166.89 4.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.717 0.77 . . . . 0.0 111.386 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.68 -56.67 4.21 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 174.59 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.4 mmm -59.27 135.75 57.74 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.475 0.637 . . . . 0.0 109.524 174.037 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -147.47 -28.22 0.36 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -170.501 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.6 t -117.42 115.8 25.91 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -177.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -40.69 108.95 0.1 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.704 1.601 . . . . 0.0 111.789 -170.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.1 t -165.7 -86.89 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -168.497 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.4 77.11 0.17 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-O 121.988 0.899 . . . . 0.0 109.322 173.593 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.409 HG22 HD23 ' A' ' 38' ' ' LEU . 19.1 p -135.53 -83.36 0.4 Allowed 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.484 2.314 . . . . 0.0 105.237 -178.024 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.7 t -53.58 -41.64 66.78 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -175.554 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.6 m -49.36 -57.6 6.61 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.608 170.123 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.26 -49.48 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.251 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.84 -64.22 0.98 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.088 0.947 . . . . 0.0 110.02 -175.013 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.34 -53.69 9.29 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.931 1.729 . . . . 0.0 112.584 174.419 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -58.3 8.38 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.874 0.837 . . . . 0.0 109.658 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.3 -33.23 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.779 1.231 . . . . 0.0 111.044 -176.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.49 -21.43 13.67 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.329 0.966 . . . . 0.0 114.013 173.147 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -85.1 -19.71 31.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.747 1.773 . . . . 0.0 111.372 176.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.65 137.17 49.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 122.231 1.015 . . . . 0.0 111.932 -166.635 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -52.91 113.4 1.08 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.86 177.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.34 -26.52 8.59 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-O 119.072 -0.849 . . . . 0.0 112.323 175.173 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.2 t -79.57 131.17 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 118.214 1.007 . . . . 0.0 109.18 -176.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -91.54 -55.7 3.4 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.896 0.879 . . . . 0.0 109.185 168.495 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.35 159.09 43.58 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.535 1.061 . . . . 0.0 109.788 -175.588 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -140.1 140.78 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.403 1.481 . . . . 0.0 110.107 176.333 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.05 124.51 31.02 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.576 1.55 . . . . 0.0 107.931 168.136 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.9 t -110.13 89.46 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.846 1.203 . . . . 0.0 110.89 177.095 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -76.88 78.08 3.46 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.686 1.194 . . . . 0.0 110.427 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -45.78 -41.6 11.05 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.483 0.713 . . . . 0.0 111.962 178.744 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.57 -54.38 1.16 Allowed 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 126.453 1.901 . . . . 0.0 111.379 170.334 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -84.95 -10.54 56.95 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.466 -171.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 61.92 21.0 11.96 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.325 1.45 . . . . 0.0 110.326 -174.113 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -136.86 144.21 43.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.624 1.57 . . . . 0.0 108.885 -172.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.49 149.56 48.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.932 1.293 . . . . 0.0 108.727 179.477 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.5 m -120.69 115.28 23.04 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -176.586 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 86.8 mt -107.32 159.97 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 171.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.72 125.79 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 167.371 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -155.42 -177.24 6.41 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 126.447 1.899 . . . . 0.0 107.749 -175.409 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.722 ' HB2' ' N ' ' A' ' 1' ' ' GLY . 1.6 tt0 -138.02 144.5 43.99 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 120.112 1.324 . . . . 0.0 110.559 167.271 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.48 77.28 0.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.071 3.18 . . . . 0.0 110.025 176.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -149.17 -53.44 0.17 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.884 0.873 . . . . 0.0 109.13 174.611 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -88.19 -25.14 23.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.12 0.568 . . . . 0.0 110.843 176.352 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.406 HD11 ' HB3' ' A' ' 56' ' ' GLU . 9.8 tp -118.95 147.43 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.012 0.925 . . . . 0.0 109.648 178.76 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.4 m -83.47 24.27 0.85 Allowed 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.673 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.256 0.5 OUTLIER 72.61 -59.85 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 127.871 2.468 . . . . 0.0 109.86 179.884 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.31 -35.85 40.5 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.211 1.804 . . . . 0.0 109.78 -175.353 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.406 ' HB3' HD11 ' A' ' 52' ' ' ILE . 5.5 mt-10 -42.22 -53.76 3.95 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 123.538 0.735 . . . . 0.0 111.458 177.447 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.89 -49.04 5.91 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.388 1.075 . . . . 0.0 112.087 -176.729 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -49.33 38.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.1 -0.375 . . . . 0.0 110.999 174.619 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -53.98 -30.04 45.44 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.044 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -57.29 -52.03 67.0 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.388 0.613 . . . . 0.0 109.525 172.069 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -58.19 -49.91 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.453 173.293 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -52.98 -48.35 67.52 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.452 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.56 -21.62 60.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.379 1.472 . . . . 0.0 114.036 179.518 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 29.4 mmt -64.17 -30.02 71.1 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.869 1.213 . . . . 0.0 110.526 172.177 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.37 -33.11 2.19 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 176.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -73.51 107.51 3.49 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-O 117.776 -1.107 . . . . 0.0 108.732 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.75 118.91 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 108.071 -1.55 . . . . 0.0 108.071 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.08 -167.39 1.54 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.254 0.479 . . . . 0.0 110.404 -174.349 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -160.1 151.09 19.12 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -175.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.45 127.83 58.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 C-N-CA 126.65 1.98 . . . . 0.0 108.834 179.035 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -93.43 -77.01 0.46 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.502 178.17 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -115.33 154.74 28.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.59 1.086 . . . . 0.0 110.18 176.507 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pp -134.29 56.96 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 123.821 0.849 . . . . 0.0 112.906 -179.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -161.01 160.31 30.47 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 164.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.59 -85.21 1.17 Allowed Glycine 0 CA--C 1.521 0.464 0 CA-C-O 119.591 -0.561 . . . . 0.0 114.077 -170.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 . . . . . 0 C--O 1.249 1.04 0 C-N-CA 126.999 2.12 . . . . 0.0 105.421 -157.12 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.757 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 8.71 81.36 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 129.476 3.11 . . . . 0.0 114.547 165.84 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.5 t -92.35 129.64 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.327 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.85 145.92 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 123.163 0.585 . . . . 0.0 109.984 177.467 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.66 HD21 HG22 ' A' ' 70' ' ' VAL . 1.4 tm? -141.94 138.38 31.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.698 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.548 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -122.1 116.39 24.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.309 1.444 . . . . 0.0 107.684 -173.769 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -121.79 149.9 42.64 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.841 1.256 . . . . 0.0 110.893 -172.379 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -98.95 132.62 44.13 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.835 1.654 . . . . 0.0 108.129 177.139 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.14 64.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.372 1.069 . . . . 0.0 110.218 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.93 153.18 41.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.823 179.09 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.26 -22.03 14.42 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.037 174.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.3 ttp -67.48 128.38 36.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.985 0.893 . . . . 0.0 109.869 -178.052 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -77.82 167.07 22.11 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.082 0.953 . . . . 0.0 111.902 -171.246 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 t -58.72 155.37 12.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.07 0.948 . . . . 0.0 111.714 -177.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -8.84 87.55 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.205 3.002 . . . . 0.0 115.006 -171.466 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 t -165.99 -77.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -171.877 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.7 m -75.62 75.02 2.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.4 p -133.04 -77.52 0.49 Allowed 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 168.412 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.6 m -54.12 -36.73 63.58 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -170.751 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -52.18 -57.86 8.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.103 0.252 . . . . 0.0 111.125 169.172 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.1 -54.28 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.203 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -57.65 -65.02 0.7 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.631 0.729 . . . . 0.0 110.746 -172.314 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.48 -53.55 12.25 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.726 1.631 . . . . 0.0 111.98 176.845 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -64.21 -50.62 67.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.112 0.956 . . . . 0.0 110.563 -176.293 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.6 mm -54.99 -39.2 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 123.406 0.682 . . . . 0.0 110.629 175.603 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.11 -20.18 13.97 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.016 1.293 . . . . 0.0 113.978 173.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -92.38 -19.42 22.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 118.987 1.393 . . . . 0.0 109.593 178.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.34 134.3 50.07 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.815 1.293 . . . . 0.0 111.816 -176.101 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.57 110.84 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.522 176.273 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.3 -25.83 7.25 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 119.085 -0.842 . . . . 0.0 112.219 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.24 136.02 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 118.382 1.091 . . . . 0.0 109.002 -178.824 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -107.89 -43.75 4.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.244 1.018 . . . . 0.0 110.736 175.17 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -155.79 161.14 40.71 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.772 0.715 . . . . 0.0 110.324 177.489 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 tt -141.01 144.68 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.896 1.278 . . . . 0.0 110.421 -176.548 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.02 98.82 3.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.329 1.852 . . . . 0.0 108.727 172.26 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -92.19 112.24 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.381 1.072 . . . . 0.0 110.042 176.382 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 m -94.98 90.96 6.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.705 1.202 . . . . 0.0 108.877 173.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 38' ' ' LEU . 5.7 mt -57.91 177.44 0.11 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.223 162.654 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.23 -61.3 0.39 Allowed 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 127.88 2.472 . . . . 0.0 109.45 -167.352 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -68.23 -17.75 64.39 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.989 0.423 . . . . 0.0 111.22 -177.32 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 67.21 41.83 2.45 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 127.332 2.253 . . . . 0.0 110.613 -178.706 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -144.27 141.93 30.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.827 -166.21 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.18 150.8 44.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.466 -0.771 . . . . 0.0 109.843 -177.083 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -130.51 121.52 25.93 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -176.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 mp -126.44 159.87 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 124.744 1.218 . . . . 0.0 108.271 -175.544 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.3 p -129.39 118.57 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.512 0.725 . . . . 0.0 109.597 178.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -159.19 -178.98 7.59 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.677 1.591 . . . . 0.0 109.864 -172.738 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -148.06 144.56 19.07 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HB3' HG23 ' A' ' 54' ' ' VAL . 49.7 Cg_endo -67.94 77.85 0.58 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.295 3.33 . . . . 0.0 110.684 175.424 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.57 -54.45 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.941 1.296 . . . . 0.0 107.586 168.218 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.7 mt -94.78 -21.37 18.76 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.843 -0.599 . . . . 0.0 111.91 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.2 tp -120.87 145.97 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.047 0.939 . . . . 0.0 109.554 -177.873 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 m -74.0 24.56 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.125 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 49' ' ' PRO . 0.8 OUTLIER 73.28 -58.07 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 127.249 2.22 . . . . 0.0 109.626 -177.885 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -80.93 -42.35 21.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.445 1.498 . . . . 0.0 109.647 -174.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.445 ' HB3' HD11 ' A' ' 52' ' ' ILE . 7.3 mt-10 -41.16 -51.04 3.51 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.882 0.873 . . . . 0.0 111.87 -174.516 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -40.31 -59.91 1.19 Allowed 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.217 1.407 . . . . 0.0 111.464 -178.303 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 tptp -73.93 -43.61 57.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -57.49 -26.91 62.0 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.149 -0.969 . . . . 0.0 112.313 -174.151 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.96 -41.81 88.36 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.031 0.832 . . . . 0.0 109.128 174.102 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -62.83 -33.97 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.179 176.496 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -61.39 -52.66 63.67 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.48 -31.84 64.43 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.206 1.002 . . . . 0.0 112.716 -174.811 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.9 mmm -51.27 -36.34 41.69 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.479 0.582 . . . . 0.0 111.43 171.383 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.29 -36.79 1.45 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.285 0.945 . . . . 0.0 111.281 176.666 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -68.01 115.29 26.93 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.263 -173.482 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.76 101.49 0.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.428 2.085 . . . . 0.0 108.815 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.09 168.42 19.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -168.32 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.68 148.5 39.2 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.324 -0.86 . . . . 0.0 112.549 -166.077 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.66 HG22 HD21 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -99.82 144.73 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.662 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -83.11 -85.11 0.12 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.568 0.747 . . . . 0.0 109.719 173.327 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -157.03 147.38 21.2 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.564 ' HB ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -133.86 123.29 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 125.67 1.588 . . . . 0.0 107.488 173.105 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.89 151.42 25.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.226 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.51 105.43 3.15 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -179.325 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.398 -1.287 . . . . 0.0 109.541 170.58 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -162.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.796 1.238 . . . . 0.0 112.192 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.57 125.42 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 124.76 1.224 . . . . 0.0 108.759 -174.157 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.5 t -79.6 145.67 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 124.83 1.252 . . . . 0.0 109.801 -178.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.53 HD11 HG22 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -137.54 149.42 46.72 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 126.138 1.775 . . . . 0.0 107.845 176.778 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.76 144.85 31.18 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.276 0.943 . . . . 0.0 111.71 155.86 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -126.89 153.72 45.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.116 1.766 . . . . 0.0 108.94 175.979 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -114.81 138.94 50.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.325 1.05 . . . . 0.0 108.529 177.224 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.04 68.86 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.857 0.863 . . . . 0.0 110.988 -172.275 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -68.29 165.96 17.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.103 0.478 . . . . 0.0 110.261 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.41 -34.82 1.55 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 121.604 -0.685 . . . . 0.0 114.063 168.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.9 151.01 7.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.034 0.917 . . . . 0.0 111.477 174.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -69.81 178.07 2.79 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.625 173.218 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 t -105.4 145.98 30.07 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.242 1.017 . . . . 0.0 111.147 -175.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.565 ' H ' HD13 ' A' ' 38' ' ' LEU . 1.1 t-160 43.72 53.31 6.07 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.416 2.286 . . . . 0.0 112.712 -177.832 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.56 18.69 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -171.833 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' HD11 ' A' ' 38' ' ' LEU . 24.7 p -164.85 56.15 0.13 Allowed 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.142 -0.974 . . . . 0.0 110.41 -167.748 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.8 p -122.69 -80.36 0.63 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 173.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 m -54.02 -37.13 63.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -168.456 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.8 m -50.06 -61.31 2.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.568 0.542 . . . . 0.0 111.246 168.273 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.6 -50.81 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.437 ' HA ' HG21 ' A' ' 34' ' ' ILE . 47.7 mt-10 -56.45 -67.59 0.29 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.129 0.966 . . . . 0.0 110.891 -174.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.68 -49.87 26.76 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.097 1.808 . . . . 0.0 112.124 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -62.62 -52.17 64.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.872 0.836 . . . . 0.0 109.62 -178.525 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.417 HD12 ' CE ' ' A' ' 57' ' ' MET . 18.0 mm -55.57 -36.28 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.183 0.593 . . . . 0.0 111.202 175.362 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.51 -19.13 11.96 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.738 -1.034 . . . . 0.0 113.807 175.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -90.25 -18.98 24.69 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 119.653 1.726 . . . . 0.0 111.16 176.761 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.12 133.85 47.56 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.659 1.219 . . . . 0.0 112.39 -170.267 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -52.62 106.34 0.15 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.449 176.731 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.69 -30.74 4.57 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-O 119.475 -0.625 . . . . 0.0 111.917 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 t -82.8 140.61 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 117.691 0.745 . . . . 0.0 109.552 -173.222 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -111.25 -41.87 4.06 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.947 0.899 . . . . 0.0 111.689 174.656 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.45 159.23 43.4 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.822 -0.549 . . . . 0.0 109.704 -179.433 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 22' ' ' GLU . 9.2 tt -146.59 145.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.59 1.556 . . . . 0.0 107.704 173.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -136.56 109.17 7.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.104 2.161 . . . . 0.0 106.465 173.63 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -102.44 120.28 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.916 1.235 . . . . 0.0 109.191 175.553 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 t -105.91 90.48 3.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.169 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.565 HD13 ' H ' ' A' ' 15' ' ' HIS . 1.0 OUTLIER -52.65 -46.13 67.02 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.356 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -56.95 2.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.968 1.707 . . . . 0.0 110.755 170.192 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -17.75 60.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.032 -175.298 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 73.12 2.53 4.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.837 2.455 . . . . 0.0 112.052 -175.822 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -111.24 151.57 28.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.406 1.882 . . . . 0.0 109.699 -179.274 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.485 ' HB3' ' SD ' ' A' ' 7' ' ' MET . . . -127.04 160.2 31.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 163.268 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.8 m -119.96 128.03 53.2 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 175.74 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.401 HG21 ' SD ' ' A' ' 57' ' ' MET . 16.0 mt -122.74 162.84 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -135.77 117.88 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.27 0.628 . . . . 0.0 110.277 177.107 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.28 -179.32 8.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.141 1.376 . . . . 0.0 110.043 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -135.71 149.77 69.97 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.209 1.004 . . . . 0.0 113.05 177.833 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.09 67.88 7.99 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.374 3.382 . . . . 0.0 109.928 -176.026 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 -55.99 0.26 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.865 0.866 . . . . 0.0 109.223 177.071 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.92 -29.03 35.62 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.048 -0.501 . . . . 0.0 109.811 -177.807 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.7 tp -118.93 145.4 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 123.433 0.693 . . . . 0.0 109.403 -178.16 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.9 m -81.67 33.83 0.38 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -174.314 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 74.36 -61.68 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 128.065 2.546 . . . . 0.0 108.262 175.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.43 -40.17 23.79 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 124.483 1.113 . . . . 0.0 109.758 -174.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.417 ' HB3' HD11 ' A' ' 52' ' ' ILE . 14.9 mt-10 -40.48 -48.54 2.8 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 123.888 0.743 . . . . 0.0 111.413 -174.465 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.417 ' CE ' HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -34.78 -65.5 0.21 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.862 1.665 . . . . 0.0 110.872 174.385 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -75.98 -41.88 50.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.671 -0.643 . . . . 0.0 112.185 178.48 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -58.31 -22.29 52.43 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.845 -174.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -62.65 -42.08 99.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.766 0.712 . . . . 0.0 109.351 173.056 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.75 -49.68 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.102 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -54.45 -44.72 72.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.78 -22.66 62.46 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.82 1.248 . . . . 0.0 114.144 176.613 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.0 mmt -66.34 -28.62 68.8 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.145 1.338 . . . . 0.0 110.586 170.532 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.21 -42.71 1.28 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -62.31 110.95 3.82 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.901 0.88 . . . . 0.0 110.824 -173.581 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.99 96.69 0.7 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.54 2.16 . . . . 0.0 109.575 -175.33 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.74 -161.17 0.75 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.948 0.899 . . . . 0.0 109.51 -174.611 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -162.56 146.51 11.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.367 0.531 . . . . 0.0 112.179 -177.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.53 HG22 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -112.12 137.21 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.57 1.548 . . . . 0.0 108.531 174.374 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -78.9 -101.12 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.115 0.566 . . . . 0.0 110.456 172.421 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -156.69 149.8 24.06 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -177.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.47 110.27 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.266 1.826 . . . . 0.0 106.831 -175.284 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.35 142.12 16.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 71.02 0.03 OUTLIER Glycine 0 C--N 1.341 0.807 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -176.574 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.311 0 CA-C-O 117.027 -1.463 . . . . 0.0 109.589 -170.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.08 148.11 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.24 0.616 . . . . 0.0 110.113 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.627 HD13 ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -139.48 141.8 37.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 171.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 130.65 56.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -121.53 151.74 39.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.244 1.818 . . . . 0.0 108.842 -176.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -95.37 136.92 35.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.41 67.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -70.26 170.15 12.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.811 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 O-C-N 121.248 -0.908 . . . . 0.0 113.504 170.328 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.3 t -52.21 -43.59 64.33 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.9 m -46.43 -60.24 2.47 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.655 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -48.79 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -57.24 -63.87 1.08 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.975 0.893 . . . . 0.0 110.085 -174.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.56 -54.96 8.39 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.826 1.679 . . . . 0.0 112.778 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -56.83 -56.61 19.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.179 0.989 . . . . 0.0 109.7 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.86 -28.29 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 110.51 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.51 -24.41 7.46 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.757 1.17 . . . . 0.0 114.306 170.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -87.55 -11.16 49.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 119.826 1.813 . . . . 0.0 111.381 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 139.09 55.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.796 0.808 . . . . 0.0 110.77 -171.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 115.73 4.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.386 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.54 -19.75 23.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.576 -1.124 . . . . 0.0 112.445 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.84 139.19 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 118.853 1.326 . . . . 0.0 109.79 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.8 -39.05 3.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.659 1.184 . . . . 0.0 110.74 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -149.73 156.78 42.44 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.795 -0.566 . . . . 0.0 109.852 172.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -137.2 145.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.565 1.546 . . . . 0.0 108.204 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -138.44 114.85 10.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.719 1.607 . . . . 0.0 107.008 166.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -102.61 129.9 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.129 0.877 . . . . 0.0 109.995 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.1 t -115.89 86.65 2.52 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.505 1.122 . . . . 0.0 108.119 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -39.07 69.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.386 -0.34 . . . . 0.0 110.374 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.93 -58.51 2.74 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.01 1.324 . . . . 0.0 110.694 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -79.09 -10.2 59.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.789 0.804 . . . . 0.0 110.456 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.83 24.41 13.74 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.101 1.761 . . . . 0.0 109.552 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -142.83 157.94 44.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.681 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HB3' ' SD ' ' A' ' 7' ' ' MET . . . -150.13 155.99 40.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -171.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.7 m -128.82 121.87 29.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.459 ' HB ' HD12 ' A' ' 5' ' ' LEU . 49.0 mt -118.73 155.17 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.38 126.48 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -156.77 179.86 8.88 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.673 1.589 . . . . 0.0 109.536 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.86 142.43 45.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.11 74.71 2.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.16 3.24 . . . . 0.0 110.125 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.36 -57.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.137 1.375 . . . . 0.0 107.452 176.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.54 -19.85 30.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.144 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.8 tp -128.32 152.3 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 111.074 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -89.62 27.56 1.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.917 0.887 . . . . 0.0 112.783 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 t 72.28 -60.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 128.147 2.579 . . . . 0.0 109.501 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.4 -35.98 30.07 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.797 1.239 . . . . 0.0 109.873 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -46.55 -46.62 19.49 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.659 0.599 . . . . 0.0 110.89 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.25 -52.57 1.48 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.583 1.153 . . . . 0.0 113.159 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -46.13 63.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 109.801 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -57.71 -29.09 64.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.452 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -63.53 -41.95 98.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.625 -0.672 . . . . 0.0 109.29 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.83 -44.99 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.389 174.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -53.28 -46.4 69.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.57 43.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.064 1.346 . . . . 0.0 113.495 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -64.04 -28.05 69.53 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.238 0.926 . . . . 0.0 110.459 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.39 -34.88 2.36 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.73 118.82 74.12 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.311 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.13 107.92 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.192 1.928 . . . . 0.0 109.089 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.95 -168.15 1.62 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.881 1.273 . . . . 0.0 108.394 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -164.15 161.05 22.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.908 -0.495 . . . . 0.0 111.755 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 110.378 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.08 148.11 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.24 0.616 . . . . 0.0 110.113 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.627 HD13 ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -139.48 141.8 37.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 171.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 130.65 56.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -121.53 151.74 39.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.244 1.818 . . . . 0.0 108.842 -176.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -95.37 136.92 35.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.41 67.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -70.26 170.15 12.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.811 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 O-C-N 121.248 -0.908 . . . . 0.0 113.504 170.328 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.3 t -52.21 -43.59 64.33 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.9 m -46.43 -60.24 2.47 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.655 169.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -48.79 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -57.24 -63.87 1.08 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.975 0.893 . . . . 0.0 110.085 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.56 -54.96 8.39 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.826 1.679 . . . . 0.0 112.778 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -56.83 -56.61 19.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.179 0.989 . . . . 0.0 109.7 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.86 -28.29 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 110.51 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.51 -24.41 7.46 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.757 1.17 . . . . 0.0 114.306 170.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -87.55 -11.16 49.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 119.826 1.813 . . . . 0.0 111.381 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 139.09 55.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.796 0.808 . . . . 0.0 110.77 -171.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 115.73 4.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.386 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.54 -19.75 23.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.576 -1.124 . . . . 0.0 112.445 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.84 139.19 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 118.853 1.326 . . . . 0.0 109.79 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.8 -39.05 3.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.659 1.184 . . . . 0.0 110.74 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -149.73 156.78 42.44 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.795 -0.566 . . . . 0.0 109.852 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -137.2 145.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.565 1.546 . . . . 0.0 108.204 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -138.44 114.85 10.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.719 1.607 . . . . 0.0 107.008 166.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -102.61 129.9 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.129 0.877 . . . . 0.0 109.995 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.1 t -115.89 86.65 2.52 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.505 1.122 . . . . 0.0 108.119 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -39.07 69.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.386 -0.34 . . . . 0.0 110.374 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.93 -58.51 2.74 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.01 1.324 . . . . 0.0 110.694 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -79.09 -10.2 59.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.789 0.804 . . . . 0.0 110.456 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.83 24.41 13.74 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.101 1.761 . . . . 0.0 109.552 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -142.83 157.94 44.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.681 -166.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HB3' ' SD ' ' A' ' 7' ' ' MET . . . -150.13 155.99 40.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -171.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.7 m -128.82 121.87 29.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.459 ' HB ' HD12 ' A' ' 5' ' ' LEU . 49.0 mt -118.73 155.17 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.38 126.48 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -156.77 179.86 8.88 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.673 1.589 . . . . 0.0 109.536 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.86 142.43 45.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.11 74.71 2.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.16 3.24 . . . . 0.0 110.125 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.36 -57.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.137 1.375 . . . . 0.0 107.452 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.54 -19.85 30.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.144 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.8 tp -128.32 152.3 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 111.074 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -89.62 27.56 1.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.917 0.887 . . . . 0.0 112.783 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 t 72.28 -60.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 128.147 2.579 . . . . 0.0 109.501 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.4 -35.98 30.07 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.797 1.239 . . . . 0.0 109.873 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -46.55 -46.62 19.49 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.659 0.599 . . . . 0.0 110.89 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.25 -52.57 1.48 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.583 1.153 . . . . 0.0 113.159 173.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -46.13 63.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 109.801 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -57.71 -29.09 64.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.452 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -63.53 -41.95 98.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.625 -0.672 . . . . 0.0 109.29 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.83 -44.99 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.389 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -53.28 -46.4 69.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.57 43.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.064 1.346 . . . . 0.0 113.495 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -64.04 -28.05 69.53 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.238 0.926 . . . . 0.0 110.459 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.39 -34.88 2.36 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.73 118.82 74.12 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.311 -175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.13 107.92 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.192 1.928 . . . . 0.0 109.089 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.95 -168.15 1.62 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.881 1.273 . . . . 0.0 108.394 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -164.15 161.05 22.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.908 -0.495 . . . . 0.0 111.755 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 110.378 179.445 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.448 -0.572 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.64 133.83 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 123.99 0.916 . . . . 0.0 108.593 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.503 HD11 ' CG2' ' A' ' 70' ' ' VAL . 2.5 tt -113.21 148.15 36.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.366 1.466 . . . . 0.0 108.21 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.97 123.02 46.97 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 161.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.429 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 12.3 ptt? -115.44 163.05 16.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.233 1.013 . . . . 0.0 109.585 169.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -108.72 131.3 55.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.988 2.115 . . . . 0.0 106.408 170.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.05 60.32 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 126.523 1.929 . . . . 0.0 106.869 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -58.77 133.38 55.91 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.764 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.107 178.709 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.223 -0.337 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 p -53.43 -43.42 67.99 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.7 m -42.01 -62.53 0.9 Allowed 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.921 0.888 . . . . 0.0 112.19 165.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.99 -48.93 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 123.908 0.883 . . . . 0.0 108.932 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -57.25 -61.07 2.73 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.47 1.128 . . . . 0.0 109.332 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.76 -53.95 19.61 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.754 1.645 . . . . 0.0 112.308 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.5 -52.55 65.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.017 0.909 . . . . 0.0 110.068 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 34' ' ' ILE . 23.3 mm -57.54 -31.82 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.708 1.203 . . . . 0.0 111.116 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.13 -18.87 10.0 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.753 -1.026 . . . . 0.0 114.227 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -86.81 -11.79 49.9 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.637 1.719 . . . . 0.0 111.095 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 135.82 45.85 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 122.269 1.033 . . . . 0.0 111.748 -170.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -57.74 110.37 0.88 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.85 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.13 -24.11 9.51 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 119.251 -0.749 . . . . 0.0 112.661 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 t -80.01 136.08 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 118.213 1.007 . . . . 0.0 109.245 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -107.14 -38.83 5.89 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.703 1.201 . . . . 0.0 110.442 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.59 167.34 30.42 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.218 -0.926 . . . . 0.0 110.62 172.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 25' ' ' ILE . 13.9 tt -150.91 144.43 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.276 1.03 . . . . 0.0 108.561 177.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -129.58 129.62 44.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.898 1.679 . . . . 0.0 106.518 167.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.82 123.42 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.581 1.082 . . . . 0.0 110.982 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.5 t -81.25 158.98 24.63 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.107 0.563 . . . . 0.0 110.045 174.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -95.87 -67.93 0.83 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 163.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.08 -54.65 8.16 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 126.193 1.797 . . . . 0.0 110.678 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -77.64 -18.74 56.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.252 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 55.06 18.82 2.47 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 127.146 2.178 . . . . 0.0 111.409 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -101.05 152.12 20.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.596 1.558 . . . . 0.0 107.933 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -148.04 152.52 37.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.846 -0.534 . . . . 0.0 109.866 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 m -130.35 115.73 17.32 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -171.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.88 157.99 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.32 116.57 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 167.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.446 ' OH ' HD13 ' A' ' 5' ' ' LEU . 40.8 p90 -159.07 178.69 9.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.425 1.49 . . . . 0.0 109.549 -173.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -138.97 149.62 62.25 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.31 75.52 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.229 3.286 . . . . 0.0 109.936 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.58 -57.0 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.259 1.423 . . . . 0.0 107.414 170.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.8 mt -90.25 -23.03 21.34 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.452 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 56' ' ' GLU . 9.6 tp -121.68 149.06 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 119.083 0.856 . . . . 0.0 110.31 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 m -82.86 24.17 0.77 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 71.13 -65.74 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 128.737 2.815 . . . . 0.0 109.055 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -68.88 -39.85 79.55 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.434 1.094 . . . . 0.0 109.215 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.45 ' HB3' HD11 ' A' ' 52' ' ' ILE . 2.7 mt-10 -42.32 -54.19 3.86 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.403 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -49.86 10.75 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.583 0.753 . . . . 0.0 110.952 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -42.9 71.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.648 0.779 . . . . 0.0 111.422 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -56.23 -35.09 66.97 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.046 -1.033 . . . . 0.0 112.652 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -62.13 -42.28 99.08 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.66 -47.43 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 118.017 -0.992 . . . . 0.0 111.523 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.48 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 6.1 mt-10 -50.76 -49.27 58.49 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.149 1.341 . . . . 0.0 109.238 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.85 -19.07 48.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.28 1.832 . . . . 0.0 114.051 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mmm -61.33 -28.72 69.42 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.656 1.116 . . . . 0.0 110.15 169.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.02 38.86 0.55 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.051 1.31 . . . . 0.0 111.554 169.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -148.88 122.18 4.58 Favored Pre-proline 0 C--O 1.224 -0.28 0 CA-C-O 117.314 -1.326 . . . . 0.0 108.055 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.81 111.26 1.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.018 1.812 . . . . 0.0 109.452 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.48 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -109.17 -176.35 3.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -160.48 149.77 17.29 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 120.399 -1.438 . . . . 0.0 111.196 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.503 ' CG2' HD11 ' A' ' 5' ' ' LEU . 8.4 p . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.875 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.86 119.49 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 125.931 1.692 . . . . 0.0 111.28 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.664 HD21 HG22 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -116.67 131.3 56.99 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.229 1.012 . . . . 0.0 108.881 178.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.487 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -101.4 119.17 38.35 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.896 1.279 . . . . 0.0 110.495 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.526 ' SD ' HD11 ' A' ' 45' ' ' ILE . 9.6 ptt? -113.34 153.24 28.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.766 1.226 . . . . 0.0 109.931 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.92 133.88 43.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 169.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.82 68.0 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.5 150.23 48.32 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.674 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 O-C-N 121.666 -0.646 . . . . 0.0 113.597 170.794 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.9 p . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.8 m -55.64 -38.5 69.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.22 -52.75 60.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.589 0.233 . . . . 0.0 110.678 171.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.11 -53.48 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.45 -61.31 2.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.078 0.942 . . . . 0.0 110.195 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.52 -55.57 7.88 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.719 1.628 . . . . 0.0 112.471 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.66 -48.76 75.93 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.37 1.085 . . . . 0.0 110.322 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.426 HG21 HD12 ' A' ' 34' ' ' ILE . 26.4 mm -59.46 -33.42 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.498 0.719 . . . . 0.0 110.171 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.8 -13.62 8.51 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.489 1.042 . . . . 0.0 114.073 172.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.13 -14.27 31.47 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.388 1.594 . . . . 0.0 109.936 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.41 137.33 52.66 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 122.655 1.217 . . . . 0.0 112.886 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -54.69 108.0 0.35 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.438 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.27 -24.65 9.14 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-O 118.67 -1.072 . . . . 0.0 111.992 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.9 135.36 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 118.579 1.19 . . . . 0.0 108.873 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -108.05 -42.35 4.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.658 1.583 . . . . 0.0 109.919 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -152.1 159.73 43.59 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 25' ' ' ILE . 15.8 tt -143.25 152.48 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 108.495 172.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.49 110.99 5.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.743 2.017 . . . . 0.0 105.676 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.55 130.93 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.022 0.929 . . . . 0.0 109.376 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 t -117.23 90.37 3.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.15 -46.07 65.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -41.96 -58.83 1.93 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.626 1.17 . . . . 0.0 111.54 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -78.07 -7.41 56.91 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.836 0.827 . . . . 0.0 111.328 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 65.07 15.77 10.18 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 127.175 2.19 . . . . 0.0 110.7 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -132.53 154.55 49.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.824 1.649 . . . . 0.0 109.685 -166.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.02 165.57 30.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -134.87 126.76 29.39 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.526 HD11 ' SD ' ' A' ' 7' ' ' MET . 1.3 mp -108.94 152.95 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 167.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.74 117.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -156.73 -179.42 8.17 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.945 1.298 . . . . 0.0 109.147 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -131.4 147.89 67.93 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.373 1.069 . . . . 0.0 112.915 173.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.25 73.04 2.14 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.977 3.118 . . . . 0.0 109.662 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.84 -62.28 0.29 Allowed 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.195 0.998 . . . . 0.0 108.803 175.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.8 mt -83.65 -24.14 31.5 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.604 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.0 tp -114.11 156.84 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.109 0.963 . . . . 0.0 109.207 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.85 17.49 1.51 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.04 0.536 . . . . 0.0 112.281 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 68.64 -59.63 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.941 2.096 . . . . 0.0 109.402 -165.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -88.57 -28.36 20.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.909 -167.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' HB3' HD11 ' A' ' 52' ' ' ILE . 2.1 mt-10 -40.81 -53.12 2.92 Favored 'General case' 0 C--N 1.343 0.321 0 O-C-N 124.069 0.856 . . . . 0.0 110.543 177.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -43.18 -67.96 0.23 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.586 1.154 . . . . 0.0 110.544 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -46.65 84.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.949 -0.469 . . . . 0.0 110.756 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -51.94 -32.67 34.09 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -69.2 -43.46 74.07 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.566 1.075 . . . . 0.0 109.327 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.96 -39.78 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.795 -0.621 . . . . 0.0 109.671 173.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 11.5 mt-10 -57.23 -55.31 36.45 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.928 0.785 . . . . 0.0 108.945 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.31 -30.56 51.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.332 1.853 . . . . 0.0 113.425 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 26.4 mmt -50.7 -35.78 32.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.065 0.848 . . . . 0.0 111.426 172.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.96 41.63 0.44 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.378 0.99 . . . . 0.0 111.648 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -145.95 126.63 7.23 Favored Pre-proline 0 C--O 1.223 -0.323 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.54 111.06 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.483 1.456 . . . . 0.0 109.052 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.495 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -108.79 -169.24 1.46 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -164.58 149.6 9.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.621 -0.674 . . . . 0.0 110.837 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.664 HG22 HD21 ' A' ' 5' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.441 -0.918 0 CA-C-O 121.188 0.518 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.403 HG13 HG23 ' A' ' 44' ' ' THR . 4.5 t -78.61 134.54 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 124.916 1.286 . . . . 0.0 108.679 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.573 HD21 HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -129.42 129.13 44.29 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.37 130.87 42.0 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.042 0.937 . . . . 0.0 110.099 170.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -131.18 146.55 52.38 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.306 1.442 . . . . 0.0 108.786 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -82.8 150.7 26.45 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.64 66.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.037 0.935 . . . . 0.0 108.707 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.53 158.75 17.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.763 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.457 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 175.19 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.6 t -55.68 -39.99 71.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -168.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -49.31 -58.47 5.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.454 0.301 . . . . 0.0 111.716 168.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.07 -52.38 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -58.79 -62.38 1.91 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.766 0.793 . . . . 0.0 110.29 -172.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.16 -55.36 6.61 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.132 1.825 . . . . 0.0 112.534 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -60.64 -54.04 50.14 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.564 1.182 . . . . 0.0 109.776 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 mm -55.24 -33.8 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.196 0.999 . . . . 0.0 110.81 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.56 -23.13 9.09 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.035 1.302 . . . . 0.0 114.184 173.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -89.75 -12.59 38.9 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.589 1.694 . . . . 0.0 111.455 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.56 135.35 51.4 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.108 0.956 . . . . 0.0 110.84 -172.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -56.54 106.06 0.26 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.489 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.42 -26.44 6.64 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-O 119.054 -0.859 . . . . 0.0 112.225 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.03 132.03 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 118.476 1.138 . . . . 0.0 108.575 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -109.11 -31.02 7.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.695 0.798 . . . . 0.0 110.884 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -159.91 170.3 21.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.255 0.934 . . . . 0.0 110.475 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.2 tt -152.6 147.16 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.703 0.801 . . . . 0.0 109.867 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -136.98 106.8 6.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.025 1.73 . . . . 0.0 107.292 168.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.8 t -93.3 113.33 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 119.43 1.014 . . . . 0.0 109.55 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.88 73.18 1.75 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 tt -46.37 -50.39 16.56 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.397 1.079 . . . . 0.0 110.424 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.83 -53.98 2.19 Favored 'General case' 0 CA--C 1.523 -0.084 0 C-N-CA 125.827 1.651 . . . . 0.0 111.628 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.1 -16.11 58.28 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.57 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 70.25 8.51 6.67 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.977 2.111 . . . . 0.0 111.605 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -124.76 143.95 50.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.862 2.065 . . . . 0.0 107.889 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.71 157.2 42.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.431 1.092 . . . . 0.0 108.72 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.403 HG23 HG13 ' A' ' 4' ' ' VAL . 7.8 m -130.49 104.69 7.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.506 1.922 . . . . 0.0 107.151 -171.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.81 153.45 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.17 117.2 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.054 0.942 . . . . 0.0 109.753 168.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -158.71 178.81 9.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.654 1.182 . . . . 0.0 110.811 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.69 142.62 37.35 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 124.121 0.968 . . . . 0.0 112.208 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.425 ' HB3' HG23 ' A' ' 54' ' ' VAL . 72.8 Cg_endo -69.43 75.06 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.871 3.048 . . . . 0.0 110.314 172.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -140.52 -54.55 0.51 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.4 mt -89.63 -22.69 22.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.261 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.551 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.1 tp -119.54 150.24 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.877 0.871 . . . . 0.0 110.003 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.2 m -86.26 29.13 0.77 Allowed 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 49' ' ' PRO 0.261 0.5 OUTLIER 74.02 -56.69 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.631 2.372 . . . . 0.0 111.14 175.771 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -85.38 -36.18 20.89 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.571 1.548 . . . . 0.0 109.749 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HB3' HD11 ' A' ' 52' ' ' ILE . 5.8 mm-40 -42.89 -50.87 5.71 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 123.842 0.714 . . . . 0.0 110.972 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.91 -53.4 3.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 123.907 0.883 . . . . 0.0 112.113 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -45.63 61.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.304 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -55.09 -29.54 57.79 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -61.72 -43.18 99.36 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.745 0.702 . . . . 0.0 109.714 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.98 -49.35 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.626 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -51.92 -48.4 64.22 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.25 -19.95 56.84 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.06 1.744 . . . . 0.0 113.973 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.0 mmm -60.91 -34.08 74.12 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.74 1.155 . . . . 0.0 109.466 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.29 -33.33 2.01 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -75.39 119.39 76.78 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.026 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.53 117.32 4.51 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.21 1.94 . . . . 0.0 108.596 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.3 -172.37 2.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.857 0.463 . . . . 0.0 109.905 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.58 137.77 9.2 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.573 HG22 HD21 ' A' ' 5' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.277 0 C-N-CA 125.348 1.459 . . . . 0.0 107.819 171.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.1 t -97.16 126.62 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 125.972 1.709 . . . . 0.0 110.632 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.82 153.56 20.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.363 1.865 . . . . 0.0 108.108 170.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -125.19 126.28 44.98 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.447 1.099 . . . . 0.0 109.08 163.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.7 ptp -121.07 161.84 21.03 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.715 1.606 . . . . 0.0 110.823 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -98.99 134.01 42.43 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.507 1.923 . . . . 0.0 108.577 165.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.4 t -116.3 71.01 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 126.369 1.867 . . . . 0.0 106.617 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -77.43 174.15 11.16 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.623 0.769 . . . . 0.0 110.745 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.838 0 CA-C-O 119.24 -0.756 . . . . 0.0 112.919 171.211 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.2 t -50.28 -42.32 52.15 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -46.55 -58.2 4.03 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.106 0.563 . . . . 0.0 111.626 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -58.57 -48.56 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 123.644 0.777 . . . . 0.0 109.727 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.465 ' HA ' HG21 ' A' ' 34' ' ' ILE . 38.1 mt-10 -55.07 -64.67 0.76 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 122.52 1.152 . . . . 0.0 110.485 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.9 -54.13 8.3 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.531 2.015 . . . . 0.0 112.244 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -54.79 43.17 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.967 0.883 . . . . 0.0 110.103 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.4 mm -59.14 -31.45 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.074 0.95 . . . . 0.0 110.91 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.05 -15.73 22.74 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.741 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -90.84 -11.43 39.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.627 1.714 . . . . 0.0 111.172 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.32 132.6 48.73 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.427 1.108 . . . . 0.0 111.068 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -57.97 107.98 0.53 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.299 172.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.08 -15.94 13.29 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.823 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 t -87.97 128.69 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 119.033 1.416 . . . . 0.0 109.426 -175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -83.62 -51.34 7.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.948 0.899 . . . . 0.0 110.282 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -158.42 167.97 28.24 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.616 0.643 . . . . 0.0 110.734 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.465 HG21 ' HA ' ' A' ' 22' ' ' GLU . 5.7 tt -142.49 140.26 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 125.591 1.557 . . . . 0.0 109.073 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -129.55 112.45 13.75 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.638 1.575 . . . . 0.0 107.414 168.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.21 108.82 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 C-N-CA 124.053 0.941 . . . . 0.0 109.6 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 m -82.42 113.74 20.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.18 179.71 0.19 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 158.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 67.54 -65.05 0.25 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 127.968 2.507 . . . . 0.0 109.498 -170.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.99 -22.96 66.49 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.247 1.019 . . . . 0.0 111.176 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 64.61 15.48 9.71 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.913 2.085 . . . . 0.0 111.91 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -120.38 132.31 55.21 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.786 1.234 . . . . 0.0 109.228 -169.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.32 150.29 47.28 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.735 0.814 . . . . 0.0 108.975 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.36 130.41 52.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.7 mt -126.7 158.34 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.88 122.68 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -158.64 179.79 8.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.93 1.292 . . . . 0.0 110.888 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -136.24 154.1 77.0 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 164.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.92 74.71 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.752 3.635 . . . . 0.0 109.958 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.01 -57.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.684 1.194 . . . . 0.0 108.081 170.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 mt -87.78 -28.03 21.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.809 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.462 ' HA ' HD12 ' A' ' 52' ' ' ILE . 9.2 tp -119.64 144.38 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 118.703 0.683 . . . . 0.0 109.882 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 m -81.57 31.05 0.35 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 72.24 -61.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 129.172 2.989 . . . . 0.0 110.166 176.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -82.81 -36.52 25.48 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.41 1.884 . . . . 0.0 109.355 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' HB3' HD11 ' A' ' 52' ' ' ILE . 1.4 mt-10 -42.06 -52.71 4.17 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.455 0.702 . . . . 0.0 111.055 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -36.48 -52.86 0.86 Allowed 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.712 2.005 . . . . 0.0 111.804 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.59 -38.55 65.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.29 1.036 . . . . 0.0 112.551 175.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -57.73 -33.17 68.15 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.632 -1.292 . . . . 0.0 112.548 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -62.66 -40.33 96.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -58.78 -46.32 90.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 117.919 -1.039 . . . . 0.0 111.75 170.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.97 -49.59 59.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.873 1.215 . . . . 0.0 108.031 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.89 -18.86 61.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.303 1.841 . . . . 0.0 114.207 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.7 mmm -62.14 -21.43 65.03 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.689 1.132 . . . . 0.0 110.532 168.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.71 34.57 2.03 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 125.238 1.399 . . . . 0.0 110.859 172.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -148.34 125.63 5.63 Favored Pre-proline 0 N--CA 1.456 -0.138 0 CA-C-O 117.764 -1.112 . . . . 0.0 108.395 -173.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.69 116.57 3.62 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.119 1.879 . . . . 0.0 110.372 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.13 -179.64 3.89 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.602 0.761 . . . . 0.0 109.465 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -162.9 149.12 12.36 Favored 'General case' 0 C--O 1.224 -0.265 0 O-C-N 120.323 -1.485 . . . . 0.0 111.809 -169.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.228 -0.056 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.1 t . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.1 t -77.4 141.26 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.637 1.575 . . . . 0.0 109.159 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -144.02 127.92 17.38 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -89.73 134.18 34.3 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.544 1.137 . . . . 0.0 109.859 171.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.87 141.64 47.46 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.08 0.952 . . . . 0.0 110.824 176.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.26 136.13 35.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.25 84.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 171.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -76.63 173.71 11.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 122.088 0.947 . . . . 0.0 110.982 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.914 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.626 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t -54.69 -39.87 68.57 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -170.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 m -49.34 -55.67 12.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.576 0.35 . . . . 0.0 111.783 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.79 -50.69 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.614 0.766 . . . . 0.0 109.179 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -52.16 -66.11 0.44 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.942 0.877 . . . . 0.0 110.124 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.82 -54.92 8.72 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.529 2.014 . . . . 0.0 112.23 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.63 -55.26 37.36 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.12 0.96 . . . . 0.0 109.802 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 mm -59.58 -31.08 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 123.598 0.759 . . . . 0.0 110.445 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.84 -16.81 19.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.921 1.248 . . . . 0.0 113.921 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -89.1 -13.76 37.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.605 1.703 . . . . 0.0 110.632 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.32 133.08 43.76 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.468 1.128 . . . . 0.0 112.284 -172.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -55.58 108.72 0.46 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.58 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.62 -25.76 7.53 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 119.186 -0.785 . . . . 0.0 111.976 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.53 131.5 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -97.75 -47.19 5.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.181 0.992 . . . . 0.0 109.374 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -154.94 166.89 32.14 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.805 -0.559 . . . . 0.0 110.316 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 tt -153.38 142.92 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.187 0.995 . . . . 0.0 109.922 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -139.55 117.3 11.58 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.179 1.792 . . . . 0.0 106.937 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -112.84 105.69 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 119.875 1.216 . . . . 0.0 109.242 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -97.24 88.15 4.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.58 -43.92 62.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.291 0.636 . . . . 0.0 110.882 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.33 -54.21 1.45 Allowed 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 125.946 1.698 . . . . 0.0 110.924 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.03 -13.41 57.39 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.681 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 66.12 9.32 6.17 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.106 2.163 . . . . 0.0 111.506 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -129.67 155.86 45.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.581 1.952 . . . . 0.0 108.599 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.26 155.94 49.37 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.146 0.978 . . . . 0.0 108.854 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.1 m -122.64 112.27 17.76 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.92 2.088 . . . . 0.0 105.557 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 mt -102.56 168.52 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.51 120.31 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -160.14 179.61 8.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.612 1.165 . . . . 0.0 110.917 -171.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.51 146.94 59.7 Favored Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -69.66 74.28 1.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.605 2.87 . . . . 0.0 109.507 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.94 -62.75 0.48 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.731 1.212 . . . . 0.0 108.249 172.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.1 mt -85.54 -21.25 28.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.992 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.0 tp -125.02 144.79 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 118.616 0.644 . . . . 0.0 110.069 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 m -76.13 28.9 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.272 0.5 OUTLIER 70.74 -53.1 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 128.979 2.912 . . . . 0.0 111.801 178.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -44.83 15.22 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 127.313 2.245 . . . . 0.0 109.705 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HB3' HD11 ' A' ' 52' ' ' ILE . 8.3 mt-10 -43.51 -51.94 6.44 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.171 0.588 . . . . 0.0 110.742 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -29.39 -63.16 0.12 Allowed 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 126.86 2.064 . . . . 0.0 110.716 172.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -45.76 36.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -59.4 -19.68 49.05 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.401 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -43.82 97.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.861 0.755 . . . . 0.0 110.022 170.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.94 -48.83 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -54.37 -47.56 72.49 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.14 -22.12 64.39 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.229 1.412 . . . . 0.0 113.953 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -63.41 -28.49 70.02 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.208 1.367 . . . . 0.0 110.071 170.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.99 -32.93 2.91 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.683 1.135 . . . . 0.0 110.743 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -73.69 126.03 90.0 Favored Pre-proline 0 N--CA 1.455 -0.191 0 CA-C-O 118.602 -0.714 . . . . 0.0 109.311 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.45 113.72 2.59 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.912 1.741 . . . . 0.0 109.687 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.25 174.61 6.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.972 0.909 . . . . 0.0 108.614 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.9 127.56 6.64 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -174.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.311 0 C-N-CA 124.997 1.319 . . . . 0.0 109.574 172.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.9 t -78.61 140.54 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.953 1.301 . . . . 0.0 108.68 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.401 HD13 ' C ' ' A' ' 5' ' ' LEU . 0.6 OUTLIER -133.19 142.02 48.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.774 2.029 . . . . 0.0 106.536 179.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -110.52 124.25 51.45 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.139 0.976 . . . . 0.0 109.122 173.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.7 ptm -117.91 155.01 30.93 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.98 1.312 . . . . 0.0 110.317 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.33 133.44 37.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 172.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.63 64.33 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.228 1.011 . . . . 0.0 109.004 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.92 166.19 16.17 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.986 0.898 . . . . 0.0 111.293 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 O-C-N 121.738 -0.601 . . . . 0.0 113.05 175.349 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.519 HG21 ' HB2' ' A' ' 38' ' ' LEU . 81.0 p . . . . . 0 C--O 1.22 -0.459 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -44.87 -41.09 6.8 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -49.82 -58.95 4.35 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.259 0.552 . . . . 0.0 111.061 168.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.85 -46.37 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.091 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -53.07 -65.24 0.59 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.425 1.466 . . . . 0.0 110.177 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.25 -55.12 6.83 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.467 1.508 . . . . 0.0 112.027 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -56.6 -53.17 60.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.795 0.797 . . . . 0.0 110.535 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.8 mm -61.49 -28.38 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.526 1.131 . . . . 0.0 110.479 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.92 -20.78 6.64 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.923 -0.932 . . . . 0.0 114.271 169.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -87.92 -14.86 38.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.89 1.845 . . . . 0.0 111.259 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 136.21 53.04 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 122.269 1.033 . . . . 0.0 111.668 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -57.68 111.25 1.07 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.532 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.97 -22.12 12.8 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 123.9 0.762 . . . . 0.0 112.757 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.2 132.58 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 118.122 0.961 . . . . 0.0 108.944 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -97.36 -47.33 5.74 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.643 1.177 . . . . 0.0 109.751 171.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -153.91 163.79 39.47 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.361 -0.837 . . . . 0.0 110.616 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 tt -146.2 136.75 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.299 1.439 . . . . 0.0 109.098 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.78 104.69 6.43 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.834 1.653 . . . . 0.0 107.592 168.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 43' ' ' ALA . 89.0 t -100.96 126.91 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 124.371 1.068 . . . . 0.0 109.993 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 m -114.5 93.76 4.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.12 0.968 . . . . 0.0 109.301 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.519 ' HB2' HG21 ' A' ' 18' ' ' THR . 0.3 OUTLIER -43.39 -49.74 6.97 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.466 1.106 . . . . 0.0 109.496 169.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.414 ' N ' HD13 ' A' ' 38' ' ' LEU . 1.3 m-20 -44.85 -58.87 2.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.677 1.591 . . . . 0.0 111.428 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.93 -14.69 59.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.55 -172.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 70.33 3.5 4.47 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.05 2.14 . . . . 0.0 111.81 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -119.16 157.86 27.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.563 1.945 . . . . 0.0 108.651 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.413 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -138.36 155.1 48.85 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.642 0.777 . . . . 0.0 109.564 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 m -124.99 116.81 22.74 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.4 mt -121.08 159.78 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.28 117.98 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.39 0.996 . . . . 0.0 110.019 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -161.21 -178.93 7.04 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.459 1.104 . . . . 0.0 111.457 -172.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.72 146.8 63.5 Favored Pre-proline 0 N--CA 1.467 0.376 0 C-N-CA 124.898 1.279 . . . . 0.0 113.946 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.26 69.44 2.52 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 124.121 3.214 . . . . 0.0 109.896 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.62 -63.96 0.36 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.11 0.964 . . . . 0.0 108.969 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.2 mt -79.72 -21.85 44.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.862 -0.59 . . . . 0.0 110.426 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 56' ' ' GLU . 8.6 tp -124.83 145.12 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 118.507 0.594 . . . . 0.0 109.955 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -80.64 29.62 0.31 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.814 0.845 . . . . 0.0 112.975 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 74.64 -56.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 128.46 2.704 . . . . 0.0 111.095 173.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.63 -40.67 20.46 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.213 1.805 . . . . 0.0 109.477 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.469 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mm-40 -41.24 -53.15 3.26 Favored 'General case' 0 C--N 1.346 0.44 0 O-C-N 124.183 0.927 . . . . 0.0 110.837 -173.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.71 -60.96 0.29 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.165 1.786 . . . . 0.0 111.053 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -41.95 68.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.092 0.957 . . . . 0.0 111.005 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -56.33 -28.28 58.43 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -64.79 -41.83 95.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.733 -0.604 . . . . 0.0 109.672 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -63.46 -49.18 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.449 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 4.2 mt-10 -53.39 -46.86 69.84 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.73 -20.53 49.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.555 1.542 . . . . 0.0 114.179 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.2 mmm -63.18 -30.18 71.38 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.777 1.171 . . . . 0.0 109.865 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.55 -32.25 2.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -79.85 116.57 62.04 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-O 117.819 -1.086 . . . . 0.0 108.468 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.25 123.81 12.78 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.765 1.643 . . . . 0.0 108.42 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.466 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -113.35 -165.74 1.02 Allowed 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 122.764 0.426 . . . . 0.0 110.271 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -162.42 138.34 7.42 Favored 'General case' 0 CA--C 1.522 -0.097 0 O-C-N 121.487 -0.758 . . . . 0.0 111.315 176.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 CA--C 1.531 0.223 0 C-N-CA 124.468 1.107 . . . . 0.0 108.677 173.206 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.63 134.34 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 123.775 0.83 . . . . 0.0 110.692 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.541 HD13 ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -123.83 139.29 54.11 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 172.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -108.46 123.2 48.51 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 45' ' ' ILE . 15.0 ptm -116.07 167.9 10.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.35 1.06 . . . . 0.0 109.957 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -114.31 134.24 55.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.485 2.314 . . . . 0.0 106.86 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 t -124.99 62.4 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.309 1.843 . . . . 0.0 107.686 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.88 145.45 46.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.28 0.562 . . . . 0.0 111.724 -170.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 178.043 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.752 HG22 HG12 ' A' ' 36' ' ' VAL . 70.7 p . . . . . 0 C--O 1.217 -0.627 0 CA-C-O 118.043 -0.98 . . . . 0.0 113.518 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t -36.86 -42.96 0.42 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.112 1.365 . . . . 0.0 113.501 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.15 -57.06 11.74 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.46 0.704 . . . . 0.0 111.273 171.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.41 -48.86 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.214 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -56.21 -59.37 5.04 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 119.936 1.244 . . . . 0.0 110.79 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -41.38 -56.93 3.31 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.852 1.692 . . . . 0.0 112.158 170.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -57.2 -53.41 58.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.014 0.907 . . . . 0.0 110.506 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.427 HG23 ' HE3' ' A' ' 57' ' ' MET . 29.1 mm -59.65 -28.04 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 125.158 1.383 . . . . 0.0 110.704 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.83 -19.2 9.81 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.735 -1.036 . . . . 0.0 114.299 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -88.18 -9.99 51.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.859 1.829 . . . . 0.0 111.333 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.8 136.22 46.99 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.172 0.987 . . . . 0.0 111.594 -171.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.78 113.86 2.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.078 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.26 -16.99 31.99 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-O 119.136 -0.813 . . . . 0.0 112.903 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 t -79.32 130.14 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 118.238 1.019 . . . . 0.0 108.581 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -97.05 -49.14 5.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.439 1.096 . . . . 0.0 109.47 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -152.81 170.54 20.05 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.625 -0.672 . . . . 0.0 110.673 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 tt -144.11 149.24 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.619 1.168 . . . . 0.0 109.407 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -143.55 98.44 3.25 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.141 2.176 . . . . 0.0 107.711 169.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.752 HG12 HG22 ' A' ' 18' ' ' THR . 91.2 t -99.62 128.24 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.554 1.142 . . . . 0.0 109.013 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 t -103.51 110.03 21.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.329 0.652 . . . . 0.0 110.602 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.585 HD23 ' H ' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -63.37 158.36 20.73 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.585 ' H ' HD23 ' A' ' 38' ' ' LEU . 3.7 m-20 71.36 -55.82 0.65 Allowed 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 129.069 2.948 . . . . 0.0 109.926 -174.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.01 -29.28 70.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.841 -174.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 64.61 16.07 10.08 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.19 2.196 . . . . 0.0 112.471 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -107.18 139.3 41.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB1' HG22 ' A' ' 36' ' ' VAL . . . -141.64 156.3 45.67 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.794 -0.566 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.9 m -130.46 125.8 35.33 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.491 HD11 ' SD ' ' A' ' 7' ' ' MET . 12.2 mt -118.33 153.25 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.62 120.84 65.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -157.71 -179.67 8.37 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 125.395 1.478 . . . . 0.0 109.628 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -140.75 151.85 64.2 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 123.221 0.609 . . . . 0.0 112.515 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -82.02 64.37 8.41 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.949 3.1 . . . . 0.0 108.684 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.52 -61.1 1.03 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.023 1.329 . . . . 0.0 107.474 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.2 mt -88.33 -20.71 25.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.666 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.7 tp -120.7 145.08 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 119.205 0.911 . . . . 0.0 110.488 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -83.96 28.32 0.61 Allowed 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 71.39 -60.07 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 128.867 2.867 . . . . 0.0 110.545 176.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -74.54 -41.11 61.17 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.804 1.242 . . . . 0.0 108.491 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mt-10 -42.81 -49.86 5.71 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 123.277 0.631 . . . . 0.0 111.551 -174.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.437 ' SD ' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -42.74 -53.74 4.4 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.859 0.864 . . . . 0.0 111.126 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.49 -44.91 77.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 122.087 -0.383 . . . . 0.0 110.761 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -54.04 -33.91 58.63 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.937 -0.477 . . . . 0.0 112.094 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -64.14 -42.67 96.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.43 0.692 . . . . 0.0 109.564 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.01 -46.83 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.791 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 11.0 mt-10 -51.67 -49.96 61.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.897 1.226 . . . . 0.0 108.674 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.86 -19.82 31.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.283 1.833 . . . . 0.0 114.27 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.1 mmm -61.82 -31.28 71.5 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.63 1.105 . . . . 0.0 110.214 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.7 39.48 0.57 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.544 1.069 . . . . 0.0 111.461 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -145.45 125.78 7.21 Favored Pre-proline 0 C--O 1.225 -0.217 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.98 107.81 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.19 1.927 . . . . 0.0 109.611 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.612 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -107.56 -177.59 3.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -163.49 156.1 18.19 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.121 -0.987 . . . . 0.0 111.612 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.4 t . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -178.094 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.9 t . . . . . 0 C--O 1.234 0.249 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.15 132.12 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.379 1.472 . . . . 0.0 109.957 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.568 ' C ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -123.56 157.85 32.72 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.371 1.469 . . . . 0.0 109.621 171.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.541 ' N ' HD22 ' A' ' 5' ' ' LEU . 11.3 ttpt -119.05 123.56 44.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.436 1.094 . . . . 0.0 108.581 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -122.79 144.66 49.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.077 1.351 . . . . 0.0 110.474 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -87.96 133.14 34.0 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.328 2.251 . . . . 0.0 108.313 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.35 65.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 126.959 2.104 . . . . 0.0 107.966 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -71.77 153.83 41.71 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.822 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.846 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.821 173.446 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -57.93 -37.28 73.81 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -166.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.8 m -51.54 -54.15 30.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.724 0.297 . . . . 0.0 111.541 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -59.25 -49.5 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -53.28 -65.06 0.63 Allowed 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 122.322 1.058 . . . . 0.0 110.4 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.56 -42.71 44.57 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.197 1.856 . . . . 0.0 113.364 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -68.67 -61.23 1.91 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.934 1.367 . . . . 0.0 109.593 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.06 -41.49 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.621 1.169 . . . . 0.0 110.37 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.73 -21.55 29.74 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.406 1.479 . . . . 0.0 113.633 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -91.35 -15.44 29.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.076 1.438 . . . . 0.0 110.836 177.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.34 134.14 52.91 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.537 1.16 . . . . 0.0 111.508 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -50.35 107.77 0.18 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.255 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.42 -29.08 5.8 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.958 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.1 t -79.45 137.25 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 118.353 1.077 . . . . 0.0 109.167 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -102.34 -43.35 5.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.039 1.335 . . . . 0.0 110.642 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -158.61 162.5 37.31 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.41 -0.806 . . . . 0.0 110.151 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 tt -144.43 141.32 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.625 1.57 . . . . 0.0 109.192 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -129.34 121.7 28.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.513 1.925 . . . . 0.0 107.046 164.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.3 t -107.47 109.02 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 119.93 1.241 . . . . 0.0 110.052 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.7 t -90.79 91.63 8.45 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.693 0.759 . . . . 0.0 109.324 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.61 166.62 0.88 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.656 163.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 66.48 -56.42 0.39 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 128.338 2.655 . . . . 0.0 110.45 -165.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -64.81 -30.27 71.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.214 1.007 . . . . 0.0 109.88 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 68.73 25.27 6.42 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 127.812 2.445 . . . . 0.0 110.255 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -125.03 127.26 46.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.714 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.1 145.45 49.25 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.061 0.945 . . . . 0.0 109.515 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.71 120.3 31.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -176.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.2 mt -128.1 157.54 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -173.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.4 p -125.32 127.81 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -155.85 176.2 12.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 110.528 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.09 145.61 54.73 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.627 1.171 . . . . 0.0 113.192 172.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -72.32 75.86 2.33 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.409 3.406 . . . . 0.0 109.887 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.05 -55.42 0.11 Allowed 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.831 -0.543 . . . . 0.0 109.902 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.14 -24.61 27.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.607 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.4 tp -124.82 145.08 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.295 0.638 . . . . 0.0 110.206 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.57 23.74 0.12 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 75.4 -53.77 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.24 1.816 . . . . 0.0 110.194 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -95.64 -33.82 12.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.151 2.18 . . . . 0.0 110.169 -172.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -42.32 -53.31 4.22 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.035 0.934 . . . . 0.0 110.532 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -37.72 -57.74 0.96 Allowed 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 126.183 1.793 . . . . 0.0 111.96 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.405 ' HE2' HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -73.38 -42.76 61.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.992 0.917 . . . . 0.0 111.656 178.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -50.69 -29.47 11.3 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.148 -0.97 . . . . 0.0 113.208 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -62.68 -35.99 81.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -69.7 -46.24 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 123.682 0.793 . . . . 0.0 109.099 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -51.09 -49.34 60.86 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.01 -20.16 62.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.426 1.491 . . . . 0.0 114.041 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 81.3 mmm -63.99 -28.45 69.82 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.886 1.221 . . . . 0.0 109.874 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.41 -33.13 2.71 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.434 1.016 . . . . 0.0 110.957 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -80.85 119.06 75.05 Favored Pre-proline 0 N--CA 1.455 -0.18 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.169 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.8 120.71 8.19 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.873 1.716 . . . . 0.0 109.52 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.68 177.85 5.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.562 1.545 . . . . 0.0 108.562 -176.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.93 158.65 35.39 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 122.924 0.49 . . . . 0.0 111.218 -173.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.405 HG23 ' HE2' ' A' ' 58' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.9 t -87.21 124.9 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.115 2.166 . . . . 0.0 110.299 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.26 142.69 41.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.623 1.169 . . . . 0.0 109.401 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 123.49 48.66 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.416 1.486 . . . . 0.0 108.95 170.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.7 ptm -125.96 134.75 51.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.067 1.347 . . . . 0.0 111.468 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 129.38 39.08 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 t -112.02 73.83 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.03 164.77 10.02 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.784 0.802 . . . . 0.0 111.101 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.102 0 O-C-N 121.629 -0.669 . . . . 0.0 112.589 177.415 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.0 p . . . . . 0 C--O 1.223 -0.321 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.8 t -56.85 -38.8 73.19 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -168.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.8 m -47.51 -60.39 2.56 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.654 167.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.55 -48.95 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.52 ' HA ' HG21 ' A' ' 34' ' ' ILE . 53.5 mt-10 -56.83 -68.0 0.26 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.875 0.845 . . . . 0.0 111.663 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.63 -48.93 22.5 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.735 1.636 . . . . 0.0 111.834 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -63.72 -55.49 22.9 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 117.945 0.872 . . . . 0.0 110.312 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.546 ' CG2' HG21 ' A' ' 31' ' ' VAL . 10.8 mm -50.67 -41.35 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.93 0.892 . . . . 0.0 110.436 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.07 -22.75 13.95 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.953 1.739 . . . . 0.0 114.138 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -94.31 -20.78 19.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 118.892 1.346 . . . . 0.0 110.492 177.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 134.21 50.69 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 122.727 1.251 . . . . 0.0 111.68 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -53.62 113.68 1.27 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.088 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.62 -26.39 7.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 118.269 -1.295 . . . . 0.0 112.141 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.811 HG23 ' HE2' ' A' ' 57' ' ' MET . 2.2 t -75.99 140.44 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 118.926 1.363 . . . . 0.0 109.457 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.503 ' HB2' HG12 ' A' ' 46' ' ' VAL . 7.8 mm-40 -103.61 -41.16 6.04 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.598 167.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -159.72 163.34 34.81 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.529 -0.732 . . . . 0.0 109.941 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 22' ' ' GLU . 14.4 tt -147.38 148.71 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 124.952 1.301 . . . . 0.0 108.946 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 102.74 4.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.907 1.683 . . . . 0.0 107.861 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -91.23 133.42 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.61 1.164 . . . . 0.0 108.894 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 t -122.49 102.63 8.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.045 0.938 . . . . 0.0 110.52 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.63 -58.24 7.88 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.641 0.777 . . . . 0.0 110.758 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -42.24 -54.46 3.69 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.218 1.407 . . . . 0.0 110.942 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.26 -19.21 51.17 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.938 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 65.88 18.88 11.22 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.205 2.202 . . . . 0.0 110.996 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.29 163.57 20.46 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.249 2.22 . . . . 0.0 108.431 -171.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.15 133.65 17.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.064 0.545 . . . . 0.0 109.839 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.1 m -106.47 100.94 10.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -173.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.4 HG12 HD12 ' A' ' 34' ' ' ILE . 80.5 mt -90.75 165.66 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 32' ' ' GLN . 1.1 t -139.67 120.41 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -157.14 176.17 13.09 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.706 0.802 . . . . 0.0 111.757 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -122.81 139.91 32.2 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -69.61 84.0 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.245 3.296 . . . . 0.0 109.574 174.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -168.43 -61.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.0 mt -82.16 -25.92 33.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.219 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 52' ' ' ILE . 11.2 tp -117.79 161.2 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 123.501 0.721 . . . . 0.0 110.423 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 m -93.86 26.79 3.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.219 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 70.11 -59.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 129.406 3.082 . . . . 0.0 110.49 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.91 -32.49 40.19 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.444 1.498 . . . . 0.0 109.562 -175.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -49.44 -48.75 47.2 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.811 ' HE2' HG23 ' A' ' 31' ' ' VAL . 5.4 mtt -44.93 -53.5 7.56 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.213 0.605 . . . . 0.0 111.512 174.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.539 ' HD3' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -72.47 -36.61 68.51 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.559 -0.713 . . . . 0.0 112.569 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.449 ' HD2' ' CE ' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -61.29 -31.68 71.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 120.535 -1.353 . . . . 0.0 110.835 176.087 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -35.14 80.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.9 -47.25 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.003 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -50.96 -48.73 60.92 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.37 0.986 . . . . 0.0 108.697 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.05 -21.72 46.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.457 1.103 . . . . 0.0 113.664 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.9 mmt -66.91 -28.03 67.98 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.553 1.069 . . . . 0.0 110.786 172.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.62 -33.38 3.0 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.759 1.171 . . . . 0.0 110.731 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -78.36 115.56 52.14 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.19 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -62.27 121.83 10.01 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.695 1.596 . . . . 0.0 109.146 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.95 163.77 26.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.662 0.785 . . . . 0.0 109.039 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CA ' ' HD2' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -151.28 140.34 21.12 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 125.211 1.405 . . . . 0.0 109.588 -156.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.539 HG23 ' HD3' ' A' ' 58' ' ' LYS . 1.2 t . . . . . 0 C--N 1.333 -0.15 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.27 124.29 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 125.579 1.552 . . . . 0.0 108.954 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.1 tp -107.57 143.21 36.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.358 1.863 . . . . 0.0 107.144 169.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -111.6 120.71 43.01 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 164.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.0 ptm -111.57 162.51 15.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.709 1.203 . . . . 0.0 109.909 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -97.2 125.88 42.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.506 1.523 . . . . 0.0 108.748 168.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 t -116.73 72.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 126.693 1.997 . . . . 0.0 106.83 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.271 3.6 pt-20 -82.48 176.77 9.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.33 0.652 . . . . 0.0 111.657 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.127 0 O-C-N 121.541 -0.724 . . . . 0.0 112.006 -175.929 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.5 p . . . . . 0 C--O 1.222 -0.377 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 m -55.79 -38.78 70.4 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -167.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.84 -53.69 48.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 171.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.04 -53.03 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -56.71 -65.06 0.68 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.804 0.811 . . . . 0.0 110.069 -174.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.26 -52.66 17.64 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.323 1.916 . . . . 0.0 112.238 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.38 -52.78 63.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.106 0.953 . . . . 0.0 109.864 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.0 mm -58.77 -30.82 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 123.176 0.59 . . . . 0.0 111.203 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.11 -20.39 27.62 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.886 1.232 . . . . 0.0 113.6 174.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.8 -9.94 47.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.368 1.584 . . . . 0.0 110.96 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.44 133.11 48.93 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.354 1.073 . . . . 0.0 110.764 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -54.66 104.89 0.13 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.807 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.18 -26.94 5.71 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 118.991 -0.894 . . . . 0.0 113.102 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.6 t -79.69 131.84 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 118.483 1.141 . . . . 0.0 110.042 -172.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -98.36 -47.31 5.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.528 1.531 . . . . 0.0 110.022 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -151.33 167.36 28.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.253 0.478 . . . . 0.0 110.191 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.8 tt -149.61 143.97 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.069 1.348 . . . . 0.0 109.439 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -130.19 122.69 28.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.309 2.244 . . . . 0.0 105.865 167.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG22 ' HB1' ' A' ' 43' ' ' ALA . 69.1 t -117.81 103.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 120.279 1.4 . . . . 0.0 109.52 176.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 m -85.21 99.45 11.11 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 mt -53.84 170.26 0.13 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.902 158.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 67.59 -60.6 0.38 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 127.991 2.516 . . . . 0.0 110.417 -171.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -24.86 67.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.574 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 65.55 23.12 11.79 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.469 1.908 . . . . 0.0 111.182 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -119.76 135.24 54.93 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.809 0.844 . . . . 0.0 109.706 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB1' HG22 ' A' ' 36' ' ' VAL . . . -132.12 152.85 51.02 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 m -129.38 120.71 26.01 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.136 1.774 . . . . 0.0 106.482 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.57 154.34 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.52 119.05 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -158.0 -179.69 8.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.825 1.25 . . . . 0.0 109.163 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -133.12 146.06 59.5 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.15 75.05 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 124.414 3.409 . . . . 0.0 109.983 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.99 -60.03 0.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.804 1.242 . . . . 0.0 107.991 172.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -80.67 -27.47 37.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.064 -0.493 . . . . 0.0 110.464 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.4 tp -122.23 144.16 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.739 0.816 . . . . 0.0 109.99 -175.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.2 m -77.29 23.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 72.12 -63.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 128.602 2.761 . . . . 0.0 109.095 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -42.08 74.33 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.019 0.928 . . . . 0.0 108.819 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -38.9 -60.17 0.88 Allowed 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.075 0.95 . . . . 0.0 110.935 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -36.58 -57.05 0.79 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.811 1.644 . . . . 0.0 111.627 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -40.86 69.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.395 0.678 . . . . 0.0 111.705 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -60.42 -26.02 66.39 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 120.986 -1.071 . . . . 0.0 112.789 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -62.81 -37.75 88.0 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.6 mp -63.9 -45.05 98.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 117.55 -1.214 . . . . 0.0 111.528 173.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -49.87 -49.98 47.41 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.44 1.473 . . . . 0.0 108.304 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.07 -20.25 51.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.672 1.189 . . . . 0.0 113.848 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.5 mmt -65.19 -25.94 67.94 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.481 1.037 . . . . 0.0 110.58 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.68 -27.71 4.34 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.446 1.022 . . . . 0.0 111.197 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -86.37 123.0 71.97 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.51 130.74 30.99 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 N-CA-C 108.632 -1.334 . . . . 0.0 108.632 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.42 -176.53 3.61 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.364 0.666 . . . . 0.0 109.276 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.97 151.02 30.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.119 -0.988 . . . . 0.0 110.864 -175.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.164 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.3 t . . . . . 0 C--O 1.233 0.187 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.1 t -85.3 133.71 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 125.748 1.619 . . . . 0.0 109.624 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.708 HD23 ' N ' ' A' ' 6' ' ' LYS . 6.0 tt -124.05 146.19 48.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.696 1.599 . . . . 0.0 108.673 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.708 ' N ' HD23 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -109.81 113.82 26.88 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.198 1.799 . . . . 0.0 109.133 178.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.4 mtt -109.2 131.53 54.98 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.738 0.815 . . . . 0.0 109.88 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -78.23 119.11 21.13 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 167.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.52 85.14 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.85 -175.35 3.03 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.543 0.737 . . . . 0.0 109.431 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.098 0 O-C-N 121.371 -0.831 . . . . 0.0 113.356 175.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.15 -38.93 68.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -168.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.6 m -48.84 -60.85 2.41 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.404 168.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.9 -50.57 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -58.65 -63.5 1.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.391 1.091 . . . . 0.0 109.153 -172.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.51 -56.59 6.29 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.99 1.757 . . . . 0.0 112.731 173.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -57.1 -52.59 64.67 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.114 0.957 . . . . 0.0 110.017 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.6 -27.43 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 123.718 0.807 . . . . 0.0 110.686 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.82 -19.95 11.81 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.069 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -85.79 -14.24 45.76 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.592 1.696 . . . . 0.0 110.146 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 132.63 48.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 122.438 1.114 . . . . 0.0 111.699 -172.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -57.78 107.03 0.41 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.25 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.38 -22.43 8.36 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.194 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.3 t -78.28 127.89 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 118.709 1.255 . . . . 0.0 108.841 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -89.67 -50.27 6.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.299 1.04 . . . . 0.0 108.77 172.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -154.25 160.89 42.03 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 118.988 0.813 . . . . 0.0 110.448 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 tt -141.77 142.27 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.623 1.569 . . . . 0.0 109.719 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -145.54 113.11 6.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.392 1.477 . . . . 0.0 107.753 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.9 t -113.0 92.47 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.47 1.508 . . . . 0.0 110.299 -172.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.1 m -82.13 78.59 8.79 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 124.171 0.988 . . . . 0.0 110.613 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.2 -42.04 28.9 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.312 0.645 . . . . 0.0 111.856 174.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -42.48 -51.86 4.88 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 125.94 1.696 . . . . 0.0 110.471 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -81.19 -13.66 58.36 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.15 -173.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 64.18 35.01 10.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 126.995 2.118 . . . . 0.0 109.572 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -156.15 144.45 19.92 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 125.434 1.709 . . . . 0.0 109.966 -166.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.5 157.91 41.38 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.402 1.081 . . . . 0.0 110.224 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 m -139.49 121.01 15.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.7 mt -124.9 162.89 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.079 1.351 . . . . 0.0 108.44 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 p -132.79 127.31 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 174.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -155.84 177.95 10.82 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.601 1.16 . . . . 0.0 108.818 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -126.25 142.41 42.66 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.314 1.046 . . . . 0.0 113.122 171.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.96 72.12 3.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.878 3.719 . . . . 0.0 110.402 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.68 -56.65 0.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.175 0.99 . . . . 0.0 108.605 172.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.38 -31.09 37.87 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.459 ' HA ' HD12 ' A' ' 52' ' ' ILE . 9.0 tp -118.64 144.1 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 123.464 0.705 . . . . 0.0 109.668 -177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 m -81.95 27.81 0.45 Allowed 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -173.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 69.84 -64.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 129.582 3.153 . . . . 0.0 109.284 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -72.97 -39.6 65.99 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.48 1.112 . . . . 0.0 108.647 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.403 ' HB3' HD11 ' A' ' 52' ' ' ILE . 4.1 mm-40 -40.7 -55.94 2.27 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.43 1.092 . . . . 0.0 111.574 -173.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.13 -60.73 0.85 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.554 1.142 . . . . 0.0 110.082 177.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HB3' ' HZ2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -70.37 -32.98 70.89 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.093 -176.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -64.54 -29.55 70.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 119.194 -2.191 . . . . 0.0 111.537 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -63.32 -44.15 95.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.13 -43.5 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.908 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -55.25 -54.15 47.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.771 1.169 . . . . 0.0 107.978 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.15 -27.73 64.05 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.816 1.646 . . . . 0.0 114.174 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.9 mmt -52.63 -28.77 22.82 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.362 0.983 . . . . 0.0 111.187 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.87 39.98 0.62 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 124.641 1.115 . . . . 0.0 110.908 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -149.07 119.22 4.05 Favored Pre-proline 0 N--CA 1.457 -0.093 0 CA-C-O 117.995 -1.002 . . . . 0.0 108.438 -175.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.48 109.87 1.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.905 1.737 . . . . 0.0 109.597 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.9 -168.36 1.31 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.949 1.3 . . . . 0.0 108.449 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -163.44 152.56 14.49 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.117 0.967 . . . . 0.0 110.504 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 64.2 t . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 170.39 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.32 121.3 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.657 1.983 . . . . 0.0 108.688 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.7 tp -112.22 119.31 37.93 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.134 0.574 . . . . 0.0 110.553 171.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.07 126.97 36.31 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.957 1.303 . . . . 0.0 109.552 170.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -132.37 157.79 43.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.975 1.31 . . . . 0.0 109.702 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 133.91 36.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 t -128.98 79.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.957 1.303 . . . . 0.0 108.448 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.66 147.18 29.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.865 0 CA-C-O 119.307 -0.718 . . . . 0.0 113.569 170.98 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.224 -0.278 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -53.01 -39.15 62.92 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -170.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.3 m -51.29 -57.9 7.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 O-C-N 123.291 0.369 . . . . 0.0 111.587 170.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.4 -51.36 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.5 -61.78 2.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.091 0.948 . . . . 0.0 110.229 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.15 -54.17 13.12 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.948 1.737 . . . . 0.0 112.391 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -59.37 -52.36 65.96 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.111 0.955 . . . . 0.0 110.541 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.415 HG21 HD12 ' A' ' 34' ' ' ILE . 19.2 mm -57.22 -36.8 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 123.834 0.854 . . . . 0.0 110.143 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.12 -20.13 33.9 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.844 1.212 . . . . 0.0 114.137 172.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -84.88 -27.44 26.67 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.477 1.638 . . . . 0.0 109.99 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.22 139.34 52.25 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.443 1.116 . . . . 0.0 112.722 -168.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -53.8 115.11 1.82 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.051 1.34 . . . . 0.0 111.52 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.72 -28.57 6.4 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 124.064 0.84 . . . . 0.0 112.053 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.68 141.38 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 117.468 0.634 . . . . 0.0 110.051 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -121.1 -21.61 6.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.4 1.08 . . . . 0.0 111.811 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -160.41 164.63 32.17 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.398 0.999 . . . . 0.0 109.706 172.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.415 HD12 HG21 ' A' ' 25' ' ' ILE . 15.4 tt -155.5 143.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 123.91 0.884 . . . . 0.0 108.655 174.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.28 113.71 10.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.284 1.833 . . . . 0.0 106.527 171.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -100.34 103.13 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.229 0.922 . . . . 0.0 109.606 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -74.0 73.29 1.67 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.303 1.041 . . . . 0.0 110.267 175.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -50.66 161.07 0.37 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.426 1.49 . . . . 0.0 109.772 167.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.575 ' H ' HD13 ' A' ' 38' ' ' LEU . 20.3 m-20 65.46 -53.5 0.35 Allowed 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 128.042 2.537 . . . . 0.0 110.952 -162.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -67.59 -23.36 65.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -172.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 68.95 26.62 5.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.987 2.115 . . . . 0.0 111.864 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -117.82 150.04 39.82 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.59 1.556 . . . . 0.0 106.876 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.03 159.9 43.42 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.295 -0.878 . . . . 0.0 109.564 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 m -132.6 106.32 7.74 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.713 1.605 . . . . 0.0 107.399 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 mt -90.08 163.16 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.45 117.86 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.153 1.381 . . . . 0.0 108.325 168.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -157.48 -178.2 7.16 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.31 1.444 . . . . 0.0 110.846 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -132.02 144.75 54.47 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.398 1.479 . . . . 0.0 113.86 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.22 68.88 4.1 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.752 3.635 . . . . 0.0 110.025 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.19 -57.06 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.541 1.136 . . . . 0.0 108.771 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.1 -20.52 37.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.65 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.1 tp -127.88 150.61 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 123.128 0.571 . . . . 0.0 110.475 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.6 m -79.46 25.02 0.33 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -176.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 71.3 -61.48 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.952 2.501 . . . . 0.0 108.889 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.08 -38.31 61.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.887 -174.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HB3' HD11 ' A' ' 52' ' ' ILE . 22.8 mt-10 -45.95 -51.24 13.69 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.819 0.736 . . . . 0.0 111.981 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.78 -54.61 6.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.225 1.01 . . . . 0.0 111.71 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -64.64 -49.38 71.25 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.652 -0.655 . . . . 0.0 110.653 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -65.62 -24.94 67.17 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.228 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -62.4 -47.49 83.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.41 -45.85 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -58.08 -49.67 76.1 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.64 -26.81 65.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.391 1.476 . . . . 0.0 113.442 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.0 mmm -54.88 -32.95 61.42 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.626 1.103 . . . . 0.0 110.387 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.6 -42.71 0.79 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -75.6 111.21 13.2 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.353 -171.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.81 110.3 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.169 1.913 . . . . 0.0 109.161 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.37 -167.16 1.27 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.192 1.397 . . . . 0.0 108.813 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.98 134.78 5.14 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.296 0.953 . . . . 0.0 113.025 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 C--N 1.338 0.093 0 C-N-CA 123.399 0.68 . . . . 0.0 110.058 174.842 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.19 133.71 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 124.535 1.134 . . . . 0.0 109.669 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.7 tp -119.97 131.72 55.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.45 1.5 . . . . 0.0 108.748 172.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -93.17 117.04 29.61 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.349 1.06 . . . . 0.0 108.516 167.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.48 ' SD ' HD11 ' A' ' 45' ' ' ILE . 14.8 ptm -114.61 156.99 23.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.392 0.677 . . . . 0.0 109.211 172.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -100.29 129.34 46.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.54 1.536 . . . . 0.0 107.052 170.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.06 69.41 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.82 163.66 25.36 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.29 0.567 . . . . 0.0 109.594 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 O-C-N 121.004 -1.06 . . . . 0.0 113.101 172.693 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.4 t -52.18 -45.18 65.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -165.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.5 m -48.5 -56.75 7.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.22 0.208 . . . . 0.0 111.117 169.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -59.93 -49.34 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 123.414 0.686 . . . . 0.0 109.415 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -59.61 -61.55 2.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.918 0.887 . . . . 0.0 109.555 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.86 -56.95 6.37 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.708 1.623 . . . . 0.0 112.401 172.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -57.68 -54.05 51.24 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.018 0.909 . . . . 0.0 110.269 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 mm -60.97 -31.94 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 124.016 0.926 . . . . 0.0 110.921 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.41 -17.9 27.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.886 1.232 . . . . 0.0 113.657 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -84.79 -13.62 50.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.941 1.371 . . . . 0.0 110.392 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.63 140.49 44.33 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.93 0.871 . . . . 0.0 111.983 -169.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -59.7 114.57 2.82 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.059 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.59 -24.5 10.31 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.212 0.911 . . . . 0.0 112.317 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.61 137.63 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 118.035 0.918 . . . . 0.0 110.126 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -106.91 -48.36 3.51 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.937 1.295 . . . . 0.0 109.554 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.04 161.84 41.97 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -178.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 tt -149.49 140.11 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 123.676 0.791 . . . . 0.0 109.246 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -135.88 101.08 4.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.795 2.038 . . . . 0.0 107.279 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -98.85 118.69 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.809 0.844 . . . . 0.0 109.128 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.9 m -98.3 90.88 4.97 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.632 0.773 . . . . 0.0 108.995 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.6 170.55 0.25 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.392 161.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 71.15 -57.36 0.6 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.092 2.557 . . . . 0.0 108.601 -168.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.69 -27.07 64.7 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.569 -174.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 70.07 20.63 6.39 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 111.862 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.16 144.94 42.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.921 1.688 . . . . 0.0 108.244 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.79 155.75 47.91 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 121.328 -0.857 . . . . 0.0 110.035 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 m -126.07 115.22 19.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.918 1.687 . . . . 0.0 106.635 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.48 HD11 ' SD ' ' A' ' 7' ' ' MET . 35.7 mt -108.41 154.91 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.31 122.28 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 118.734 0.697 . . . . 0.0 109.789 168.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -156.25 177.82 11.0 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.952 1.701 . . . . 0.0 108.872 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -124.2 136.89 28.17 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 119.427 1.012 . . . . 0.0 111.736 169.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.8 73.07 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.136 3.224 . . . . 0.0 110.332 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -135.3 -50.57 0.75 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.4 mt -94.02 -17.63 22.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.782 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 52' ' ' ILE . 11.2 tp -119.78 150.4 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.519 1.054 . . . . 0.0 110.21 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.3 m -83.54 19.82 1.51 Allowed 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 70.67 -62.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 128.038 2.535 . . . . 0.0 109.573 -177.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -70.2 -38.05 75.24 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -49.75 -47.64 50.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 123.534 0.521 . . . . 0.0 111.442 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -40.93 -52.09 3.14 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 177.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.09 -44.92 68.07 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.276 -0.265 . . . . 0.0 110.89 177.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -54.85 -32.17 60.37 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.593 -0.692 . . . . 0.0 112.7 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -37.85 88.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.38 -50.99 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.909 170.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 8.2 mt-10 -52.34 -46.82 66.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.336 0.971 . . . . 0.0 109.393 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.44 -21.36 50.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.94 1.696 . . . . 0.0 113.554 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.9 mmt -65.51 -31.95 73.29 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.372 0.987 . . . . 0.0 110.15 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.89 -37.01 1.47 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.906 0.765 . . . . 0.0 111.301 173.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -75.91 116.36 54.77 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 117.784 -1.103 . . . . 0.0 108.876 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.24 120.24 7.61 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.124 1.883 . . . . 0.0 108.685 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.403 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -115.08 -170.3 1.73 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.808 0.813 . . . . 0.0 109.413 -175.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.35 152.99 19.16 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.841 -1.162 . . . . 0.0 110.674 -176.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -173.848 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.8 t -79.25 115.61 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 126.074 1.75 . . . . 0.0 109.231 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 6' ' ' LYS . 6.6 tt -89.21 155.86 19.14 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.663 0.785 . . . . 0.0 109.493 169.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' N ' HD23 ' A' ' 5' ' ' LEU . 3.6 tmtt? -135.44 116.63 14.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.511 ' SD ' HD11 ' A' ' 45' ' ' ILE . 5.0 ptm -128.99 153.2 47.8 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.948 1.299 . . . . 0.0 110.792 -170.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.99 129.16 49.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.076 0.951 . . . . 0.0 108.598 170.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.05 76.45 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 125.379 1.472 . . . . 0.0 107.77 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.3 114.79 3.37 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.126 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 C-N-CA 124.978 1.275 . . . . 0.0 111.407 -179.848 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -54.64 -36.35 64.46 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 m -52.32 -58.66 5.97 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 123.105 0.253 . . . . 0.0 111.18 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.33 -52.21 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -58.21 -67.37 0.35 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.881 0.848 . . . . 0.0 110.996 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.33 -51.68 11.57 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.581 1.563 . . . . 0.0 112.358 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -63.99 -48.84 74.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.09 0.945 . . . . 0.0 110.362 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.2 mm -59.44 -30.15 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 O-C-N 122.059 -0.401 . . . . 0.0 110.954 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.81 -23.24 6.72 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.391 0.996 . . . . 0.0 114.253 170.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -81.86 -18.22 44.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.799 1.799 . . . . 0.0 111.524 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.28 136.34 56.47 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.865 0.84 . . . . 0.0 111.038 -165.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -56.27 100.66 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.794 1.238 . . . . 0.0 110.324 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.96 -27.2 5.18 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.059 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.31 134.84 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 118.598 1.199 . . . . 0.0 109.76 -172.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -105.64 -36.97 6.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.771 1.228 . . . . 0.0 110.309 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -159.05 169.77 23.52 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.296 0.953 . . . . 0.0 111.459 173.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -150.14 152.67 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.548 1.539 . . . . 0.0 108.932 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -150.38 116.2 5.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.706 1.603 . . . . 0.0 108.345 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.3 t -110.96 117.76 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.639 1.576 . . . . 0.0 109.96 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.4 m -103.23 108.21 19.34 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.445 1.498 . . . . 0.0 110.107 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mt -60.55 -179.05 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.485 1.114 . . . . 0.0 110.308 164.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 63.43 -70.06 0.07 Allowed 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 128.103 2.561 . . . . 0.0 111.029 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -61.57 -28.36 69.29 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.043 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.59 60.43 1.34 Allowed 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 126.711 2.005 . . . . 0.0 111.359 173.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -151.57 156.44 40.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.18 166.52 24.48 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.873 -0.517 . . . . 0.0 109.953 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.36 144.0 34.3 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.511 HD11 ' SD ' ' A' ' 7' ' ' MET . 13.2 mt -123.25 162.95 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.27 1.5 p -134.55 113.27 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 119.243 0.929 . . . . 0.0 108.715 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -158.96 179.54 8.98 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.077 1.351 . . . . 0.0 109.578 -170.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.74 147.92 53.55 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.47 79.33 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.666 2.911 . . . . 0.0 109.901 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.22 -52.62 0.5 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.765 1.626 . . . . 0.0 107.147 166.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.05 -22.69 18.98 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.236 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 tp -129.13 147.67 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 123.724 0.81 . . . . 0.0 111.204 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -80.74 27.24 0.38 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -170.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 71.67 -60.65 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 127.879 2.472 . . . . 0.0 109.862 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.54 -42.32 52.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.009 1.324 . . . . 0.0 109.304 -177.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -50.47 -52.97 33.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 123.566 0.541 . . . . 0.0 110.648 -171.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -36.93 -63.38 0.42 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.774 1.229 . . . . 0.0 111.538 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -39.24 72.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.771 -0.581 . . . . 0.0 110.359 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -58.29 -27.33 63.98 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.04 -1.038 . . . . 0.0 113.162 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -41.99 96.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.766 1.167 . . . . 0.0 108.787 176.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.77 -39.09 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.314 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -60.43 -49.84 75.97 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.87 -28.89 64.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.438 1.095 . . . . 0.0 113.195 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.0 mmt -53.05 -34.34 56.06 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.215 0.916 . . . . 0.0 111.463 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.56 -38.91 1.33 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -73.3 113.06 18.63 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.585 -173.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.74 108.63 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.08 1.853 . . . . 0.0 108.384 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.09 -177.43 4.13 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.305 1.042 . . . . 0.0 108.336 -171.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -156.91 140.18 15.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.099 0.863 . . . . 0.0 112.69 -165.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.226 -0.171 0 C-N-CA 126.667 1.987 . . . . 0.0 109.887 -176.915 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.84 125.36 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.595 HD13 ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -131.38 137.16 48.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -93.13 129.32 39.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.263 0.625 . . . . 0.0 111.079 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.465 ' CG ' HD11 ' A' ' 5' ' ' LEU . 27.0 mtt -108.44 155.24 20.81 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.171 0.988 . . . . 0.0 109.977 169.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 118.35 36.59 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 167.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.0 t -100.86 76.91 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.13 168.73 19.42 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.686 0.755 . . . . 0.0 111.675 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.109 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.206 -178.854 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.223 -0.294 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.2 t -50.7 -43.14 57.65 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 m -49.53 -56.2 10.7 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.248 -0.283 . . . . 0.0 111.064 170.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.31 -49.11 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.294 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -51.81 -67.65 0.23 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.52 1.054 . . . . 0.0 110.806 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.33 -50.17 29.89 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.621 1.582 . . . . 0.0 111.882 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.23 -55.31 36.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.696 0.748 . . . . 0.0 109.846 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.9 mm -61.79 -28.75 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 124.2 1.0 . . . . 0.0 110.726 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.45 -20.36 16.45 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.632 1.11 . . . . 0.0 113.581 173.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -90.13 -6.22 55.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.304 1.552 . . . . 0.0 111.408 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.21 135.65 47.63 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 122.044 0.926 . . . . 0.0 111.291 -173.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -57.95 101.63 0.08 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.292 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.46 -24.85 6.41 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.821 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 t -81.95 137.76 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 118.917 1.358 . . . . 0.0 108.253 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -117.35 -34.59 4.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.087 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.11 161.28 38.4 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.818 1.19 . . . . 0.0 110.332 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tt -152.75 143.43 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.628 1.171 . . . . 0.0 110.054 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -141.08 108.68 5.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.365 1.866 . . . . 0.0 108.164 168.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.62 118.48 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 124.731 1.212 . . . . 0.0 109.352 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 t -104.89 82.45 1.87 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.441 1.097 . . . . 0.0 109.164 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -49.37 62.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.988 0.915 . . . . 0.0 111.3 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -44.43 -51.91 8.27 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 125.162 1.385 . . . . 0.0 110.866 172.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -75.58 -9.55 58.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.946 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 62.7 24.03 14.3 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.034 2.134 . . . . 0.0 110.896 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -141.78 160.42 40.23 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.89 1.276 . . . . 0.0 109.678 -170.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.99 158.87 43.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.8 0.84 . . . . 0.0 109.364 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.3 m -132.65 108.05 8.8 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 127.526 2.33 . . . . 0.0 106.202 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mt -116.82 156.23 18.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 124.044 0.938 . . . . 0.0 108.81 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.257 0.5 OUTLIER -132.3 114.07 22.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 118.078 0.399 . . . . 0.0 109.94 -175.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.444 ' HE1' HD12 ' A' ' 5' ' ' LEU . 52.8 p90 -157.41 179.05 9.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.402 1.081 . . . . 0.0 110.248 -169.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -141.17 132.18 13.47 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 123.902 0.881 . . . . 0.0 110.482 -170.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.22 73.5 2.07 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.751 2.968 . . . . 0.0 110.108 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -144.79 -51.7 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -87.87 -27.84 21.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.707 -0.664 . . . . 0.0 111.236 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.3 tp -120.93 143.6 32.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 CA-C-N 118.897 0.771 . . . . 0.0 110.169 -175.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -83.44 31.37 0.46 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -171.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.284 0.5 OUTLIER 74.78 -58.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 128.411 2.684 . . . . 0.0 111.447 170.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -80.77 -38.95 27.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.463 1.905 . . . . 0.0 108.247 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HB3' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -44.8 -53.53 7.33 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 123.774 0.83 . . . . 0.0 111.696 -174.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -34.9 -56.98 0.56 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.613 1.565 . . . . 0.0 110.065 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -42.09 71.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.765 0.426 . . . . 0.0 111.14 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -56.76 -28.5 61.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -63.22 -44.18 95.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.37 -46.26 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 117.987 -1.006 . . . . 0.0 111.038 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -52.12 -51.83 55.36 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.754 1.161 . . . . 0.0 108.421 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.59 -20.9 63.83 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.55 2.34 . . . . 0.0 114.056 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.4 mmt -54.82 -32.61 60.6 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.625 1.102 . . . . 0.0 110.123 168.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.47 43.08 0.48 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -147.05 132.61 9.24 Favored Pre-proline 0 C--O 1.223 -0.296 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.7 123.34 11.54 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 121.083 1.423 . . . . 0.0 108.953 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.71 175.02 9.37 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.572 1.177 . . . . 0.0 110.102 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.98 150.91 24.75 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.992 -1.068 . . . . 0.0 111.017 -163.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.457 ' CG2' HD21 ' A' ' 5' ' ' LEU . 10.0 p . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -174.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.3 t -92.08 132.42 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 125.501 1.52 . . . . 0.0 108.47 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.483 HD13 ' C ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -110.33 129.91 55.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 170.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.59 121.9 44.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.29 1.436 . . . . 0.0 107.127 169.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.451 ' HB3' HD11 ' A' ' 5' ' ' LEU . 26.4 ptt? -129.91 140.21 50.99 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.302 0.641 . . . . 0.0 110.479 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.84 145.22 34.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 164.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 t -136.16 72.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.663 1.585 . . . . 0.0 107.269 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -71.45 176.17 4.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.684 0.754 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 CA-C-O 119.553 -0.581 . . . . 0.0 113.149 166.935 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.95 -36.31 65.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -168.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.3 m -49.98 -61.66 2.01 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.871 167.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.83 -51.1 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.31 -63.82 1.13 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.516 0.674 . . . . 0.0 110.549 -173.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.7 -54.38 6.69 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.998 1.761 . . . . 0.0 112.165 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -59.3 -54.38 47.46 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.151 0.975 . . . . 0.0 110.447 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.1 mm -56.52 -33.33 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.448 0.699 . . . . 0.0 111.302 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.65 -20.44 17.91 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.645 1.117 . . . . 0.0 113.904 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -84.59 -20.25 31.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.646 1.723 . . . . 0.0 111.138 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 136.24 53.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 122.339 1.066 . . . . 0.0 111.75 -167.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.59 115.15 1.81 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.905 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.88 -22.38 12.7 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-O 119.076 -0.847 . . . . 0.0 112.507 176.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.25 128.31 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 118.318 1.059 . . . . 0.0 109.388 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -88.6 -48.47 7.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.935 1.294 . . . . 0.0 109.116 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.72 171.27 19.84 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.309 0.958 . . . . 0.0 111.124 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 tt -141.55 142.78 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 124.703 1.201 . . . . 0.0 109.677 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.78 106.79 6.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.259 1.424 . . . . 0.0 107.774 170.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.64 125.76 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.2 1.0 . . . . 0.0 109.352 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -115.01 82.62 1.77 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.725 1.21 . . . . 0.0 108.283 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -52.23 -44.29 64.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.836 0.854 . . . . 0.0 110.298 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -40.89 -55.19 2.55 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.95 1.3 . . . . 0.0 111.085 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -79.68 -7.61 58.69 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.234 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 61.49 23.66 13.9 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.551 2.34 . . . . 0.0 111.283 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -139.69 159.81 41.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.034 -168.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.63 159.03 44.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.299 0.64 . . . . 0.0 109.482 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.4 m -132.77 119.89 20.9 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.8 mt -106.64 155.17 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.45 121.19 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 168.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -157.75 -177.3 6.47 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 127.478 2.311 . . . . 0.0 107.95 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -137.76 149.05 63.31 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 119.98 1.264 . . . . 0.0 112.278 170.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.56 72.49 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.259 3.306 . . . . 0.0 110.266 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.15 -61.43 0.42 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.242 1.417 . . . . 0.0 108.372 173.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.1 mt -84.75 -19.82 32.05 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.798 -0.62 . . . . 0.0 110.815 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.3 tp -123.97 152.33 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 123.288 0.635 . . . . 0.0 110.143 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 m -81.39 20.27 0.89 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.141 0.977 . . . . 0.0 113.433 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 66.91 -61.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 129.23 3.012 . . . . 0.0 109.84 -172.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.94 -39.0 72.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.643 0.777 . . . . 0.0 110.066 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.4 mt-10 -47.47 -50.7 22.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.364 0.415 . . . . 0.0 111.663 -174.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.21 -48.22 6.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 122.934 0.494 . . . . 0.0 111.626 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -51.66 24.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 122.227 -0.296 . . . . 0.0 110.71 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -57.99 -27.6 63.63 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -60.51 -51.38 69.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.894 0.877 . . . . 0.0 108.681 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.95 -50.14 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.659 173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -53.93 -47.44 71.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.34 -20.64 60.12 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.441 1.496 . . . . 0.0 114.227 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.7 mmt -60.94 -29.97 69.94 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.956 1.253 . . . . 0.0 110.348 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.42 -34.74 1.7 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 173.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -77.09 110.53 12.39 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.192 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.72 116.95 4.23 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.737 1.625 . . . . 0.0 109.217 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.84 -169.5 2.13 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.236 1.014 . . . . 0.0 109.438 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.46 136.87 8.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.753 1.16 . . . . 0.0 113.355 -169.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.529 0.168 0 C-N-CA 124.76 1.224 . . . . 0.0 108.913 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.592 0.711 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.7 t -80.69 136.45 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 125.262 1.425 . . . . 0.0 109.784 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.662 HD21 HG22 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -127.65 138.37 52.81 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.274 1.83 . . . . 0.0 108.077 177.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.556 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.2 ttpt -110.68 114.79 28.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.806 1.242 . . . . 0.0 109.77 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.5 ptp -109.52 151.5 26.67 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.372 1.069 . . . . 0.0 109.827 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -89.67 133.34 34.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 163.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 t -118.71 78.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -72.91 167.93 20.0 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.928 0.87 . . . . 0.0 111.475 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.352 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.468 HG22 HG12 ' A' ' 36' ' ' VAL . 9.9 p . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.4 m -49.08 -40.91 33.69 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -175.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.3 m -48.99 -58.49 4.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.144 0.497 . . . . 0.0 111.698 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.58 -45.24 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 123.937 0.895 . . . . 0.0 108.988 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HA ' HG21 ' A' ' 34' ' ' ILE . 47.1 mt-10 -54.35 -62.5 1.62 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.645 1.111 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.4 -54.01 14.34 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.352 1.453 . . . . 0.0 111.754 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -60.73 -58.14 9.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.624 0.712 . . . . 0.0 110.45 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.435 HG21 HD12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -57.31 -39.05 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.063 0.945 . . . . 0.0 110.3 -177.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.06 -13.98 9.97 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.042 1.306 . . . . 0.0 113.829 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -95.5 -15.35 22.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.849 1.324 . . . . 0.0 110.667 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 141.2 55.66 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 119.528 1.058 . . . . 0.0 111.96 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -59.32 114.32 2.6 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.677 173.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.05 -22.74 9.62 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.436 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.16 139.01 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 117.966 0.883 . . . . 0.0 109.265 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -105.48 -45.87 4.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.468 1.507 . . . . 0.0 110.207 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.59 161.7 42.06 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 22' ' ' GLU . 7.9 tt -146.78 140.49 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.712 1.205 . . . . 0.0 109.375 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.63 105.18 6.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.319 1.847 . . . . 0.0 106.903 173.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.468 HG12 HG22 ' A' ' 18' ' ' THR . 46.3 t -105.56 116.44 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.816 1.189 . . . . 0.0 108.862 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -80.47 179.69 7.6 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.338 0.589 . . . . 0.0 110.176 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.2 -59.74 1.3 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.284 1.434 . . . . 0.0 108.225 173.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -43.84 -54.64 5.09 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.983 1.313 . . . . 0.0 110.083 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -80.55 -12.66 59.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.012 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 61.95 15.76 7.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.963 1.705 . . . . 0.0 112.736 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -124.76 156.72 37.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.556 1.543 . . . . 0.0 109.689 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HB2' HG13 ' A' ' 36' ' ' VAL . . . -139.56 152.63 47.04 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.538 0.735 . . . . 0.0 110.104 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.3 m -128.24 113.85 16.19 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.548 1.939 . . . . 0.0 105.991 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.73 160.59 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -128.51 119.11 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -158.28 178.13 10.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.261 1.424 . . . . 0.0 110.239 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -133.53 149.82 73.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.295 1.038 . . . . 0.0 113.547 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.68 80.67 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.665 2.91 . . . . 0.0 109.114 169.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.2 -61.2 0.25 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.46 1.104 . . . . 0.0 108.073 173.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.9 mt -87.59 -21.12 25.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.003 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.2 tp -123.96 148.79 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.07 0.948 . . . . 0.0 109.851 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.0 m -79.39 23.98 0.37 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.256 0.8 OUTLIER 70.09 -57.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 128.047 2.539 . . . . 0.0 110.054 -176.18 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.09 -40.7 37.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.398 1.079 . . . . 0.0 110.144 -176.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -48.19 -48.44 34.69 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 122.739 0.415 . . . . 0.0 111.668 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -37.89 -56.43 1.11 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.695 1.198 . . . . 0.0 112.212 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.17 -45.19 42.28 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.254 1.021 . . . . 0.0 112.478 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.44 -29.36 15.82 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.191 -0.943 . . . . 0.0 112.663 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -62.27 -34.31 76.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -70.1 -44.32 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 118.419 -0.801 . . . . 0.0 109.811 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -50.86 -49.34 59.25 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.51 44.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.273 1.029 . . . . 0.0 113.756 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.3 mmm -66.8 -30.85 71.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.444 1.02 . . . . 0.0 110.247 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.23 -36.91 1.99 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.315 0.96 . . . . 0.0 111.142 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -79.56 123.73 84.09 Favored Pre-proline 0 N--CA 1.455 -0.179 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.305 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.15 118.33 5.35 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.508 1.472 . . . . 0.0 108.596 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.76 -174.56 2.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -162.87 143.79 9.73 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.888 -1.132 . . . . 0.0 110.935 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.662 HG22 HD21 ' A' ' 5' ' ' LEU . 1.2 t . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.7 t . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 t -77.1 121.41 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.602 HD21 HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -117.96 132.75 56.36 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.551 1.54 . . . . 0.0 106.897 175.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.97 137.84 36.94 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.2 1.0 . . . . 0.0 110.196 171.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -138.71 147.44 42.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.177 0.991 . . . . 0.0 109.882 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -92.25 128.56 38.14 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 t -120.65 73.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 125.24 1.416 . . . . 0.0 108.755 -171.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -73.27 174.7 7.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.784 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 O-C-N 121.807 -0.558 . . . . 0.0 113.015 167.517 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 m -56.4 -38.19 71.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -169.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -50.18 -59.34 4.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.75 0.42 . . . . 0.0 110.404 168.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.72 -49.34 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 118.563 -0.732 . . . . 0.0 109.372 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.38 -65.65 0.54 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.063 0.847 . . . . 0.0 111.071 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.9 -52.22 26.68 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.117 1.342 . . . . 0.0 112.206 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -52.15 -58.05 7.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.533 0.733 . . . . 0.0 109.461 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.44 -34.98 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.6 1.16 . . . . 0.0 111.108 -176.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.87 -23.03 10.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.01 1.29 . . . . 0.0 113.664 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -89.36 -17.22 29.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.577 1.188 . . . . 0.0 110.239 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.43 136.63 49.71 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.327 1.06 . . . . 0.0 111.688 -173.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -52.08 109.27 0.36 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.037 1.335 . . . . 0.0 111.111 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.24 -23.48 8.56 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 118.928 -0.929 . . . . 0.0 112.788 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.3 t -79.79 142.9 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 118.49 1.145 . . . . 0.0 110.056 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -117.12 -40.24 3.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.546 1.138 . . . . 0.0 111.812 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.89 165.68 34.7 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.748 0.704 . . . . 0.0 109.168 173.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -143.95 145.05 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.518 1.527 . . . . 0.0 108.417 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -139.99 97.98 3.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.424 2.29 . . . . 0.0 107.101 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -96.09 116.43 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.131 0.972 . . . . 0.0 109.09 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.8 t -108.72 80.01 1.29 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -54.02 -41.01 67.53 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.855 0.462 . . . . 0.0 111.747 -176.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.81 -55.05 3.83 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.93 1.292 . . . . 0.0 110.584 168.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -78.57 -19.83 51.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.75 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 72.65 4.72 5.07 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.796 2.438 . . . . 0.0 111.627 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -109.99 151.95 26.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.541 1.536 . . . . 0.0 109.02 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.6 157.81 44.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.991 0.916 . . . . 0.0 108.63 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -129.33 121.56 27.72 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.8 mt -111.52 153.35 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.254 7.0 p -117.87 114.7 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.991 0.917 . . . . 0.0 108.906 173.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -158.95 178.93 9.55 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.721 1.208 . . . . 0.0 110.681 -171.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -138.19 144.73 44.48 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HB3' HG23 ' A' ' 54' ' ' VAL . 73.9 Cg_endo -69.6 71.93 1.4 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.547 3.498 . . . . 0.0 110.826 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.32 -58.15 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.399 1.08 . . . . 0.0 108.507 172.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.3 mt -87.5 -21.81 25.26 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.877 -0.582 . . . . 0.0 110.869 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.0 tp -118.76 151.12 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 123.622 0.769 . . . . 0.0 109.823 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 m -85.88 29.83 0.7 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.637 0.775 . . . . 0.0 112.72 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 49' ' ' PRO 0.265 0.5 OUTLIER 73.76 -59.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.085 2.554 . . . . 0.0 110.4 176.115 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -81.01 -38.01 28.2 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.303 1.441 . . . . 0.0 109.786 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.555 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.8 mm-40 -43.76 -48.69 8.1 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 123.747 0.655 . . . . 0.0 111.346 -174.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.24 -53.74 3.11 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.661 0.784 . . . . 0.0 112.029 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -47.22 54.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.199 0.2 . . . . 0.0 110.619 177.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -54.54 -28.38 45.16 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -62.53 -52.24 64.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.5 mp -58.2 -43.14 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.183 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -55.48 -53.71 52.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.5 -27.35 62.47 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.172 1.789 . . . . 0.0 114.097 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.2 mmm -51.37 -31.45 22.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.687 1.13 . . . . 0.0 110.974 172.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.63 42.72 0.28 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -146.82 120.52 5.07 Favored Pre-proline 0 C--O 1.227 -0.087 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.13 102.04 0.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.953 1.769 . . . . 0.0 109.345 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.22 -175.47 3.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.819 0.848 . . . . 0.0 108.898 -175.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.33 143.83 15.34 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.602 HG22 HD21 ' A' ' 5' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 125.546 1.538 . . . . 0.0 108.42 172.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.2 t . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.72 120.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -123.88 156.02 37.01 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.555 1.142 . . . . 0.0 109.237 -177.103 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.592 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -102.35 123.05 45.45 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.401 0.681 . . . . 0.0 110.039 177.708 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.1 mmt -105.95 157.72 17.3 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.703 1.201 . . . . 0.0 109.052 174.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.93 127.14 54.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 168.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.5 73.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.9 169.84 17.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.801 -174.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.231 0 CA-C-O 118.934 -0.926 . . . . 0.0 113.708 172.524 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.5 t -53.08 -39.31 63.23 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -172.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.5 m -45.77 -61.36 1.75 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 123.194 0.598 . . . . 0.0 112.561 165.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.78 -49.12 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.317 1.047 . . . . 0.0 108.975 178.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -56.41 -65.91 0.53 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.989 0.916 . . . . 0.0 109.428 -176.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.05 -52.83 11.51 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.195 1.379 . . . . 0.0 112.492 176.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.19 -55.42 35.16 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.851 0.825 . . . . 0.0 110.233 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.7 mm -60.59 -30.07 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 123.797 0.839 . . . . 0.0 110.851 -178.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.85 -19.52 6.98 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.07 171.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -90.51 -13.53 34.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 119.784 1.792 . . . . 0.0 111.217 177.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.65 134.0 50.36 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.496 1.141 . . . . 0.0 111.033 -173.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -55.55 110.9 0.78 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.116 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.38 -25.42 8.2 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.329 176.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 t -81.28 136.06 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 118.194 0.997 . . . . 0.0 109.045 -177.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -101.72 -42.92 6.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.797 1.239 . . . . 0.0 110.201 173.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 ttt-85 -153.98 161.35 42.03 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.849 0.75 . . . . 0.0 109.987 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 tt -149.08 139.33 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.583 1.153 . . . . 0.0 109.545 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -139.6 114.81 9.71 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.094 1.758 . . . . 0.0 106.593 174.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -113.99 126.23 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.986 1.314 . . . . 0.0 109.07 -178.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.3 t -84.58 172.41 11.63 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.536 0.684 . . . . 0.0 110.345 172.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.1 -63.25 1.48 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 170.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -52.64 -49.96 64.13 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.29 1.036 . . . . 0.0 109.313 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.9 -18.09 59.53 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.292 -172.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 62.62 4.74 1.46 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.324 1.85 . . . . 0.0 113.239 -175.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -107.86 152.93 23.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.263 1.825 . . . . 0.0 108.014 -169.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.13 161.27 37.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.47 0.708 . . . . 0.0 109.833 178.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.7 m -137.68 118.29 13.96 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 mt -120.27 160.85 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.244 1.018 . . . . 0.0 108.282 178.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.263 14.1 p -130.25 114.89 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.355 0.662 . . . . 0.0 109.888 178.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -158.97 178.66 9.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.229 1.011 . . . . 0.0 111.392 -175.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -134.65 148.82 68.89 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.419 1.088 . . . . 0.0 113.177 173.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.69 74.83 0.85 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.403 3.402 . . . . 0.0 110.006 171.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.26 -61.31 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.752 1.221 . . . . 0.0 107.812 170.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.4 mt -85.66 -20.86 28.79 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.092 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.436 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.9 tp -123.4 147.3 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 m -79.81 27.0 0.31 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.36 0.982 . . . . 0.0 112.68 -176.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.27 0.5 OUTLIER 73.25 -54.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 128.01 2.524 . . . . 0.0 110.817 179.334 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -88.3 -32.81 18.27 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.597 0.759 . . . . 0.0 111.218 -178.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.436 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.5 mt-10 -40.76 -51.57 3.07 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 123.254 0.622 . . . . 0.0 110.775 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -37.0 -63.94 0.39 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.443 1.497 . . . . 0.0 109.922 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.3 -43.99 97.54 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.905 -0.497 . . . . 0.0 111.091 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -58.08 -31.64 67.28 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -60.18 -48.38 81.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -58.6 -48.37 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.863 175.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -52.15 -50.79 61.06 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.324 0.966 . . . . 0.0 108.477 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.27 -21.46 61.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.067 1.747 . . . . 0.0 114.036 -177.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.0 mmt -63.26 -23.95 67.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.955 1.252 . . . . 0.0 110.478 172.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.99 40.77 0.74 Allowed Glycine 0 C--N 1.338 0.66 0 C-N-CA 124.279 0.942 . . . . 0.0 111.358 170.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -148.53 123.3 4.94 Favored Pre-proline 0 C--O 1.226 -0.152 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.8 118.28 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.361 1.374 . . . . 0.0 109.078 -178.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.66 -171.13 1.83 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.96 152.45 13.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.036 -1.04 . . . . 0.0 111.206 -173.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.448 -0.565 0 C-N-CA 126.362 1.865 . . . . 0.0 106.383 -178.097 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.2 t . . . . . 0 CA--C 1.521 -0.142 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.82 141.78 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.583 HD21 HG22 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -142.64 131.91 23.41 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.773 0.829 . . . . 0.0 109.266 -179.579 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' N ' HD22 ' A' ' 5' ' ' LEU . 1.4 mtmt -103.62 129.78 50.96 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.04 1.336 . . . . 0.0 111.387 178.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.3 ptp -127.01 159.68 33.4 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.294 1.038 . . . . 0.0 110.67 176.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -98.73 124.81 43.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.014 1.726 . . . . 0.0 107.681 164.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -111.97 77.44 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.065 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 169.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.283 10.6 pt-20 -84.2 165.63 18.23 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.665 178.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.113 0 CA-C-O 119.459 -0.634 . . . . 0.0 113.759 176.644 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.222 -0.38 0 CA-C-O 118.381 -0.819 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -49.32 -37.17 23.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -175.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.25 -51.37 69.85 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 175.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.59 -53.38 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.176 172.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -55.86 -61.1 2.59 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.325 0.966 . . . . 0.0 109.92 -171.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.48 -52.9 22.53 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.319 1.438 . . . . 0.0 111.729 177.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -60.7 -50.86 71.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.047 0.923 . . . . 0.0 110.323 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.5 mm -66.33 -24.33 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.89 0.876 . . . . 0.0 110.788 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.11 -14.55 32.72 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.604 170.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -84.54 -12.93 53.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.64 1.72 . . . . 0.0 110.607 173.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.63 135.31 46.88 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 122.307 1.051 . . . . 0.0 111.447 -171.156 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -60.93 113.77 2.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.221 177.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.83 -21.87 15.47 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-O 119.366 -0.686 . . . . 0.0 112.945 175.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 t -81.59 131.34 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.26 -51.34 5.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.151 1.38 . . . . 0.0 109.163 174.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -152.1 160.86 43.33 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tt -143.51 141.55 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.151 1.38 . . . . 0.0 108.488 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.54 125.93 20.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.734 1.614 . . . . 0.0 107.097 171.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -115.95 154.31 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.026 1.33 . . . . 0.0 107.696 -178.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.2 t -130.28 155.53 46.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.111 0.964 . . . . 0.0 109.216 176.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mt -104.36 -59.71 1.7 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.299 1.84 . . . . 0.0 108.732 -177.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.79 -58.27 7.85 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.065 1.346 . . . . 0.0 109.619 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.7 -22.36 62.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.32 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 55.75 59.29 3.9 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 126.581 1.952 . . . . 0.0 109.775 176.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -156.34 160.72 39.95 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.465 1.506 . . . . 0.0 107.137 -172.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.63 159.04 43.01 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 118.931 0.787 . . . . 0.0 110.536 174.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.9 m -126.23 130.28 50.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 174.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.411 HG21 ' SD ' ' A' ' 57' ' ' MET . 2.6 mp -118.36 163.66 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.4 117.71 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.108 0.963 . . . . 0.0 108.846 176.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -159.61 -177.14 6.18 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.535 1.134 . . . . 0.0 111.255 -171.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -136.73 152.61 74.7 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 165.175 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.79 76.55 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.32 3.347 . . . . 0.0 109.541 171.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.71 -62.43 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.227 1.011 . . . . 0.0 108.679 175.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.9 mt -84.14 -27.21 28.3 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 119.361 -0.352 . . . . 0.0 110.142 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 52' ' ' ILE . 9.4 tp -117.74 146.74 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.321 1.048 . . . . 0.0 109.281 177.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -84.1 27.78 0.65 Allowed 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.262 0.9 OUTLIER 70.42 -57.54 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 128.787 2.835 . . . . 0.0 111.42 179.883 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.72 -33.56 40.78 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.08 1.352 . . . . 0.0 110.04 -177.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -52.87 -49.61 65.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 123.203 0.314 . . . . 0.0 110.777 -177.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -31.57 -58.67 0.26 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.491 1.516 . . . . 0.0 111.283 172.316 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -46.71 67.13 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.177 -0.327 . . . . 0.0 111.306 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.8 -32.02 59.73 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.819 -0.551 . . . . 0.0 112.321 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -42.16 99.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.19 -47.94 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.694 172.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 7.5 mt-10 -49.79 -51.07 42.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.17 0.986 . . . . 0.0 108.835 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.84 -19.59 51.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.781 2.032 . . . . 0.0 114.056 -178.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.8 mmm -61.34 -30.47 70.53 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.626 1.103 . . . . 0.0 109.626 170.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.25 40.68 0.39 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.839 1.209 . . . . 0.0 111.553 170.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -148.62 122.12 4.66 Favored Pre-proline 0 C--O 1.223 -0.291 0 CA-C-O 117.12 -1.419 . . . . 0.0 107.604 -177.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -62.69 118.66 5.56 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.623 1.549 . . . . 0.0 109.001 -176.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -120.78 175.16 6.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.216 1.008 . . . . 0.0 109.991 -178.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.81 138.67 18.02 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.95 -1.094 . . . . 0.0 111.178 -170.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.583 HG22 HD21 ' A' ' 5' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -177.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.443 -0.777 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.49 135.44 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.515 HD21 HG22 ' A' ' 70' ' ' VAL . 1.5 tm? -125.67 144.41 50.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.272 1.429 . . . . 0.0 107.375 178.368 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.409 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -117.06 129.04 55.74 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.431 1.492 . . . . 0.0 109.136 174.679 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 ptp -124.04 152.07 43.04 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.614 1.166 . . . . 0.0 109.877 179.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -89.94 151.43 21.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 162.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -132.27 68.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -62.9 115.47 4.41 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.672 -170.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.912 0 CA-C-O 119.389 -0.673 . . . . 0.0 113.37 173.611 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 m -55.33 -36.25 66.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -171.099 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.6 m -50.76 -60.63 2.86 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.416 0.447 . . . . 0.0 111.051 167.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.9 -51.22 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -57.49 -66.75 0.41 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.552 0.691 . . . . 0.0 110.63 -174.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.19 -51.26 26.36 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.881 1.705 . . . . 0.0 111.911 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -54.89 -56.68 16.92 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.813 0.806 . . . . 0.0 109.367 177.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.9 mm -64.24 -28.56 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 C-N-CA 123.157 0.583 . . . . 0.0 111.052 -174.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.78 -19.98 23.43 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.376 0.989 . . . . 0.0 113.44 171.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -85.84 -18.61 32.37 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 119.627 1.714 . . . . 0.0 109.419 177.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.46 133.7 49.02 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.453 1.121 . . . . 0.0 111.336 -172.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -58.23 111.43 1.2 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.027 175.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.67 -27.34 6.28 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-O 119.165 -0.797 . . . . 0.0 112.639 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.07 136.19 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 118.167 0.984 . . . . 0.0 109.382 -176.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -107.87 -46.0 3.87 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.581 1.152 . . . . 0.0 110.668 176.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.61 159.7 42.37 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.5 tt -142.7 148.15 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.072 1.349 . . . . 0.0 109.854 179.1 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -145.27 113.11 6.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.791 2.036 . . . . 0.0 108.193 171.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.0 t -102.92 120.66 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.23 1.012 . . . . 0.0 110.168 176.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 m -102.72 89.32 3.46 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.516 1.126 . . . . 0.0 109.061 175.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 38' ' ' LEU . 8.3 mt -58.81 173.66 0.41 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.201 160.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 66.41 -65.63 0.19 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 127.968 2.507 . . . . 0.0 109.574 -170.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -27.85 69.0 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.095 178.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.93 50.82 0.8 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.674 2.39 . . . . 0.0 111.718 172.628 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -140.22 148.16 41.11 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.217 2.207 . . . . 0.0 106.206 -174.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.43 155.84 45.13 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 120.924 -1.11 . . . . 0.0 109.679 172.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.76 136.66 34.35 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.41 163.17 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.36 119.1 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -159.0 -179.33 7.95 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.684 1.194 . . . . 0.0 109.908 -172.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -138.23 144.1 41.79 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.1 80.27 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.305 3.337 . . . . 0.0 109.921 174.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -158.35 -54.32 0.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.7 mt -86.75 -29.48 22.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.417 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.6 tp -115.68 145.13 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m -78.24 23.49 0.28 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 -175.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 76.03 -58.51 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 127.27 2.228 . . . . 0.0 109.786 176.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.99 -39.26 42.93 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.476 1.511 . . . . 0.0 109.669 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.407 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.4 mt-10 -40.39 -57.11 1.86 Allowed 'General case' 0 C--N 1.345 0.388 0 C-N-CA 123.942 0.897 . . . . 0.0 111.043 -178.381 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.5 -58.29 0.33 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.999 1.72 . . . . 0.0 110.477 175.505 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -48.08 51.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.151 -0.343 . . . . 0.0 111.838 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -55.93 -30.43 61.64 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -174.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.6 -46.41 89.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -63.93 -47.11 92.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.008 175.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -50.38 -51.94 41.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.79 -18.83 57.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.503 1.921 . . . . 0.0 114.209 -178.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.6 mmm -59.12 -29.76 67.62 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.874 1.216 . . . . 0.0 109.796 170.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.94 44.36 0.28 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 124.347 0.975 . . . . 0.0 110.851 171.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -146.76 120.98 5.16 Favored Pre-proline 0 C--O 1.225 -0.196 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -175.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.22 99.01 0.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.942 1.761 . . . . 0.0 110.086 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.22 -176.63 2.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -174.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.6 141.13 11.57 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.6 0.36 . . . . 0.0 111.572 -176.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.515 HG22 HD21 ' A' ' 5' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.22 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.09 143.73 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 124.619 1.168 . . . . 0.0 111.389 -175.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.43 132.86 53.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.278 1.431 . . . . 0.0 108.191 175.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.43 109.71 21.49 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.301 1.44 . . . . 0.0 107.648 175.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.7 ptm -113.39 164.78 13.16 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.691 0.796 . . . . 0.0 111.084 174.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -109.99 131.02 55.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 129.711 3.204 . . . . 0.0 106.581 177.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 t -121.25 77.69 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.03 177.13 4.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.954 0.883 . . . . 0.0 111.7 -176.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.809 0 O-C-N 121.626 -0.671 . . . . 0.0 111.546 176.58 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 t -55.04 -38.31 67.81 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -164.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -49.36 -58.4 5.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.876 0.47 . . . . 0.0 111.789 167.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.65 -51.43 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.752 0.821 . . . . 0.0 108.914 176.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.32 -63.59 1.14 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.28 0.632 . . . . 0.0 110.436 -174.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.98 -53.57 14.1 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.712 1.625 . . . . 0.0 112.411 174.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -62.14 -51.67 66.93 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.199 0.999 . . . . 0.0 110.925 -176.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 mm -55.63 -35.88 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.738 0.815 . . . . 0.0 110.537 173.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.01 -12.45 22.61 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.626 1.108 . . . . 0.0 114.006 173.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -87.94 -20.35 26.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.447 1.623 . . . . 0.0 109.914 172.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 131.78 45.82 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.714 1.245 . . . . 0.0 112.156 -172.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -50.06 107.29 0.15 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.551 170.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.7 -27.3 6.29 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-O 118.9 -0.945 . . . . 0.0 112.464 175.299 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 t -81.9 133.15 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.37 -41.97 5.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.342 0.519 . . . . 0.0 111.931 167.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.411 ' H ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -136.78 161.73 35.16 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.161 0.891 . . . . 0.0 110.006 -175.23 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 tt -152.68 146.99 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.95 0.9 . . . . 0.0 110.96 -176.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -144.84 102.27 3.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.579 1.952 . . . . 0.0 108.658 169.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.5 t -99.26 100.1 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.286 1.034 . . . . 0.0 110.089 177.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.0 m -89.12 77.53 7.55 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.92 0.888 . . . . 0.0 109.609 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.0 tp -53.61 -35.12 60.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.596 0.758 . . . . 0.0 110.334 177.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -38.71 -52.3 1.68 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.361 1.464 . . . . 0.0 111.325 167.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.28 -7.14 58.73 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.096 -173.152 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 63.56 17.1 10.14 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.969 2.108 . . . . 0.0 111.312 -172.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -139.61 145.29 38.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.79 1.236 . . . . 0.0 110.225 -170.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.03 147.79 46.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.401 0.68 . . . . 0.0 110.809 -167.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -130.15 110.81 11.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.99 1.716 . . . . 0.0 107.073 -167.44 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.21 171.46 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 33' ' ' ARG . 0.6 OUTLIER -141.65 123.76 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.096 0.862 . . . . 0.0 109.619 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -155.93 176.73 12.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.776 0.83 . . . . 0.0 110.711 -174.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -123.65 141.14 35.79 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.236 1.014 . . . . 0.0 112.367 175.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.39 81.04 1.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.151 3.234 . . . . 0.0 109.753 176.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 -51.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.5 0.72 . . . . 0.0 109.512 177.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.4 mt -86.72 -36.59 18.57 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -179.208 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.5 tp -109.4 149.5 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 m -86.64 32.91 0.64 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 122.912 0.485 . . . . 0.0 111.645 -174.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 68.55 -56.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 129.911 3.284 . . . . 0.0 111.641 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -96.21 -26.81 15.29 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 126.846 2.059 . . . . 0.0 110.689 -170.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -43.18 -48.46 6.46 Favored 'General case' 0 C--N 1.347 0.484 0 O-C-N 123.524 0.515 . . . . 0.0 110.723 177.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -47.24 -61.52 1.86 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 123.272 0.629 . . . . 0.0 111.267 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.24 -45.44 93.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.232 1.013 . . . . 0.0 110.395 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -57.19 -27.88 62.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.876 176.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -47.89 75.45 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 175.288 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.64 -45.01 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.563 -0.732 . . . . 0.0 109.604 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -54.74 -52.94 60.95 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 122.128 0.966 . . . . 0.0 108.796 176.011 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.69 -24.52 66.81 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.683 1.593 . . . . 0.0 113.416 -174.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.6 mmm -53.38 -35.11 59.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.26 0.937 . . . . 0.0 110.179 168.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.94 -30.48 2.56 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.59 1.091 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.93 127.98 60.07 Favored Pre-proline 0 N--CA 1.456 -0.154 0 CA-C-O 118.389 -0.815 . . . . 0.0 108.945 -173.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.92 129.14 26.36 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.061 1.841 . . . . 0.0 109.383 -178.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.46 165.71 24.55 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.622 0.725 . . . . 0.0 109.723 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -156.0 153.58 29.72 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.192 -0.942 . . . . 0.0 110.786 -161.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.456 -0.166 0 C-N-CA 124.01 0.924 . . . . 0.0 109.183 -171.594 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 t . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.02 130.36 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.29 1.036 . . . . 0.0 110.901 -177.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -123.97 152.32 42.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.732 1.613 . . . . 0.0 108.072 175.106 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.589 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.58 136.79 54.7 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.501 1.12 . . . . 0.0 109.063 174.874 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 ptp -126.4 143.1 51.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.8 1.64 . . . . 0.0 109.209 -177.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.26 131.39 34.74 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 167.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.12 84.55 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.84 161.6 30.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.428 0.632 . . . . 0.0 112.516 -174.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.334 0 C-N-CA 123.69 0.662 . . . . 0.0 113.739 176.058 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 C--O 1.221 -0.44 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.8 t -53.16 -41.92 65.63 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -172.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.6 m -48.27 -56.68 7.4 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.651 168.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.45 -49.16 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -53.28 -66.67 0.35 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.341 0.973 . . . . 0.0 110.593 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.25 -53.93 8.95 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.728 1.633 . . . . 0.0 112.396 176.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -57.55 -51.0 71.27 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 117.825 0.813 . . . . 0.0 110.317 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.1 mm -62.98 -28.61 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.216 0.607 . . . . 0.0 110.603 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.61 -17.07 8.08 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 118.705 -1.053 . . . . 0.0 114.207 169.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -87.43 -18.02 30.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 120.123 1.961 . . . . 0.0 111.093 174.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.3 136.0 56.74 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.068 0.937 . . . . 0.0 110.566 -171.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -68.46 119.69 13.34 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.642 -175.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.59 -20.14 23.09 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-O 118.824 -0.987 . . . . 0.0 112.937 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.77 136.66 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 118.669 1.234 . . . . 0.0 109.547 -177.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -100.98 -47.79 4.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.054 1.342 . . . . 0.0 110.181 174.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.97 161.04 43.02 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.42 0.554 . . . . 0.0 109.53 -178.127 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 tt -138.5 145.03 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.5 1.52 . . . . 0.0 109.234 177.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -138.7 106.89 5.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.223 2.209 . . . . 0.0 107.582 171.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.5 t -102.05 98.96 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.308 0.958 . . . . 0.0 110.335 176.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 m -88.31 82.16 7.11 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.288 1.035 . . . . 0.0 109.61 177.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -49.94 -43.69 50.12 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.58 0.752 . . . . 0.0 111.367 -179.581 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.63 -52.45 2.22 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 125.953 1.701 . . . . 0.0 111.204 170.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -82.71 -9.62 59.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.88 -172.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 64.04 20.43 12.19 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.323 1.849 . . . . 0.0 111.279 -178.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -144.23 141.71 30.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.208 1.403 . . . . 0.0 109.354 -169.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.65 151.77 44.49 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.902 0.881 . . . . 0.0 109.476 -178.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.1 m -124.52 119.57 29.5 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 127.105 2.162 . . . . 0.0 105.667 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.415 HG21 ' SD ' ' A' ' 57' ' ' MET . 58.3 mt -125.07 161.19 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.04 123.97 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -156.22 173.14 17.28 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.506 1.122 . . . . 0.0 109.238 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.51 146.85 51.12 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 170.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -71.66 75.99 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.757 3.638 . . . . 0.0 110.332 177.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -151.85 -54.67 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.5 mt -89.28 -22.47 22.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.669 -177.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' A' ' 56' ' ' GLU . 9.0 tp -121.47 149.46 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.785 0.834 . . . . 0.0 109.537 177.471 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.9 m -84.95 30.46 0.58 Allowed 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 123.491 0.717 . . . . 0.0 112.098 -175.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 72.1 -62.77 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 128.931 2.893 . . . . 0.0 108.568 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -84.92 -31.07 23.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.98 -171.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HB3' HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -43.96 -51.81 7.41 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 123.83 0.706 . . . . 0.0 110.965 -179.287 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.415 ' SD ' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -39.79 -61.11 0.88 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.061 1.344 . . . . 0.0 109.193 -179.977 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -44.86 88.08 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.027 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -54.4 -33.57 59.57 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.942 0.792 . . . . 0.0 112.913 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -59.75 -47.39 85.87 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.28 -48.93 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.912 174.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -53.59 -48.21 69.44 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.101 0.953 . . . . 0.0 109.042 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.13 -20.05 62.23 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.324 1.449 . . . . 0.0 113.546 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 79.9 mmm -62.43 -29.84 70.8 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.687 1.13 . . . . 0.0 109.933 170.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.93 -34.93 2.1 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.064 0.84 . . . . 0.0 111.046 177.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -82.07 112.76 38.23 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-O 117.482 -1.247 . . . . 0.0 108.201 -178.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -60.64 137.15 71.54 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.506 1.471 . . . . 0.0 108.888 -179.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.53 -162.98 0.98 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.839 0.456 . . . . 0.0 110.098 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -170.07 148.48 3.4 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.658 0.783 . . . . 0.0 111.226 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.563 0 C-N-CA 124.581 1.152 . . . . 0.0 108.283 177.026 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.6 t -79.27 140.48 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.491 1.116 . . . . 0.0 109.063 -177.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.55 HD22 ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -123.58 129.29 50.96 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 126.17 1.788 . . . . 0.0 106.989 173.679 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.55 ' N ' HD22 ' A' ' 5' ' ' LEU . 7.7 ttpt -108.82 130.44 55.4 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.806 0.691 . . . . 0.0 109.615 172.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -138.21 157.65 45.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.162 0.985 . . . . 0.0 110.989 -172.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.7 144.52 26.6 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 170.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 t -128.61 66.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.58 1.552 . . . . 0.0 107.485 175.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.77 173.44 12.48 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.293 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.193 0 CA-C-O 119.273 -0.737 . . . . 0.0 113.809 175.172 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.224 -0.283 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 m -55.81 -37.13 68.23 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -163.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.9 m -52.38 -56.56 14.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 168.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.29 -49.63 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -53.21 -64.03 0.95 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.122 0.963 . . . . 0.0 110.9 -177.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.84 -51.28 13.42 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.632 1.587 . . . . 0.0 112.902 174.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -60.54 -63.72 1.2 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.618 0.709 . . . . 0.0 109.866 -178.481 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -53.24 -40.06 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.071 1.348 . . . . 0.0 110.613 -179.62 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.81 -23.66 16.01 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.012 1.291 . . . . 0.0 113.568 177.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -88.67 -17.01 30.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 119.151 1.475 . . . . 0.0 111.147 178.142 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 134.6 53.38 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.472 1.13 . . . . 0.0 111.861 -172.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -52.73 107.18 0.2 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.137 176.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.29 -32.76 4.03 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-O 119.144 -0.809 . . . . 0.0 111.773 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.29 136.99 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 118.093 0.947 . . . . 0.0 109.283 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -103.2 -45.63 4.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.273 1.429 . . . . 0.0 110.478 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -153.66 160.22 42.3 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.82 -0.55 . . . . 0.0 110.004 -178.313 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.8 tt -141.01 140.02 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.331 1.452 . . . . 0.0 109.776 178.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -133.05 117.16 17.23 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.8 1.64 . . . . 0.0 107.782 165.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.2 t -108.61 107.61 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 124.491 1.117 . . . . 0.0 109.868 177.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -89.5 89.47 7.86 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.48 -45.93 69.8 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.381 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -41.84 -61.18 1.17 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 126.114 1.766 . . . . 0.0 110.709 171.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -75.38 -9.92 58.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.05 -174.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 67.28 6.79 5.06 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 127.313 2.245 . . . . 0.0 111.741 -174.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -119.88 144.11 47.57 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.331 1.853 . . . . 0.0 108.132 -171.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.01 155.14 48.53 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.37 0.668 . . . . 0.0 109.23 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 m -135.68 112.74 10.38 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 126.195 1.798 . . . . 0.0 106.521 -171.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.94 169.08 6.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -137.78 123.71 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -159.23 -178.33 7.11 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.105 1.362 . . . . 0.0 109.982 -173.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -130.6 150.35 76.09 Favored Pre-proline 0 C--N 1.347 0.499 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 164.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.45 74.81 0.55 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.698 3.599 . . . . 0.0 109.506 169.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -147.62 -61.86 0.27 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.859 1.264 . . . . 0.0 107.617 -177.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.5 mt -91.98 -21.63 20.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.126 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 52' ' ' ILE . 11.3 tp -121.52 146.86 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.095 0.958 . . . . 0.0 108.637 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.4 m -82.39 31.93 0.4 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 119.378 0.99 . . . . 0.0 113.03 -174.032 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.252 0.5 OUTLIER 72.64 -62.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 127.876 2.47 . . . . 0.0 108.01 -177.082 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -86.43 -28.09 23.74 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.89 -170.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -46.54 -44.89 18.23 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.36 0.527 . . . . 0.0 110.779 177.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.9 -69.22 0.14 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.22 1.408 . . . . 0.0 109.954 173.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -41.97 97.58 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.64 -0.663 . . . . 0.0 110.756 -177.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -59.61 -24.79 64.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.959 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.91 -39.92 96.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.646 1.112 . . . . 0.0 109.074 173.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.88 -49.42 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -54.18 -46.12 72.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.04 -19.44 64.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.813 1.645 . . . . 0.0 114.371 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.2 mmm -59.82 -28.69 67.68 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 120.243 1.383 . . . . 0.0 109.602 168.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.08 -25.89 4.83 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.445 1.021 . . . . 0.0 110.791 175.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -75.38 123.65 88.73 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.73 111.37 1.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.064 1.843 . . . . 0.0 109.273 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.9 -174.46 2.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.435 1.094 . . . . 0.0 108.27 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -169.65 146.21 3.25 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.722 0.692 . . . . 0.0 112.383 -167.073 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.453 -0.28 0 C-N-CA 125.15 1.38 . . . . 0.0 109.352 178.147 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.7 t -77.05 153.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.045 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.55 HD11 ' CG2' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -138.47 135.83 35.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.374 -1.714 . . . . 0.0 106.374 173.271 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -111.7 135.13 52.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.131 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -143.14 143.14 31.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.599 0.76 . . . . 0.0 110.883 -176.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -75.75 147.42 39.31 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 166.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.28 48.6 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 126.014 1.726 . . . . 0.0 108.725 178.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -58.4 142.96 46.86 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.802 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.0 171.89 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.3 t -55.07 -41.62 71.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 119.084 0.856 . . . . 0.0 112.361 -166.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.1 m -45.13 -60.1 2.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.431 0.693 . . . . 0.0 112.245 165.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mp -57.72 -48.56 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 124.028 0.931 . . . . 0.0 109.152 178.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -56.97 -62.5 1.7 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.492 1.139 . . . . 0.0 109.445 -174.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.12 -56.02 8.18 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.302 1.429 . . . . 0.0 112.304 173.716 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -61.56 -50.36 72.94 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.871 0.836 . . . . 0.0 110.911 -176.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.41 -34.0 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 124.079 0.952 . . . . 0.0 110.539 177.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.67 -17.56 6.77 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.926 -0.93 . . . . 0.0 114.812 170.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -86.89 -18.08 31.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.793 1.797 . . . . 0.0 110.816 176.147 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.7 141.78 48.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.949 0.881 . . . . 0.0 112.243 -168.657 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -59.13 117.55 4.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.929 0.892 . . . . 0.0 111.04 175.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.79 -24.99 12.27 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.269 173.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.96 142.5 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -108.84 -45.85 3.73 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.134 1.374 . . . . 0.0 109.455 172.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -154.01 162.83 40.91 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.466 -0.771 . . . . 0.0 110.305 177.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.7 tt -145.99 138.03 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 124.505 1.122 . . . . 0.0 109.137 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -130.53 117.88 20.26 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.628 1.971 . . . . 0.0 106.781 172.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.415 HG22 ' CB ' ' A' ' 43' ' ' ALA . 75.1 t -117.24 114.93 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.067 1.303 . . . . 0.0 109.474 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.1 t -90.22 106.54 18.55 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.921 -0.487 . . . . 0.0 109.829 -179.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.544 HD13 ' N ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -48.76 -48.52 40.84 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 164.686 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.544 ' N ' HD13 ' A' ' 38' ' ' LEU . 3.4 m-20 -56.3 -59.55 4.78 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.035 0.534 . . . . 0.0 111.029 -178.316 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -74.6 -21.4 59.49 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.231 1.015 . . . . 0.0 110.723 -170.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 62.63 19.73 11.53 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.181 1.792 . . . . 0.0 110.36 -172.326 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -120.54 156.04 32.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.303 1.841 . . . . 0.0 108.286 175.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -140.47 154.38 46.6 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.463 1.105 . . . . 0.0 109.011 -178.153 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.8 m -125.64 111.55 15.1 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -177.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 78.5 mt -98.99 161.0 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 171.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 p -124.42 121.17 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 162.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.457 ' CE2' HD13 ' A' ' 5' ' ' LEU . 14.1 p90 -157.06 176.41 12.79 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.84 1.656 . . . . 0.0 108.72 -178.017 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.08 150.5 74.44 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 120.735 1.607 . . . . 0.0 113.734 169.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.67 72.3 1.41 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 124.745 3.63 . . . . 0.0 110.145 176.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -143.59 -60.12 0.41 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.302 1.041 . . . . 0.0 108.579 177.097 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.6 mt -88.18 -21.32 24.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.656 179.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.59 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.6 tp -120.86 148.67 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.124 0.57 . . . . 0.0 110.053 178.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.1 m -83.33 26.57 0.64 Allowed 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.272 0.5 OUTLIER 71.38 -61.14 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 128.913 2.885 . . . . 0.0 110.063 177.514 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -43.16 71.56 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.492 1.117 . . . . 0.0 108.863 179.374 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.6 mt-10 -44.67 -51.61 9.01 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 123.542 0.526 . . . . 0.0 111.28 -173.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.06 -52.64 5.25 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.225 0.61 . . . . 0.0 111.986 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -46.37 73.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 122.095 -0.378 . . . . 0.0 110.452 178.356 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -59.6 -28.82 67.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.136 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -61.31 -46.1 91.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 173.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.9 -48.42 88.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.32 173.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -51.32 -50.89 58.52 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.65 -19.43 49.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.5 1.92 . . . . 0.0 114.678 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.9 mmt -57.7 -32.15 67.09 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 120.106 1.321 . . . . 0.0 109.595 170.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.18 43.27 0.33 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.448 1.023 . . . . 0.0 110.844 173.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -145.11 121.53 6.07 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.78 94.37 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.605 2.203 . . . . 0.0 109.738 -175.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.97 -172.46 2.08 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.362 1.065 . . . . 0.0 108.637 -172.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.24 132.35 2.47 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 118.503 0.592 . . . . 0.0 112.381 -175.356 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.55 ' CG2' HD11 ' A' ' 5' ' ' LEU . 9.7 p . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 123.172 0.589 . . . . 0.0 110.168 174.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.31 138.95 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 124.442 1.097 . . . . 0.0 108.775 173.306 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.411 HD13 ' C ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -124.34 130.66 52.89 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.465 1.506 . . . . 0.0 107.074 175.002 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -101.21 116.78 33.61 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.615 1.566 . . . . 0.0 108.196 170.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.8 ptp -119.54 135.96 54.55 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.842 0.857 . . . . 0.0 110.339 178.459 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -74.95 153.93 38.35 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 167.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.25 72.85 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 176.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -62.55 166.89 4.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.717 0.77 . . . . 0.0 111.386 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 174.59 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.409 HG22 HD23 ' A' ' 38' ' ' LEU . 19.1 p . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.7 t -53.58 -41.64 66.78 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -175.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.6 m -49.36 -57.6 6.61 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.608 170.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.26 -49.48 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.84 -64.22 0.98 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.088 0.947 . . . . 0.0 110.02 -175.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.34 -53.69 9.29 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.931 1.729 . . . . 0.0 112.584 174.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -58.3 8.38 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.874 0.837 . . . . 0.0 109.658 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.3 -33.23 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.779 1.231 . . . . 0.0 111.044 -176.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.49 -21.43 13.67 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.329 0.966 . . . . 0.0 114.013 173.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -85.1 -19.71 31.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.747 1.773 . . . . 0.0 111.372 176.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.65 137.17 49.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 122.231 1.015 . . . . 0.0 111.932 -166.635 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -52.91 113.4 1.08 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.86 177.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.34 -26.52 8.59 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-O 119.072 -0.849 . . . . 0.0 112.323 175.173 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.2 t -79.57 131.17 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 118.214 1.007 . . . . 0.0 109.18 -176.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -91.54 -55.7 3.4 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.896 0.879 . . . . 0.0 109.185 168.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.35 159.09 43.58 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.535 1.061 . . . . 0.0 109.788 -175.588 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -140.1 140.78 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.403 1.481 . . . . 0.0 110.107 176.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.05 124.51 31.02 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.576 1.55 . . . . 0.0 107.931 168.136 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.9 t -110.13 89.46 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.846 1.203 . . . . 0.0 110.89 177.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -76.88 78.08 3.46 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.686 1.194 . . . . 0.0 110.427 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -45.78 -41.6 11.05 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.483 0.713 . . . . 0.0 111.962 178.744 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.57 -54.38 1.16 Allowed 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 126.453 1.901 . . . . 0.0 111.379 170.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -84.95 -10.54 56.95 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.466 -171.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 61.92 21.0 11.96 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.325 1.45 . . . . 0.0 110.326 -174.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -136.86 144.21 43.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.624 1.57 . . . . 0.0 108.885 -172.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.49 149.56 48.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.932 1.293 . . . . 0.0 108.727 179.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.5 m -120.69 115.28 23.04 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -176.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 86.8 mt -107.32 159.97 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 171.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.72 125.79 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 167.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -155.42 -177.24 6.41 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 126.447 1.899 . . . . 0.0 107.749 -175.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -138.02 144.5 43.99 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 120.112 1.324 . . . . 0.0 110.559 167.271 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.48 77.28 0.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.071 3.18 . . . . 0.0 110.025 176.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -149.17 -53.44 0.17 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.884 0.873 . . . . 0.0 109.13 174.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -88.19 -25.14 23.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.12 0.568 . . . . 0.0 110.843 176.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.406 HD11 ' HB3' ' A' ' 56' ' ' GLU . 9.8 tp -118.95 147.43 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.012 0.925 . . . . 0.0 109.648 178.76 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.4 m -83.47 24.27 0.85 Allowed 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.256 0.5 OUTLIER 72.61 -59.85 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 127.871 2.468 . . . . 0.0 109.86 179.884 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.31 -35.85 40.5 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.211 1.804 . . . . 0.0 109.78 -175.353 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.406 ' HB3' HD11 ' A' ' 52' ' ' ILE . 5.5 mt-10 -42.22 -53.76 3.95 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 123.538 0.735 . . . . 0.0 111.458 177.447 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.89 -49.04 5.91 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.388 1.075 . . . . 0.0 112.087 -176.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -49.33 38.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.1 -0.375 . . . . 0.0 110.999 174.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -53.98 -30.04 45.44 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -57.29 -52.03 67.0 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.388 0.613 . . . . 0.0 109.525 172.069 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -58.19 -49.91 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.453 173.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -52.98 -48.35 67.52 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.452 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.56 -21.62 60.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.379 1.472 . . . . 0.0 114.036 179.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 29.4 mmt -64.17 -30.02 71.1 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.869 1.213 . . . . 0.0 110.526 172.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.37 -33.11 2.19 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 176.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -73.51 107.51 3.49 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-O 117.776 -1.107 . . . . 0.0 108.732 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.75 118.91 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 108.071 -1.55 . . . . 0.0 108.071 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.08 -167.39 1.54 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.254 0.479 . . . . 0.0 110.404 -174.349 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -160.1 151.09 19.12 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -175.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.5 t . . . . . 0 C--N 1.339 0.135 0 C-N-CA 126.65 1.98 . . . . 0.0 108.834 179.035 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.85 145.92 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 123.163 0.585 . . . . 0.0 109.984 177.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.66 HD21 HG22 ' A' ' 70' ' ' VAL . 1.4 tm? -141.94 138.38 31.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.548 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -122.1 116.39 24.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.309 1.444 . . . . 0.0 107.684 -173.769 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -121.79 149.9 42.64 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.841 1.256 . . . . 0.0 110.893 -172.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -98.95 132.62 44.13 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.835 1.654 . . . . 0.0 108.129 177.139 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.14 64.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.372 1.069 . . . . 0.0 110.218 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.93 153.18 41.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.823 179.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.037 174.895 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.4 p . . . . . 0 C--O 1.222 -0.343 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.6 m -54.12 -36.73 63.58 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -170.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -52.18 -57.86 8.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.103 0.252 . . . . 0.0 111.125 169.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.1 -54.28 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.203 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -57.65 -65.02 0.7 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.631 0.729 . . . . 0.0 110.746 -172.314 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.48 -53.55 12.25 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.726 1.631 . . . . 0.0 111.98 176.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -64.21 -50.62 67.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.112 0.956 . . . . 0.0 110.563 -176.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.6 mm -54.99 -39.2 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 123.406 0.682 . . . . 0.0 110.629 175.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.11 -20.18 13.97 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.016 1.293 . . . . 0.0 113.978 173.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -92.38 -19.42 22.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 118.987 1.393 . . . . 0.0 109.593 178.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.34 134.3 50.07 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.815 1.293 . . . . 0.0 111.816 -176.101 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.57 110.84 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.522 176.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.3 -25.83 7.25 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 119.085 -0.842 . . . . 0.0 112.219 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.24 136.02 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 118.382 1.091 . . . . 0.0 109.002 -178.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -107.89 -43.75 4.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.244 1.018 . . . . 0.0 110.736 175.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -155.79 161.14 40.71 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.772 0.715 . . . . 0.0 110.324 177.489 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 tt -141.01 144.68 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.896 1.278 . . . . 0.0 110.421 -176.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.02 98.82 3.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.329 1.852 . . . . 0.0 108.727 172.26 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -92.19 112.24 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.381 1.072 . . . . 0.0 110.042 176.382 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 m -94.98 90.96 6.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.705 1.202 . . . . 0.0 108.877 173.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 38' ' ' LEU . 5.7 mt -57.91 177.44 0.11 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.223 162.654 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.23 -61.3 0.39 Allowed 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 127.88 2.472 . . . . 0.0 109.45 -167.352 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -68.23 -17.75 64.39 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.989 0.423 . . . . 0.0 111.22 -177.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 67.21 41.83 2.45 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 127.332 2.253 . . . . 0.0 110.613 -178.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -144.27 141.93 30.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.827 -166.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.18 150.8 44.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.466 -0.771 . . . . 0.0 109.843 -177.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -130.51 121.52 25.93 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -176.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 mp -126.44 159.87 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 124.744 1.218 . . . . 0.0 108.271 -175.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.3 p -129.39 118.57 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.512 0.725 . . . . 0.0 109.597 178.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -159.19 -178.98 7.59 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.677 1.591 . . . . 0.0 109.864 -172.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -148.06 144.56 19.07 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HB3' HG23 ' A' ' 54' ' ' VAL . 49.7 Cg_endo -67.94 77.85 0.58 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.295 3.33 . . . . 0.0 110.684 175.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.57 -54.45 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.941 1.296 . . . . 0.0 107.586 168.218 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.7 mt -94.78 -21.37 18.76 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.843 -0.599 . . . . 0.0 111.91 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.2 tp -120.87 145.97 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.047 0.939 . . . . 0.0 109.554 -177.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 m -74.0 24.56 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.125 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 49' ' ' PRO . 0.8 OUTLIER 73.28 -58.07 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 127.249 2.22 . . . . 0.0 109.626 -177.885 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -80.93 -42.35 21.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.445 1.498 . . . . 0.0 109.647 -174.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.445 ' HB3' HD11 ' A' ' 52' ' ' ILE . 7.3 mt-10 -41.16 -51.04 3.51 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.882 0.873 . . . . 0.0 111.87 -174.516 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -40.31 -59.91 1.19 Allowed 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.217 1.407 . . . . 0.0 111.464 -178.303 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 tptp -73.93 -43.61 57.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -57.49 -26.91 62.0 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.149 -0.969 . . . . 0.0 112.313 -174.151 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.96 -41.81 88.36 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.031 0.832 . . . . 0.0 109.128 174.102 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -62.83 -33.97 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.179 176.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -61.39 -52.66 63.67 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.48 -31.84 64.43 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.206 1.002 . . . . 0.0 112.716 -174.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.9 mmm -51.27 -36.34 41.69 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.479 0.582 . . . . 0.0 111.43 171.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.29 -36.79 1.45 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.285 0.945 . . . . 0.0 111.281 176.666 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -68.01 115.29 26.93 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.263 -173.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.76 101.49 0.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.428 2.085 . . . . 0.0 108.815 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.09 168.42 19.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -168.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.68 148.5 39.2 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.324 -0.86 . . . . 0.0 112.549 -166.077 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.66 HG22 HD21 ' A' ' 5' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.437 -1.12 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.5 t -79.6 145.67 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 124.83 1.252 . . . . 0.0 109.801 -178.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.53 HD11 HG22 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -137.54 149.42 46.72 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 126.138 1.775 . . . . 0.0 107.845 176.778 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.76 144.85 31.18 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.276 0.943 . . . . 0.0 111.71 155.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -126.89 153.72 45.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.116 1.766 . . . . 0.0 108.94 175.979 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -114.81 138.94 50.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.325 1.05 . . . . 0.0 108.529 177.224 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.04 68.86 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.857 0.863 . . . . 0.0 110.988 -172.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -68.29 165.96 17.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.103 0.478 . . . . 0.0 110.261 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 O-C-N 121.604 -0.685 . . . . 0.0 114.063 168.958 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 m -54.02 -37.13 63.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -168.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.8 m -50.06 -61.31 2.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.568 0.542 . . . . 0.0 111.246 168.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.6 -50.81 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.437 ' HA ' HG21 ' A' ' 34' ' ' ILE . 47.7 mt-10 -56.45 -67.59 0.29 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.129 0.966 . . . . 0.0 110.891 -174.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.68 -49.87 26.76 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.097 1.808 . . . . 0.0 112.124 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -62.62 -52.17 64.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.872 0.836 . . . . 0.0 109.62 -178.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.417 HD12 ' CE ' ' A' ' 57' ' ' MET . 18.0 mm -55.57 -36.28 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.183 0.593 . . . . 0.0 111.202 175.362 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.51 -19.13 11.96 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.738 -1.034 . . . . 0.0 113.807 175.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -90.25 -18.98 24.69 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 119.653 1.726 . . . . 0.0 111.16 176.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.12 133.85 47.56 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.659 1.219 . . . . 0.0 112.39 -170.267 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -52.62 106.34 0.15 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.449 176.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.69 -30.74 4.57 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-O 119.475 -0.625 . . . . 0.0 111.917 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 t -82.8 140.61 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 117.691 0.745 . . . . 0.0 109.552 -173.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -111.25 -41.87 4.06 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.947 0.899 . . . . 0.0 111.689 174.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.45 159.23 43.4 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.822 -0.549 . . . . 0.0 109.704 -179.433 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 22' ' ' GLU . 9.2 tt -146.59 145.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.59 1.556 . . . . 0.0 107.704 173.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -136.56 109.17 7.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.104 2.161 . . . . 0.0 106.465 173.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -102.44 120.28 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.916 1.235 . . . . 0.0 109.191 175.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 t -105.91 90.48 3.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.169 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -46.13 67.02 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.356 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -56.95 2.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.968 1.707 . . . . 0.0 110.755 170.192 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -17.75 60.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.032 -175.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 73.12 2.53 4.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.837 2.455 . . . . 0.0 112.052 -175.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -111.24 151.57 28.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.406 1.882 . . . . 0.0 109.699 -179.274 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.485 ' HB3' ' SD ' ' A' ' 7' ' ' MET . . . -127.04 160.2 31.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 163.268 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.8 m -119.96 128.03 53.2 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 175.74 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.401 HG21 ' SD ' ' A' ' 57' ' ' MET . 16.0 mt -122.74 162.84 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -135.77 117.88 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.27 0.628 . . . . 0.0 110.277 177.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.28 -179.32 8.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.141 1.376 . . . . 0.0 110.043 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -135.71 149.77 69.97 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.209 1.004 . . . . 0.0 113.05 177.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.09 67.88 7.99 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.374 3.382 . . . . 0.0 109.928 -176.026 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 -55.99 0.26 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.865 0.866 . . . . 0.0 109.223 177.071 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.92 -29.03 35.62 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.048 -0.501 . . . . 0.0 109.811 -177.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.7 tp -118.93 145.4 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 123.433 0.693 . . . . 0.0 109.403 -178.16 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.9 m -81.67 33.83 0.38 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -174.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 74.36 -61.68 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 128.065 2.546 . . . . 0.0 108.262 175.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.43 -40.17 23.79 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 124.483 1.113 . . . . 0.0 109.758 -174.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.417 ' HB3' HD11 ' A' ' 52' ' ' ILE . 14.9 mt-10 -40.48 -48.54 2.8 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 123.888 0.743 . . . . 0.0 111.413 -174.465 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.417 ' CE ' HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -34.78 -65.5 0.21 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.862 1.665 . . . . 0.0 110.872 174.385 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -75.98 -41.88 50.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.671 -0.643 . . . . 0.0 112.185 178.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -58.31 -22.29 52.43 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.845 -174.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -62.65 -42.08 99.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.766 0.712 . . . . 0.0 109.351 173.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.75 -49.68 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.102 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -54.45 -44.72 72.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.78 -22.66 62.46 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.82 1.248 . . . . 0.0 114.144 176.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.0 mmt -66.34 -28.62 68.8 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.145 1.338 . . . . 0.0 110.586 170.532 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.21 -42.71 1.28 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -62.31 110.95 3.82 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.901 0.88 . . . . 0.0 110.824 -173.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.99 96.69 0.7 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.54 2.16 . . . . 0.0 109.575 -175.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.74 -161.17 0.75 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.948 0.899 . . . . 0.0 109.51 -174.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -162.56 146.51 11.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.367 0.531 . . . . 0.0 112.179 -177.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.53 HG22 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 C-N-CA 125.57 1.548 . . . . 0.0 108.531 174.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.44 175.77 10.26 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 124.874 0.985 . . . . 0.0 111.097 -171.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.54 136.9 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.624 1.169 . . . . 0.0 108.373 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.08 148.11 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.24 0.616 . . . . 0.0 110.113 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.627 HD13 ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -139.48 141.8 37.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 171.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 130.65 56.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -121.53 151.74 39.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.244 1.818 . . . . 0.0 108.842 -176.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -95.37 136.92 35.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.41 67.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -70.26 170.15 12.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.811 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.7 -42.94 2.76 Favored Glycine 0 CA--C 1.529 0.926 0 O-C-N 121.248 -0.908 . . . . 0.0 113.504 170.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.1 mtt -58.46 -52.52 65.3 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.574 1.187 . . . . 0.0 111.306 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.5 t 46.92 24.13 0.33 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.475 1.91 . . . . 0.0 115.246 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -149.87 132.95 16.26 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -74.91 56.83 0.76 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.037 1.335 . . . . 0.0 111.018 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -149.67 21.2 0.91 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.101 0.96 . . . . 0.0 110.211 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.15 63.36 1.1 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p -121.3 -78.01 0.59 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.3 t -52.21 -43.59 64.33 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.9 m -46.43 -60.24 2.47 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.655 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -48.79 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -57.24 -63.87 1.08 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.975 0.893 . . . . 0.0 110.085 -174.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.56 -54.96 8.39 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.826 1.679 . . . . 0.0 112.778 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -56.83 -56.61 19.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.179 0.989 . . . . 0.0 109.7 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.86 -28.29 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 110.51 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.51 -24.41 7.46 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.757 1.17 . . . . 0.0 114.306 170.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -87.55 -11.16 49.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 119.826 1.813 . . . . 0.0 111.381 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 139.09 55.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.796 0.808 . . . . 0.0 110.77 -171.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 115.73 4.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.386 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.54 -19.75 23.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.576 -1.124 . . . . 0.0 112.445 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.84 139.19 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 118.853 1.326 . . . . 0.0 109.79 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.8 -39.05 3.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.659 1.184 . . . . 0.0 110.74 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -149.73 156.78 42.44 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.795 -0.566 . . . . 0.0 109.852 172.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -137.2 145.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.565 1.546 . . . . 0.0 108.204 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -138.44 114.85 10.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.719 1.607 . . . . 0.0 107.008 166.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -102.61 129.9 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.129 0.877 . . . . 0.0 109.995 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.1 t -115.89 86.65 2.52 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.505 1.122 . . . . 0.0 108.119 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -39.07 69.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.386 -0.34 . . . . 0.0 110.374 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.93 -58.51 2.74 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.01 1.324 . . . . 0.0 110.694 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -79.09 -10.2 59.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.789 0.804 . . . . 0.0 110.456 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.83 24.41 13.74 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.101 1.761 . . . . 0.0 109.552 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -142.83 157.94 44.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.681 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HB3' ' SD ' ' A' ' 7' ' ' MET . . . -150.13 155.99 40.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -171.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.7 m -128.82 121.87 29.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.459 ' HB ' HD12 ' A' ' 5' ' ' LEU . 49.0 mt -118.73 155.17 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.38 126.48 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -156.77 179.86 8.88 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.673 1.589 . . . . 0.0 109.536 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.86 142.43 45.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 172.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.11 74.71 2.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.16 3.24 . . . . 0.0 110.125 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.36 -57.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.137 1.375 . . . . 0.0 107.452 176.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.54 -19.85 30.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.144 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.8 tp -128.32 152.3 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 111.074 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -89.62 27.56 1.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.917 0.887 . . . . 0.0 112.783 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 t 72.28 -60.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 128.147 2.579 . . . . 0.0 109.501 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.4 -35.98 30.07 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.797 1.239 . . . . 0.0 109.873 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -46.55 -46.62 19.49 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.659 0.599 . . . . 0.0 110.89 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.25 -52.57 1.48 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.583 1.153 . . . . 0.0 113.159 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -46.13 63.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 109.801 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -57.71 -29.09 64.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.452 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -63.53 -41.95 98.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.625 -0.672 . . . . 0.0 109.29 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.83 -44.99 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.389 174.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -53.28 -46.4 69.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.57 43.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.064 1.346 . . . . 0.0 113.495 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -64.04 -28.05 69.53 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.238 0.926 . . . . 0.0 110.459 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.39 -34.88 2.36 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.73 118.82 74.12 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.311 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.13 107.92 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.192 1.928 . . . . 0.0 109.089 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.95 -168.15 1.62 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.881 1.273 . . . . 0.0 108.394 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -164.15 161.05 22.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.908 -0.495 . . . . 0.0 111.755 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -98.62 119.43 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 110.378 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -98.57 -61.01 1.43 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.989 -0.444 . . . . 0.0 111.077 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -101.93 179.31 4.37 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.639 0.775 . . . . 0.0 109.4 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.52 177.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 124.807 1.243 . . . . 0.0 107.796 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.4 151.09 41.3 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.22 172.79 39.06 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 172.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 . . . . . 0 C--O 1.254 1.319 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 171.746 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.44 175.77 10.26 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 124.874 0.985 . . . . 0.0 111.097 -171.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.54 136.9 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 124.624 1.169 . . . . 0.0 108.373 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.08 148.11 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.24 0.616 . . . . 0.0 110.113 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.627 HD13 ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -139.48 141.8 37.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 171.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 130.65 56.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 169.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -121.53 151.74 39.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.244 1.818 . . . . 0.0 108.842 -176.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -95.37 136.92 35.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.41 67.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -70.26 170.15 12.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.811 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.7 -42.94 2.76 Favored Glycine 0 CA--C 1.529 0.926 0 O-C-N 121.248 -0.908 . . . . 0.0 113.504 170.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.1 mtt -58.46 -52.52 65.3 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.574 1.187 . . . . 0.0 111.306 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.5 t 46.92 24.13 0.33 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.475 1.91 . . . . 0.0 115.246 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -149.87 132.95 16.26 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -74.91 56.83 0.76 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.037 1.335 . . . . 0.0 111.018 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -149.67 21.2 0.91 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.101 0.96 . . . . 0.0 110.211 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.15 63.36 1.1 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p -121.3 -78.01 0.59 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.3 t -52.21 -43.59 64.33 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.9 m -46.43 -60.24 2.47 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.655 169.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -48.79 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -57.24 -63.87 1.08 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.975 0.893 . . . . 0.0 110.085 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.56 -54.96 8.39 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.826 1.679 . . . . 0.0 112.778 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -56.83 -56.61 19.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.179 0.989 . . . . 0.0 109.7 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.86 -28.29 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 110.51 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.51 -24.41 7.46 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.757 1.17 . . . . 0.0 114.306 170.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -87.55 -11.16 49.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 119.826 1.813 . . . . 0.0 111.381 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.92 139.09 55.09 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 121.796 0.808 . . . . 0.0 110.77 -171.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.53 115.73 4.14 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.386 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.54 -19.75 23.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.576 -1.124 . . . . 0.0 112.445 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.84 139.19 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 118.853 1.326 . . . . 0.0 109.79 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.8 -39.05 3.33 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.659 1.184 . . . . 0.0 110.74 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -149.73 156.78 42.44 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 121.795 -0.566 . . . . 0.0 109.852 172.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -137.2 145.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.565 1.546 . . . . 0.0 108.204 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -138.44 114.85 10.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.719 1.607 . . . . 0.0 107.008 166.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -102.61 129.9 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 119.129 0.877 . . . . 0.0 109.995 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.1 t -115.89 86.65 2.52 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.505 1.122 . . . . 0.0 108.119 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -39.07 69.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.386 -0.34 . . . . 0.0 110.374 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.93 -58.51 2.74 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 125.01 1.324 . . . . 0.0 110.694 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -79.09 -10.2 59.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.789 0.804 . . . . 0.0 110.456 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.83 24.41 13.74 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.101 1.761 . . . . 0.0 109.552 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -142.83 157.94 44.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.681 -166.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HB3' ' SD ' ' A' ' 7' ' ' MET . . . -150.13 155.99 40.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -171.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.7 m -128.82 121.87 29.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.459 ' HB ' HD12 ' A' ' 5' ' ' LEU . 49.0 mt -118.73 155.17 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 p -125.38 126.48 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -156.77 179.86 8.88 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.673 1.589 . . . . 0.0 109.536 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.86 142.43 45.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.11 74.71 2.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.16 3.24 . . . . 0.0 110.125 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.36 -57.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.137 1.375 . . . . 0.0 107.452 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.54 -19.85 30.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.144 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.8 tp -128.32 152.3 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 111.074 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -89.62 27.56 1.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.917 0.887 . . . . 0.0 112.783 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 t 72.28 -60.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 128.147 2.579 . . . . 0.0 109.501 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.4 -35.98 30.07 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 124.797 1.239 . . . . 0.0 109.873 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -46.55 -46.62 19.49 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.659 0.599 . . . . 0.0 110.89 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.25 -52.57 1.48 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.583 1.153 . . . . 0.0 113.159 173.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.75 -46.13 63.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 109.801 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -57.71 -29.09 64.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.452 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -63.53 -41.95 98.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.625 -0.672 . . . . 0.0 109.29 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.83 -44.99 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.389 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -53.28 -46.4 69.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.57 43.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.064 1.346 . . . . 0.0 113.495 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -64.04 -28.05 69.53 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.238 0.926 . . . . 0.0 110.459 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.39 -34.88 2.36 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.73 118.82 74.12 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.311 -175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.13 107.92 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.192 1.928 . . . . 0.0 109.089 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.95 -168.15 1.62 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.881 1.273 . . . . 0.0 108.394 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -164.15 161.05 22.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.908 -0.495 . . . . 0.0 111.755 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -98.62 119.43 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.014 1.326 . . . . 0.0 110.378 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -98.57 -61.01 1.43 Allowed 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.989 -0.444 . . . . 0.0 111.077 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -101.93 179.31 4.37 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.639 0.775 . . . . 0.0 109.4 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.52 177.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 124.807 1.243 . . . . 0.0 107.796 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.4 151.09 41.3 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.22 172.79 39.06 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 . . . . . 0 C--O 1.254 1.319 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 171.746 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.092 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 32.4 mp0 -70.31 -178.36 1.68 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.797 2.039 . . . . 0.0 109.334 163.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.0 t -116.6 136.96 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 126.263 1.825 . . . . 0.0 108.381 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.64 133.83 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 123.99 0.916 . . . . 0.0 108.593 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.562 HD12 ' HB ' ' A' ' 73' ' ' ILE . 2.5 tt -113.21 148.15 36.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.366 1.466 . . . . 0.0 108.21 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.97 123.02 46.97 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 161.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.429 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 12.3 ptt? -115.44 163.05 16.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.233 1.013 . . . . 0.0 109.585 169.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -108.72 131.3 55.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.988 2.115 . . . . 0.0 106.408 170.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -115.05 60.32 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 126.523 1.929 . . . . 0.0 106.869 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -58.77 133.38 55.91 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.14 -45.36 1.33 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.107 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.5 mmt -77.48 69.1 3.69 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.026 1.413 . . . . 0.0 109.266 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 t -121.5 0.62 9.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.953 1.301 . . . . 0.0 111.802 -173.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.5 m -77.39 -81.48 0.09 Allowed 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.594 -0.691 . . . . 0.0 111.01 -173.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -170.62 130.9 0.87 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.432 ' H ' HD11 ' A' ' 38' ' ' LEU . 35.2 t 55.79 51.1 12.88 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.639 1.575 . . . . 0.0 112.949 174.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 m -125.64 53.84 1.53 Allowed 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.266 1.427 . . . . 0.0 107.924 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.7 p -135.59 -69.61 0.49 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.709 1.204 . . . . 0.0 108.253 -172.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 p -53.43 -43.42 67.99 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.7 m -42.01 -62.53 0.9 Allowed 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.921 0.888 . . . . 0.0 112.19 165.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.99 -48.93 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 123.908 0.883 . . . . 0.0 108.932 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -57.25 -61.07 2.73 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.47 1.128 . . . . 0.0 109.332 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.76 -53.95 19.61 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.754 1.645 . . . . 0.0 112.308 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.5 -52.55 65.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.017 0.909 . . . . 0.0 110.068 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 34' ' ' ILE . 23.3 mm -57.54 -31.82 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.708 1.203 . . . . 0.0 111.116 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.13 -18.87 10.0 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.753 -1.026 . . . . 0.0 114.227 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -86.81 -11.79 49.9 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.637 1.719 . . . . 0.0 111.095 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 135.82 45.85 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 122.269 1.033 . . . . 0.0 111.748 -170.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -57.74 110.37 0.88 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.85 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.13 -24.11 9.51 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 119.251 -0.749 . . . . 0.0 112.661 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 t -80.01 136.08 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 118.213 1.007 . . . . 0.0 109.245 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -107.14 -38.83 5.89 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.703 1.201 . . . . 0.0 110.442 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.59 167.34 30.42 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.218 -0.926 . . . . 0.0 110.62 172.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 25' ' ' ILE . 13.9 tt -150.91 144.43 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.276 1.03 . . . . 0.0 108.561 177.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -129.58 129.62 44.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.898 1.679 . . . . 0.0 106.518 167.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.82 123.42 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.581 1.082 . . . . 0.0 110.982 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.5 t -81.25 158.98 24.63 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.107 0.563 . . . . 0.0 110.045 174.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.432 HD11 ' H ' ' A' ' 16' ' ' SER . 1.5 mt -95.87 -67.93 0.83 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 163.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.08 -54.65 8.16 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 126.193 1.797 . . . . 0.0 110.678 -172.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -77.64 -18.74 56.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.252 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 55.06 18.82 2.47 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 127.146 2.178 . . . . 0.0 111.409 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -101.05 152.12 20.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.596 1.558 . . . . 0.0 107.933 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -148.04 152.52 37.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.846 -0.534 . . . . 0.0 109.866 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 m -130.35 115.73 17.32 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -171.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mt -104.88 157.99 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.32 116.57 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 167.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.446 ' OH ' HD13 ' A' ' 5' ' ' LEU . 40.8 p90 -159.07 178.69 9.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.425 1.49 . . . . 0.0 109.549 -173.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -138.97 149.62 62.25 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.31 75.52 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.229 3.286 . . . . 0.0 109.936 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.58 -57.0 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.259 1.423 . . . . 0.0 107.414 170.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.8 mt -90.25 -23.03 21.34 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.452 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 56' ' ' GLU . 9.6 tp -121.68 149.06 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 119.083 0.856 . . . . 0.0 110.31 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 m -82.86 24.17 0.77 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 71.13 -65.74 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 128.737 2.815 . . . . 0.0 109.055 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -68.88 -39.85 79.55 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.434 1.094 . . . . 0.0 109.215 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.45 ' HB3' HD11 ' A' ' 52' ' ' ILE . 2.7 mt-10 -42.32 -54.19 3.86 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.403 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.9 -49.86 10.75 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.583 0.753 . . . . 0.0 110.952 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -42.9 71.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.648 0.779 . . . . 0.0 111.422 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -56.23 -35.09 66.97 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.046 -1.033 . . . . 0.0 112.652 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -62.13 -42.28 99.08 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.66 -47.43 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 118.017 -0.992 . . . . 0.0 111.523 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 6.1 mt-10 -50.76 -49.27 58.49 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.149 1.341 . . . . 0.0 109.238 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.85 -19.07 48.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.28 1.832 . . . . 0.0 114.051 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mmm -61.33 -28.72 69.42 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.656 1.116 . . . . 0.0 110.15 169.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.02 38.86 0.55 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.051 1.31 . . . . 0.0 111.554 169.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -148.88 122.18 4.58 Favored Pre-proline 0 C--O 1.224 -0.28 0 CA-C-O 117.314 -1.326 . . . . 0.0 108.055 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.81 111.26 1.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.018 1.812 . . . . 0.0 109.452 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.48 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -109.17 -176.35 3.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -160.48 149.77 17.29 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 120.399 -1.438 . . . . 0.0 111.196 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.503 ' CG2' HD11 ' A' ' 5' ' ' LEU . 8.4 p -119.07 127.74 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -175.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.8 mtpm? -78.52 -73.21 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 121.156 -0.218 . . . . 0.0 111.582 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -158.74 153.75 25.16 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.087 0.955 . . . . 0.0 108.49 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.562 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -159.2 120.48 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.741 1.216 . . . . 0.0 110.209 173.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -157.06 158.07 35.78 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.945 1.298 . . . . 0.0 107.862 167.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.43 -122.12 2.18 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.268 0.937 . . . . 0.0 111.916 -175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.042 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.468 ' N ' ' OXT' ' A' ' 76' ' ' ARG . . . . . . . . 0 N--CA 1.471 0.975 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -168.86 140.16 2.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.41 146.49 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 123.688 0.795 . . . . 0.0 109.284 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.86 119.49 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 125.931 1.692 . . . . 0.0 111.28 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.664 HD21 HG22 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -116.67 131.3 56.99 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.229 1.012 . . . . 0.0 108.881 178.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.487 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -101.4 119.17 38.35 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.896 1.279 . . . . 0.0 110.495 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.526 ' SD ' HD11 ' A' ' 45' ' ' ILE . 9.6 ptt? -113.34 153.24 28.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.766 1.226 . . . . 0.0 109.931 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.92 133.88 43.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 169.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.82 68.0 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.5 150.23 48.32 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.674 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.75 -40.99 2.24 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.666 -0.646 . . . . 0.0 113.597 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.1 mtt -62.46 117.22 5.88 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.578 1.189 . . . . 0.0 108.772 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.6 t -120.17 142.4 49.0 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.339 1.055 . . . . 0.0 110.041 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 t 68.0 122.51 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.646 1.979 . . . . 0.0 111.895 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -47.85 103.48 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.302 1.041 . . . . 0.0 111.865 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 m -170.03 -64.49 0.02 OUTLIER 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.672 1.589 . . . . 0.0 108.886 -172.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.2 m -77.79 71.7 4.28 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.9 p -136.09 -75.71 0.43 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.401 1.48 . . . . 0.0 107.116 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.8 m -55.64 -38.5 69.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.22 -52.75 60.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.589 0.233 . . . . 0.0 110.678 171.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.11 -53.48 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.45 -61.31 2.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.078 0.942 . . . . 0.0 110.195 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.52 -55.57 7.88 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.719 1.628 . . . . 0.0 112.471 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.66 -48.76 75.93 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.37 1.085 . . . . 0.0 110.322 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.426 HG21 HD12 ' A' ' 34' ' ' ILE . 26.4 mm -59.46 -33.42 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.498 0.719 . . . . 0.0 110.171 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.8 -13.62 8.51 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.489 1.042 . . . . 0.0 114.073 172.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.13 -14.27 31.47 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.388 1.594 . . . . 0.0 109.936 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.41 137.33 52.66 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 122.655 1.217 . . . . 0.0 112.886 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -54.69 108.0 0.35 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.438 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.27 -24.65 9.14 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-O 118.67 -1.072 . . . . 0.0 111.992 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.9 135.36 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 118.579 1.19 . . . . 0.0 108.873 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -108.05 -42.35 4.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.658 1.583 . . . . 0.0 109.919 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -152.1 159.73 43.59 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 25' ' ' ILE . 15.8 tt -143.25 152.48 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 108.495 172.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.49 110.99 5.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.743 2.017 . . . . 0.0 105.676 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.55 130.93 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.022 0.929 . . . . 0.0 109.376 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 t -117.23 90.37 3.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tt -52.15 -46.07 65.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -41.96 -58.83 1.93 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.626 1.17 . . . . 0.0 111.54 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -78.07 -7.41 56.91 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.836 0.827 . . . . 0.0 111.328 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 65.07 15.77 10.18 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 127.175 2.19 . . . . 0.0 110.7 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -132.53 154.55 49.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.824 1.649 . . . . 0.0 109.685 -166.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.02 165.57 30.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -134.87 126.76 29.39 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.526 HD11 ' SD ' ' A' ' 7' ' ' MET . 1.3 mp -108.94 152.95 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 167.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.74 117.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -156.73 -179.42 8.17 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.945 1.298 . . . . 0.0 109.147 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -131.4 147.89 67.93 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.373 1.069 . . . . 0.0 112.915 173.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.25 73.04 2.14 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.977 3.118 . . . . 0.0 109.662 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.84 -62.28 0.29 Allowed 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.195 0.998 . . . . 0.0 108.803 175.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.8 mt -83.65 -24.14 31.5 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.604 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.0 tp -114.11 156.84 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.109 0.963 . . . . 0.0 109.207 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.85 17.49 1.51 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.04 0.536 . . . . 0.0 112.281 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 68.64 -59.63 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.941 2.096 . . . . 0.0 109.402 -165.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -88.57 -28.36 20.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.909 -167.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' HB3' HD11 ' A' ' 52' ' ' ILE . 2.1 mt-10 -40.81 -53.12 2.92 Favored 'General case' 0 C--N 1.343 0.321 0 O-C-N 124.069 0.856 . . . . 0.0 110.543 177.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -43.18 -67.96 0.23 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.586 1.154 . . . . 0.0 110.544 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -46.65 84.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.949 -0.469 . . . . 0.0 110.756 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -51.94 -32.67 34.09 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -69.2 -43.46 74.07 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.566 1.075 . . . . 0.0 109.327 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.96 -39.78 73.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.795 -0.621 . . . . 0.0 109.671 173.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 11.5 mt-10 -57.23 -55.31 36.45 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.928 0.785 . . . . 0.0 108.945 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.31 -30.56 51.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.332 1.853 . . . . 0.0 113.425 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 26.4 mmt -50.7 -35.78 32.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.065 0.848 . . . . 0.0 111.426 172.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.96 41.63 0.44 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.378 0.99 . . . . 0.0 111.648 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -145.95 126.63 7.23 Favored Pre-proline 0 C--O 1.223 -0.323 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.54 111.06 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.483 1.456 . . . . 0.0 109.052 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.495 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -108.79 -169.24 1.46 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -164.58 149.6 9.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.621 -0.674 . . . . 0.0 110.837 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.664 HG22 HD21 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -123.39 131.1 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -73.22 -94.46 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.774 0.671 . . . . 0.0 111.135 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.92 150.27 25.73 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.607 ' HB ' HD23 ' A' ' 5' ' ' LEU . 3.9 tp -157.2 146.35 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 126.433 1.893 . . . . 0.0 106.556 -172.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -156.39 161.37 40.12 Favored 'General case' 0 N--CA 1.458 -0.035 0 C-N-CA 126.904 2.082 . . . . 0.0 105.986 166.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.91 173.85 33.89 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.468 ' OXT' ' N ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.855 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 165.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.939 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 7.23 84.1 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 129.624 3.17 . . . . 0.0 113.711 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -108.54 146.89 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 123.683 0.793 . . . . 0.0 109.794 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.403 HG13 HG23 ' A' ' 44' ' ' THR . 4.5 t -78.61 134.54 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 124.916 1.286 . . . . 0.0 108.679 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.573 HD21 HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -129.42 129.13 44.29 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.37 130.87 42.0 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.042 0.937 . . . . 0.0 110.099 170.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -131.18 146.55 52.38 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.306 1.442 . . . . 0.0 108.786 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -82.8 150.7 26.45 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 171.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.64 66.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.037 0.935 . . . . 0.0 108.707 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.53 158.75 17.24 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.763 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.12 -60.69 0.36 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.5 mmm -70.34 131.15 43.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.327 0.564 . . . . 0.0 110.198 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -132.84 -33.03 1.21 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.483 1.113 . . . . 0.0 111.763 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.8 p -91.85 141.01 29.12 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.405 0.682 . . . . 0.0 109.465 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.29 111.26 1.15 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.39 -85.29 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.962 1.305 . . . . 0.0 108.081 -178.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.29 81.67 1.02 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.87 0.843 . . . . 0.0 109.727 -170.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.6 p -132.55 -80.26 0.5 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.629 1.972 . . . . 0.0 106.518 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.6 t -55.68 -39.99 71.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -168.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -49.31 -58.47 5.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.454 0.301 . . . . 0.0 111.716 168.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.07 -52.38 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -58.79 -62.38 1.91 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.766 0.793 . . . . 0.0 110.29 -172.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.16 -55.36 6.61 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.132 1.825 . . . . 0.0 112.534 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -60.64 -54.04 50.14 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.564 1.182 . . . . 0.0 109.776 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 mm -55.24 -33.8 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.196 0.999 . . . . 0.0 110.81 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.56 -23.13 9.09 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.035 1.302 . . . . 0.0 114.184 173.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -89.75 -12.59 38.9 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.589 1.694 . . . . 0.0 111.455 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.56 135.35 51.4 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.108 0.956 . . . . 0.0 110.84 -172.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -56.54 106.06 0.26 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.489 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.42 -26.44 6.64 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-O 119.054 -0.859 . . . . 0.0 112.225 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.03 132.03 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 118.476 1.138 . . . . 0.0 108.575 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -109.11 -31.02 7.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.695 0.798 . . . . 0.0 110.884 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -159.91 170.3 21.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.255 0.934 . . . . 0.0 110.475 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.2 tt -152.6 147.16 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.703 0.801 . . . . 0.0 109.867 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -136.98 106.8 6.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.025 1.73 . . . . 0.0 107.292 168.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.8 t -93.3 113.33 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 119.43 1.014 . . . . 0.0 109.55 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.88 73.18 1.75 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 tt -46.37 -50.39 16.56 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.397 1.079 . . . . 0.0 110.424 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.83 -53.98 2.19 Favored 'General case' 0 CA--C 1.523 -0.084 0 C-N-CA 125.827 1.651 . . . . 0.0 111.628 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.1 -16.11 58.28 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.57 -173.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 70.25 8.51 6.67 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.977 2.111 . . . . 0.0 111.605 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -124.76 143.95 50.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.862 2.065 . . . . 0.0 107.889 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.71 157.2 42.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.431 1.092 . . . . 0.0 108.72 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.403 HG23 HG13 ' A' ' 4' ' ' VAL . 7.8 m -130.49 104.69 7.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.506 1.922 . . . . 0.0 107.151 -171.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.81 153.45 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.17 117.2 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.054 0.942 . . . . 0.0 109.753 168.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -158.71 178.81 9.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.654 1.182 . . . . 0.0 110.811 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.69 142.62 37.35 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 124.121 0.968 . . . . 0.0 112.208 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.425 ' HB3' HG23 ' A' ' 54' ' ' VAL . 72.8 Cg_endo -69.43 75.06 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.871 3.048 . . . . 0.0 110.314 172.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -140.52 -54.55 0.51 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.4 mt -89.63 -22.69 22.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.261 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.551 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.1 tp -119.54 150.24 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.877 0.871 . . . . 0.0 110.003 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.2 m -86.26 29.13 0.77 Allowed 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 49' ' ' PRO 0.261 0.5 OUTLIER 74.02 -56.69 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.631 2.372 . . . . 0.0 111.14 175.771 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -85.38 -36.18 20.89 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.571 1.548 . . . . 0.0 109.749 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HB3' HD11 ' A' ' 52' ' ' ILE . 5.8 mm-40 -42.89 -50.87 5.71 Favored 'General case' 0 C--N 1.344 0.355 0 O-C-N 123.842 0.714 . . . . 0.0 110.972 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.91 -53.4 3.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 123.907 0.883 . . . . 0.0 112.113 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -45.63 61.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.304 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -55.09 -29.54 57.79 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -61.72 -43.18 99.36 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.745 0.702 . . . . 0.0 109.714 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.98 -49.35 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.626 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -51.92 -48.4 64.22 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.25 -19.95 56.84 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.06 1.744 . . . . 0.0 113.973 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.0 mmm -60.91 -34.08 74.12 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.74 1.155 . . . . 0.0 109.466 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.29 -33.33 2.01 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -75.39 119.39 76.78 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.026 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -65.53 117.32 4.51 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.21 1.94 . . . . 0.0 108.596 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.3 -172.37 2.61 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.857 0.463 . . . . 0.0 109.905 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.58 137.77 9.2 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.573 HG22 HD21 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -93.11 136.62 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.348 1.459 . . . . 0.0 107.819 171.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -88.03 -77.77 0.34 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.41 ' O ' HD23 ' A' ' 5' ' ' LEU . 13.7 tttp -155.4 143.81 20.3 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 119.269 0.94 . . . . 0.0 110.283 -175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -154.92 114.17 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.831 1.253 . . . . 0.0 108.074 -164.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -160.59 140.71 11.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.7 81.02 0.06 OUTLIER Glycine 0 CA--C 1.531 1.039 0 CA-C-N 120.142 1.337 . . . . 0.0 115.436 -169.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.245 0 C-N-CA 129.019 2.928 . . . . 0.0 108.673 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.952 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -116.18 173.86 6.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.63 1.172 . . . . 0.0 109.833 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -97.23 151.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -168.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.1 t -97.16 126.62 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 125.972 1.709 . . . . 0.0 110.632 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.82 153.56 20.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.363 1.865 . . . . 0.0 108.108 170.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -125.19 126.28 44.98 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.447 1.099 . . . . 0.0 109.08 163.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.7 ptp -121.07 161.84 21.03 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.715 1.606 . . . . 0.0 110.823 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp -98.99 134.01 42.43 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.507 1.923 . . . . 0.0 108.577 165.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.4 t -116.3 71.01 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 126.369 1.867 . . . . 0.0 106.617 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -77.43 174.15 11.16 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.623 0.769 . . . . 0.0 110.745 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.56 -50.45 3.54 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.24 -0.756 . . . . 0.0 112.919 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -40.0 -55.66 2.0 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.772 1.629 . . . . 0.0 111.456 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.251 5.9 t 50.78 -170.59 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.148 1.779 . . . . 0.0 113.441 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 t 65.4 156.2 0.09 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 126.211 1.804 . . . . 0.0 112.163 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.73 39.52 0.42 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.517 -1.364 . . . . 0.0 112.226 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 t -171.0 108.14 0.29 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.121 1.368 . . . . 0.0 109.19 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.4 p 178.82 53.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.656 1.582 . . . . 0.0 108.006 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -130.54 -73.52 0.55 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.2 t -50.28 -42.32 52.15 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -46.55 -58.2 4.03 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.106 0.563 . . . . 0.0 111.626 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -58.57 -48.56 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 C-N-CA 123.644 0.777 . . . . 0.0 109.727 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.465 ' HA ' HG21 ' A' ' 34' ' ' ILE . 38.1 mt-10 -55.07 -64.67 0.76 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 122.52 1.152 . . . . 0.0 110.485 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.9 -54.13 8.3 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.531 2.015 . . . . 0.0 112.244 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -54.79 43.17 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.967 0.883 . . . . 0.0 110.103 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.4 mm -59.14 -31.45 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.074 0.95 . . . . 0.0 110.91 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.05 -15.73 22.74 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.741 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -90.84 -11.43 39.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.627 1.714 . . . . 0.0 111.172 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.32 132.6 48.73 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 122.427 1.108 . . . . 0.0 111.068 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -57.97 107.98 0.53 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.299 172.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.08 -15.94 13.29 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.823 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 t -87.97 128.69 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 119.033 1.416 . . . . 0.0 109.426 -175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -83.62 -51.34 7.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.948 0.899 . . . . 0.0 110.282 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -158.42 167.97 28.24 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.616 0.643 . . . . 0.0 110.734 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.465 HG21 ' HA ' ' A' ' 22' ' ' GLU . 5.7 tt -142.49 140.26 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 125.591 1.557 . . . . 0.0 109.073 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -129.55 112.45 13.75 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.638 1.575 . . . . 0.0 107.414 168.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.21 108.82 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 C-N-CA 124.053 0.941 . . . . 0.0 109.6 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 m -82.42 113.74 20.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 168.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.18 179.71 0.19 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 158.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 67.54 -65.05 0.25 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 127.968 2.507 . . . . 0.0 109.498 -170.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.99 -22.96 66.49 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.247 1.019 . . . . 0.0 111.176 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 64.61 15.48 9.71 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.913 2.085 . . . . 0.0 111.91 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -120.38 132.31 55.21 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.786 1.234 . . . . 0.0 109.228 -169.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.32 150.29 47.28 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.735 0.814 . . . . 0.0 108.975 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.36 130.41 52.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.7 mt -126.7 158.34 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.88 122.68 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -158.64 179.79 8.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.93 1.292 . . . . 0.0 110.888 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -136.24 154.1 77.0 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 164.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.92 74.71 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.752 3.635 . . . . 0.0 109.958 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.01 -57.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.684 1.194 . . . . 0.0 108.081 170.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 mt -87.78 -28.03 21.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.809 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.462 ' HA ' HD12 ' A' ' 52' ' ' ILE . 9.2 tp -119.64 144.38 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 118.703 0.683 . . . . 0.0 109.882 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 m -81.57 31.05 0.35 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 72.24 -61.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 129.172 2.989 . . . . 0.0 110.166 176.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -82.81 -36.52 25.48 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.41 1.884 . . . . 0.0 109.355 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' HB3' HD11 ' A' ' 52' ' ' ILE . 1.4 mt-10 -42.06 -52.71 4.17 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.455 0.702 . . . . 0.0 111.055 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -36.48 -52.86 0.86 Allowed 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.712 2.005 . . . . 0.0 111.804 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.59 -38.55 65.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.29 1.036 . . . . 0.0 112.551 175.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -57.73 -33.17 68.15 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.632 -1.292 . . . . 0.0 112.548 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -62.66 -40.33 96.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -58.78 -46.32 90.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 117.919 -1.039 . . . . 0.0 111.75 170.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.97 -49.59 59.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.873 1.215 . . . . 0.0 108.031 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.89 -18.86 61.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.303 1.841 . . . . 0.0 114.207 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.7 mmm -62.14 -21.43 65.03 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.689 1.132 . . . . 0.0 110.532 168.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.71 34.57 2.03 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 125.238 1.399 . . . . 0.0 110.859 172.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -148.34 125.63 5.63 Favored Pre-proline 0 N--CA 1.456 -0.138 0 CA-C-O 117.764 -1.112 . . . . 0.0 108.395 -173.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.69 116.57 3.62 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.119 1.879 . . . . 0.0 110.372 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.13 -179.64 3.89 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.602 0.761 . . . . 0.0 109.465 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -162.9 149.12 12.36 Favored 'General case' 0 C--O 1.224 -0.265 0 O-C-N 120.323 -1.485 . . . . 0.0 111.809 -169.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 t -98.89 129.44 49.26 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.056 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -100.73 -63.7 1.11 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.78 0.432 . . . . 0.0 110.671 170.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.59 153.33 19.84 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.8 tt -142.66 167.4 14.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 124.837 1.255 . . . . 0.0 108.904 -173.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.57 70.13 1.77 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.679 1.992 . . . . 0.0 111.174 -167.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.85 -161.51 35.29 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.92 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 154.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -154.22 159.69 41.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.073 0.949 . . . . 0.0 109.27 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.1 t -122.86 136.67 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 125.31 1.444 . . . . 0.0 108.288 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.1 t -77.4 141.26 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.637 1.575 . . . . 0.0 109.159 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -144.02 127.92 17.38 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -89.73 134.18 34.3 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.544 1.137 . . . . 0.0 109.859 171.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.87 141.64 47.46 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.08 0.952 . . . . 0.0 110.824 176.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.26 136.13 35.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.25 84.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 171.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -76.63 173.71 11.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 122.088 0.947 . . . . 0.0 110.982 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.5 -58.01 4.13 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.8 mmt -68.21 73.9 0.22 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.638 1.209 . . . . 0.0 109.746 173.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 p -85.59 -44.66 12.44 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 128.552 2.741 . . . . 0.0 108.843 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.18 151.87 39.92 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.044 0.538 . . . . 0.0 110.386 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -69.38 177.72 2.73 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.522 0.677 . . . . 0.0 111.974 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 t 72.97 47.82 0.19 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.397 1.079 . . . . 0.0 111.577 168.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.01 66.48 0.47 Allowed 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 171.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -133.83 -70.57 0.52 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.585 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t -54.69 -39.87 68.57 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -170.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 m -49.34 -55.67 12.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.576 0.35 . . . . 0.0 111.783 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.79 -50.69 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 123.614 0.766 . . . . 0.0 109.179 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -52.16 -66.11 0.44 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.942 0.877 . . . . 0.0 110.124 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.82 -54.92 8.72 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 126.529 2.014 . . . . 0.0 112.23 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.63 -55.26 37.36 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.12 0.96 . . . . 0.0 109.802 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 mm -59.58 -31.08 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 123.598 0.759 . . . . 0.0 110.445 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.84 -16.81 19.11 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.921 1.248 . . . . 0.0 113.921 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -89.1 -13.76 37.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.605 1.703 . . . . 0.0 110.632 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.32 133.08 43.76 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.468 1.128 . . . . 0.0 112.284 -172.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -55.58 108.72 0.46 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.58 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.62 -25.76 7.53 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 119.186 -0.785 . . . . 0.0 111.976 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.53 131.5 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -97.75 -47.19 5.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.181 0.992 . . . . 0.0 109.374 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -154.94 166.89 32.14 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.805 -0.559 . . . . 0.0 110.316 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 tt -153.38 142.92 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.187 0.995 . . . . 0.0 109.922 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -139.55 117.3 11.58 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.179 1.792 . . . . 0.0 106.937 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -112.84 105.69 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 119.875 1.216 . . . . 0.0 109.242 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -97.24 88.15 4.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.58 -43.92 62.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.291 0.636 . . . . 0.0 110.882 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -38.33 -54.21 1.45 Allowed 'General case' 0 N--CA 1.458 -0.066 0 C-N-CA 125.946 1.698 . . . . 0.0 110.924 169.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.03 -13.41 57.39 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.681 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 66.12 9.32 6.17 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.106 2.163 . . . . 0.0 111.506 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -129.67 155.86 45.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.581 1.952 . . . . 0.0 108.599 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.26 155.94 49.37 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.146 0.978 . . . . 0.0 108.854 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.1 m -122.64 112.27 17.76 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.92 2.088 . . . . 0.0 105.557 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 mt -102.56 168.52 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.51 120.31 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -160.14 179.61 8.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.612 1.165 . . . . 0.0 110.917 -171.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.51 146.94 59.7 Favored Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -69.66 74.28 1.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.605 2.87 . . . . 0.0 109.507 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.94 -62.75 0.48 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.731 1.212 . . . . 0.0 108.249 172.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.1 mt -85.54 -21.25 28.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.992 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.0 tp -125.02 144.79 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 118.616 0.644 . . . . 0.0 110.069 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 m -76.13 28.9 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.272 0.5 OUTLIER 70.74 -53.1 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 128.979 2.912 . . . . 0.0 111.801 178.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -44.83 15.22 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 127.313 2.245 . . . . 0.0 109.705 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HB3' HD11 ' A' ' 52' ' ' ILE . 8.3 mt-10 -43.51 -51.94 6.44 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.171 0.588 . . . . 0.0 110.742 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -29.39 -63.16 0.12 Allowed 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 126.86 2.064 . . . . 0.0 110.716 172.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -45.76 36.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -59.4 -19.68 49.05 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.401 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -43.82 97.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.861 0.755 . . . . 0.0 110.022 170.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.94 -48.83 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -54.37 -47.56 72.49 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.14 -22.12 64.39 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.229 1.412 . . . . 0.0 113.953 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.5 mmt -63.41 -28.49 70.02 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.208 1.367 . . . . 0.0 110.071 170.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.99 -32.93 2.91 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.683 1.135 . . . . 0.0 110.743 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -73.69 126.03 90.0 Favored Pre-proline 0 N--CA 1.455 -0.191 0 CA-C-O 118.602 -0.714 . . . . 0.0 109.311 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.45 113.72 2.59 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.912 1.741 . . . . 0.0 109.687 -178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.25 174.61 6.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.972 0.909 . . . . 0.0 108.614 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.9 127.56 6.64 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -174.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.77 137.39 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.997 1.319 . . . . 0.0 109.574 172.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -84.1 -101.26 0.05 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.264 0.626 . . . . 0.0 111.253 171.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -151.85 140.27 20.54 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.312 1.045 . . . . 0.0 108.615 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.66 131.17 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 127.534 2.334 . . . . 0.0 106.443 -174.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -158.24 158.48 34.56 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.339 0.972 . . . . 0.0 110.642 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.63 -174.18 39.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.4 ' H ' ' CD ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 116.887 -1.53 . . . . 0.0 109.747 167.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -44.59 133.96 5.59 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.823 1.249 . . . . 0.0 111.564 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.73 146.62 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.275 0.63 . . . . 0.0 110.042 -176.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.9 t -78.61 140.54 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.953 1.301 . . . . 0.0 108.68 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.497 HD23 ' HB ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -133.19 142.02 48.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.774 2.029 . . . . 0.0 106.536 179.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -110.52 124.25 51.45 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.139 0.976 . . . . 0.0 109.122 173.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.7 ptm -117.91 155.01 30.93 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.98 1.312 . . . . 0.0 110.317 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.33 133.44 37.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 172.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.63 64.33 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.228 1.011 . . . . 0.0 109.004 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.92 166.19 16.17 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.986 0.898 . . . . 0.0 111.293 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.98 -46.38 2.66 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 121.738 -0.601 . . . . 0.0 113.05 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.6 mtt -59.16 110.51 1.08 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.287 1.043 . . . . 0.0 109.779 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 t -115.1 147.63 39.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.391 1.076 . . . . 0.0 108.9 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.9 m 62.57 162.34 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.334 1.854 . . . . 0.0 113.095 -177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -75.11 69.2 1.97 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.829 0.823 . . . . 0.0 109.422 173.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 m -117.57 -54.37 2.37 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.385 1.874 . . . . 0.0 109.092 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.7 m -88.48 -103.58 0.08 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.519 HG21 ' HB2' ' A' ' 38' ' ' LEU . 81.0 p 22.99 -89.26 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 127.877 2.471 . . . . 0.0 113.824 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -44.87 -41.09 6.8 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 m -49.82 -58.95 4.35 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.259 0.552 . . . . 0.0 111.061 168.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.85 -46.37 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.091 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -53.07 -65.24 0.59 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.425 1.466 . . . . 0.0 110.177 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.25 -55.12 6.83 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.467 1.508 . . . . 0.0 112.027 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -56.6 -53.17 60.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.795 0.797 . . . . 0.0 110.535 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.8 mm -61.49 -28.38 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.526 1.131 . . . . 0.0 110.479 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.92 -20.78 6.64 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.923 -0.932 . . . . 0.0 114.271 169.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -87.92 -14.86 38.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.89 1.845 . . . . 0.0 111.259 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 136.21 53.04 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 122.269 1.033 . . . . 0.0 111.668 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -57.68 111.25 1.07 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.532 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.97 -22.12 12.8 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 123.9 0.762 . . . . 0.0 112.757 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.2 132.58 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 118.122 0.961 . . . . 0.0 108.944 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -97.36 -47.33 5.74 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.643 1.177 . . . . 0.0 109.751 171.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -153.91 163.79 39.47 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.361 -0.837 . . . . 0.0 110.616 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 tt -146.2 136.75 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.299 1.439 . . . . 0.0 109.098 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.78 104.69 6.43 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.834 1.653 . . . . 0.0 107.592 168.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 43' ' ' ALA . 89.0 t -100.96 126.91 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 124.371 1.068 . . . . 0.0 109.993 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 m -114.5 93.76 4.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.12 0.968 . . . . 0.0 109.301 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.519 ' HB2' HG21 ' A' ' 18' ' ' THR . 0.3 OUTLIER -43.39 -49.74 6.97 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.466 1.106 . . . . 0.0 109.496 169.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.414 ' N ' HD13 ' A' ' 38' ' ' LEU . 1.3 m-20 -44.85 -58.87 2.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.677 1.591 . . . . 0.0 111.428 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.93 -14.69 59.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.55 -172.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 70.33 3.5 4.47 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 127.05 2.14 . . . . 0.0 111.81 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -119.16 157.86 27.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.563 1.945 . . . . 0.0 108.651 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.413 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -138.36 155.1 48.85 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.642 0.777 . . . . 0.0 109.564 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 m -124.99 116.81 22.74 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 -175.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.4 mt -121.08 159.78 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.28 117.98 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.39 0.996 . . . . 0.0 110.019 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -161.21 -178.93 7.04 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.459 1.104 . . . . 0.0 111.457 -172.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.72 146.8 63.5 Favored Pre-proline 0 N--CA 1.467 0.376 0 C-N-CA 124.898 1.279 . . . . 0.0 113.946 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.26 69.44 2.52 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 124.121 3.214 . . . . 0.0 109.896 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.62 -63.96 0.36 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.11 0.964 . . . . 0.0 108.969 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.2 mt -79.72 -21.85 44.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.862 -0.59 . . . . 0.0 110.426 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 56' ' ' GLU . 8.6 tp -124.83 145.12 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 118.507 0.594 . . . . 0.0 109.955 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 m -80.64 29.62 0.31 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 123.814 0.845 . . . . 0.0 112.975 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 74.64 -56.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 128.46 2.704 . . . . 0.0 111.095 173.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.63 -40.67 20.46 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.213 1.805 . . . . 0.0 109.477 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.469 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mm-40 -41.24 -53.15 3.26 Favored 'General case' 0 C--N 1.346 0.44 0 O-C-N 124.183 0.927 . . . . 0.0 110.837 -173.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.71 -60.96 0.29 Allowed 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.165 1.786 . . . . 0.0 111.053 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -41.95 68.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.092 0.957 . . . . 0.0 111.005 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -56.33 -28.28 58.43 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -64.79 -41.83 95.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.733 -0.604 . . . . 0.0 109.672 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -63.46 -49.18 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.449 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 4.2 mt-10 -53.39 -46.86 69.84 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.73 -20.53 49.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.555 1.542 . . . . 0.0 114.179 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.2 mmm -63.18 -30.18 71.38 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.777 1.171 . . . . 0.0 109.865 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.55 -32.25 2.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -79.85 116.57 62.04 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-O 117.819 -1.086 . . . . 0.0 108.468 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.25 123.81 12.78 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.765 1.643 . . . . 0.0 108.42 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.466 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -113.35 -165.74 1.02 Allowed 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 122.764 0.426 . . . . 0.0 110.271 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -162.42 138.34 7.42 Favored 'General case' 0 CA--C 1.522 -0.097 0 O-C-N 121.487 -0.758 . . . . 0.0 111.315 176.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.01 132.06 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 124.468 1.107 . . . . 0.0 108.677 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 mtpt -82.55 -83.03 0.13 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 117.858 0.299 . . . . 0.0 110.987 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -155.81 141.43 17.87 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.497 ' HB ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -148.39 123.41 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 125.787 1.635 . . . . 0.0 107.563 177.097 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -147.98 143.38 27.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 168.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.3 -133.83 4.23 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 . . . . . 0 C--O 1.245 0.839 0 N-CA-C 104.006 -2.59 . . . . 0.0 104.006 176.823 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.164 0 CA-C-O 116.893 -2.059 . . . . 0.0 108.277 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 31.67 71.02 0.08 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.522 1.929 . . . . 0.0 113.722 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' A' ' 74' ' ' GLU . 43.2 t -110.37 142.35 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.555 1.542 . . . . 0.0 108.759 -173.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.63 134.34 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 123.775 0.83 . . . . 0.0 110.692 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.541 HD13 ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -123.83 139.29 54.11 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 172.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -108.46 123.2 48.51 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 45' ' ' ILE . 15.0 ptm -116.07 167.9 10.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.35 1.06 . . . . 0.0 109.957 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -114.31 134.24 55.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.485 2.314 . . . . 0.0 106.86 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 t -124.99 62.4 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 126.309 1.843 . . . . 0.0 107.686 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.88 145.45 46.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.28 0.562 . . . . 0.0 111.724 -170.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.33 -46.3 1.16 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.7 mmm -80.94 104.85 11.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.172 0.486 . . . . 0.0 110.951 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.2 p -114.97 -59.35 2.03 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.66 1.184 . . . . 0.0 109.948 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.5 p -55.6 133.67 50.58 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.248 0.619 . . . . 0.0 110.964 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -61.04 164.87 4.63 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -170.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.8 t 81.65 84.23 0.04 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.11 2.164 . . . . 0.0 111.947 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.4 t -163.95 -111.05 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.687 -1.149 . . . . 0.0 109.382 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.752 HG22 HG12 ' A' ' 36' ' ' VAL . 70.7 p 27.42 -88.05 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 128.109 2.564 . . . . 0.0 113.518 169.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t -36.86 -42.96 0.42 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.112 1.365 . . . . 0.0 113.501 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.15 -57.06 11.74 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.46 0.704 . . . . 0.0 111.273 171.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.41 -48.86 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.214 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -56.21 -59.37 5.04 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 119.936 1.244 . . . . 0.0 110.79 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -41.38 -56.93 3.31 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.852 1.692 . . . . 0.0 112.158 170.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -57.2 -53.41 58.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.014 0.907 . . . . 0.0 110.506 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.427 HG23 ' HE3' ' A' ' 57' ' ' MET . 29.1 mm -59.65 -28.04 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 125.158 1.383 . . . . 0.0 110.704 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.83 -19.2 9.81 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.735 -1.036 . . . . 0.0 114.299 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -88.18 -9.99 51.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.859 1.829 . . . . 0.0 111.333 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.8 136.22 46.99 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.172 0.987 . . . . 0.0 111.594 -171.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.78 113.86 2.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.078 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.26 -16.99 31.99 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-O 119.136 -0.813 . . . . 0.0 112.903 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 t -79.32 130.14 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 118.238 1.019 . . . . 0.0 108.581 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -97.05 -49.14 5.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.439 1.096 . . . . 0.0 109.47 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -152.81 170.54 20.05 Favored 'General case' 0 C--N 1.341 0.198 0 O-C-N 121.625 -0.672 . . . . 0.0 110.673 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 tt -144.11 149.24 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.619 1.168 . . . . 0.0 109.407 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -143.55 98.44 3.25 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.141 2.176 . . . . 0.0 107.711 169.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.752 HG12 HG22 ' A' ' 18' ' ' THR . 91.2 t -99.62 128.24 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.554 1.142 . . . . 0.0 109.013 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 t -103.51 110.03 21.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.329 0.652 . . . . 0.0 110.602 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.585 HD23 ' H ' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -63.37 158.36 20.73 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.585 ' H ' HD23 ' A' ' 38' ' ' LEU . 3.7 m-20 71.36 -55.82 0.65 Allowed 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 129.069 2.948 . . . . 0.0 109.926 -174.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.01 -29.28 70.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.841 -174.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 64.61 16.07 10.08 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.19 2.196 . . . . 0.0 112.471 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -107.18 139.3 41.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB1' HG22 ' A' ' 36' ' ' VAL . . . -141.64 156.3 45.67 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.794 -0.566 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.9 m -130.46 125.8 35.33 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.491 HD11 ' SD ' ' A' ' 7' ' ' MET . 12.2 mt -118.33 153.25 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.62 120.84 65.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -157.71 -179.67 8.37 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 125.395 1.478 . . . . 0.0 109.628 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -140.75 151.85 64.2 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 123.221 0.609 . . . . 0.0 112.515 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -82.02 64.37 8.41 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.949 3.1 . . . . 0.0 108.684 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.52 -61.1 1.03 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.023 1.329 . . . . 0.0 107.474 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.2 mt -88.33 -20.71 25.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.666 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.7 tp -120.7 145.08 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 119.205 0.911 . . . . 0.0 110.488 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -83.96 28.32 0.61 Allowed 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 71.39 -60.07 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 128.867 2.867 . . . . 0.0 110.545 176.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -74.54 -41.11 61.17 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.804 1.242 . . . . 0.0 108.491 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.8 mt-10 -42.81 -49.86 5.71 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 123.277 0.631 . . . . 0.0 111.551 -174.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.437 ' SD ' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -42.74 -53.74 4.4 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 123.859 0.864 . . . . 0.0 111.126 -179.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.49 -44.91 77.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 122.087 -0.383 . . . . 0.0 110.761 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -54.04 -33.91 58.63 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.937 -0.477 . . . . 0.0 112.094 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -64.14 -42.67 96.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.43 0.692 . . . . 0.0 109.564 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.01 -46.83 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.791 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 11.0 mt-10 -51.67 -49.96 61.34 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.897 1.226 . . . . 0.0 108.674 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.86 -19.82 31.99 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.283 1.833 . . . . 0.0 114.27 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.1 mmm -61.82 -31.28 71.5 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.63 1.105 . . . . 0.0 110.214 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.7 39.48 0.57 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.544 1.069 . . . . 0.0 111.461 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -145.45 125.78 7.21 Favored Pre-proline 0 C--O 1.225 -0.217 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.98 107.81 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.19 1.927 . . . . 0.0 109.611 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.612 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -107.56 -177.59 3.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -163.49 156.1 18.19 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.121 -0.987 . . . . 0.0 111.612 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.4 t -106.42 118.68 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -94.42 -67.81 0.83 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.458 0.303 . . . . 0.0 110.632 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -86.95 176.37 7.69 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.4 tt -159.99 169.6 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.406 ' HA ' HG11 ' A' ' 3' ' ' VAL . 2.7 mp0 -73.37 145.07 46.18 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.756 1.162 . . . . 0.0 111.728 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.06 63.02 0.29 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.467 1.032 . . . . 0.0 111.353 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.255 1.375 0 C-N-CA 124.813 1.245 . . . . 0.0 111.691 171.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.964 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 178.05 148.99 0.18 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 -161.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.9 t -147.51 147.28 17.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.15 132.12 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.379 1.472 . . . . 0.0 109.957 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.568 ' C ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -123.56 157.85 32.72 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.371 1.469 . . . . 0.0 109.621 171.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.541 ' N ' HD22 ' A' ' 5' ' ' LEU . 11.3 ttpt -119.05 123.56 44.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.436 1.094 . . . . 0.0 108.581 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -122.79 144.66 49.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.077 1.351 . . . . 0.0 110.474 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -87.96 133.14 34.0 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.328 2.251 . . . . 0.0 108.313 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.35 65.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 126.959 2.104 . . . . 0.0 107.966 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -71.77 153.83 41.71 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.822 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.61 -43.46 2.07 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.634 -0.537 . . . . 0.0 112.821 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.6 mtt -63.49 127.92 33.51 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.505 1.152 . . . . 0.0 108.779 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -133.03 149.09 52.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.157 0.983 . . . . 0.0 108.651 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.5 m 68.58 140.82 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.811 2.045 . . . . 0.0 112.166 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -63.55 84.03 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.184 0.994 . . . . 0.0 109.959 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -149.24 -59.36 0.21 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.822 1.649 . . . . 0.0 108.511 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.9 m -77.72 69.94 4.03 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.3 p -133.33 -73.8 0.49 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.447 1.499 . . . . 0.0 107.224 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -57.93 -37.28 73.81 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -166.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.8 m -51.54 -54.15 30.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.724 0.297 . . . . 0.0 111.541 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -59.25 -49.5 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -53.28 -65.06 0.63 Allowed 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 122.322 1.058 . . . . 0.0 110.4 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.56 -42.71 44.57 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.197 1.856 . . . . 0.0 113.364 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -68.67 -61.23 1.91 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.934 1.367 . . . . 0.0 109.593 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.06 -41.49 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.621 1.169 . . . . 0.0 110.37 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.73 -21.55 29.74 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.406 1.479 . . . . 0.0 113.633 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -91.35 -15.44 29.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.076 1.438 . . . . 0.0 110.836 177.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.34 134.14 52.91 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.537 1.16 . . . . 0.0 111.508 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -50.35 107.77 0.18 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.255 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.42 -29.08 5.8 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.958 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.1 t -79.45 137.25 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 118.353 1.077 . . . . 0.0 109.167 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -102.34 -43.35 5.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.039 1.335 . . . . 0.0 110.642 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -158.61 162.5 37.31 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.41 -0.806 . . . . 0.0 110.151 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 tt -144.43 141.32 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.625 1.57 . . . . 0.0 109.192 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -129.34 121.7 28.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.513 1.925 . . . . 0.0 107.046 164.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.3 t -107.47 109.02 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 119.93 1.241 . . . . 0.0 110.052 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.7 t -90.79 91.63 8.45 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.693 0.759 . . . . 0.0 109.324 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.61 166.62 0.88 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.656 163.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 66.48 -56.42 0.39 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 128.338 2.655 . . . . 0.0 110.45 -165.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -64.81 -30.27 71.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.214 1.007 . . . . 0.0 109.88 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 68.73 25.27 6.42 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 127.812 2.445 . . . . 0.0 110.255 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -125.03 127.26 46.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.714 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.1 145.45 49.25 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.061 0.945 . . . . 0.0 109.515 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.71 120.3 31.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -176.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.2 mt -128.1 157.54 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -173.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.4 p -125.32 127.81 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -155.85 176.2 12.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 110.528 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.09 145.61 54.73 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.627 1.171 . . . . 0.0 113.192 172.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -72.32 75.86 2.33 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.409 3.406 . . . . 0.0 109.887 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.05 -55.42 0.11 Allowed 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.831 -0.543 . . . . 0.0 109.902 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.14 -24.61 27.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.607 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.4 tp -124.82 145.08 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.295 0.638 . . . . 0.0 110.206 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.57 23.74 0.12 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 75.4 -53.77 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.24 1.816 . . . . 0.0 110.194 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -95.64 -33.82 12.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.151 2.18 . . . . 0.0 110.169 -172.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -42.32 -53.31 4.22 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.035 0.934 . . . . 0.0 110.532 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -37.72 -57.74 0.96 Allowed 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 126.183 1.793 . . . . 0.0 111.96 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.405 ' HE2' HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -73.38 -42.76 61.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.992 0.917 . . . . 0.0 111.656 178.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -50.69 -29.47 11.3 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.148 -0.97 . . . . 0.0 113.208 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -62.68 -35.99 81.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -69.7 -46.24 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 123.682 0.793 . . . . 0.0 109.099 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -51.09 -49.34 60.86 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.01 -20.16 62.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.426 1.491 . . . . 0.0 114.041 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 81.3 mmm -63.99 -28.45 69.82 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.886 1.221 . . . . 0.0 109.874 171.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.41 -33.13 2.71 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.434 1.016 . . . . 0.0 110.957 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -80.85 119.06 75.05 Favored Pre-proline 0 N--CA 1.455 -0.18 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.169 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.8 120.71 8.19 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.873 1.716 . . . . 0.0 109.52 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.68 177.85 5.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.562 1.545 . . . . 0.0 108.562 -176.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.93 158.65 35.39 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 122.924 0.49 . . . . 0.0 111.218 -173.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.405 HG23 ' HE2' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -105.0 126.21 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -99.84 -61.59 1.35 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.688 0.395 . . . . 0.0 110.852 172.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -95.8 169.1 10.24 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.2 tt -150.7 175.73 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -75.36 178.96 5.47 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.251 1.021 . . . . 0.0 110.375 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.34 171.82 12.88 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.301 1.429 . . . . 0.0 111.036 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.311 0 CA-C-O 115.78 -2.057 . . . . 0.0 106.442 172.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.163 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.46 121.02 13.4 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.07 0.948 . . . . 0.0 109.773 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -136.56 156.94 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.504 1.521 . . . . 0.0 108.908 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 72.9 t -87.21 124.9 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.115 2.166 . . . . 0.0 110.299 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.26 142.69 41.5 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.623 1.169 . . . . 0.0 109.401 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 123.49 48.66 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.416 1.486 . . . . 0.0 108.95 170.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.7 ptm -125.96 134.75 51.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.067 1.347 . . . . 0.0 111.468 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 129.38 39.08 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 t -112.02 73.83 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.03 164.77 10.02 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.784 0.802 . . . . 0.0 111.101 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.79 -41.71 2.39 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 121.629 -0.669 . . . . 0.0 112.589 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 ttm -46.05 123.8 4.92 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.435 1.094 . . . . 0.0 109.761 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.8 t -152.03 139.49 19.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m 60.26 162.25 0.05 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.978 1.711 . . . . 0.0 112.186 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -58.88 87.41 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.106 0.963 . . . . 0.0 111.535 -171.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.9 t -172.95 170.85 4.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.937 1.295 . . . . 0.0 107.695 -164.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 m 37.13 52.44 1.13 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.884 1.674 . . . . 0.0 112.598 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.0 p -127.08 -76.1 0.58 Allowed 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 175.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.8 t -56.85 -38.8 73.19 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -168.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.8 m -47.51 -60.39 2.56 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.654 167.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.55 -48.95 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.52 ' HA ' HG21 ' A' ' 34' ' ' ILE . 53.5 mt-10 -56.83 -68.0 0.26 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.875 0.845 . . . . 0.0 111.663 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.63 -48.93 22.5 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.735 1.636 . . . . 0.0 111.834 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -63.72 -55.49 22.9 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 117.945 0.872 . . . . 0.0 110.312 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.546 ' CG2' HG21 ' A' ' 31' ' ' VAL . 10.8 mm -50.67 -41.35 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.93 0.892 . . . . 0.0 110.436 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.07 -22.75 13.95 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.953 1.739 . . . . 0.0 114.138 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -94.31 -20.78 19.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 118.892 1.346 . . . . 0.0 110.492 177.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 134.21 50.69 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 122.727 1.251 . . . . 0.0 111.68 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -53.62 113.68 1.27 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.549 -1.66 . . . . 0.0 110.088 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.62 -26.39 7.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 118.269 -1.295 . . . . 0.0 112.141 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.811 HG23 ' HE2' ' A' ' 57' ' ' MET . 2.2 t -75.99 140.44 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 118.926 1.363 . . . . 0.0 109.457 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.503 ' HB2' HG12 ' A' ' 46' ' ' VAL . 7.8 mm-40 -103.61 -41.16 6.04 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.598 167.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -159.72 163.34 34.81 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.529 -0.732 . . . . 0.0 109.941 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 22' ' ' GLU . 14.4 tt -147.38 148.71 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 124.952 1.301 . . . . 0.0 108.946 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.07 102.74 4.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.907 1.683 . . . . 0.0 107.861 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -91.23 133.42 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.61 1.164 . . . . 0.0 108.894 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 t -122.49 102.63 8.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.045 0.938 . . . . 0.0 110.52 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.63 -58.24 7.88 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.641 0.777 . . . . 0.0 110.758 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -42.24 -54.46 3.69 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.218 1.407 . . . . 0.0 110.942 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.26 -19.21 51.17 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.938 -171.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 65.88 18.88 11.22 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.205 2.202 . . . . 0.0 110.996 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.29 163.57 20.46 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.249 2.22 . . . . 0.0 108.431 -171.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.15 133.65 17.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.064 0.545 . . . . 0.0 109.839 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.1 m -106.47 100.94 10.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -173.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.4 HG12 HD12 ' A' ' 34' ' ' ILE . 80.5 mt -90.75 165.66 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 32' ' ' GLN . 1.1 t -139.67 120.41 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -157.14 176.17 13.09 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.706 0.802 . . . . 0.0 111.757 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -122.81 139.91 32.2 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -69.61 84.0 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.245 3.296 . . . . 0.0 109.574 174.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -168.43 -61.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.0 mt -82.16 -25.92 33.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.219 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 52' ' ' ILE . 11.2 tp -117.79 161.2 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 123.501 0.721 . . . . 0.0 110.423 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 m -93.86 26.79 3.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.219 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 70.11 -59.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 129.406 3.082 . . . . 0.0 110.49 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.91 -32.49 40.19 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.444 1.498 . . . . 0.0 109.562 -175.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -49.44 -48.75 47.2 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -173.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.811 ' HE2' HG23 ' A' ' 31' ' ' VAL . 5.4 mtt -44.93 -53.5 7.56 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.213 0.605 . . . . 0.0 111.512 174.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.539 ' HD3' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -72.47 -36.61 68.51 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.559 -0.713 . . . . 0.0 112.569 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.449 ' HD2' ' CE ' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -61.29 -31.68 71.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 120.535 -1.353 . . . . 0.0 110.835 176.087 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -35.14 80.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mp -62.9 -47.25 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.003 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -50.96 -48.73 60.92 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.37 0.986 . . . . 0.0 108.697 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.05 -21.72 46.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.457 1.103 . . . . 0.0 113.664 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.9 mmt -66.91 -28.03 67.98 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.553 1.069 . . . . 0.0 110.786 172.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.62 -33.38 3.0 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.759 1.171 . . . . 0.0 110.731 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -78.36 115.56 52.14 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.19 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -62.27 121.83 10.01 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.695 1.596 . . . . 0.0 109.146 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.95 163.77 26.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.662 0.785 . . . . 0.0 109.039 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CA ' ' HD2' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -151.28 140.34 21.12 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 125.211 1.405 . . . . 0.0 109.588 -156.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.539 HG23 ' HD3' ' A' ' 58' ' ' LYS . 1.2 t -91.53 127.25 43.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -100.26 -64.43 1.04 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.895 0.478 . . . . 0.0 110.689 171.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -92.2 170.4 9.84 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.66 177.06 3.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.89 1.276 . . . . 0.0 109.128 -174.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -75.4 176.32 7.6 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.923 1.289 . . . . 0.0 109.339 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.2 -176.15 17.55 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.322 0.963 . . . . 0.0 111.328 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 . . . . . 0 C--O 1.249 1.045 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 173.267 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.689 0 N-CA-C 107.289 -2.325 . . . . 0.0 107.289 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 22.85 65.63 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.934 2.094 . . . . 0.0 114.363 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.18 145.18 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 124.532 1.133 . . . . 0.0 109.404 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.27 124.29 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 125.579 1.552 . . . . 0.0 108.954 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.455 HD13 ' HB ' ' A' ' 73' ' ' ILE . 16.1 tp -107.57 143.21 36.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.358 1.863 . . . . 0.0 107.144 169.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -111.6 120.71 43.01 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 164.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.0 ptm -111.57 162.51 15.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.709 1.203 . . . . 0.0 109.909 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -97.2 125.88 42.02 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.506 1.523 . . . . 0.0 108.748 168.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 t -116.73 72.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 126.693 1.997 . . . . 0.0 106.83 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.271 3.6 pt-20 -82.48 176.77 9.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.33 0.652 . . . . 0.0 111.657 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.94 -57.53 3.93 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 121.541 -0.724 . . . . 0.0 112.006 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -58.56 130.22 45.78 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.328 1.064 . . . . 0.0 110.294 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.0 t -165.97 74.68 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.121 0.969 . . . . 0.0 109.176 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.7 p -158.78 28.2 0.22 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.251 -0.906 . . . . 0.0 113.118 -171.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 35.05 51.56 0.55 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.473 1.909 . . . . 0.0 113.643 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 t -161.02 -50.62 0.05 OUTLIER 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.661 0.784 . . . . 0.0 109.725 -169.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.4 m -72.5 69.34 0.85 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.685 0.794 . . . . 0.0 111.065 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.5 p -131.14 -72.91 0.54 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 m -55.79 -38.78 70.4 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -167.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.84 -53.69 48.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 171.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.04 -53.03 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -56.71 -65.06 0.68 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.804 0.811 . . . . 0.0 110.069 -174.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.26 -52.66 17.64 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.323 1.916 . . . . 0.0 112.238 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.38 -52.78 63.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.106 0.953 . . . . 0.0 109.864 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.0 mm -58.77 -30.82 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 123.176 0.59 . . . . 0.0 111.203 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -56.11 -20.39 27.62 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.886 1.232 . . . . 0.0 113.6 174.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -89.8 -9.94 47.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.368 1.584 . . . . 0.0 110.96 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.44 133.11 48.93 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.354 1.073 . . . . 0.0 110.764 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -54.66 104.89 0.13 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.807 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.18 -26.94 5.71 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 118.991 -0.894 . . . . 0.0 113.102 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.6 t -79.69 131.84 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 118.483 1.141 . . . . 0.0 110.042 -172.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -98.36 -47.31 5.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.528 1.531 . . . . 0.0 110.022 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -151.33 167.36 28.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.253 0.478 . . . . 0.0 110.191 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.8 tt -149.61 143.97 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.069 1.348 . . . . 0.0 109.439 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -130.19 122.69 28.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.309 2.244 . . . . 0.0 105.865 167.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG22 ' HB1' ' A' ' 43' ' ' ALA . 69.1 t -117.81 103.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 120.279 1.4 . . . . 0.0 109.52 176.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 m -85.21 99.45 11.11 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 mt -53.84 170.26 0.13 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.902 158.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 67.59 -60.6 0.38 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 127.991 2.516 . . . . 0.0 110.417 -171.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -24.86 67.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.574 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 65.55 23.12 11.79 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 126.469 1.908 . . . . 0.0 111.182 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -119.76 135.24 54.93 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.809 0.844 . . . . 0.0 109.706 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB1' HG22 ' A' ' 36' ' ' VAL . . . -132.12 152.85 51.02 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 m -129.38 120.71 26.01 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.136 1.774 . . . . 0.0 106.482 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.57 154.34 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.52 119.05 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -158.0 -179.69 8.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.825 1.25 . . . . 0.0 109.163 -176.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -133.12 146.06 59.5 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.15 75.05 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 124.414 3.409 . . . . 0.0 109.983 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.99 -60.03 0.32 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.804 1.242 . . . . 0.0 107.991 172.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -80.67 -27.47 37.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 119.064 -0.493 . . . . 0.0 110.464 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.4 tp -122.23 144.16 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.739 0.816 . . . . 0.0 109.99 -175.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.2 m -77.29 23.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 72.12 -63.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 128.602 2.761 . . . . 0.0 109.095 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -42.08 74.33 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.019 0.928 . . . . 0.0 108.819 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -38.9 -60.17 0.88 Allowed 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.075 0.95 . . . . 0.0 110.935 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -36.58 -57.05 0.79 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.811 1.644 . . . . 0.0 111.627 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -40.86 69.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.395 0.678 . . . . 0.0 111.705 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -60.42 -26.02 66.39 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 120.986 -1.071 . . . . 0.0 112.789 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -62.81 -37.75 88.0 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.6 mp -63.9 -45.05 98.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 117.55 -1.214 . . . . 0.0 111.528 173.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -49.87 -49.98 47.41 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.44 1.473 . . . . 0.0 108.304 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.07 -20.25 51.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.672 1.189 . . . . 0.0 113.848 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.5 mmt -65.19 -25.94 67.94 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.481 1.037 . . . . 0.0 110.58 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.68 -27.71 4.34 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.446 1.022 . . . . 0.0 111.197 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -86.37 123.0 71.97 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.51 130.74 30.99 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 N-CA-C 108.632 -1.334 . . . . 0.0 108.632 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.42 -176.53 3.61 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.364 0.666 . . . . 0.0 109.276 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.97 151.02 30.65 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.119 -0.988 . . . . 0.0 110.864 -175.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -119.31 133.01 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -78.16 -83.09 0.09 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.208 0.603 . . . . 0.0 110.562 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.47 149.19 23.77 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.455 ' HB ' HD13 ' A' ' 5' ' ' LEU . 3.3 tp -158.5 125.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 123.982 0.913 . . . . 0.0 109.357 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -150.32 163.06 39.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.35 168.59 38.8 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.981 -1.485 . . . . 0.0 110.837 -176.95 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.065 0 N-CA-C 108.489 -1.845 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -63.62 122.35 16.12 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.795 1.297 . . . . 0.0 107.652 167.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.3 t -145.61 148.85 17.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.1 t -85.3 133.71 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 C-N-CA 125.748 1.619 . . . . 0.0 109.624 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.708 HD23 ' N ' ' A' ' 6' ' ' LYS . 6.0 tt -124.05 146.19 48.73 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.696 1.599 . . . . 0.0 108.673 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.708 ' N ' HD23 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -109.81 113.82 26.88 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.198 1.799 . . . . 0.0 109.133 178.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 60.4 mtt -109.2 131.53 54.98 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.738 0.815 . . . . 0.0 109.88 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -78.23 119.11 21.13 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 167.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.52 85.14 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.85 -175.35 3.03 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.543 0.737 . . . . 0.0 109.431 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.77 -40.79 2.29 Favored Glycine 0 CA--C 1.532 1.098 0 O-C-N 121.371 -0.831 . . . . 0.0 113.356 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -49.32 130.85 20.06 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.378 1.089 . . . . 0.0 110.111 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 t -44.58 -58.65 2.89 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.786 1.234 . . . . 0.0 112.152 -174.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 165.13 126.13 0.01 OUTLIER 'General case' 0 C--N 1.338 0.107 0 C-N-CA 127.228 2.211 . . . . 0.0 107.436 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 36.22 43.65 0.23 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.398 1.879 . . . . 0.0 114.538 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 t -146.93 39.55 1.03 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -176.78 70.28 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.912 1.285 . . . . 0.0 108.256 174.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p -120.02 -76.85 0.58 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.15 -38.93 68.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -168.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.6 m -48.84 -60.85 2.41 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.404 168.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.9 -50.57 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -58.65 -63.5 1.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.391 1.091 . . . . 0.0 109.153 -172.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.51 -56.59 6.29 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.99 1.757 . . . . 0.0 112.731 173.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -57.1 -52.59 64.67 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.114 0.957 . . . . 0.0 110.017 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.6 -27.43 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 123.718 0.807 . . . . 0.0 110.686 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.82 -19.95 11.81 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.069 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -85.79 -14.24 45.76 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.592 1.696 . . . . 0.0 110.146 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.38 132.63 48.05 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 122.438 1.114 . . . . 0.0 111.699 -172.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -57.78 107.03 0.41 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.25 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.38 -22.43 8.36 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.194 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.3 t -78.28 127.89 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 118.709 1.255 . . . . 0.0 108.841 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -89.67 -50.27 6.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.299 1.04 . . . . 0.0 108.77 172.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -154.25 160.89 42.03 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 118.988 0.813 . . . . 0.0 110.448 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 tt -141.77 142.27 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.623 1.569 . . . . 0.0 109.719 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -145.54 113.11 6.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.392 1.477 . . . . 0.0 107.753 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.9 t -113.0 92.47 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.47 1.508 . . . . 0.0 110.299 -172.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.1 m -82.13 78.59 8.79 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 124.171 0.988 . . . . 0.0 110.613 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.2 -42.04 28.9 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.312 0.645 . . . . 0.0 111.856 174.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -42.48 -51.86 4.88 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 125.94 1.696 . . . . 0.0 110.471 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -81.19 -13.66 58.36 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.15 -173.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 64.18 35.01 10.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 126.995 2.118 . . . . 0.0 109.572 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -156.15 144.45 19.92 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 125.434 1.709 . . . . 0.0 109.966 -166.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.5 157.91 41.38 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.402 1.081 . . . . 0.0 110.224 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.4 m -139.49 121.01 15.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.7 mt -124.9 162.89 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.079 1.351 . . . . 0.0 108.44 -173.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.6 p -132.79 127.31 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 174.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -155.84 177.95 10.82 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.601 1.16 . . . . 0.0 108.818 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -126.25 142.41 42.66 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.314 1.046 . . . . 0.0 113.122 171.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.96 72.12 3.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.878 3.719 . . . . 0.0 110.402 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.68 -56.65 0.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.175 0.99 . . . . 0.0 108.605 172.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.38 -31.09 37.87 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.459 ' HA ' HD12 ' A' ' 52' ' ' ILE . 9.0 tp -118.64 144.1 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 123.464 0.705 . . . . 0.0 109.668 -177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 m -81.95 27.81 0.45 Allowed 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -173.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 69.84 -64.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 129.582 3.153 . . . . 0.0 109.284 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -72.97 -39.6 65.99 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.48 1.112 . . . . 0.0 108.647 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' HB3' HD11 ' A' ' 52' ' ' ILE . 4.1 mm-40 -40.7 -55.94 2.27 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.43 1.092 . . . . 0.0 111.574 -173.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.13 -60.73 0.85 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.554 1.142 . . . . 0.0 110.082 177.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HB3' ' HZ2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -70.37 -32.98 70.89 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.093 -176.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -64.54 -29.55 70.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 119.194 -2.191 . . . . 0.0 111.537 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -63.32 -44.15 95.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.13 -43.5 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.908 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -55.25 -54.15 47.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.771 1.169 . . . . 0.0 107.978 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.15 -27.73 64.05 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.816 1.646 . . . . 0.0 114.174 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.9 mmt -52.63 -28.77 22.82 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.362 0.983 . . . . 0.0 111.187 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.87 39.98 0.62 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 124.641 1.115 . . . . 0.0 110.908 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -149.07 119.22 4.05 Favored Pre-proline 0 N--CA 1.457 -0.093 0 CA-C-O 117.995 -1.002 . . . . 0.0 108.438 -175.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.48 109.87 1.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.905 1.737 . . . . 0.0 109.597 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.9 -168.36 1.31 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.949 1.3 . . . . 0.0 108.449 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -163.44 152.56 14.49 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.117 0.967 . . . . 0.0 110.504 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 64.2 t -94.35 128.32 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 170.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -98.7 -68.48 0.8 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.215 0.461 . . . . 0.0 111.165 169.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -88.52 175.48 7.56 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 tt -156.89 177.37 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 119.394 0.997 . . . . 0.0 109.368 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.61 143.22 48.29 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.538 1.063 . . . . 0.0 108.283 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.84 -174.04 46.75 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 . . . . . 0 C--O 1.248 0.988 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 169.922 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 76' ' ' ARG . . . . . . . . 0 N--CA 1.468 0.784 0 N-CA-C 106.449 -2.661 . . . . 0.0 106.449 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -30.03 101.21 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.551 1.94 . . . . 0.0 113.588 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.591 HG21 ' O ' ' A' ' 74' ' ' GLU . 3.9 p -117.1 149.29 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.934 0.894 . . . . 0.0 109.185 176.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.32 121.3 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.657 1.983 . . . . 0.0 108.688 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.433 HD13 ' HB ' ' A' ' 73' ' ' ILE . 16.7 tp -112.22 119.31 37.93 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.134 0.574 . . . . 0.0 110.553 171.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.07 126.97 36.31 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.957 1.303 . . . . 0.0 109.552 170.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -132.37 157.79 43.61 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.975 1.31 . . . . 0.0 109.702 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 133.91 36.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 173.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 t -128.98 79.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.957 1.303 . . . . 0.0 108.448 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.66 147.18 29.67 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.2 -38.54 2.55 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.307 -0.718 . . . . 0.0 113.569 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -56.35 120.46 7.66 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.427 1.114 . . . . 0.0 109.762 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 t -76.97 50.64 0.74 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.443 1.097 . . . . 0.0 111.675 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p 46.35 -162.44 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.661 1.584 . . . . 0.0 112.517 -167.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.6 m170 46.08 92.85 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.098 1.759 . . . . 0.0 114.806 174.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.4 t 66.62 -153.93 0.23 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.767 0.827 . . . . 0.0 109.595 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m 60.97 34.57 19.36 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.954 0.902 . . . . 0.0 109.608 -169.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.91 -72.33 0.69 Allowed 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 170.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -53.01 -39.15 62.92 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -170.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.3 m -51.29 -57.9 7.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 O-C-N 123.291 0.369 . . . . 0.0 111.587 170.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.4 -51.36 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.5 -61.78 2.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.091 0.948 . . . . 0.0 110.229 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.15 -54.17 13.12 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.948 1.737 . . . . 0.0 112.391 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -59.37 -52.36 65.96 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.111 0.955 . . . . 0.0 110.541 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.415 HG21 HD12 ' A' ' 34' ' ' ILE . 19.2 mm -57.22 -36.8 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 123.834 0.854 . . . . 0.0 110.143 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.12 -20.13 33.9 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.844 1.212 . . . . 0.0 114.137 172.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -84.88 -27.44 26.67 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.477 1.638 . . . . 0.0 109.99 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.22 139.34 52.25 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.443 1.116 . . . . 0.0 112.722 -168.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -53.8 115.11 1.82 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.051 1.34 . . . . 0.0 111.52 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.72 -28.57 6.4 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 124.064 0.84 . . . . 0.0 112.053 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.68 141.38 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 117.468 0.634 . . . . 0.0 110.051 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -121.1 -21.61 6.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.4 1.08 . . . . 0.0 111.811 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -160.41 164.63 32.17 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.398 0.999 . . . . 0.0 109.706 172.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.415 HD12 HG21 ' A' ' 25' ' ' ILE . 15.4 tt -155.5 143.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 123.91 0.884 . . . . 0.0 108.655 174.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.28 113.71 10.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.284 1.833 . . . . 0.0 106.527 171.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -100.34 103.13 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.229 0.922 . . . . 0.0 109.606 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -74.0 73.29 1.67 Allowed 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.303 1.041 . . . . 0.0 110.267 175.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 39' ' ' ASP . 0.2 OUTLIER -50.66 161.07 0.37 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.426 1.49 . . . . 0.0 109.772 167.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.575 ' H ' HD13 ' A' ' 38' ' ' LEU . 20.3 m-20 65.46 -53.5 0.35 Allowed 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 128.042 2.537 . . . . 0.0 110.952 -162.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -67.59 -23.36 65.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -172.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 68.95 26.62 5.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.987 2.115 . . . . 0.0 111.864 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -117.82 150.04 39.82 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.59 1.556 . . . . 0.0 106.876 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.03 159.9 43.42 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.295 -0.878 . . . . 0.0 109.564 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 m -132.6 106.32 7.74 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.713 1.605 . . . . 0.0 107.399 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 mt -90.08 163.16 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.45 117.86 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.153 1.381 . . . . 0.0 108.325 168.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -157.48 -178.2 7.16 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.31 1.444 . . . . 0.0 110.846 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -132.02 144.75 54.47 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.398 1.479 . . . . 0.0 113.86 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.22 68.88 4.1 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.752 3.635 . . . . 0.0 110.025 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.19 -57.06 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.541 1.136 . . . . 0.0 108.771 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.1 -20.52 37.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 118.736 -0.65 . . . . 0.0 110.65 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.1 tp -127.88 150.61 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 123.128 0.571 . . . . 0.0 110.475 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.6 m -79.46 25.02 0.33 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -176.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 71.3 -61.48 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 127.952 2.501 . . . . 0.0 108.889 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.08 -38.31 61.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.887 -174.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HB3' HD11 ' A' ' 52' ' ' ILE . 22.8 mt-10 -45.95 -51.24 13.69 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 118.819 0.736 . . . . 0.0 111.981 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.78 -54.61 6.14 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.225 1.01 . . . . 0.0 111.71 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -64.64 -49.38 71.25 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.652 -0.655 . . . . 0.0 110.653 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -65.62 -24.94 67.17 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.228 -170.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -62.4 -47.49 83.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.41 -45.85 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -58.08 -49.67 76.1 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.64 -26.81 65.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.391 1.476 . . . . 0.0 113.442 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.0 mmm -54.88 -32.95 61.42 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.626 1.103 . . . . 0.0 110.387 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.6 -42.71 0.79 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -75.6 111.21 13.2 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.353 -171.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.81 110.3 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.169 1.913 . . . . 0.0 109.161 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.37 -167.16 1.27 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.192 1.397 . . . . 0.0 108.813 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.98 134.78 5.14 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.296 0.953 . . . . 0.0 113.025 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.6 p -87.5 138.38 19.19 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 C-N-CA 123.399 0.68 . . . . 0.0 110.058 174.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -83.29 -86.84 0.11 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.768 0.427 . . . . 0.0 110.308 173.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -157.14 157.62 34.8 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.433 ' HB ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -153.54 150.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 126.871 2.069 . . . . 0.0 106.625 -178.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.591 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -157.34 147.89 21.17 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 165.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.12 133.21 8.12 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.576 1.084 . . . . 0.0 111.945 -165.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 1' ' ' GLY . 58.1 ttt180 . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.132 -1.414 . . . . 0.0 112.728 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.082 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -164.88 155.28 14.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -169.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.467 HG23 HD11 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -134.28 147.53 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.399 1.479 . . . . 0.0 109.378 -174.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.19 133.71 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 124.535 1.134 . . . . 0.0 109.669 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.423 HD13 ' HB ' ' A' ' 73' ' ' ILE . 16.7 tp -119.97 131.72 55.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.45 1.5 . . . . 0.0 108.748 172.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -93.17 117.04 29.61 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.349 1.06 . . . . 0.0 108.516 167.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.48 ' SD ' HD11 ' A' ' 45' ' ' ILE . 14.8 ptm -114.61 156.99 23.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.392 0.677 . . . . 0.0 109.211 172.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -100.29 129.34 46.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.54 1.536 . . . . 0.0 107.052 170.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.06 69.41 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.82 163.66 25.36 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.29 0.567 . . . . 0.0 109.594 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.44 -40.11 2.84 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 121.004 -1.06 . . . . 0.0 113.101 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.3 mtt -67.86 84.76 0.21 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.676 1.238 . . . . 0.0 109.506 172.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.7 p -99.5 26.11 6.41 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.756 1.223 . . . . 0.0 111.587 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.1 t -117.79 118.3 31.66 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.197 0.999 . . . . 0.0 108.36 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -49.58 -40.16 37.7 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.072 0.549 . . . . 0.0 111.882 -174.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 t -80.26 56.39 2.47 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.814 -0.554 . . . . 0.0 110.698 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 m -139.33 49.45 1.82 Allowed 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.3 p -120.48 -76.15 0.58 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 173.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.4 t -52.18 -45.18 65.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -165.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.5 m -48.5 -56.75 7.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.22 0.208 . . . . 0.0 111.117 169.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -59.93 -49.34 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 123.414 0.686 . . . . 0.0 109.415 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -59.61 -61.55 2.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.918 0.887 . . . . 0.0 109.555 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.86 -56.95 6.37 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.708 1.623 . . . . 0.0 112.401 172.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -57.68 -54.05 51.24 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.018 0.909 . . . . 0.0 110.269 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.0 mm -60.97 -31.94 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 124.016 0.926 . . . . 0.0 110.921 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.41 -17.9 27.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.886 1.232 . . . . 0.0 113.657 173.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -84.79 -13.62 50.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.941 1.371 . . . . 0.0 110.392 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.63 140.49 44.33 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.93 0.871 . . . . 0.0 111.983 -169.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -59.7 114.57 2.82 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.059 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.59 -24.5 10.31 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.212 0.911 . . . . 0.0 112.317 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.61 137.63 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 118.035 0.918 . . . . 0.0 110.126 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -106.91 -48.36 3.51 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.937 1.295 . . . . 0.0 109.554 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.04 161.84 41.97 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -178.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 tt -149.49 140.11 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 123.676 0.791 . . . . 0.0 109.246 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -135.88 101.08 4.63 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.795 2.038 . . . . 0.0 107.279 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -98.85 118.69 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.809 0.844 . . . . 0.0 109.128 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.9 m -98.3 90.88 4.97 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.632 0.773 . . . . 0.0 108.995 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.6 170.55 0.25 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.392 161.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 71.15 -57.36 0.6 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.092 2.557 . . . . 0.0 108.601 -168.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.69 -27.07 64.7 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.569 -174.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 70.07 20.63 6.39 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 111.862 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.16 144.94 42.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.921 1.688 . . . . 0.0 108.244 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.79 155.75 47.91 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 121.328 -0.857 . . . . 0.0 110.035 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 m -126.07 115.22 19.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.918 1.687 . . . . 0.0 106.635 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.48 HD11 ' SD ' ' A' ' 7' ' ' MET . 35.7 mt -108.41 154.91 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.31 122.28 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 118.734 0.697 . . . . 0.0 109.789 168.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -156.25 177.82 11.0 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.952 1.701 . . . . 0.0 108.872 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -124.2 136.89 28.17 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 119.427 1.012 . . . . 0.0 111.736 169.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.8 73.07 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.136 3.224 . . . . 0.0 110.332 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -135.3 -50.57 0.75 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 42.4 mt -94.02 -17.63 22.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.782 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 52' ' ' ILE . 11.2 tp -119.78 150.4 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.519 1.054 . . . . 0.0 110.21 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.3 m -83.54 19.82 1.51 Allowed 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 70.67 -62.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 128.038 2.535 . . . . 0.0 109.573 -177.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -70.2 -38.05 75.24 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -49.75 -47.64 50.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 123.534 0.521 . . . . 0.0 111.442 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -40.93 -52.09 3.14 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 177.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.09 -44.92 68.07 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.276 -0.265 . . . . 0.0 110.89 177.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -54.85 -32.17 60.37 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.593 -0.692 . . . . 0.0 112.7 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -37.85 88.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.38 -50.99 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.909 170.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 8.2 mt-10 -52.34 -46.82 66.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.336 0.971 . . . . 0.0 109.393 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.44 -21.36 50.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.94 1.696 . . . . 0.0 113.554 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.9 mmt -65.51 -31.95 73.29 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.372 0.987 . . . . 0.0 110.15 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.89 -37.01 1.47 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.906 0.765 . . . . 0.0 111.301 173.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -75.91 116.36 54.77 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 117.784 -1.103 . . . . 0.0 108.876 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.24 120.24 7.61 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.124 1.883 . . . . 0.0 108.685 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.403 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -115.08 -170.3 1.73 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.808 0.813 . . . . 0.0 109.413 -175.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.35 152.99 19.16 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.841 -1.162 . . . . 0.0 110.674 -176.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.84 132.08 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -83.5 -127.66 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.622 0.576 . . . . 0.0 109.526 172.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.2 146.98 33.28 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 118.695 0.68 . . . . 0.0 110.129 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.467 HD11 HG23 ' A' ' 3' ' ' VAL . 1.9 tp -157.43 125.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -156.87 154.74 30.29 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.01 75.57 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 106.98 -2.448 . . . . 0.0 106.98 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 116.714 -1.612 . . . . 0.0 108.564 176.897 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.034 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -108.18 -164.03 0.93 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.365 1.066 . . . . 0.0 109.641 -159.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.3 t -82.88 123.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.8 t -79.25 115.61 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 126.074 1.75 . . . . 0.0 109.231 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 6' ' ' LYS . 6.6 tt -89.21 155.86 19.14 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.663 0.785 . . . . 0.0 109.493 169.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' N ' HD23 ' A' ' 5' ' ' LEU . 3.6 tmtt? -135.44 116.63 14.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.511 ' SD ' HD11 ' A' ' 45' ' ' ILE . 5.0 ptm -128.99 153.2 47.8 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.948 1.299 . . . . 0.0 110.792 -170.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.99 129.16 49.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.076 0.951 . . . . 0.0 108.598 170.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.05 76.45 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 125.379 1.472 . . . . 0.0 107.77 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.3 114.79 3.37 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.126 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.98 -67.35 0.54 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.978 1.275 . . . . 0.0 111.407 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.9 mmt -80.75 93.53 6.22 Favored 'General case' 0 C--N 1.335 -0.034 0 O-C-N 121.936 -0.743 . . . . 0.0 111.129 -166.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 t -124.99 12.04 8.34 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.474 1.11 . . . . 0.0 112.855 -172.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.8 t -152.91 109.87 3.48 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.927 -1.108 . . . . 0.0 109.816 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.432 ' HA ' HD13 ' A' ' 38' ' ' LEU . 12.6 t-80 -1.82 78.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 128.967 2.907 . . . . 0.0 115.362 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 t -166.46 153.96 9.76 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -175.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 34.61 73.78 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.121 1.768 . . . . 0.0 113.229 176.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 p -127.13 -71.98 0.66 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -54.64 -36.35 64.46 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 m -52.32 -58.66 5.97 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 123.105 0.253 . . . . 0.0 111.18 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.33 -52.21 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -58.21 -67.37 0.35 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.881 0.848 . . . . 0.0 110.996 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.33 -51.68 11.57 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.581 1.563 . . . . 0.0 112.358 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -63.99 -48.84 74.83 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.09 0.945 . . . . 0.0 110.362 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.2 mm -59.44 -30.15 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 O-C-N 122.059 -0.401 . . . . 0.0 110.954 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.81 -23.24 6.72 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.391 0.996 . . . . 0.0 114.253 170.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -81.86 -18.22 44.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 119.799 1.799 . . . . 0.0 111.524 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.28 136.34 56.47 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.865 0.84 . . . . 0.0 111.038 -165.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -56.27 100.66 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.794 1.238 . . . . 0.0 110.324 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.96 -27.2 5.18 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.059 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.31 134.84 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 118.598 1.199 . . . . 0.0 109.76 -172.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -105.64 -36.97 6.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.771 1.228 . . . . 0.0 110.309 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -159.05 169.77 23.52 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.296 0.953 . . . . 0.0 111.459 173.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -150.14 152.67 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.548 1.539 . . . . 0.0 108.932 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -150.38 116.2 5.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.706 1.603 . . . . 0.0 108.345 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.3 t -110.96 117.76 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.639 1.576 . . . . 0.0 109.96 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.4 m -103.23 108.21 19.34 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.445 1.498 . . . . 0.0 110.107 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 15' ' ' HIS . 3.5 mt -60.55 -179.05 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.485 1.114 . . . . 0.0 110.308 164.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 63.43 -70.06 0.07 Allowed 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 128.103 2.561 . . . . 0.0 111.029 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -61.57 -28.36 69.29 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.043 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.59 60.43 1.34 Allowed 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 126.711 2.005 . . . . 0.0 111.359 173.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -151.57 156.44 40.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.18 166.52 24.48 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.873 -0.517 . . . . 0.0 109.953 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.36 144.0 34.3 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.511 HD11 ' SD ' ' A' ' 7' ' ' MET . 13.2 mt -123.25 162.95 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.27 1.5 p -134.55 113.27 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 119.243 0.929 . . . . 0.0 108.715 176.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -158.96 179.54 8.98 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 125.077 1.351 . . . . 0.0 109.578 -170.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.74 147.92 53.55 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.47 79.33 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.666 2.911 . . . . 0.0 109.901 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.22 -52.62 0.5 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.765 1.626 . . . . 0.0 107.147 166.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.05 -22.69 18.98 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.236 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 tp -129.13 147.67 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 123.724 0.81 . . . . 0.0 111.204 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 m -80.74 27.24 0.38 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -170.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 71.67 -60.65 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 127.879 2.472 . . . . 0.0 109.862 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.54 -42.32 52.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.009 1.324 . . . . 0.0 109.304 -177.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -50.47 -52.97 33.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 123.566 0.541 . . . . 0.0 110.648 -171.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -36.93 -63.38 0.42 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.774 1.229 . . . . 0.0 111.538 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -39.24 72.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.771 -0.581 . . . . 0.0 110.359 -177.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -58.29 -27.33 63.98 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.04 -1.038 . . . . 0.0 113.162 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -41.99 96.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.766 1.167 . . . . 0.0 108.787 176.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.77 -39.09 80.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.314 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -60.43 -49.84 75.97 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.87 -28.89 64.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.438 1.095 . . . . 0.0 113.195 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.0 mmt -53.05 -34.34 56.06 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.215 0.916 . . . . 0.0 111.463 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.56 -38.91 1.33 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -73.3 113.06 18.63 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-O 118.272 -0.87 . . . . 0.0 109.585 -173.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.74 108.63 1.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.08 1.853 . . . . 0.0 108.384 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.09 -177.43 4.13 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.305 1.042 . . . . 0.0 108.336 -171.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -156.91 140.18 15.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.099 0.863 . . . . 0.0 112.69 -165.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -102.23 133.13 46.73 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 126.667 1.987 . . . . 0.0 109.887 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -82.71 -77.39 0.24 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.885 0.474 . . . . 0.0 110.792 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.17 157.85 35.17 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.49 115.62 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.58 1.152 . . . . 0.0 110.145 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -155.59 160.01 40.12 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.89 161.82 4.72 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 123.797 0.686 . . . . 0.0 112.356 175.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.005 -1.474 . . . . 0.0 110.533 179.767 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.009 0 CA-C-O 118.392 -1.227 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 38.44 56.28 1.8 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.483 1.135 . . . . 0.0 111.161 -172.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t -81.17 126.2 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 124.825 1.25 . . . . 0.0 107.993 -171.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.84 125.36 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.595 HD13 ' C ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -131.38 137.16 48.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -93.13 129.32 39.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.263 0.625 . . . . 0.0 111.079 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.465 ' CG ' HD11 ' A' ' 5' ' ' LEU . 27.0 mtt -108.44 155.24 20.81 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.171 0.988 . . . . 0.0 109.977 169.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 118.35 36.59 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 167.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.0 t -100.86 76.91 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.13 168.73 19.42 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.686 0.755 . . . . 0.0 111.675 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.8 -46.51 2.36 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.206 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.416 ' HB3' HD21 ' A' ' 38' ' ' LEU . 1.4 mpt? -51.92 102.51 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.916 0.858 . . . . 0.0 110.295 171.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -123.52 33.22 5.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.729 1.211 . . . . 0.0 110.353 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.1 t -156.58 138.43 14.33 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.427 0.691 . . . . 0.0 109.692 174.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -73.72 43.3 0.15 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.441 1.496 . . . . 0.0 113.705 -171.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -137.93 12.87 2.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.136 0.974 . . . . 0.0 111.027 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.7 m -127.58 60.01 1.43 Allowed 'General case' 0 C--N 1.339 0.135 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.73 -75.31 0.5 Allowed 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.2 t -50.7 -43.14 57.65 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 m -49.53 -56.2 10.7 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.248 -0.283 . . . . 0.0 111.064 170.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.31 -49.11 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.294 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -51.81 -67.65 0.23 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.52 1.054 . . . . 0.0 110.806 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.33 -50.17 29.89 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.621 1.582 . . . . 0.0 111.882 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.23 -55.31 36.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.696 0.748 . . . . 0.0 109.846 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.9 mm -61.79 -28.75 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 124.2 1.0 . . . . 0.0 110.726 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.45 -20.36 16.45 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.632 1.11 . . . . 0.0 113.581 173.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -90.13 -6.22 55.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 119.304 1.552 . . . . 0.0 111.408 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.21 135.65 47.63 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 122.044 0.926 . . . . 0.0 111.291 -173.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -57.95 101.63 0.08 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.292 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.46 -24.85 6.41 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.821 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 t -81.95 137.76 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 118.917 1.358 . . . . 0.0 108.253 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -117.35 -34.59 4.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.087 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.11 161.28 38.4 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.818 1.19 . . . . 0.0 110.332 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tt -152.75 143.43 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.628 1.171 . . . . 0.0 110.054 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -141.08 108.68 5.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.365 1.866 . . . . 0.0 108.164 168.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.62 118.48 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 124.731 1.212 . . . . 0.0 109.352 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 t -104.89 82.45 1.87 Allowed 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.441 1.097 . . . . 0.0 109.164 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 12' ' ' MET . 0.2 OUTLIER -51.53 -49.37 62.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.988 0.915 . . . . 0.0 111.3 -176.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -44.43 -51.91 8.27 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 125.162 1.385 . . . . 0.0 110.866 172.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -75.58 -9.55 58.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.946 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 62.7 24.03 14.3 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.034 2.134 . . . . 0.0 110.896 -176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -141.78 160.42 40.23 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.89 1.276 . . . . 0.0 109.678 -170.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.99 158.87 43.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.8 0.84 . . . . 0.0 109.364 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.3 m -132.65 108.05 8.8 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 127.526 2.33 . . . . 0.0 106.202 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mt -116.82 156.23 18.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 124.044 0.938 . . . . 0.0 108.81 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.257 0.5 OUTLIER -132.3 114.07 22.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 118.078 0.399 . . . . 0.0 109.94 -175.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.444 ' HE1' HD12 ' A' ' 5' ' ' LEU . 52.8 p90 -157.41 179.05 9.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.402 1.081 . . . . 0.0 110.248 -169.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -141.17 132.18 13.47 Favored Pre-proline 0 N--CA 1.44 -0.934 0 C-N-CA 123.902 0.881 . . . . 0.0 110.482 -170.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.22 73.5 2.07 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.751 2.968 . . . . 0.0 110.108 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -144.79 -51.7 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.1 mt -87.87 -27.84 21.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.707 -0.664 . . . . 0.0 111.236 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.3 tp -120.93 143.6 32.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 CA-C-N 118.897 0.771 . . . . 0.0 110.169 -175.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -83.44 31.37 0.46 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -171.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.284 0.5 OUTLIER 74.78 -58.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 128.411 2.684 . . . . 0.0 111.447 170.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -80.77 -38.95 27.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.463 1.905 . . . . 0.0 108.247 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HB3' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -44.8 -53.53 7.33 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 123.774 0.83 . . . . 0.0 111.696 -174.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -34.9 -56.98 0.56 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.613 1.565 . . . . 0.0 110.065 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -42.09 71.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.765 0.426 . . . . 0.0 111.14 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -56.76 -28.5 61.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -63.22 -44.18 95.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.37 -46.26 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 117.987 -1.006 . . . . 0.0 111.038 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -52.12 -51.83 55.36 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.754 1.161 . . . . 0.0 108.421 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.59 -20.9 63.83 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.55 2.34 . . . . 0.0 114.056 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.4 mmt -54.82 -32.61 60.6 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.625 1.102 . . . . 0.0 110.123 168.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.47 43.08 0.48 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -147.05 132.61 9.24 Favored Pre-proline 0 C--O 1.223 -0.296 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.7 123.34 11.54 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 121.083 1.423 . . . . 0.0 108.953 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.71 175.02 9.37 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.572 1.177 . . . . 0.0 110.102 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -156.98 150.91 24.75 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.992 -1.068 . . . . 0.0 111.017 -163.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.457 ' CG2' HD21 ' A' ' 5' ' ' LEU . 10.0 p -126.58 125.21 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -174.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.3 mtmt -77.57 -71.06 0.44 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.262 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.42 ' O ' HD23 ' A' ' 5' ' ' LEU . 14.7 mttt -157.19 138.8 14.02 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 tp -147.97 102.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 125.371 1.468 . . . . 0.0 107.281 -174.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -156.46 154.66 30.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.456 0.571 . . . . 0.0 110.052 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.21 -173.0 31.43 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 107.587 -2.205 . . . . 0.0 107.587 -175.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 . . . . . 0 C--O 1.25 1.129 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 179.293 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.032 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -131.26 89.11 2.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.669 0.788 . . . . 0.0 109.442 -168.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.52 138.35 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 127.123 2.169 . . . . 0.0 107.1 174.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.3 t -92.08 132.42 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 125.501 1.52 . . . . 0.0 108.47 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.516 HD23 HG23 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -110.33 129.91 55.65 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 170.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.59 121.9 44.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.29 1.436 . . . . 0.0 107.127 169.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.451 ' HB3' HD11 ' A' ' 5' ' ' LEU . 26.4 ptt? -129.91 140.21 50.99 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.302 0.641 . . . . 0.0 110.479 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.84 145.22 34.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 164.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 t -136.16 72.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 125.663 1.585 . . . . 0.0 107.269 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -71.45 176.17 4.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.684 0.754 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.74 -48.17 3.94 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.553 -0.581 . . . . 0.0 113.149 166.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.43 ' HB3' HD11 ' A' ' 38' ' ' LEU . 2.3 mpt? -56.54 144.58 31.05 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.345 1.073 . . . . 0.0 109.577 172.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.4 t -143.21 138.26 29.56 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.554 0.742 . . . . 0.0 109.82 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m 60.01 152.8 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.775 2.03 . . . . 0.0 111.368 -168.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -71.74 70.68 0.71 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.465 -0.772 . . . . 0.0 111.352 -172.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.3 t -123.64 -79.79 0.62 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.571 1.948 . . . . 0.0 107.719 -166.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 60.9 m -68.36 72.53 0.21 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.041 1.337 . . . . 0.0 109.742 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.2 p -139.05 -86.73 0.23 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.408 1.883 . . . . 0.0 106.629 -174.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.95 -36.31 65.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -168.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.3 m -49.98 -61.66 2.01 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.871 167.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.83 -51.1 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -58.31 -63.82 1.13 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.516 0.674 . . . . 0.0 110.549 -173.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.7 -54.38 6.69 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.998 1.761 . . . . 0.0 112.165 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -59.3 -54.38 47.46 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.151 0.975 . . . . 0.0 110.447 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.1 mm -56.52 -33.33 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.448 0.699 . . . . 0.0 111.302 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.65 -20.44 17.91 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.645 1.117 . . . . 0.0 113.904 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -84.59 -20.25 31.76 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.646 1.723 . . . . 0.0 111.138 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 136.24 53.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 122.339 1.066 . . . . 0.0 111.75 -167.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.59 115.15 1.81 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.905 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.88 -22.38 12.7 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-O 119.076 -0.847 . . . . 0.0 112.507 176.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.25 128.31 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 118.318 1.059 . . . . 0.0 109.388 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -88.6 -48.47 7.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.935 1.294 . . . . 0.0 109.116 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.72 171.27 19.84 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.309 0.958 . . . . 0.0 111.124 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 tt -141.55 142.78 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 124.703 1.201 . . . . 0.0 109.677 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.78 106.79 6.3 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.259 1.424 . . . . 0.0 107.774 170.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.64 125.76 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.2 1.0 . . . . 0.0 109.352 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -115.01 82.62 1.77 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.725 1.21 . . . . 0.0 108.283 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.43 HD11 ' HB3' ' A' ' 12' ' ' MET . 3.9 tt -52.23 -44.29 64.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.836 0.854 . . . . 0.0 110.298 176.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -40.89 -55.19 2.55 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.95 1.3 . . . . 0.0 111.085 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -79.68 -7.61 58.69 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.234 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 61.49 23.66 13.9 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.551 2.34 . . . . 0.0 111.283 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -139.69 159.81 41.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.034 -168.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.63 159.03 44.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.299 0.64 . . . . 0.0 109.482 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.4 m -132.77 119.89 20.9 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.8 mt -106.64 155.17 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.45 121.19 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 168.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -157.75 -177.3 6.47 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 127.478 2.311 . . . . 0.0 107.95 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -137.76 149.05 63.31 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 119.98 1.264 . . . . 0.0 112.278 170.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.56 72.49 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.259 3.306 . . . . 0.0 110.266 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.15 -61.43 0.42 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.242 1.417 . . . . 0.0 108.372 173.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.1 mt -84.75 -19.82 32.05 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.798 -0.62 . . . . 0.0 110.815 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.3 tp -123.97 152.33 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 123.288 0.635 . . . . 0.0 110.143 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 m -81.39 20.27 0.89 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.141 0.977 . . . . 0.0 113.433 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 66.91 -61.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 129.23 3.012 . . . . 0.0 109.84 -172.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.94 -39.0 72.89 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.643 0.777 . . . . 0.0 110.066 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.4 mt-10 -47.47 -50.7 22.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.364 0.415 . . . . 0.0 111.663 -174.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.21 -48.22 6.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 122.934 0.494 . . . . 0.0 111.626 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -51.66 24.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 122.227 -0.296 . . . . 0.0 110.71 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -57.99 -27.6 63.63 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -60.51 -51.38 69.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.894 0.877 . . . . 0.0 108.681 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -56.95 -50.14 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.659 173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -53.93 -47.44 71.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.34 -20.64 60.12 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.441 1.496 . . . . 0.0 114.227 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 34.7 mmt -60.94 -29.97 69.94 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.956 1.253 . . . . 0.0 110.348 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.42 -34.74 1.7 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 173.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -77.09 110.53 12.39 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.192 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.72 116.95 4.23 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.737 1.625 . . . . 0.0 109.217 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.84 -169.5 2.13 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.236 1.014 . . . . 0.0 109.438 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.46 136.87 8.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.753 1.16 . . . . 0.0 113.355 -169.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.04 136.11 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.76 1.224 . . . . 0.0 108.913 174.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -96.46 -70.63 0.71 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -147.12 158.89 44.09 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.516 HG23 HD23 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -145.63 83.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 125.461 1.504 . . . . 0.0 110.735 -159.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -161.4 177.41 10.14 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.416 0.553 . . . . 0.0 111.941 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.52 -157.33 6.44 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.433 0.54 . . . . 0.0 111.938 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 116.908 -1.52 . . . . 0.0 108.937 173.459 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.26 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -117.25 171.12 8.16 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.253 1.021 . . . . 0.0 109.151 -169.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.793 HG13 HD11 ' A' ' 73' ' ' ILE . 7.4 p -95.07 142.33 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.592 0.711 . . . . 0.0 109.896 -174.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.7 t -80.69 136.45 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 125.262 1.425 . . . . 0.0 109.784 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.662 HD21 HG22 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -127.65 138.37 52.81 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.274 1.83 . . . . 0.0 108.077 177.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.556 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.2 ttpt -110.68 114.79 28.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.806 1.242 . . . . 0.0 109.77 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.5 ptp -109.52 151.5 26.67 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.372 1.069 . . . . 0.0 109.827 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -89.67 133.34 34.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 163.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 t -118.71 78.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -72.91 167.93 20.0 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.928 0.87 . . . . 0.0 111.475 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.18 -76.95 1.04 Allowed Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.8 ttp 46.75 -127.78 1.53 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.372 1.469 . . . . 0.0 112.349 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.6 t -162.77 -171.89 2.88 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.194 1.361 . . . . 0.0 109.385 171.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 92.0 m -51.57 -70.91 0.07 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 126.182 1.793 . . . . 0.0 113.246 -170.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -140.88 43.38 1.82 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.669 0.747 . . . . 0.0 109.612 177.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.5 t -158.7 -152.41 0.33 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m 51.44 46.59 26.27 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -165.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.468 HG22 HG12 ' A' ' 36' ' ' VAL . 9.9 p -128.62 -77.09 0.56 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 174.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.4 m -49.08 -40.91 33.69 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -175.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.3 m -48.99 -58.49 4.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.144 0.497 . . . . 0.0 111.698 169.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.58 -45.24 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 123.937 0.895 . . . . 0.0 108.988 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HA ' HG21 ' A' ' 34' ' ' ILE . 47.1 mt-10 -54.35 -62.5 1.62 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.645 1.111 . . . . 0.0 110.568 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.4 -54.01 14.34 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.352 1.453 . . . . 0.0 111.754 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -60.73 -58.14 9.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.624 0.712 . . . . 0.0 110.45 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.435 HG21 HD12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -57.31 -39.05 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.063 0.945 . . . . 0.0 110.3 -177.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.06 -13.98 9.97 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.042 1.306 . . . . 0.0 113.829 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -95.5 -15.35 22.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.849 1.324 . . . . 0.0 110.667 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 141.2 55.66 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 119.528 1.058 . . . . 0.0 111.96 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -59.32 114.32 2.6 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.677 173.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.05 -22.74 9.62 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.436 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.16 139.01 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 117.966 0.883 . . . . 0.0 109.265 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -105.48 -45.87 4.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.468 1.507 . . . . 0.0 110.207 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.59 161.7 42.06 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 22' ' ' GLU . 7.9 tt -146.78 140.49 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.712 1.205 . . . . 0.0 109.375 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.63 105.18 6.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.319 1.847 . . . . 0.0 106.903 173.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.468 HG12 HG22 ' A' ' 18' ' ' THR . 46.3 t -105.56 116.44 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.816 1.189 . . . . 0.0 108.862 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -80.47 179.69 7.6 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.338 0.589 . . . . 0.0 110.176 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.2 -59.74 1.3 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.284 1.434 . . . . 0.0 108.225 173.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -43.84 -54.64 5.09 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.983 1.313 . . . . 0.0 110.083 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -80.55 -12.66 59.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.012 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 61.95 15.76 7.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.963 1.705 . . . . 0.0 112.736 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -124.76 156.72 37.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.556 1.543 . . . . 0.0 109.689 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HB2' HG13 ' A' ' 36' ' ' VAL . . . -139.56 152.63 47.04 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.538 0.735 . . . . 0.0 110.104 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.3 m -128.24 113.85 16.19 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.548 1.939 . . . . 0.0 105.991 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.73 160.59 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -128.51 119.11 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -158.28 178.13 10.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.261 1.424 . . . . 0.0 110.239 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -133.53 149.82 73.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.295 1.038 . . . . 0.0 113.547 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.68 80.67 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.665 2.91 . . . . 0.0 109.114 169.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.2 -61.2 0.25 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.46 1.104 . . . . 0.0 108.073 173.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 40.9 mt -87.59 -21.12 25.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.003 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.2 tp -123.96 148.79 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.07 0.948 . . . . 0.0 109.851 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.0 m -79.39 23.98 0.37 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.256 0.8 OUTLIER 70.09 -57.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 128.047 2.539 . . . . 0.0 110.054 -176.18 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.09 -40.7 37.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.398 1.079 . . . . 0.0 110.144 -176.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -48.19 -48.44 34.69 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 122.739 0.415 . . . . 0.0 111.668 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -37.89 -56.43 1.11 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.695 1.198 . . . . 0.0 112.212 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.17 -45.19 42.28 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.254 1.021 . . . . 0.0 112.478 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.44 -29.36 15.82 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.191 -0.943 . . . . 0.0 112.663 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -62.27 -34.31 76.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -70.1 -44.32 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 118.419 -0.801 . . . . 0.0 109.811 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -50.86 -49.34 59.25 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.51 44.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.273 1.029 . . . . 0.0 113.756 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.3 mmm -66.8 -30.85 71.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.444 1.02 . . . . 0.0 110.247 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.23 -36.91 1.99 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.315 0.96 . . . . 0.0 111.142 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -79.56 123.73 84.09 Favored Pre-proline 0 N--CA 1.455 -0.179 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.305 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.15 118.33 5.35 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.508 1.472 . . . . 0.0 108.596 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.76 -174.56 2.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -162.87 143.79 9.73 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.888 -1.132 . . . . 0.0 110.935 -174.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.662 HG22 HD21 ' A' ' 5' ' ' LEU . 1.2 t -111.8 132.61 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -77.41 -74.44 0.25 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.811 0.444 . . . . 0.0 111.046 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -156.7 151.24 25.57 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.793 HD11 HG13 ' A' ' 3' ' ' VAL . 4.3 tp -155.39 138.5 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 125.034 1.334 . . . . 0.0 108.979 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.439 ' O ' HG21 ' A' ' 3' ' ' VAL . 8.4 pt-20 -159.19 147.02 17.58 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.741 1.217 . . . . 0.0 108.974 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.46 109.6 0.3 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -171.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? . . . . . 0 C--O 1.249 1.053 0 CA-C-O 116.636 -1.65 . . . . 0.0 110.224 -159.37 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.444 0 CA-C-O 119.801 -0.444 . . . . 0.0 113.66 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.46 ' HB2' HG22 ' A' ' 46' ' ' VAL . 23.3 mp0 -87.63 179.83 6.45 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.95 1.3 . . . . 0.0 109.137 -164.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.7 t -83.62 125.78 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -173.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 t -77.1 121.41 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.602 HD21 HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -117.96 132.75 56.36 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.551 1.54 . . . . 0.0 106.897 175.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.97 137.84 36.94 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.2 1.0 . . . . 0.0 110.196 171.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -138.71 147.44 42.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.177 0.991 . . . . 0.0 109.882 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -92.25 128.56 38.14 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 t -120.65 73.01 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 125.24 1.416 . . . . 0.0 108.755 -171.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -73.27 174.7 7.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.784 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.18 -45.66 3.25 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 121.807 -0.558 . . . . 0.0 113.015 167.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -56.2 153.93 8.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.04 0.92 . . . . 0.0 109.508 167.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -142.87 129.24 19.99 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.805 0.842 . . . . 0.0 109.378 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 m 60.93 175.54 0.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.114 1.365 . . . . 0.0 112.208 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -74.96 56.24 0.74 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.196 0.999 . . . . 0.0 111.173 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.9 p -104.09 -80.87 0.53 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.753 1.221 . . . . 0.0 107.956 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.1 m -74.73 68.95 1.75 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.321 1.448 . . . . 0.0 108.375 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.5 p -129.71 -78.1 0.55 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 m -56.4 -38.19 71.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -169.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -50.18 -59.34 4.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.75 0.42 . . . . 0.0 110.404 168.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.72 -49.34 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 118.563 -0.732 . . . . 0.0 109.372 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.38 -65.65 0.54 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 119.063 0.847 . . . . 0.0 111.071 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.9 -52.22 26.68 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.117 1.342 . . . . 0.0 112.206 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.2 tptt -52.15 -58.05 7.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.533 0.733 . . . . 0.0 109.461 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.44 -34.98 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.6 1.16 . . . . 0.0 111.108 -176.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.87 -23.03 10.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.01 1.29 . . . . 0.0 113.664 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -89.36 -17.22 29.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.577 1.188 . . . . 0.0 110.239 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.43 136.63 49.71 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.327 1.06 . . . . 0.0 111.688 -173.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -52.08 109.27 0.36 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.037 1.335 . . . . 0.0 111.111 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.24 -23.48 8.56 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 118.928 -0.929 . . . . 0.0 112.788 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.3 t -79.79 142.9 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 118.49 1.145 . . . . 0.0 110.056 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -117.12 -40.24 3.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.546 1.138 . . . . 0.0 111.812 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.89 165.68 34.7 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.748 0.704 . . . . 0.0 109.168 173.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -143.95 145.05 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 125.518 1.527 . . . . 0.0 108.417 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -139.99 97.98 3.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.424 2.29 . . . . 0.0 107.101 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -96.09 116.43 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.131 0.972 . . . . 0.0 109.09 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.8 t -108.72 80.01 1.29 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -54.02 -41.01 67.53 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.855 0.462 . . . . 0.0 111.747 -176.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.81 -55.05 3.83 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.93 1.292 . . . . 0.0 110.584 168.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -78.57 -19.83 51.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.75 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 72.65 4.72 5.07 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.796 2.438 . . . . 0.0 111.627 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -109.99 151.95 26.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.541 1.536 . . . . 0.0 109.02 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.6 157.81 44.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.991 0.916 . . . . 0.0 108.63 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -129.33 121.56 27.72 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.8 mt -111.52 153.35 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 2' ' ' GLU 0.254 7.0 p -117.87 114.7 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.991 0.917 . . . . 0.0 108.906 173.095 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -158.95 178.93 9.55 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.721 1.208 . . . . 0.0 110.681 -171.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -138.19 144.73 44.48 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HB3' HG23 ' A' ' 54' ' ' VAL . 73.9 Cg_endo -69.6 71.93 1.4 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.547 3.498 . . . . 0.0 110.826 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.32 -58.15 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.399 1.08 . . . . 0.0 108.507 172.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.3 mt -87.5 -21.81 25.26 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.877 -0.582 . . . . 0.0 110.869 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.0 tp -118.76 151.12 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 123.622 0.769 . . . . 0.0 109.823 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 m -85.88 29.83 0.7 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.637 0.775 . . . . 0.0 112.72 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 49' ' ' PRO 0.265 0.5 OUTLIER 73.76 -59.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.085 2.554 . . . . 0.0 110.4 176.115 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -81.01 -38.01 28.2 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.303 1.441 . . . . 0.0 109.786 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.555 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.8 mm-40 -43.76 -48.69 8.1 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 123.747 0.655 . . . . 0.0 111.346 -174.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.24 -53.74 3.11 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.661 0.784 . . . . 0.0 112.029 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -47.22 54.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.199 0.2 . . . . 0.0 110.619 177.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -54.54 -28.38 45.16 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -62.53 -52.24 64.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.5 mp -58.2 -43.14 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.183 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -55.48 -53.71 52.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.5 -27.35 62.47 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.172 1.789 . . . . 0.0 114.097 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.2 mmm -51.37 -31.45 22.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.687 1.13 . . . . 0.0 110.974 172.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.63 42.72 0.28 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -146.82 120.52 5.07 Favored Pre-proline 0 C--O 1.227 -0.087 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.13 102.04 0.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.953 1.769 . . . . 0.0 109.345 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.22 -175.47 3.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.819 0.848 . . . . 0.0 108.898 -175.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.33 143.83 15.34 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.602 HG22 HD21 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -93.97 136.71 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.546 1.538 . . . . 0.0 108.42 172.067 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -79.16 -81.81 0.11 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.543 0.156 . . . . 0.0 111.031 171.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -156.28 144.12 19.51 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.538 -0.726 . . . . 0.0 109.169 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -145.86 122.88 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 126.581 1.953 . . . . 0.0 105.838 -173.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.64 153.35 26.63 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.797 0.839 . . . . 0.0 109.023 171.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.98 113.68 0.91 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.413 1.006 . . . . 0.0 111.256 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? . . . . . 0 C--O 1.254 1.302 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.503 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.95 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.13 137.18 22.54 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.106 0.962 . . . . 0.0 111.832 -174.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.18 126.46 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 124.915 1.286 . . . . 0.0 108.561 -174.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.0 t -78.72 120.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -123.88 156.02 37.01 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.555 1.142 . . . . 0.0 109.237 -177.103 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.592 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -102.35 123.05 45.45 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.401 0.681 . . . . 0.0 110.039 177.708 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.1 mmt -105.95 157.72 17.3 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.703 1.201 . . . . 0.0 109.052 174.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.93 127.14 54.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 168.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.5 73.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.9 169.84 17.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.801 -174.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.73 -40.72 1.85 Allowed Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.934 -0.926 . . . . 0.0 113.708 172.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -59.88 80.31 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.581 1.153 . . . . 0.0 110.693 174.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.19 -38.8 12.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.844 1.658 . . . . 0.0 110.7 -174.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.7 p -59.86 134.18 56.79 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.21 42.67 0.42 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -165.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.9 t -172.13 85.51 0.07 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.797 1.239 . . . . 0.0 108.104 173.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 t -160.06 57.17 0.36 Allowed 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 p -135.68 -69.82 0.49 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.241 -172.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.5 t -53.08 -39.31 63.23 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -172.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 94.5 m -45.77 -61.36 1.75 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 123.194 0.598 . . . . 0.0 112.561 165.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.78 -49.12 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.317 1.047 . . . . 0.0 108.975 178.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -56.41 -65.91 0.53 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.989 0.916 . . . . 0.0 109.428 -176.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.05 -52.83 11.51 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.195 1.379 . . . . 0.0 112.492 176.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.19 -55.42 35.16 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.851 0.825 . . . . 0.0 110.233 -179.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.7 mm -60.59 -30.07 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 123.797 0.839 . . . . 0.0 110.851 -178.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.85 -19.52 6.98 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.07 171.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -90.51 -13.53 34.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 119.784 1.792 . . . . 0.0 111.217 177.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.65 134.0 50.36 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.496 1.141 . . . . 0.0 111.033 -173.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -55.55 110.9 0.78 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.116 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.38 -25.42 8.2 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.329 176.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 t -81.28 136.06 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 118.194 0.997 . . . . 0.0 109.045 -177.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -101.72 -42.92 6.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.797 1.239 . . . . 0.0 110.201 173.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 ttt-85 -153.98 161.35 42.03 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.849 0.75 . . . . 0.0 109.987 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 tt -149.08 139.33 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.583 1.153 . . . . 0.0 109.545 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -139.6 114.81 9.71 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.094 1.758 . . . . 0.0 106.593 174.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -113.99 126.23 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.986 1.314 . . . . 0.0 109.07 -178.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.3 t -84.58 172.41 11.63 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.536 0.684 . . . . 0.0 110.345 172.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.1 -63.25 1.48 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 170.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -52.64 -49.96 64.13 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 124.29 1.036 . . . . 0.0 109.313 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.9 -18.09 59.53 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.292 -172.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 62.62 4.74 1.46 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.324 1.85 . . . . 0.0 113.239 -175.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -107.86 152.93 23.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.263 1.825 . . . . 0.0 108.014 -169.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.13 161.27 37.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.47 0.708 . . . . 0.0 109.833 178.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.7 m -137.68 118.29 13.96 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 mt -120.27 160.85 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.244 1.018 . . . . 0.0 108.282 178.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.263 14.1 p -130.25 114.89 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.355 0.662 . . . . 0.0 109.888 178.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -158.97 178.66 9.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.229 1.011 . . . . 0.0 111.392 -175.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -134.65 148.82 68.89 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.419 1.088 . . . . 0.0 113.177 173.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -68.69 74.83 0.85 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.403 3.402 . . . . 0.0 110.006 171.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.26 -61.31 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.752 1.221 . . . . 0.0 107.812 170.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.4 mt -85.66 -20.86 28.79 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.092 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.436 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.9 tp -123.4 147.3 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 m -79.81 27.0 0.31 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.36 0.982 . . . . 0.0 112.68 -176.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.27 0.5 OUTLIER 73.25 -54.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 128.01 2.524 . . . . 0.0 110.817 179.334 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -88.3 -32.81 18.27 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.597 0.759 . . . . 0.0 111.218 -178.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.436 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.5 mt-10 -40.76 -51.57 3.07 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 123.254 0.622 . . . . 0.0 110.775 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -37.0 -63.94 0.39 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.443 1.497 . . . . 0.0 109.922 174.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.3 -43.99 97.54 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.905 -0.497 . . . . 0.0 111.091 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -58.08 -31.64 67.28 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -60.18 -48.38 81.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mp -58.6 -48.37 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.863 175.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -52.15 -50.79 61.06 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.324 0.966 . . . . 0.0 108.477 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.27 -21.46 61.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.067 1.747 . . . . 0.0 114.036 -177.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.0 mmt -63.26 -23.95 67.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.955 1.252 . . . . 0.0 110.478 172.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.99 40.77 0.74 Allowed Glycine 0 C--N 1.338 0.66 0 C-N-CA 124.279 0.942 . . . . 0.0 111.358 170.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -148.53 123.3 4.94 Favored Pre-proline 0 C--O 1.226 -0.152 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.8 118.28 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.361 1.374 . . . . 0.0 109.078 -178.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.66 -171.13 1.83 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.96 152.45 13.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.036 -1.04 . . . . 0.0 111.206 -173.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 p -118.62 124.23 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 126.362 1.865 . . . . 0.0 106.383 -178.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -74.91 -80.26 0.08 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.883 175.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -156.75 155.84 32.31 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 170.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -155.68 111.71 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.861 2.064 . . . . 0.0 107.41 -170.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -155.3 155.67 34.16 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.847 1.259 . . . . 0.0 107.795 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.69 169.33 37.9 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 172.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 . . . . . 0 C--O 1.25 1.116 0 C-N-CA 126.97 2.108 . . . . 0.0 109.235 -168.577 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.11 0 CA-C-O 118.649 -1.084 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -163.63 60.13 0.17 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 117.619 0.709 . . . . 0.0 110.967 -171.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.2 t -100.97 127.63 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 173.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.82 141.78 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.652 HD23 ' HB ' ' A' ' 73' ' ' ILE . 0.7 OUTLIER -142.64 131.91 23.41 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.773 0.829 . . . . 0.0 109.266 -179.579 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' N ' HD22 ' A' ' 5' ' ' LEU . 1.4 mtmt -103.62 129.78 50.96 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.04 1.336 . . . . 0.0 111.387 178.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.3 ptp -127.01 159.68 33.4 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.294 1.038 . . . . 0.0 110.67 176.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -98.73 124.81 43.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.014 1.726 . . . . 0.0 107.681 164.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -111.97 77.44 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.065 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 169.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.283 10.6 pt-20 -84.2 165.63 18.23 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.665 178.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.88 -35.99 4.39 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.459 -0.634 . . . . 0.0 113.759 176.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -65.57 159.83 23.78 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.78 1.29 . . . . 0.0 111.954 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.2 p -90.14 166.1 13.59 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.438 1.095 . . . . 0.0 110.608 -178.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.8 p -57.73 138.03 55.91 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.74 0.416 . . . . 0.0 110.546 175.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.8 t60 40.24 65.61 0.73 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.784 1.634 . . . . 0.0 113.077 176.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -160.07 27.88 0.17 Allowed 'General case' 0 CA--C 1.535 0.368 0 O-C-N 122.005 -0.434 . . . . 0.0 111.998 -170.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.554 ' SG ' HD21 ' A' ' 38' ' ' LEU . 15.6 p -167.33 -111.59 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.493 -167.559 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.7 p 33.82 -98.03 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 127.483 2.313 . . . . 0.0 111.931 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -49.32 -37.17 23.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -175.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.25 -51.37 69.85 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 175.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.59 -53.38 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.176 172.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -55.86 -61.1 2.59 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.325 0.966 . . . . 0.0 109.92 -171.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.48 -52.9 22.53 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.319 1.438 . . . . 0.0 111.729 177.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -60.7 -50.86 71.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.047 0.923 . . . . 0.0 110.323 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.5 mm -66.33 -24.33 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.89 0.876 . . . . 0.0 110.788 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.11 -14.55 32.72 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.945 -0.92 . . . . 0.0 113.604 170.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -84.54 -12.93 53.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.64 1.72 . . . . 0.0 110.607 173.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.63 135.31 46.88 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 122.307 1.051 . . . . 0.0 111.447 -171.156 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -60.93 113.77 2.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.221 177.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.83 -21.87 15.47 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-O 119.366 -0.686 . . . . 0.0 112.945 175.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 t -81.59 131.34 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.26 -51.34 5.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.151 1.38 . . . . 0.0 109.163 174.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -152.1 160.86 43.33 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tt -143.51 141.55 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.151 1.38 . . . . 0.0 108.488 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.54 125.93 20.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.734 1.614 . . . . 0.0 107.097 171.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -115.95 154.31 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.026 1.33 . . . . 0.0 107.696 -178.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.2 t -130.28 155.53 46.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.111 0.964 . . . . 0.0 109.216 176.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.554 HD21 ' SG ' ' A' ' 17' ' ' CYS . 3.6 mt -104.36 -59.71 1.7 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.299 1.84 . . . . 0.0 108.732 -177.155 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.79 -58.27 7.85 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.065 1.346 . . . . 0.0 109.619 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.7 -22.36 62.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.32 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 55.75 59.29 3.9 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 126.581 1.952 . . . . 0.0 109.775 176.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -156.34 160.72 39.95 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.465 1.506 . . . . 0.0 107.137 -172.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.63 159.04 43.01 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 118.931 0.787 . . . . 0.0 110.536 174.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.9 m -126.23 130.28 50.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 174.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.411 HG21 ' SD ' ' A' ' 57' ' ' MET . 2.6 mp -118.36 163.66 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.4 117.71 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.108 0.963 . . . . 0.0 108.846 176.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -159.61 -177.14 6.18 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.535 1.134 . . . . 0.0 111.255 -171.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -136.73 152.61 74.7 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 165.175 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.79 76.55 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.32 3.347 . . . . 0.0 109.541 171.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.71 -62.43 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.227 1.011 . . . . 0.0 108.679 175.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.9 mt -84.14 -27.21 28.3 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 119.361 -0.352 . . . . 0.0 110.142 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 52' ' ' ILE . 9.4 tp -117.74 146.74 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.321 1.048 . . . . 0.0 109.281 177.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -84.1 27.78 0.65 Allowed 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.434 ' CG2' HD12 ' A' ' 73' ' ' ILE 0.262 0.9 OUTLIER 70.42 -57.54 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 128.787 2.835 . . . . 0.0 111.42 179.883 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.72 -33.56 40.78 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.08 1.352 . . . . 0.0 110.04 -177.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -52.87 -49.61 65.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 123.203 0.314 . . . . 0.0 110.777 -177.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -31.57 -58.67 0.26 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.491 1.516 . . . . 0.0 111.283 172.316 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -46.71 67.13 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.177 -0.327 . . . . 0.0 111.306 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.8 -32.02 59.73 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.819 -0.551 . . . . 0.0 112.321 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -42.16 99.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.19 -47.94 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.694 172.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 7.5 mt-10 -49.79 -51.07 42.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.17 0.986 . . . . 0.0 108.835 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.84 -19.59 51.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.781 2.032 . . . . 0.0 114.056 -178.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.8 mmm -61.34 -30.47 70.53 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.626 1.103 . . . . 0.0 109.626 170.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.25 40.68 0.39 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.839 1.209 . . . . 0.0 111.553 170.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -148.62 122.12 4.66 Favored Pre-proline 0 C--O 1.223 -0.291 0 CA-C-O 117.12 -1.419 . . . . 0.0 107.604 -177.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -62.69 118.66 5.56 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.623 1.549 . . . . 0.0 109.001 -176.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . . . -120.78 175.16 6.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.216 1.008 . . . . 0.0 109.991 -178.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.81 138.67 18.02 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.95 -1.094 . . . . 0.0 111.178 -170.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.583 HG22 HD21 ' A' ' 5' ' ' LEU . 1.6 p -114.11 131.19 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -177.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -80.19 -83.04 0.11 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -178.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.93 146.97 17.96 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.108 0.563 . . . . 0.0 110.297 176.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.652 ' HB ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -148.91 133.27 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 127.543 2.337 . . . . 0.0 106.624 -177.586 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.97 161.42 39.6 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 165.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -47.36 119.94 5.19 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 174.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 . . . . . 0 C--O 1.251 1.173 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.585 -174.97 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.844 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 19.93 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.113 2.165 . . . . 0.0 115.364 173.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.14 130.92 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.49 135.44 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.515 HD21 HG22 ' A' ' 70' ' ' VAL . 1.5 tm? -125.67 144.41 50.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.272 1.429 . . . . 0.0 107.375 178.368 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.409 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -117.06 129.04 55.74 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.431 1.492 . . . . 0.0 109.136 174.679 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.3 ptp -124.04 152.07 43.04 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.614 1.166 . . . . 0.0 109.877 179.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -89.94 151.43 21.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 162.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG12 ' SD ' ' A' ' 12' ' ' MET . 1.6 t -132.27 68.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -62.9 115.47 4.41 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.672 -170.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 119.26 -34.41 4.3 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.389 -0.673 . . . . 0.0 113.37 173.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.44 ' HB3' HD21 ' A' ' 38' ' ' LEU . 1.7 mpt? -72.05 110.53 6.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.091 1.446 . . . . 0.0 108.078 173.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 t -160.07 61.81 0.35 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.852 0.751 . . . . 0.0 111.27 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 t -158.85 71.96 0.56 Allowed 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.222 -0.299 . . . . 0.0 110.234 174.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 10.38 70.35 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.709 2.803 . . . . 0.0 114.588 -179.211 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.1 t -159.84 -70.99 0.08 Allowed 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -174.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.5 m -65.5 78.37 0.07 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.587 1.155 . . . . 0.0 110.73 -176.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.6 p -140.53 -84.44 0.22 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.978 2.111 . . . . 0.0 106.403 -179.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 m -55.33 -36.25 66.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -171.099 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.6 m -50.76 -60.63 2.86 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.416 0.447 . . . . 0.0 111.051 167.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.9 -51.22 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -57.49 -66.75 0.41 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.552 0.691 . . . . 0.0 110.63 -174.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.19 -51.26 26.36 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.881 1.705 . . . . 0.0 111.911 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -54.89 -56.68 16.92 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.813 0.806 . . . . 0.0 109.367 177.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.9 mm -64.24 -28.56 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 C-N-CA 123.157 0.583 . . . . 0.0 111.052 -174.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.78 -19.98 23.43 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.376 0.989 . . . . 0.0 113.44 171.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -85.84 -18.61 32.37 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 119.627 1.714 . . . . 0.0 109.419 177.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.46 133.7 49.02 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.453 1.121 . . . . 0.0 111.336 -172.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -58.23 111.43 1.2 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.027 175.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.67 -27.34 6.28 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-O 119.165 -0.797 . . . . 0.0 112.639 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 t -81.07 136.19 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 118.167 0.984 . . . . 0.0 109.382 -176.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -107.87 -46.0 3.87 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.581 1.152 . . . . 0.0 110.668 176.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.61 159.7 42.37 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.5 tt -142.7 148.15 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.072 1.349 . . . . 0.0 109.854 179.1 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -145.27 113.11 6.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.791 2.036 . . . . 0.0 108.193 171.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.0 t -102.92 120.66 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.23 1.012 . . . . 0.0 110.168 176.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 m -102.72 89.32 3.46 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.516 1.126 . . . . 0.0 109.061 175.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 12' ' ' MET . 8.3 mt -58.81 173.66 0.41 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.201 160.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 66.41 -65.63 0.19 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 127.968 2.507 . . . . 0.0 109.574 -170.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -27.85 69.0 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.095 178.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.93 50.82 0.8 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.674 2.39 . . . . 0.0 111.718 172.628 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -140.22 148.16 41.11 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.217 2.207 . . . . 0.0 106.206 -174.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.43 155.84 45.13 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 120.924 -1.11 . . . . 0.0 109.679 172.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.76 136.66 34.35 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.41 163.17 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.36 119.1 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -159.0 -179.33 7.95 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.684 1.194 . . . . 0.0 109.908 -172.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -138.23 144.1 41.79 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.1 80.27 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.305 3.337 . . . . 0.0 109.921 174.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -158.35 -54.32 0.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.7 mt -86.75 -29.48 22.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.417 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.6 tp -115.68 145.13 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m -78.24 23.49 0.28 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 -175.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 76.03 -58.51 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 127.27 2.228 . . . . 0.0 109.786 176.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.99 -39.26 42.93 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.476 1.511 . . . . 0.0 109.669 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.407 ' HB3' HD11 ' A' ' 52' ' ' ILE . 3.4 mt-10 -40.39 -57.11 1.86 Allowed 'General case' 0 C--N 1.345 0.388 0 C-N-CA 123.942 0.897 . . . . 0.0 111.043 -178.381 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.5 -58.29 0.33 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.999 1.72 . . . . 0.0 110.477 175.505 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -48.08 51.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.151 -0.343 . . . . 0.0 111.838 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -55.93 -30.43 61.64 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -174.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -59.6 -46.41 89.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -63.93 -47.11 92.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.008 175.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -50.38 -51.94 41.64 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.79 -18.83 57.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.503 1.921 . . . . 0.0 114.209 -178.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.6 mmm -59.12 -29.76 67.62 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.874 1.216 . . . . 0.0 109.796 170.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.94 44.36 0.28 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 124.347 0.975 . . . . 0.0 110.851 171.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -146.76 120.98 5.16 Favored Pre-proline 0 C--O 1.225 -0.196 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -175.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.22 99.01 0.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.942 1.761 . . . . 0.0 110.086 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.22 -176.63 2.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -174.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.6 141.13 11.57 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 122.6 0.36 . . . . 0.0 111.572 -176.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.515 HG22 HD21 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -95.12 143.61 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.22 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -83.29 -89.72 0.09 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.418 1.087 . . . . 0.0 110.171 175.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 142.14 22.63 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.515 ' HB ' HD23 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -134.8 127.74 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 129.133 2.973 . . . . 0.0 103.925 179.563 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -162.98 151.79 14.59 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 119.204 0.911 . . . . 0.0 110.178 167.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.25 -156.61 23.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 174.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.1 ttm105 . . . . . 0 C--O 1.255 1.373 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 170.451 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.114 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -99.04 158.49 15.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.684 0.794 . . . . 0.0 109.902 -174.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.3 t -124.07 151.55 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 125.511 1.524 . . . . 0.0 108.411 -176.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.09 143.73 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 124.619 1.168 . . . . 0.0 111.389 -175.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.43 132.86 53.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.278 1.431 . . . . 0.0 108.191 175.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.43 109.71 21.49 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.301 1.44 . . . . 0.0 107.648 175.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.7 ptm -113.39 164.78 13.16 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.691 0.796 . . . . 0.0 111.084 174.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -109.99 131.02 55.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 129.711 3.204 . . . . 0.0 106.581 177.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.4 t -121.25 77.69 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.03 177.13 4.53 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.954 0.883 . . . . 0.0 111.7 -176.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.47 -53.61 4.5 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.626 -0.671 . . . . 0.0 111.546 176.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.7 mmt -69.23 131.83 45.54 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.205 -0.585 . . . . 0.0 110.008 175.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 t -164.36 46.84 0.11 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.539 0.735 . . . . 0.0 110.199 179.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.2 t -154.5 45.22 0.54 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.508 -0.745 . . . . 0.0 111.09 -179.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 24.66 57.69 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.288 2.235 . . . . 0.0 114.158 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.3 t -159.43 40.65 0.21 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -173.056 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -167.99 69.03 0.08 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.9 p -129.85 -79.09 0.55 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 t -55.04 -38.31 67.81 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -164.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -49.36 -58.4 5.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.876 0.47 . . . . 0.0 111.789 167.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.65 -51.43 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.752 0.821 . . . . 0.0 108.914 176.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.32 -63.59 1.14 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.28 0.632 . . . . 0.0 110.436 -174.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.98 -53.57 14.1 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.712 1.625 . . . . 0.0 112.411 174.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -62.14 -51.67 66.93 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.199 0.999 . . . . 0.0 110.925 -176.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 mm -55.63 -35.88 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.738 0.815 . . . . 0.0 110.537 173.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.01 -12.45 22.61 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.626 1.108 . . . . 0.0 114.006 173.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -87.94 -20.35 26.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.447 1.623 . . . . 0.0 109.914 172.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 131.78 45.82 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.714 1.245 . . . . 0.0 112.156 -172.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -50.06 107.29 0.15 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.551 170.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.7 -27.3 6.29 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-O 118.9 -0.945 . . . . 0.0 112.464 175.299 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 t -81.9 133.15 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.37 -41.97 5.37 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.342 0.519 . . . . 0.0 111.931 167.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.411 ' H ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -136.78 161.73 35.16 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.161 0.891 . . . . 0.0 110.006 -175.23 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 tt -152.68 146.99 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.95 0.9 . . . . 0.0 110.96 -176.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -144.84 102.27 3.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.579 1.952 . . . . 0.0 108.658 169.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.5 t -99.26 100.1 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.286 1.034 . . . . 0.0 110.089 177.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.0 m -89.12 77.53 7.55 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.92 0.888 . . . . 0.0 109.609 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.0 tp -53.61 -35.12 60.56 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.596 0.758 . . . . 0.0 110.334 177.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -38.71 -52.3 1.68 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.361 1.464 . . . . 0.0 111.325 167.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.28 -7.14 58.73 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.096 -173.152 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 63.56 17.1 10.14 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.969 2.108 . . . . 0.0 111.312 -172.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -139.61 145.29 38.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.79 1.236 . . . . 0.0 110.225 -170.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.03 147.79 46.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.401 0.68 . . . . 0.0 110.809 -167.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -130.15 110.81 11.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.99 1.716 . . . . 0.0 107.073 -167.44 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.21 171.46 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 33' ' ' ARG . 0.6 OUTLIER -141.65 123.76 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 119.096 0.862 . . . . 0.0 109.619 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -155.93 176.73 12.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.776 0.83 . . . . 0.0 110.711 -174.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -123.65 141.14 35.79 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.236 1.014 . . . . 0.0 112.367 175.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.39 81.04 1.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.151 3.234 . . . . 0.0 109.753 176.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 -51.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.5 0.72 . . . . 0.0 109.512 177.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.4 mt -86.72 -36.59 18.57 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -179.208 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.5 tp -109.4 149.5 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 m -86.64 32.91 0.64 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 122.912 0.485 . . . . 0.0 111.645 -174.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 68.55 -56.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 129.911 3.284 . . . . 0.0 111.641 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -96.21 -26.81 15.29 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 126.846 2.059 . . . . 0.0 110.689 -170.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -43.18 -48.46 6.46 Favored 'General case' 0 C--N 1.347 0.484 0 O-C-N 123.524 0.515 . . . . 0.0 110.723 177.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -47.24 -61.52 1.86 Allowed 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 123.272 0.629 . . . . 0.0 111.267 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.24 -45.44 93.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.232 1.013 . . . . 0.0 110.395 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -57.19 -27.88 62.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.876 176.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -47.89 75.45 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 175.288 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.64 -45.01 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 118.563 -0.732 . . . . 0.0 109.604 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -54.74 -52.94 60.95 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 122.128 0.966 . . . . 0.0 108.796 176.011 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.69 -24.52 66.81 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.683 1.593 . . . . 0.0 113.416 -174.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.6 mmm -53.38 -35.11 59.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.26 0.937 . . . . 0.0 110.179 168.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.94 -30.48 2.56 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.59 1.091 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.93 127.98 60.07 Favored Pre-proline 0 N--CA 1.456 -0.154 0 CA-C-O 118.389 -0.815 . . . . 0.0 108.945 -173.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.92 129.14 26.36 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.061 1.841 . . . . 0.0 109.383 -178.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -134.46 165.71 24.55 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.622 0.725 . . . . 0.0 109.723 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -156.0 153.58 29.72 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.192 -0.942 . . . . 0.0 110.786 -161.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.88 122.06 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.01 0.924 . . . . 0.0 109.183 -171.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.3 mttt -94.25 -54.99 3.34 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.203 0.601 . . . . 0.0 110.87 177.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -123.46 136.99 54.88 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.787 0.435 . . . . 0.0 110.142 -175.059 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.7 177.56 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.119 2.168 . . . . 0.0 110.183 -168.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.07 176.89 9.24 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.368 1.467 . . . . 0.0 111.059 -176.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 55.4 -154.15 12.13 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.598 0.618 . . . . 0.0 112.07 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.375 1.07 . . . . 0.0 111.915 166.021 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.298 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -51.02 149.92 3.36 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 131.439 3.896 . . . . 0.0 111.909 169.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 t -138.77 151.09 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 126.083 1.753 . . . . 0.0 107.656 -178.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.02 130.36 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.29 1.036 . . . . 0.0 110.901 -177.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -123.97 152.32 42.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.732 1.613 . . . . 0.0 108.072 175.106 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.589 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.58 136.79 54.7 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.501 1.12 . . . . 0.0 109.063 174.874 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 ptp -126.4 143.1 51.29 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.8 1.64 . . . . 0.0 109.209 -177.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.26 131.39 34.74 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 167.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.12 84.55 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.84 161.6 30.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.428 0.632 . . . . 0.0 112.516 -174.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.35 -47.69 1.73 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.69 0.662 . . . . 0.0 113.739 176.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.4 ttp -56.94 109.79 0.7 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.488 1.515 . . . . 0.0 109.93 -175.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -119.08 153.15 35.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.488 1.115 . . . . 0.0 110.622 -171.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.3 m 67.96 151.41 0.08 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.066 2.146 . . . . 0.0 112.261 179.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -76.42 58.02 1.27 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.322 1.049 . . . . 0.0 111.288 -174.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.7 t -133.54 -69.27 0.55 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.186 1.394 . . . . 0.0 107.449 -167.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.1 m -70.44 77.1 0.56 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 168.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.4 p -148.17 -80.49 0.14 Allowed 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.757 1.623 . . . . 0.0 107.15 178.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.8 t -53.16 -41.92 65.63 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -172.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.6 m -48.27 -56.68 7.4 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.651 168.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.45 -49.16 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -53.28 -66.67 0.35 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.341 0.973 . . . . 0.0 110.593 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.25 -53.93 8.95 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.728 1.633 . . . . 0.0 112.396 176.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -57.55 -51.0 71.27 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 117.825 0.813 . . . . 0.0 110.317 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.1 mm -62.98 -28.61 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.216 0.607 . . . . 0.0 110.603 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.61 -17.07 8.08 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 118.705 -1.053 . . . . 0.0 114.207 169.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -87.43 -18.02 30.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 120.123 1.961 . . . . 0.0 111.093 174.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.3 136.0 56.74 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.068 0.937 . . . . 0.0 110.566 -171.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -68.46 119.69 13.34 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.642 -175.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.59 -20.14 23.09 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-O 118.824 -0.987 . . . . 0.0 112.937 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.77 136.66 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 118.669 1.234 . . . . 0.0 109.547 -177.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -100.98 -47.79 4.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.054 1.342 . . . . 0.0 110.181 174.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.97 161.04 43.02 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.42 0.554 . . . . 0.0 109.53 -178.127 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 tt -138.5 145.03 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.5 1.52 . . . . 0.0 109.234 177.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -138.7 106.89 5.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.223 2.209 . . . . 0.0 107.582 171.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.5 t -102.05 98.96 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.308 0.958 . . . . 0.0 110.335 176.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 m -88.31 82.16 7.11 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.288 1.035 . . . . 0.0 109.61 177.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -49.94 -43.69 50.12 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.58 0.752 . . . . 0.0 111.367 -179.581 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.63 -52.45 2.22 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 125.953 1.701 . . . . 0.0 111.204 170.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -82.71 -9.62 59.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.88 -172.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 64.04 20.43 12.19 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.323 1.849 . . . . 0.0 111.279 -178.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -144.23 141.71 30.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.208 1.403 . . . . 0.0 109.354 -169.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.65 151.77 44.49 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.902 0.881 . . . . 0.0 109.476 -178.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.1 m -124.52 119.57 29.5 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 127.105 2.162 . . . . 0.0 105.667 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.415 HG21 ' SD ' ' A' ' 57' ' ' MET . 58.3 mt -125.07 161.19 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.04 123.97 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -156.22 173.14 17.28 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.506 1.122 . . . . 0.0 109.238 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.51 146.85 51.12 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 170.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -71.66 75.99 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.757 3.638 . . . . 0.0 110.332 177.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -151.85 -54.67 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.5 mt -89.28 -22.47 22.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.669 -177.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' A' ' 56' ' ' GLU . 9.0 tp -121.47 149.46 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.785 0.834 . . . . 0.0 109.537 177.471 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.9 m -84.95 30.46 0.58 Allowed 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 123.491 0.717 . . . . 0.0 112.098 -175.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 t 72.1 -62.77 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 128.931 2.893 . . . . 0.0 108.568 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -84.92 -31.07 23.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.98 -171.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HB3' HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -43.96 -51.81 7.41 Favored 'General case' 0 C--N 1.342 0.248 0 O-C-N 123.83 0.706 . . . . 0.0 110.965 -179.287 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.415 ' SD ' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -39.79 -61.11 0.88 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.061 1.344 . . . . 0.0 109.193 -179.977 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -44.86 88.08 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.027 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -54.4 -33.57 59.57 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.942 0.792 . . . . 0.0 112.913 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -59.75 -47.39 85.87 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.28 -48.93 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.912 174.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -53.59 -48.21 69.44 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.101 0.953 . . . . 0.0 109.042 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.13 -20.05 62.23 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.324 1.449 . . . . 0.0 113.546 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 79.9 mmm -62.43 -29.84 70.8 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.687 1.13 . . . . 0.0 109.933 170.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.93 -34.93 2.1 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.064 0.84 . . . . 0.0 111.046 177.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -82.07 112.76 38.23 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-O 117.482 -1.247 . . . . 0.0 108.201 -178.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -60.64 137.15 71.54 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.506 1.471 . . . . 0.0 108.888 -179.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.53 -162.98 0.98 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.839 0.456 . . . . 0.0 110.098 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -170.07 148.48 3.4 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.658 0.783 . . . . 0.0 111.226 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.84 128.66 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.581 1.152 . . . . 0.0 108.283 177.026 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -105.34 -68.98 0.84 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 117.895 0.316 . . . . 0.0 111.101 168.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HB2' ' H ' ' A' ' 6' ' ' LYS . 31.4 mtpt -89.01 174.29 7.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.0 tt -156.84 177.88 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.271 1.828 . . . . 0.0 106.672 -172.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.4 176.33 7.59 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.289 1.404 . . . . 0.0 110.02 -178.245 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.05 -161.29 28.44 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.284 0 C-N-CA 127.721 2.408 . . . . 0.0 104.895 -178.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.269 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.04 122.12 10.24 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.219 1.51 . . . . 0.0 109.51 179.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.4 143.91 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.624 1.17 . . . . 0.0 108.802 -178.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.6 t -79.27 140.48 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.491 1.116 . . . . 0.0 109.063 -177.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.55 HD22 ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -123.58 129.29 50.96 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 126.17 1.788 . . . . 0.0 106.989 173.679 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.55 ' N ' HD22 ' A' ' 5' ' ' LEU . 7.7 ttpt -108.82 130.44 55.4 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.806 0.691 . . . . 0.0 109.615 172.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -138.21 157.65 45.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.162 0.985 . . . . 0.0 110.989 -172.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.7 144.52 26.6 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 170.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 t -128.61 66.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.58 1.552 . . . . 0.0 107.485 175.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.77 173.44 12.48 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.293 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.42 -40.12 1.51 Allowed Glycine 0 CA--C 1.533 1.193 0 CA-C-O 119.273 -0.737 . . . . 0.0 113.809 175.172 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.67 143.07 2.89 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.219 1.01 . . . . 0.0 111.978 177.039 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 t -54.98 148.63 13.15 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.112 167.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.8 m -60.65 162.1 6.96 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 166.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 t60 8.89 79.46 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.249 3.02 . . . . 0.0 114.598 -177.658 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 m -172.14 -62.57 0.02 OUTLIER 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.862 1.265 . . . . 0.0 109.299 177.345 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.4 m -80.1 65.17 5.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.967 0.413 . . . . 0.0 110.792 -172.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.6 p -120.18 -80.65 0.62 Allowed 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 167.547 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 m -55.81 -37.13 68.23 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -163.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.9 m -52.38 -56.56 14.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 168.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.29 -49.63 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -53.21 -64.03 0.95 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.122 0.963 . . . . 0.0 110.9 -177.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.84 -51.28 13.42 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.632 1.587 . . . . 0.0 112.902 174.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -60.54 -63.72 1.2 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.618 0.709 . . . . 0.0 109.866 -178.481 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -53.24 -40.06 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.071 1.348 . . . . 0.0 110.613 -179.62 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.81 -23.66 16.01 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.012 1.291 . . . . 0.0 113.568 177.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -88.67 -17.01 30.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 119.151 1.475 . . . . 0.0 111.147 178.142 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 134.6 53.38 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.472 1.13 . . . . 0.0 111.861 -172.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -52.73 107.18 0.2 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.137 176.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.29 -32.76 4.03 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-O 119.144 -0.809 . . . . 0.0 111.773 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.29 136.99 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 118.093 0.947 . . . . 0.0 109.283 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -103.2 -45.63 4.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.273 1.429 . . . . 0.0 110.478 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -153.66 160.22 42.3 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 121.82 -0.55 . . . . 0.0 110.004 -178.313 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.8 tt -141.01 140.02 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.331 1.452 . . . . 0.0 109.776 178.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -133.05 117.16 17.23 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.8 1.64 . . . . 0.0 107.782 165.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.2 t -108.61 107.61 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 124.491 1.117 . . . . 0.0 109.868 177.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -89.5 89.47 7.86 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.48 -45.93 69.8 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.381 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -41.84 -61.18 1.17 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 126.114 1.766 . . . . 0.0 110.709 171.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -75.38 -9.92 58.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.05 -174.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 67.28 6.79 5.06 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 127.313 2.245 . . . . 0.0 111.741 -174.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -119.88 144.11 47.57 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.331 1.853 . . . . 0.0 108.132 -171.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.01 155.14 48.53 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.37 0.668 . . . . 0.0 109.23 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 m -135.68 112.74 10.38 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 126.195 1.798 . . . . 0.0 106.521 -171.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.94 169.08 6.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -137.78 123.71 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -159.23 -178.33 7.11 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.105 1.362 . . . . 0.0 109.982 -173.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -130.6 150.35 76.09 Favored Pre-proline 0 C--N 1.347 0.499 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 164.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.45 74.81 0.55 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.698 3.599 . . . . 0.0 109.506 169.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -147.62 -61.86 0.27 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.859 1.264 . . . . 0.0 107.617 -177.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.5 mt -91.98 -21.63 20.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.126 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 52' ' ' ILE . 11.3 tp -121.52 146.86 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.095 0.958 . . . . 0.0 108.637 179.306 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.4 m -82.39 31.93 0.4 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 119.378 0.99 . . . . 0.0 113.03 -174.032 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.252 0.5 OUTLIER 72.64 -62.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 127.876 2.47 . . . . 0.0 108.01 -177.082 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -86.43 -28.09 23.74 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.89 -170.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -46.54 -44.89 18.23 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.36 0.527 . . . . 0.0 110.779 177.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.9 -69.22 0.14 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.22 1.408 . . . . 0.0 109.954 173.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -41.97 97.58 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.64 -0.663 . . . . 0.0 110.756 -177.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -59.61 -24.79 64.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.959 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.91 -39.92 96.0 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.646 1.112 . . . . 0.0 109.074 173.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.88 -49.42 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -54.18 -46.12 72.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.04 -19.44 64.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.813 1.645 . . . . 0.0 114.371 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.2 mmm -59.82 -28.69 67.68 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 120.243 1.383 . . . . 0.0 109.602 168.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.08 -25.89 4.83 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.445 1.021 . . . . 0.0 110.791 175.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -75.38 123.65 88.73 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.73 111.37 1.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.064 1.843 . . . . 0.0 109.273 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.9 -174.46 2.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.435 1.094 . . . . 0.0 108.27 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -169.65 146.21 3.25 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.722 0.692 . . . . 0.0 112.383 -167.073 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.3 t -80.96 130.37 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.15 1.38 . . . . 0.0 109.352 178.147 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -95.86 -55.91 2.84 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 160.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -147.58 78.27 1.46 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.437 0.295 . . . . 0.0 110.262 -172.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.5 tt -85.75 52.5 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 111.186 -178.144 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -161.99 168.58 22.57 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.338 1.455 . . . . 0.0 107.148 173.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.27 -131.01 2.79 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.427 1.013 . . . . 0.0 112.64 -179.173 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 . . . . . 0 C--O 1.249 1.041 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -177.784 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.902 0 N-CA-C 106.615 -2.594 . . . . 0.0 106.615 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -57.49 126.1 25.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.593 1.196 . . . . 0.0 110.464 -177.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 m -120.01 153.75 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 126.343 1.857 . . . . 0.0 108.915 -177.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.7 t -77.05 153.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.045 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.55 HD11 ' CG2' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -138.47 135.83 35.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.374 -1.714 . . . . 0.0 106.374 173.271 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -111.7 135.13 52.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.131 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -143.14 143.14 31.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.599 0.76 . . . . 0.0 110.883 -176.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -75.75 147.42 39.31 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 166.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.28 48.6 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 126.014 1.726 . . . . 0.0 108.725 178.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -58.4 142.96 46.86 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.26 -33.53 4.96 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.0 171.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.7 mtm -57.99 145.25 36.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.29 1.045 . . . . 0.0 109.737 176.46 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -78.57 -164.11 0.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.222 1.009 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.6 p -60.72 -179.69 0.13 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.744 -0.598 . . . . 0.0 111.625 173.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -48.57 72.29 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.25 2.62 . . . . 0.0 115.074 -174.607 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.7 t -162.55 30.15 0.11 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.811 1.244 . . . . 0.0 109.226 -168.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -163.82 -145.93 0.1 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -177.662 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 61.16 -71.49 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 125.776 1.631 . . . . 0.0 111.285 -176.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.3 t -55.07 -41.62 71.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 119.084 0.856 . . . . 0.0 112.361 -166.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.1 m -45.13 -60.1 2.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.431 0.693 . . . . 0.0 112.245 165.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mp -57.72 -48.56 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 124.028 0.931 . . . . 0.0 109.152 178.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -56.97 -62.5 1.7 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.492 1.139 . . . . 0.0 109.445 -174.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.12 -56.02 8.18 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.302 1.429 . . . . 0.0 112.304 173.716 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -61.56 -50.36 72.94 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.871 0.836 . . . . 0.0 110.911 -176.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.41 -34.0 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 124.079 0.952 . . . . 0.0 110.539 177.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.67 -17.56 6.77 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.926 -0.93 . . . . 0.0 114.812 170.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -86.89 -18.08 31.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.793 1.797 . . . . 0.0 110.816 176.147 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.7 141.78 48.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.949 0.881 . . . . 0.0 112.243 -168.657 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -59.13 117.55 4.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.929 0.892 . . . . 0.0 111.04 175.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.79 -24.99 12.27 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.269 173.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.96 142.5 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -108.84 -45.85 3.73 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.134 1.374 . . . . 0.0 109.455 172.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -154.01 162.83 40.91 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.466 -0.771 . . . . 0.0 110.305 177.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.7 tt -145.99 138.03 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 124.505 1.122 . . . . 0.0 109.137 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -130.53 117.88 20.26 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.628 1.971 . . . . 0.0 106.781 172.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.415 HG22 ' CB ' ' A' ' 43' ' ' ALA . 75.1 t -117.24 114.93 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.067 1.303 . . . . 0.0 109.474 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.1 t -90.22 106.54 18.55 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.921 -0.487 . . . . 0.0 109.829 -179.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.544 HD13 ' N ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -48.76 -48.52 40.84 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 164.686 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.544 ' N ' HD13 ' A' ' 38' ' ' LEU . 3.4 m-20 -56.3 -59.55 4.78 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.035 0.534 . . . . 0.0 111.029 -178.316 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -74.6 -21.4 59.49 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.231 1.015 . . . . 0.0 110.723 -170.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 62.63 19.73 11.53 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.181 1.792 . . . . 0.0 110.36 -172.326 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -120.54 156.04 32.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.303 1.841 . . . . 0.0 108.286 175.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -140.47 154.38 46.6 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.463 1.105 . . . . 0.0 109.011 -178.153 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.8 m -125.64 111.55 15.1 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -177.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 78.5 mt -98.99 161.0 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 171.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 p -124.42 121.17 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 162.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.457 ' CE2' HD13 ' A' ' 5' ' ' LEU . 14.1 p90 -157.06 176.41 12.79 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.84 1.656 . . . . 0.0 108.72 -178.017 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.08 150.5 74.44 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 120.735 1.607 . . . . 0.0 113.734 169.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.67 72.3 1.41 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 124.745 3.63 . . . . 0.0 110.145 176.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -143.59 -60.12 0.41 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.302 1.041 . . . . 0.0 108.579 177.097 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.6 mt -88.18 -21.32 24.64 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.656 179.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.59 HD11 ' HB3' ' A' ' 56' ' ' GLU . 10.6 tp -120.86 148.67 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 123.124 0.57 . . . . 0.0 110.053 178.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.1 m -83.33 26.57 0.64 Allowed 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.272 0.5 OUTLIER 71.38 -61.14 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 128.913 2.885 . . . . 0.0 110.063 177.514 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -43.16 71.56 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.492 1.117 . . . . 0.0 108.863 179.374 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HB3' HD11 ' A' ' 52' ' ' ILE . 6.6 mt-10 -44.67 -51.61 9.01 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 123.542 0.526 . . . . 0.0 111.28 -173.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.06 -52.64 5.25 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.225 0.61 . . . . 0.0 111.986 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -46.37 73.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 122.095 -0.378 . . . . 0.0 110.452 178.356 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -59.6 -28.82 67.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -175.136 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -61.31 -46.1 91.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 173.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.9 -48.42 88.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.32 173.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -51.32 -50.89 58.52 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.65 -19.43 49.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.5 1.92 . . . . 0.0 114.678 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.9 mmt -57.7 -32.15 67.09 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 120.106 1.321 . . . . 0.0 109.595 170.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.18 43.27 0.33 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.448 1.023 . . . . 0.0 110.844 173.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -145.11 121.53 6.07 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.78 94.37 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.605 2.203 . . . . 0.0 109.738 -175.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.97 -172.46 2.08 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.362 1.065 . . . . 0.0 108.637 -172.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -166.24 132.35 2.47 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 118.503 0.592 . . . . 0.0 112.381 -175.356 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.55 ' CG2' HD11 ' A' ' 5' ' ' LEU . 9.7 p -83.1 140.6 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 123.172 0.589 . . . . 0.0 110.168 174.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.8 mtpm? -93.73 -122.14 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.284 0.633 . . . . 0.0 110.33 167.417 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -79.37 162.83 25.3 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.244 0.929 . . . . 0.0 111.468 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.6 54.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 125.542 1.537 . . . . 0.0 110.874 -173.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -157.58 167.41 30.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.072 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.55 -84.93 0.27 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.234 0.921 . . . . 0.0 112.087 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 . . . . . 0 C--O 1.249 1.072 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 178.597 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.722 ' N ' ' HB2' ' A' ' 48' ' ' GLN . . . . . . . . 0 C--O 1.224 -0.493 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 60.21 58.0 2.77 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 123.0 1.381 . . . . 0.0 110.901 177.05 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.11 124.52 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 127.055 2.142 . . . . 0.0 107.414 168.338 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.3 t -79.31 138.95 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 C-N-CA 124.442 1.097 . . . . 0.0 108.775 173.306 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.411 HD13 ' C ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -124.34 130.66 52.89 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.465 1.506 . . . . 0.0 107.074 175.002 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -101.21 116.78 33.61 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.615 1.566 . . . . 0.0 108.196 170.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.8 ptp -119.54 135.96 54.55 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.842 0.857 . . . . 0.0 110.339 178.459 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -74.95 153.93 38.35 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 167.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.25 72.85 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 176.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -62.55 166.89 4.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.717 0.77 . . . . 0.0 111.386 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.68 -56.67 4.21 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 174.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.4 mmm -59.27 135.75 57.74 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.475 0.637 . . . . 0.0 109.524 174.037 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -147.47 -28.22 0.36 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -170.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.6 t -117.42 115.8 25.91 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -177.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -40.69 108.95 0.1 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.704 1.601 . . . . 0.0 111.789 -170.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.1 t -165.7 -86.89 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -168.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.4 77.11 0.17 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-O 121.988 0.899 . . . . 0.0 109.322 173.593 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.409 HG22 HD23 ' A' ' 38' ' ' LEU . 19.1 p -135.53 -83.36 0.4 Allowed 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 127.484 2.314 . . . . 0.0 105.237 -178.024 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.7 t -53.58 -41.64 66.78 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -175.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 60.6 m -49.36 -57.6 6.61 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.608 170.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.26 -49.48 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -57.84 -64.22 0.98 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.088 0.947 . . . . 0.0 110.02 -175.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -46.34 -53.69 9.29 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.931 1.729 . . . . 0.0 112.584 174.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -58.3 8.38 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.874 0.837 . . . . 0.0 109.658 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.3 -33.23 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.779 1.231 . . . . 0.0 111.044 -176.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.49 -21.43 13.67 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.329 0.966 . . . . 0.0 114.013 173.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -85.1 -19.71 31.45 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.747 1.773 . . . . 0.0 111.372 176.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.65 137.17 49.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 122.231 1.015 . . . . 0.0 111.932 -166.635 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -52.91 113.4 1.08 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.86 177.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.34 -26.52 8.59 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-O 119.072 -0.849 . . . . 0.0 112.323 175.173 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.2 t -79.57 131.17 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 118.214 1.007 . . . . 0.0 109.18 -176.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -91.54 -55.7 3.4 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.896 0.879 . . . . 0.0 109.185 168.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.35 159.09 43.58 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.535 1.061 . . . . 0.0 109.788 -175.588 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -140.1 140.78 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.403 1.481 . . . . 0.0 110.107 176.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.05 124.51 31.02 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.576 1.55 . . . . 0.0 107.931 168.136 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.9 t -110.13 89.46 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.846 1.203 . . . . 0.0 110.89 177.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -76.88 78.08 3.46 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.686 1.194 . . . . 0.0 110.427 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -45.78 -41.6 11.05 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.483 0.713 . . . . 0.0 111.962 178.744 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.57 -54.38 1.16 Allowed 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 126.453 1.901 . . . . 0.0 111.379 170.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -84.95 -10.54 56.95 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.466 -171.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 61.92 21.0 11.96 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.325 1.45 . . . . 0.0 110.326 -174.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -136.86 144.21 43.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.624 1.57 . . . . 0.0 108.885 -172.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.49 149.56 48.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.932 1.293 . . . . 0.0 108.727 179.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.5 m -120.69 115.28 23.04 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -176.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 86.8 mt -107.32 159.97 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 171.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.72 125.79 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 167.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -155.42 -177.24 6.41 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 126.447 1.899 . . . . 0.0 107.749 -175.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.722 ' HB2' ' N ' ' A' ' 1' ' ' GLY . 1.6 tt0 -138.02 144.5 43.99 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 120.112 1.324 . . . . 0.0 110.559 167.271 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.48 77.28 0.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.071 3.18 . . . . 0.0 110.025 176.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -149.17 -53.44 0.17 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.884 0.873 . . . . 0.0 109.13 174.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -88.19 -25.14 23.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.12 0.568 . . . . 0.0 110.843 176.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.406 HD11 ' HB3' ' A' ' 56' ' ' GLU . 9.8 tp -118.95 147.43 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.012 0.925 . . . . 0.0 109.648 178.76 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.4 m -83.47 24.27 0.85 Allowed 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.256 0.5 OUTLIER 72.61 -59.85 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 127.871 2.468 . . . . 0.0 109.86 179.884 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.31 -35.85 40.5 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.211 1.804 . . . . 0.0 109.78 -175.353 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.406 ' HB3' HD11 ' A' ' 52' ' ' ILE . 5.5 mt-10 -42.22 -53.76 3.95 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 123.538 0.735 . . . . 0.0 111.458 177.447 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.89 -49.04 5.91 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.388 1.075 . . . . 0.0 112.087 -176.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -49.33 38.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.1 -0.375 . . . . 0.0 110.999 174.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -53.98 -30.04 45.44 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -57.29 -52.03 67.0 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.388 0.613 . . . . 0.0 109.525 172.069 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -58.19 -49.91 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.453 173.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -52.98 -48.35 67.52 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.452 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.56 -21.62 60.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.379 1.472 . . . . 0.0 114.036 179.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 29.4 mmt -64.17 -30.02 71.1 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.869 1.213 . . . . 0.0 110.526 172.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.37 -33.11 2.19 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 176.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -73.51 107.51 3.49 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-O 117.776 -1.107 . . . . 0.0 108.732 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.75 118.91 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 108.071 -1.55 . . . . 0.0 108.071 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.08 -167.39 1.54 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.254 0.479 . . . . 0.0 110.404 -174.349 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -160.1 151.09 19.12 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -175.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.45 127.83 58.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 C-N-CA 126.65 1.98 . . . . 0.0 108.834 179.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -93.43 -77.01 0.46 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.502 178.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -115.33 154.74 28.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.59 1.086 . . . . 0.0 110.18 176.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pp -134.29 56.96 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 123.821 0.849 . . . . 0.0 112.906 -179.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -161.01 160.31 30.47 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 164.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.59 -85.21 1.17 Allowed Glycine 0 CA--C 1.521 0.464 0 CA-C-O 119.591 -0.561 . . . . 0.0 114.077 -170.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 . . . . . 0 C--O 1.249 1.04 0 C-N-CA 126.999 2.12 . . . . 0.0 105.421 -157.12 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.757 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 8.71 81.36 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 129.476 3.11 . . . . 0.0 114.547 165.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.5 t -92.35 129.64 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.327 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.85 145.92 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 123.163 0.585 . . . . 0.0 109.984 177.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.66 HD21 HG22 ' A' ' 70' ' ' VAL . 1.4 tm? -141.94 138.38 31.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.548 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -122.1 116.39 24.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.309 1.444 . . . . 0.0 107.684 -173.769 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -121.79 149.9 42.64 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.841 1.256 . . . . 0.0 110.893 -172.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -98.95 132.62 44.13 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.835 1.654 . . . . 0.0 108.129 177.139 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.14 64.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.372 1.069 . . . . 0.0 110.218 -171.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.93 153.18 41.2 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.823 179.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.26 -22.03 14.42 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.037 174.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.3 ttp -67.48 128.38 36.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.985 0.893 . . . . 0.0 109.869 -178.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -77.82 167.07 22.11 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.082 0.953 . . . . 0.0 111.902 -171.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 t -58.72 155.37 12.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.07 0.948 . . . . 0.0 111.714 -177.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -8.84 87.55 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.205 3.002 . . . . 0.0 115.006 -171.466 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 t -165.99 -77.53 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -171.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.7 m -75.62 75.02 2.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.4 p -133.04 -77.52 0.49 Allowed 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 168.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.6 m -54.12 -36.73 63.58 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -170.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 m -52.18 -57.86 8.37 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.103 0.252 . . . . 0.0 111.125 169.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.1 -54.28 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.203 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -57.65 -65.02 0.7 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.631 0.729 . . . . 0.0 110.746 -172.314 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.48 -53.55 12.25 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.726 1.631 . . . . 0.0 111.98 176.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -64.21 -50.62 67.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.112 0.956 . . . . 0.0 110.563 -176.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.6 mm -54.99 -39.2 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 123.406 0.682 . . . . 0.0 110.629 175.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.11 -20.18 13.97 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.016 1.293 . . . . 0.0 113.978 173.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -92.38 -19.42 22.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 118.987 1.393 . . . . 0.0 109.593 178.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.34 134.3 50.07 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.815 1.293 . . . . 0.0 111.816 -176.101 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.57 110.84 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.522 176.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.3 -25.83 7.25 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 119.085 -0.842 . . . . 0.0 112.219 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.24 136.02 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-N 118.382 1.091 . . . . 0.0 109.002 -178.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -107.89 -43.75 4.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.244 1.018 . . . . 0.0 110.736 175.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -155.79 161.14 40.71 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.772 0.715 . . . . 0.0 110.324 177.489 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 tt -141.01 144.68 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.896 1.278 . . . . 0.0 110.421 -176.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.02 98.82 3.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.329 1.852 . . . . 0.0 108.727 172.26 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -92.19 112.24 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.381 1.072 . . . . 0.0 110.042 176.382 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 m -94.98 90.96 6.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.705 1.202 . . . . 0.0 108.877 173.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 38' ' ' LEU . 5.7 mt -57.91 177.44 0.11 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.223 162.654 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.23 -61.3 0.39 Allowed 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 127.88 2.472 . . . . 0.0 109.45 -167.352 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -68.23 -17.75 64.39 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.989 0.423 . . . . 0.0 111.22 -177.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 67.21 41.83 2.45 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 127.332 2.253 . . . . 0.0 110.613 -178.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -144.27 141.93 30.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.827 -166.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.18 150.8 44.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.466 -0.771 . . . . 0.0 109.843 -177.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -130.51 121.52 25.93 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -176.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 mp -126.44 159.87 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 124.744 1.218 . . . . 0.0 108.271 -175.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.3 p -129.39 118.57 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.512 0.725 . . . . 0.0 109.597 178.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -159.19 -178.98 7.59 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.677 1.591 . . . . 0.0 109.864 -172.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -148.06 144.56 19.07 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HB3' HG23 ' A' ' 54' ' ' VAL . 49.7 Cg_endo -67.94 77.85 0.58 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.295 3.33 . . . . 0.0 110.684 175.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.57 -54.45 0.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.941 1.296 . . . . 0.0 107.586 168.218 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.7 mt -94.78 -21.37 18.76 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.843 -0.599 . . . . 0.0 111.91 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 56' ' ' GLU . 11.2 tp -120.87 145.97 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.047 0.939 . . . . 0.0 109.554 -177.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 m -74.0 24.56 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.125 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 49' ' ' PRO . 0.8 OUTLIER 73.28 -58.07 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 127.249 2.22 . . . . 0.0 109.626 -177.885 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -80.93 -42.35 21.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.445 1.498 . . . . 0.0 109.647 -174.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.445 ' HB3' HD11 ' A' ' 52' ' ' ILE . 7.3 mt-10 -41.16 -51.04 3.51 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.882 0.873 . . . . 0.0 111.87 -174.516 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -40.31 -59.91 1.19 Allowed 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.217 1.407 . . . . 0.0 111.464 -178.303 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 tptp -73.93 -43.61 57.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -57.49 -26.91 62.0 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.149 -0.969 . . . . 0.0 112.313 -174.151 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.96 -41.81 88.36 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.031 0.832 . . . . 0.0 109.128 174.102 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -62.83 -33.97 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.179 176.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -61.39 -52.66 63.67 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.48 -31.84 64.43 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.206 1.002 . . . . 0.0 112.716 -174.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.9 mmm -51.27 -36.34 41.69 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.479 0.582 . . . . 0.0 111.43 171.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.29 -36.79 1.45 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.285 0.945 . . . . 0.0 111.281 176.666 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -68.01 115.29 26.93 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.263 -173.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.76 101.49 0.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.428 2.085 . . . . 0.0 108.815 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.09 168.42 19.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -168.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.68 148.5 39.2 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.324 -0.86 . . . . 0.0 112.549 -166.077 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.66 HG22 HD21 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -99.82 144.73 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.662 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -83.11 -85.11 0.12 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.568 0.747 . . . . 0.0 109.719 173.327 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -157.03 147.38 21.2 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.564 ' HB ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -133.86 123.29 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 125.67 1.588 . . . . 0.0 107.488 173.105 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.89 151.42 25.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.226 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.51 105.43 3.15 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -179.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.398 -1.287 . . . . 0.0 109.541 170.58 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -162.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.796 1.238 . . . . 0.0 112.192 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.57 125.42 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 124.76 1.224 . . . . 0.0 108.759 -174.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.5 t -79.6 145.67 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 124.83 1.252 . . . . 0.0 109.801 -178.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.53 HD11 HG22 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -137.54 149.42 46.72 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 126.138 1.775 . . . . 0.0 107.845 176.778 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.76 144.85 31.18 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.276 0.943 . . . . 0.0 111.71 155.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -126.89 153.72 45.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.116 1.766 . . . . 0.0 108.94 175.979 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -114.81 138.94 50.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.325 1.05 . . . . 0.0 108.529 177.224 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.04 68.86 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.857 0.863 . . . . 0.0 110.988 -172.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -68.29 165.96 17.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.103 0.478 . . . . 0.0 110.261 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.41 -34.82 1.55 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 121.604 -0.685 . . . . 0.0 114.063 168.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.9 151.01 7.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.034 0.917 . . . . 0.0 111.477 174.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -69.81 178.07 2.79 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.625 173.218 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.6 t -105.4 145.98 30.07 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.242 1.017 . . . . 0.0 111.147 -175.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.565 ' H ' HD13 ' A' ' 38' ' ' LEU . 1.1 t-160 43.72 53.31 6.07 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.416 2.286 . . . . 0.0 112.712 -177.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.56 18.69 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -171.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' HD11 ' A' ' 38' ' ' LEU . 24.7 p -164.85 56.15 0.13 Allowed 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.142 -0.974 . . . . 0.0 110.41 -167.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.8 p -122.69 -80.36 0.63 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 173.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 m -54.02 -37.13 63.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -168.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.8 m -50.06 -61.31 2.22 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.568 0.542 . . . . 0.0 111.246 168.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.6 -50.81 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.437 ' HA ' HG21 ' A' ' 34' ' ' ILE . 47.7 mt-10 -56.45 -67.59 0.29 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.129 0.966 . . . . 0.0 110.891 -174.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.68 -49.87 26.76 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.097 1.808 . . . . 0.0 112.124 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -62.62 -52.17 64.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.872 0.836 . . . . 0.0 109.62 -178.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.417 HD12 ' CE ' ' A' ' 57' ' ' MET . 18.0 mm -55.57 -36.28 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.183 0.593 . . . . 0.0 111.202 175.362 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.51 -19.13 11.96 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.738 -1.034 . . . . 0.0 113.807 175.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -90.25 -18.98 24.69 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 119.653 1.726 . . . . 0.0 111.16 176.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.12 133.85 47.56 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.659 1.219 . . . . 0.0 112.39 -170.267 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -52.62 106.34 0.15 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.449 176.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.69 -30.74 4.57 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-O 119.475 -0.625 . . . . 0.0 111.917 176.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 t -82.8 140.61 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 117.691 0.745 . . . . 0.0 109.552 -173.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -111.25 -41.87 4.06 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.947 0.899 . . . . 0.0 111.689 174.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.45 159.23 43.4 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.822 -0.549 . . . . 0.0 109.704 -179.433 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 22' ' ' GLU . 9.2 tt -146.59 145.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.59 1.556 . . . . 0.0 107.704 173.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -136.56 109.17 7.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.104 2.161 . . . . 0.0 106.465 173.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -102.44 120.28 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.916 1.235 . . . . 0.0 109.191 175.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 t -105.91 90.48 3.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.169 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.565 HD13 ' H ' ' A' ' 15' ' ' HIS . 1.0 OUTLIER -52.65 -46.13 67.02 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.356 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.59 -56.95 2.42 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.968 1.707 . . . . 0.0 110.755 170.192 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -17.75 60.67 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.032 -175.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 73.12 2.53 4.39 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.837 2.455 . . . . 0.0 112.052 -175.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -111.24 151.57 28.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.406 1.882 . . . . 0.0 109.699 -179.274 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.485 ' HB3' ' SD ' ' A' ' 7' ' ' MET . . . -127.04 160.2 31.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 163.268 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.8 m -119.96 128.03 53.2 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 175.74 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.401 HG21 ' SD ' ' A' ' 57' ' ' MET . 16.0 mt -122.74 162.84 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -135.77 117.88 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.27 0.628 . . . . 0.0 110.277 177.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.28 -179.32 8.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.141 1.376 . . . . 0.0 110.043 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -135.71 149.77 69.97 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.209 1.004 . . . . 0.0 113.05 177.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.09 67.88 7.99 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.374 3.382 . . . . 0.0 109.928 -176.026 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 -55.99 0.26 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.865 0.866 . . . . 0.0 109.223 177.071 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.92 -29.03 35.62 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.048 -0.501 . . . . 0.0 109.811 -177.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 52' ' ' ILE . 10.7 tp -118.93 145.4 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 123.433 0.693 . . . . 0.0 109.403 -178.16 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.9 m -81.67 33.83 0.38 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -174.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER 74.36 -61.68 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 128.065 2.546 . . . . 0.0 108.262 175.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.43 -40.17 23.79 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 124.483 1.113 . . . . 0.0 109.758 -174.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.417 ' HB3' HD11 ' A' ' 52' ' ' ILE . 14.9 mt-10 -40.48 -48.54 2.8 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 123.888 0.743 . . . . 0.0 111.413 -174.465 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.417 ' CE ' HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -34.78 -65.5 0.21 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.862 1.665 . . . . 0.0 110.872 174.385 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -75.98 -41.88 50.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.671 -0.643 . . . . 0.0 112.185 178.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -58.31 -22.29 52.43 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.845 -174.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -62.65 -42.08 99.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.766 0.712 . . . . 0.0 109.351 173.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.75 -49.68 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.102 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -54.45 -44.72 72.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.78 -22.66 62.46 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.82 1.248 . . . . 0.0 114.144 176.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.0 mmt -66.34 -28.62 68.8 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.145 1.338 . . . . 0.0 110.586 170.532 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.21 -42.71 1.28 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -62.31 110.95 3.82 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.901 0.88 . . . . 0.0 110.824 -173.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.99 96.69 0.7 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.54 2.16 . . . . 0.0 109.575 -175.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.74 -161.17 0.75 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.948 0.899 . . . . 0.0 109.51 -174.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -162.56 146.51 11.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.367 0.531 . . . . 0.0 112.179 -177.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.53 HG22 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -112.12 137.21 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.57 1.548 . . . . 0.0 108.531 174.374 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -78.9 -101.12 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.115 0.566 . . . . 0.0 110.456 172.421 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -156.69 149.8 24.06 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -177.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.47 110.27 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.266 1.826 . . . . 0.0 106.831 -175.284 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.35 142.12 16.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.92 71.02 0.03 OUTLIER Glycine 0 C--N 1.341 0.807 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 -176.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.311 0 CA-C-O 117.027 -1.463 . . . . 0.0 109.589 -170.46 . . . . . . . . 1 1 . 1 stop_ save_